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P1231
Acute bacterial conjuctivitis in children
A. Makri, X. Agathokleous, H. Papavasileiou, F. Lykou,
N. Manios, A. Voyatzi (Athens, GR)
Introduction: Acute bacterial conjunctivitis (ABC) is one of the
most commonly ocular diseases in children examined by
pediatricians at the outpatients Department. Since the treatment
is usually empirical and prior cultures are not normally taken,
the virulent factors involved in the process are often unidenti-
ﬁed.
Objectives: 1. To determine the incidence of the isolated
pathogens from conjunctival exudates cultures and 2.To exam-
ine the antibiotic susceptibility for the efﬁcacy of the therapy in
the management of conﬁrmed ABC in children.
Methods: Conjunctival swabs were collected from 780 children,
aged 1 month to 14 years old, who were attended with the
diagnosis of ABC in our Children Hospital, during a 5-years
period (2000–2004). All bacteria were identiﬁed by classical
microbiological methods and the antimicrobial susceptibility
was performed according to NCCLS guidelines.
Results: 453 cultures out of 780 ocular specimens were posit-
ive(58%). A total of 501 bacteria were isolated. The most
frequent isolated bacteria were: Haemophilus inﬂuenzae (37.5%),
Streptococcus pneumoniae (20%), Staphylococcus coagulase negative
(CNS) (15.2%),and Staphylococcus aureus (14.8%) followed by
Streptococcus viridans (4%), various Gram negative bacteria (3%),
Moraxella catarrhalis (2.5%) and Haemophilus spp (1.6%).42
patients developed mixed cultures with two or more types of
bacteria. Among 99 isolates of S. pneumoniae tested, were
resistant for penicillin 14.1% and for gentamicin (Gm) and
tobramycin (Tob) 45.4% and 49.5% respectively. Resistance to
ampicillin was recovered in 9.5% of H. inﬂuenzae, of 66.6% of
S. aureus and in 79.5% of CNS strains. Aminoglycosides showed
higher resistance (Gm 17.9%, Tob 25.6%) against CNS isolates, in
comparison to S. aureus (Gm 12%, Tob 14.6%) and H. inﬂuenzae
strains (Gm 1.6%,Tob 2.6%) respectively. The most isolates were
sensitive to chloramphenicol and ciproﬂoxacin.
Conclusions: 1. The main pathogens causing ABC were
H. inﬂuenzae and S. pneumoniae. 2. Chloramphenicol and ciproﬂ-
oxacin showed favorable in vitro activity against the majority of
pathogens. 3. Resistance rates indicate the need for continuous
surveillance and for motoring studies.
P1232
Pertussis of adults and infants in Bulgarian
population: role of PCR diagnosis
S. Panaiotov, V. Levterova, I. Ivanov, T. Kantardjiev,
N. Vladimirova, V. Voinova, E. Kazarova (Soﬁa, BG)
Pertussis continues to be an important vaccine preventable
disease. There is a long lasting tradition in Bulgaria in pertussis
prevention. More than 40 years a whole-cell pertussis vaccine is
administered to infants and a high vaccine coverage is achieved
and maintained. Pertussis morbidity decreased dramatically but
pertussis continues to occur among different ages. Making a
speciﬁc diagnosis of pertussis in patients with clinical evidence
of infection is one of the many challenges presented by Bordetella
pertussis. For more than 20 years, pertussis diagnosis in Bulgaria
routinely is done using two classic lab methods: the direct
ﬂuorescent antibody test and the pertussis-agglutinating anti-
body test. Recently ELISA method is introduced too but only for
research purposes.
Objectives: 1. To describe the PCR diagnosis of B. pertussis in
our country and to present ﬁrst results of this assay in pertussis
suspect patients
2. To compare results between PCR diagnosis and direct
ﬂuorescent antibody test in the same patients.
3. To assess the role of Mycoplasma pneumoniae and Chlamidia
pneumoniae as causatives of infants’ respiratory infections mis-
diagnosed by the general practitioners as pertussis infection.
Results: 334 nasopharyngeal swabs were collected from infants
with pertussis symptoms and contact adults. All samples were
tested by PCR. PCR was performed for insertion element IS481
of B. pertussis. 69 samples out of them were found positive for B.
pertussis by PCR. Two were positive for M. pneumoniae by
PCR.100 samples were tested comparatively by two methods
:PCR and direct ﬂuorescent antibody test. Vaccination status of
patients and clinical data were analysed too.
Conclusions: First results of B. pertussis PCR assay are
presented. Pertussis continues to circulate in Bulgaria even the
achieved high vaccine coverage of infants and children. PCR is
rapid and simpliﬁes the laboratory diagnosis of pertussis.
Further serological, immunoﬂuorescence or culture comparative
studies are needed with the aim to better evaluate the role of
PCR diagnosis.
P1233
Molecular epidemiology of respiratory syncytial
virus infection in a university hospital in Kuala
Lumpur, Malaysia
Z. Sekawi, G. Vinomarlini, N.S. Mariana, D.S. Shamala,
K. Thilakavathy (Kuala Lumpur, MYS)
Respiratory syncytial virus (RSV) is an important cause of acute
lower respiratory infections in babies and young children
worldwide. There are two major distinct RSV groups, RSV
Group A and RSV Group B. To add to its complexity, additional
genetic variability occurs within the groups. RSV infection is
endemic in Malaysia with peak pattern reported to be related to
the rainy season which is usually at the end of the year.
However, the molecular epidemiology of RSV in Malaysia is
unknown.
Objective: To determine the molecular epidemiology of RSV
infection in a University Hospital, Kuala Lumpur, Malaysia.
Method: Paediatric patients who were hospitalized with acute
lower respiratory infections from September 2002 to March 2004
were screened for RSV infection. Nasopharyngeal aspirate
(NPA) samples were collected and subjected to direct immuno-
ﬂuorescence (DIF) assay and isolation by tissue culture. The total
viral RNA was extracted and subjected to reverse transcriptase –
polymerase chain reaction (RT-PCR). Seminested PCR was done
Method
Age-group
0–3
Age-group
3–14
Age-group
>14 years Total
PCR positive 34 30 5 69
PCR negative 118 110 47 275
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by using speciﬁc primers for each RSV group. Random Ampli-
ﬁcation of Polymorphic DNA (RAPD) technique was performed
as a simple method to observe the genetic diversity of the
isolated RSV.
Results: Thirty NPA samples were positive for RSV using the
DIF assay but only 20 samples were positive by tissue culture.
The peak months are from the months of October to January for
both years. Seminested PCR on RSV isolates revealed 17 cases of
RSV Group A while the remaining three cases, RSV Group B.
RAPD result suggested that there may be ﬁve main subgroups
during the study period.
Conclusion: This study conﬁrmed RSV Group A as the more
dominant group and may be more virulent in the Malaysian
context. This is similar to most studies in other parts of the
world. Intragroup variation occurs throughout the duration of
the study. This variation may have a considerable effect of the
efﬁciency of transmission and virulence. Restriction analysis
study will be done in order to compare the isolates objectively
with other studies. These ﬁndings can be used as part of the
globally initiative towards vaccine development.
P1234
Respiratory syncytial virus infections in Croatia,
1994–99
A. Lukic-Grlic, G. Mlinaric-Galinovic, V. Drazenovic, A. Barisin,
A. Bace, V. Hresic-Krsulovic, R. Sim, B. Berberovic,
E. Berberovic (Zagreb, HR)
Objective: To determine epidemiological characteristics, i.e. the
occurrence of respiratory syncytial virus (RSV) infection in
Croatian children with acute respiratory tract infections.
Methods: At Virology Department, Croatian National Institute
of Public Health (CNIPH), we tested nasopharyngeal secretions
obtained from 1232 patients most of whom were hospitalized in
two Zagreb hospitals for acute respiratory infections. Demon-
stration of the virus was by isolating it in cell culture and/or by
detecting it with monoclonal antibodies in the direct immuno-
ﬂuorescence assay.
Results: Most often, the virus demonstrated was RSV (43.8%;
540/1232). Other respiratory viruses (adeno, parainﬂuenza,
inﬂuenza) were shown considerably less commonly (5.1%).
Viral infection could not be demonstrated in 629 (51.1%)
patients. As to bronchiolitis, RSV was demonstrated to be its
most common cause (60.77%; 251/413). It was also proven to be
the most common causative agent of infections in children aged
0–6 months (55.6%; 300/540). Bronchiolitis (63%; 190/300) and,
less commonly, pneumonia (9.7%; 29/300) were the diagnoses
linked with RSV in this age group. On the other hand, RSV was
demonstrated in 21% (63/300) of the children diagnosed with
upper respiratory tract infection (URTI). We showed the
presence of the majority of RSV infections in winter months,
i.e. between November and June.
Conclusion: RSV is a common cause of lower respiratory tract
infections in Croatian infants and young children with its annual
outbreaks occurring in winter season. Their onset is mostly in
November.
P1235
Human metapneumovirus infection among
children hospitalised with acute respiratory
illness in Taiwan
C.Y. Lin, J.S. Lin (Changhua, TW)
Objectives: To understand the association of human metapneu-
movirus (hMPV) with acute respiratory infection (RI) among
hospitalized children in Taiwan, we conducted this study.
Methods: From February to August 2004, consecutive nasopha-
ryngeal aspirates (NPAs) collected from children hospitalized
with acute RI and submitted to a virology laboratory for rapid
detection of respiratory syncytial virus (RSV) antigens were
retrospectively analysed for hMPV. After extraction of nucleic
acids from these frozen NPAs, RSV was ﬁrst detected by
amplifying RSV-speciﬁc fusion (F) and nucleocapsid (N) genes,
respectively, using reverse transcription-polymerase chain reac-
tion (RT-PCR). The same extracts were subsequently detected
for hMPV by amplifying hMPV-speciﬁc F and N genes,
respectively, using nested RT-PCR. If multiple samples during
the same course of illness were submitted, either one of the
virus-positive samples (ﬁrst choice) or one of the virus-negative
samples (second choice) was included for analysis to decrease a
statistical bias.
Results: 667 NPAs collected from 623 hospitalized children
with acute RI were examined, however, only 580 NPAs of them
had been successfully detected for both RSV and hMPV by
RT-PCR. The age of patients ranged from 0 to 9 years. A positive
rate of RSV or hMPV in NPAs was 39.1% (n = 227) and 8.6
(n = 50) respectively. In 353 NPAs negative for RSV, hMPV was
found in 13.3% (n = 47) of samples. Only 2 NPAs (0.3%) were
positive for both viruses. The infection rates of hMPV were
signiﬁcantly related to the month of recruitment (p = 0.001,
Pearson Chi-squared test), with peak rates of 17.0% and 16.9% in
May and June, respectively. According to the clinical diagnosis,
486 samples (83.8%) with pneumonia, bronchiolitis, bronchitis
or brochopneumonia were arbitrarily deﬁned to have a lower RI,
otherwise, upper RI was recognized (16.2%, n = 94). Among
NPAs negative for RSV, lower RI was signiﬁcantly associated
with hMPV when compared with upper RI (p = 0.034, Fisher’s
exact test).
Conclusions: This preliminary study discloses that hMPV plays
a role in Taiwanese children with acute RI with a comparable
rate of infection as reported in western countries. hMPV
infection in children may have seasonal preference as shown
in this study, though a longer period of evaluation remains
necessary. The rare co-infection of RSV and hMPV in children
with acute RI implies the importance of hMPV detection
especially in NPAs negative for RSV.
P1236
Acute CMV infection in paediatric population
P. Koudounis, M. Pagkalou, G. Triantaﬁllou, P. Rozi (Serres, GR)
Objectives: The aim of this study is the laboratory conﬁrmation
of acute CMV infection in children who have been hospitalized
or have attended the Outpatient’s Department with signs and
symptoms that suggest recent CMV infection.
Methods: Blood samples were taken from 66 children (40 boys
and 26 girls), aged 9 months to 13 years, with symptoms
suggesting recent CMV infection, from July 2002 to December
2003. They were tested for detection of CMV antibodies (IgM
and IgG) by Microparticle Enzyme Immunoassay (AXSYM,
ABBOTT) Enzyme linked Fluorescent Assay was used as a
method of conﬁrmation of the IgM positive tests. Also, the test of
IgG-avidity was used as a supplementary means for the
exclusion of a recent primary infection of less than 3 months
(Vidas, bioMerieux).
Results: Out of the total of 66 children examined, the 17 (group
I) were found to be positive both for IgM and IgG antibodies, 3
(group II) were found to be positive only for IgM antibodies and
24 (group III) were found to be positive only for IgG antibodies.
22 children haven’t been exposed to the disease (IgM-/IgG-). In
group I children, with the use of the CMV-avidity test, the acute
infection was excluded in 8 out of 17 children, a fact that was
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also conﬁrmed with the second antibody detection test. In group
II, 2 in 3 children were excluded in the same way, while in the
other child acute infection was conﬁrmed in the tests of
conﬁrmation. In group III, old infection was found with the
CMV avidity test.
Conclusion: Those results give us indicative information about
the incidence of CMV infections in our hospital in the chrono-
logical period that is referred above. This study showed that the
use of conﬁrmation tests are necessary in several cases, especi-
ally those with unclear clinical and laboratory ﬁndings.
P1237
The patterns of nasopharyngeal microﬂora in
pre-school children with recurrent respiratory
tract infections
U. Kosikowska, I. Korona-Glowniak, R. Los, A. Biernasiuk,
A. Malm (Lublin, PL)
Objectives: Respiratory tract infections, predominantly of viral
etiology, are the most common, community-acquired infections
in young children. Some of them are complicated by bacterial
infections usually of endogenous origin. The mucous mem-
branes of nasopharynx are known to be the important reservoir
of some opportunistic or potentially pathogenic bacteria. The
aim of the present study was to compare the nasopharyngeal
microﬂora in two groups of pre-school children – without or
with the recurrent respiratory tract infections.
Methods: Nasal and throat specimens were obtained from 225
children aged 3–5 years. The cotton swabs were immediately
placed onto appropriate nonselective (blood agar) or selective
media (Haemophilus chocolate agar, Chapman agar, McConkey
agar or Sabouraud agar). Plates were incubated in an appropri-
ate atmosphere – with or without increased CO2 concentration)
for 18–48 hrs at 35C. The isolated microorganisms were
identiﬁed on the basis of routinely methods (macroscopic,
microscopic or biochemical assays) or by rapid commercial latex
tests – Slidex Staph-Kit and Slidex Pneumo-Kit (bioMerieux).
Results: The prevalence of potentially pathogenic bacteria
typical for nasopharynx such as Staphylococcus aureus, Strepto-
coccus pneumoniae, Moraxella catarrhalis or Haemophilus inﬂuenzae
and also of yeast-like fungi (Candida sp., mostly C. albicans) was
similar in both groups of children. However, in nasopharynx of
children with the recurrent respiratory tract infections several
opportunistic bacteria belonging to Enterobacteriaceae (Escheri-
chia coli, Citrobacter freundii) or non-fermentative rods (Pseudo-
monas putida, Agrobacterium radiobacter, Acinetobacter lwofﬁi) were
found. Also other bacteria such as slime-producing Bacillus sp.
or streptomycetes were isolated from this group of children.
Conclusion: The obtained data suggest that young childrenwith
the recurrent respiratory tract infections are predisposed for
nasopharynx colonization by several opportunistic bacterial
species of Gram-negative rods or even by some unusual micro-
organisms, e.g. slime-producing Bacillus sp. or streptomycetes.
P1238
Correlation of S. pneumoniae and H. inﬂuenzae
antimicrobial resistance and history of
antimicrobial use or vaccination in children with
upper respiratory tract infections – Brazil 2002 to
2004
C.M. Mendes, C. Oplustil, J.L. Sampaio, P. Garbes, P. Lima, L.
Pedneault, C.R. Kiffer (Sao Paulo, Rio de Janeiro, BR; Brussels, B)
Objective: Establish a correlation between antimicrobial resist-
ance in S. pneumoniae and H. inﬂuenzae, isolated from children
with upper respiratory tract infection (URTI) in Sa˜o Paulo,
Brazil, and their history of antimicrobial use and/or vaccination.
Methods: Samples (one per patient) were selected from patients
under 7 years old between 2002 and 2004. All subjects were
diagnosed with URTI and had a positive culture result for at
least one of the selected pathogens (S. pneumoniae and
H. inﬂuenzae). Clinical data related to age, gender, diagnosis
and samples are described. S. pneumoniae isolates were tested
against penicillin and another ﬁve antimicrobials for minimum
inhibitory concentrations (MICs) by E-test methodology. Inter-
pretative criteria used were those described by NCCLS docu-
ment M100-S14. H. inﬂuenzae isolates were tested for beta-
lactamase production by a chromogenic cephalosporin method.
Logistic regression was performed to investigate the correlation
between S. pneumoniae (intermediate and high) penicillin resist-
ance and previous antimicrobial use and pneumococcal vaccin-
ation. The same procedure was done for beta-lactamase-positive
H. inﬂuenzae and previous antimicrobial use and vaccination
against H. inﬂuenzae type b (Hib).
Results: Of patients with S. pneumoniae isolation, 62 had
information on previous antibiotic use and 53 on pneumococcal
vaccination. Of patients with H. inﬂuenzae isolation, 121 had
information on previous antibiotic use and 101 on vaccination to
H. inﬂuenzae. There was no correlation between presence of
penicillin-resistant S. pneumoniae and previous antibiotic use
(p = 0.16; OR = 2.28; IC95% = 0.73–7.16) or vaccination against
pneumococci (p = 0.61; OR = 0.72; IC95% = 0.20–2.54). Simi-
larly, no correlation was found between presence of beta-
lactamase-producing H. inﬂuenzae and previous antibiotic use
(p = 0.71; OR = 0.78; IC95% = 0.21–2.96) or Hib vaccination
(p = 0.78; OR = 0.72; IC95% = 0.08–6.72).
Conclusions: No correlation was found between antibiotic use
and respective vaccinations against S. pneumoniae and Hib and
their related resistance characteristics, penicillin resistance and
beta-lactamase production respectively. However, among poss-
ible bias inﬂuencing the results, vaccination against both
pathogens is still low in the study population and it was not
possible to compare resistance and previous antimicrobial use
by drug class.
P1239
Staphylococcus aureus small colony variants in
patients with cystic ﬁbrosis in Franfurt/Main,
Germany
S. Besier, A. Ludwig, C. von Mallinckrodt, H.-G. Posselt,
T.A. Wichelhaus (Frankfurt/ Main, D)
Objectives: In spite of intense and modern antibiotic treatment,
mortality and morbidity of patients with cystic ﬁbrosis (CF) are
dominated by chronic bronchopulmonary infections. Staphylo-
coccus aureus is one of the most important pathogens isolated
from the chronically infected airways of CF patients. Interest-
ingly, the persistence of S. aureus in the bronchial system is
associated with the isolation of a subpopulation of S. aureus – the
small colony variants (SCVs). In contrast to normal S. aureus,
SCVs are often affected in their electron transport activity or
thymidine synthesis, thus growing as nonhemolytic, nonpig-
mented small colonies exhibiting auxotrophism for distinct
growth factors.
Methods: Sputa and deep throat swabs of CF patients attending
the ambulance of the university hospital in Frankfurt/Main,
Germany, between January 2004 and May 2004 were screened
for the prevalence of S. aureus SCVs.
Results: Of 113 patients, 34 (30.1%) harboured S. aureus in their
respiratory specimens. Of these 34, 23 (67.6%) had normal
S. aureus (NCVs) and 11 (32.4%) had NCVs plus SCVs or SCVs
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alone. The median age of patients with SCVs differed distinctly
from the median age of patients with only NCVs [28.6 years
(range, 2–45) vs. 19 years (range, 1–39)]. Persistence of the SCVs
could be demonstrated for all SCV-positive patients with
subsequent microbiological investigation during the study
period. An antibiotic prophylaxis with trimethoprim-sulfameth-
oxazol could be elicited for 7 (63.6%) of the 11 SCV-positive
patients. All SCV isolates were resistant to trimethoprim-
sulfamethoxazol and high resistance rates were also documen-
ted for ciproﬂoxacin (53.8%) and gentamicin (46.2%). Analysis
of the underlying auxotrophism revealed a predominance of
thymidine dependence in 69.2% of the SCV isolates. Most of the
SCVs showed the known fried-egg or pinpoint morphology,
while 4 strains exhibited a mucous phenotype not previously
observed.
Conclusions: The presented data show that S. aureus SCVs can
be isolated frequently and repeatedly from the airways of CF
patients. Further investigations are required to illuminate the
genetic background and pathogenic role of this S. aureus
phenotype in persistent infections.
P1240
Epidemiological features of Stenotrophomonas
maltophilia isolation from the sputum of children
with cystic ﬁbrosis
H. Alexandrou-Athanasoulis, S. Doudounakis, A. Sergounioti,
I. Loucou, A. Pangalis (Athens, GR)
Stenotrophomonas maltophilia (Sm) has been isolated from the
airway secretions of children with Cystic Fibrosis (CF) with
increasing prevalence last years. The aim of our study is to
determine trends in prevalence and in resistance to the 1st
choice antibiotics for these patients.
Material and method: We reviewed retrospectively the clinical,
demographic and laboratory data of the 388 patients who have
been attended our hospital, between 01/2000 and 11/2004 for at
least one year. During this period 5010 sputum or deep throat
specimens were cultured. The identiﬁcation of the isolates was
made by the API 20NE identiﬁcation system (Biomerieux,
France) and the antibiotic resistance was determined with the
E-test strips (AB Biodisk, Sweden).
Results: (1) Sm has been harboured by 62 (16.0 %) of our
patients (38 were female and 24 male). Chronically infected
remained 11.3 % of them, while 59.7 % had only one positive
culture for Sm. (2) The mean age of the 1st isolation of Sm was
8.3 ± 4.9 years. (3) The yearly incidence rate of Sm acquisition
and the yearly prevalence were 2.8–3.6% and 4.7–9.2% respect-
ively. (4) The sensitivity to ticarcillin/clavulanic acid as well as
to co-trimoxazole were 59.3% and 62.6% respectively.
Conclusions: (1)Yearly prevalence and incidence rates for Sm
in CF patients showed no trends. (2)the resistance to ticarcillin/
clavulanic acid is gradually increasing.
P1241
Subclonal variation of a cystic ﬁbrosis epidemic
strain of Pseudomonas aeruginosa
S. Panagea, J.E. Corkill, C. Winstanley, A.C. Hart (Liverpool, UK)
Objectives: A highly transmissible, epidemic strain of Pseudo-
monas aeruginosa is widespread among cystic ﬁbrosis patients
attending clinics in Liverpool, United Kingdom. We studied the
emergence of clonal variants of this Liverpool Epidemic strain
(LES) over time in chronically infected patients.
Methods: Forty LES isolates from seven patients were typed by
macrorestriction analysis of SpeI and XbaI-digested DNA by
pulsed ﬁeld gel electrophoresis (PFGE). A total of 4 to 8 isolates
from each patient were studied, collected at three different times
during their colonisation (1995–2003). Macrorestriction fragment
patterns were compared with the ﬁrst LES in our collection
isolated in 1988 and clonal variants had 1 to 3 band differences
from this control strain. All isolates were tested positive with a
PCR assay speciﬁc for LES.
Results: PFGE analysis of SpeI and XbaI digests revealed 9 and
7 clonal variants of LES respectively. There was overall good
correlation between SpeI and XbaI fragment patterns, however
digestion with SpeI was more discriminatory in this study. All
patients had clonal variants of LES (range 2–4). The variant with
identical fragment pattern to the 1988 isolate was the most
common and was isolated from all but one patient at least once.
Two other variants were also common and were detected in
three or more patients. Emergence of clonal variants in individ-
ual patients appeared to occur at random and did not persist
throughout the study period in most of them. There was no
correlation between clonal variants and phenotype or antibiotic
sensitivity pattern of the isolates.
Conclusion: Clonal variants of LES are common and were
detected in all the patients. This study conﬁrms that genomic
diversity and evolution of a clonal lineage as indicated by subtle
band shifts of the macrorestriction fragment pattern is common
in chronically infected cystic ﬁbrosis patients.
P1242
In vitro effect of subMICs of antibiotics on the
antigenic structure of Pseudomonas aeruginosa
strains isolated from patients with cystic ﬁbrosis
J. Vranes, B. Bedenic, D. Tjesic-Drinkovic,
N. Jarza-Davila (Zagreb, HR)
Objectives: Pseudomonas aeruginosa is the leading pathogen
responsible for morbidity and mortality in patients with cystic
ﬁbrosis (CF), and is the primary reason for the reduced survival
age. Different molecules are responsible for P. aeruginosa
virulence, including lipopolysaccharide (LPS) as a cellular
component. Suppression or modulation of P. aeruginosa viru-
lence factors may be an alternative strategy for treatment of lung
infections in CF. The aim of this study was to examine the
inﬂuence of subminimal inhibitory concentrations (subMICs) of
ceftazidime and ciproﬂoxacin on the LPS structure of P. aerugi-
nosa strains isolated from patients with CF.
Methods: A total of 20 strains isolated from sputa of patients
with CF were used. Serotyping based on the detection of heat
stable LPS bacterial surface antigens (O-antigens) was per-
formed as slide agglutination tests using O-speciﬁc polyclonal
sera and a suspension of live bacterial isolate to be examined,
according to the International Antigenic Typing System. Sero-
typing was performed before and after exposure of strains to 1/
2, 1/4, 1/8, 1/16, and 1/32 MIC of antibiotics.
Results: The slide agglutination test with polyclonal diagnostic
sera showed that only nine strains were typable, while six
strains were polyagglutinable, three strains were non-typable,
and two strains were auto-agglutinable. After the exposure of
strains in exponential phase of their growth to subMICs of
antibiotics, a signiﬁcant difference in typeability of the strains
were observed. Treatment with subMICs of ceftazidime and
ciproﬂoxacin resulted in the alteration of polysaccharide struc-
ture of typable strains. Out of nine monoagglutinable strains,
seven strains have become auto-agglutinable after exposure to
1/2, 1/4, 1/8 and 1/16 MIC of ceftazidime, while two strains
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have become polyagglutinable, suggesting the loss of most of
the O-antigenic determinants of the LPS. The polyagglutinability
was observed more frequently after exposure of those strains to
1/2, 1/4 and 1/8 MIC of ciproﬂoxacin (ﬁve out of nine strains).
The non-typable strains have become auto-agglutinable or
polyagglutinable, depending on the concentration of antibiotic.
Conclusion: The results of this study have shown that the
antigenic structure of P. aeruginosa strains isolated from sputa of
patients with CF was signiﬁcantly changed after in vitro
exposure to subMICs of ceftazidime and ciproﬂoxacin, due to
the loss of O-antigenic determinants.
P1243
Dynamics of antibody response to
Pneumocystis jirovecii in patients with cystic
ﬁbrosis
N. Respaldiza, J. Dapena, M. Montes-Cano, C. de la Horra,
I. Mateos, V. Friaza, I. Wichmann, J.M. Varela, E. Calderon,
F.J. Medrano (Seville, E)
Objectives: The asymptomatic colonisation by Pneumocystis
jirovecii (Pc) has been recently demonstrated in immunocompe-
tent patients, mainly in subjects with different pulmonary
diseases. Cross-sectional studies have shown that healthy
adults have frequently serum antibodies to Pneumocystis, and
the primary contact usually occurs at an early age. However, the
dynamic of the humoral immune response against this pathogen
still remains unknown. The objective of this study was to
evaluate the dynamic of antibody response to P. jirovecii in
patients with cystic ﬁbrosis (CF).
Methods: (1) Population: Cohort study in which were included
a total of 75 consecutive patients with CF, attended in a
specialized unit between May 2001 and July 2002. Patients were
followed every six months during one year. At each visit
respiratory and serum samples were collected for Pc evaluation.
(2)Methods: Nested PCR was performed in respiratory samples
to detect the presence of Pc colonization. Serum specimens were
assayed for total IgA/IgM/IgG antibodies to Pneumocystis
antigens by western blot (WB). A commercial monoclonal
antibody (MoAb) to a human Pc component (DAKO, Glostrup,
Denmark) was used as a positive control. The presence of an
immunoreactive band of 120 kDa (molecular weight of MoAb)
was interpreted as a positive result.
Results: The mean age of the CF patients was 16.4 ± 6.7 years
(range: 1–35), 31 (41%) of whom were male. Pc carriage was
found in 14/75 (18.7%) of the CF patients at baseline. During the
follow-up Pc colonisation was observed in 36 (48%) of the 61
initially PCR-negative subjects. WB was positive at baseline in
37/75 (49%) of the patients with CF. During the follow-up
serologic dynamic was as follows: among the 37 initially WB-
positive subjects 32 (86%) remained positive, but in 5 (14%) cases
a seroreversion was observed (WB became negative); among the
38 initially WB-negative subjects a seroconversion was observed
in 20 (53%) cases and the remaining 18 (47%) were persistently
negative.
Conclusions: There is a high rate of Pneumocystis exposition in
patients with cystic ﬁbrosis. Contrary to previous belief, our
results show for the ﬁrst time that serologic response to
P. jirovecii is not permanent, and that the presence of speciﬁc
antibodies could be a result of repeated exposure to the
pathogen. This study was supported by the Grants FIS
03/1743 and Consejerı´a de Salud 32/02 and by Thematic
Network for Joint Research (G03/90.
P1244
Nosocomial infections in paediatric patients
M. Renko, S. Kinnula, M. Uhari (Oulu, FIN)
Background and aim: We evaluated the incidence of nosoco-
mial infections occurring within 14 days after care at the
paediatric infection ward of Oulu University Hospital between
VI/2001 and V/2003.
Methods: At discharge from the hospital data on clinical
diagnosis, aetiology of the infection, number of patients in the
same room and whether or not the child got a nosocomial
infection during the hospital stay were registered. Two weeks
after the child was discharged the parents ﬁlled in a question-
naire concerning whether the child became ill after the dis-
charge.
Results: We have data from 1922 patients. Most of the patients
(90%) were treated in a single patient room. The most common
diagnoses were obstructive bronchitis in 437 (23%) and gastro-
enteritis in 566 (29%) cases. Twenty-three out of 1922 (1.3%) got
a nosocomial infection during their stay at the ward, most of
them gastroenteritis. Parents of 1136 patients (59%) returned the
questionnaires. 313 children out of 1136 (28%) were taken ill
after discharge, 88 (8%) of these within 72 hours. Cough was the
most common symptom on those taken ill 4–14 days after
discharge (53%), and diarrhoea on those taken ill within the ﬁrst
72 hours (49%) (Figure). The children who got nosocomial
infections were younger than the other patients (mean 2.3 years,
vs. others 3.0, P = 0.03) and the duration of the hospital care was
longer in them (mean 3.6 vs 2.9 days, P = 0.005).
Conclusions: Due to the short hospital care only a few children
were reported to get a nosocomial infection during their stay.
Yet, 8% of the children discharged from the ward were taken ill
within 72 hours. Viruses causing gastroenteritis seem to be more
difﬁcult to prevent from spreading than respiratory viruses.
P1245
Procalcitonin controlled administration of IgM-
enriched immunoglobulins in early post-op can
prevent postoperative infectious complications in
high-risk children with congenital heart diseases
N.V. Beloborodova, D.A. Popov, A.I. Melko (Moscow, RUS)
Objectives: To estimate the effectiveness of procalcitonin (PCT)
controlled administration of IgM-enriched immunoglobulins in
high-risk children with congenital heart diseases after cardiac
surgery with cardiopulmonary bypass (CPB).
Methods: Thirty-one consecutive patients (mean age
25 ± 8 months) were studied. Patients who had PCT blood
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plasma levels above 2 ng/ml on the 1st day after surgery
(n = 28) were randomized into two groups. IgM-enriched
immunoglobulin preparation (Pentaglobin, Biotest Pharma
GmbH, Germany) was administrated to the patients in the
study group (n = 15) in addition to standard treatment
(1–3 days after surgery, 5 ml/kg each day). Patients in the
control group (n = 13) received only standard treatment.
Patients in both groups were comparable by severity of initial
condition, age and CPB time. PCT blood plasma concentrations
were measured on the 1st, 2nd, 3rd and 6th days after surgery
by immunoluminometric method (PCT LIA, B.R.A.H.M.S Akti-
engesellschaft GmbH, Germany). Post-op infections rates were
analysed in these groups. The data were compared by Mann–
Whitney U-test and p-value of (0.05 was considered statistically
signiﬁcant.
Results: None of the patients had exhibited any signs of
infection before surgery. Patients with PCT blood plasma
levels less than 2 ng/ml on the 1st day after surgery (n = 3)
had smooth post-op period. The rate of post-op infectious
complications was signiﬁcantly lower in the study group (1/15
(6.7%) vs. 5/13 (38.5%), p = 0.03). Two deaths in the control
group occurred due to sepsis and (n = 1) and peritonitis (n = 1).
Postoperative PCT levels were signiﬁcantly higher in the control
group during all observation period (see the table). The data are
expressed as median (ng/ml) and 25th and 75th percentiles.
Conclusions: High PCT levels on the 1st day after surgery are
associated with infectious complications. PCT monitoring
allows to select patients with systemic bacterial inﬂammation
after CPB. Early post-op administration of IgM-enriched immu-
noglobulins effectively prevents infectious complications in
these patients after cardiac surgery.
P1246
Clinical characteristics of rotavirus, enteric
adenovirus and astrovirus infections among
hospitalised children in Hungary
F. Jakab, L. Varga, Z. Nyul, D. Mitchell, J. Walter, T. Berke,
D. Matson, G. Szucs (Pecs, HUN; Norfolk, USA)
Objectives: The aim of this study was to determine the
prevalence, severity and clinical characteristics of viral gastro-
enteritis caused by astrovirus (HAstV), rotavirus (RV) or enteric
adenovirus (EAd) resulting in hospitalization among children in
Baranya County, Hungary.
Methods: Stool specimens were collected between May 2003
and May 2004 from children hospitalized for gastroenteritis.
Samples were tested for HAstV, RV, and EAd. HAstVs were
detected by reverse transcriptase-polymerase chain reaction
while RV and EAd were identiﬁed by latex agglutination test.
Demographic and clinical data were collected for all enrolled
children. Clinical symptoms and severity of illness were deter-
mined.
Results: During this 1-year period, 227 children hospitalized for
acute gastroenteritis were enrolled. The mean age was
37 months (range: 21 days to 213 months). HAstV, RV or EAd
were detected in 51% of enrolled children. RV was detected in 94
(41%), EAd in 13 (6%) and HAstV in 12 (5%) from the collected
stool samples. The most common clinical presentation of RV
infected children were the combination of diarrhoea, vomiting
and fever (34%), while in children with HAstV or EAd infection
diarrhoea alone was more characteristic (50% and 62%, respect-
ively). Children infected with either virus had diarrhoea lasting
1–4 days with 1–3 episodes per day, vomiting episodes lasted 1–
2 days and fever ‡38.0C. Based on the 20-point Vesikari
severity score system; 58% of RV infected children had moderate
or severe infection (score: ‡8) while 77% of children with EAd or
67% with HAstV had rather mild disease (score: £ 7); (p < 0.05).
Conclusion: Clinical presentations of gastroenteritis by RV,
HAstV or EAd are similar with diarrhoea the most common
manifestation followed by vomiting and/or fever. RV infected
patients had a more severe illness than those children infected
with EAd or HAstV. Based on the epidemiological and clinical
data we can conclude that these enteric viruses are a signiﬁcant
burden of disease based upon hospitalizations for childhood
gastroenteritis in Baranya County, Hungary.
P1247
Investigation of the modulatory effect of pre- and
probiotics on the gastrointestinal ﬂora in post
surgical neonates
N. Mackay, C. Lucas, G. Mackay, C. Davies,
C. Wiliams (Glasgow, UK)
Background: The neonatal gut normally becomes colonised
with a variety of bacterial species. However, surgical interven-
tion, nutritional deprivation and antibiotic therapy devastate the
normal gastro-intestinal (GI) ecosystem and may contribute to
the risk of bacterial translocation (BT). Intervention using
probiotic bacteria or prebiotic carbohydrates has been proposed
to reduce this problem but few studies have looked at the ability
of probiotic bacteria to colonise the abnormal gut.
Objectives: To demonstrate the persistence of probiotic bacteria
demonstrate a biological effect using short chain fatty acid
proﬁles.
Methods: Conventional culture of stools and stoma ﬂuid was
performed on 5% Horse blood, neomycin blood agar and
MacConkey agar Extended culture was performed using Rogosa
agar for Lactobacillus spp. and Beeren’s Agar for Biﬁdobacterium
spp. Short Chain Fatty Acid (SCFA) Analysis was performed by
Gas Liquid Chromatography Chromatography and Isolates of
lactobacilli were genotyped using. Random Ampliﬁcation of
Polymorphic DNA (RAPD) using primer 272 a eubacterial
primer followed by gel electrophoresis.
Results: Routine bacterial culture on 320 specimens yielded
Coagulase Negative Staphylococci (CNS), Enterococci and coli-
forms with Gram positive bacilli being isolated from only 7
specimens. On extended culture of 170 specimens Gram positive
bacilli were isolated on 39 occasions. Short Chain Fatty Acid
(SCFA) analysis showed that no patient samples demonstrated a
SCFA proﬁle similar to a healthy breastfed infants. In one patient
studied longitudinally a change of diet alongwith administration
of a probiotic resulted in a change in the fatty acid proﬁle from
being predominantly octanoic acid to proprionic acid. RAPD
analysis showed that a lactobacillus indistinguishable from the
probiotic strain could be isolated from the faeces of one patient
throughout the period of probiotic administration.
Conclusions: This pilot study conﬁrms the potential for SCFA
analysis to detect changes as a result of pre and probiotic dietary
supplements and the RAPD method used successfully discrim-
inated between the Lactobacillus spp investigated. Further work
needs to be done in this area in particular the on resolution of
RAPD and whether other DNA-based methodologies e.g. FISH
may further improve the detection of speciﬁc probiotic strains
and allow greater understanding of the effects detected by SCFA
analysis.
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P1248
Children’s urinary pathogens: one-year survey
in a Greek hospital
L. Zachariadou, M. Chondrogianni, M. Nikolaou, M. Liakata,
E. Petridou, A. Pangalis (Athens, GR)
Objectives: To present the frequency of pathogens of urinary
tract infections in children and the possible differentiation in
isolation rates of species among hospitalized and non hospital-
ized patients.
Methods: 12819 urine specimens were examined from August
2003 to July 2004. 7583 samples were taken from hospitalized
children and 5236 from non hospitalized ones either visiting the
emergency unit or on a monthly follow up due to urinary tract
congenital anatomic or functional abnormalities. The percentage
of boys and girls was 50.3 and 49.7 respectively. Samples were
collected by suprapubic aspiration, urethral catheterization,
clean-catch midstream or ‘bagged’ specimen, depending on
the age of the little patients. The diagnosis of urinary tract
infection was based on precise clinical and laboratory criteria
according to the European guidelines and in case of doubt the
culture was repeated.
Results: 1062(8.3%) cultures were positive for one causative
pathogen and only 11(0.08%) for two. As expected, the dominant
pathogen in all isolates was E. coli (73.6%), followed by
K. pneumoniae (6.8%), P. mirabilis (6.7%), P. aeruginosa (3.5%)
and Enterococcus spp (3.3%). The remaining 6.1% of isolates
belonged to C. albicans, E. cloacae, K. oxytoca, Coagulase Negative
Staphylococci (CNS),P. vulgaris, C. freundii, S. marcescens,
S. aureus, S. bovis, E. vulneris, Y. enterocolitica, A. calco. lwofﬁ,
M. morganii and K. terrigena. The incidence of E. coli in non
hospitalized children reached 79.6%, followed by P. mirabilis
(10.1%) and K. pneumoniae (4.0%). In hospitalized children, the
most frequent isolate was E. coli (69.4%), followed by
K. pneumoniae (8.8%) and P. aeruginosa (4.9%). P. mirabilis was
more frequent in girls(55.6%) than in boys. The vast majority of
P. aeruginosa, P. vulgaris and E. cloacae strains were isolated from
children with vesicoureteral reﬂux(3rd grade or more), surgery
in the urinary tract or immunosuppression. C. albicans, CNS, S.
aureus, S. bovis and A. calco.lwofﬁ were isolated only from
hospitalized patients. 5/6 CNS strains were isolated from
neonates (one with concomitant isolation of C. albicans) and 1/
6 from a child with malignancy.
Conclusions: 1. E. coli is the predominant causative pathogen
of urinary tract in children, with an increased prevalence in non
hospitalized patients. 2. The higher isolation of P. mirabilis in
girls(55.6%) shows that boys are not the great preference of this
uropathogen. 3. There is a low frequency of mixed urinary tract
infections in children.
P1249
Antimicrobial susceptibility of urinary
pathogens: comparison between paediatric and
paediatric surgical units
E. Iosiﬁdis, E. Farmaki, C. Antachopoulos, D. Soﬁanou,
E. Roilides (Thessaloniki, GR)
Objectives: Urinary tract infections (UTI) are usually treated
empirically before results of urine cultures are available.
Periodic evaluation of antimicrobial susceptibility of the caus-
ative microorganisms is warranted due to the emerging bacterial
resistance. Purpose of this study was to review current antimi-
crobial susceptibility patterns of pathogens causing UTI and
compare them between paediatric (PU) and paediatric surgical
(PSU) in a tertiary care hospital.
Methods: Retrospective analysis of microbiology records on
bacterial isolates from urine cultures of children with UTI
admitted in two PU and one PSU in Hippokration Hospital
during 2002–03. Identiﬁcation and susceptibility testing were
performed using the Vitek 2 automated system (bioMerieux,
France).
Results: A total of 369 isolates were reviewed from 270
children. The distribution of Escherichia coli (E. coli) varied
signiﬁcantly between PU and PSU (69.4% vs 29.6%, p <0.0001).
Susceptibility rates of E. coli varied (p ( 0.006) among isolates
from PU and PSU in amikacin (AM, 99 vs 62%), ampicillin (54 vs
15%), trimethoprim/sulfamethoxazole (S/T, 71 vs 35%), cefalo-
thin (66 vs 19%) and ceftazidime (TAZ, 95 vs 39%), respectively.
On the other hand, there were no signiﬁcant differences between
PU and PSU for cefoxitin (96% each), amoxicillin/clavulanate
(84 vs 73%), nitrofurantoin (96 vs 92%) and ciproﬂoxacin (CIP,
100 vs 96%). In addition, 4% of E. coli isolates in PU and 54% in
PSU had the phenotype of extended-spectrum a-lactamase
(ESBL) producers. Other common pathogens were Pseudomonas
aeruginosa (PSA), Klebsiella pneumoniae (KPN) and Enterobacter
cloacae (ECL). Most PSA isolates were susceptible to AM, TAZ,
piperacillin/tazobactam, ticarcillin and imipenem (IMI) in both
departments (74–100%). Susceptibility rates of KPN and ECL in
patients from PU were signiﬁcantly higher than those in PSU
(p < 0.05) for AM, TAZ and S/T, but there was no difference for
IMI and CIP ((95%).
Conclusions: Resistance of E. coli isolates from PU and partic-
ularly PSU to common antimicrobials and the presence of ESBL-
producing strains are of concern. The increased resistance rates
of all common isolates in PSU patients should be highlighted.
Continuous evaluation of antimicrobial susceptibility patterns of
uropathogens is necessary to ascertain optimal empiric therapy.
P1250
Prevalence of vaginal pathogens in childhood
and adolescence
R. Kourkouli, S. Baka, E. Kouskouni (Athens, GR)
Objective: The microbiology of the female genital tract is a
complex entity always found in a dynamic situation. In children
and adolescents normal ﬂora cannot be easily deﬁned. The
purpose of this study was to assess the prevalence of pathogens
in vaginal cultures obtained from children presenting to our
hospital.
Methods: Between January 2003 and October 2004 we exam-
ined 227 vaginal cultures from an equal number of symptomatic
non-sexually active young girls (mean age 8.5 years, range
5–14 years). Vaginal secretions were inoculated onto culture
plates and were incubated in aerobic and anaerobic conditions
for 24 and 48 h, respectively. Isolation, identiﬁcation and
susceptibility to antibiotics were carried out under standard
conditions using the VITEK System ATB Expression (Bio-
Merieux, France). For the detection of Mycoplasma hominis each
specimen was inoculated on DNA agar and then incubated in
anaerobic conditions for 48 h whereas Ureaplasma urealyticum
was identiﬁed by urease production using urea broth.
Results: Our results show that out of 227 young girls 146
(64.3%) had positive cultures, 69 (30.4%) had negative cultures
for pathogens and in 12 cases (5.2%) there was no growth on the
plates whatsoever. Of the 146 positive cultures we isolated 179
pathogens: 29.6% anaerobic bacteria, 22.9% Streptococci, 16.8%
Ureaplasma urealyticum, 13.4% Gram-negative rods, 13.4% Gard-
nerella vaginalis, 3.3% Staphylococci and 0.6% Mycoplasma
hominis.
Conclusions: Distinguishing pathogenic isolates from nonpath-
ogenic ones is not a simple task in children and adolescents. The
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most commonly isolated pathogens were anaerobic bacteria and
streptococci. The prevalence of Ureaplasma urealyticum in our
study group was high. Since our results indicate the involve-
ment of Ureaplasma urealyticum in young girls’ vulvovaginitis a
routine examination for this pathogen is suggested.
P1251
Fever in infants less than three months of age
M. Christodoulaki, F. Barabouti, V. Makri, D. Athanasopoulos,
E. Kataki, E. Balomenaki (Chania, GR)
Objective: Management of febrile infants younger than
3 months of age is a difﬁcult challenge for pediatricians because
of the relatively high prevalence of serious bacterial infection.
The purpose of this study was to evaluate the clinical charac-
teristics, management and infectious outcomes of febrile infants
aged 1 to 3 months.
Methods: We reviewed 153 cases of febrile infants (rectal
temperature ‡ 38C) 29–90 days old who admitted to our
hospital during the period 2002–2003. Infants were considered
as low risk for serious bacterial infection if they met the
following (Rochester) criteria: (1) appear well; (2) were previ-
ously healthy; (3) have no focal infection; (4) have white blood
cell (WBC) count 5000–15,000/mm3, band form count £1500/
mm3, £ 10 WBC per high power ﬁeld on microscopic examina-
tion of urine sediment, and £ 5 WBC per high power ﬁeld on
microscopic examination of a stool smear (if diarrhoea). The
remaining infants were classiﬁed as being at high risk group.
Serious bacterial infection was deﬁned as a positive culture of
blood, urine, cerebrospinal ﬂuid, stool or any aspirated speci-
men.
Results: Of 153 infants that were studied, 89 (58%) were boys
and 64 (42%) were girls. 71 (46.4%) of all infants classiﬁed as
being at low risk group and 82 (53.6%) as being at high risk
group. The overall incidence of serious bacterial infection was
34% (53 patients): 32 infants (60.3%) had a urinary tract
infection; 14 (26.4%) bacteraemia; 5 (9.4%) meningitis; 1 (1.8%)
bacterial enteritis and 1 (1.8%) pneumonia. Antibiotics admin-
istered in 85 infants (55.5%). The mean duration of hospitaliza-
tion was 7.8 (4–14) days. All infants had good outcome except of
one infant with meningitis who was transferred to intensive care
unit because of refractory seizures. Only 4 (5.6%) of the infants
in the low risk group had a serious infection, compared with 49
(55.5%) of the infants in the high risk group (p < 0.0001). None
of the infants in the low risk group had bacteraemia.
Conclusion: Infants younger than three months of age with
fever who meet the low risk criteria are unlikely to have serious
bacterial infection. This probability forms a basis for well
founded decisions in the management of the individual febrile
infants.
P1252
Evaluation in new born child of the structures
with prolonged post partum morphogenesis.
Implications for paediatric infections
G.S. Dragoi, E. Trasca, L. Rizea, F.A. Vreju, R. Dogaru
(Craiova, RO)
Objective: The frequency, relative enlarged, in the new born
and toddler, of the respiratory system’s infections, accompanied
by morpho-functional alterations of the excretory renal system
and/or of the suprarenal glands, draw attention on the know-
ledge of the structural particularities of those systems that can
become a risk factor in the prognostic of the infections’
evolutions. It is known that the morphogenesis of those systems
is incomplete in the moment of the birth and that it continues
long time post partum. We proposed to ourselves to evaluate the
morpho-differentiation of the functional structures from the
respiratory, renal excretory in order to know the potentialities of
evolution and/or extension of the inﬂammatory processes.
Methods: The lung and kidney fragments, harvested from 15
new born and 10 toddlers deceased by cardio-respiratory
insufﬁciency, were ﬁxed using formaldehyde 1% at the pH 7.5.
The sections made after the parafﬁn inclusion, were colored
with HE, Van Gieson, Go¨mo¨ri and PAS stains.
Results: In the serial sections’ analysis of the new born’s lung,
we noticed the presence of the "terminal bags" (synonym with
"pulmonary alveoli"), with entoblastic origin, lined by a cylin-
drical epithelium and here and there cubical. On the sections
realized on the new born kidney we noticed a structural
heterogeneity of the renal cortex, due to the presence pf the
intermediary stages in genesis of the ‘excretory unities of the
metanephros’. In the extracellular matrix, surrounding the renal
corpuscle partially differentiated, we found an enlargement of
the heparin-sulfate proteoglycans’ quantities.
Conclusions: The identiﬁcation in new born’s lungs and kid-
neys of the functional structures, still in differentiation shows
that those organs are reactional instability sources to the
infectious aggressions.
P1253
The inﬂuence of severe early-onset infections on
dynamic changes of serum gastrin concentration
in full-term and pre-term neonates
J. Behrendt, M. Stojewska, J. Karpe, B. Sadownik,
U. Godula-Stuglik (Zabrze, PL)
Objectives: To evaluate the inﬂuence of early-onset sepsis and
pneumonia on serum gastrin concentration (s.g.c.) in the
neonates according to their gestational age and to ﬁnd out the
relation between the functional disorders of the alimentary tract
and s.g.c.
Methods: The study population consisted of 74 neonates (45
boys, 29 girls), among them 42 full-term (25 infected, 17 healthy)
and 32 preterm (20 infected, 12 healthy) Sepsis in 23 cases (11
due to staphyloccocal strains: Staph. haemolyticus, hominis,
epidermidis and aureus, 12 due to gram-negative bacteria:
Klebsiella pn. 5 cases, Pseudomonas aerug.-3 cases, Enterobacter-2
cases, Haemophilus latens-1 case, Acinetobacter baumanii-1 case)
and pneumonia in 22 cases were diagnosed. Main clinical signs
of sepsis: gastrointestinal disorders and pneumonia were
observed in all cases. Septic shock and DIC syndrome in 63%,
intensive jaundice with hepatosplenomegaly in 75% and puru-
lent meningitis in 25% of septic neonates was noted. The
functional disorders were noted in 34 infected neonates (in 20
with sepsis, in 14 with pneumonia). S.g.c. (pg/ml) was deter-
mined in peripheral vein blood twice (ﬁrst between 3rd and 4th
day of life and second between 14th and 21st day of life) using
radioimmunologic method with ready DCT sets.
Results: In the ﬁrst week of life infected full-term neonates had
signiﬁcantly (p < 0.001) higher mean s.g.c. (29.38 ± 10.27,
ranged from 11.90 to 67.90) than healthy (14.76 ± 3.24, ranged
from 11.46 to 19.96) and infected prematures (19.29 ± 19.26,
ranged from 11.45 to 21.32). The infected prematures in 3rd
week of life had signiﬁcantly higher mean s.g.c. (120.03 ± 32.03,
ranged from 87.84 to 167.71) than the healthy ones
(61.72 ± 23.51, ranged from 46.39 to 113.38) and infected full-
term neonates (88.99 ± 29.44, ranged from 35.91 to 133.72). The
mean value of s.g.c. in ﬁrst determination in infected premature
neonates with functional disorders of alimentary tract was
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signiﬁcantly higher than in infected prematures without these
symptoms. In second determination, the mean s.g.c. in full-term
infected neonates with alimentary tract disorders (79.09 ± 22.37)
was lower (p < 0.005) than in full-term neonates without such
disorders (114.47 ± 31.56).
Conclusion: The dynamic changes in serum gastrin concentra-
tion in course of severe early-onset neonatal infections, observed
in ﬁrst month of life, both in full-term and preterm newborns,
indicate its function on alimentary tract disorders.
P1254
An abrupt onset of tularaemia in children in
Kosovo
M. Djordjevic, J. Garbino, I. Uckay, V. Kostic, D. Tasic (Nis, CS;
Geneve, CH)
Objective: An unexpected, suddenly outbreak of fever, sore
throat and enlargement of cervical lymph node happened
among children from the same school, in village Donja Budriga
around Gnjilane, in Kosovo, during winter months, from
December 2001 to March 2002. There were 8 children, age
from 6 to 14, complained about the similar difﬁculties. All of
them had abrupt onset of the disease with high fever from 38.8
to 39.9C in duration of 3–7 days, sore throat and unilateral
enlargement of neck mass. Until then, it was the ﬁrst epidemic of
unknown disease in that region.
Methods and Results: Epidemiologic questionnaire revealed
the presumptive water-borne disease: children drunk the same
water from the common school’s well where the dead cat was
found from. Before hospitalization the children were treated by
lactam antibiotics unsuccessfully. After the hospitalization,
presumptive clinical diagnosis of tonsiloglandular tularemia
and glandular tularemia were conﬁrmed by serological micro-
agglutination test: MAT was from 1:160 to 1: 640. In three
children out of eight, pathohistological diagnosis of lymphade-
nitis granulomatosa was obtained. In one of them PH diagnosis
of Lymphadenitis tuberculosa caseoproductiva was excluded
after serological conﬁrmance by MAT (1:640). All were treated
by gentamycin or amikacin in duration from 7 to 14 days and
four of them were undergone by surgical incision and biopsy. In
all cases, a large amount of pus was obtained. Microbiological
isolation F. tularensis from culture was negative. All of children
were completely recovered. Relapse happened at one patient
after l9 months of byopsy of cervical lymph node with new
enlargement of adjacent lymph node which did not respond to
antibiotic therapy. Byopsy was recommended again. Tularemia
was serological conﬁrmed again. MAT 1:320, ELISA IgM
positive.
Conclusion: The most probably mode of transmission tularae-
mia in children in Kososvo, was water-borne. That is why the
most common clinical form was tosiloglandular and glandular.
The high per cent of persisted lymphadenopathy, recurrence of
lymphadenitis and surgical approach (biopsy and incision),
pointed out to greater resistance of F. tularesis on antibiotics.
P1255
Efﬁcacy of cotrimoxasol plus rifampin for six and
eight weeks of therapy in childhood brucellosis
M.R Hasanjani Roushan, S.M Smailnejad Gangi,
N. Janmohammadi, M.J Soleimani Amiri (Babol, IR)
Objectives: In endemic regions of brucellosis, the disease
frequently occurs in children. The purpose of this study was
to evaluate the efﬁcacy of cotrimoxasol plus rifampin for six and
eight weeks of therapy.
Methods: From March 1998 to July 2003, 41 patients (group 1)
and 38 patients (group 2) were treated randomly with cotri-
moxasol plus rifampin for six and eight weeks, respectively. All
patients were followed-up for one year after completion of
therapy. Clinical features and outcome of treatment for all cases
were recorded.
Results: In group1, twenty ﬁve males and 16 females, with the
mean age of 10.17 ± 3.58 years and in group two,16 males and 22
females, with the mean age of 8.42 ± 2.81 years were treated
(P = 0.073). Clinical manifestations in two groups of patients were
similar (P > 0.05%). Failure of therapy was seen in 3 (7.3%) cases in
group 1, and in no case in group 2 .Relapsewas seen in 3 (7.3%) cases
in group 1, but 1 (2.7%) case in group 2. Cure rate with eight weeks
of therapy was 97.4% and for six weeks was 85.4% (P = 0.067).
Conclusion: Eight weeks of therapy with cotrimoxasol plus
rifampin is better than six weeks of therapy in children with
brucellosis. Follow-up of these patients for ﬁnding of relapse
cases are necessary.
P1256
Linezolid efﬁcacy and tolerability in the
treatment of infectious complications in children
M. Shneider, E. Kurnikova, L. Zharikova, E. Boichenko,
A. Kolbin, A. Maschan (Moscow, St. Petersburg, RUS)
Objectives: Infections caused by Gram(+) ﬂora are a major
cause of morbidity in patients with haematological conditions
associated with neutropenia. Although vancomycin is often
indicated for these infections, it is associated with infusion-
related reactions and renal toxicity. This study was to evaluate
the efﬁcacy and tolerability of linezolid, the ﬁrst member of a
new class of antibacterial agents, oxazolidinones, in the treat-
ment of infectious complications in oncohematological patients.
Methods: This was a retrospective analysis based on data from
46 paediatric patients (age 8 mo to 16 y) with haematological
conditions. Linezolid 10 mg/kg bid was administered by 1-h
intravenous infusion, always as a component of combined
antibacterial therapy (ceftazidime, cefepim or carbapenem with
or without amikacin). Indications for antibacterial therapy
included fever of unknown origin in neutropenic patients, soft
tissue infection, mucositis, enterocolitis, catheter related infec-
tions, pneumonia, osteomyelitis, urinary tract infection and
subhepatic abscesses. Microbiological samples were taken
before the start of therapy and repeated on days 7 and 14 of
treatment if the results were positive.
Results: A total of 50 courses of linezolid were delivered. The
mean duration of therapy was 9 days (5–106 days). Clinical
response to therapy was observed in 76% (38/50) of courses,
including complete resolution of the symptoms in 68% (34/50)
of courses and eradication of Gram(+) organisms in patients
with mixed fungal and bacterial infection in 8% (4/50) of
courses. Clinical response was achieved in 70% (26/37) of
empirical therapy courses. In courses with documented Gram(+)
infection, eradication was 100% (13/13). Complete resolution of
symptoms was achieved in 50% (8/16) and improvement in 19%
(3/13) of courses in patients who were switched to linezolid
following ineffective vancomycin therapy. Only 1 (2%) course of
linezolid therapy had to be discontinued due to exacerbation of
cytopenia in a child with acquired severe aplastic anemia.
Conclusions: This is the ﬁrst study assessing the efﬁcacy and
tolerability of linezolid in children with infectious complications
of oncohematological diseases. Linezolid was highly effective
when used as a component of empirical therapy of the febrile
neutropenia. Haematological toxicity of linezolid was low, even
when baseline suppression of hemopoiesis was present, allow-
ing full compliance with treatment schedule.
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P1257
Chryseobacterium indologenes bacteraemia in a
diabetic child. Case report
C. Iaria, G. Stassi, G.B. Costa, G. Crisafulli, A. Cascio (Messina, I)
Background: Chryseobacterium indologenes is a non-fermentative
Gram-negative bacillus that is a rare pathogen in humans. Its
occurrence in diabetic children has never been reported. In
this report, we describe a case with C. indologenes bacterae-
mia possibly associated with the use of a peripheral venous
catheter.
Case presentation: A 2-year-old boy with type I diabetes
mellitus admitted for coma due to cerebral oedema and treated
successfully with insulin, dexamethasone, mannitol and KCl, on
the tenth day presented with fever of 40C, agitation, restless-
ness, lack of appetite, somnolence, fatigue. Pulse rate 90 per min,
respiratory rate 20 per min. Laboratory studies revealed a white
blood cell count of 4900/mm3 with 67% neutrophils and 27%
lymphocytes. Cultures of blood yielded C. indologenes. Treat-
ment with ceftriaxone was started before the culture results
were achieved, and was continued after susceptibility test
results C. indologenes were obtained. The patient became afebrile
after 48 hours, and his general conditions improved within
36 hours. The infection did not recur.
Conclusions: This is the third case of bacteraemia outside of
Asia due to C. indologenes and the ﬁrst occurred in a diabetic
child not otherwise immunocompromised. Our case indicates
that C. indologenes infection can occur in diabetic children
without ventilator or central venous catheter and might be
treated with a single agent after in vitro susceptibility tests have
been performed.
P1258
Antibiotic control in a paediatric teaching
hospital
N. Goldman, A. Vergison (Brussels, B)
Objectives: To evaluate the impact of antibiotics control poli-
cies in a 170-beds paediatric teaching hospital between 2001 &
2003. The aims were to (1) decrease broad spectrum antibiotics
use, (2) promote rapid switch to oral treatment, (3) reduce
spectrum of the antibiotics used for the treatment of community
acquired pneumonia (CAP).
Methods: Written guidelines for themanagement of CAP, set up
by all concerned specialists, were implemented in the hospital in
2002. Since march 2002, seminars on antibiotic resistance and
rationalized antibiotic prescription took place twice yearly.
Objectives were regularly discussed with the infectious disease
specialist in the different wards. Antibiotic consumption was
analysed through pharmacy billing data. Data were expressed in
DDD/100 patient-days (PD) and retrieved for each department
(excepted for oncology, nephrology and neonatology).
Results: Amoxicillin-clavulanic acid (AC) use decreased from
89 to 48 DDD/100 PD during the studied period. The reduction
was marked in the general paediatrics and pneumology depart-
ment (30 to 9 DDD/100 PD). Both Oral and IV use of AC
decreased (41 to 24 DDD/100 PD and 48 to 24 DDD/100 PD for
oral and IV use respectively). Oral cefuroxime-axetil increased
from 3 to 47 DDD/100 PD and IV cefuroxime from 11 to
26 DDD/100 PD. Penicillin consumption raised from 5 to
9 DDD/100 PD and altogether, narrow spectrum antibiotics
(ampicillin, penicillin oxacillin and amoxicillin) increased from
40 to 47 DDD/100 PD. Oral antibiotics (AC, cefuroxime-axetil,
amoxicillin and ciproﬂoxacin) increased from 51 to 82 DDD/
100PD, mainly explained by the rise of cefuroxime (share from 6
to 58% of total oral drugs). The IV drugs decreased from 156 to
140 DDD/100 PD and total antibiotics consumption was slightly
increased (207 DDD/100 PD in 2001 versus 222 DDD/100 PD in
2003. Broad spectrum antibiotics use decreased (133 to 85 DDD/
100 PD), mainly due to decrease in AC and ceftriaxone which
went down from 17.4 to 9.3 DDD/100 PD.
Conclusion: 1. Antibiotics use analysis showed adherence to
new CAP guidelines with change in ceftriaxone, AC, cefuroxime
and penicillin prescription pattern. 2. Oral drugs increased and
IV antibiotics decreased. 3. Broad spectrum drugs decreased and
narrow spectrum ones increased. These data provide interest-
ing information feedback for all hospital physicians and
should encourage the implementation of more concerted
guidelines.
P1259
Determinants of under- and overuse of
antibiotics in primary care patients with acute
otitis media
A.E. Akkerman, M.M. Kuyvenhoven, J.C. van der Wouden,
T.J.M. Verheij (Utrecht, Rotterdam, NL)
Objectives: In the Netherlands, antibiotic prescribing rates for
acute otitis media (AOM) are very low compared to other
countries. Some publications suggested a relation between
decline in antibiotic use and a rise in complications of respir-
atory tract infections. Therefore it is important to study not only
overprescription but also underprescription of antibiotics, and
which clinical factors are associated with both phenomena.
Thus, a study was undertaken to assess the appropriateness of
antibiotic treatment in AOM in a low prescribing country like
the Netherlands and to assess clinical patient characteristics that
cause both under- and overprescribing of antibiotics in cases of
AOM.
Methods: During four weeks in the winter of 2002/2003, 146
Dutch GPs in the middle region of the Netherlands included all
patients with acute ear complaints. They registered patient
demographics, clinical presentation (signs and symptoms), sever-
ity of illness, whether they thought patients expected antibiotic
treatment, diagnosis and management. Using key issues of
current guidelines on AOM as benchmark, we assessed the
appropriateness of antibiotic prescribing in cases of AOM. In
addition, we assessed the association between clinical patient
characteristics and under- or overprescribing of antibiotics in
cases of AOM.
Results: In seven out of ten patients with acute ear complaints
antibiotic treatment was according to the guidelines. In 17% of
all consultations antibiotics were indicated but not prescribed
(underprescribing) and in 12% antibiotics were not indicated but
prescribed (overprescribing). The lower the GP assessed the
severity of illness, if there was no worsening since the previous
contact, if the duration of symptoms prior to the consultation
was short, or if the patient had only one inﬂammation sign,
more underprescribing occurred. If the GP assessed a high
severity of illness, if the patient was coughing, or if the GP
thought the patient expected an antibiotic, then the GP
prescribed more often antibiotics without indication (overpre-
scribing).
Conclusion: Both incorrect interpretation of signs and symp-
toms and perceived expectation of patients were correlated with
incorrect antibiotic management in acute otitis media.
Abstracts
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P1260
Clarithromycin, a good alternative to
tetracyclines, in the treatment of Mediterranean
spotted fever in children. A randomised trial
E. Anto´n, T. Mun˜oz, B. Font, M.D. Ferrer, I. Sanfeliu,
F. Segura (Sabadell, E)
Background: In vitro and in vivo studies demonstrated the high
efﬁcacy of doxycycline in the treatment of MSF. However, it is
convenient to have another alternatives available for patients
who are allergic to tetracyclines, pregnant, or for children under
8 years. Based on good results in vitro we considered of interest
to evaluate the clinical efﬁcacy of clarithromycin in the treat-
ment of MSF.
Methods: Randomized therapeutic study . Group A received
clarithromycin 500 mg/12 h for 5 days in adults and 15
mg/kg/12 h for 5 days in children. Group B received the
treatment of choice which was, doxycycline (200 mg/12 h for
1 day) in adults and doxycycline (5 mg/kg/12 h for 1 day) or
josamycin (50 mg/kg/12 h for 5 days) in children. Inclusion
criteria: patients who had the compatible clinical with MSF and
the presence of the primary lesion (tache noire) or a positive
serology against R. conorii. Exclusion criteria: patients who had
received effective antibiotic treatment or whose symptoms
appeared 8 or more days before enrolment in the study.
Results: There were randomized 48 patients. There were
excluded 14 patients, 10 from group A and 4 from group B. 34
patients were evaluated. 20 males. Mean age: 38.4 years. 12 were
under 14 years. 33 patients presented fever. The exanthema was
presented in 30 cases. The tache noire was observed in 29 cases.
The diagnosis was conﬁrmed by serology in 31 cases. 14 patients
received clarithromycin (group A) and 20 doxycycline or
josamycin (group B). The interval between the onset of the
symptoms and the start of treatment was 3.6 ± 2.2 days in group
A and 3.6 ± 1.9 days in group B (p = NS). The time taken for
disappearance of the fever after treatment was 2.57 ± 1.7 days in
group A vs 2.19 ± 1.4 days in group B (p = NS). The symptoms
had disappeared at 4.35 ± 2.5 days in group A vs
4.52 ± 3.4 days in group B (p = NS). There were no adverse
reactions to the treatment or relapses in either group.
Conclusion: Clarithromycin could be considered as an alter-
native in the treatment of MSF.
Mechanisms of antibiotic resistance in Gram-negative bacilli
P1261
Fitness-cost and silencing of antibiotic resistance-
coding mobile genetic elements in Escherichia
coli
V.I. Enne, A.A. Delsol, C.M. Hayes, J.M. Roe,
P.M. Bennett (Bristol, UK)
Objectives: Many questions remain unanswered about the fate
of antibiotic resistance (AbR) in drug-free environments. We
examined the ﬁtness cost and expression of ﬁve AbR–coding
mobile genetic elements in the absence of drug selection.
Methods: Plasmids RP1, pUB307 and N3, the transposon Tn1
and the ICE element R391 were separately introduced into 345–2
RifR, a rifampicin-resistant derivative of a recent porcine isolate.
The insertion site of Tn1 was identiﬁed using PCR and DNA
sequencing. The ﬁtness cost of each AbR element was assessed
in vitro by pairwise growth competition and in vivo by
monitoring the number of CFU/g of faeces regularly for
21 days following inoculation of six seven-week old organic
piglets with 1010 CFU. The bacteria were recovered by plating
onto MacConkey agar containing rifampicin and retention of the
AbR elements monitored by replicating onto agar containing the
appropriate antibiotics. Isolates that did not express the expec-
ted resistance proﬁle were characterised by PCR and DNA
sequencing.
Results: Tn1 inserted into a cryptic DNA sequence adjacent to
the rhsD gene. The insertion site was 2.1 kb away from an
independent insertion made in a previous study, where we
found that Tn1 enhanced host ﬁtness. The Tn1 insertion
described here had no effect on ﬁtness in vitro and in vivo.
The plasmid RP1 had a 3.3 ± 0.9% ﬁtness cost per generation in
vitro but was recovered at the same rate from the pig gut as the
plasmid-free strain (p = 0.09). Similarly the plasmid pUB307,
which is RP1 without Tn1, had an in vitro ﬁtness cost of
1.9 ± 0.8% but no effect on ﬁtness in vivo (p = 0.21). The
plasmid N3 had a large ﬁtness cost of 9.1 ± 1.8% in vitro and
was also recovered at lower rates in vivo (p = 0.04). The ICE
element R391 had a neutral effect on ﬁtness in vitro and in vivo.
Most AbR element-carrying strains recovered from the animals
retained resistance to the relevant antibiotics, except three RP1-
carrying isolates, which lost resistance to ampicillin, tetracycline
and kanamycin. These isolates retained the plasmid including
intact wild-type resistance gene and promoter sequences,
indicating the genes have been silenced.
Conclusions: The ﬁtness impact exerted upon E. coli 345–2 RifR
by carriage of AbR elements is variable depending on the
element, and can also be absent. The advantage sometimes
conferred by Tn1 appears dependent on the insertion site.
Silencing of resistance genes encoded on RP1 can occur in vivo.
P1262
Development of a protein based test for multiple
antibiotic-resistant Salmonella typhimurium
N.G. Coldham, L.P. Randall, L.J.V. Piddock,
M.J Woodward (Surrey, Birmingham, UK)
Objectives: The multiple antibiotic resistance (Mar)phenotype
is characterised by resistance to different classes of antibiotics
(e.g. ﬂuoroquinolones, beta-lactams and tetracycline), disinfect-
ants and certain dyes. The development of this phenotype is
considered to be an important step in the transition to high level
antibiotic resistance of clinical signiﬁcance. Active efﬂux by
proteins of the AcrA/B-TolC system has been closely associated
with the Mar phenotype and development of high level
resistance to ﬂuoroquinolones. There is no single accepted test
in widespread use for the Mar phenotype. The objective of the
present study was to identify target proteins for the develop-
ment of a simple test for the Mar phenotype.
Methods: Previous proteomic studies (Coldham and Wood-
ward, 2004) have demonstrated the presence of proteins
associated with the Mar phenotype in the cell envelope fraction
derived from S. typhimurium (strain SL1344). Cell envelope
proteomes were prepared from S. typhimurium following
treatment with the ﬂuoroquinolones ciproﬂoxacin and enroﬂ-
oxacin (0.032 and 0.008 lg/ml) and analysed by 2-dimensional
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gel electrophoresis and 2-dimensional HPLC-mass
spectrometry.
Results: The number of proteins detected in 2D gels derived
from control cultures was signiﬁcantly (P < 0.05) reduced
following treatment with ciproﬂoxacin (31.2 ng/ml) from
296 ± 77 to 153 ± 36 (mean + 1 SD) respectively. However,
increased expression (P < 0.05) of 17 cell envelope proteins was
detected. The greatest increase in expression, by up to 10 fold
(P < 0.0001), was observed in the AtpA, AtpB, AtpC and AtpH
protein sub units of the F1F0-ATP synthase proton pump
complex. Increased expression of other proteins including the
outer membrane channel protein TolC, organic solvent tolerance
protein Imp, the outer membrane protein OmpA and the porin
OmpB was also observed. Analysis of the cell envelope
proteome by 2D-HPLC-MSn provided a more complete assess-
ment and identiﬁcation scores suggested increased expression of
many other proteins including AcrA and AcrB.
Conclusion: The F1F0-ATP synthase proton pump complex
provides the motive force for efﬂux activity and may modulate
the membrane potential for porin selective molecular inﬂux and
presents a possible target protein complex for Mar. The
expression of other outer membrane proteins, such as phosp-
holipase A, was increased after treatment with ﬂuoroquinolones
and may provide alternative targets.
P1263
Molecular epidemiology and mechanisms of
resistance to several antimicrobial agents in
sporadic Salmonella spp. strains causing acute
gastroenteritis in Cuba
R. Cabrera, J. Ruiz, M. Ramı´rez, L. Bravo, A. Ferna´ndez,
A. Aladuen˜a, A. Echeı´ta, J. Gasco´n, P. Alonso, J. Vila (Barcelona,
E; Havana, CUB; Madrid, E)
Objective: Determine the antimicrobial susceptibility and the
molecular mechanisms of resistance of Salmonella spp. strains
causing acute gastroenteritis in Cuba and determine the poten-
tial dissemination of a resistant clone.
Methods: A total of 34 Salmonella strains isolated from feces of
patients with acute gastroenteritis isolated from different
regions of Cuba in 2002 were received and processed in the
laboratory of Clinical Microbiology of Clı´nic Hospital in Barce-
lona. The antimicrobial susceptibility to 9 antibiotics: ampicillin,
amoxicillin/clavulanic acid, nalidixic acid, tetracycline, trimeth-
oprim/sulphametoxazole, chloramphenicol, gentamicin, ciproﬂ-
oxacin and spectinomycin, was determined using the agar
dilution method. The molecular mechanisms of resistance to
several antimicrobial agents were detected by PCR and the
chloramphenicol acetyl transferase activity by a colorimetric
assay. Analysis of molecular epidemiology was performed by
pulsed ﬁeld gel electrophoresis using the low frequency restric-
tion enzyme XbaI.
Results: Twenty-two strains presented resistance, 64% was
multirresistant. The serotype Typhimurium phagetype 104 was
the most frequent and presented similar genetic proﬁles of
PFGE. High levels of resistance to tetracycline (53%), spectino-
mycin (50%), ampicillin (44%) and chloramphenicol (41%) were
found. Resistance to tetracycline was associated with the tet G
and tet A genes. Resistance to ampicillin was due to the presence
of b-lactamases, mainly the CARB type. The ﬂoR gene was the
main mechanism of resistance to chloramphenicol. Among the
susceptible strains, six belong to the serotype Agona were
epidemiologically related.
Conclusions: The presence of two main clones was detected in
Cuba, with the widespread dissemination of a multiresistant
clone of Salmonella enterica serotype Typhimurium DT 104 and
an antimicrobial susceptible clone of Salmonella enterica serotype
Agona in two separate regions in the country.
P1264
Molecular characterisation of antibiotic resistance
in clinical isolates of Pseudomonas putida
T. Horii, Y. Shiba, H. Muramatsu, A. Takeshita,
M. Maekawa (Hamamatsu, Nagoya, JP)
Objectives: Infections caused by Pseudomonas putida are mostly
reported in compromised patients such as newborns and cancer
patients. Recently, emergence of resistance to carbapenems and
other antibiotics have been reported. In the present study, we
examined susceptibilities and characterized resistance to beta-
lactams and ﬂuoroquinolones in clinical isolates of P. putida.
Methods: Six clinical isolates of P. putida from the different
patients and Pseudomonas aeruginosa PAO-1 were used. These
isolates showed different pulsed-ﬁeld gel electrophoresis geno-
types. MICs were determined by an agar dilution method as
described by the National Committee for Clinical Laboratory
Standards. Detection of the metallo-beta-lactamase genes,
blaIMP-1, blaVIM-1 and blaVIM-2, was carried out by polym-
erase chain reaction ampliﬁcation. Outer membrane protein
proﬁles were characterized by SDS-PAGE. Nucleotide
sequences of the quinolone resistance-detemining regions
(QRDRs) of the gyrA, gyrB and parC genes were determined
in 6 isolates of P. putida and P. aeruginosa PAO-1.
Results: Five P. putida isolates showed resistance to beta-
lactams, including ampicillin (>128 mg/L), ceftazidime
(>128 mg/L) and carbapenems (8–>128 mg/L) such as imipe-
nem and meropenem. Four isolates showed high resistance to
ﬂuoroquinolones (>128 mg/L), including norﬂoxacin, levoﬂoxa-
cin, sparﬂoxacin, gatiﬂoxacin and pazuﬂoxacin. The MIC range
for sitaﬂoxacin was between <0.25 and 8 mg/L. Four isolates
resistant to both beta-lactams and ﬂuoroquinolones also showed
minocycline resistance (>16 mg/L). One isolate was susceptible
to both beta-lactams and ﬂuoroquinolones. All of carbapenem-
resistant isolates had the blaIMP-1 gene. In one isolate highly
resistant to all carbapenems (>128 mg/L) except sitaﬂoxacin
(8 mg/L) SDS-PAGE showed reduced production of a protein
band, which was identiﬁed as OprD by amino acid sequencing.
Some speciﬁc mutations conferring ﬂuoroquinolone resistance
were found in the QRDRs of GyrA (Thr83Ile), GyrB (Glu469Asp)
and ParC (Ser87Leu) in P. putida isolates.
Conclusion: Five of 6 isolates of P. putida were resistant to
carbapenems because of acquisition of the metallo-bata-lacta-
mase gene. Our results suggested that reduced production of
OprD was associated with increse in MICs of carbapenems. Four
isolates showing resistance to ﬂuoroquinolones except sitaﬂoxa-
cin had a combination of 3 amino acid alterations in the QRDRs
of GyrA, GyrB and ParC.
P1265
Porin expression among clinical isolates of
Escherichia coli showing AmpC-hyperproduction
phenotype
J.W. Huizing, M.C. Conejo, G. Amblar, A. Pascual, L. Martı´nez-
Martı´nez, E.J. Perea (Seville, Santander, E)
Objective: To evaluate outer membrane protein (OMP) proﬁles
of 80 clinical isolates of E. coli showing an AmpC hyperproduc-
tion phenotype and to relate them with susceptibility to
antimicrobial agents.
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Methods: Eighty clinical isolates of E. coli collected in the
laboratory of Microbiology, University Hospital Virgen Macare-
na of Seville, in the period 1999–-2001, were studied. They
represented sixty different clones, as determined by REP-PCR.
AmpC hyperproduction phenotype was deﬁned as co-resistance
to ampicillin, cephalotin, cefoxitin, and amoxicillin-clavulanic
acid, in the absence (NCCLS guidelines) of extended spectrum
beta-lactamase expression. To analyze OMP proﬁle bacterial
cells were grown in nutrient broth (NB; low osmolarity medium)
and in Mueller Hinton broth (MHB; high osmolarity medium).
Cell envelopes were obtained from lysed cells by sonication.
OMPs were isolated as sodium-lauryl sarcosynate insoluble
material. The proteins were resolved by SDS-PAGE through 10%
acrylamide-6 M urea gels. E. coli K12 and derivatives lacking
either or both OmpF and OmpC were used as controls. The
OMP pattern was compared with the resistance phenotype to
betalactams, ﬂuoroquinolones, aminoglycosides, tetracycline
and cotrimoxazole, as determined by broth microdilution
(NCCLS guidelines).
Results: An OMP proﬁle similar to that of E. coli K12 (expres-
sion or both OmpF and OmpC in NB and downregulation of
OmpF in MHB) was found in 33 (41%) strains Absence of OmpF
and expression of OmpC in both NB and MHB was observed in
23 (29%) strains. Expression of both OmpF and OmpC in both
NB and MHB was observed in 11 (14%) strains. Loss of both
porins was only found in one strain. A variety of proﬁles were
noted for the remaining 12 (15%) strains. All strains were
susceptible to cefepime, carbapenems and amikacin, but for
other agents susceptible and resistant strains were included in
every proﬁle group, with a wide range of MICs in every group.
Conclusions: 1. OMP proﬁle among clinical isolates of E. coli
showing an AmpC hyperproduction phenotype is diverse, with
only 41% of strains showing a proﬁle similar to that of E. coli
K-12. 2. There was a great variation inMIC values of the different
antimicrobial agents for strains with the same porin proﬁle.
P1266
Carbapenem-resistant, CTX-M-producing
Klebsiella pneumoniae in the UK
M.E. Ward, N. Woodford, M. Warner, R. Pike, M.-F.I. Palepou,
M.E. Kaufmann, J. Turton, I. Eltringham,
D.M. Livermore (London, UK)
Objectives: From June-August 2004, ARMRL received 4 carb-
apenem-resistant isolates of K. pneumoniae from separate
patients on the Liver ICU of a London tertiary care hospital
for investigation. Two isolates were from blood cultures, one
from bronchial washings and one from a wound swab. All
patients had clinical infections and were treated with broad-
spectrum antibiotics, including colistin. One patient with bac-
teraemia died shortly after beginning treatment, but there was
no other attributable mortality. We sought to deﬁne the
resistance mechanisms of the isolates.
Methods: Isolates were compared by PFGE of XbaI-digested
genomic DNA and analysed with BioNumerics software. MICs
were determined and interpreted according to BSAC guidelines.
Isolates were screened for beta-lactamase genes, including those
for known carbapenemases by PCR. Imipenem hydrolysis was
investigated by spectrophotometry. Iso-electric focusing (IEF)
was performed to visualise beta-lactamase. Outer membrane
proﬁles were examined by SDS-PAGE analysis.
Results: The four isolates were 95% similar by PFGE and
represented a single strain. Their antibiogram was complex.
Resistance was evident to ertapenem (MIC > 16 mg/L), but less
marked to meropenem (MIC 4–16 mg/L) and imipenem
(1–8 mg/L). MICs were unaffected by EDTA, and no
carbapenemase activity or genes were detected by spectropho-
tometry or PCR, respectively. Resistance to all cephalosporins
tested, including cefepime (MIC > 64 mg/L), was not reduced
signiﬁcantly by clavulanate; isolates were also highly resistant to
cefoxitin (MIC > 64 mg/L). Isolates were resistant to gentami-
cin, tobramycin and ciproﬂoxacin. All were susceptible to
colistin, and 3 showed borderline susceptibility to amikacin
(MIC 4 mg/L). Two beta-lactamases were apparent by IEF, and
were consistent with the group 1 blaCTX-M and blaOXA-1-like
alleles detected by PCR; blaSHV was also detected. Neither IEF
nor PCR yielded evidence of AmpC production. SDS-PAGE
showed the loss of a major outer membrane protein (OMP).
Conclusions: Impermeability, associated with OMP loss, com-
bined with the production of group 1 CTX-M and OXA-1-like
enzymes appears to underlie the complex pattern of beta-lactam
resistance in this K. pneumoniae strain. However, the lack of
potentiation of cephalosporins by clavulanate is unusual for
CTX-M producing klebsiellae, as is the carbapenem resistance.
Limited treatment options for these more resistant variants
poses a signiﬁcant clinical problem.
P1267
Characterisation of a multiresistant mutator
strain of Pseudomonas aeruginosa from an ICU
patient
B. Henrichfreise, I. Wiegand, B. Wiedemann (Bonn, D)
Objectives: Hypermutation is a common feature of P. aerugi-
nosa from cystic ﬁbrosis patients with chronic infections. Little is
known about mutator strains from patients with acute infections
among which hypermutation seems to be rare. The aim of our
study was (I) to characterize the molecular alteration responsible
for the mutator phenotype and (II) to investigate mutation-
mediated resistance in a multiresistant mutator strain of
P. aeruginosa from an ICU patient.
Methods: Amultiresistant P. aeruginosa strain was isolated from
a wound swab from a 63-year old patient in an IC unit of a
German hospital in 2004. The strain showed resistance to
Levoﬂoxacin and Piperacillin and intermediate resistance to
Imipenem, Ceftazidime, and Gentamicin. Hypermutation was
detected by disk diffusion tests. Mutation frequency was
determined on selective rifampicin agar. The mismatch repair
system genes mutS, mutL and uvrD were ampliﬁed and
sequenced. Efﬂuxpump overexpression was detected by testing
levoﬂoxacin MICs both with and without the efﬂuxpump
inhibitor MC-270,110. MexR coding for the repressor of the
mexABoprM operon and the QRDR of gyrA and parC and were
ampliﬁed and sequenced.
Results: The mutation rate of the strain was 2.26 · 10)6.
Sequencing of the mismatch repair system genes revealed a
1 bp deletion (A1250) in mutL resulting in a frameshift. The
levoﬂoxacin MIC was reduced from 128 mg/L to 2 mg/L in
presence of MC-270,110 indicating efﬂuxpump overexpression
and alterations in type II topoisomerases. In mexR a N insertion
after L52 was detected. Two changes in gyrA (T83I, D87G) and
one change in parC (S80L) were found.
Conclusions: This is the ﬁrst genetic characterisation of a
multiresistant mutator strain of P. aeruginosa from an ICU
patient with an acute infection. A new mutation in mutL of
P. aeruginosa responsible for the mutator phenotype was found.
A mutator phenotype can confer a selective advantage in
stressful environments. So, one could consider coselection of the
mutator and the mutation-mediated resistance phenotype in this
strain. Further work will be necessary to understand the
underlying mechanisms of this evolutionary process in a strain
of a patient with an acute infection.
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P1268
A novel class 1 integron containing an aadA
aminoglycoside resistance gene cassette resulting
from in vivo homologous recombination
M.E. Cano, I. de Benito, J.M. Garcı´a-Lobo, J. Agu¨ero (Santander,
E)
Objective: To describe a new variant of the aadA gene
encoding resistance to aminoglycosides, as the result of a
sequence reassortment between the aadA2 and aadA1a gene
cassettes.
Methods: A total of 78 clinical isolates of Yersinia enterocolitica
collected from different patients in our area between 1994 and
2003, were analysed for the presence of class 1 integrons.
Identiﬁcation and susceptibility testing were performed with the
Microscan Walkaway System (Dade Behring). Susceptibility to
chloramphenicol, nalidixic acid, tetracycline, kanamycin, strep-
tomycin and spectinomycin was determined by disk-diffusion.
Strains were screened by PCR using primers speciﬁc for IntI1
gene, and gene cassettes were identiﬁed by sequencing the PCR
products of the integron variable regions obtained with primers
5’CS and 3’CS.
Results: Sixty out of the 78 Y. enterocolitica isolates (77%) showed
the presence of integrons, and they could all be grouped into two
clusters of 1000 bp (45 isolates) and 1900 bp (15 isolates)
according to the two patterns obtained from the ampliﬁcation
of the variable region. The sequencing of the 1000 bp products
revealed the presence of a new aadA gene cassette the sequence
of which was a mosaic built up from pieces from both aadA2 and
aadA1a. All the isolates were resistant to streptomycin, spec-
tinomycin and chloramphenicol, and susceptible to gentamicin,
tobramycin, amikacin and kanamycin.
Conclusions: The new aadA gene described here enlarges the
reported examples of integron containing gene cassettes. Fur-
thermore, nucleotide sequence analysis revealed that new gene
variants can be produced in nature by exchange mechanisms
probably mediated by homologous recombination.
P1269
Sulfamethoxazole resistance genes in
uropathogenic E. coli
J. Shchepetova, K. Truusalu, E. Sepp, M. Mikelsaar (Tartu, EST)
Increasing antimicrobial resistance among E. coli (Ec) causing
urinary tract infection (UTI) is a serious worldwide problem.
The treatment with co-trimoxazole (ST), a combination of
sulfamethoxazol (Sulfa) and trimetoprim, often does not prevent
recurrent UTI (rUTI). The sensitivity to antibiotics of consecutive
rUTI isolates is usually detected by disk-diffusion or E-test, but
it does not always reﬂect the presence of resistance genes. Sulfa
resistance in enterobacteria arises from acquisition of two
additional genes, sulI and sulII, encoding the dihydropteroate
synthetase. These genes are located on different types of mobile
elements: sulI is associated with type I integrons and sulII with
non-conjugative plasmids. However, there are few data on the
prevalence of Sulfa resistant genes and integron 1 in commu-
nity-acquired Ec strains isolated from children with rUTI. One of
the putative reasons for rUTI may lie in non-accordance of
pheno- and genotypical results of antibiotic susceptibility
determination, resulting in non-efﬁcient antimicrobial treat-
ment. The aim of this study was to determine the prevalence of
Sulfa resistance genes (Int1, SulI and SulII) among Ec causing
rUTI in children.
Material and methods: Altogether 29 consecutive Ec isolates
from 10 rUTI patients (Tartu University Children Hospital) with
changes in antibiotic resistance to ST were applied. Ec resistance
to Sulfa was detected by E-test (Bio Mereux). DNA was
extracted using QIAamp DNA Mini Kit (QIAGEN). Int1, sulI
and sulII genes were detected by PCR (Polymerase Chain
Reaction).
Results: 20 out of 29 (65.5%) Ec isolates were resistant to Sulfa
(MIC3512 mg/L). Int 1 was present in 15 out 29 (51.7%) Ec
isolates. SulI and/or sulII genes were detected in all resistant
Ec isolates. Three different combinations of genes were found: 9
isolates contained sulI and sulII; 3 isolates only sulI and 8
isolates only sulII gene. Among 9 phenotypically sensitive Ec
strains 3 isolates (MIC 8 mg/L) carried sulI and sulII genes
while 6 strains (MIC 12–32 mg/L) did not contain any of the
three genes.
Conclusions: This study demonstrates that the resistance genes
of Sulfa (sulI and sulII) are widely distributed in Ec strains from
children with rUTI. Half of the rUTI causing strains carry
integron 1 providing them with capability to obtain multiresis-
tance. The detection of Sulfa gene in Ec might be of importance
in prevention of rUTI.
P1270
Plasmid transfer from Klebsiella pneumoniae to
Escherichia coli
S. Schjørring, C. Struve, K.A. Krogfelt (Copenhagen, DK)
Objectives: The increased number of gastrointestinal infections
and the rapid increase in antibiotic bacterial resistance, makes
investigation of antibiotic resistance development during intes-
tinal colonization a very important issue. The objectives are to
investigate aKlebsiella pneumoniae strain’s ability to conjugatewith
Escherichia coli, in vitro in vivo, and to characterise the transcon-
jugants by plasmid proﬁling and restriction fragment analysis.
Methods: The donor K. pneumoniae ATCC 700721 strain was a
multi-resistant mucoid strain, which contains three large plas-
mids (100–-150 kbp.) and two small ones (<7 kbp.). The
recipient was an E. coli MG1655 StrepR, RifR. The in vitro
conjugation was performed on solid and liquid media, whereas
the in vivo conjugations were performed during colonisation of
the large intestine of streptomycin/ampicillin treated mice.
Transconjugants were isolated from both in vitro and in vivo
experiments. A combination of plasmid puriﬁcation (which
purify large plasmids in a way that allows following restriction
cutting), plasmid proﬁles, and restriction fragment analysis, was
used to characterise the transconjugants obtained from these
experiments.
Results: In vitro conjugation between K. pneumoniae and E. coli
showed transfer of either only 1 or all 5 plasmids depending on
the conditions. When K. pneumoniae was used to colonise the
large intestine, it was shown that K. pneumoniae transferred one
of its plasmids containing antibiotic resistance genes to an
indigenous E. coli strain. When mice were co-infected with
K. pneumoniae and the laboratory E. coli strain, it was seen that
K. pneumoniae again transferred its plasmid with antibiotic
resistance to E. coli. Both the laboratory strain and the indigen-
ous E. coli with the newly acquired plasmids were tested for
their conjugative ability and it was seen that they both had
obtained conjugative plasmids from K. pneumoniae. Further-
more, the plasmids were characterised by restriction fragment
analysis conﬁrming, that all the transconjugants plasmids were
identical with the plasmids from the original donor; the
K. pneumoniae ATCC 700721.
Conclusion: K. pneumoniae ATCC 700721 contains conjugative
plasmids, and conjugation is occurring in a high frequency both
in vivo and in vitro. The type of plasmid, which is conjugated
depends on the environmental conditions.
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P1271
Accuracy of the Microscan Walkaway system for
identifying P. aeruginosa strains carrying class 1
integrons with MICs of cefepime higher than
those of ceftazidime
E. Ugalde, A.B. Campo-Esquisabel, M.E. Cano, J. Calvo-Montes,
J. Agu¨ero, L. Martı´nez-Martı´nez (Santander, E)
Objectives: MICs of Cefepime (FEP) against P. aeruginosa are
usually similar to those of Ceftazidime (CAZ), but isolates
expressing efﬂux pumps and containing PSE-1 or OXA enzymes
may present MICs of FEP higher than those of CAZ. In this
study we have evaluated the Microscan Walkaway system
(W/A)fordetectingP. aeruginosa isolateswithanyof the following
phenotypes: 1. CAZ susceptible (S) and FEP intermediate (I); 2.
CAZ-S and FEP resistant (R); 3. CAZ-I and FEP-R. The presence of
Class 1 integrons in these isolates was also investigated.
Methods: From May to Sept. 2004, all P. aeruginosa isolates (one
per patient) I or R to FEP and S to CAZ, and the ﬁrst 30 strains I
or R to both CAZ and FEP were evaluated. MICs of FEP and
CAZ were determined by reference microdilution (NCCLS
guidelines). Then clinical categories obtained with W/A for
organisms with any of the previously indicated phenotypes
were compared with those obtained by the reference method.
Class 1 integrons were detected by PCR using primers speciﬁc
for the type 1 integrase gene and primers speciﬁc for conserved
regions 5’ and 3’ of class 1 integrons. Gene cassettes were
identiﬁed by sequencing the amplicons obtained from two
different isolates for each integron type found.
Results: The following phenotypes of CAZ/FEP and number of
isolates were identiﬁed by the W/A system as: S/I:9; S/R:4; I/
I:15; R/I:4, and R/R:11. Reference microdilution conﬁrmed that
23 isolates were more susceptible to CAZ than to FEP. The W/A
correctly identiﬁed 13 out of these isolates (53.5% sensitivity).
Reference microdilution conﬁrmed higher susceptibility to CAZ
than to FEP in all 13 isolates detected by W/A (100% speciﬁcity).
For the 23 isolates, the W/A did not cause any Major (false
resistance) error for CAZ or FEP. The phenotypes of CAZ/FEP
for the 10 isolates not recognized by W/A were I/I (n = 6), R/I
(n = 3) or R/R (n = 1). A class 1 integron was identiﬁed in 18 out
of the 23 (78.3%)isolates: 13 with a 1600 bp integron, coding for
an OXA protein which shares the highest aminoacid identity
with group II OXA enzymes (77%), 3 with a 1200 bp integron,
coding for PSE-1, and 2 in which PCR failed to amplify any
integron conserved region.
Conclusions: The W/A system is very speciﬁc, but poorly
sensitive, for recognition of P. aeruginosa more susceptible to
CAZ than to FEP. In our centre, this phenotype is often
associated to the presence of integrons coding for an OXA
enzyme or PSE-1.
P1272
Non-beta-lactamase mediated beta-lactam
resistance in Stenotrophomonas maltophilia
V. Gould, D. Miller, R.A. Howe, M. Avison (Bristol, UK)
Objectives: Stenotrophomonas maltophilia is an important, emer-
ging, Gram-negative, nosocomial pathogen that can cause
bacteraemias, respiratory tract colonisation and other organ-
speciﬁc infections. Isolates have the potential to mutate to
multidrug resistance (MDR), which has been linked to over-
expression of the efﬂux pump SmeDEF. Beta-lactam resistance is
thought to be due to beta-lactamase over-expression since
SmeDEF does not pump out beta-lactams.
Methods: Beta-lactam resistant mutants of S. maltophilia isolates
K279a and N531 were selected using either ceftazidime or
meropenem. MICs of various classes of antimicrobial agents
were determined by Etest using Muller-Hinton agar. Beta-
lactamase induction was attempted using cefoxitin challenge
(10 mg/L, 2 h) and speciﬁc beta-lactamase assays were per-
formed using nitroceﬁn with (L2) or without (L1+L2) EDTA
(500 mM). RNA extraction and RT-PCR for smeE and smeF used
kits from Quiagen.
Results: From parent isolate K279a one high level meropenem-
resistant (MIC ‡ 512) and one high level ceftazidime resistant
mutant (MIC = 16) were selected. From parent isolate N531 one
high level meropenem resistant mutant was selected
(MIC ‡ 512). Beta-lactamase assays in the absence of inducer
revealed that none of these mutants over-express beta-lacta-
mase. Indeed, unlike the parent strains, beta-lactamase expres-
sion in the mutants was not inducible under the conditions
tested. MICs of other classes of antimicrobials revealed
increased MICs of ﬂuoroquinolones against the beta-lactam
resistant mutants. RT-PCR conﬁrmed that smeDEF are not over-
expressed in any of the mutants.
Conclusions: These data suggest that beta-lactam resistance is
part of an MDR phenotype in some S. maltophilia mutants. The
mechanism involved appears to alter drug accumulation rates,
since beta-lactam inducer was not able to reach a concentration
high enough to stimulate beta-lactamase expression. The mech-
anism is most likely to be efﬂux-pump mediated, suggesting the
existence of a previously uncharacterised efﬂux pump in
S. maltophilia.
P1273
First complete sequence of a penicillin-binding
protein of the genus Aeromonas
A. Schiefer, K. Westphal, I. Wiegand, B. Wiedemann (Bonn, D)
Objectives: Members of the genus Aeromonas are human
pathogens causing several infections especially to immunocom-
promised patients and patients with severe underlying diseases.
Antibiotic resistance is an increasing problem for effective
therapeutic strategies and it is important to understand the
mechansims of resistance. Beta-Lactam antibiotics are known to
bind to and inhibit PBPs which leads to a disturbance of the
peptidoglycan metabolism. Until now there is only little infor-
mation about the PBPs of Aeromonas veronii. Eight PBPs with
different molecular masses were identiﬁed. Tn5 insertion
mutants of Aeromonas that over-express beta-lactamases have a
disruption within one of two different genes. The partial
sequences of both gene products have been assigned functions
as D-D-carboxypeptidases. We identiﬁed the complete sequence
of one of the inactivated genes encoding a D-D-carboxypepti-
dase with homology to PBP4 from different species, in order to
create a basis for further studies of the cell wall metabolism and
beta-lactamase induction.
Methods: Puriﬁed genomic DNA from one Tn5 insertion
mutant was digested with EcoRI or SalI. The DNA-fragments
were ligated into an equal linearized vector, pSU18 and
transformed into E. coli DH5a. The selected colonies were
investigated for recombinant plasmids with the correct insert.
Sequences were determined using primer walking strategy.
Results: The sequenced fragment codes for an open reading
frame of 481 amino acids with a calculated MW of 52 kDa. This
MW is in good agreement with the MW of PBP4 from E. coli,
Vibrio and Shewanella where the MW ranges between
52–56 kDa. The deduced protein shows homology to PBP4
from different species, a bifunctional enzyme with both
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
405
D-D-carboxypeptidase and D-D-endopeptidase function. All
characteristic active-site ﬁngerprints of PBPs are located in the
sequence.
Conclusions: This is the ﬁrst complete sequence of a PBP of the
genus Aeromonas. The disruption of this pbp-gene leads to over-
expression of beta-lactamases in Aeromonas veronii. This result
will be the starting point for further studies of the role of PBPs in
peptidoglycan metabolism and beta-lactamase induction of
Aeromonas veronii.
P1274
Metronidazole resistance in nim-positive and
nim-negative B. fragilis strains after several
passages on metronidazole containing Columbia
agar plates
R. Schaumann, S. Petzold, A.C. Rodloff (Leipzig, D)
Objectives: Recent data show an emergence of B. fragilis strains
resistant against ﬂuoroquinolones and in part against other
antimicrobial agents. The aim of the present study was to
investigate inducible metronidazole (MTR) resistant in B. fragilis
strains.
Methods: Of 18 B. fragilis strains (including 4 nim-positive
reference strains and one ATCC strain) MIC values for MTR
were determined by E-test and analysed for nim-genes (A-D) by
PCR. After that bacterial suspension were incubated on supple-
mented columbia agar plates containing MTR at twice the MIC-
value of the speciﬁc strain tested and incubated under anaerobic
conditions for 48 h. After incubation growing bacteria were
harvested and cultivated and thereafter incubated at 4 timesMIC.
This procedure was repeated with increasing antibiotic concen-
trations. The resulting MIC-values were conﬁrmed by E-test.
Results: The MIC-values for MTR of the four nim-positive
reference strains ranged from 3 to 8 mg/L. Three clinical isolates
of B. fragilis strains showed MIC-values >256 mg/L. In all 3
strains the nim-gene was detected by PCR. The B. fragilis ATCC
25285 strain was nim-negative with a MIC-value of 0.19 mg/L.
The other 10 clinical isolates of B. fragiliswere also nim-negative.
MIC-values ranged from 0.25 to 0.75 mg/L. The nim-positive
reference strains showed after few passages MIC-values
>256 mg/L for MTR. After several passages on MTR containing
agar, all other B. fragilis strains including the ATCC 25285 strain
exhibited MIC values of 8 to 256 mg/L.
Conclusion: MTR resistance can be selected not only in nim-
positive B. fragilis strains but also in nim-negative strains. This
suggests that mechanisms other than nim are involved in MTR
resistance. These ﬁndings underscore the importance of suscep-
tibility testing of anaerobes even in routine laboratories.
P1275
Dissemination of nitroimidazole resistance
determinants among Gram-negative anaerobic
bacteria in Greece
A. Katsandri, J. Papaparaskevas, A. Pantazatou,
L.S. Tzouvelekis, G.L. Petrikkos, N.J. Legakis, A. Avlamis on
behalf of The Hellenic Study Group on Gram-Negative Anaerobic
Bacteria
Objectives: The surveillance of the incidence of nitroimidazole
resistance (nim) determinants among Gram-negative anaerobic
clinical isolates in Greece.
Materials and methods: A total of 185 Gram-negative anaerobic
bacteria collected from eight hospitals in Athens, Greece, were
tested for metronidazole resistance using the Etest method on
brucella blood agar plates. Incubation in a ChelLab Anaerobic
Chamber was performed for 48 hours. Interpretation of the
results was according to NCCLS guidelines. For quality control
the strains B. fragilis ATCC25285 and B. thetaiotaomicron
ATCC29741 were used. Strains having an MIC > 1 mg/L were
screened for nim genes by PCR using the nim3/nim5 set of
primers. PCR products were stained with ethidium bromide and
documented under UV illumination. Sequencing was performed
in an ABI 3100 genetic analyzer using the BigDye terminator kit.
The Blast search programme of the National Center for Biotech-
nology Information was used to search the Gene Bank for
signiﬁcant alignments.
Results: A total of 16 isolates having an MIC > 1 mg/L were
detected (four Bacteroides fragilis group, eight Prevotella spp.,
one Bacteroides spp. non-fragilis and three miscellaneous). Three,
three, two, one and seven strains had MICs of 2, 4, 8, 16 and
32 mg/L or higher, respectively. Eight strains were positive by
PCR for the 458 bp amplicon, of which three had a metroni-
dazole MIC of 4 to 16 mg/L (lower than the current NCCLS
breakpoint). DNA sequencing revealed that one, two, two and
three strains harboured nimA, nimC, nimD and nimE genes,
respectively. No strain was detected harbouring the nimB gene.
No particular relationship was detected regarding species or
MIC distribution and nim gene class.
Conclusions: Nitroimidazole resistance determinants were
detected among both metronidazole resistant and susceptible
Gram-negative anaerobic bacteria in Greece. This study con-
ﬁrms the widespread occurrence of nim genes and demonstrates
that ‘silent’ nim genes can be detected by PCR in metronidazole
susceptible isolates.Members of The Hellenic Study Group on
Gram-Negative Anaerobic Bacteria are: A. Avlamis, C. Koutsia-
Karouzou, C. Kontou-Kastelanou, A. Pangalis, E. Papafrangas,
E. Trika-Grafakos, H. Malamou-Ladas and A. Vogiatzi.
P1276
Morphological changes in Clostridium difﬁcile
during exposure to metronidazole
T. Pela´ez, R. Alonso, L. Alcala´, J. Martı´nez-Alarco´n,
E. Cercenado, M. Rodriguez-Cre´ixems, E. Bouza (Madrid, E)
Background: We report a high prevalence (6%) of metronidaz-
ole (MTZ) resistance in Clostridium difﬁcile in our institution.
Resistance to MTZ seems to be heterogeneous and unstable. We
observed morphological alterations in the strains growing in the
presence of metronidazole.
Objective: The aim of this study was to characterize these
morphological changes and to study the stability of the altered
phenotypes after MTZ removal.
Methods: We selected a total of 18 isolates which were resistant
to metronidazole (MICs from 16 to 64 mg/L). C. difﬁcile ATCC
9689 was also included as a control. Brain Heart Infusion broth
tubes (B.H.I.) were prepared with 4 and 8 mg/L MTZ. Brucella
plates without antibiotic were also used. Bacterial morphology
was evaluated by microscopy (Gram-stained) and also by plate
colonies. A volume of 0.1 mL, from a 0.5 McFarland culture, was
used to inoculate the B.H.I. tubes. Broths were incubated at 37C
in an anaerobic chamber for 10 days. Every two days, the cultures
were screened by microscopy and by serial passages performed
on Brucella plates without antibiotic. Plates were further incuba-
ted under the same conditions and observed for 10 days.
Results: The ATCC 9689 C. difﬁcile strain was not able to grow
in the presence of any of the MTZ concentrations. Gram stains of
MTZ-resistant C. difﬁcile strains, grown in the presence of both
assayed MTZ concentrations, revealed Gram-positive coccoid
forms that co-existed, at ﬁrst with typical Gram-positive
bacillary forms, which became progressively predominant
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during the 10 day-period. Subcultures of the antibiotic B.H.I.
tubes on Brucella plates rendered colonies with an atypical
white appearance and round shape. Colonies reverted progres-
sively to typical C. difﬁcile phenotypes and after 7–10 days’
incubation in free-MTZ Brucella plates, they showed their
characteristic pleomorphic and yellow–green, ground glass
appearance. Gram staining of the reverted phenotypes showed
the typical spore-forming, Gram-positive bacilli.
Conclusions: The presence of MTZ induces morphological
changes in C. difﬁcile that can easily be reverted in antibiotic-
free medium. A similar phenomenon has been described in
another genus (Helicobacter pylori), and is related to a decrease in
intracellular ATP levels, although further studies are needed to
explain this phenomenon in C. difﬁcile.
P1277
A reporter gene system for the identiﬁcation and
characterisation of multiple antibiotic resistance
(mar) in E. coli associated with altered expression
of the AcrAB-TolC drug efﬂux pump
N. Matthiessen, P. Heisig (Hamburg, D)
Objectives: The increasing prevalence of bacterial resistance to
antibiotics is a worldwide problem for the therapy of infectious
diseases. Among the three basic mechanism leading to antibiotic
resistance, i.e. alteration of the target, inactivation of the drug ,
and reduced accumulation of the drug at the target site, the
latter has become the most important resistance-mechanism due
to the following reasons: (i) it is the most abundant mechanism
detectable in both Gram-negative and Gram-positive bacteria,
(ii) it often mediates multi drug resistance (mdr) to a broad
range of – unrelated – drug classes, (iii) it can favor the
acquisition of additional mechanisms of resistance. Most fre-
quently mdr is achieved by one of several mutations resulting in
the deregulation of mdr efﬂux pump expression. The major
multidrug efﬂux pump in E.coli AcrAB-TolC is a constitutively
expressed tripartite complex consisting of a RND-type trans-
porter AcrB, a membrane fusion protein AcrA and an outer
membrane channel TolC. The expression of acrAB is regulated
by a local repressor AcrR and known global regulator systems
MarRAB, SoxRS and Rob. Since any mutation inactivating AcrR
or a global regulator, like MarR may result in acrAB overex-
pression, detection of a resistance mutation requires extensive
sequencing and additional susceptibility tests using different
antibiotics.
Methods: Thus, a reporter gene system has been developed that
senses alterations in the expression of the AcrAB-TolC efﬂux
pump caused by induction and/or mutation/deletion of the
local and/or global regulators. Brieﬂy, the luciferase gene luc of
the ﬁreﬂy Photinus pyralis as a reporter gene was fused to the
promotor pacrAB by a modiﬁed PCR technique (SOEing) and
inserted into the plasmid pBR322.
Results: Fireﬂy luciferase as a reporter is advantageous due to
the high sensitivity with no background activity, wide range of
applicability, ease of use and cost efﬁciency. Alterations in the
expression of acrAB either due to the presence of inductors or
mutations in marR could be detected as increased luciferase
activities by this reporter gene system.
Conclusions: Thus, this newly developed reporter gene system
can be used to identify acrR mutants and to quantify alterations
of the expression of the acrAB operon. Moreover, it is a useful
tool to study under different environmental conditions the
expression and to screen for inductors or inhibitors of the
AcrAB-TolC efﬂux pump.
P1278
Expression of mRNA for efﬂux pump proteins in
Pseudomonas aeruginosa strains from cystic
ﬁbrosis patients in relation to antibiotic
resistance
S Islam, H. Oh, S. Jalal, O. Ciofu, N. Hoiby,
B. Wretlind (Stockholm, S; Copenhagen, DK)
Objectives: Multidrug efﬂux system plays a prominent role in
resistance to several antibiotics in Pseudomonas aeruginosa. To
date, 7 different MDR efﬂux systems have been characterized in
P. aeruginosa: MexAB-OprM, MexCD-OprJ, MexEF-OprN,
MexXY-OprM, MexJK-OprM, MexVW-OprM and MexHI-
OpmD. The aim of the present investigation was to discern to
which extent overexpression of efﬂux pumps contributes to
antimicrobial resistance, with particular interest on quinolone
and aminoglycoside resistance in P. aeruginosa strains from
CF-patients.
Methods: Twenty Pseudomonas aeruginosa isolates collected
from six cystic ﬁbrosis (CF) patients, aged 27 to 33, in 1994 (9
isolates) and 1997 (11 isolates) at the CF Center, Copenhagen,
Denmark, were studied. MICs to norﬂoxacin, ciproﬂoxacin,
amikacin, tobramycin, tetracycline, ceftazidime, piperacillin/
tazobactam, meropenem and imipenem were determined using
Etest. The relative expression of mRNA for four efﬂux pump
proteins was determined by real-time PCR and correlated with
susceptibilities to two ﬂuoroquinolones and seven other anti-
microbial agents.
Results: A strain was considered to hyperproduce mRNA for
pump proteins if cDNA level was >5x strain PAO1. MexY
mRNA overproduction (18/20 strains) did not seem to achieve
clinically relevant levels of resistance to quinolones but was
correlated with decreased susceptibility to aminoglycosides.
MexB overproduction (3/20 strains, <23x PAO1) did not
mediate any signiﬁcant quinolone resistance, but seemed to
decrease susceptibilities to other antimicrobials. High-level
overexpression of MexD (4/20) affected quinolone susceptibil-
ity. No clear correlation between the R82L alteration in 16/20
strains in NfxB (regulates MexCD-OprJ) and MexD mRNA
hyperproduction was seen. MexF mRNA expressed at high
levels (6/20) was correlated with resistance to quinolones and
imipenem.
Conclusion: Elevated production of mRNA for the four efﬂux
pumps tested correlated not only to decreased susceptibility to
quinolones, but also to other antimicrobials including penems,
aminoglycosides and beta-lactams.
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Public health, surveillance and geographic information systems
P1279
International Circumpolar Surveillance of
invasive bacterial diseases, 2000–2004
T. Cottle, M. Bruce, D. Parks, S.L. Deeks, T. Tam, K. Brinklov
Jensen, A. Nystedt, A.J. Parkinson (Anchorage, AK, USA; Ottawa,
ON, CAN; Nuuk, GRL; Lulea, S)
Background: The International Circumpolar Surveillance (ICS)
system conducts population-based surveillance of invasive bac-
terial diseases in Greenland (GN), Northern Canada (N Can),
Northern Sweden (N Swe) and in the U.S. Arctic (Alaska [AK]).
Methods: Isolates from patients with invasive diseases caused
by Haemophilus inﬂuenzae (Hi), Neisseria meningitidis (Nm),
Group A Streptococcus (GAS), and Group B Streptococcus (GBS)
were forwarded to reference laboratories in Alaska (2000–2004),
Canada (2000–2004), Greenland (2001–2003), and Sweden (2003)
for conﬁrmation and serotyping. Clinical and demographic
information were collected using standardized surveillance
forms. Data reported for 2004 is preliminary.
Results: The total numbers of reported cases were 110 Hi, 43
Nm, 153 GAS, and 130 GBS. Crude annualized rates of invasive
disease per 100,000 population varied by country and organism
(Table 1). AK Native and N Can Aboriginal people had
consistently higher rates of disease (except GBS in N Can)
than non-Aboriginals. Of the 105 Hi cases that were serotyped,
20 (19%) were Hib [AK 15 cases (rate 0.48), N Can 5 cases (rate
0.80)] and age ranged from <1 to 69 years; most Hib disease
occurred in persons <2 years of age (AK = 53%, N Can = 80%).
Thirty-three (31%) Hi cases were serotype a (Hia) [AK 10 cases
(rate 0.32), N Can 23 cases (rate 3.68)]. No Hia cases were
reported in AK during 2000, 2001 and 2004 to date; in 2002 and
2003, rates in AK were 0.62 and 0.92, respectively. In N Can, Hia
cases were reported during each year from 2000–2004; rates
were 2.99, 7.03, 3.13, 2.34 and 2.82 respectively. Case fatality
ratios were higher in AK than N Can and GN for invasive
disease caused by both Hi (AK = 18%, N Can = 7.4%) and Nm
(AK = 12.2%, N Can = 0%, GN = 0%).
Conclusion: Aboriginal peoples of AK and N Can have high
rates of invasive bacterial disease caused by Hi, Nm, GAS and
GBS. Overall rates of Nm disease are higher in GN than AK, N
Can and N Swe. Cases of invasive Hib disease continue to occur
in children <2 years of age. Rates of Hia appear to be elevated in
N Can; this trend merits further surveillance.
P1280
Enter-net Italia: integrated medical and veterinary
surveillance of salmonellosis in Italy
A.M. Dionisi, P. Galetta, E. Filetici, I. Benedetti, S. Arena,
L. Busani, C. Graziani, A. Ricci, V. Cibin, L. Barco, M.C. Dalla
Pozza, I. Luzzi (Rome, Padua, I)
Objectives: The laboratory surveillance of Salmonella in Italy
has a high level of integration among involved institutions. It is
represented by the Enter-net system, coordinated by the Istituto
Superiore di Sanita`, which concerns notiﬁcations from human
cases, food items and environmental sampling, and the Enter-
vet network, coordinated by the Istituto Zooproﬁlattico Speri-
mentale delle Venezie, which collects information on isolations
from animals and food of animal origin.
Methods: The networks use harmonised microbiological meth-
ods and share their databases. Data on Salmonella serotypes,
phagetypes and antimicrobial resistance are collected with
epidemiological informations. Each year, the network collects
and analyzes data on about 6000 human isolates and 2000
isolates each from animals, foods and environment. More than
70% of the human isolates is represented by S. typhimurium (ST)
and S. enteritidis. Subdivision within phagetypes is becoming
necessary to elucidate outbreaks during investigations because,
since the 1990s, some phagetype of epidemiological importance
have predominated: S. enteritidis phagetype 4 and S. typhimu-
rium phagetype 104 are the more common phagetypes among
human and animal isolates. Molecular typing may be an
important subtyping tool for isolates belonging to the same
phagetype and Pulsed-Field Gel Electrophoresis analysis is
considered the gold standard method.
Results: An accurate analysis of the Enter-net and Enter-vet
databases allowed us to detect an increase during 2002 and 2003
in the prevalence of S. typhimurium non phagetypable (NT) and
of an atypical monophasic strain, deﬁned as 4,5,12: i,- , both in
human cases and in veterinary samples. ST NT accounted for
the 25% of the ST isolated in humans during this period and for
the 20% of the ST isolated from sample of swine origin. The
resistance to Ampicillin, Streptomycin, Sulphonamides, and
Tetracycline is the typical proﬁle found in a high percentage of
human and swine strains such as PFGE shows the same proﬁle
of restriction for the most part of human and swine ST NT
isolates.
Conclusions: The Italian surveillance integrated network for
Salmonella represents an important database for the study of
Salmonella infection epidemiology. Epidemiological data
together with serotyping, phagetyping and molecular typing
of Salmonella isolates from human and animal sources provide
further information for a better estimate of risk factor for human
infections.
P1281
Knowledge and attitude of Iranian healthcare
worker about Crimean Congo haemorraghic fever
M. Mardani, M. Rahnavardi, M. Rajaeinejad, K. Holakouie
Naieni, F. Pourmalek (Tehran, IR)
Background: Crimean-Congo Haemorrhagic Fever (CCHF) is a
potentially fatal viral infection caused by a tick-born virus,
nosocomial outbreaks with high mortality among hospital staff
been documented. Sporadic cases occur through In 1999, 3
health care workers (HCWs) in Iran were infected with CCHF
virus following contact with one suspected case of CCHF that
one of them died. Systan-Baluchestan (south-east of Iran) and
Isfahan (centre of Iran) provinces are now endemic area of
CCHF infection in Iran. HCWs of these two provinces are
frequently in contact with CCHF cases.
Materials & Methods: 191 pre-tested and self-administered
questionnaires were ﬁlled by HCWs who work in admitting
wards of hospitals of Systan-Baluchestan and Isfahan provinces
of Iran. Collected data was analysed to determine the level of
Table 1: Rates* of Invasive Disease, ICS Data, 2000–2004
Country Hi Nm GAS GBS
AK 2.04 1.00 4.02 3.43
GN 0 4.72 0.59 1.77
N Can 7.37 0.48 4.33 2.56
N Swe 0.39 0.39 0.39 1.97
* annualized crude rate per 100,000
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knowledge and attitude of these staff and to distinguish the
predicting factors of knowledge and attitude.
Results: 82% of these HCWs had good knowledge on CCHF,
while 83% showed acceptable attitude towards the disease.
Knowledge is directly associated with attitude (p < 0.03). Those
in higher job rank had better knowledge (p < 0.001) and higher
attitude (p < 0.01). The most common used source of data on
CCHF was ‘Poster and pamphlet’ (32.2%) among these HCWs.
Those who used ‘Poster and pamphlets’ had higher knowledge
(p < 0.05). No signiﬁcant difference was seen among different
sex, job or provinces groups in using ‘Poster and pamphlets’.
The most common type of contact to CCHF patients was ‘Intact
skin to blood’ contact in 37.3% of enrolled HCWs, while 10%
had ‘Percutaneous’ contact with CCHF cases. Working in
Systan-Baluchestan province was accompanied with higher
risk of contact with CCHF cases (p < 0.05).
Conclusion: We conclude that enrolled HCWs in Systan-Balu-
chestan and Isfahan provinces of Iran had acceptable knowledge
and attitude. Improvement of knowledge via ‘Poster and
pamphlet’ could be an effective modality in these setting.
Health authority should pay more attention on Systan-Baluche-
stan province to provide it with sufﬁcient and effective universal
protection to lower nosocomial transmission risk of CCHF in
HCWs of this area.
P1282
Seroprevalence of rubella among puerperae in an
area of North-Eastern Italy
A. Beltrame, L. Driul, G. Rorato, L. Scudeller, C. Negri,
D. Marchesoni, P. Viale (Udine, I)
Objectives: The proportion of susceptible individuals represent
one of the main elements of the decisional workup for a
vaccination campaign. In particular, eradication of congenital
rubella is achievable only when protective levels of antibodies
are maintained among women of reproductive age. The aim of
our study was to assess adherence to and results of rubella
serological screening among pregnant women in an area of Italy,
Country where vaccination is not compulsory.
Methods: Puerperae delivering at the Teaching Hospital of
Udine were prospectively enrolled and interviewed by means of
a standardised CRF recording demographic and obstetric data,
number of living children, history of childhood viral exanthema,
history of vaccination, prenatal screening for rubella and
appropriate retesting (i.e. monthly retesting for IgG negative
women and no additional testing for IgG positive women).
Descriptive statistics were obtained; comparisons were made by
t-test, Mann-Whitney or J2 tests as appropriate.
Results: From February to July 2004, 568 puerperae were
enrolled. Mean age was 33 years (range 18 to 47 years). Country
of origin was Italy in 494 (87%), Eastern Europe in 35 (6%),
Africa in 16 (3%), America in 12 (2%), Asia in 6 (1%), Western
Europe in 5 (1%). First pregnancies were 301 (37%). A history of
rubella infection was reported in 314 (55.4%) and of rubella
vaccination in 130 (22.9%). Prenatal screening tests for rubella
was available for 414 women (73.2%), with no difference
between Italians and other nationalities (73% vs 76%, p = NS).
Serologic evidence of susceptibility to rubella infection was
found in 44 (9.7%). The proportion of susceptible women did not
vary across different ages (18–39 yrs 9.8%, >39 yrs 8.8%, P = NS)
and nationality groups (Italians 9.7%, other 9.6%, P = NS).
Correct retesting in pregnancy occurred in 365 cases (64.5%).
Among 44 susceptible women, 24 (54.5%) had been pregnant at
least once before (8 had two child or more). No acute infection
during pregnancy was diagnosed.
Conclusion: In our study, prenatal screening rates for rubella in
puerperae was unsatisfactory. Moreover a proportion of nearly
10% of susceptible pregnant women results in a high risk of
rubella infection in pregnancy. No correlation was found
between age, nationality and rubella susceptibility. Besides
more than half of rubella susceptible puerperae had one child or
more. These results also suggest a need for improved postpar-
tum vaccine implementation.
P1283
Spatial distribution and registry based case-
control analysis of Campylobacter infections in
Denmark, 1991–2001
S. Ethelberg, J. Simonsen, P. Gerner-Smidt, K.E.P. Olsen,
K. Mølbak (Copenhagen, DK)
Objective: To examine the potential of environmental sources
contributing to Campylobacter infections in Denmark, using
geographical analyses.
Methods: We analysed available information on the place of
living of all registered laboratory conﬁrmed domestically
acquired cases of campylobacteriosis in Denmark over a period
of 11 years. The study was performed as a register-based case
control study; 15 controls for each case were selected from the
national population register, individually matched on age,
gender and county of residence. A total of 22,066 cases were
compared to 318,958 controls and variables relating to geography
and the addresses of living were analysed by logistic regression.
Results: Three factors were independently associated with an
increased risk of infection: 1) Type of housing. Relative to the
one-family house, there was a decrease in odds of housing typical
of cities and an increase in odds of housing typical of rural areas.
2) Living in areas with a low population density. This was
assessed by counting the people living in a 1 km2 square
surrounding each case and control subject. Children were largely
responsible for the increased odds ratio associated with areas
with a low population density. 3) The municipality of residence.
After adjustment for type of housing and population density the
odds of living in different municipalities (274 in Denmark) varied
(p < 0.0001) and there was no apparent order in low/high risk
municipalities when they were visualized on a map.
Conclusions: This is the largest study so far made of the
geography and type of housing of Campylobacter cases. We
found that children living in non-urban areas are at increased
risk of Campylobacter infections. Under the assumption that
risk foods (i.e. fresh chicken in particular) are equally distri-
buted across the country, the results indicate that exposures via
animals and the environment are the sources of a substantial
proportion of sporadic infections of Campylobacter among
children in the countryside. Furthermore, contaminated drink-
ing water is a likely explanation of the ﬁnding of varying risks
between municipalities, since people in different municipalities
have different water suppliers in Denmark.
P1284
Use of spatial analysis on a survey of
H. inﬂuenzae and S. pneumoniae isolated from
children in an urban area of southeastern Brazil
A.M. Monteiro, C.M. Mendes, J.L. Sampaio, C. Oplustil,
P. Garbes, P. Lima, L. Pedneault, G. Camara, C.R. Kiffer (Sao
Jose dos Campos, Sao Paulo, Rio de Janeiro, BR; Brussels, B)
Objectives: This study examines the spatial distribution and
patterns of H. inﬂuenzae and S. pneumoniae and their resistance
patterns isolated from children of an urban area in Brazil.
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Methods: Spatial analyses were used on a population of
children under 7 years old with symptomatic upper respiratory
tract infections (URTI) submitted to routine cultures of respir-
atory specimens, as part of a surveillance study on the
prevalence of resistance among H. inﬂuenzae and S. pneumoniae
in the city of Sa˜o Paulo, Brazil. Patients were only included in
the study if they had a positive culture result for the above
pathogens. S. pneumoniae isolates were tested against penicillin
and other antimicrobials with Minimum Inhibitory Concentra-
tions (MICs) determined by Etest methodology. Interpretative
criteria used were those described by NCCLS document M100-
S14. H. inﬂuenzae isolates were tested for beta-lactamase pro-
duction by a chromogenic cephalosporin method. Cases and
their respective resistance patterns were geocoded in a digital
map and the spatial analysis technique applied was the Kernel
function method in order to explore possible cluster formations.
Results: There were 111 S. pneumoniae and 146 H. inﬂuenzae
isolates from this population. Only 50 S. pneumoniae cases (16
with a penicillin MIC in the intermediate or resistant range), and
59 cases of H. inﬂuenzae (8 beta-lactamase producers) were
geocoded, due to apparent random geocoding technique losses.
Preliminary spatial analysis method (Kernel function) based on
geographical information systems (GIS) showed a possible non-
random pattern located in the eastern region of the city.
Conclusion: Kernel function is an initial exploratory technique
for interpolating and smoothing point events and is mainly used
for identifying possible cluster formations. Further analyses are
required for precisely determining the existence of S. pneumoniae
andH. inﬂuenzae clusters and their related risk factors. However,
it seems that there is a speciﬁc transmission pattern of bacterial
pathogens within a population under elevated risk for resist-
ance. GIS and spatial methods can be applied to better
understand epidemiological patterns and to discriminate
target areas for public health interventions.
P1285
Human tuberculosis in the Ile-de-Cayenne,
French Guiana. Risk maps for better prevention
and effective control strategies
V. Guernier, X. Deparis, J-M. Fotsing, J-F. Gue´gan (Montpellier,
Cayenne, Orle´ans, F)
Objectives: In French Guiana, tuberculosis (TB) incidence
appear to be great, but many problems prevent from effective
TB control in this region. One way of improving TB control is to
increase case-ﬁnding rates and therefore the proportion of cases
treated by the identiﬁcation of population at risk for tubercu-
losis. The aim of the study presented here is to determine
vulnerability index of populations living in the Ile-de-Cayenne
for tuberculosis, in order to produce risk map for tuberculosis.
Methods: A geographic information system (G.I.S.) is a tool that
allows to organize and analyze data that can be referenced
spatially, i.e. data that can be tied to a physical location. Many
types of data have a spatial aspect, including epidemiological
studies. A digital map from IGN and a Spot-5 satellite image
were included in the G.I.S. as a cartographic base. In addition,
data that should be used to assess the degree of insalubrity of
the urban area was included, as well as demographic data that
can inﬂuence transmission rate. These different layers were
cross-linked to assess the vulnerability index of populations. The
cartography of tuberculosis cases was combined to the vulner-
ability map in order to adjust the model of risk map for
tuberculosis.
Results: The distribution of the 387 TB cases reported from 1
January 1996 to 31 December 2003 have been monitored by GPS
using home locations of the patients. A vulnerability index of
populations have been derived from a qualitative analysis of
both urban landscape and socioeconomic data. Using a G.I.S.
and geostatistical tools, we cross-linked variables as habitat
typology (derived from air photo interpretation), population
density, or type of urban sewerage systems, which are indeed
indicative of existing socio-spatial inequalities. A map of
tuberculosis risk among populations was established, coupling
the cartography of tuberculosis cases with the cartography of
vulnerability.
Conclusion: This framework will allow to reveal some trans-
mission patterns of tuberculosis in the Ile-de-Cayenne, provi-
ding support for the development of health policies and
programmes in French Guiana. It will also offer the unique
opportunity to dispose of an impressive environment-health
database which will serve to regional health authorities for
health planiﬁcation and forecasting.
P1286
Prevention of infectious diseases in the Aral
Sea region
Re. Khaydarov, Ra. Khaydarov (Tashkent, UZB)
According to announcements of the Ministry of Public health of
Republic of Uzbekistan - a quality of portable water is the main
reason of infectious diseases in the Aral Sea Region, where fresh
water resources are limited and unevenly distributed, and
drinking water often contains extraordinary large numbers of
pathogenic bacteria. The water disinfecting method presented in
this work is based on the destructive impact of low concentra-
tions of metal ions on bacteria in water. During the disinfection
process, alloyed electrodes are placed into the water body and a
current applied to the electrode causes the release of metal ions.
The metal ions bind to the bacterial cell wall, causing its
disruption and lyses. The efﬁcacy of using different metal ions
(Ag+, Cu2+, Au) combinations (within the limits of current
drinking water regulations) for killing typhoid–paratyphoid,
Legionella pneumophila, Salmonella, V. Cholerae etc. has been
examined. The cultivation, culture enrichment and the testing
bacteria were performed following the Standard Methods for
the Examination of Water and Wastewater (American Public
Health Association, 1995) for the evaluation of disinfection.
Tests which were carried out by various independent labs and
universities during the period of 1999 through 2003 have shown
the dependence of bacteria killing time against metal ion
concentration, different initial bacteria concentrations (from 103
to 1012 CFU/L), and the inﬂuence of different ion (Cl-, SO, S2),
Fe2+, Fe3+) concentrations on the disinfection process. The best
disinfection is obtained by using an alloy of silver/copper/gold
composition with concentrations of metals in the ratio 70–90%/
10–30%/0.1–0.2%, respectively. In the Aral Sea region (Uzbek-
istan) water disinfecting devices that were based on the
developed method were installed on several hundreds manual
water pumps, that allowed to decrease community-acquired
infectious diseases in this region.
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Endocarditis
P1287
Epidemiology of infective endocarditis in
Hungary
A. Heczey, G. Prinz, E´. Ba´n (Budapest, HUN)
Objectives: In Hungary, statistical data of infective endocarditis
(IE) is unknown; therefore, a prospective study was conducted.
The goal of this investigation was to determine the most
common pathogens, predisposing factors, affected valves, the
mean time from the ﬁrst symptoms to the established diagnosis,
the incidence of vascular phenomena, the percentage when
surgery is needed, and the total in-hospital mortality.
Methods: Between October 1, 2002 and September 30, 2004. 80
patients were identiﬁed and examined by one member of our
Department. Patients were either hospitalized in our Institution
or were encountered through infectious disease consultations.
The diagnosis of infective endocarditis was made by using the
modiﬁed Duke Criteria. All cases were deﬁnite IE.
Results: The number of patients: 80 (52 men, 28 women). Mean
time to established diagnosis from the ﬁrst symptoms:
6.28 weeks (SD: 6.8). Average age: 58.1 The distribution of
isolated pathogens was: Enterococcus spp. 19 cases (23.75%);
Staphylococcus aureus 15 cases (18.75%); viridans streptococci 8
cases (10%); Group B Streptococcus 5 (6.25%); Streptococcus bovis 4
cases (5%); Coagulase negative Staphylococcus 3 cases (3.75%);
Streptococcus pneumoniae 2 cases (2.5%); Lactobacillus 2 cases
(2.5%); Haemophilus spp. 2 cases (2.5%); plus 4 other pathogens
one case each. 15 cases were haemoculture negative.The affected
valves were: only mitral: 28 cases (35%), only aorta 26 cases
(32.5%), only tricuspidal: 3 cases (3.75%), aortic and mitral: 18
cases (22.5%), aortic, mitral and tricuspidal: 1 case (1.25%). The
predisposing factors of IE were: previous valve disease: 25 cases
(31.25%), prosthetic valve: 23 (28.75%), pacemaker: 9 cases
(11.25%). IE in intravenous drug users or HIV infected patients
was not present in this period. Vascular phenomena were
observed in 35 patients (43.75%). Cerebral embolism: 17
(21.25%), spleen infarction: 5(6.25%), pulmonary embolism
4(5%), lower extremitiy embolism 2 (2.5%). Janeway phenomen:
6(7.5%). Surgical intervention was performed in 45 (56.25%)
cases. The overall mortality of IE was 22.5%, among the
medically treated patients 25.71%, among the surgically and
medically treated patients: 20%.
Conclusion: Enterococcus spp. became the leading pathogen of
IE in adults in Hungary. Other data is not signiﬁcantly different
from previously published epidemiological studies.
P1288
Epidemiologic and clinical aspects of infective
endocarditis in Turkey
H. Leblebicioglu, H. Yilmaz, Y. Tasova, E. Alp, R. Saba,
R. Caylan, M. Bakir, A. Akbulut, B. Arda, S. Esen on behalf of
the Endocarditis Study Group
Objective: The aim of our study was to establish the etiology,
risk factors of infective endocarditis (IE) and determine the
prognostic factors for adverse outcome during hospital admis-
sion in a Turkish population.
Material and Methods: Between January 2002 and January
2004, the clinical and laboratory features of 112 consecutive
adult patients (>18 years) with a diagnosis of IE who referred to
infectious diseases clinics/departments of 17 teaching hospitals
in Turkey were evaluated. Cases of IE were deﬁned according to
modiﬁed Duke Criteria. Mortality was deﬁned as death occur-
ring within 30 days or during hospital stay period. Univariate
and multivariate analysis of factors predicting a fatal outcome
were performed.
Results: 112 consecutive patients presented with 101 deﬁnite
and 11 probable IE episodes deﬁned according to the modiﬁed
Duke Criteria. The mean age was 45.2 ± 19.9. 50% of the patients
were male. 90 (60.4%) of 112 patients have risk factors for
infective endocarditis and 48 (42.9%) of them have ‡ 2 risk
factors. 49.1% of patients have cardiac risk factors. Blood
cultures were positive in 94 (83.9%) cases. Staphylococci were
the most common agents (50.0%), followed by streptococci
(28.7%) and enterococi (16.0%). Native cardiac valves were
present in 93 (83%) of the episodes of suspected IE. Valvuler
involvement was present in 103 (92%) patients, the mitral valve,
alone or in combination with other valves, was affected in 70
(62.5%). Echocardiography was able to detect vegetations in 105
patients (93.8%). The mortality was 28.6%. Three factors were
independently associated with mortality; haemodialysis OR:
14.5 (95% CI: 1.5–138.2), mobile vegetation OR: 4.7 (95% CI: 1.5–
15.4) and mental alteration OR: 4.1 (95% CI: 1.1–15.6).
Conclusion: Mortality is still high in IE. Our data indicate that
patients with altered mental status or mobile vegetation or being
on haemodialysis had poorer prognosis.
P1289
Blood culture negative endocarditis. Analysis
of 59 cases
J.D. Ruiz-Mesa, J.M. Reguera, A. Alarco´n, F. Miralles, A. Plata,
A. Mun˜oz, A. Villalobos, J. Pacho´n, J.D. Colmenero (Malaga,
Seville, E)
Objectives: To know the clinical features and possible etiologic
agents of the blood culture negative endocarditis (BCNE).
Methods: We have carried out a descriptive cross sectional
study in a serie of patients with Infectious Endocarditis (IE)
diagnosed from January 1985 to December 2001 in two tertiary
hospitals in the south of Spain excluding those who were
intravenous drug user. All the patients presented a clinically
deﬁnitive IE or pathologically proven according to the Duke
criteria.
Results: Fifty nine (16.4%) of 359 cases of IE included were
categorized as BCNE affecting in 45 (76.3%) and 14 patients
(23.7%) to native and prosthetic valves respectively. The mean
age was 44.5 ± 14.8 with a range from 11 to 73. Forty one (69.5%)
patients were male and 18 female. The most affected valve was
aortic in 33 cases (55.9%), mitral in 17 (28.8%) and both valves in
9 (15.3%). A previous valvular disease was found in 39 cases
(66.1%). An infectious focus was suspected in 16 (27.1%)
patients. The symptoms were fever (96%), chills (78%), sweating
(65%), malaise (69%), new murmur (27.1%) and splenomegaly
(26%). In a total of 23 patients (38.9%) we detected vascular
phenomena and immunological phenomena were present in 9
patients (15.5%). Thirty ﬁve patients (59.32%) developed heart
failure. We performed at least two blood cultures in all of
patients. Antibiotics were used previously in 29 (49.1%) patients.
Fifteen cases had positive serologic test for C. burnetti and 4 for
Brucella. All of patients had a transthoracic echocardiogram
(TTE) and 16 (27.1%) had a transesophageal echocardiogram
(TEE). Valvular regurgitation were seen in 52 (88.1%)and
vegetations in 37 cases (62.7%). Surgery was undertaken in 31
cases (52.5%) during the hospital admission and in 5 cases later.
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Congestive heart failure was the main reason for surgery
(52.5%). Surgery allowed us to conﬁrm the etiologic agents in
11 cases (2 Aspergillus, 1 Mucor). The global mortality ratio was
20.3%.
Conclusions: 1) Antibiotics taken before a IE diagnosed is the
main factor for the negativity of the blood culture. 2) Serologic
tests for Brucella and C. burnetti might be considered in BCNE
mainly in endemic areas. 3) The histologic and microbiologic
examination of the valves after the surgery is so much important
to identify the etiologic agent. 4) Molecular techniques may be
an interesting alternative diagnostic test for IE caused by
bacteria that usually give a negative blood culture.
P1290
Culture negative endocarditis: the value of 16S
rDNA PCR and sequencing
A.A. van Zwet, S. Riemens, L. Laterveer,
M. Kooistra (Groningen, Meppel, NL)
Objectives: An essential element in the diagnosis of bacterial
endocarditis is the ﬁnding of positive bloodcultures. In patients
with endocarditis successive negative bloodcultures can be
misleading and ﬁnally at best, by exclusion, the inadequate
diagnosis of a so-called ‘culture negative endocarditis’ is made.
In these special cases 16S rDNA PCR and sequencing of a blood
sample can be of great value as is demonstrated in the following
case history.
Patient and Methods: A 64 years old man presented himself at
our hospital with complaints of fatigue, fever and weight loss
since a couple of weeks. Eight years ago he had received an
aortic valve bioprosthesis. Under the working diagnosis of a
bacterial endocarditis several blood- and a bone marrow
samples were taken for culture. Incubation time was extended,
however, all cultures remained negative. Since trans-esopha-
geal-echoscopy of the valves could not conﬁrm the diagnosis of
an endocarditis, uncertainty concerning the diagnosis was
growing.Finally, a 3 ml EDTA blood sample was taken for 16S
rDNA PCR and sequencing. DNA was extracted from the
sample by a bead-beating/silica/guanidinium thiocyanate pro-
cedure. Ampliﬁcation was performed with universal bacterial
primers. A positive signal was found and subsequent sequen-
cing revealed a Bartonella species. A positive Bartonella serology
(IgG titer 500) conﬁrmed our 16S rDNA PCR ﬁnding and the
diagnosis of a Bartonella endocarditis was made. Patient was
treated with a combination of antibiotics.
Conclusion: Direct detection of bacterial DNA in an EDTA
blood sample using broad-range PCR and subsequent DNA
sequencing is an important diagnostic tool, particularly helpful
in cases where bacteraemia is suspected but bloodcultures
nevertheless remain negative.
P1291
Evaluation of a real-time universal 16S rRNA
gene PCR and sequencing method for diagnosis
of infective endocarditis directly from heart valve
tissue
M. Marı´n, P. Mun˜oz, M. Rodrı´guez-Creixems, L. Alcala´,
C. Sa´nchez, E. Bouza on behalf of the Gregorio Maran˜o´n Hospital
Endocarditis Study Group
Objective: Traditionally, infective endocarditis (IE) has been
microbiologically diagnosed by culture. In recent years, the
diagnostic importance of PCR has been proven. Our objective is
to evaluate the usefulness of a real-time universal PCR method
followed by sequencing in explanted heart valves for IE
diagnosis, in the routine of a clinical microbiology laboratory,
compared with conventional microbiological culture of blood
(BC) or heart valve tissue (HVT).
Methods: One hundred and three HVT from 100 patients were
studied. Twenty-two HVT belonged to 20 patients with deﬁnite
EI. Eighty patients were free of IE and their 80 HVT were
included as negative controls. Universal 16S rRNA gene PCR
was made with primers PSL and P13P by real-time PCR in a
Light-Cycler instrument using Sybr-green and 35 PCR cycles.
Positive samples were subsequently sequenced for identiﬁca-
tion. The results obtained were compared with those of
microbiological cultures of HVT and BC. Analytical sensitivity
was assessed by extracting DNA from tenfold dilutions of a
suspension of Streptococcus oralis spiked in a culture-negative
HVT.
Results: All but one of the HVT from patients free of IE gave
negative PCR results. All culture-positive samples were also
positive by PCR and in all cases microorganisms identiﬁed from
HVT by this molecular method matched with those isolated by
culture methods. The causative organisms of IE were diagnosed
only by PCR in two patients whose microbiological cultures
were negative. All culture-positive samples ampliﬁed before 27
PCR cycles. One PCR positive sample that ampliﬁed at cycle 29,
belonged to a patient without EI and gave a mixed sequence,
being considered contaminated. The median time of analysis to
obtain a PCR result was 2.5 hours and to a bacterial identiﬁca-
tion by sequencing was 2 days. The analytical sensitivity of this
assay was 100 cfu/mg. Sensitivity, speciﬁcity, positive predic-
tive and negative predictive values of this real-time PCR method
were respectively: 100%, 98.76%, 95.6% and 100%.
Conclusions: This method of universal real-time PCR followed
by direct sequencing applied to resected heart valves has proved
to be more sensitive, speciﬁc and rapid than conventional
culture methods. This real-time assay makes it possible to
predict IE by the number of cycles of PCR at which samples of
HVT amplify.Supported in part by \\‘Red Espan˜ola de Inves-
tigacio´n en Patologı´a Infecciosa’ (REIPI - C03/14).
P1292
Clinical spectrum of endocarditis in patients with
cancer: a case-control evaluation of culture-
positive (CPE) and culture-negative (CNE)
disease, 1994–2004
S.W. Yusuf, S. Ali, A. Tong, J. Swafford, J.B. Durand,
D.P. Kontoyiannis, K.V. Rolston, I.I. Raad, A. Safdar
(Houston, USA)
Background: Spectrum of endocarditis in patients with cancer
is not certain. We sought to evaluate characteristics of culture-
positive (CPE) and culture-negative (CNE) in patients with
cancer.
Methods: A retrospective evaluation of all transthoracic (TTE)
and transesophageal echocardiograms (TEE) during these
10 years was undertaken after obtaining IRB approval. A
positive result included demonstration of vegetation along the
heart valve.
Results: Forty-ﬁve (7%) of 654 patients had a positive result; 26
(58%) had positive concurrent blood culture, whereas 19
patients (42%) blood cultures remained sterile. Among CPE,
Staphylococcus species (9 Staphyococcus aureus, and 6 coagulase-
negative staphylococcus) were common, followed by 4 Enterococ-
cus spp. The median age was 55 ± 18.6 years (range, 14 to 84) in
30 (67%) men and 15 (33%) women. Hematologic malignancies
were observed in 23 (51%); among solid-organ cancers
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gastrointestinal malignancies were common (N = 8; 18%) fol-
lowed by lung cancer (N = 4; 9%). All 45 patients had TTE, while
TEE was done in 22 (49%) of 45 patients. All 16 (100%) patients
with negative TTE had a diagnosis of endocarditis made on TEE,
whereas one patient with positive TTE had a negative TEE
(P < 0.0001). Eighteen (78%) of 23 patients with CVC had CPE
compared with 8 (36%) of 22 without CVC had a positive blood
culture (OR = 6.30; 95% CI: 1.69–23.53; P < 0.0062). Similarly, 24
of 45 patients with endocarditis had received antineoplastic
therapywithin 60 days of infection diagnosis (OR = 3.24; 95%CI:
0.94–11.12; P = 0.0619). Presence of severe neutropenia
(<500 cells/uL) was evenly present in CPE (n = 6 of 26) and
patients with CNE (n = 4 of 19). Interestingly, embolization to
brain more common in patients with CNE (n = 7 of 19; 37%),
compared to 3 (12%) of 26 with CPE (P = 0.07). Septic emboli to
lung occurred in patients with CPE (4 of 26, 15%; P < 0.04); all 4
patients had endocarditis due to Staphylococcus aureus. Seven of 8
patients who were candidates for valve replacement surgery
underwent operation; of these 6 had CPE (3 had valvular
Abscesses). Endocarditis was attributed to death in 6 (31.6%) of
19 CNE patients, whereas only 1 (3.9%) death was attributed to
endocarditis in CPE group (n = 26; P < 0.03).
Conclusions: CNE was more severe disease, which may be
related to delayed diagnosis and possibly suboptimum antimi-
crobial therapy. Presence of CVC has appeared as an important
predictor of CPE in these high-risk cancer patients.
P1293
Outcomes of treatment of infective endocarditis
with home intravenous antibiotic therapy
M.A. Goenaga, C. Garde, M. Millet, J.A. Carrera, E. Arzellus,
A. Cuende (San Sebastian, E)
Objective: Evaluate outcomes of patients (pts) with EI treated
with home intravenous antibiotic therapy (HIVAT).
Methods: IE cases referred for HIVAT were identiﬁed though
our HIVAT registry. Information was extracted from hospital
records with follow up of all cases.
Results: 23 cases of IE, in 22 pts, were treated with HIVAT. 86%
male, 14% female. Age range 26–89 yrs, mean 59 yrs. Underly-
ing cardiac pathologies were present in 14 cases. All pts were
evaluated by an internal or infectious disease physician in
hospital. All patients were medically stable, 2pts had required
surgical intervention. 7 (30%) cases were on prosthetic valve (5),
deﬁbrillator wire (1) or pacemaker wire (1). Causative microor-
ganisms were S. viridans (10), MSSA (3), S. epidermidis (3),
E. faecalis (2), M. morganii (1), G. haemolysens (1), P. aeruginosa (1)
blood culture negative (2). All cases, less one, the treatment was
initiated in hospital. Antimicrobial agents used were ceftriaxone
(7), vancomicin (5), penicillin G (3), ampicillin (3), cloxacillin (3),
ceftazidime (1), teicoplanin (1). Aminoglycosides were associ-
ated in 10 cases. The mean hospital length of stay was 14.5 d
(range 0–36 d) and at home 28 d (range 2–125 d). The mean 65%
(range 14–100%) of treatment was realized at home. 22 cases
(95.6%) ended treatment at home with good clinical response
and 1 case (blood culture negative, valve prosthetic) return to
hospital due fever. 4 cases (17%) had iv access problems. One
patient develop a benign intracraneal hypertension. There were
no serious IE or HIVAT complications. In the follow up (median
46 months, range 5–89 m) 21 pts are cured, one pts died not
related IE.
Conclusions: In our group, after a carefully inpatient selection,
pts with IE can be treated with safe at home. Prosthetic valve
disease or other microorganisms than S. viridans had not worse
outcomes.
P1294
Non-toxigenic Corynebacterium diphtheriae as a
cause of bacterial endocarditis in children with
congenital heart defects
M.G. Dove, R.P. Loxton, E.J. Olivier, B. Prinsloo (Pretoria, ZA)
Introduction: Non-toxigenic strains of C. diphtheriae have been
increasingly recognised as a cause of invasive disease. Bacter-
aemia and endocarditis caused by these strains have been
reported with increasing frequency. Other invasive diseases
such as septic arthritis, splenic abscesses and mycotic cerebral
aneurisms have also been described. To date at least 67 cases of
non-toxigenic C. diphtheriae causing endocarditis have been
reported worldwide. Most of these cases were in either native or
prosthetic heart valves and in IV drug abusers.
Objective: We report on 4 cases of infective endocarditis caused
by non-toxigenic C. diphtheriae in patients with underlying
congenital heart defects, occurring at the Pretoria Academic
Hospital over the past 7 years.
Method: Endocarditis was conﬁrmed by the presence of diph-
theroid organisms in the blood cultures of all the patients. A
ﬁnal diagnosis was made on microscopy (Gram and Albert’s
stains), culture on blood agar and Hoyle’s medium, in-house
biochemical tests substantiated by API CORYNE (Biomerieux)
An elek test for toxin production was performed on all isolates.
Results: The ages of the 4 patients were between 3 and 16 years.
Positive blood cultures (Bactec 9240 System) were obtained from
all patients on multiple occasions. Characteristic ‘Chinese letter’
arrangements of the bacilli were seen on both Gram and Alber’s
stains, as were metachromatic granules. In-house biochemical
tests validated by API CORYNE conﬁrmed all organisms to be
C. diphtheriae var gravis. Elek tests in all cases indicated no toxin
production. Sensitivities to a number of antibiotics (ampicillin,
penicillin, erythromycin, gentamicin, piperacillin and cefuroxi-
me) were determined by the Kirby-Bauer disc diffusion method.
With the exception of penicillin and Ampicillin resistance in one
patient, all antibiotics tested were sensitive. Patients were
treated with penicillin and gentamicin parenterally and all
survived without complications.
Conclusion: Non-toxigenic C. diphtheriae is an infectious patho-
gen, and detection of coryneform bacteria in the blood can no
longer be dismissed as contamination and must be investigated.
Failure to recognise this pathogen can delay ﬁnal diagnosis and
initiation of appropriate chemotherapy. Species identiﬁcation is
important as mortality differs with the different biotypes. The
importance of this organism as emergent pathogen should not
be underestimated.
P1295
Aerococcus urinae – a rarely detected pathogen of
infective endocarditis
M. Slany, P. Pavlik, J. Cerny, T. Freiberger (Brno, CZ)
Objectives: Aerococcus urinae is a rarely reported pathogen,
possibly due to difﬁculties in the identiﬁcation of the organism.
A. urinae is a Gram-positive coccus that grows in pairs and
clusters as alpha-hemolytic colonies on blood agar. Because of
these characteristics A. urinae is often misidentiﬁed as a
streptococcus, enterococcus, or staphylococcus. In addition,
there were also reported several cases of blood culture negative
infections due to A. urinae. Most infections are mild, but serious
ones such as endocarditis and septicemia can occur. To our best
knowledge, the total number of thirteen cases of infective
endocarditis including eight fatal cases have been described in
the world literature so far.
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Methods: Silica based DNA isolation from aortic valve tissue
sample and broad range 16S rRNA PCR followed by sequencing
analysis was used.
Results: Here we report a case of blood culture negative and
culture negative aortic valve endocarditis caused by A. urinae in
69-year-old male. Patient was successfully treated with surgical
aortic valve replacement and ceftriaxon (4 g daily) applied for
12 weeks.
Discussion: Most patients infected with A. urinae are elderly
males with predisposing conditions who present initially with
urinary tract infections (UTI). However, our patient developed
infective endocarditis in the absence of UTI symptoms.
Conclusion: Broad range 16S rRNA PCR is shown to be a
power tool in detection of bacterial pathogens in culture
negative cases of infective endocarditis.This work was suppor-
ted by grant of the MZ CR No. 209775.
P1296
Trends in antimicrobial susceptibilities of
viridans group streptococci isolated in patients
with infective endocarditis from 1990 to 2003
F. Marco, Y. Armero, C. Garcı´a de la Ma`ria, E. Amat, M. Almela,
A. Moreno, X. Claramonte, N. Pe´rez, C.A. Mestres, J.M. Gatell,
M.T. Jime´nez de Anta, J.M. Miro´ (Barcelona, E)
Objective: To know the current incidence of resistance to
penicillin and other antibiotics in viridans group streptococci
(VGS) isolated in patients with endocarditis in our institution
from 1990 to 2003.
Methods: A total of 107 consecutive VGS strains isolated from
patients with infective endocarditis (IE) were included in the
study. Antimicrobial agents tested were: penicillin (PN), amp-
icillin (AM), ceftriaxone (CR), imipenem (IM), vancomycin (VA),
teicoplanin (TP), erythromycin (EE), clindamycin (CD), telithro-
mycin (TL), quinupristin/dalfopristin (Q/D), linezolid (LZ),
ciproﬂoxacin (CP), moxiﬂoxacin (MX), levoﬂoxacin (LV) and
gatiﬂoxacin (GA). MICs were determined following the NCCLS
recommendations. Tolerance to glucopeptides and high-level
resistance to gentamicin (GN) and streptomycin (ST) was also
studied. In addition, the combination of PN, LZ or LV plus GN
was investigated in selected isolates (Penicillin MIC >1 mcg/
mL) by time-killing curves and the checkerboard method.
Results: The species identiﬁed were as follows: S. bovis (26%),
S. oralis (25%), S. mitis (21%), S. sanguis (7%), anginosus group
(8%) and 13% miscellaneous (S. mutans, S. salivarius, S. gordonii
and S. parasanguis). MICs 50/90 (mcg/mL) were: PN (0.06/0.5),
AM (0.12/1), CR (0.06/0.5), IM (0.015/0.12), VA (0.5/1), TP
(0.06/0.12), ER (0.12/256), CD (0.06/256), TL (0.007/2), Q/D
(0.5/2), LZ (1/1), CP (1/2), MX (0.12/0.25), LV (0.5/1), GA
(0.25/0.25). Overall, 18.7% of the isolates had reduced PN
susceptibility (MIC range: 0.25–4 mcg/ml). Among these, S.
mitis, S. oralis and S. sanguis isolates had the highest prevalence
of PN resistance, whereas all S. bovis and S. mutans isolates were
susceptible. Only 3 isolates (2 S. mitis and 1 S. oralis) showed a
MIC of 4 mcg/ml, but it was notable that they were identiﬁed
during the last 3 years. All isolates were susceptible to VA, TP
and LZ. Tolerance to VA and TP was found in 83 isolates
(77.6%). High-level resistance to GN and ST was detected in 1
(0.9%) and 11 (10.3%) isolates, respectively. Among the three
combinations tested in PN resistant isolates, only LZ + GN
showed synergistic activity.
Conclusion: Decreased susceptibility to betalactam antibiotics
is a common feature in VGS isolated in patients with infective
endocarditis in our institution.
Enteric infection
P1297
Standard inoculum for a broth microdilution
method for antimicrobial sensitivity testing of
Campylobacter jejuni
V. Gindonis, M. Hakkinen, H. Nummi,
A.-L. Myllyniemi (Helsinki, FIN)
Objectives: Antimicrobial resistance in campylobacters has
become a subject of great concern as resistant strains are more
and more commonly found in samples of both human and
animal origin. C. jejuniATCC 33560-strain has been conﬁrmed to
be a suitable quality control (QC) strain for campylobacters.
However, so far only tentative ranges of minimal inhibitory
concentrations (MICs) for this strain are available. In this study a
broth microdilution method (VetMICTM) was validated for C.
jejuni. The manufacturer’s method guideline for VetMICTM
Camp-plates (SVA, Sweden) was modiﬁed to standardize the
size of the inoculum.
Methods: A nephelometer and colony counts were used to
measure inoculum densities. Inoculum sizes were determined
for bovine intestinal isolates and repeatedly for the QC strain
using both pre-incubation and direct inoculation. The QC strain
was tested in 28 independent VetMICTM-procedures using pre-
incubation in broth and 25 times by direct inoculation.
Results: No correlation was detected between colony counts
and McFarland levels by nephelometer. It was concluded that
standardizing the inoculum size could not be based on this, for
other bacteria commonly used method. However, it was noticed
that growing campylobacters in Brucella broth for 24 hours
yielded consistently approximately 10 to the 8th CFU/ml. The
mean cell density for bovine isolates was 8.2 log10 CFU/ml with
the standard deviation (SD) of 0.3 when campylobacters were
pre-incubated in broth (n = 140). By direct inoculation the mean
cell density was 8.9 log10 CFU/ml (SD 0.2, n = 156). Cell
densities for the QC strain were 8.3 log10 CFU/ml (SD 0.2,
n = 24) and 8.9 log10 CFU/ml (SD 0.2, n = 27) respectively. Pre-
incubation in broth yielded more accurately the target inoculum
size of 10 to the 8th CFU/ml. All VetMICTM-results of the QC
strain for erythromycin, nalixidic acid, oxytetracyclin and
gentamicin by both methods were within tentative QC ranges
given by NCCLS. Slight differences could be seen in distribu-
tions of results between methods. Based on the results we set QC
limits of 2–8 mg/l for ampicillin and 0.25–0.5 mg/l for enroﬂ-
oxacin to be used in our laboratory for the modiﬁed method.
Conclusion: The results suggest that the modiﬁed broth micro-
dilution method presented here is reliable and reproducible for
testing antimicrobial resistance in C. jejuni.
P1298
Diagnosis of Salmonella gastro-intestinal
infections by LPS-based ELISA, a follow-up
study
M. Strid, K. Mølbak, T. Dalby, K.A. Krogfelt (Copenhagen, DK)
Objectives: Diagnosis of human gastrointestinal salmonellosis
is traditionally done by fecal culturing and agglutination assays.
An automatized ELISA is an obvious candidate for a more
Abstracts
414
reliable, fast and easy method of diagnosis. An indirect ELISA
employing LPS antigens was developed and evaluated.
Methods: Two automatized indirect ELISAs employing com-
mercially available Salmonella enteritidis (SE) LPS, respectively
Salmonella typhimurium (ST) LPS were developed. Both IgA,
IgM and IgG antibodies were detected. Sera from 153 Danish
patients diagnosed with infection by Salmonella enteritidis and
from 150 Danish patients diagnosed with infection by Salmonella
typhimurium were obtained and analysed. Blood-samples were
collected at approximately one, three, six and twelve months
after onset of salmonellosis. Cut-off values were deﬁned as the
mean plus two standard-deviations when analysing sera from
164 healthy, Danish blood-donors.
Results: The developed ELISAs proved reliable, and sensitivi-
ties of 96% for both analyses were reached when sera collected
less than 35 days after onset of salmonellosis were analysed. The
found detection rates at approx. one, three, six and twelve
months after onset were: 95%, 85%, 62% and 40% for the SE-
patients and 89%, 55%, 40% and 16% for the ST-patients.
Crossreactions between the two types of anti-LPS antibodies
were found, as well as few crossreaction to antibodies against
other gastrointestinal bacteria.
Conclusion: The LPS-based ELISA was found to detect recent
cases of gastrointestinal salmonellosis with a sensitivity of 96%.
This makes it a likely candidate for routine diagnosis. The
method was incapable of discriminating between SE- and
ST-patients; but a mix-ELISA incorporating both antigens
could however be a very promising means of a combined
high-sensitivity, fast serologic diagnosis of these two, the
commonest, Salmonella infections.
P1299
Evaluation of the LOUIS test for the presumptive
reporting of Salmonella from selective agars
employing hydrogen sulphide as a
discriminatory character and as a conﬁrmatory
test from chromogenic agars
G. Wilson (Stirling, UK)
Objectives: The LOUIS test is a rapid biochemical based
screening protocol, which can be used to facilitate the rapid
identiﬁcation of Salmonella. The test has previously been
evaluated for use with Lactose non-fermenting colony types.
The purpose of this study was to evaluate its use with media
that employ hydrogen-sulphide as a discriminatory character
and also to evaluate its use in colony conﬁrmation from
Salmonella chromogenic media.
Methods: Over a 6 month period 500 out patient stool samples
were inoculated onto 4 different agar types: SSI enteric (Statens
Serum Institute, Denmark), Salmonella-Shigella, SMID2 (both
bioMerieux, France) and ABC (LabM, England). A selenite F
broth (Oxoid, England) was inoculated and after incubation
cultured to the 4 agars. This gave rise to 161 H2S positive and 93
chromogenic positive isolates for testing. Isolates were inocula-
ted to 1 ml of sterile saline to give a suspension equivalent to at
least McFarland No. 4. Suspensions were dispensed (0.2 ml) in
to 3 test tubes, a nutrient agar slope (Oxoid, England) and a
purity plate. Individual reagent tablets (Rosco, Denmark) were
then added to the tubes and incubated at 37C/3 h. A new
algorithm (Table 1) was developed for use with H2S positive
colonies and the original algorithm (Table 2) was used for
isolates from chromogenic media. The API rapid ID32E gallery
(bioMerieux, France) was used for full biochemical conﬁrma-
tion. Polyvalent and group speciﬁc sera (Murex, England) were
used for serological identiﬁcation.
Results: The application of the new algorithm to isolates from
SSI and SS agars correctly identiﬁed 96 isolates as Salmonella
and discarded 61 isolates, leaving 4 unknown isolates for full
identiﬁcation. None were signiﬁcant. When applied to isolates
from chromogenic media the original algorithm correctly dis-
carded 9 isolates as non-signiﬁcant. Of the 83 Salmonella proﬁles
produced 2 were false positives (1 ONPG negative Hafnia alvei
and 1 atypical E. coli). One unknown isolate required full
identiﬁcation (Serratia spp). Overall the LOUIS test had a
sensitivity and speciﬁcity for Salmonella identiﬁcation of 99.9
(CI of 97.9–100) and 97.4 (CI of 91–99.3).
Conclusions: Early presumptive reporting of Salmonella can be
achieved with a positive LDC proﬁle with conﬁrmatory serology
3 h after isolation on chromogenic media and also on media that
utilise hydrogen sulphide as a discriminatory character.
P1300
Comparison of three Clostridium difﬁcile toxin
assays, C. difﬁcile GDH-antigen EIA, C. difﬁcile
GDH-PCR, bacterial culture and cytotoxicity
assay for the diagnosis of C. difﬁcile-associated
diarrhoea
K. Sachs, G. Ackermann, A.C. Rodloff (Leipzig, D)
Objectives: Clostridium difﬁcile- associated diarrhoea (CDAD)
remains the leading cause of nosocomial-acquired diarrhoea.
Prolonged hospital stay and diagnostic and therapeutic proce-
dures due to CDAD cause additional costs. The present study
had the aim to assess the value of different assays to detect
C. difﬁcile infections among patients with nosokomial diarrhoea.
Table 2: Original LOUIS test algorithm
LDC CNPG URE IND
Possible
identiﬁcation STEP 1 STEP 2
+ + - + E. coli Discard
+ - - +
- - + + Proteus spp or Discard
- - + - Morganella
morganii
+ - - - Salmonella Conﬁrm by
serology
(O and
H antigens)
Positive
API rapid
ID32E (4h)
Negative
serology:
Discard
- - - - Shigella spp
(possible LDC
negative
Salmonella)
API rapid
ID32E (4h)
Conﬁrm by
serology
Negative
serology:
Discard
- - - + Shigella spp API rapid
ID32E (4h)
Conﬁrm by
serology
Negative
serology:
Discard
- + - - Shigella sonnei
or Sh.
dsyenteriae 1
Conﬁrm by
serology
Positive
API rapid
ID32E (4h)
Negative
serology:
Discard
± Discard any other combination of reactions
Table 1. LOUIS test algorithm for H.S positive colonies
LDC ONPG URE IND Possible
indentiﬁcation
STEP 1 STEP 2
+ – – – Salmonella Conﬁrm by
serology
(O and H
antigens)
Positive
Full biochemical
ID
Negative serology.
Discard
– – – – Possible LDC
negative
Salmonella
API rapid
ID32E (4h)
Conﬁrm with
serology
Negative serology.
Discard
– – + + Proteus spp or
Morganella
morganii
Discard
– – + –
– + – – Citrobacter spp Discard
* Discard any other combination or reactions
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Methods: 377 stool samples from patients from a tertiary care
hospital were investigated for C. difﬁcile toxins using three Toxin
A/B assays (RIDASCREEN, r-biopharm; Premier C. difﬁcile
Toxin A&B, Meridian; Immunocard Toxins A&B, Meridian), a
C. difﬁcile GDH antigen EIA (C. DIFF CHEK, Techlab), C. difﬁcile
GDH PCR, stool culture and cytotoxicity assay. Toxin assays
and GDH-antigen EIA were performed according to the
instructions of the manufacturer. Stool culture was done using
cycloserin-cefoxitin-fructose agar.
Results: The toxin A/B positive results received from the three
toxin assays were as follows: RIDASCREEN, 55 (14.6%); Premier
Toxin A&B, 87 (23%); Immunocard Toxin A&B, 106 (28%).
GDH-antigen was detected in 121 (32%) stool samples using the
C. DIFF CHEK and in 100 (26.5%) specimens by PCR. C. difﬁcile
grew from 66 stool samples (17.5%). Speciﬁc cytopathic effect in
cell culture due to toxin B of C. difﬁcile was detected in 137
(36.3%) stool preparations.
Conclusion: Higher sensitivity and faster protocols make new
C. difﬁcile tests more attractive for routine diagnostics. The
performance of the Immunocard Toxin A&B assay and the two
GDH-antigen tests were excellent. Nevertheless, C. difﬁcile
culture is still necessary for further investigations as for
toxigenicity, antimicrobial susceptibility and typing.
P1301
Evaluation of three commercial tests for the
rapid diagnosis of Clostridium difﬁcile-mediated
antibiotic-associated diarrhoea: a routine
laboratory perspective
Y. Miendje, O. Vandenberg, F. Crockaert, M. Gerard, A. Dediste,
P. Retore, G. Mascart, G. Zissis (Brussels, B)
Objectives: Clostridium difﬁcile is the most important infectious
cause of nosocomial diarrhoea in industrialized countries. Early
diagnosis is associated with better prognosis, therefore rapid
laboratory diagnosis is highly desirable. Therefore, we have
compared under routine conditions three commercial Clostrid-
ium difﬁcile toxin immunoassays (EIA) (Premier Toxins A&B –
Meridian (PTAB), Immunocard Toxins A&B – Meridian
(ICTAB) and C. difﬁcile Toxin A test – Oxoid (TAO)) allowing
a rapid diagnosis of C. difﬁcile associated diarrhoea (CDAD)
directly on the stool specimen.
Methods: From January 04 to November 04, all stool samples
submitted for routine investigation of C. difﬁcile infection to our
hospital laboratory serving four University Hospitals in Brus-
sels, Belgium were evaluated with the 3 EIAs. For comparison
purpose, the combination of the culture carried out on cyclo-
serine-cefoxitin-fructose agar and the demonstration of the
toxigenicity in cell lines Hep2 performed directly from the
stool or from the C. difﬁcile isolate (‘second look’) was consid-
ered as the gold standard.
Results: Of the 234 stool specimens from 188 patients included
in the study, 25 were found positive (by the toxigenicity assays)
for C. difﬁcile, giving an overall recovery rate of 10.7%.The
sensitivity and speciﬁcity of the tested methods were respect-
ively, 88% and 97.6% for the PTAB test, 92% and 100% for the
ICTAB test and 60.0% and 99.5% for the TAO test. The positive
and negative predictive values found were respectively, 81.5%
and 98.6% for the PTAB, 100.0% and 99.1% for the ICTAB and
93.8% and 95.4% for the TAO.
Conclusion: These data suggest that the PTAB, ICTAB and
TAO assays are acceptable tests for the rapid diagnosis of CDAD
due to high negative predictive value but are not equivalent to
the cytotoxin assay. Because, the ICTAB is the most sensitive
and speciﬁc EIA evaluated, we recommend this test for a rapid
screening of patient with nosocomial diarrhoea.
P1302
Multicentre evaluation of a new rapid Tox A+B
test (Meridian ICTAB) for the diagnosis of
Clostridium difﬁcile-associated diarrhoea
J. Van Broeck, J. Verhaegen, D. Van Kerkhoven, B. Van Meensel,
M. Delme´e (Brussels, Leuven, B)
Objective: We evaluated the performances of a new rapid
enzyme immunoassay (Tox A+B) for the detection of Clostridium
difﬁcile Toxins A and B (Immunocard Toxin A&B – ICTAB,
Meridian Cincinnati, Ohio USA) on stool specimens received in
two university hospitals. Tox A+B was compared to a toxin A
latex immunoassay (Tox A) (C. difﬁcile toxin A test, Oxoid
Basingstoke England) and to the standard procedure in use in
the laboratories which comprises faecal cytotoxin detection and
faecal toxigenic culture.
Methods: Stools were from inpatients older than 2 years and
suffering from nosocomial diarrhoea following antimicrobial- or
chemo-therapy in two large university hospitals (St Luc-UCL
hospital in Brussels and Gasthuisberg-KULeuven hospital in
Leuven). Tox A+B and Tox A were performed according to the
respective manufacturer’s instructions. Faecal tissue culture
assay was performed using HeLa cells. Toxigenic culture
consisted of culture of faeces on CCFA medium followed, if
the culture was positive, by toxin detection on colonies using the
Tox A and Tox A+B assays. Toxigenic culture was considered
the gold standard.
Results: A total of 533 stools from 398 patients were included.
Culture was positive in 62 cases (11.6%) and 50/62 (80.6%)
strains were shown to be toxigenic. The following table
summarizes the main results. The assays’ sensitivity, speciﬁcity,
PPV and NPV were respectively:
Cytotoxin assay : 56%, 100%, 100%, 95.6%
Tox A: 66%, 98.6%, 82.5%, 96.5%
Tox A+B: 88%, 99.1%, 91.7%, 98.8%
Among the 50 stools with a positive toxigenic culture, 24 were
positive for the three toxin assays, 9 were positive for Tox A and
Tox A+B, 4 for Tox A+B and faecal cytotoxin, 8 for Tox A+B only
and 7 for none of the three tests. Among the 4 specimens with
positive Tox A+B and negative culture, one was from a patient
who had a positive stool culture ten days before.
Conclusion: Tox A+B was the most sensitive and highly
speciﬁc assay for the detection of C. difﬁcile toxins in faecal
specimens. Moreover, compared to other detection methods,
Tox A+B is particularly fast, easy to perform and has the added
beneﬁt of detecting both toxins.
P1303
A new approach to laboratory diagnostic of
infectious gastroenteritis
B. Olesen, D.S. Hansen, H. Tybring, A. Hansen, K.E.P. Olsen,
B.G. Bruun (Hillerød, Copenhagen, DK)
Objectives: In order to optimize use of laboratory facilities and
ensure ﬂexibility in relation to current epidemiology, a new
approach to laboratory diagnosis of infectious gastroenteritis
was applied: choice of examinations for the various pathogens
was deﬁned by the demographic, clinical and epidemiological
information submitted on the request form.
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Methods: From April 1-August 31, 2004, hospitals and general
practitioners submitted a request form with the following
information together with the stool sample(s): 1) acute diarrhoea
or persistent diarrhoea (duration > 2 weeks); 2) bloody stools; 3)
recent history of foreign travel; 4) > 2 persons with similar
symptoms in the surroundings; and 5) nosocomial infection.
Based on this information, microbiological analyses were per-
formed according to predeﬁned algorithms. Examination for
Salmonella, Campylobacter ¸ Yersinia, Shigella, Clostridium diff-
icile and Vibrio spp. were done by culturing. Verotoxin-
producing E. coli (VTEC), enteropathogenic E. coli (EPEC),
enterotoxigenic E. coli (ETEC) and enteroinvasive E. coli (EIEC)
were identiﬁed by PCR of virulence genes and serotyping. Rota-
and adenovirus were detected by antigen tests, norovirus by
PCR and parasites by microscopy.
Results: In the study period our department examined 2,463
stool samples from 1,242 patients. Preliminary results indicate
that 501 patients had acute diarrhoea, 13% of these were infected
with Campylobacter, 3% with Salmonella, and 1% each with
VTEC, ETEC and rotavirus; 573 patients had persistent diar-
rhoea, 4% of these were infected with Campylobacter, 1% each
with Salmonella and Giardia lamblia; 260 patients had a history
of recent foreign travel, 8% of these were infected with
Campylobacter, 5% with Salmonella, 4% with Giardia and 3%
with ETEC; 77 patients had bloody stools, 16% of these were
infected with Campylobacter, 7% with VTEC and 1% with
Salmonella. An outbreak of VTEC O157:H7 occurred among
visitors to a local petting farm. Sheep and goats on the farm
were found to be colonized with O157:H7 with the same distinct
PFGE pattern as isolates from the patients.
Conclusions: The new approach to microbiological examina-
tion of stools according to predeﬁned criteria has a number of
advantages: better patient management; collection of microbio-
logical data on deﬁned patient groups, hopefully optimizing use
of laboratory facilities; and ﬂexibility regarding adaptation to
current epidemiological knowledge.
P1304
Genetic proﬁling, clonal diversity and antibiotic
susceptibility in Escherichia coliO157:H7 isolated
in Catalun˜a (Spain)
A. Benavente, N. Larrosa, E. Rosello´, J. Blanco, A. Echeita,
R. Bartolome´ (Barcelona, Lugo, Madrid, E)
Objectives: To detect the major virulence genes, the clonal
diversity, phage types and antibiotic susceptibility evolution of
30 Escherichia coli O157:H7 strains isolated from patients with
gastroenteritis in Catalunya for the last 13 years (1990–2003).
Methods: The main virulence genes from E. coli O157:H7 were
characterized by classic PCR with speciﬁc primers for the phage-
encoded cytotoxins stx1 and stx2 genes (shiga toxins 1 and 2),
eae-gamma1 (speciﬁc O157:H7 intimin) and the plasmidic ehxA
gene (enterohemolysin). We also studied the chromosomal
encoded eae (intimin) gene and the plasmid encoded pO157
gene (pCDV419 plasmid). The serotypes were conﬁrmed by
multiplex PCR, detecting the somatic antigen O157 (rfbEO157
gene) and the ﬂagellar antigen H7 (ﬂiCH7 gene). The epidemi-
ologic subtyping was performed by pulsed ﬁeld electrophoresis
(PFGE) method. Cleavege of the agarose-embedded total
genomic DNA was achieved with XbaI. Phage typing (16
strains) was carried out in the Enterobacterial Department of
the Carlos III Health Institute. The sensitivity of the 30 strains
was assayed with 23 antibiotics using the Kirby-Bauer method.
Results: PCR showed that 21 (70%) isolates harboured both stx1
and stx2 genes (stx1+/stx2+) whereas 8 (26.6%) only carried stx2
gene (stx1-/stx2+). Only 1 (3.3%) strain carried the stx1 gene at
all (stx1+/stx2-). The speciﬁc O157:H7 eae-gamma1 gene, the
pCDV419 plasmid, the enterohemolysin, as well as the somatic
and ﬂagellar antigens, were detected in all the strains (100%).
The PFGE studies showed 29 diferent macrorrestriction patterns
(1 strain non-typeable), while phage typing showed 6 (3 strains
non-typeable) proﬁles: phage types 2, 8, 14, 31, 54 and 87.
Nevertheless, 9 strains (56.2%) could be grouped in only 3
phage-types. The 60% (18/30) of the strains were susceptible to
all the antibiotics assayed. Moreover, 8 (26.6%) were resistant to
cotrimoxazol, 8 (26.6%) to doxicycline, 4 (13.3%) to ampicillin, 3
(10%) to nalidixic acid, 2 (6%) to cloramphenicol and 1 (3.3%) to
kanamycin. The 26.6% (8 strains) were multirresistant.
Conclusions: In our geographical area, like in other countries
the greatest part of the E. coli O157:H7 strains, encodes the shiga
toxin 2 and more rarely the shiga toxin 1. Phage typing is a less
discriminative than PFGE as a typing method because strains
with the same phage type, showed different macrorrestriction
PFGE proﬁles. All the strains remain quite sensitive.
P1305
Eight new E. coli O groups that include
verocytotoxin-producing E. coli
F. Scheutz, T. Cheasty, D. Woodward, H.R. Smith (Copenhagen,
DK; London, UK; Winnipeg, CAN)
Objectives: Serotype and investigate virulence factors and
occurrence of the two temporary E. coli O group strains OX3
and OX7 and six presumptive new O groups in order to
establish them as test strains for O groups O174-O181.
Methods: Serotyping using agglutination tests and immuno-
chemistry, and virulence typing of isolates from our strain
collections combined with a review of the literature on new
types.
Results: O174 and O175 were originally isolated from cases of
human diarrhoea. The O174 strain is negative for known
virulence genes, the O175 strain is positive for astA and daaC.
Six new strains produced Verocytotoxin and were positive for
vtx1, vtx2 or both genes. Additional virulence genes associated
with diarrhoeal disease in humans were found in four of the
strains. O176 and O177 strains were isolated from calves, O178
and O181 strains from meat, the O179 strain from human bloody
diarrhoea, and the O180 strain from swine.
Conclusion: The agglutination tests, the epidemiological and
clinical data were more than sufﬁcient for the establishment of O
groups O174 through O181 as part of the existing serotyping
scheme for E. coli and will serve to characterise strains of E. coli
belonging to both diarrhoeagenic E. coli (DEC), extraintestinal
pathogenic E. coli (ExPEC) and nonpathogenic E. coli.
P1306
Ongoing cluster of Salmonella typhimurium PT
U291 infections in Austria, starting September
2003
D. Schmid, P. Much, A.M. Pichler, C. Kornschober, C. Berghold,
F. Allerberger (Vienna, Graz, A)
Objectives: S. typhimurium phage type U291 has not been
documented in Austria before Sept. 2003. Since then, this phage
type has spread to all but one of the nine provinces in Austria.
We describe this cluster.
Methods: From Sept. 2003 till Nov. 2004 187 laboratory-con-
ﬁrmed cases of infection with PT U291 were identiﬁed by the
National Reference Laboratory. Investigations revealed another
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45 epidemiologically related clinical cases, and included con-
sultation of the other European Salmonella Reference laborator-
ies via Enternet.
Results: The cluster consists of three outbreaks and a further 100
laboratory conﬁrmed cases without common links. The three
outbreaks (one hotel-associated continuous source outbreak, one
family point source outbreak, and one wedding celebration-
associated point source) comprised 30, 7, and 86 clinical cases,
respectively. The hotel-associated outbreak comprised 24 labor-
atory-conﬁrmed cases and 6 epidemiologically related clinical
cases, and occurred between 05.10 and 11.10.2003. The cases were
Austrian and German tourists, and employees of a hotel in a
western Austrian province. Case series data indicated that illness
was primarily associated with tiramisu, but no epidemiological
or microbiological evidence for this hypothesis was provided.
The family outbreak affected seven persons between 21.10 and
22.10.2003 in the same province. Cases were linked by common
exposure to a self-made tiramisu on 20.10.2003. Food examina-
tions revealed no salmonella. The third outbreak having affected
two eastern neighbouring provinces in Austria was associated
with a wedding celebration (Turkish ethnicity) on 4 Sept. 2004. A
total of 86 of approx. 230 wedding guests met the case deﬁnition
criteria. Non-human isolates of the causative agent were found in
samples of abraded walnuts and pistachios, and also in the
sample of the reﬁner obtained from that bakery having provided
the wedding cake, which was the most likely source of infection.
No Salmonella was identiﬁed in the food samples taken from the
restaurant, where the weeding celebration has taken place.
Conclusions: In absence of S. typhimurium PT U291 in most of
Europe, the increasing occurrence of this previously rare phage
type in Austria points to locally produced food as the culprit.
This cluster also underlines the importance of the zoonoses
directive, requiring adequate epidemiological and microbiolo-
gical studies of food-borne outbreaks, for disease prevention.
P1307
Prevalence of intestinal parasites and
enteropathogens micro-organisms in outpatients
of a central are of Madrid, Spain
M.A. Orellana, M. Aramendi, G. Galera, M.T. Sanchez, L. Garcia,
C. Manzanares, M.A. Amerigo (Madrid, E)
Background: The intestinal parasitic and enteric infections are a
public health problem that must be controlled in each area. The
inmigration and international travels have increased the number
of these process.
Objectives: To know the prevalence of intestinal parasites and
enteropathogens microorganisms infections in outpatients of
Center Area from Madrid (Spain).
Methods: )3.875 coprocultures and 4.391 parasite studies were
examined between February 2.003 and September 2.004.
COPROCULTURE: The stools were inoculated in XLD, Cam-
pylosel and CYN-agar(Biomerieux),and Selenito F (Pronadisa).
Adenovirus and rotavirus were detected by immunocromato-
graphie COMBI-STRIP(FASTIA). PARASITE STUDY: The stools
were concentrated using formalin-ethyl-acetate(Biosepar, Ger-
many); criptosporidium was detected by CRYPTO-STRIP
method (FASTIA) and enterobius vermicularis using perineal
samples(Graham test).
Results: The prevalence of positive coprocultures was:9.47%.
The frequency was: Salmonella 191(52.0%), Campylobacter sp
131(35.7%), Rotavirus 26(7.1%), Adenovirus 13(3.5%), Shigella
sp.2(0.5%), Yersinia sp.2(0.5%) and Aeromona sp.2(0.5%).Among
Samonellas the most frequent was S. enteritidis (111), followed
by S. group D(51), Salmonella sp.(10), S. paratyphi B(9), S. group
C(5), S. paratyphi A(3) and S. choleraesuis (2). The overall
prevalence of intestinal parasitisms was: 17.10%. The frequency
was: Blastocystis hominis 377 (56.9%), Entamoeba Coli 109
(16.4%), Giardia intestinalis 106 (16.0%), Criptosporidium
parvum 16 (2.4%), Iodamoeba butschlii 11 (1.6%), Ascaris
lumbricoides 10 (1.5%), enterobius vermicularis 8(1.2%), Estron-
giloides estercolaris 6 (0.9%), Endolimax nana 6 (0.9%), Hime-
nolepsis nana 4 (0.6%), Tenia sp 4 (0.6%), E.histolytica/dispar 2
(0.3%), Trichuri trichura 2 (0.3%)and Anquilostoma duodenale 1
(0.1%). Two or more parasites/sample were found in 5.9%.
Conclusion: Salmonella was the enteropathogen more frequent
isolated, followed by Campylobacter. The high prevalence of
intestinal parasites in our area is a public health problem and
controls are necessary to improve the prevention and contain
their spread.
P1308
Serotypes and antibiotic resistance of enteric
Salmonella isolated in outpatients in a central
area of Madrid, Spain
M.A. Orellana, G. Galera, M.T. Sanchez, M. Aramendi, L. Garcia,
C. Manzanares, M.A. Amerigo (Madrid, E)
Objective: To study the resistance patterns and serotypes of
enteric Salmonella isolated in outpatients in Center Area of
Madrid (Spain).
Methods: 305 enteric Salmonellas strains were isolated from
coproculture between January 2002 to September 2004.Identiﬁ-
cation and susceptibility were performed by Walkaway
MicroScan System(DADE-Behring)according to NCCLS recom-
mendation. The antimicrobial agents tested were:Ampicillin/
Sulbactam(A/S), Gentamicin(Gm), Cotrimoxazol(T/S), Pipera-
cillin(Pi), Meropenem(Me), Amoxicillin/A.clavula´nico(AMC),
Ciproﬂoxacin(Cp), and Ampicillin(Am). The seropyping was
tested using antisera for ﬂagelar and somatic antigens(Difco and
Biorad).
Results: The serotypes of Salmonellas isolated were: S. enterit-
idis 162 (53.1%), S.group D 78 (25.6%), S. paratyphi B 28(9.2%),
Salmonella sp.21 (6.9%), S. choleraesuis 7 (2.3%), S. group C 6
(1.9%) and S. paratyphi A 3 (0.9%). The resistance to antimicro-
bials tested was: Am 20.9%, T/S 3.9%, Gm 2.3%, A/S 20.9%, Pi
20.3%, Ti 20.9%, AMC 4.9%, Cp 0.6% and Me 0%. The 75.4% of
the strains studied were susceptible to all the antibiotics tested.
The most frequent antibiotic resistance patterns were: A/S, Ti,
Pi, Am: 18.8%; A/S, Ti, Pi, AMC, Am:2.9%; A/S, T/S, Ti, Pi,
Am:1.6% and 8.2% showed a different resistance pattern.
Among the different serotypes the susceptibility to all antibiotic
tested was: S. enteritidis 82.7%, S. group D 75.6%, S. paratyphi B
25%, Salmonella sp. 76.2%, S. choleraesuis 100%, S. group C 100%
and S. paratyphi A 33.3%.
Conclusions: S. enteritidis was the serotype isolated more
frequent. The 75% of Salmonellas studied were susceptible to
all antibiotics tested. Ampicillin, Ampicillin/Sulbactam, Pipera-
cillin and Ticarcillin were the antimicrobials less sensitive. The
antibiotic resistance pattern more frequent was: A/S, Ti, Pi, Am.
The serotype with more resistance to antibiotic tested was S.
paratyphi B.
P1309
Distribution of Salmonella enterica serovar
Enteritidis phage types in the Slovak Republic
during 1995–2004
L. Majtanova, V. Majta´n (Bratislava, SVK)
Objectives: In the last few decades, Salmonella enterica serovar
Enteritidis (S. Enteritidis) has emerged as a major cause of food-
borne illness worldwide. Nearly 90% of human salmonelloses in
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the SR are caused by this serovar. The object of this study was to
describe the distribution of S. Enteritidis phage types which
occurred from January 1995 to October 2004 in the SR.
Methods: Two thousand ﬁve hundred and sixty six strains
were phage typed during 1995–2004. The strains were isolated
from both human and food sources. The phage types were
identiﬁed according to Ward et al. (1987) in the National
Reference Center for phage typing of Salmonellae (head: Dr.
L. Majta´nova´).
Results: 2481 strains (96.7%) were typeable and belonged to 23
different phage types (PT). PT8 (62.8%) predominated in the
SR. Majority from outbreaks as well as from sporadic cases were
caused by strains of this PT. The second most frequently isolated
phage type was PT4 (9.2%). Further phage types according to
their occurrence were PT6 (4.0%), PT2 (3.9%), PT1 (3.8%), PT13a
(2.1%), PT15 (1.2%), PT9a (0.7%), PT21 (0.6%). Other phage types
have been occurred with low frequencies in all sources inves-
tigated. In addition, strains of RDNC (react but not conform to
designated phage types) and untypeable (UT) were isolated at
frequencies of 5.5% and 3.3%, respectively.
Conclusion: The distribution of phage types among sporadic
cases of Enteritidis isolates was similar to that among outbreak-
associated cases. This may suggest the common reservoirs for
both cases of salmonelloses. From the public health view it as
necessary to control on an international basis the spread of
infection caused by this serovar as well as the spread of the
individual phage types. This surveillance can be helpful,
together with molecular typing techniques, to clarify the
epidemiology of S. Enteritidis.
Acknowledgements: This work was supported by Science and
Technology Assistance Agency under the contract No. APVT-
21–052602.
P1310
Non-typhoid Salmonella bacteraemia in a Danish
county: a population-based prognostic follow-up
study
K.O. Gradel, H.C. Schønheyder, L. Pedersen, H.T. Sørensen,
R.W. Thomsen, M. Nørgaard, H. Nielsen (Aalborg, Aarhus, DK)
Objectives: We performed a population-based prognostic
follow-up study of Non-typhoid Salmonella (NTS) bacteraemia
patients in North Jutland County, Denmark. Data on age,
co-morbidity, clinical presentation, medicine use, and microbio-
logical factors were evaluated as prognostic determinants.
Methods: In North Jutland County, Denmark, all bacteraemias
are recorded in a research database, from which we extracted all
111 patients with NTS bacteraemia during a 10-year period,
1994–2003. The Hospital Discharge Registry (all discharge
diagnoses), the Prescription Registry (redemption of prescrip-
tion drugs), the Central Population Registry (data on domicile,
migrations, and deaths) and medical hospital records were used
as data sources, all linked by the unique Danish personal
identiﬁcation number. Medical records could not be retrieved
from one patient and one was a non-Danish resident. The
primary outcomes were mortality within 30 and 180 days of the
ﬁrst NTS positive blood sample.
Results: The incidence rate (mean 0.22/100,000 person years)
increased steadily from age 40–49 years (0.17) until age beyond
90 years (1.46). Twelve (11%) and 24 (22%) patients diedwithin 30
and 180 days, respectively. The 15 patients in whom a secondary
focus was diagnosed did not have signiﬁcantly higher 30-d
(OR = 0.6 (95% conﬁdence intervals 0.02–4.7)) or 180-d (OR = 1.4
(0.3–5.3)) mortality. The 30-d mortality rates (MRs) were 2/51
(3.9%), 5/41 (12.2%), and 5/17 (29.4%) in patients having
co-morbidity scores (Charlson index) of 0, 1–2, and ‡3, respect-
ively (p = 0.014), a distinctive trendmaintainedafter 180d (0 p: 3/
51 (5.9%); 1–2 p: 12/41 (29.3%); ‡3 p: 9/17 (52.9%) (p = 0.0001)).
Patients with major gastro-intestinal (GI) disorders did not have
higher mortality (30-d OR = 0.7 (0.03–6.3); 180-d OR = 1.2 (0.2–
5.5)). The 180-d MRs and density of bacteraemia measured by
numbers of positive blood culture bottles were positively corre-
lated. No other microbiological factors (e.g., serotype, antibiotic
resistance) were associated with mortality.
Conclusions: The presence of co-morbid diseases was a major
determinant of mortality, whereas age per se, microbiological
factors and GI related conditions seemed less important.
P1311
Food poisoning outbreak at a bank cafeteria: the
investigation report
N. Hanna, A. Saraﬁan, M. Mokbel, Z. Daoud, S. Adib (Beirut,
LBN)
An investigative group was called on 26/5/04 by the Ministry of
Public Health to investigate a food poisoning outbreak which
had occurred at the central ofﬁce of one of the biggest banks in
Lebanon. The ﬁrst symptoms of gastro-enteritis compatible with
food poisoning appeared among bank employees in the evening
of 17/4/04. On that day, many employees had eaten at the bank
cafeteria. All of those with signs and symptoms shared the fact
that they had eaten the main dish of ‘poulet aux nouilles’. In at
least one case, the ‘poulet aux nouilles’ was the only food item
consumed at the cafeteria. Of the 32 contacted persons, 26
people eventually reported signs and symptoms compatible
with food poisoning; The attack rate for this outbreak was thus
very high at 81%, suggesting a very large infective dose ingested
in the incriminated dish. Most commonly reported signs are
shown in Table 1. In one case, severe septicemia occurred. These
ﬁndings are compatible with acute salmonellosis. The diagnosis
of salmonellosis was conﬁrmed with stool and blood cultures
within 48–72 hours after hospital admission of ﬁrst cases.
Investigation of the source: All 18 kitchen workers were
subjected to a sampling of rectal and nasal mucosa to be
cultured at the laboratory of the Saint-Georges Hospital (HSG)
in Beirut.Results conﬁrm the absence of Salmonella carriage in
all. At the time of the outbreak, water was provided from a
tanker company. Water samples were repeatedly done on May
18 and 21 yielding high fecal coliform counts but no Salmonella.
Different food samples were collected from different batches. A
portion of left-overs of the ‘poulet aux nouilles’ dish which was
sent out on 18/5/04 revealed the presence of Salmonella on
7/6/04, thus conﬁrming the contamination of the dish. As per
the chicken analysis, two specimens heavily grew Salmonella
from the surface and internal tissues of raw chicken. Genetic
studies have been done on the different isolated strains from
chicken, leftovers, and patient, showing clear genetic similarity
(Salmonella enteritidis) and suggesting therefore the same origin:
chicken.
Frequency of signs and hospitalization following the outbreak
(N = 32)
SIGNS/SYMPTOMS n %
Diarrhea 23 88.5
Fever 22 84.6
Abdominal pain 21 80.8
Vomiting 16 61.0
Loss of consciousness 3 11.5
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Conclusion: Based on our results, the source of contamination
was raw chicken. It is important to protect the public from
contaminated raw chicken, and to investigate sources of con-
tamination at the chicken farm level.
P1312
An outbreak of gastroenteritis due to Aeromonas
hydrophila
M. Carev, D. Tandara, P. Rizvan, Z. Barisic, K. Sisko Kraljevic,
E. Borzic (Split, HR)
Objectives: Our goal was to report an outbreak of Aeromonas
hydrophila gastrointestinal infection due to consumption of
contaminated water, in the rural area of Dalmatia County,
Croatia. This report warns about diagnostic difﬁculties and
importance of ﬁnding Aeromonas in both water and human
stool samples.
Methods: Our epidemiologist personally interviewed 30 symp-
tomatic and 36 asymptomatic villagers. Four human stools
(13.3%) from the diseased were analysed on: Salmonella spp.,
Shigella spp., Yersinia spp., Vibrio spp., Campylobacter spp., Rota
and Adenoviruses, intestinal protozoa and helmint eggs. Six
water samples were examined bacteriologically, virologically
and parasitologically.
Results: All diseased were drinking water from local drinking
water distribution system, with pipelines very distant from the
water source. Main symptoms were abdominal pain, watery
diarrhoea and tiredness. Most of the patients recovered com-
pletely after 48 hrs and were only treated symptomatically. 28
persons (78%) from control group didn’t drink that water at
all.All stool samples were negative on viruses, parasites and
bacterial pathogens. The result of water analyses was negative
for viruses and intestinal parasites. Bacteriological analyses of
ﬁrst water sample showed that the number of aerobic mesophi-
lic and psychrophilic bacteria per ml was higher than standard.
A. hydrophila was isolated from Cefsulodin Irgasan Novobiocin
(CIN) agar (>1800 CFU/100 ml). Further analysis of the last two
stool samples included additional testing of pink colonies from
CIN agar. They were transferred on Kligler Iron Agar and
incubated at 37C and 25C. Oxydase and catalase tests were
positive and Api 20E and BBL crystals conﬁrmed isolates as
A. hydrophila. Stool and water isolates showed same suscep-
tibility patterns for antibiotics (resistance to amoxicillin and
cefazolin). This was the ﬁrst conﬁrmed isolation of these bacteria
as cause of an outbreak in our County. After cleaning, chlorin-
ation and connection to new water source, water samples were
in accordance to the standards. There were no new cases.
Conclusion: Identical biochemical and antimicrobial suscepti-
bility patterns of human and water strains, with positive clinical
ﬁndings and epidemiological data showed us that this small
outbreak was due to A. hydrophila. This conclusion was suppor-
ted by negative tests for other pathogens. Real prevalence of this
pathogen is still unknown and probably underestimated.
P1313
Antimicrobial resistance and molecular typing of
Salmonella isolates from food
S. Valdezate, M. Arroyo, R. Gonza´lez, R. Ramiro,
S. Herrera-Leo´n, M.A. Usera, J.A. Lo´pez Portole´s,
A. Echeita (Madrid, E)
Objectives: To study the clonal relationship and the antimicro-
bial resistance showed by strains of different serotypes of
Salmonella spp. isolated from food for human consumption
during a one-year period.
Methods: Antimicrobial susceptibility to 23 antibiotics was
determined by disk diffusion in 380 Salmonella spp. isolates
submitted to LNRSSE from all Spanish regions with the
following distribution by serotypes: Enteritidis (n = 176),
Typhimurium (n = 60) and other serotypes (n = 144). Molecular
epidemiology of Enteritidis and Typhimurium serotypes was
investigated using PFGE and computerized numerical analysis
of the data. Phage typing was also performed.
Results: Analysis was carried out with strains without epide-
miological link. Analyzed Enteritidis strains (n = 96) were
mainly from eggs and derived (27%) and from poultry and
derived (24%), detecting 16 phage types (PT) with predomin-
ance of PT1 (39%). They were identiﬁed 9 pulsetypes, with a
similarity genetic range of 81–96%, emerging a frequent clone
(74%). Analyzed Typhimurium strains (n = 53) were from
sausage and cold meat (21%), pig and derived (15%), and
from poultry and derived (15%), detecting 12 DTs, with
predominance of DT104 (28%) and U302 (19%). They were
identiﬁed 13 pulsetypes, with a similarity genetic range of 64–
86%, emerging a frequent clone (34%). Antimicrobial resistance
rates (NCCLS, M100-S13) for the strains of Enteritidis,
Typhimurium, and other 49 different serotypes (n = 115) were,
respectively: ampicillin (8, 62 and 14%), spectinomycin (99, 87
and 100%), streptomycin (1, 53 and 59%), gentamicin (1, 4 and
0%), tobramycin (1, 4 and 0%), amikacin (1, 0 and 0%), netilmicin
(1, 4 and 0%), nalidixic acid (41, 22 and 14%), tetracycline (16, 72
and 31%), sulphonamide (7, 62 and 21%), trimethoprim-sulpha-
methoxazole (7, 19 and 14%) and cloramphenicol (0, 51 and 9%).
All the strains were susceptible to the other tested betalactams
and ﬂuorquinolones.
Conclusion: High clonality of food strains of Enteritidis sero-
type, showing higher discrimination index (ID) the phage typing
(0.81) than PFGE (0.44) with a high nalidixic acid resistance
(42%). High efﬁciency of PFGE in the serotype Typhimurium,
with similar ID in both techniques (0.86), noteworthy resistances
higher than 50% for ampicillin, streptomycin, tetracycline,
sulphonamide and cloramphenicol. Strains of other serotypes
showed minor resistance rates.
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P1314
A survey on drug resistance in Shigella
organisms in 3 hospitals in Tehran over a six
month period
L. Chamani, M.A. Noyan Ashraf, S. Asadi (Tehran, IR)
Objectives: Shigellosis is a common disease in Asian countries
esp in warm months. Knowledge of the pattern of resistance in a
given population which changes by time is useful. We designed
this study to evaluate drug resistance in Shigella spp in 3
hospitals of Tehran in order to ﬁnd the suitable empirical
antibiotic therapy in shigellosis.
Methods: It was a cross sectional prospective study in three
different hospitals of Tehran from March to April 2003. Fresh
stool samples of patients with dysentery were cultured on
MacConkey agar and Hectoen enteric agar and incubated
overnight at 37 degrees. Lactone negative colonies were trans-
ferred to triple sugar iron agar and lysine-iron agar slants and
reincubated. Those with characteristic reaction (alkaline salt,
acid butt, and no gass) were tested biochemically and then
serologically identiﬁed with shigella grouping and typing
antisera. Drug Resistance was evaluated in cultured Shigella
organisms by disk diffusion susceptibility testing.
Results: Shigella spp. Were cultured in 96 of 1476 stool cultures
(6.5%). The antibiotic susceptibility testing results were as
bellow:- Shigella spp. Were completely(100%) sensitive to
Ciproﬂoxacin, Oﬂoxacin & Norﬂoxacin and 96% sensitive to
Nalidixic Acid. 1. They were 100% sensitive to Ceftriaxone and
Cefotaxime but 85% to Ceftizoxime and 80% to Cefazolin. 2.
There was 100% resistance to Ampicilline and 85% resistance to
Cotrimoxazole.- They were 54% sensitive,12% resistant and 34%
intermediatly resistant to Gentamicin.
Conclusion: It seems that new Fluoroquinolones for adults and
Nalidixic Acid for chidren are suitable empirical antibiotic
therapy of shigellosis in Tehran. Ceftriaxone and Cefotaxime are
suitable for severe cases and hospitalized patients and ceftizox-
ime & cefazoline may be useful alternatively. Ampicilline and
Cotrimoxazole should not be used for treatment any more.
Supported by the BIB, Avesina Research Institute, Tehran, Iran.
P1315
Severe pseudomembranous colitis mimicking an
acute abdomen in elderly patients
L. Legout, L. Bernard, D. Gasselin, M. Assal, P. Rohner,
P. Hoffmeyer (Geneve, CH; Paris, F)
Background: Pseudomembranous colitis is a life threatening
complication of broad spectrum antibiotic therapy caused by
Clostridium difﬁcile. The frequency of pseudomembranous colitis
with potential fatal outcome is underestimated especially in
elderly patients.
Patients and methods: We report 5 cases of pseudomembra-
nous colitis in elderly patients who had an adynamic ileus
mimicking an acute abdomen. C. difﬁcilewas identiﬁed by toxins
and culture. Plain ﬁlms of the abdomen and CT were performed
for all patients.
Results: 5 females ( median age: 83 years- range: 76–95) were
admitted in hospital for pneumonia (n = 1), osteomyelitis
(n = 2), diarrhoea (n = 1), elective orthopaedic surgery (n = 1)
and received a betalactamin (n = 4), or clindamycin (n = 1).
Their co-morbidity were lupus (n = 2), diabetes mellitus (n = 1),
cancer (n = 1), renal chronic failure (n = 1). They had fever
(n = 5), bad general condition (n = 5), cramping abdominal
pains (n = 5) following by an acute abdominal (n = 5). The
diarrhoea was only present at the beginning of medical history
for 2 patients. The biological exams found:white-cell count: 30.7
G/L (15.4–49.7); neutrophils polynuclear count: 25.8 G/L (10.1–
41.2), platelets count: 481 G/L (313–622); C-reactive protein:
235 mg/l (180–300); creatinine:129 lmol/l (82–270); urea:
8.5 mmol/l (4–17.8). The liver tests and chest x-ray were all
normal. Plain ﬁlms of the abdomen showed a megacolon (n = 2).
Abdomen CT suspected a volvulus of caecum (n = 1), diverti-
culitis (n = 1), found wall thickening of the transverse colon
(n = 4), ascites (n = 1) but no perforation. 2 patients had have an
abdominal laparoscopic exploration. After 4 days of treatment
with metronidazole, the outcome was fatal for 2 patients due to
heart failure.
Discussion and conclusions: The diagnosis of pseudomembra-
nous colitis must be evocated in elderly patients especially if an
history of antibiotic therapy even a short course (for example
perioperative prophylaxis) is found and cramping abdominal
pain is associated with a high white cell count (> 25 G/L). If
surgical treatment is required, the overall mortality increase.
P1316
Characterisation of Campylobacter jejuni/coli
strains isolated in Serbia and Montenegro
B. Miljkovic-Selimovic, L. Ng, D. Woodward, L. Price, T. Babic,
M. Ratkovic-Jankovic, L. Ristic, B. Kocic (Nis, CS; Winnipeg,
CAN)
Objective: Campylobacter jejuni (C. jejuni), and Campylobacter coli
(C. coli), represent the main cause of bacterial diarrhoea in
developed countries and one of the most frequent causes of
enterocolitis in developing countries. After C. jejuni infection,
severe chronic sequelae may occur, such as reactive arthritis,
post-infective neuropathy, Guillain-Barre´ syndrome (GBS) and
Miller-Fisher Syndrome (MFS) In addition, some serotypes are
more often associated with GBS and MFS. Serotyping based on
heat stable antigens, (HS, Penner serotyping) is methods for the
investigation of the clonality of the C. jejuni/coli strains isolated
in patients with diarrhoea and in patients with post-infective
neuropathy. In addition, there is lack of evidence about data
related to serotype distribution for some geographical areas and
also for GBS associated strains.
Methods: In this study, we have characterized a strain of
thermophilic Campylobacter isolated in a patient with GBS, 37
strains of thermophilic Campylobacters isolated in patients with
diarrhoea in Nis, and 6 strains from the collection of the Institute
for Immunobiology and Virology ‘‘Torlak’’, Belgrad. Strains
presumptively identiﬁed as campylobacters were differentiated
to the species level by a combination of biotyping tests and by
the use of a PCR-based RFLP test. HS serotyping was performed
using a passive hemagglutination test using erythrocytes sensi-
tized with heat extracted antigens and antisera.
Results: The GBS associated strain was identiﬁed as Campylo-
bacter jejuni, biotype II, O19. Among the isolates from Nis,
C. jejuni dominated over C. coli and biotype I dominated over
other biotypes. In these C. jejuni strains, diversity of HS serotypes
were detected (O:1, O:2, O:2,66, O:3, O:3,50, O:4complex ,O:6,57,
O:8, O:8,17, O:9,21,58, O:10, O:11...). as well as among C. coli
strains (O:4,28,32, O:14,34, O:24, O:34, O:49, O:64,66). In the 6
strains collected at Torlak, all isolates were identiﬁed as C. coli.
All of these isolates were identiﬁed as biotype I and three
different HS serotypes were found (O:14,34, O:34, O:49).
Conclusion: The investigation of HS serotypes in isolated
C. jejuni and C. coli strains, conﬁrmed their clonal diversity
indicating epidemiologcaly unrelated origin of the strains.
Detected HS serotype (O:19) of the GBS associated C. jejuni, is
the most often described one in this post-infective complication.
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P1317
Tigecycline compared with imipenem/cilastatin
in the treatment of complicated intra-abdominal
infections
E.J. Ellis-Grosse, E. Loh on behalf of the Tigecycline 301 Study
Group
Objective: Due to their diverse bacteriology and emergence of
bacterial resistance, treatment of complicated intra-abdominal
infections (cIAI) represents a clinical challenge. The efﬁcacy of
tigecycline (TGC) monotherapy, a novel, expanded broad-
spectrum glycylcycline, was compared with imipenem/cilasta-
tin (IMI/CIS) in adult hospitalized patients with cIAI.
Methods: In this double-blind, phase 3, multinational trial,
patients were stratiﬁed by disease severity (APACHE II score
£15 vs >15 but <31), and randomly assigned to IV TGC (100 mg
loading, then 50 mg q12h) or IV IMI/CIS adjusted for body
weight (500/500 mg q6h for ‡70 kg) for 5–14 days. Clinical
response at test-of-cure (TOC, 12–44 days after therapy) for
microbiological evaluable (ME) and microbiological modiﬁed
intent-to-treat (m-mITT) populations were co-primary efﬁcacy
endpoints in which cure/failure responses were determined.
Results: Of 825 mITT patients who received more than 1 dose of
study drug, 621 (75%) comprised the m-mITT cohort (309 TGC,
312 IMI/CIS) and 502 (61%) were ME (247 TGC, 255 IMI/CIS).
Treatment groups were balanced with respect to demographic/
baseline medical characteristics. Patients were predominately
males (65%) with a mean age of 44 years. The primary diagnoses
for the mITT group were complicated appendicitis (52%),
perforation of intestine (10%), gastric/duodenal perforation
(10%), cholecystitis (8%), and intraabdominal abscess (8%).
The median duration of therapy was 7 days. For the ME
group, clinical cure rates at TOC were 80.6% (199/247) for TGC
vs 82.4% (210/255) for IMI/CIS (95% CI = )8.4, 5.1; p < 0.001).
Corresponding clinical cure rates for the m-mITT cohort were
73.5% (227/309) for TGC vs 78.2% (244/312) for IMI/CIS (95%
CI = )11.0, 2.5; p < 0.001). The most commonly reported
adverse events for TGC and IMI/CIS were nausea (31.0% and
24.8%) and vomiting (25.7% and 19.4%).
Conclusions: TGC is an expanded-broad-spectrum IV glycyl-
cycline with activity against gram-positive, gram-negative and
anaerobic pathogens, including strains resistant to commonly
used antibiotics. TGCmet statistical criteria for non-inferiority to
the comparator IMI/CIS and appears to be safe and effecacious
in the treatment of hospitalized patients with cIAI.
P1318
Detection of viral, bacterial and parasitological
RNA or DNA of nine intestinal pathogens in
faecal samples archived as part of the Infectious
Intestinal Disease Study: assessment of the
stability of target nucleic acid
C.F.L. Amar, C. East, J. Gray, E. Maclure, J. McLauchlin (London,
UK)
Objective: The purpose of this study was to apply PCR based
procedures to assess the stability of pathogen speciﬁc nucleic
acid sequences present in frozen and archived faecal samples of
the English Infectious Intestinal disease (IID).
Methods: Faecal samples were collected from cases and con-
trols as part of the IID study and were stored as frozen
suspensions for eight to 12 years. Samples were selected from
the archive where either Cryptosporidium, Giardia, Salmonella,
Campylobacter, enteroaggregative Escherichia coli (EAggEC),
enterotoxigenic Clostridium perfringens, rotaviruses, norovirus-
es or sapoviruses had been previously detected. A generic
nucleic acid extraction method to recover RNA or DNA was
used. Complementary DNA was generated from RNA by
reverse transcription with random priming. Block based and
real time PCR assays were used to amplify and detect gene
fragments from each of these pathogens.
Results: The percentage of target detected was as follows:
Giardia duodenalis 68%, Cryptosporidium 96%, Campylobacter
98%, Salmonella 98%, enterotoxigenic C. perfringens 34%,
EAggEC 93.3%, rotavirus 95%, norovirus 73% and sapovirus
85%.
Conclusion: This study has shown that nucleic acid could be
extracted and speciﬁc sequences ampliﬁed and detected from
archived faecal samples. The IID archive therefore represents a
valuable resource for further studies, especially the investigation
of the samples where no pathogens had previously been
detected.
P1319
Norovirus associated gastroenteritis at a tertiary
hospital in Greece
P. Karabogia-Karaﬁllidis, M. Orfanidou, A. Strouza,
E. Vagiakou-Voudris, H. Malamou-Lada (Athens Papagos, GR)
Objectives: To report the ﬁrst laboratory diagnosed cases of
Norovirus associated gastroenteritis at a tertiary hospital in
Athens, Greece.
Methods: During two months period (1/9/04–1/11/04) 45
stool specimens obtained from 44 patients and one healthcare
worker with acute gastroenteritis were investigated for the
presence of enteropathogens (Salmonella, Shigella, Campylo-
bacter, Yersinia, E. coli O 157-H7, C. difﬁcile) by conventional
methods. Norovirus was detected by an EIA, antigen assay
(IDEIA TM Norovirus, Dako Cytomation) which differentiates
Norovirus genotypes G1 and G2. Moreover EIA was applied in
stool specimens of 10 healthy controls.
Results: Noroviruses were detected in 15/45 (33.3%) patients
with acute gastroenteritis. None of the healthy controls was
found to be positive for Noroviruses. G1 was deﬁned in two (2/
15, 13%) outpatients. Both G1+G2 were detected in three (3/15,
20%) hospitalized patients while G2 was deﬁned in 10 (10/15,
66.7%). Two were outpatients and three were hospitalized in
various wards. Moreover, the ﬁve remaining cases (three
inpatients, one visitor and one health worker) were observed
in the Nephrology ward in one week period. Salmonella
enteritidis and C. difﬁcile were isolated in four patients.
Conclusions: These are the ﬁrst laboratory diagnosed cases of
Norovirus associated acute gastroenteritis in Greece. Most of the
cases were hospital-acquired infections caused mainly by G2
Norovirus. An outbreak was observed at the Nephrology
department. No false positive results were found in the healthy
controls. ELISA is a rapid and useful test for early diagnosis of
Norovirus gastroenteritis and prevention of Norovirus spread in
the hospital environment.
P1320
Intracellular expression of B subunit of heat-
labile enterotoxin of ETEC in Saccharomyces
cerevisiae
M. Ahangarzadeh Rezaee, A. Rezaee, A. Salmanian,
M. Moazeni, S. Najar Peerayeh, M. Arzanlou (Tehran, IR)
Objectives: Heat-labile enterotoxin (LT) of ETEC, consists of A
and B subunits. Heat-labile enterotoxin B subunit (LTB) has been
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used in many scientiﬁc applications. LTB is a subunit vaccine
candidate against diarrhoea caused by enterotoxigenic E. coli. It
has been already expressed in several bacterial and plant
systems. In this study, we expressed LTB in yeast Saccharomyces
cerevisiae.
Methods: In order to construction of yeast expressing vector for
LTB protein, the eltB gene encoding LTB was ampliﬁed from a
human origin enterotoxigenic E. coli DNA by PCR. The
expression plasmid pLTB83 was constructed by inserting eltB
gene into pYES2 shuttle vector immediately downstream of the
GAL1 promoter. The new construct was introduced into
S. cerevisiae cells. The cells were induced in the presence of 2%
galactose.
Results: Immunoblot analysis showed the presence of LTB in
yeast lysate and indicated that the yeast-derived LTB protein
was antigenically indistinguishable from bacterial LTB protein.
The monomeric LTB protein molecules (11.6 KDa) were the
dominant molecular species detected in yeast total soluble
protein.
Conclusions: Since, whole recombinant yeast introduced as a
new vaccine formulation, expression of LTB in S. cerevisiae
may offer an effective and inexpensive strategy to protect
people especially in developing countries against ETEC and
cholera.
P1321
Expression of B subunit of cholera toxin in
Saccharomyces cerevisiae
M. Arzanlou, A. Rezaee, N. Shahrokhi, A. Zavaran Hosseini,
M. Ahangarzadeh Rezaee (Tehran, IR)
Objectives: Cholera toxin, secreted by Vibrio cholera, consists
of A and B subunits. Cholera toxin B subunit (CTB) has been
used in many scientiﬁc applications. CTB is a subunit vaccine
candidate against cholera. It has been already expressed in
several bacterial and plant systems.
Methods: In this study, in order to construction of yeast
expressing vector for CTB protein, the ctxB gene (309 bp)
encoding CTB was ampliﬁed from Vibrio cholera genomic DNA
by PCR. The expression plasmid pCTB83 was constructed by
inserting ctxB gene into pYES2 shuttle vector immediately down
stream of the GAL1 promoter. The new construct was intro-
duced into S. cerevisiae cells. The cells were induced in the
presence of 2% galactose.
Results: Immunoblat analysis showed the presence of CTB in
yeast lysate and indicated that the yeast-derived CTB protein
was antigenically indistinguishable from bacterial CTB protein.
The monomeric CTB protein molecules (11.6 KDa) were the
dominant molecular species detected in yeast total soluble
protein.
Conclusions: Since, whole recombinant yeast introduced as
new vaccine formulation, expression of CTB in S cerevisiae may
offer an effective and inexpensive strategy to protect people
against cholera and enterotoxigenic E. coli in high risk areas.
Respiratory tract infection
P1322
Relationship between bacterial colonisation,
exacerbations and current smoking in 575
patients with chronic obstructive pulmonary
disease
L.H. Mygind, J. Vestbo, J.J. Christensen, C. Pedersen,
N. Frimodt-Møller, S.S. Pedersen (Odense, DK; Manchester, UK;
Copenhagen, DK)
Objectives: Patients with COPD are often colonised with
bacteria in their lower respiratory tract, but the clinical relevance
is debatable. One small study has shown, that colonisation in
stable state was related to exacerbation frequency. Previous
studies have found a correlation between current smoking and
the degree of colonization, which could not be reproduced in a
more recent study. We want to investigate the degree of
colonisation and compare the ﬁndings with exacerbations and
smoking habits.
Methods: 575 COPD patients with a previous hospitalization
due to an exacerbation were included in the study. Inclusion
criteria were: age ( 49 years, FEV1 ( 60% predicted, FEV1/
FVC < 70% and (4 weeks in a clinically stable state. Lung
function was measured and spontaneous sputum collected. A
severe exacerbation was deﬁned as one requiring hospitalisa-
tion.
Results: Age 50–88 (median 71): FEV1 0.18–3.19 l (median 0.90 l,
39% predicted) and FVC 0.57–4.43 l (median 2.00 l). 266 (46%)
patients could produce sputum samples: 231 samples were
considered representative of lower airways. 77(33%) patients
were colonised with potentially pathogenic bacteria (PPB) and
154 patients had growth of respiratory non-pathogenic bacteria
(non-PB). The frequencies of PPB were: Haemophilus inﬂuenzae
26, Moraxella catarrhalis 18, Streptococcus pneumoniae 18, Entero-
bacteriaceae 21, Pseudomonas aeruginosa 7. In 13 patients more
than one bacterium were found. The patients with PPB had 1.7
mean exacerbations/year compared to 1.5 in patients with non-
PB. The patients were stratiﬁed according to severity of COPD:
18% were moderate (FEV1 ( 50%), 56% were severe (FEV1 (30%
to (50%) and 26% were very severe (FEV1 ( 30%). In the very
severe COPD group patients with PPB and non-PB had 2.2 and
1.9 and in the severe COPD group patients had 1.5 and 1.4 mean
exacerbations/year, respectively. There was not a higher fre-
quency of colonisation in current smokers as compared to
ex-smokers neither in the whole group nor when stratiﬁed for
severity.
Conclusion: 46% of the 575 stable COPD patients spontane-
ously produced sputum, and of these 33% had pathogenic
bacteria. There was no correlation between colonisation and
current smoking. The patients with colonisation had an
increased number of severe exacerbations, even when stratiﬁed
for severity of COPD, suggesting that the presence of bacteria is
clinically relevant. The next step will be to perform intervention
studies aimed at reducing colonisation.
P1323
Predictors of pneumonia in patients with lower
respiratory tract infection in primary care
A. Holm, J. Nexoe, L.P. Nielsen, N. Obel, S.S. Pedersen,
C. Pedersen (Odense, DK)
Objectives: The majority of out-patients with lower respiratory
tract infection (LRTI) is treated with antibiotics, although the
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beneﬁt of this is questionable. The objective of our study was to
identify predictors of pneumonia that could contribute to the
identiﬁcation of patients in need of antibiotic treatment. This
may lead to a reduction in antibiotic prescribing in the group of
patients with non-pneumonic LRTI.
Methods: We prospectively studied 364 consecutive out-
patients with LRTI. Patient characteristics were registered, a
chest x-ray was taken, and blood samples were drawn for
measuring C-reactive protein (CRP) and leukocytes. Pneumonia
was deﬁned by a transient inﬁltrate on chest X-ray.
Results: Pneumonia was found in 48 patients (13%). The
pneumonic patients were older with a median age of 61 years
compared to 48 years in the non-pneumonic patients. There
were no differences in the occurrence of cough, dyspnoea, chest
pain or auscultative abnormalities, but sputum production was
less common in pneumonic compared to non-pneumonic
patients (69% vs. 83%; p = 0.03). The median CRP was higher
in pneumonic patients (73 mg/l vs. 11 mg/l; p ( 0.01), as was
the median leukocyte count (10 · 109/l vs. 8 · 109/l; p ( 0.01).
There was no signiﬁcant difference in the median temperature
between groups (37.5C vs. 37.3C). The median respiratory
frequency was higher (21/min vs. 18/min; p ( 0.01), and the
oxygen saturation lower (0.95 vs. 0.98; p ( 0.01) in the pneu-
monic patients.
Conclusions: Pneumonic patients differed from non-pneumonic
patients in being older and presenting less often with a
productive cough. The respiratory frequency was higher, and
the oxygen saturation lower. A promising predictor was found in
the measure of CRP found to be higher in pneumonic patients. A
point-of-care-test for CRP is available for use in primary care.
This may guide the general practitioner in identifying patients
with LRTI in need of antibiotic treatment.
P1324
Community outbreaks of legionellosis in
Catalonia, 1990–2003
J. Alvarez, A. Dominguez, M. Sabria`, L. Ruiz, N. Torner, J. Cayla`,
I. Barrabeig, M.R. Sala, P. Godoy, N. Camps, S. Minguell for the
Working Group on Communicable Diseases of the RCESP
Objectives: 1. To analyze the characteristics of the community-
acquired outbreaks notiﬁed in Catalonia during the period
1990–2003 2. To compare the characteristics of the outbreaks of
the period 1990–1996, with those of the period 1997–2003 when
the urinary antigen test was widely used.
Materials and methods: Epidemiological records of all com-
munity outbreaks of legionellosis reported to the Department of
Health of the Generalitat of Catalonia (6.3 million inhabitants),
Spain, excluding those of nosocomial origin, during the period
1990–2003 were studied. An epidemic outbreak was considered
as the appearance of two or more epidemiologically-related
cases of legionellosis. Descriptive variables were recorded for
each outbreak and a comparative analysis made of outbreaks
occurring between 1990 and 1996 (period I) and 1997 and 2003
(period II). v2 test was used to compare qualitative variables.
Results: Ninety outbreaks were studied. The origin was deter-
mined solely by epidemiological data in 47 (52.2%), and by
epidemiological data and molecular biology in 6 (6.7%). The
origin could not be determined in the remaining outbreaks.
Cooling towers were involved in 34.4% of the outbreaks. The
annual evolution of the number of outbreaks has been progres-
sively greater from 1990 with a clear increase from 1999
onwards. 71.1% of the outbreaks occurred in the period June–
October. The total number of people affected in all 90 outbreaks
was 558 and the median number affected per outbreak was 3
(range 2–113). The average age of those affected was 57.3 years
(SD 10.8). Hospitalization was required in 463 (82.9%) cases and
27 people died (global case-fatality rate 4.8%). The outbreaks
during period I were smaller, the average age of patients was
higher and the outbreak was detected later. The case-fatality rate
was signiﬁcantly higher in period I than in period II (12.2%
versus 4.1%). In period I, the diagnostic methods used were
BCYE and serology, whereas 97.1% of the outbreaks in period II
were diagnosed by the urinary antigen test.
Conclusion: In Catalonia, the number and size of LD outbreaks
has risen clearly from the 1990s to the present. However, the
beginning of the outbreaks was detected sooner and the case
fatality rate has fallen signiﬁcantly. The use of more sensitive
diagnostic tests for Legionella and the rapid establishment of
appropriate treatment may explain these results.
P1325
High prevalence of rhinovirus in lower
respiratory tract specimens
C. Minosse, M. Selleri, S. Zaniratti, G. Cappiello, F.N. Lauria,
R. Longo, P. Roselli, S. Antonelli, E. Schifano, M. Visca, M. Cava,
A. Spano`, M.R. Capobianchi, V. Puro (Rome, Vasto, I)
Objectives: To assess the prevalence of respiratory viruses in
the lower respiratory tract specimens of hospitalized patients
and their potential role on respiratory disease outcomes.
Methods: Sputum and endotracheal aspirate (EA)samples con-
secutively sent to the microbiology laboratories of two general
hospitals in Italy were collected during April–October 2004.
Sputum was considered valid if it contained more than 25
polymorphonuclear leucocytes per ﬁeld. In addition to routine
microbiological tests (i.e. direct sputum examination and cul-
ture), clinical specimens were analysed by PCR or RT-PCR for
the presence of eleven different viruses (Inﬂuenza A and B,
Metapneumovirus, Adenoviruses, Parainﬂuenza 1, 2 and 3,
RSV, Rhinovirus (RV), Coronaviruses OC43 e 229E), as well as
Clamydia and Mycoplasma pneumoniae and Legionella pneumophil-
ia. A nested PCR was used for the detection of RV. Positive and
negative controls were included in each PCR and RT-PCR assay.
Patients’ clinical data are correlated with microbiological and
virological results.
Results: On a total of 60 specimens collected, 17 of 36 (47%)
sputum and 12 of 24 (50%) EA were positive for RV. In an
additional case, isolated Parainﬂuenza 1 was detected; no other
viruses were identiﬁed. RV-positive patients had pneumonia (7
cases), exacerbation of chronic obstructive pulmonary disease
(COPD, 9 cases) or other respiratory events; mean age was
62 years (median 69); 30% had mixed bacterial infections. No
statistically signiﬁcant differences were found among RV pos-
itive and negative patients with regard to respiratory events and
disease outcomes.
Conclusions: Lower respiratory tract infections are a leading
cause of morbidity whose etiology remains undetermined in
more than 50% of cases. Our study shows an unexpected high
prevalence of RV RNA in lower respiratory tract specimens
obtained by adult patients with pneumonia, exacerbation of
COPD or other respiratory events. Such a high rate of RV
infection has not been reported before PCR application. The
study is consistent with recent evidences on paediatric popula-
tion, showing that, when sensitive detection methods are used,
the prevalence of RV is much higher than previously thought
and suggest that RV can infect the lower respiratory tract.
Further and larger studies are needed to assess the role of RV as
a leading cause of low respiratory tract infections. Funded by
Ministero della Salute Ricerca Finalizzata e Ricerca Corrente
IRCCS
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P1326
Evaluation of 2 ampliﬁcation methods and 4
serological tests for the detection of Chlamydia
pneumoniae in patients with community-acquired
pneumonia
K. Loens, D. Ursi, L. Danie¨ls, H. Goossens, M. Ieven (Edegem, B)
Objectives: Studies comparing serology and nucleic acid ampli-
ﬁcation methods for diagnosis of C. pneumoniae (CP) in CAP are
rare. The aim of this study was to evaluate PCR, nucleic acid
sequence-based ampliﬁcation (NASBA), microimmunoﬂuores-
cence (MIF) and 3 different EIA assays for the detection of CP in
patients with CAP.
Methods: 195 paired and 18 acute phase sera from 213 patients
with community acquired pneumonia (CAP) were available.
MIF (IgM and IgG) (Focus Technologies) and 3 different EIA’s
were evaluated: Medac IgM and IgG EIA (Medac); AniLabsys-
tems IgM and IgG EIA (Biomedical Diagnostics); and Euroim-
mun IgM, and IgG EIA (Biognost). PCR and NASBA were
applied to respiratory specimens from all 213 patients collected
on admission to the hospital. An expanded gold standard was
used to calculate the sensitivities and speciﬁcities of all tests: (1)
positive by PCR and NASBA or (2) positive by 1 ampliﬁcation
test and at least one serological test (either IgM or a serocon-
version or signiﬁcant rise of IgG antibodies), or (3) a serocon-
version or signiﬁcant rise of IgG antibodies in at least two
different EIA’s.
Results: 21 patients met the criteria of the expanded gold
standard. The sensitivities of the IgM assays ranged from 29% to
57% for IgM in the acute phase serum and from 33% to 71% for
IgM in the convalescent serum sample. IgG seroconversion or a
signiﬁcant rise in titre ranged from 43% to 81.0%. Low
sensitivities were obtained for PCR and NASBA: 24% and
29%, respectively. The speciﬁcities ranged from 83% to 99.5% for
IgM in the acute phase serum, from 81% to 99% for IgM in the
convalescent phase serum, and from 90% to 97% for IgG. The
speciﬁcities of PCR and NASBA were 100% and 99.5%, respect-
ively. The CP IgM assay with the best combined values for
sensitivity and speciﬁcity was the Medac EIA. The best CP IgG
assay was the Anilabsystems EIA. CP PCR and NASBA positive
patients had usually higher rises in IgG titre than CP PCR and
NASBA negative patients. The MIF test had the lowest sensi-
tivity and speciﬁcity scores in all serologic tests.
Conclusion: Substantial differences between the performances
of the assays were found. Ampliﬁcation tests seem to be less
sensitive. However, since important discordances between the
different serological tests were observed, both the sensitivities
and speciﬁcities of these tests have to be questioned.
P1327
Invasive procedures and aetiological diagnosis in
severe community-acquired pneumonia: a case
study of 46 patients
S. Cordani, A. Manna, M. Vignali, A. Carpenzano, E. Battolla,
PA. Canessa (Sarzana, I)
Objectives: The aim of this study was to improve the etiological
diagnostic accuracy in patients with severe community-acquired
pneumonia (sCAP) using an invasive procedure (IP).
Methods: Over a 2-year period, 46 patients showing clinical and
radiological characteristics of severe CAP and failing to respond
to antimicrobial therapy were studied. 33 males and 13 females
with a mean age of 60 years and ranging between the ages of
21 and 84 years were admitted either to the Pneumology
Department or Intensive Care Unit (ICU). Severe pneumonia
was deﬁned by clinical criteria determined according to FINE
score class IV or V. In conjunction to initial routine serological
and microbiological diagnostic tests on blood, urine and sputum
(if available), Bronchoalveolar Lavage (BAL) or Transthoracic
Fine Needle Agoaspiration (TTFNA) was performed to identify
the responsible infecting pathogen. Granulocytes (50% and a
bacterial culture cut-off (10.000 CFU/ml deﬁned infectious
pneumonia.
Results: Of the 46 patients enrolled, 10 presented a noninfec-
tious lung disease that mimicked CAP. The ﬁnal differential
diagnoses were: 3 lung carcinoma, 1 ARDS, 2 BOOP, 1 T cell
lung lymphoma, 1 drug parenchymal damage, 1 Wegener’s
Granulomatosis, and 1 unknown diagnosis but granulocytes
(50% in BAL ruled out infectious pneumonia. Of the remaining
36 patients, 1 had a malignancy overlapping infectious pneu-
monia. By means of invasive procedure, an etiological diagnosis
was achieved in 13 cases. M. tuberculosis was isolated in 4 of
these cases. Therapeutic treatment was modiﬁed in 9 cases.
Conclusions: Invasive procedure signiﬁcantly improved the
diagnostic accuracy in patients with sCAP and established the
differential diagnosis in noninfectious and unusual infectious
pneumonia that mimicked sCAP. Though not routinely used, IP
had a substantial impact on the etiological diagnosis and
decisively inﬂuenced change in therapeutic strategy in a selected
number of cases. The implementation of IP proved to be a safe
and effective means of reducing therapeutic failure in sCAP.
Identiﬁcation of unsuspected or resistant pathogens would
otherwise have been unattainable and patient survival reduced.
P1328
The unexpected ﬁndings of pertussis by 16S
rDNA sequencing in broncho-alveolar lavage
ﬂuid in an immunocompromised patient in an
endemic setting
S. Dudman, T.Ø. Jonassen, M. Steinbakk (Lørenskog, N)
Objectives: The immunization of infants has reduced the
prevalence of pertussis in Norway, however in 1997 an epidemic
of whooping cough started to spread in older children and
adolescents throughout the country. Pertussis is a notiﬁable
disease and in 2002 a total of 3182 cases were reported. The
diagnosis of this disease can be made by the isolation of
B. pertussis or detection by PCR from respiratory secretions, as
well as using serological methods (ELISA) at our laboratory.
This paper reports the results from the different methods used,
and describes a case where pertussis was found unexpectedly.
Methods: All cases of pertussis were included from January 1st
to October 31st 2004, and the positive rates were calculated
according to the different laboratory methods. For the case of
pertussis detected in broncho-alveolar lavage ﬂuid, medical
records were obtained.
Results: A total number of 458 patients were diagnosed with
pertussis during the observation period. In some patients, the
organism could be found in two different specimens. 391 (15%)
out of 2614 samples were found positive by serological methods.
74 (8%) out of 954 samples were found to be PCR positive. In 6
(5%) of the 110 cultured samples, the B. pertussis could be
isolated from nasopharyngeal secretions. In one case the bacteria
was isolated from a blood culture. In addition, one case was
detected in broncho-alveolar lavage ﬂuid, this patient suffered
from chronic lymphatic leukaemia. He was admitted to hospital
because of a fever, dyspnoea and a dry cough, and was
diagnosed with interstitial pneumonia. 16S rDNA sequencing
performed directly on the culture negative broncho-alveolar
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lavage ﬂuid showed B. pertussis. The patient was successfully
treated with Chlarithromycin.
Conclusions: In view of the epidemic levels of whooping
cough, it is important to routinely screen for this disease even
in patients not showing typical symptoms of pertussis but are
suffering from coughing.
P1329
Mycoplasma pneumoniae pneumonia in
hospitalised patients
A. Anastasovska, I. Kondova Topuzovska, K. Marangozova,
M. Arapova, I. Vidinic (Skopje, MK)
Objective: To determinate incidence of the acute Mycoplasma
pneumoniae infection in hospitalized patients with low respirat-
ory tract infection.
Methods: A total of 93 children and 72 adult hospitalized
patients with CAP within one year period (2002/2003) were
included in our study. The mean age was 4.6 years (range:1–17)
for children and 45 years (range:18–74) for adults. From children
there were 57 (61.29%) male and 36 (38.70%) female and from
adults there were 47 (65%) male and 25 (35%) female. Diagnosis
of Mycoplasma pneumoniae infection was established by serolog-
ical conﬁrmation by detection of IgM, IgG or total antibody
against Mycoplasma pneumoniae Ag with Pneumoslide M (Vir-
cell) IF test and/or Mycoplasma pneumoniae IgM, IgG (Vircell)
ELISA test.
Results: Acute Mycoplasma pneumoniae infection as a cause of
CAP from 93 hospitalized children was detected in 11 (11.83%)
patients and from 72 adult hospitalized patient was detected in 6
(8.33%) patients. There was no signiﬁcant discrepancy, from
urban or rural distribution of these patients. From children in 1
of 11 patients with Mycoplasma pneumoniae infection, coinfection
with Coxiella burnetti was detected and in 2 with Inﬂuenza B. In
the group of adults there was no detected coinfection with some
other pathogen of low respiratory tract infections.
Conclusions: Acute Mycoplasma pneumoniae infection takes sig-
niﬁcant place among low respiratory infections, in adults with
8.33% of the patients hospitalized with CAP and in the group of
hospitalized children with CAP in 11.83%. Further analyze in
few years period will give us dates to determine prevalence and
epidemiological model of acute Mycoplasma pneumoniae low
respiratory infection in this region
P1330
Prevalence of nosocomial pneumonia in severe
trauma patients (according to autopsy data)
L. Stratchounski, A. Jdanuk, I. Gudkov, E. Ryabkova (Smolensk,
RUS)
Objectives: Nosocomial pneumonia (NP) is one of most serious
infectious complications in severe trauma patients, especially in
those who receive mechanical ventilation. Data on the preval-
ence and etiology of NP in severe trauma patients are scarce as
diagnostics of NP is difﬁcult and in some cases NP remains
undiagnosed. Thus, the objective of our study was to assess
prevalence and etiology of NP in died patients with severe
trauma.
Methods: Retrospective analysis of medical records and aut-
opsy protocols of died patient from 2 traumatology and 1
neurosurgery units of Clinical Hospital of Emergency Medicine.
Results: Among 9771 trauma patients hospitalized in 2001–03
the overall mortality rate was 4.7%. Autopsy was performed in
411/458 (89.7%) patients. Morphological signs of NP was found
in 138 (33.6%) patients. NP was most common in patients with
head trauma (79%), chest trauma (26.8%) and proximal femoral
fractures (10.9%). Mean age was 51.9 ± 17.6 (21–89) years.
Impaired conciseness presented in 97.8% patients; 81.9%
patients were admitted to ICU, 78.3% patients were mechanic-
ally ventilated. Bilateral pneumonia was observed in 84.7%
patients, pleurisy – in 19.6%, right-sided pneumonia – in 9.5%
and left sided pneumonia – in 5.8%. In spite chest X-ray was
performed in all patients, it failed to reveal 34.1% cases of NP
intravitally. Microbiological investigation both intravitally and
postmortem was performed in 21.7% cases. Among pathogens
isolated Acinetobacter spp. (20%), Pseudomonas aeruginosa (20%),
Klebsiella pneumoniae (14%) and Proteus mirabilis (8%) were the
most common.
Conclusion: NP is a frequent infectious complication in severe
trauma patients that difﬁcult to diagnose intravitally. The most
common pathogens of NP in this category of patients are gram-
negative bacteria that should be taken into consideration for
choice of empirical antimicrobial therapy.
P1331
X-ray changes of Chlamydia pneumoniae
pneumonia
I. Kondova Topuzovska, G. Kondov, Z. Trajkovski, D. Dimitriev,
A. Anastasovska (Skopje, MK)
A prospective study was performed that comprised 407 hospit-
alized adult patients with community acquired pneumonia
(CAP). Chlamydia pneumoniae (CP) as a cause of CAP was
detected in 13.27% (n = 54) and it was a single cause in 10.32%
(n = 42). The diagnosis was made serologically with EIA and
MIF assays. Mean age of the patients with CP pneumonia
(n = 42) was x = 47, 57 years (s = 18.26). There were 66.7%
(n = 28) males. Clinical, laboratory and radiographic ﬁndings
were analysed and compared with a control group of patients
with bacterial etiology of the CAP (n = 80). The analysis of
radiographic changes prior to admission in the hospital of those
patients with Chlamydia pneumoniae pneumonia revealed that
only half of them had interstitial inﬁltration (v2 ‡ 100, p £ 0.001)
and the remaining had alveolar or mixed inﬁltration. Beside of
domination of diffuse extension of changes in 71.4%, in 16.7% of
the patients with CP pneumonia there was lobar and in 11.9%
segmental extension of the inﬁltration in the lungs (v2 = 10.54,
p = 0.0144). Pleural effusion was found in 7.1% (v2 = 1.177,
p = 0.758) of the patients with CP pneumonia and hilar
adenopathy in 23.8% (v2 = 1.959, p = 0.16). Partial regression
of the changes was found in 4.8% and contra lateral progression
in 2.4% (v2 = 2.85, p = 0.24). Inﬁltrations were more frequently
in lower lobes either left or right (v2 = 3.5857, p = 0.3098). In
order to increase the percentage of patients with CP pneumonia
who would be initially treated with adequate antimicrobial
therapy, multifactor regression and discrimination factors ana-
lyses were done based on the results obtained. This was
followed by postulating diagnostic algorithm for making more
exact diagnosis – Chlamydia pneumoniae pneumonia.
P1332
Surveillance of probably bacterial pneumonia in
children less than 5 years old in two geographical
areas in Argentina
R. Ruvinsky, A. Gentile, F. Gentile, C. Gil, J. Kupervaser,
M. Quiriconi, J. Bakir, J. Pace, S. Garcı´a, J. Andrews on behalf of
the Argentine Pneumoniae Working Group
Background: Bacterial pneumonia represents an important
cause of morbimortality in children (5 ys old in Latin American
countries.
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Objectives: (a) Determine the incidence of PBP cases in Conc-
ordia and Parana´ Departments (CPD) and Pilar Department
(PD), based in WHO standardized radiological criteria (b)
evaluate pediatricians and radiologist concordance.
Methods: Population: CPD 44,892 and PD 27,209 children (5 ys
old. Inclusion criteria was all children (5 ys with clinical-
radiological signs of PBP, from 1–11–2002 to 30-04-2004
(18 months), belonging to these Departments (CPD n = 1000),
PD n = 525). Chest-Rx was digitalized and sent to the reference
radiologist, who conﬁrmed the presence of consolidation.
Serotyping and CIM’s of S. pneumoniae isolated from blood or
pleural ﬂuid culture, was made in the National Reference
Laboratory. Concordance on consolidation between pediatrician
and radiologist independent diagnosis was analysed.
Results: Total of pneumonia cases with chest-Rx consolidation:
CPD 509/1000 (47.8%) PD 294/525 (56.0%); Incidence/100,000
children (5 ys per year was: Concordia 1.189.0; Parana´ 709.7 and
Pilar 962.9. Hospitalized children: CPD 69.5%, PD 63.6%. Low
and medium social-economical level: CPD 90.4%, PD 84.4%; Age
(2 ys: CPD 65.8% and PD 68.7%; undernutrition: 6.2% in both
centres; previous antibiotic therapy (3 months): CPD 27.1%, PD
10.9%. Bacterial isolation: CPD 5.9% (S.pn 5.6%) and PD 9.2%
(Spn 4.6%). the most frequent serotypes: 14, 5, 6B, 7F and 23F.
Letality: CPD 0.8% and PD 0.5%. Consolidation concordance:
CPD 791/1000 (79.1%) and PD 307/446 (68.8%)
Conclusions: (a) High incidence of pneumonia with consolid-
ation in (5 years (b) Low rate of bacteriological documentation
as expected in pneumonia; (c) Consolidation concordance
between pediatricians and radiologist was moderate
P1333
Colonisation of lower airways with potential
pathogenic bacteria in healthy patients and
patients with chronic lung diseases
U. Møller Weinreich, J. Korsgaard (Aalborg, DK)
Introduction: Patients with chronic lung disease often suffer
from repeated lower respiratory tract infections. For patients
with chronic obstructive lung diseases alone 25000 patients are
admitted to hospital in Denmark each year.
Material: From January 1st 2003 until June 30th 2004 a total of 151
adult patients underwent bronchoscopy with bronchial lavage
and bacterial culture. Patients with ongoing infection with recent
(within 24 hours) antibiotic treatment (15) and/or signiﬁcant
leucocytosis (>11 · 109/l) (19) or patientswith a ﬁnal diagnosis of
carcinoma (20)were excluded so that 97 adult patientswith a ﬁnal
diagnosis of normal (27), recent lower respiratory tract infection
(22), chronic obstructive lung diseases and/or lung ﬁbrosis (29)
and patients with a ﬁnal diagnosis of bronchiectasies (19) were
included in this retro-spective analysis.
Methods: Patients were investigated with ﬁbre optic bronchos-
copy and investigated with bronchial lavage with 10 ml of
isotonic NaCl and the aspirate send for semiquantitative
bacterial culture at the department of microbiology. Culture
was performed with 10 and 1 ll of lavage ﬂuid on separate halfs
of chocolate agar plates and results expressed as colony forming
units (cfu) per ml lavage ﬂuid, and identiﬁcation as potential
pathogenic bacteria (ppb) or normal respiratory tract ﬂora.
Results: 43 (44%) of 97 patients were grown with ppb with 4
patients grown with 2 ppb’s and 1 patient grown with 3 ppb’s
adding up to 49 separate isolates of ppb’s among the 43 patients.
The most frequent isolate was H. Inﬂuenzae (20) followed by
S. Pneumoniae (15), other gram negative bacteria (8) and 6 isolates
of S. Aureus. The frequency varied from 15% with ppb among
normal (4/27), to 34% (10/29) in patients with stable disease with
COPD and/or ﬁbrosis, to 61 % in patients with recent (weeks to
months) lower respiratory tract infection, while the highest
colonization rate was found among patients with bronchiectasies
(15/19) where 79% were colonized with ppb in the lower
airways. The mean cfu/ml of ppb was 2000 in normal patients,
39,000 in patients with recent infection, 35,000 in patients with
COPD and 87,000 in patients with bronchiectasi (p < 0.001)
Conclusion: Healthy persons are rarely (15%) colonized with
ppb while patients with chronic lung diseases in stable fase (34–
79%) and patients with recent lower respiratory tract infection
(61%) frequently are colonized with ppb in the lower airways.
P1334
Bacterial causes of community-acquired
pneumonia and antibiotic resistance on adult
patients hospitalised during 2002–2003
M. Zoumberi, C. Papaefstathiou, A. Karaitianou,
A. Koutoumanis, S. Botsari, G. Kouppari (Athens, GR)
Objective: To study the bacterial causes of community acquired
pneumonia in patients who were hospitalized during 2002–2003.
The antibiotic resistance in adult patients is also to be studied.
Methods: Of the 268 patients (193 male and 75 female) who
were hospitalized with lower respiratory tract infection, 235
sputum cultures, 33 bronchotracheal secretions cultures and 125
urine cultures were sent to be examined for detection of
S. pneumoniae and Legionella antigens. All specimens were
cultured on appropriate media for aerobic and anaerobic
microorganisms and smears were performed by Gram stain.
The identiﬁcation of the isolated bacteria was performed by
standard methods and the API-system (Bio Merieux). The
susceptibility testing was carried out by disk diffusion method
and E-test (AB Biodisk Solna Sweden). The detection of
Legionella and S. pneumonia in urine samples was performed
by immunochromatographic assay. (Now, binax)
Results: One hundred and seventeen patients had community-
acquired pneumonia, 121 suffered from some other infection of
the lower respiratory system. Of the patients with community-
acquired pneumonia were isolated in order of appearance: S.
pneumoniae (27.3%), H. inﬂuenzae (20.5%), P. aeruginosa (15.4%),
K. pneumoniae (9.4%), L. pneumophila (7.7%), H. parainﬂuenzae
(7.7%), S. maltophilia (4.3%), S. aureus (2.6%), and others (5.1%).
Of S. pneumoniae isolates 30% were intermediate susceptible to
Penicillin, 0% were resistant to cefotaxime, 0% to vancomycin,
0% to oﬂoxacin and 5% to clindamycin. Of H. inﬂuenzae isolates
2.4% were intermediate susceptible to ciproﬂoxacin, (4.7%) were
resistant to ampicillin, 0% to cefotaxime, (19%) to co-trimoxaz-
ole, and 0% to imipenem. Of P. aeruginosa isolates 32% were
resistant to ceftazidime, 42% to ciptoﬂoxacin, 40% to gentamycin
and 42% to imipenem.
Conclusion: Themost common isolated bacteria in patients with
community-acquired pneumoniae were: S. pneumoniae, H. inﬂu-
enzae, P. aeruginosa, H. pneumoniae and L. pneumophila. Among
strains of S. pneumoniae 30% were intermediate susceptible to
Penicillin and all of them were susceptible to Vancomycin.
P1335
The prevalence of Mycoplasma pneumoniae in
hospitalised children with lower respiratory
infections
I. Varzakakos, G. Tapaki, H. Papavasileiou, E. Damaskopoulou,
K. Avgerinakou, G. Giorzatou, A. Voyatzi (Athens, GR)
Objectives: The aim of this study was 1. To determine the
prevalence of Mycoplasma pneumoniae IgG and IgM antibodies
in relation to age in hospitalized children with conﬁrmed
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community – acquired pneumonia (CAP) or extrapulmonary
symptoms. 2. To provide epidemiological data for the seasonal
distribution and the annual incidence of Mycoplasma pneumoniae
infections.
Materials and methods: A total of 1074 patients from 2 to
14 years old with symptoms and signs compatible with CAP
were enrolled during a 4-year period (2001–2004). Thorax
radiography and paired sera were obtained from each patient
and the course of illness was monitored uniformly. Speciﬁc IgG
and IgM antibodies were measured by enzyme linked immu-
nosorbent assay (Remel, USA) and Immunocard based IgM EIA
(Meridian France). The children were divided in three age
groups: Group A: 2–6 years old Group B: 7–12 years and Group
C: more than 12 years. The serum CRP concentration was also
determined by nephelometry.
Results: IgG and IgM antibodies were detected in a total of
337(31.8%) children out of 1074 patients. IgM antibodies were
found only in 191 patients (17.8%). No signiﬁcant difference
between sexes was found. Signiﬁcantly higher frequency of
M. pneumoniae infections was recorded during the two last winter
months and the springtime. Seroprevalence toM. pneumoniaewas
found to increase in the group B, 7–12 years old, (101 patients,
52.8%). The incidence per year ranged between 10.7% and 29.2%.
The majority of the hospitalized children dominated high
temperatures, cough, headache and chest pain, while 27 patients
developed extrapulmonary manifestations. 13 cases with rash, 8
cases with pleural effusion, 3 with gastrointestinal manifesta-
tions, 2 with otitis media and 1case with erythema nodosum.
Conclusion: The results show the high incidence of M. pneu-
moniae in the etiology of lower respiratory infections in Greek
hospitalized children and especially in children aged more than
7 or more years old while the extrapulmonary manifestations
are not rare. The importance of timely diagnosis and treatment
is obvious.
P1336
Demography and Fine score of community-
acquired pneumonia in adults admitted to
hospital in Spain
E. Pe´rez-Trallero, F. Baquero, J. Torres, C. Garcı´a-Rey,
J.M. Nogueira on behalf of the NACER Group
Objectives: Despite of its considerable frequency there is little
epidemiological information about the demography of adults
with community-acquired pneumonia (CAP) admitted to hos-
pitals and their Fine scores in large and recent Spanish series.
Methods: Retrospective review of the hospital charts of patients
admitted to 10 geographically scattered hospitals with the
diagnosis of CAP over a 1-year period in Spain. Subjects
included were those with diagnosed with CAP at discharge
from 1 Nov 01 to 31 Oct 02.
Results: Overall, data were available from 3233 patients. The 10
hospitals have 8523 beds (5.4% of the nation capacity). The
occupation rate of adult CAP with hospital admission was 37.9/
100 beds/year. Males represented a 64% of the sample with a
mean, median and modal age of 66.6, 71 and 78 years. Up to 44%
of the sample were 80-year-old or older, 27% had an age
between 60 and 79, 16% between 40 and 59, and 13% between 18
and 39. Comorbidities were very common since up to 83%
reported at least one of them. Of these, their frequency was as
follows: previous hospital admittance in the last 5 years 22%;
COPD 13%; diabetes mellitus 10%; smoker 10%; previous
episode of pneumonia 8%; malignancy 7%; immunosuppres-
sion, chronic heart failure and cerebrovascular disease 5% each;
hepatopathy 4%; alcoholism and nephropathy 3% each; others
2%. Antibiotics were already being taken before admission in
26.2% (penicillins 8.6%; macrolides 6.2%; quinolones 5.6%;
cephalosporins 3.9%). The data of proper inﬂuenza and/or
pneumococcal vaccination was of no use in the medical
management of these patients. The antecedent of vaccination
was acknowledged in 0.6% and 0.8% of the subjects studied.
Only 0.2% of the subjects were participating in a clinical trial of
CAP. Mean, median and modal length of hospital stay for the
CAP episode was 11.3, 9 and 8 days, respectively. Five per cent
of the subject entered the ICU with a corresponding mean,
median and modal stay of 9.3, 5 and 1 day, respectively. Fine
variables were properly recorded in only 1722 subjects (53.3%),
whose distribution is broken down in the Table.
Conclusions: The occupation rate of hospital admitted adult
CAP was 37.9/100 beds/year. There was a male predominance
and a clear trend age disbalance as 71% of the patients were at
least 60 years old. 26.2% of the subjects were already taking
antibiotics when admitted. 47.2% of the subjects were admitted
to hospital with very low Fine scores (I-III), but hypoxemia
occurred in 34.1% of them.
P1337
Hospital differences in the diagnostic
microbiological workup in patients admitted to
hospital with community-acquired pneumonia in
Spain
E. Pe´rez-Trallero, J.L. Pe´rez, C. Garcı´a-Rey, R. Landı´nez, J. Garau
on behalf of the NACER Group
Objectives: The processing of microbiological samples is known
to yield different results depending on many external factors
some of them logistic in nature. We sought to assess the
differences in microbiological workup in patients with commu-
nity-acquiredpneumonia (CAP) admitted to10Spanishhospitals.
Methods: Retrospective review of the microbiological workup,
its results and diagnosis at discharge of patients admitted to the
hospital with the diagnosis of CAP over a 1-year period (1 Nov
01 to 31 Oct 02) in 10 geographically scattered hospitals in Spain.
Data were available from 3233 patients.
Results: Blood cultures were drawn in 57.2% of the patients,
and of these, 78.7% were taken before antimicrobial treatment.
Sputa were collected from 41.7% of the cases, and of these, only
43.2% were taken before therapy.Overall etiology was unknown
in 77.6% of the subjects. Among the 22.4% etiologically diag-
nosed, S. pneumoniae was the main cause (58.8%), followed by
Legionella spp. (9.4%), H. inﬂuenzae (6.4%), M. pneumoniae (5.3%),
S. aureus (4.1%), P. aeruginosa (3.6%), and others (12.5%).
Microbiological performance (%) was very different among
hospitals. See Table.
Score N (%) % hypoxemia % hypotension
LOS
Mean Median Mode
Total 1722 49.7 8.3 11.1 9 8
I 201 (11.7) 24.9 5.0 8.2 7 4
II 255 (14.8) 26.7 9.0 9.1 8 6
III 357 (20.7) 44.5 5.0 10.9 9 8
IV 623 (36.2) 58.4 8.2 12.5 10 8
V 286 (16.5) 74.8 8.2 12.1 10 10
Centre 1 2 3 4 5 6 7 8 9 I0
Etiology known 7.1 39.0 31.6 20.0 16.5 13.8 23.5 23.5 13.9 12.3
Blood culture
(properly taken)
66.3
(80.9)
62.2
(91.9)
82.6
(98.4)
56.6
(79.7)
29.4
(54.7)
66.7
(92.8)
59.9
(93.7)
422
(66.2)
45.5
(50.4)
606
(78.0)
Sputa obtained
(properly taken)
28.1
(19.1)
63.3
(58.1)
19.1
(68.2)
45.5
(45.8)
47.5
(45.0)
42.0
(46.2)
59.4
(47.8)
38.4
(18.6)
26.4
(31.6)
46.8
(52.1)
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Conclusions: (1) Microbiological conﬁrmation was obtained in
only 22.4% of the patients and diagnostic performance varied
considerably among centres (Mean: 20.1%; Min: 7.1%, Max:
39.0%).
(2) Large differences were observed among hospitals in the
number and the quality of the diagnostic microbiological
procedures done.
(3) Globally, only 57.2% of the adult patients with CAP admitted
to hospital had blood cultures done (range: 29.4–82.6%). Besides
centres with a lower proportion of blood cultures ((55%) seemed
also to have done them more frequently at the wrong time, and
in fact, blood was drawn before starting antibiotic therapy in
78.7% of the episodes. Therefore, a proper blood sample for
microbiological processing occurred in 45.0%
(4) Success in obtaining sputa from patients was also diverse,
but even in those providing sputum for microbiological exam a
considerable proportion was done while on antibiotic treatment.
Mean proportion of sputa obtained was 41.7%, and properly
obtained in 43.2%.
P1338
Clinical presentation of community-acquired
pneumonia in adults admitted to hospital in
Spain
J.L. Pe´rez, J. Ruiz, J.E. Martı´n-Herrero, R. Dal-Re´, J. Garau on
behalf of the NACER Group
Objectives: To assess the frequency of classical signs and
symptoms of acute pneumonia in a large series of adult patients
with community-acquired pneumonia (CAP) that required
hospital admission.
Methods: Retrospective review of the hospital charts of patients
admitted to the hospital with the diagnosis of CAP over a 1-year
period in 10 geographically scattered hospitals in Spain. All
patients admitted from 1 November 2001 to 31 October 2002
were included. Data were available from 3233 patients.
Results: Fever deﬁned as an axillary temperature >38C was
present in only 38.7% of subjects, and its presence decreased in
patients with high risk Fine score (groups IV–V) compared with
low risk Fine score (groups I–III) (35.0% vs. 45.4%; p ( 0.0001).
Leukocytosis was present in 68.9% and the sputa were purulent
in 53.8%. An abrupt onset was recorded in 34.7%. Hypoxemia
occurred in 45.2%, hypotension in 9.3% and mechanic ventila-
tion was needed in 3.1% of the subjects. Based on the above
results, the estimated probability of the classic association of
fever, leukocytosis, purulent sputum and abrupt onset, typical
of classic pneumococcal pneumonia would only have taken
place in 5% of the adults patients with CAP admitted to the
hospital. As for chest X-ray ﬁlms, 85% of the cases were
unilateral, and 77.6% were monolobar. A predominant alveolar
pattern occurred in 80.3%, an interstitial in 7.2%, pleural
effusion in 11.3% and only 1.1% presented cavitation.
Conclusions: (1) In real practice classic clinical presentation of
bacterial pneumonia does not ﬁt well with that presented in
patients with CAP admitted to hospital. Isolated signs and
symptoms have not a good sensibility as predictors of admission
to hospital in CAP. (2) Only 5% of subject can be expected to
present a classic pneumococcal presentation. (3) An alveolar
chest X-ray pattern was predominant in our experience. Pleural
effusion was not uncommon at all since it occurred in one tenth
of subjects. (4) The proportion of patients with a body tempera-
ture >38C decreases as Fine store increases.
P1339
Development of a prediction rule for
hospitalisation or death in elderly primary care
patients with a lower respiratory tract infection
J. Bont, E. Hak, A.W. Hoes, M.J.M. Bonten, T.J.M. Verheij on
behalf of ESPRIT
Objectives: Acute lower respiratory tract infections (LRTIs) in
elderly are of great concern to general practitioners since their
course is often more complicated. Classiﬁcation into low- or
high risk may improve medical care, hence reducing unneces-
sary treatment and target monitoring and therapy more efﬁ-
ciently. Our objective was to develop a prediction rule for
30-day hospitalization or death in elderly primary care patients
with a LRTI.
Methods: To develop a prediction rule we retrospectively
analysed easily obtainable medical data from 3166 episodes of
physician-attended LRTI including pneumonia, acute bronchitis
and exacerbations of COPD in patients ‡65 years of age.
Characteristics were identiﬁed that were predictive for 30-day
hospitalisation or mortality. We subsequently developed a
prediction rule with the use of logistic regression.
Results: Hospitalization or death in 30 days, occurred in 274
(8.7%) of all episodes (2.4% all cause mortality). Increasing age,
male gender, hospitalization in 12 month prior to diagnosis,
heart failure, diabetes, use of oral glucocorticoids, use of
antibiotics in the prior month and a diagnosis of pneumonia
or an exacerbation of COPD were predictors for hospitalization
or death. Patients with £3 points had a 97 % chance of an
uncomplicated course. Patients with ‡8 points had a 30% chance
of hospitalization or death.
Conclusions: This prediction rule discerns elderly patients with
high or low risk for hospitalization or death. Classiﬁcation into
risk groups can help the general practitioner to adjust his
preventive and therapeutic decisions to the expected prognosis.
This might lead to fewer complications and lower costs.
P1340
Identiﬁcation of a major immunogenic
polypeptide of Mycoplasma pneumoniae
Z. Greenberg, O. Dvir, J. Schlesinger, M. Lee (Ashdod, IL)
Objectives: Mycoplasma pneumoniae (MP) is an etiological agent
responsible for 10–30% of community-acquired pneumonia
cases. Pneumonia due to MP is labeled under atypical pneu-
monia infections. MP may be detected in all parts of the
respiratory system, and its effects are well recognized and
documented. In respect to diagnosis and treatment, the most
prominent structural feature of MP is the lack of a cell wall. It
has been shown that surface-exposed polypeptides elicit immu-
nogenic response, in particular those that are involved in the
attachment organelle of MP. This attachment organelle is
composed of a complex of polypeptides, in which P1 Cytadhesin
Protein has a major role. Due to its high immunogenicity P1 is a
paradigm for utilizing a deﬁnitive antigen in sero-diagnostical
systems. On the way to produce either a recombinant- or a
peptide-based antigen of a similar nature, a modiﬁed extraction
procedure of membranous proteins has been employed.
Methods: MP cells were exposed to the non-ionic detergent
Triton X-114. The same detergent was applied then on the
separated membranes, extracting insoluble proteins in a tem-
perature-dependent way. The antigenic activity of the revealed
extract was tested in ELISA with characterized sera, utilizing
detection systems speciﬁc to IgG, IgM and IgA.
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Results: The insoluble phase of the Triton X-114 extract was
comprised of a single 65 kDa polypeptide, as shown in SDS-
PAGE. The soluble phase of the extraction, aswell as the currently
used antigen in SeroMP test, has shown multiple bands. Com-
parison in ELISAbetween the threepreparations revealed that the
antigenic activity of the insoluble extract is comparable to that of
the current assay. This result was repeated for IgG, IgM and IgA,
meaning that themajority of the antigenic activity in the insoluble
fraction may be attributed to the 65 kDa polypeptide.
Conclusions: The current observation is supported by previous
works that have indicated the same size of polypeptide as a detergent
extractable and being associated with the attachment organelle. We
show here the antigenic potential of the 65 kDa extracted in our
modiﬁed procedure, which reveals a comparable activity as the
current assay. This ﬁnding identiﬁes the 65 kDa polypeptide as an
appropriate candidate to be used in diagnostic tests.
P1341
Characterisation of Legionella pneumophila
isolates from geographically different Bulgarian
regions
I. Tomova, S. Panaiotov, V. Levterova, I. Ivanov,
T. Kantardjiev (Soﬁa, BG)
Nowadays legionellae are known as commonwater bacteria with
ability to cause outbreaks and epidemics of both: Legionnaires’
disease and Pontiac fever. In the time of intensive traveling of
people the laboratories must be capable to type environmental
and human isolates and to give clear answers about the source of
infection. In Bulgaria there were no data concerning the type-
scope of the L. pneumophila strains circulating in the potable
waters. We present here the results from a pilot study for the
typing L. pneumophila (Lp) strains isolated from water samples
from three geographically different Bulgarian regions. After
isolation of the strains they were subjected to characterization
by the use of serogroup speciﬁc techniques, monoclonal antibody
and Ampliﬁed Fragment Length Polymorﬁsm (AFLP) typing
methods. Water samples collected from buildings located in one
west and two east Bulgarian regions revealed presence of variety
L. pneumophila isolates. A total of twenty six Lp strains were
isolated. The predominant serogroup was Lp serogroup 1, but
there were also 7 isolates belonging to Lp serogroup 6, Lp
serogroup 8 and Lp serogroup 15. Co-contamination of water
samples with different Lp serogroups was observed. The most
frequent Lp serogroup 1 monoclonal subtypes were Knoxville
and Allentown. The obtained AFLP proﬁles show good discrim-
inatory power. Our results from this pilot study point that Lp
serogroup 1 is not so rare ﬁnding in our potable waters as it was
considered in the past based on a restricted study in one town Lp
serogroup 15 was isolated for the ﬁrst time in our country during
this study. The necessity for use of a complex of methods for clear
epidemiological typing was demonstrated. The results show that
more extensive studies are needed to give clear picture of the
environmental distribution of Lp types in Bulgarianwaters and to
compare Lp types from environmental sources with those from
clinical cases of Legionnaires’ disease.
P1342
Clinical and economical efﬁcacy of microbiology
investigations in hospitalised patients with
pneumonia
T. Chernenkaja, M. Bogdanov, A. Podolcev (Moscow, RUS)
Objectives: To evaluate clinical and economical efﬁcacy of
microbiological investigations (MI) in hospitalised patients with
pneumonia.
Methods: The records of hospitalized pneumonia patients were
screened for MI and results of antibiotic treatment (AT). 222
records with MI were selected for years 2000–2002. There were
evaluated presence of clinically signiﬁcant pathogens, the time
between MI and beginning of AT, accordance between patho-
gens sensitivity (SN) to antibiotics and real AT, results of AT.
The MI were interpreted as utilized if SN was available before of
within 3 days after the beginning of AT according SN. The MI
were interpreted as non-utilised if pathogens were not identi-
ﬁed, or SN was available 3 days after beginning of AT, or there
were discrepancy between SN and real AT. Clinical effective-
ness of AT was determined in the case of utilised and non-
utilised MI. Also it was evaluated the number of MI needed to
determine SN; the formula ‘Number needed to screen’ (NNS)
was used to calculate the number of MI with SN needed to
prevent one case of ineffective AT. The cost of total number of
MI was compared with the buying costs of second-line antibi-
otics such as 3rd, 4th generation cephalosporins, vancomycin
and carbapenems for course of treatment. The other costs
associated with ineffective ﬁrst AT course were not calculated.
Results: In the case of pneumonia etiologically signiﬁcant
pathogens were identiﬁed in 44% of probes, it means that 2.27
MI were done to get one SN. In the case of utilised and non-
utilised MI the effectiveness of AT was 95% and 47% respect-
ively, based on these ﬁgures NNS calculation demonstrate that
2.09 MI with SN were needed to prevent one case of ineffective
AT. So the total number of MI needed for prevention of one case
of ineffective AT was 4.74 (2.2 multiply 2.09). The costs of 4.74
MI were signiﬁcantly less than the buying costs of any second-
line antibiotics.
Conclusion: MI signiﬁcantly increase the effectiveness of AT of
pneumonia. In the hospital were investigation was performed
the direct buying costs of second-line antibiotics were higher
than cost of MI. To increase the effectiveness of MI it is necessary
to reduce number of MI without pathogens, MI with wrong SN
and MI which are not used by physicians for selection of AT. In
the settings with other cost structure to evaluate economical
effectiveness of MI it may require to calculate the full costs
associated with ineffective AT.
P1343
The outcome of non-hospital pneumonia
depending on pre-hospital tactics during
patient’s ﬁrst application for medical aid
A. Vertkin, A. Naumov (Moscow, RUS)
Aim: Elaboration, introduction and evaluation of the effective-
ness of clinical recommendations for treating patients with non-
hospital pneumonia on the pre-hospital stage.
Methods: The research was carried out in 1081 patients with
community acquired pneumonia (CAP). The patients were
divided into 3 groups: I – 431, patients diagnosed with CAP,
in a number of cases, was not conﬁrmed while in hospital; II –
391,the tactics of treating CAP on the pre-hospital stage did not
correspond to the clinical recommendations; III – 259 patients
with conﬁrmed CAP, the diagnosis of which and the pre-
hospital treatment corresponded to the clinical recommenda-
tions. The patients of all the groups were comparable.
Results: On the pre-hospital stage the clinical picture was
evaluated only in 4% of the patients, on average. The underes-
timation of the clinical picture caused hyper diagnostics of CAP
on the pre-hospital stage, whereas in hospital, the absence of
characteristic complaints and physical signs of CAP allowed to
evaluate the situation adequately and to change the diagnosis.
On the pre-hospital stage the patients of group II did not have
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the clinical criteria of CAP (70.3%)in the accompanying docu-
ments, their concomitant diseases were not revealed (81.4%), the
anamnesis and data about the previous treatment were not
collected, the adequate treatment of CAP was not carried out
(antibacterial drugs were not administered in any of the cases).
The risk of unfavorable termination was known to be not
evaluated in 47% of the cases, and the hospitalization of more
than one third of the patients was non-proﬁle. Besides, the index
of the pre-day lethality came to 12.1% and the general lethality
came to 4.6%. in this group. In group III all the patients had the
symptoms of CAP which allowed to evaluate the degree of the
disease severity correctly, to administer the therapy of antibi-
otics – amoxicillin (Phlemoxin Solutab) in the case of non-severe
pneumonia and ceftriaxon in case of severe pneumonia and to
carry out correct sorting of the patients. The pre-day lethality
came to 3.1% and the general lethality came to 2.3%. in this
group. The time of group III patients’ stay in hospital came to
17 ± 3.4 days, and that of group II patients came to
21 ± 4.7 days (p ( 0.05). Moreover, the necessity of antibacterial
therapy changing in group III, when in hospital, occurred only
in 13.1% of the observation, whereas in group II it happened in
34.3% of the cases.
P1344
Comparison the bacteriology and beta-lactamase
production of the tonsils and adenoids surface
and core ﬂora
I. Ozcan, I. Mumcuoglu, N. Balaban, I. Taylan, I. Baran,
A. Ulusoy, H. Dere (Ankara, TR)
Objectives: Adenoidectomy and tonsillectomy, indicated for
children with recurrent or persistent symptoms of infection or
hypertrophy, are among the most frequent operations per-
formed in children. This study was carried out for investigating
the microbial surface and core ﬂora of the tonsils and adenoids.
Methods: Core and surface cultures were taken from the tonsils
and adenoids of the 40 patients at the time of the surgery for
tonsillectomy and adenoidectomy. Patients’ ages ranged from 3
to 13 years (mean age 6.6 years). Specimens were inoculated
onto 5% sheep blood, chocolate, EMB agar and Haemophilus
medium (BioMerieux/France). For anaerobic bacteria, core
samples were inoculated onto anaerobic blood agar and incu-
bated in Genbaganaer pockets (Biomerieux/France). The anaer-
obic plates examined at 48 and 96 hours. Aerobic organisms
were identiﬁed by conventional methods and anaerobic organ-
ism were identiﬁed by VITEK ANI (Biomerieux/France) sys-
tems. Chocolate agar and Haemophilus medium (HAEM) were
also compared for Haemophilus inﬂuenza identiﬁcation.
Results: One hundred and thirty three aerobic bacterial isolates
were recovered from surface of the tonsils, 111 from core of the
tonsils, 128 from surface of the adenoids and 74 from core of the
adenoids. Eight anaerobic bacteria were identiﬁed from core of
the tonsils and 14 from core of the adenoids. The most
frequently isolated microorganisms were alpha-haemolytic
streptococci, Neisseria spp, and H. inﬂuenza. Beta-lactamase
producing bacteria (BLPB) were found in all patients. The
most frequently BLPB were Staphylococcus aureus (100% of the
isolates), H. inﬂuenza (58% of the isolates), and Neisseria spp
(45.2% of the isolates). Potential pathogenic microorganisms
(beta-haemolytic streptococci, S. aureus, H. inﬂuenza and
S. pneumoniae) were isolated in 33 patients.
Conclusion: This study demonstrates a polymicrobial aerobic–
anaerobic ﬂora in both adenoids and tonsils. There was a close
relationship between the bacteriology of the tonsil and adenoid
core and surface ﬂora. We could not ﬁnd any statistical
difference between the bacteriology and BLPB of the tonsil
and adenoid core and surface ﬂora. HAEM and chocolate agar
were also found similar for H. inﬂuenza but for H. parainﬂuenza a
statistical difference was found.
P1345
Microbial colonization of laryngectomy stomas
M. Villar Vidal, E. Eraso, L. Madariaga, C. Marcos, A. Acha,
J. Aguirre, G. Quindo´s (Bizkaia, E)
Objective: To investigate the microbial colonization of the
stoma of laryngectomy patients.
Patients and methods: Nineteen consecutive patients who had
previously undergone laryngectomy were recruited from the
Odontology Clinic of our University. Swabs were taken from the
laryngectomy stoma site. Microbiological culture and isolation
were performed following standard procedures in Columbia
agar and Candida ID2 chromogenic agar plates (bioMe´rieux,
France). Identiﬁcation of isolates was done by catalase produc-
tion detection, differential growth in Mannitol–Salt agar, Slidex
Staph Plus latex reagent and ID 32 STAPH (bioMe´rieux). Slidex
MRSA detection test (bioMe´rieux) was used for the evaluation of
methicillin resistance.
Results: Despite no clinical sign of infection, 13 patients were
carriers of potentially pathogenic microorganisms (68.4%).
Staphylococcus aureus was detected in the stoma of 10 patients
(52.6%). Methicillin-resistant S. aureus (MRSA) were not isolated.
Staphylococcus epidermidis was isolated from three patients
(15.8%). Staphylococcus xylosus was isolated from the stoma of
a patient (5.3%) also colonized by S. aureus. Candida albicans and
yeast species were not isolated from these clinical specimens.
Conclusion: We have found a high incidence of colonization
with Staphylococci in laryngectomy stomas with no clinical
signs of infection. These microorganisms could be the poten-
tially source for superﬁcial or deep infections.
P1346
The epidemiology of peritonsillar abscess disease
in Northern Ireland
B. Hanna, R. McMullan, G. Gallagher, S. Hedderwick (Belfast,
UK)
Objectives: 1. To describe the epidemiology of peritonsillar
abscessdisease inNorthern Ireland. 2. To investigate the impact of
the nature of microbiological sampling on culture results. 3. To
describe the impact of culture and sensitivity results on individual
patient treatment and for guiding empirical antibiotic therapy.
Methods: Retrospective review of cases of peritonsillar abscess
identiﬁed by diagnostic coding in three centres in Northern
Ireland between August 2001 and July 2002.
Results: 128 patients with conﬁrmed peritonsillar abscess were
treated as inpatients accounting for 1 in 10,000 per year of the
population in the hospitals’ catchment area. The mean age was
26.4 years (range 9–78). Sixty-nine (54%) patients were male; the
mean length of hospital stay was 3 days. Needle aspirates,
swabs of pus, throat swabs and blood were submitted for
microbial culture. Culture yield was greatest from needle
aspirates, and was similar even with prior antibiotic exposure,
although the relative frequency of pathogens was different in
the group who had received prior antibiotics. Beta-haemolytic
streptococci were the most common isolates, however a variety
of pathogens were implicated. Throat swabs and blood cultures
were typically unhelpful. The results of culture and sensitivity
did not affect individual patient treatment, but reviewing the
sensitivities demonstrated frequent resistance of isolates of
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Group A beta-haemolytic streptococci to macrolide antibiotics.
Heterophil antibody testing was routine and revealed that
Epstein–Barr Virus infectious mononucleosis had a prevalence
of 1.8% in this population.
Conclusion: We support the view that aspirates of pus from
peritonsillar abscesses should be periodically cultured to guide
empirical antibiotic management since performing cultures in
every case may be unnecessary. Patients who have taken anti-
biotics prior to aspiration may be included in such surveillance.
P1347
Single-dose azithromycin microspheres versus
three-day azithromycin for the treatment of group
A beta-haemolytic streptococcal (GABHS)
pharyngitis/tonsillitis in adults and adolescents
S. Kegel, C. McCoig, D. Jorgensen (Erkner, D; Madrid, E; New
London, USA)
Objective: Antibiotic therapy for GABHS pharyngitis is recom-
mended for earlier symptom resolution, prevention of compli-
cations, and reduced spread of disease. Azithromycin (500 mg
QD for 3 days) is an effective treatment for documented GABHS
pharyngitis in adults. A novel microsphere formulation of
azithromycin now makes it possible to administer a full course
of therapy as a single dose while maintaining tolerability and
optimizing compliance. The objective of this study was to test
the hypothesis that a single 2.0 g dose of azithromycin micro-
spheres is bacteriologically noninferior to 3 days of azithromy-
cin (500 mg QD for 3 days) when used to treat adults and
adolescents with GABHS pharyngitis/tonsillitis.
Methods: This was a Phase III multicentre, randomized,
double-blind, double-dummy trial conducted in North America,
Europe, and India. The primary endpoint was bacteriologic
response at Test of Cure (TOC; Day 24–28) in the Bacteriologic
Per Protocol (BPP) population. The secondary endpoints were
clinical response at TOC and safety.
Results: Five hundred ninety-eight subjects were enrolled in the
study; of the 594 treated subjects 420 (70.7%)were included in the
BPP population. Bacteriologic eradication was achieved in 86.3%
(177/205) and 81.4% (175/215) subjects in the azithromycin
microspheres and 3-day azithromycin groups, respectively at
TOC (95%CI (2.1, 12.0). At Long-TermFollowUp (LFTU;Day 38–
45), bacteriologic recurrence was observed in 5.5% (9/163)
subjects in the azithromycin-microspheres group, compared
with 7.7% (12/156) subjects in the 3-day azithromycin group.
Clinical cure was observed in 99.0% (203/205) of subjects in the
azithromycin microspheres group and 96.7% (208/215) in the
3-day azithromycin group. Both treatments were well tolerated
and most adverse events were mild to moderate in intensity. The
most frequent adverse event (AE) was diarrhoea/loose stools,
which occurred in 11% of both treatment groups. No subjects in
eithergroupdiscontinuedtreatmentduetotreatment-relatedAEs.
Conclusion: A single 2.0 g dose of azithromycin microspheres
is as effective and well tolerated as 3 days of azithromycin
(500 mg QD) for treating GABHS pharyngitis in adults and
adolescents.
P1348
Predicting prognosis and effect of antibiotic
treatment in rhinosinusitis
A. De Sutter, M.B. Lemiengre, G. van Maele, M. van Driel,
M. De Meyere, T. Christiaens, J. De Maeseneer (Ghent, B)
Background: In dealing with patients with suspected rhinosi-
nusitis , family physicians have to rely mainly on history,
physical examination and plain radiographs. Yet, evidence of
the value of this information for the management is sparse. The
aim of this study was to examine whether in patients with
suspected rhinosinusitis illness duration and/or the effect of
antibiotic treatment can be predicted on basis of clinical
symptoms/signs or radiology.
Methods: Participants were 300 patients with suspected rhino-
sinusitis participating in an RCT comparing amoxicillin with
placebo. By means of Cox regression we assessed the association
between the presence at baseline of rhinosinusitis symptoms/
signs or an abnormal radiograph and the subsequent illness
course. By testing for interactions we investigated whether the
presence at baseline of any of these symptoms/signs could
predict a beneﬁcial effect of antibiotic treatment.
Results: ‘Poor general condition’ {Hazard ratio 0.77(0.60–0.99)}
and ‘reduced productivity’ {(HR 0.68(0.53–0.88)} at baseline
were independently associated with a prolonged course. None
of the classical sinusitis-like symptoms, nor abnormalities on
radiography had any prognostic value. Prognosis also remained
unchanged whether or not the patient was treated with
antibiotics, regardless of his baseline symptoms.
Conclusions: In a representative group of patients with sus-
pected acute rhinosinusitis in FP, neither the presence of
sinusitis symptoms/signs nor an abnormal radiograph provi-
ded information with regard to the prognosis or effect of
amoxicillin treatment. Patients who felt poorly at baseline, or
didn’t feel able to work, needed more time to recover, but this
could not be inﬂuenced by amoxicillin.
P1349
Effects of moxiﬂoxacin and clarithromycin on the
chlamydial gene expression in treatment-
refractory persistent Chlamydia pneumoniae
infection
J. Rupp, V. Wobbe, M. Maass (Lu¨beck, D)
Objectives: Chlamydia pneumoniae causes chronic infections that
have been related to asthma bronchiale and atherosclerosis.
These chronic infections cannot be eradicated by short-term
antimicrobial treatment due to a non-replicating persistent state
of C. pneumoniae that survives and continues to synthesize
mRNA in the presence of antibiotics. It is unknown if antibiotics
modify the gene expression proﬁle of these persistent chlamy-
diae in a clinically relevant manner. Therefore, we analysed the
differential expression of selected genes in the presence of
moxiﬂoxacin and clarithromycin, which both are active in acute
chlamydial infection, using a model of chlamydial persistence in
peripheral blood monocytes (PBMC).
Methods: Persistent infection with C. pneumoniae was initiated
in PBMC in established methodology. Infected cells were
continuously exposed to moxiﬂoxacin (3.1 lg/ml) or clarithro-
mycin (2 lg/ml) or kept in antibiotic-free medium. Differential
gene expression of selected C. pneumoniae target genes (type III
secretion: LcrD, YscL, YscN; inclusion membrane: IncA, IncC;
amino acid metabolism; TyrB, GlyA) was quantitatively ana-
lysed between 1 and 192 h after infection by RT-PCR using the
LightCycler system.
Results: In antibiotic-free medium gene expression levels
varied individually over time for each gene analysed. However,
all target genes showed a 5- to 9-fold upregulation of mRNA
peaking at 120 h under exposure to moxiﬂoxacin. This was less
prominent under clarithromycin.
Conclusion: Our initial expectation to further reduce transcrip-
tion levels in persistent C. pneumoniae by adding antibiotics
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proved wrong. The surprisingly clear upregulation of gene
expression under moxiﬂoxacin rather indicated a general
regulatory effect of the drug on the pathogen. This is the ﬁrst
demonstration that chlamydiae in the persistent state are not
completely inert and show a reaction to antibiotics. It is under
investigation whether protein synthesis is upregulated in par-
allel. The potential clinical relevance of this ﬁnding regarding
host cell response and course of the infection remains to be
analysed in in vivo models for which this study provides the
basis.
P1350
The application of a validated risk score
safely reduces the rate of hospital admission
in patients with community-acquired
pneumonia presenting to the emergency
department
L. Richeldi, F. Marchetti, M. De Guglielmo, D. Giovanardi,
L. Fabbri (Modena, Verona, I)
Objectives: Patients receiving a diagnosis of community
acquired pneumonia (CAP) in the hospital Emergency Depart-
ment (ED) need to be carefully evaluated to be treated as in- or
out-patients. The Pneumonia Score Index (PSI) is a validated
score predicting the short term risk of death in patients with
CAP and could therefore assist in deciding whether a single
patient with CAP needs to be hospitalized or not.
Methods: We implemented a computer-based critical decision
pathway for the management of patients with CAP, based on
the PSI score and a dedicated software (GesPOrExª). Brieﬂy,
all adults aged >18 years with provisional diagnosis of CAP
were eligible for inclusion in the study. All patients received
written information about their diagnosis of pneumonia and
their treatment plan. CAP was deﬁned as the presence of new
pulmonary inﬁltrate on chest Rx and symptoms consistent
with pneumonia, including cough, dyspnea, change in
sputum, pleuritic chest pain. The PSI score was then calcula-
ted for all patients meeting eligibility criteria. Patients with
scores of 90 points or lower were recommended for outpa-
tients treatment, whereas those with higher scores were
recommended for hospital admission. The PSI score was
used only as a guide to the admission decision and did not
superseded clinical judgment. The follow-up consisted of two
visits, within 10 days and about 1 month after discharge from
the hospital.
Results: The protocol was applied to 117 consecutive patients
with CAP presenting at our ED. Compared to the previous year,
we detected a signiﬁcant 37% reduction (p < 0.001, 95% CI 26–
49%) in the rate of admissions to the hospital of patients with
CAP. Moreover, the length of stay in the hospital showed a
trend toward reduction (from 9 ± 2 days before protocol imple-
mentation, to 7 ± 5 days). In the 3 months follow up, we did not
detect any re-hospitalization in patients treated as out-patients
and the rate of cure was similar before and after the protocol
implementation.
Conclusion: We estimated that the application of this critical
pathway generated a potential saving of about 110.00 Euros in
one year. Interestingly, after the study end the trend towards a
reduction in admission rate for CAP patients was maintained,
thus suggesting that the use of the PSI score entered clinical
practice with persistent beneﬁcial effects on clinically safe and
cost-effective management of CAP patients.
P1351
Adult community-acquired pneumonia.
Evaluation of the antibiotherapy proposed in an
emergency department and analysis of the impact
of training
L. Piglione, V. Blanc, L. Lerousseau, D. Raﬁdiniaina,
C. Rotomondo (Antibes, F)
Objectives: We evaluated the quality of adult community-
acquired pneumonia (CAP) probabilist antibiotherapy within an
Emergency Department and the inﬂuence of a targeted training
on this prescription.
Methods: Study took place in a medium sized general hospital.
All the ﬁles related to patients admitted for the diagnosis of CAP
and hospitalized were reviewed in a prospective way by a local
committee of independent Experts during the ﬁrst half-year
2003 (T1) and the ﬁrst half-year 2004 (T2), and compared.
Between the two periods, the prescribing physicians have been
trained (educational sessions based on the guidelines for
pneumonia care of the French Society of Infectious Diseases
(SPILF)). Three major quality indicators were used: initial
molecule selection, dosage and time to ﬁrst dose. Cost of
antibiotherapy was calculated.
Results: 53 ﬁles were selected during T1 and 42 during T2. The
2 groups were well matched (age, sex, Fine’s score). Inadequate
initial molecule selection decreased from 43% to 29% (NS),
inadequate dosage decreased from 4% to 0% (NS). Time to ﬁrst
dose was <4 hours in the 2 groups. Between T1 and T2, the
prescription of amoxicillin increased by 15%, at the expense of
ﬂuoroquinolones ()13%) and of the 3rd-generation cephalospo-
rins ()9%). Macrolides prescription remained stable. Antibio-
therapy cost decreased by a 2.5 fold ratio (p < 0.05)
Conclusions: Our work demonstrates that, even if the dosage
errors are rare and the antibiotic therapy is always early, there
was a mediocre adhesion to the recommendations as regards to
the choice of the molecule, before the intervention. Even though
results obtained with our targeted training are modest, they are
encouraging as they increased the use of guidelines recommen-
ded antibiotherapy, and leaded to signiﬁcant cost gain. The
development of different educational strategies is essential for
the application of good medical practices for a better patient’s
management from the moment they are admitted in the
Emergency Department.
P1352
Moraxella catarrhalis replacement in the
nasopharynx of asymptomatic children
A. Sulikowska, P. Grzesiowski, W. Hryniewicz (Warsaw, PL)
Objective: The aim of the study was to analyse, using pheno-
typic and molecular methods, the dynamics of nasopharyngeal
carriage of Moraxella catarrhalis in asymptomatic children sam-
pled at two time points with a 4-month interval.
Methods: 77 children (43 from an orphanage and 34 from a day
care centre – DCC) were examined twice, ﬁrst in Winter and
again in the following Spring. Clinical data and information
about sex, age, socio-economic status, respiratory tract infections
and antibiotic treatment within 3-months prior the sampling,
were collected by questionnaire. Nasopharyngeal swabs were
processed and M. catarrhalis was identiﬁed by standard proce-
dures. The b-lactamase production was determined using the
nitroceﬁn test. Pulsed-ﬁeld gel electrophoresis (PFGE) of BcuI-
digested M. catarrhalis DNA was performed to determine the
relatedness among isolates.
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Results: Altogether 58 M. catarrhalis isolates were identiﬁed; 35
were derived from children from the orphanage and 23 from the
DCC. Thirty children (17 from the orphanage and 13 from the
DCC) were colonised in Winter and 28 (18 from the orphanage
and 10 from the DCC) in Spring. Fourteen children (9 from the
orphanage and 5 from the DCC) were colonised byM. catarrhalis
both in Winter and Spring. Out of them only one child was
colonised by the same strain during the ﬁrst and second
sampling. In most cases, M. catarrhalis isolated at 2 different
points of the year from the same child were unrelated. All
isolates of M. catarrhalis were b-lactamase producers.
Conclusions: Colonisation of nasopharynx by M. catarrhalis
represents a dynamic process – bacteria are acquired, eliminated
and re-acquired over a period of 3–4 months. Long-term
colonization (over 4 months) involved only 1 of the 77 investi-
gated children.
P1353
Characterisation of invasive and non-invasive
Haemophilus inﬂuenzae-isolates in a highly
vaccinated population
B Gro¨ndahl (Mainz, D)
Objectives: Characterization of invasive and non-invasive Hae-
mophilus inﬂuenzae (Hi)-strains has not been done since the
implementation of general vaccination against Hi type b in
Germany.
Methods: Invasive isolates were acquired through a population
based, nationwide surveillance using 2 detection systems.
Colonizing, non-invasive isolates were isolated from nasopha-
ryngeal aspirates of hospitalized children with acute respiratory
diseases.
Results: From 09/2001 to 08/2004 a total of 175 invasive isolates
were collected, of which 160 (91.4%) could be evaluated. Most
strains were non-capsulated (n = 99; 56.6%). The most frequent
capsular type was type b (n = 39; 22.3%), followed by types f
(n = 19; 10.9%), e (n = 3; 1.7%) and a (n = 1; 0.6%). Types c and d
were not detected. There was no increase of ‘non-b’-isolates over
the observation period. More capsulated Hi (13%) were detected
by PCR than by agglutination (n = 62 vs. n = 54). The most
frequent biotype was type I (n = 65; 37.1%), followed by type II
(n = 51; 29.1%) and type III (n = 26; 14.9%). Only a small
proportion of isolates produced beta-lactamase (n = 6; 3.4%). In
the same period 102 non-invasive, colonizing Hi were isolated.
All strains but one (capsular type e) were non-capsulated. No Hi
type b could be detected. The most frequent biotype was type II
(n = 41; 42.7%), followed by type I (n = 23; 24.0%) and III
(n = 20; 20.8%). Only four isolates produced beta-lactamase
(3.9%).
Conclusions: Haemophilus inﬂuenzae type b as colonizing or as
invasive pathogen has almost disappeared in Germany.
Replacement was not observed. Invasive or colonizing
Hi-isolates rarely produced beta-lactamase (3.4 – 3.9%).
P1354
Chlamydia-like micro-organism, Simkania
negevensis, as a possible emerging pathogen in
Finland?
M. Paldanius, J. Hietala, M. Leinonen, M. Uhari,
P. Saikku (Oulu, FIN)
Objectives: Simkania negevensis, environmental Chlamydia-like
intracellular bacterium, has been shown, in a few reports, to be
associated to respiratory infections in infants and in adults (1).
There is no data available on the prevalence of S. negevensis
antibodies or infections from Finland. We developed micro-
immunoﬂuorescence (MIF) method for the measurement of
S. negevensis antibodies and tested paired sera obtained from
Finnish children with infectious episode using this method.
Methods: Serum samples from 262 children were screened for
IgG, IgA and IgM antibodies by in-house MIF test utilizing
urograﬁn puriﬁed formalinized bacteria of S. negevensis, ATCC
strain (VR-1471) as antigens. The incubation time was overnight.
If the patient had three sera, the middle serum sample was
selected and when only paired sera were available, the last
serum was selected for the screening. All S. negevensis positive
screenings (a titer of ‡8) were tested with paired sera (or three
sera). The presence of IgM antibodies (after removing IgG
antibodies with Gullsorb reagent) or four-fold titer rise in IgG or
IgA between paired sera were considered diagnostic for acute
infection.
Results: The prevalence of S. negevensis antibodies was 19 % for
IgG, 0 % for IgA and 5.7 % for IgM. Acute S. negevensis infection
was diagnosed in altogether 23 (8.8%) of 262 children: in six
cases by IgG seroconversions and in 18 cases by the presence of
IgM antibodies.
Conclusion: S. negevensis antibodies were demonstrated for the
ﬁrst time in Finnish children. Serological diagnosis of acute
S. negevensis infection was obtained in 9% of children. Further
studies using e.g. direct demonstration of S. negevensis by
culture and PCR in clinical samples are needed to elucidate the
pathogenetic signiﬁcance and clinical picture associated to this
bacterium. MIF method developed in this study seems to be
suitable for the measurement of S. negevensis antibodies and
there seems to be no cross-reactivity with Chlamydia pneumoniae
antibodies when using this test. 1. Friedman MG, Dvoskin B,
Kahane S. Infections with the Chlamydia-like microorganism
Simkania negevensis, a possible emerging pathogen. Review.
Microbes Infect 5:1013–21, 2003
P1355
Macrolide treatment failure in pulmonary
Nocardia nova infection
Y. Keynan, H. Sprecher, G. Weber (Haifa, IL)
Objectives: To describe failure of Clarithromycin in the treat-
ment of pulmonary Nocardia Nova infection, despite in vitro
susceptibility to macrolides.
Patient and Methods: A 61-year-old male with diabetes mell-
itus, non Hodgkin’s lymphoma after chemotherapy, chronic
adrenal replacement therapy (due to lymphomatous inﬁltration
of the adrenals), presented with persistent cough in the previous
3 month. Weakly acid fast bacilii were detected in sputum and
treatment with ethambutol, rifampin and clarithromycin was
given for presumed MOTT infection. Although the patient
reports strict compliance with drug therapy for three weeks,
neither symptomatic nor radiographic improvement was noted.
Nocardia spp. was isolated from sputum culture. DNA was
extracted from bacterial colonies. A 439-bp fragment encompas-
sing the hsp-65 gene was PCR-ampliﬁed and subsequently
digested with BstEII and HaeIII endonucleases. Bacterial DNA
was also PCR-ampliﬁed using a primer pair speciﬁc for
conserved regions of 16S rRNA. The nucleotide sequence of
the resulting amplicons was established and analysed using the
BLAST software.
Results: PCR-RFLP analysis revealed a restriction pattern com-
patible with that of N. Nova. This identiﬁcation was ultimately
conﬁrmed as N. Nova, (99% homology) based on BLAST
analysis of the bacteria 16S rRNA sequence. The isolate was
sensitive to erythromycin. The patient received trimethoprim/
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sulfamethoxazole with gradual clinical and radiologic improve-
ment. After three month of follow-up he remains well.
Conclusions: Nocardia Nova may account for 20% of Nocardia
isolates identiﬁed as N. asteroides. N. Nova strains were previ-
ously noted for their susceptibility to ampicillin, cephalosporins
and erythromycin. A macrolide was suggested as an alternative
to sulfonamide in nonresponders or those with allergy to sulfa.
The apparent disparity between in vitro susceptibility to
macrolides and clinical failure warrants cautious use of these
antibiotics in N. nova infections. Sequence based identiﬁcation
allows for accurate separation of N. nova from other related
species.
Pneumococcal pneumonia
P1356
Changing antimicrobial susceptibility patterns
among S. pneumoniae and H. inﬂuenzae from
Brazil: report from the SENTRY Antimicrobial
Surveillance Programme 1998–2003
H. Sader, A. Gales, R. Jones (North Liberty, USA; Sao Paulo, BR; )
Background: Although antimicrobial resistance (R) rates among
S. pneumoniae (SPN) and H. inﬂuenzae (HI) have increased
signiﬁcantly in most countries in the last years, most studies
from Brazil report relatively low R rates among these pathogens.
We analysed the susceptibility (S) patterns of SPN and HI from
Brazil (6 years) for signiﬁcant trends.
Methods: 729 SPN and 566 HI collected from 1998–2003, mainly
from respiratory tract and bloodstream infections, were suscep-
tibility (S) tested by NCCLS broth microdilution methods
against >30 drugs and the results analysed by year.
Results: Results are summarized below:
Conclusions: R to PEN has increased markedly among SPN
over 6 years (from 3 to 10%). R to T/S also escalated from 50 to
61%, but S to ERY, CLI and TET signiﬁcantly decreased among
SPN strains. R to the antimicrobials tested remained very stable
among HI with only some year-to-year variations. R to the
newer ﬂuoroquinolones was not detected and CHL showed an
excellent spectrum (>95% S) against both pathogens.
P1357
Contemporary activity of gemiﬂoxacin and other
ﬂuoroquinolones tested against Streptococcus
pneumoniae isolated during 1999–2004 in Europe
and America
D. Biedenbach, J. Ross, H. Sader, T. Fritsche, A. Fuhrmeister,
R. Jones (North Liberty, USA)
Objectives: To determine the potency of gemiﬂoxacin (GEMI)
tested against S. pneumoniae (SPN) for the years 1999–2004. The
evaluation of GEMI compared to other currently marketed
ﬂuoroquinolones (FQ) will also be made including mechanisms
of resistance (R).
Methods: During a six year period (1999–2004), a total of 5892
SPN isolates were collected from medical centres on three
continents and tested for antimicrobial susceptibility (S) using
reference NCCLS broth microdilution methods and interpretive
criteria (M100-S15, 2005). The antimicrobial agents tested inclu-
ded ﬁve FQs: GEMI, ciproﬂoxacin (CIPRO), levoﬂoxacin
(LEVO), gatiﬂoxacin (GATI) and moxiﬂoxacin (MOXI). Analysis
of the quinolone resistance determining region (QRDR) was
performed for 35 FQ- R strains (LEVO MIC at >4 mg/L).
Results: The activity of GEMI against SPN over a six year
period is shown in the table: During the six years, the rank order
of potency (MIC90, mg/L) for the FQs was GEMI (0.03) > MOXI
(0.12–0.25) > GATI (0.5) > LEVO (1–2) > CIPRO (2). All FQ
median and modal potencies remained stable over the monit-
ored interval. SPN isolates with CIPRO MIC values ‡4 mg/L
ranged from 1.6 to 2.1% with no detectable trend towards
increasing R across all regions. The most common QRDR
mutations among strains with CIPRO and LEVO MIC values
‡4 mg/L were: gyrA (S83F or T), parC (S79F or T and D83N)
and parE (I460V). Against these isolates, GEMI maintained the
most potent activity at MIC50/90 values of 0.5/1 mg/L and a
MIC range of only 0.25–2 mg/L.
Conclusions: Among the FQs tested, GEMI was clearly the most
potent agent and remains a valuable candidate for treating multi-
drug R SPN, an increasingly observed respiratory-tract pathogen.
During the study years, FQ-R did not increase signiﬁcantly and S
rates to GEMI remained at >99.2% and was unrelated to
increasing R among beta-lactam and macrolide antimicrobials.
P1358
Resistance patterns of S. pneumoniae and
H. inﬂuenzae isolated from children with upper
respiratory tract infection in Southern Brazil –
2003 and 2004
C.M. Mendes, A.C. Arruda, C. Oplustil, J.L. Sampaio, P. Garbes,
P. Lima, L. Pedneault, A. Gonc¸alves, C. Dias, A. Barth, C.R.
Kiffer (Sao Paulo, Rio de Janeiro, BR; Brussels, B; Porto Alegre, BR)
Objective: Establish the susceptibility proﬁle of S. pneumoniae
and the beta-lactamase production of H. inﬂuenzae isolated from
children with upper respiratory tract infection (URTI) from 3
cities in Brazil.
Methods: Samples (one per patient) were selected from patients
under 7 years old during 2003 and 2004. Only patients with
clinical diagnosis of URTI and a positive culture result for
Year (no. tested)
GEMI-MIC (mg/L) % by category
50% 90% S I R
1999 (554) £0.03 £0.03 99.6 0.4 0.0
2000 (508) £0.03 £0.03 99.6 0.2 0.2
2001 (1.435) 0.016 0.03 99.4 0.3 0.3
2002 (1.502) 0.016 0.03 99.5 0.3 0.2
2003 (890) 0.016 0.03 100.0 0.0 0.0
2004 (1.003) 0.016 0.03 99.2 0.7 0.1
All years (5.892) 0.016 0.03 99.5 0.3 0.2
Antimicrobial
% S by year (SPN/HI)
1998 1999 2000 2001 2002 2003
Penicillin (PEN) 84 (3)a/10b 83 (6)a/13b 75 (5)a/7b 82 (8)a/16b 78 (8)a/16b 72 (10)a/10b
Erythromycin (ERY)/
Clarithromycin
85/90 88/100 91/92 90/91 94/90 91/94
Clindamycin (CLI) 94/- 95/- 96/- 95/- 100/- 98/-
Gatiﬂoxacin/Levoﬂoxacin 100/100 100/100 100/100 100/100 100/100 100/100
Chloramphenicol (CHL) 99/96 98/99 99/97 100/95 99/93 100/96
Tetracycline (TET) 72/96 75/84 82/95 78/95 86/98 85/96
Co-trimoxazole 50/53 52/53 51/55 40/48 39/54 39/57
a. % RCMI (‡ 2 mg/L) to PEN.
b. b-lactamase producing strains.
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S. pneumoniae or H. inﬂuenzae were included in the study.
Clinical data related to age, gender, diagnosis and samples were
described. S. pneumoniae isolates were tested against penicillin,
amoxicillin, amoxicillin/clavulanic acid, cefuroxime, cefaclor,
and azithromycin. Minimum Inhibitory Concentrations (MICs)
were determined by E-test methodology (testing conditions 35C;
5%CO2; 20–24 hours). Interpretative criteria used were those
described by NCCLS documents M100-S14 for all antimicrobi-
als, except for azithromycin (AB Biodisk). H. inﬂuenzae isolates
were tested for beta-lactamase production by a chromogenic
cephalosporin method.
Results: There were 137 S. pneumoniae and 170 H. inﬂuenzae
isolates from children under 7 years old. Demographic data are
presented in the table. Of H. inﬂuenzae, 10.6% were beta-
lactamase producers. Among S. pneumoniae, 66.4% were sus-
ceptible (S), 23.4% intermediate (I) and 10.2% resistant (R) to
penicillin (MIC90 = 1.5 lg/mL). As for azithromycin, 90.5%
were S, 1.5% I, and 8% R (MIC90 = 4 lg/mL). Only one isolate
(0.7%) was resistant to amoxacillin (MIC = 3.0 lg/mL).
Conclusions: A signiﬁcant rate of beta-lactamase production in
H. inﬂuenzae was detected. The prevalence of penicillin inter-
mediate/resistant S. pneumoniae, was high and more common
compared with previous years. Empiric therapy with penicillins
alone or in low dose should be avoided in this population.
Amoxicillin would still be appropriate to treat pneumococcal
infections (despite penicillin resistance) and so would be
co-amoxiclav.
P1359
Evidence for the emergence of non-vaccine types
causing invasive pneumococcal disease in Spain
E. Cercenado, C. Arenas, A. Fenoll, E. Bouza (Madrid,
Majadahonda, E)
Objectives: S. pneumoniae (Sp) is an important cause of mor-
bidity and mortality in children and in adults. Vaccination
reduces carriage and prevents the disease. In a nationwide point
prevalence study, 147 institutions from all areas of Spain
collected all Sp isolated during one week (February 16–22th,
2004). The isolates were sent to a central laboratory for
susceptibility testing and serotyping. In this study we analyze
the distribution of serotypes and the resistance to antimicrobials
of Sp isolated from children and adults.
Methods: A total of 360 Sp isolates were identiﬁed. Suscepti-
bility testing was performed by the broth microdilution method
in cation-adjusted Mueller-Hinton broth with 5% lysed horse
blood following NCCLS guidelines. Serotyping was performed
by standard methods.
Results: The isolates belonged to 251 adults (70%) and 109
children. Origins were: respiratory tract (48%), blood (24%), ear
(12%), conjunctiva (7%), CSF (4%), other sterile ﬂuids (3%) and
miscellaneous (2%). Penicillin resistance (I+R) was 42%, and
erythromycin resistance was 36%. A total of 34 isolates were
non-typeable and were excluded for further analysis. The most
frequent serotypes (St) were 3, 19F, and 19A. St 14, 19F, and 23F
were the most frequent among the penicillin-resistant strains,
and St 3 among susceptible strains. The most frequent St of the
96 invasive isolates (blood and CSF) were 14 and 19F, in children
and in adults, respectively. Among the 96 invasive isolates, 84%
corresponded to St included in the 23-valent (23-V) vaccine, and
46% to St included in the 7-valent (7-V) vaccine. The most
frequent non-vaccine St were 6A, 16, 31, 34, 35B, and 35F. A total
of 106 (45%)of Sp isolated from adults belonged to St frequently
isolated from children (6, 14, 18, 19, and 23). Considering Sp
isolated from all origins, the estimated coverage of the 7-V
vaccine was 40% in children and 38% in adults; and the
estimated coverage of the 23-V vaccine was 77% in adults.
Considering only invasive isolates, the estimated coverage of the
7-V vaccine was 61% in children and 41% in adults; and the
estimated coverage of the 23-V vaccine was 79% in adults.
Conclusions: These results conﬁrm the high rates of resistance
of Sp to penicillin and erythromycin, the spread to adults of St
frequently isolated from children, the evidence for the emer-
gence of non-vaccine types causing invasive pneumococcal
disease, and the moderate coverage of the 7-valent pneumococ-
cal vaccine.
P1360
Incidence, predisposing conditions and outcome
of invasive pneumococcal infections in Finland
P. Klemets, O. Lyytika¨inen, P. Ruutu, J. Ollgren,
P. Nuorti (Helsinki, FIN)
Objectives: To determine the incidence of invasive pneumo-
coccal infections (IPI) in patient groups recommended to receive
pneumococcal polysaccaride vaccine (PPV23) as well as out-
come of the illness.
Methods: All laboratories performing blood and cerebrospinal
ﬂuid (CSF) cultures submitted data on isolation of Streptococcus
pneumoniae from blood or CSF during 1995–2002. Information
on vital status, comorbidities and denominator data on persons
at risk were obtained from the Population Information System,
National Hospital Discharge Registry, Cancer Registry, National
Social Insurance Institution, and National Infectious Disease
Registry. The patient’s national identity code was used for
linking databases. Only the ﬁrst episode of IPI was included in
the analysis.
Results: A total of 4357 episodes of IPI were identiﬁed (inci-
dence 10.6 cases per 100,000 population). Highest incidence of
IPI was seen in patients with haematological malignancy (547
per 100,000 population), organ or bone marrow transplantation
(164), males aged ‡55 with chronic obstructive pulmonary
disease (143) and persons with HIV (130). The overall case-
fatality proportions (CFPs) at 7, 28 and 90 days after the positive
culture were 9%, 12% and 16%, respectively. At 28 days the
CFPs ranged from 1% to 25% in different age groups. In patients
aged ‡50 they were signiﬁcantly higher in men than in women
(20% vs 15%; p < 0.01). Patients with non-hematological malig-
nancy and alcoholism had the highest CFPs at 28 days, 31% and
27%, respectively. In patients with hematological malignancy
the 28-day CFP was 16% and 6% among healthy adults aged
18–64 years. In adults aged 18–64 years, 931 (42%) of 2216 cases
had an underlying condition for which PPV23 is recommended.
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Conclusion: The incidence and outcome of IPI varied consid-
erably in different patient groups. However, the patient groups
with highest rates of IPI were not always the same as those at
highest risk of death. The overall mortality associated with IPI
was nearly twice as high 90 days after infection compared with
the ﬁrst week, suggesting the contribution of pre-existing illness
or long-term sequelae. Among non-elderly adults, the high
prevalence of underlying conditions for which PPV23 is recom-
mended emphasizes the importance of vaccinating groups at
highest risk of disease and death.
P1361
Usefulness of prognostic score systems –
Pneumonia Severity Index (PSI), CURB-65, and
Ewig scores – in community-acquired
bacteraemic pneumococcal pneumonia
C. Spindler, A˚. O¨rtqvist (Stockholm, S)
Objectives: Predictive score systems for CAP have all been
developed for the heterogeneous group of ‘all’ CAP, but none
have been evaluated for pneumonia caused by a single patho-
gen. Streptococcus pneumoniae is the most common cause of CAP
and the most common cause of fatal pneumonia. We have
prospectively studied the accuracy of three score systems, PSI,
CURB-65, and Ewig’s score, for predicting need of ICU-treat-
ment, and death due to community-acquired bacteraemic
pneumococcal pneumonia (BPP).
Methods: All adult patients (n = 114) with invasive pneumo-
coccal disease (IPD) and x-ray veriﬁed pneumonia at Karolinska
and Danderyd Hospitals, Stockholm, Sweden, 1999–2000, were
included. 88 patients were treated in the dpt of Infectious
Diseases (DID) and 26 patients in other dpts (ODs). Severity
scores were calculated according to the original publications and
the independent prognostic importance of different variables
was analysed by multiple regression analyses.
Results: PSI > III, CURB-65 > 1, and presence of 1 major or >1
minor risk factor in Ewig’s score all had a high sensitivity, but
somewhat less good speciﬁcity, for predicting fatal outcome
(Table). The area under the Receiver Operating Characteristics
curves for predicting death were between 0.83 and 0.85 for all
three tests. The death rate was 12% (14/114), but patients treated
in DID had a signiﬁcantly lower rates than those treated in ODs,
5% (4/88) vs. 35% (10/26) (p < 0.0001). Also within the same
severity score strata mortality was lower among patients treated
in DID than in ODs. The fatality for a PSI-score of IV-V was 9/20
in OD vs. 4/33 in DID (p = 0.01). No other factors explaining
this difference were found in the multiple regression analyses.
Conclusions: All score-systems were useful for predicting need
of ICU-care and risk for death due to BPP. PSI was the most
sensitive, but CURB-65 score more easy to use. That the death
rate was 3–4 times higher for patients treated in OD, compared
to those treated in DID, despite the same severity score,
illustrates that comparisons of mortality between different
patient materials must be interpreted with caution, even if the
analysis is based on calculation of severity of disease.
P1362
Prevalence of international clones among
invasive isolates from Portugal
I. Serrano, J. Melo-Cristino, M. Ramirez (Lisbon, P)
Objective: To evaluate the prevalence of international clones
recognized by the Pneumococcal Molecular Epidemiology Net-
work (PMEN) among invasive isolates from Portugal.
Methods: A collection of 465 invasive isolates from Portugal
(1999–2002) described recently (Serrano, I., et al. 2004. Invasive
Streptococcus pneumoniae from Portugal: implications for
vaccination and antimicrobial therapy. Clin Microbiol Infect
10:652–6.) was characterized using a combination of macrore-
striction proﬁling, using SmaI and pulsed ﬁeld gel electrophor-
esis (PFGE), and multi-locus sequence typing. Serotypes 14, 1, 3,
4, 8, 9V, 23F, 7F, 19A and 12B were the 10 most prevalent overall
by decreasing rank order. A total of 12% of the strains were
recovered from children <2 years old.
Results: By combining the PFGE data with the sequence types
(ST) of 104 isolates we were able to identify the genetic lineages
of the majority of the strains. We found 66 STs, including 20
novel STs, corresponding to 47 different lineages by e-BURST
analysis. Out of the 26 clones currently recognized by the PMEN
we found representatives of 5 among our collection: Spain23F-1,
Spain6B-2, Spain9V-3, England14-9, Poland6B-20, Greece6B-22
and Colombia23F-26. The clones Greece6B-22 and Spain6B-2
grouped into a single PFGE cluster including 57% (n = 8) of the
isolates expressing serotype 6B. An additional 3 isolates
belonged to the same cluster as the clone Poland6B-20, such
that 79% of the isolates expressing serotype 6B belonged to
either one of the clones. In serotype 9V all the isolates (n = 21)
belonged to the same cluster as clone Spain9V-3. This same
clone accounted for the majority (n = 52) of the serotype 14
isolates. Since the cluster including the England14-9 clone
encompassed 9 strains, a total of 98% of the strains expressing
serotype 14 belonged to PMEN clones. Among serotype 19A
strains, clone Spain23F-1 accounted for 41% (n = 7) of the
isolates. The clones Colombia23F-26 (n = 17) and Spain23F-1
(n = 3) accounted for 91% of all 23F isolates. The PMEN clones
accounted for 87% of penicillin non-susceptible (PNS) strains,
including all resistant isolates, as well as the majority (61%) of
the strains resistant to erythromycin.
Conclusion: International clones recognized by the PMEN
accounted for 26% of all isolates in our collection including
87% of PNS and 61% of erythromycin resistant strains. Strains
belonging to clone Spain9V-3, expressing either serotype 9V or
14, constituted 16% of all isolates.
P1363
Pneumococcal bacteraemia in children in
northern Taiwan: clinical, serotyping and
genotyping analysis
C.L Lin, Y.C Huang, C.-H Chiu, T.Y Lin (Kweishan, Taoyuan,
TW)
Objectives: To assess the association among the clinical pres-
entations of children with Streptococcus pneumoniae bacteraemia
and the serotypes and genotypes of the isolates.
Methods: Children less than 18 years of age with S. pneumoniae
bacteraemia from Chang Gung Children Hospital were identi-
ﬁed retrospectively from January, 2001, to December, 2003.
Demographic data, clinical features were reviewed. Clinical
isolates were studied by standard microbiologic methods,
Quellung test and pulsed-ﬁeld gel electrophoresis.
Mortality IUC-treatment
PSI
IV-V
CURB-65
(2–5)
Ewig (1 major
or >1 minor)
PSI
IV-V
CURB-65
(2–5)
Ewig (1 major
or >1 minor)
Sensitivity 100% 92% 85% 95% 85% 90%
Speciﬁcity 60% 67% 84% 64% 70% 90%
PPV 25% 27% 41% 36% 38% 67%
NPV 100% 99% 98% 98% 96% 98%
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Results: A total of 77 patients with 78 disease episodes and 79
isolates were included. The mean age was 2.5 yrs (1mo–9 yr)
and 46 (59%) children were male. Clinical spectrums included
occult bacteraemia (22/78, 28.2%), uncomplicated pneumonia
(16/78, 20.5%), complicated pneumonia (15/78, 19.2%), men-
ingitis (13/78, 16.7%), septic shock (5/78, 6.4%), septic arthritis
(3/78, 3.8%), mastoiditis (1/78, 1.2%), and nosocomial bac-
teraemia (3/78, 3.8%). 82% of the isolates were penicillin
nonsusceptible (MIC > 0.1 lg/mL). Nine children (12%) died,
and 6 of them had underlying diseases. A total of 7 serotypes
were found and three predominant serotypes, including 23F
(30%), 14 (28%), and 6B (27%), were found. Serotype 14
accounted for 14 (45%) of 31 isolates from patients with
pneumonia. Serotype 23F isolates (71%) presented more resist-
ant to penicillin than serotype 14 (18%). 31 PFGE types were
identiﬁed. There were only two genotypes with 10 or more
isolates (15 and 10). Fourteen of 15 isolates of genotype 3 were
serotype 23F. All 10 isolates of genotype 1 were serotype 14
and 7 of them caused pneumonia.
Conclusions: Pneumonia and occult bacteraemia were the two
most common presentations. Three were three major serotypes.
Relative clusters in two genotypes were identiﬁed with one
clone associated with serotype 14 and pneumonia.
P1364
Levoﬂoxacin is effective in the treatment of RTIs
caused by penicillin-susceptible and penicillin-
resistant Streptococcus pneumoniae (SELECT
Study)
J. Yamakita, M.D. O’Hare (Tokyo, JP; Bournemouth, UK)
Objectives: To retrospectively assess the efﬁcacy of levoﬂoxacin
for respiratory tract infections (RTIs) caused by penicillin-
susceptible Streptococcus pneumoniae (PSSP) or penicillin-non-
susceptible S. pneumoniae (PNSSP).
Methods: 18 investigators in Europe (Belgium 2; France 6;
Germany 1; Italy 4; Spain 5) collected data on 100 cases of
levoﬂoxacin-treated RTIs caused by S. pneumoniae (49 PNSSP
[18 PRSP and 31 PISP], 51 PSSP). Each patient was treated
with levoﬂoxacin (i.v./oral), at a dosage of 500 mg once or
twice daily for a planned minimum 7 day duration.
S. pneumoniae was to have been isolated within 2 days prior
to the start of levoﬂoxacin treatment. Clinical outcome was
analysed according to penicillin susceptibility. Other factors
examined included medical history, primary clinical diagnosis,
other antimicrobials prescribed, and number of days spent in
hospital.
Results: There were no major differences in the subject demo-
graphy or medical history between patients with PSSPs and
PNSSPs. 90/100 subjects (90%) were clinical successes; two
subjects (2%) were clinical failures (one in each group) and eight
subjects (8%) died due to initial infection (4 in PSSP subjects and
4 in PNSSP subjects). Clinical success was equally common
among patients with PSSPs (46/51 subjects, 90.2%) and PNSSPs
(44/49 subjects, 89.8%). For all cases in total, there was no
difference between clinical success rate of subjects with PSSP
infection and those with PNSSP infection.
Conclusions: Levoﬂoxacin is highly effective in the treatment of
RTIs caused by S. pneumoniae, regardless of penicillin suscep-
tibility, with 90.2% success in PSSPs and 89.8% success in
PNSSPs. This is very similar to success rates in clinical trials and
thus there is no evidence of a decline in efﬁcacy over the seven
years since the launch of levoﬂoxacin in Europe. The usefulness
of levoﬂoxacin therapy for RTI due to PNSSP is clearly
demonstrated.
P1365
Bacteriological outcomes with
pharmacokinetically enhanced amoxicillin/
clavulanate (2000/125 mg) in patients with
community-acquired respiratory infection caused
by Streptococcus pneumoniae, including drug-
resistant strains
S. Miller, M. Twynholm, E. Berkowitz, S. Gormley, A. White,
L.A. Miller, C. Jakielaszek (Harlow, Greenford, UK; Collegeville,
USA)
Objectives: To assess the bacteriological efﬁcacy of pharmacoki-
netically enhanced amoxicillin/clavulanate 2000/125 mg (PKE
AMX/CA) against Streptococcus pneumoniae infections, partic-
ularly strains resistant to penicillin+ ‡1 other antibacterial class
(drug-resistant, DRSP), which are now of global clinical concern.
Methods: Bacteriological data were obtained from patients in
the bacteriology per-protocol populations (‡1 pathogen isolated
at screening and adherence to study protocol) of 13 clinical
studies of PKE AMX/CA (community-acquired pneumonia
[CAP], 6; acute bacterial sinusitis [ABS], 3; acute exacerbations of
chronic bronchitis [AECB], 4). Data from 840 patients with S.
pneumoniae isolated at screening were analysed to assess overall
bacteriological efﬁcacy against S. pneumoniae. MICs of AMX/CA
(2:1 ratio based on AMX content), penicillin and 16 other
antibacterials were determined, and isolate susceptibility
assessed based on NCCLS breakpoints. Isolates resistant to
penicillin (PRSP, MIC ‡2 mg/L) and ‡1 other antibacterial class
were considered DRSP. Success, as deﬁned in the individual
trials, was the eradication or presumed eradication, based on
clinical evidence, of the initial pathogen. Failure was the
persistence/recurrence of the initial pathogen in a repeat culture
sample or, in the absence of a repeat sample, clinical evidence of
persistence/recurrence. Data from the follow-up visit of each
study were used. Exact methodology was used to determine
95% conﬁdence intervals (CIs).
Results: PKE AMX/CA achieved bacteriological success in
94.2% (791/840; 95% CI 92.4, 95.7) of patients with S. pneumoniae
isolates in the pooled analysis. Against DRSP strains, success
was 97.6% (81/83; 95% CI 91.6, 99.7) and against non-DRSP was
93.8% (710/757; 95% CI 91.8, 95.4). PKE AMX/CA was success-
ful against 46/46 isolates with an AMX/CA MIC of 2/1 mg/L,
14/14 with an AMX/CA MIC of 4/2 mg/L and 9/11 with
AMX/CA MICs of 8/4–16/8 mg/L. Bacteriological success
against DRSP was 97.7% (43/44; 95% CI 88.0. 99.9) in CAP,
100% (33/33; 95% CI 89.4, 100) in ABS and 83.3% (5/6; 95% CI
35.9, 99.6) in AECB.
Conclusion: PKE AMX/CA was highly bacteriologically suc-
cessful against S. pneumoniae, including DRSP, across all three
respiratory indications studied, and against strains with eleva-
ted AMX/CA MICs. PKE AMX/CA should, therefore, be
effective in treating S. pneumoniae respiratory infections, even
when PRSP or DRSP are suspected.
P1366
Study of antibiotic resistant commensal and
invasive Pneumococci isolated in Romania
between 1996–2003
M. Pana, M. Ghita, I. Nistor, R. Papagheorghe, N. Popescu,
G. Bancescu, M. Andrei, V. Ungureanu (Bucharest, RO)
Objective: To study the antibiotic resistance in Romanian
Pneumococci isolated from carriers and ill people between 1996
and 2003.
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Methods: 1109 strains of Streptococcus pneumoniae coming from
blood, CSF, tracheal aspirate, pleural ﬂuid, middle ear ﬂuid and
376 strains coming from nasopharynx from HIV infected
children were isolated between 1996 and 2003 at the National
reference Center for Streptococcus. The strains were serotyped
with in house co-agglutinant reagents prepared with pneumo-
coccal antigens from Serum Staten Institute Copenhagen). The
isolates were tested for susceptibility (MICs) to the following
antibiotics: Penicillin(Pc), erythromycin(Em), cephalothin(Kf),
cefuroxim(cxm), cefotaxim(Ctx), amoxicillin(Amx), trimetho-
prim/sulfamethoxazole(Sxt), oﬂoxacin(Ofx), vancomicin(va) by
standard dilution MIC testing with Steers replicator.
Results: Breakpoints were used as proposed by NCCLS 2004.
Invasive strains of Pneumococci showed lower levels of antibiotic
resistance ( 40%Pc, 22%Kf, 7.3%Cxm, 5%Ctx, 6%Amx, 25%Em,
2.5%Ofx, 69%Sxt) against strains from carriers which revealed
high levels of resistance (65%Pc, 27%Kf, 10.8%Cxm, 6%Ctx,
8.7%Amx, 59%Em, 4%Ofx, 74%Sxt). No resitant strain to Va was
found. The pneumococcal strains isolated from carriers
belonged only to few serotypes: 23,14,19,and 6 closely correlated
with the antibioresistance. The most frequently serotypes
encountered in invasive strains were: 8,7,1,19,14,23,6.
Conclusion: During the study period the most efﬁcient antibi-
otics were: Cxm,Ctx,Amx and Ofx. There is an urgent need in
Romania for the surveillance,prevention and control of antibi-
otic resistant Pneumococci and to enhance the use of an efﬁcient
pneumococcal vaccine.
Pneumonia in non-HIV immunosuppressed patients
P1367
Pneumocystis jiroveci-pneumonia in
immununodeﬁcient patients without AIDS
T. Blum, A. Roth, H. Mauch, H. Lode (Berlin, D)
Introduction: Patients with pneumonia resistant to treatment
prove to be a common problem in chest Hospitals. Pneumocystis
jiroveci (PJ) should always be thought of as an opportunistic
pathogen in case of potential, especially T-cell-related immuno-
deﬁciency – even if AIDS-disease is not apparent. We report on
cases of PJP without associated AIDS-disease in a chest hospital.
Objectives: The aim of the study was to investigate frequency,
diagnostic procedures, course and outcome of PJP without
associated AIDS-disease in our hospital.
Methods: In a retrospective study, we evaluated hospitalized
patients presenting with pneumonia during January 1st 2003
and August 31st 2004 in our hospital. The identiﬁcation of the
cases with PJP was based upon discharge diagnosis as well as
our microbiological database (conﬁrmed PJ in broncho-alveolar
lavage by immunoﬂuorescence-test (IFT) and/or PCR).
Results: The diagnosis of PJP without associated AIDS-disease
could be made in 7 out of 506 patients (1.4%) hospitalized
because of proven pneumonia. All 7 patients were treated with
immunosuppressive medication prior to admission (indications:
pulmonary ﬁbrosis, COPD, and cerebral edema respectively).
CD4-cell-counts were substantially decreased (CD4 cells <200/
ll) in 3 out of 6 cases. To establish the diagnosis of PJP a PJ-PCR
(using broncho-alveolar lavage as material) was necessary in 5
cases – in all of these cases the PJ-IFT proved falsely-negative.
Severe hypoxemia could successfully bridged by non-invasive
Ventilation in 2 patients, l patient had to be ventilated
invasively. The mortality-rate was 28.6 % (2 out 7 patients).
See table 1 for details.
Conclusion: PJP is an important differential diagnosis and at
the same time a severe pulmonary complication in immunode-
ﬁcient patients. We were able to conﬁrm the high mortality rates
of 30–60 % in PJP-patients without associated AIDS-disease
published in literature. As expected, PJ-PCR was superior to PJ-
IFT and should therefore be performed on a routine basis for
diagnosing PJP. Non-invasive Ventilation demonstrated to be a
worthwhile therapeutic Option for bridging severe hypoxemia
in patients with PJP.
P1368
Molecular epidemiology of Pneumocystis
jirovecii carriage in idiopathic interstitial
pneumonia
C. de la Horra, F.J. Medrano, M. Montes-Cano, N. Respaldiza,
I. Mateos, V. Friaza, S. Vidal, J. Martin-Juan, E. Rodriguez-
Becerra, J.M. Varela, E. Calderon (Seville, E)
Introduction: The Idiopathic Interstitial Pneumonia (IIP) is one
of the most severe pulmonary diseases. Initial chronic inﬂam-
mation leading to parenchymal ﬁbrosis is the common charac-
teristic of this process; and infectious agents are the possible
cause for the initial inﬂammation. It has been proved that
Pneumocystis jirovecii (Pj) mediate an inﬂammatory response,
increasing the permeability of alveolo-capillary membrane and,
causes diffuse alveolar damage. Therefore, pulmonary carriage
of Pj could play a role in the pathogenesis of the disease.
However, the molecular epidemiology of Pj in this kind of
patients is still unknown.
Objective: To study the prevalence and molecular epidemiol-
ogy of Pj carriers in IIP patients.
Patients andMethods: Thestudy included95consecutivepatients
with a ﬁnal diagnosis of IIP. DNA was isolated from 80 broncho-
alveolar lavage and 15 oropharyngeal wash samples. A nested PCR
protocolwas used to analyse the presence of Pj. The polymorphisms
at mt LSU rRNA region were studied by direct sequencing. A
touchdown-PCR protocol followed by RFLP with AccI and HaeIII
was assayed to determinate mutations at DHPS gene.
Table 1
Initials Age Sex Comorbidity
Immunosuppressive
medication prior to
admission
CD4 cell
count (per
microliter) PJ-IFT PJ-PCR Outcome
1 E.B. 68 female Idiopathic
pulmonary
ﬁbrosis
prednisolone
30 mg daily
azathioprine
75 mg daily
264 - + deceased
2 R.B. 80 female COPD,
cerebral
edema
dexamethasone
12 mg daily
46 - + alive
3 K.E. 66 male Idiopathic
pulmonary
ﬁbrosis
prednisolone
20 mg daily
azathioprine
75 mg daily
490 + + alive
4 R.H. 55 male Idiopathic
pulmonary
ﬁbrosis
prednisolone
30 mg daily,
cyclophosphamide
150 mg daily
147 + + alive
5 J.H. 57 male COPD none 240 - + alive
6 D.K. 70 male Idiopathic
pulmonary
ﬁbrosis
prednisolone
20 mg daily
azathioprine
150 mg daily
16 - + alive
7 D.T. 56 male NSCLC dexamethasone
12 mg daily
not done - + deceased
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Results: The prevalence of Pj carriage was 31.5% among IIP
patients. Only 17 patients were successfully sequenced at mt
LSU rRNA gene. The genotype 85C/248C was founded in 15
(88.2%) and the genotype 85T/248C in two cases (11.8%). The
analysis of DHPS mutations shows a low rate of resistant strains
1/16 (6%) among IIP patients.
Conclusions: There is a high prevalence of Pj carriers among
IIP. The genotype 1 (85C/248C) is amply distributed in the lung
of IIP patients. We found a low rate of mutations in DHPS gene,
related to sulpha-resistance drugs. New studies will be neces-
sary to elucidate the role of Pj colonisation in this pathology.
This study was partially supported by the Spanish Ministry of
Science and Technology (ref.: SAF2003–06061) and Thematic
Network for Joint Research (G03/90)
P1369
P. carinii in sputum of asymptomatic HIV
seronegative oncologic patients
A. Georgouli, E. Chinou, P. Apostolakopoulos, M. Alexiou,
E. Skouteli, P. Golemati (Athens, GR)
Objectives: To investigate the presence of ‘asymptomatic car-
riers’ of P. carinii among oncologic patients without HIV.
Methods: Induced sputum specimens from 438 HIV seronega-
tive asymptomatic oncologic patients (196 M, 242 F, of mean age
59 years), were studied for the detection of P. carinii cysts and
trophozoites using a direct immunoﬂuorescent procedure.
Hematologic malignancy in 286 (65.3%) and solid tumors in
152 (34.7%). Four patients were the underlying diseases, while
83.8% of them were undergoing chemotherapy during the last
six months.
Results: P. carinii cysts and trophozoites were detected in 82 out
of 438 of our patients (18.7%). There was no signiﬁcant
difference between the patient with hematologic malignancy
(19.2%, 55/286) and those with solid tumors (17.8%, 27/152). All
82 of patients with presence of P.carinii in sputum had
undergone chemotherapy during the last 6 months and 73 of
them (89%) were also receiving long-term corticosteriod therapy
(mean duration: 3 months).
Conclusion: The prevalence of P. carinii colonization is quite
high among oncologic patients. This may imply a higher risk of
pneumonia in these patients due to reactivation of the organism.
P1370
Prevalence and genotypes characterisation of
Pneumocystis jirovecii colonisation among cystic
ﬁbrosis patients in Spain
I. Mateos, J. Dapena, C. de la Horra, M.A. Montes-Cano,
V. Friaza, N. Respaldiza, F.J. Medrano, E. Calderon,
J.M. Varela (Seville, E)
Introduction: Pneumocystis jirovecii carriers may exist among
cystic ﬁbrosis (CF) patients due to their underlying pulmonary
diseases, but their role in the natural history of the disease is
poorly understood. The prevalence and molecular epidemiology
patients still remains unknown. Moreover, the knowledge of
P. jiroveci genotypes distribution may help for understanding
the epidemiology of this pathogen.
Objective: To describe the prevalence and genotypes distribu-
tion of P. jirovecii in a population of CF Spanish patients.
Methods: A cross-sectional study was performed in 100 CF
patients, including 12 lung transplant recipients. P. jirovecii was
identify by nested PCR the mt LSU rRNA gene in respiratory
samples (sputum or oropharyngeal washes). The genotype was
analysed by direct sequencing at positions 85 and 248.
Results: The overall prevalence of P. jirovecii colonization
among CF patients was 24%. The prevalence in lung transplant
recipients was higher than in non transplanted CF patients. The
polymorphism 85C/248C (42.8%) and 85T/248C (28.5%) were
predominant, and also genotype 85A/248C (21.4%) was iden-
tiﬁed; in one case we founded a mix of genotypes. The
colonisation is higher in CF patients under 18 years old. Besides,
35.7% patients receiving prophylaxis with cotrimoxazol and
17.2% with azithromycin were colonized for P. jirovecii but none
of them developed Pneumocystis pneumonia (PcP) for a year
follow-up. The analysis shows concordance in the colonization
status between brother groups.
Conclusions: They are a high prevalence of P. jirovecii carriers
among CF patients in Spain. These data suggest that chemoproph-
ylaxis with Cotrimoxazol and Azithromycin may prevent PcP but
not avoid colonization. The concordance observed amongbrothers
support the idea of a common source of infection or person-to-
person transmission. This study was partially supported by the
SpanishMinistry of Health (FIS 03/1743) and by the Consejeria de
Salud de la Junta de Andalucia (Research Project 32/02)
P1371
Distribution of Pneumocystis jirovecii genotypes
in patients with different pulmonary diseases
M. Montes-Cano, J.M. Varela, C. de la Horra, N. Respaldiza,
I. Mateos, V. Friaza, S. Vidal, J. Martin-Juan, E. Rodriguez-
Becerra, F.J. Medrano, E. Calderon (Seville, E)
Introduction: In recent years, asymptomatic carriers of Pneumo-
cystis jirovecii has been identiﬁed among immunocompetent
patientswithdifferentpulmonarydiseases asChronicObstructive
Pulmonary Disease (COPD) or Idiopathic Interstitial Pneumonia
(IIP) subjects. The knowledge of genotypes distribution may help
for understanding the role of the microorganism in the natural
history of these pathologies. However, the genotypes distribution
of P. jirovecii status in these diseases remains unknown.
Objectives: To describe P. jiroveci genotypes distribution in
COPD vs IIP patients based on mt LSU rRNA polymorphisms
and DHPS mutations
Patients and Methods: The study analysed the respiratory
samples from 36 COPD patients and 17 IIP subjects colonised by
P. jiroveci. The genotypes at mt LSU rRNA gene were analysed
by nested-PCR using and direct sequencing at 85 and 248
nucleotide positions. DHPS mutations were assayed by RFLP:
Touchdown-PCR at and digestion with AccI and HaeIII.
Results: Based on the analysis of mt LSU rRNA and DHPS gene
we found:
Genotypes mt LSU rRNA
COPD IIP
N = 38 % N = 17 %
85C/248C 15 41.6 15 82.2*
85A/248C 4 11.1 0 0
85T/248C 15 41.6 2 11.8
Mix 2 5.5 0 0
* (p ¼ 0.004, OR ¼ 10.5, CI 95% 1.9–103)
Genotypes DHPS
COPD IIP
N = 15 % N = 16 %
wt/wt 10 66.6 15 94
55/wt 1 6.6 0 0
wt/57 2 13.3 1 6
55/57 1 6.6 0 0
Mix 1 6.6 0 0
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Conclusions: The genotypes distribution at mt LSU rRNA is
signiﬁcantly different among the groups studied. In COPD
patients exists a high rate of sulfa-resistence respect to the IIP
patients, probably related to previous exposition to sulfa-drugs.
New studies are required to elucidate the role of the genotypes in
the evolution of patients. This study was partially supported by
the Spanish Ministry of Science and Technology (ref.: SAF2003–
06061) and Thematic Network for Joint Research (G03/90)
P1372
Pneumonia in cancer patients
M. Aguilar-Guisado, E. Cordero, J. Cisneros, I. Espigado,
M. Noguer, R. Parody, J. Pacho´n (Seville, E)
Introduction: Pneumonia in cancer patients is frequent and
mortality is high.
Objectives: To analyse the epidemiology, aetiology, clinical
features and outcome of pneumonia in cancer patients, inclu-
ding these with neutropenia.
Patients and method: Prospective study of all patients with
cancer admitted in Oncology and Haematology Departments
that had a pneumonia. Study period: from November 2002 to
August 2004.
Results: Eighty-ﬁve cases in 73 patients were included, 61%
males. The median age was 53 years (range from 16–84 years).
Pneumonia incidence was 33 episodes for each 1000 admissions.
Most of episodes (71.8%)were in patientswith lymphoma (30.6%)
andacute leukaemia (21%). 23.5%were blood stem-cell transplant
recipients. 66% of episodes were community acquired. 60% had
neutropenia at the diagnosis of pneumonia, and 14% were
bacteriemic. An aetiologic diagnosis was established in 46% of
episodes. Bacterial aetiology was predominant (n = 21, 55%),
followedby fungal (n = 17, 45%). Themost frequent bacteriawere
Pseudomonas aeruginosa (n = 8, 21%), Streptococcus pneumoniae
(n = 4, 10%), Legionella pneumophila (n = 2, 5%) and Fusobacterium
nucleatum (n = 2, 5%). The aetiology of invasive mycosis were
aspergillosis (n = 13, 34%, deﬁnitive n = 3, probable n = 1, and
possible n = 9), and Pneumocystis jiroveci (n = 4, 10%). Diagnostic
yield of blood cultures was 14%. TC had diagnostic usefulness in
37%. The global mortality at 30th day was 32%, and in patients
withneutropeniawas33%.Thepresenceofneutropenia (p = 0.02;
RR 1.9; CI95% 1.05–3.3), bacteraemia (p < 0.001; RR 4.6; IC95%:
2.6–7.9) and multilobar extension (p = 0.01; RR 3.1; CI95%: 1.5–
6.5) were associated with severe clinical features in the ﬁrst
48 hours. The presence of initial respiratory failure was the only
independent factor of adverse outcome selected by multivariate
analysis (p = 0.001; RR 5.4; CI95%: 1.4–20.6).
Conclusions: The incidence of pneumonia in cancer patients is
high. Aetiology is eestablished in one half of episodes. Bacteria
are the most frequent aetiology, and P. aeruginosa the more
frequent specie. Aspergillus spp make up one third of the
episodes. Mortality of pneumonia in these patients is high and
associated with initial respiratory failure.
P1373
Nocardiosis in a teaching hospital in the Central
Anatolia region: treatment and outcome
O. Yildiz, E. Alp, B. Tokgoz, B. Tucer, B. Aygen, B. Sumerkan,
A. Couble, P. Boiron, M. Doganay (Kayseri, TR; Lyon, F)
Objectives: To evaluate the main characteristics of the patients
with nocardiosis retrospectively.
Methods: A retrospective study was carried out from January
2001 to February 2004 in a University Hospital. We analysed
predisposing factors, clinical features, radiological ﬁndings,
antimicrobial susceptibility patterns, treatments, duration of
treatments and outcomes of the patients with nocardiosis.
Treatment was started empirically with ceftriaxone (4 g/d) plus
amikacin (1 g/d) and modiﬁed according to the antimicrobial
susceptibility pattern and was continued for 6–12 months.
Results: Nocardia species were isolated from consecutive nine
patients. In six of the nine patients (67%), predisposing factors
were identiﬁed. The most common predisposing factor included
receiving immunosuppressive therapy (67%), cadaveric kidney
transplant (44%), diabetes mellitus (22%) and systemic lupus
erythematosus (11%). Clinical syndromes of nocardial infection
seen were pulmonary infection in three patients, cerebral
infection in ﬁve patients and disseminated infection in one
patient. All previously healthy patients developed cerebral
nocardiosis due to Nocardia farcinica. The initial antibiotics used
were not appropriate in four of the nine patients (44%). However,
only two of these four patients experienced relapse and one with
relapse died of disease. Overall mortality in our patients was
33%; in two cases death was due to the Nocardia infection.
Conclusions: Despite its relative rarity, Nocardia is an important
cause of infection, especially for patients with a predisposing
factor. The use of imipenem or meropenem in combination with
amikacin is suggested for initial therapy of serious Nocardia
infections. The duration of therapy should be protracted for
12 months for preventing relapse.
P1374
Stenotrophomonas maltophilia: changing
spectrum of bacterial pneumonia in cancer
patients with low-suspicion of S. maltophilia
infection
G. Aisenberg, J. Tarrand, K.V. Rolston, D. Kontoyiannis, I. Raad,
A. Safdar (Houston, USA)
Background: S. maltophilia, a nonfermentative gram-negative
bacteria is often associated with serious ventilator-associated
pneumonia. We sought to determine characteristics of
S. maltophilia lung infections in cancer patients who had low-
suspicion of S. maltophilia infection.
Methods: All S. maltophilia from respiratory samples during
1998–2004 were evaluated retrospectively. Patients with estab-
lished risk of S. maltophilia infection such as critical care unit
(CCU) stay, mechanical ventilation (MV), neutropenia (ANC
<500 cells/lL), HIV infection and underlying structural lung
disease were excluded.
Results: In 40 patients, median age was 54 ± 16 years, 27 (68%)
were male, 10 patients (25%) had severe lymphocytopenia
(<500 cells/lL), APACHE II score was 10 ± 4, and 9 (33%) of 27
with hematologic malignancies had acute leukaemia. Fourteen
(82%) of 17 BMT recipients had received allogeneic grafts and
were being treated for chronic graft-versus-host disease (cGVHD;
systemic corticosteroids >60 mgdaily prednisolone or equivalent
dose). Infection occurred 184 ± 325 days (range, 35–1458 days)
after BMT. 15 patients (38%) had refractory or advanced cancer, 7
(18%) haddiabetesmellitus and 4 (10%) hadCOPD. Twenty-three
patients (58%) had nosocomial infection. None had either prior
S. maltophilia orointestinal, genitourinary tract colonization or
concomitant S. maltophilia bacteraemia. Cough was common
(n = 24; 60%), dyspnea and fever occurred in 22 (55%) and 16
(40%) patients, respectively. Thirty-three patients (83%) presen-
ted with pneumonia while receiving broad-spectrum systemic
antibiotics for 7 ± 31 days. Most S. maltophilia (n = 37; 93%) were
susceptible to trimethoprim-sulfamethoxazole and ticarcillin-
clavulanic acid (n = 26; 65%). Fifteen patients (38%) did not
need hospitalization. In 25 hospitalized patients, 6 (15%) required
CCU admission and 5 MV for 3 ± 5 days. Eight (20%) deaths
were attributed to S. maltophilia pneumonia; presence of young
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age (37 vs 59 years; P < 0.004), prolonged hospitalization (42 vs
14 days; P < 0.01), and high APACHE II score (13 vs 10; P = 0.05)
were associated with increased mortality. By univariate analysis,
presence of acute leukaemia, APACHE II score >16, MV, CCU
stay and cGVHD were poor predictors of outcome, by stepwise
logistic regression analysis, only the later 2 emerged as signiﬁcant
prognosticators of death.
Conclusions: S. maltophilia pneumonia was a serious lung infec-
tion in these non-neutropenic, non-CCU patients with cancer.
P1375
Usual interstitial pneumonia associated with
cytomegalovirus infection after percutaneous
transluminal coronary angioplasty
M. Falagas, M. Rizos, S. Tsiodras, A. Betsou, P. Foukas,
A. Michalopoulos (Athens, GR)
Background: Ventilator associated pneumonia due to CMV is a
largely unexpected but probably underestimated diagnosis.
Methods: We describe a patient with usual interstitial pneu-
monia associated with cytomegalovirus infection after percuta-
neous transluminal coronary angioplasty.
Results: A 71-year-old woman, with history of diabetes mell-
itus, was admitted to the ICU of our hospital due to acute
myocardial infarction. Percutaneous transluminal coronary
angioplasty was performed. Two days following ICU discharge,
the patient became febrile 38.5C with non-productive cough
and progressive dyspnoea. Three days later, she was readmitted
to the ICU due to severe dyspnoea and type I respiratory failure.
The patient was intubated and admission-CXR revealed diffuse
inﬁltrates in both lungs and pleural effusions. The patient was
treated with intravenous piperacillin-tazobactam, oﬂoxacin and
teicoplanin. She remained febrile 39C with no improvement. A
chest CT-scan demonstrated conﬂuent opacities in the right
upper and middle lobes and in the left lower lobe as well as air-
bronchograms, an extensive right pleural effusion and a patho-
logical swelling of pretracheal lymph nodes. Serologic tests for
CMV revealed positive IgG antibodies, with no IgM antibodies
present. An open lung biopsy revealed distortion of lung
parenchyma, moderate inﬂammation and patchy ﬁbrosis with
a subpleural accentuation. The ﬁbrotic areas consisted of dense
collagen with focal ‘honeycomb’ pattern alternating with areas
of relatively normal alveolar parenchyma. There were also focal
alveolar macrophage accumulation, smooth muscle proliferation
and focal subpleural fatty metaplasia. The overall pattern was
consistent with usual interstitial pneumonia. Some epithelial
type II pneumocytes showed atypia with abundant cytoplasma
and large pleomorphic nuclei harbouring intranuclear inclu-
sions consistent with CMV infection. Despite treatment with
ganciclovir the patient died two weeks later from severe ARDS
and multiple organ failure.
Conclusion: Clinicians should be aware of CMV associated
severe bilateral pneumonia after cardiac procedures even in
non-transplanted patients. Correct diagnosis depends on clinical
awareness in the appropriate setting along with proof of viral
infection.
Detection of methicillin resistance
P1376
Rising MRSA occurrence in Central Norway –
importance of swab sites
T. Jacobsen, A.W. Børseth, L. Marstein, O. Scheel (Trondheim, N)
Objectives: The MRSA epidemic in Norway is steadily growing
with a more than 10-fold increase in reported cases since 1997. In
the last years, a signiﬁcant increase in MRSA-cases in nursing
homes has been reported. In August 2003 a more sensitive
method for MRSA detection has been introduced in the
reference laboratory for Central Norway at St Olav Hospital.
In this same period, we have observed a growing incidence of
MRSA in the throat, both alone and combined with ﬁndings at
other sites of the body. The aim of the present study was to
investigate the importance of including throat swabs in MRSA
screening.
Materials and Methods: We have examined the occurrence of
all new patients positive for MRSA in any site A (in the
period January 1st 1997–October 22nd 2004, and B) in the
period from August 1st 2003 to October 22nd 2004, the same
period the new MRSA detection broth has been in used. Only
the ﬁrst positive specimen-set from new patients, both
carriage and infections, were included. In period A the
specimens were grown on a selective mannitol agar contain-
ing 6% NaCl (2% NaCl after October 2002) and Oxacillin
4 mg/L, whereas in period B the specimens were grown in a
selective broth containing phenol red mannitol with aztreo-
nam 75 mg/L and ceftizoxime 5 mg/L. Isolates of MRSA
were veriﬁed by PCR detection of nuc and mecA genes by
PCR in both periods.
Results: The total number of new MRSA positive patients has
increased from 1 (1997) to 71 (until Oct. 22nd 2004), mainly in
nursing home residents. Among 88 new MRSA positive indi-
viduals in period B, 48 persons had throat swabs taken. 23
(47.9%) grew MRSA in throat combined with other sites. Five
(10.4%) grewMRSA in throat only. Among 50 persons examined
with perineum swabs, only 12 (24.0 %) were positive combined
with other MRSA positive locations, but none were MRSA
positive in perineum only.
Discussion: In the last eight years, we have experienced a 70-
fold increase in new MRSA positive patients in Central Norway.
Many outbreaks have not been thoroughly cleared because of
wrong examination sites. Based on the ﬁnding of MRSA positive
swabs from 5 persons from throat and none from perineum as
the only location for MRSA, we conclude that throat swabs must
be a part of routine MRSA screening.
P1377
Evaluation of oxoid mannitol salt agar with
cefoxitin for the detection of methicillin-resistant
Staphylococcus aureus from surveillance
specimens
B.M. Willey, P. Akhavan, N. Kreiswirth, K. Wong, O. Imas,
A. McGeer, T. Mazzulli, S. Poutanen, J. Strauss, G. Small,
I. Edwards, N. Nelson, M. Skulnick (Toronto, CAN)
Objectives: Challenged by an increasing demand for MRSA
surveillance and declining resources, clinical laboratories
require sensitive and speciﬁc screening media to ensure a
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rapid turn-around-time (TAT) to notiﬁcation and a low false-
positivity rate if costs and MRSA are to be controlled. This study
compares routine Mannitol Salt agar with 4 lg/mL oxacillin
(MSO) to Oxoid’s Mannitol Salt (MSF) and Analine Blue Salt
(ABF) agars, both containing 10 lg cefoxitin per mL.
Methods: 1343 surveillance swabs from 750 patients (427 nasal,
409 rectal, 305 nasal/axilla/groin/perineum, 161 wound, 41
other) were prospectively screened for MRSA on MSO, MSF and
ABF agars. Each media was incubated in ambient air at 35C,
and read independently at 24 and 48 h. Yellow colonies from
MSO and MSF, and blue colonies from ABF were tested for
capsular antigens 5 and 8 (Pastorex Staph Plus, BioRad), tube
coagulase and PBP2a (Denka Seiken) to identify MRSA. Positive
PBP2a reactions were conﬁrmed using the NCCLS 6 lg/mL
oxacillin screen agar. Discrepant strains were reconﬁrmed to be
MRSA and typed by SmaI PFGE.
Results: Overall 78 MRSA were recovered within 48 h: 73 from
MSF, 43 from MSO and 32 from ABF, generating relative
sensitivities of 93.6%, 55.1% and 41%, respectively. The MSF
grew 30 (41%) of its 73 MRSA within 24 h, compared to 11
(34.3%) on ABF and 8 (18.6%) on MSO. 54 (74%) of strains
growing on MSF could be provisionally identiﬁed as MRSA
directly from the plate allowing for same day notiﬁcation of
infection control: 17 within 24 h and 37 within 48 h. Notably,
when discrepancies between media were identiﬁed (>48 h), 23
additional MRSA could be recovered from mixed blue colonies
on ABF and 3 mannitol non-fermenting MRSA were identiﬁed
from the MSF. Also, 25 MRSA (representing 4 distinct clones
prevalent in Toronto) were recovered on MSO after broth
enrichment from the original swabs that initially failed to yield
MRSA on routine MSO. From the 1265 MRSA-negative swabs,
breakthrough coagulase negative Staphylococci required work-
up at 24 h and 48 h on 45 and 278 AB, 38 and 219 MSF and 8 and
216 MSO plates, respectively, resulting in overall speciﬁcities of
84.9% for MSO, 83.1% for MSF and 74.9% for ABF.
Conclusion: MSFwas signiﬁcantlymore sensitive thanMSOand
ABF (P < 0.0001) without loss of speciﬁcity or increase in cost. In
addition, the TAT was markedly improved on MSF as 74% of
MRSA were able to be identiﬁed directly from the plate at 24 h.
P1378
Evaluation of BBL CHROMagar MRSA for
detection of methicillin-resistant Staphylococcus
aureus from surveillance swabs
B.M. Willey, A. McGeer, T. Mazzulli, S. Poutanen, J. Strauss,
A. Tyler, K. Wong, O. Imas, P. Akhavan, N. Kreiswirth, G. Small,
I. Edwards, N. Nelson, M. Skulnick (Toronto, CAN)
Objectives: Highly sensitive screening media and a rapid turn-
around-time (TAT) to notiﬁcation is imperative in the control of
MRSA. Good speciﬁcity is also paramount as false positives
signiﬁcantly increase labour and material costs. This study
compares selective CHROM agar MRSA with 6 lg/mL cefoxitin
(CFOX) to routine mannitol salt agar with 4 g/mL oxacillin
(MSOX) in a population with <5% prevalence.
Methods: MRSA screens from 750 patients (427 nasal, 409
rectal, 305 nasal/axilla/groin/perineum, 161 wound, 41 other)
were planted to CFOX and MSOX on receipt. The plating order
was alternated every 200 swabs. CFOX were incubated in the
dark at 35C. Media were read independently at 24 and 48 h.
Mauve colonies from CFOX and yellow from MSOX were tested
for capsular antigens 5 and 8 (Pastorex Staph Plus, BioRad), tube
coagulase and PBP2a (Denka Seiken) to identify MRSA. Positive
PBP2a reactions were conﬁrmed using the NCCLS 6 lg/mL
oxacillin screen agar. Identities of discrepant strains were
conﬁrmed and typed by SmaI PFGE.
Results: From 1343 swabs, 78 (5.8%) grew MRSA on at least one
medium (71 CFOX; 43 MSOX; 36 both) generating a relative
sensitivity of 91% for CFOX and 55% for MSOX. The identities of
35 MRSA that failed to grow on MSOX were conﬁrmed and 25 of
these (from 4 distinct PFGE clones) were grown on MSOX from
the original swabs after broth enrichment. There was no
difference in MRSA growth rate between media: CFOX grew
17% MRSA at 24 h and 83% at 48 h; MSOX grew 18.6% at 24 h
and 81.4% at 48 h. From the 1265 MRSA-negative swabs,
breakthrough coagulase negative Staphylococci required work-
up at 24 h and 48 h on 1 and 28 from CFOX and 8 and 216 from
MSOX, resulting in 24 h/48 h speciﬁcities of 99.9%/97.8% for
CFOX and 99.4%/85.4% for MSOX, respectively. MRSA was
identiﬁed directly from CFOX in 66.2% cases, allowing for same
day notiﬁcation to infection control of 10 MRSA at 24 h and 39 at
48 h, while 19 were notiﬁed at 72 h, and 3 at 96 h. By
comparison, all 43 MRSA from MSOX were cultured to blood
agar prior to identiﬁcation, and of the 5 new MRSA cases that
required rapid notiﬁcation, 3 were notiﬁed at 72 h, and 1 each at
4 and 5d (38 cases had been previously identiﬁed).
Conclusion: While the CFOX plates were more costly, they
were signiﬁcantly more sensitive (P < 0.0001) and speciﬁc
(P < 0.0001) than MSOX resulting in less material and labour
costs. The TAT to notiﬁcation appears reduced due the ease of
working directly from the CFOX plate.
P1379
Comparison of MRSA ID medium and
enrichment broth culture for detection of
methicillin resistant Staphylococcus aureus
carriers by muco-cutaneous surveillance cultures
C. Nonhoff, M.J. Struelens, A. Brenner, N. Legros, C. Thiroux,
O. Denis (Brussels, B)
Objectives: To evaluate the performance of a new chromogenic
agar medium, MRSA ID (BioMe´rieux), for detection of methi-
cillin resistant Staphylococcus aureus (MRSA) from surveillance
cultures of muco-cutaneous swab specimens in patients admit-
ted to a 860-bed teaching hospital.
Methods: Hospitalized patients (n = 331) were screened for
MRSA carriage by sampling swabs from nares (n = 363), throat
(n = 47), perineum (n = 46) and skin (n = 35). Swabs were
inoculated into nutrient broth (SB) supplemented with 7.5%
NaCl, Columbia sheep blood agar with cefoxitin disk (30 lg)
(SBA) and MRSA ID agar at 35C. SB broths were sub-cultured
after 24 h onto SBA with cefoxitin disk (30 lg) and MRSA ID
agar. S. aureus isolates were identiﬁed by coagulase test.
Susceptibility to oxacillin was determined by cefoxitin disk
method according to NCCLS. Identiﬁcation and oxacillin resist-
ance were conﬁrmed by PCR for 16S rRNA, nuc and mecA
genes.
Results: MRSA strains were isolated in 55 (11%) specimens,
either from primary MRSA ID (n = 53), primary SBA (n = 37),
secondary MRSA ID (n = 53), or secondary SBA (n = 48),
respectively. Sensitivities/speciﬁcities of the different media
were: 96%/99% for primary MRSA ID, 63%/85% for primary
SAB, 96%/99% for secondary MRSA ID and 86%/85% for
secondary SAB. The combination of MRSA ID agar with salt
enrichment broth did not increase the screening sensitivity in
contrast with SBA. The median times to MRSA identiﬁcation
were 3 days for both agars (range 2–4 days) and 3 days after
enrichment broth (range 3–4 days). Sixty-four per cent MRSA
recovered from MRSA ID were detected after 24 h incubation.
Conclusions: MRSA ID was found to be a sensitive and speciﬁc
medium for the screening of MRSA carriage in hospitalized
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patients. Prolonged incubation of MRSA ID for 48 h increased
the yield of this medium by 36%. According to the results
obtained with the MRSA ID screen plate, it does not require the
additional phase of enrichment broth. The direct consequences
are a gain of time-to-result of 24 h as well as an important
simpliﬁcation of methodology for the culture surveillance of
MRSA.
P1380
Evaluation of 10, 30 and 60 mcg cefoxitin neo-
sensitabs for prediction of methicillin resistance
in S. aureus
R. Skov, A.R. Larsen, N. Frimodt-Møller (Copenhagen, DK)
Objective: Cefoxitin paperdisks have been shown to accurately
predict methicillin resistance in S. aureus. In this paper we
evaluate 10, 30 and 60 mcg Cefoxitin Neo-Sensitabs tablets for
predicting methicillin resistance using a challenge set of
S. aureus.
Methods: A total of 196 recently isolated S. aureus all tested for
presence of the mecA gene (EVIGENE, SSI, Denmark) were
investigated. The mecA positive isolates (N = 62) were a chal-
lenge set consisting of the most heterogeneous resistant MRSA
isolates found in a recent investigation (Skov et al, J Antimicrob
Chemother). The isolates represented 39 different PFGE types (at
least one band difference) and included isolates with oxacillin
MIC <2 mg/L. The mecA negative isolates were consecutive
blood culture isolates (N = 99) as well as the mecA negative
isolates with the smallest cefoxitin zones in a recent evaluation
(N= 35). S. aureusATCC29213 and 25923were included as control
strains in each run. All isolateswere testedwith conﬂuent growth
and 18–22 h incubation at 35–37C on Mueller Hinton Agar
(BBLII, Becton Dickinson, US) using 10, 30 and 60 mcg Neo-
Sensitabs tablets (Rosco, Taastrup, Denmark). Inhibition zone
diameters were measured to the nearest millimetre at the inner
zone edge–disregarding a faint haze, if present.
Results: Using a breakpoint of R < 19 mm (cefox 10);
R < 24 mm (cefox 30) and R < 29 mm (cefox 60) two, three
and two mecA positive isolates tested false susceptible,
respectively. Five, four and six mecA negative isolates tested
false resistant. Zone edges for the 10 mcg tablet were more
distinct and easier to read. For S. aureus ATCC 29213 the
following zone diameters were found 21–23 mm, 27–29 mm and
29–33 mm, respectively and for S. aureus ATCC 25923 22–
23 mm; 27–29 mm, and 32–33 mm, respectively.
Conclusions: All three cefoxitin Neo-Sensitabs performed with
high accuracy using this challenge set and as good as the results
obtained in a recent evaluation of a 10 mcg paperdisk. The
cefoxitin 10 mcg Neo-Sensitabs performed slightly better than
the 30 or 60 mcg and zone edges were easier to read why we
will suggest the use of 10 mcg tablet.
P1381
Evaluation of lipovitellin-salt-mannitol-agar with
an oxacillin and cefoxitin disc as primary
screening medium for methicillin-resistant
Staphylococcus aureus
M. Boudewijns, K. Lagrou, J. Verhaegen (Leuven, B)
Introduction: Numerous primary media have been advocated
for the enhanced detection of methicillin-resistant Staphylococcus
aureus (MRSA). Recently, a lipovitellin-salt-mannitol-agar (LSM)
with an oxacillin disk has been described. On this medium,
detection of MRSA isolates is enhanced due to production of a
lecithinase, which results in enlarged colonies surrounded by a
zone of opaciﬁcation. Also, the use of a cefoxitin disk method
has recently been described. It has been reported as being
superior to the oxacillin disk method.
Aim: To evaluate the performance of LSM with a 1 lg oxacillin
disk and a 30 lg cefoxitin disk (LSMoc) as selective and
differential primary medium for detection of MRSA from
screening specimens.
Materials and methods: Screening specimens (swabs of nose
and perineum) were obtained from a patient population at the
intensive care unit. The LSMoc medium was compared with an
in house method using colistin-nalidixic acid agar (CNA) with
5% horse blood by performing parallel inoculation. S. aureus
isolates were presumptively identiﬁed by colonial morphology
and conﬁrmed by coagulase tube test and Vitek 2 ID-GPC
testcard. Methicillin resistance on the LSMoc medium was
presumptively detected by reading the zones of inhibition
around both disks and conﬁrmed by disk diffusion and PBP2’
latex agglutination assay.
Results: 149 (19.7%) of 754 screening specimens were positive
for MRSA by one or both methods. Sensitivity of the LSMoc
medium (90%) was higher than sensitivity of the in house
method (76%) (P < 0.01). However, in contrast to the CNA
medium, the LSMoc medium required an additional 24–
48 hours of incubation before it could be examined for the
presence of MRSA. The LSMoc mediummisidentiﬁed 22 isolates
as MRSA (speciﬁcity 96.4%). These were mostly coagulase-
negative Staphylococci, mainly belonging to the species S. capitis,
which gave opaciﬁcation. There was no difference in the number
of MRSA isolates detected on the LSMoc medium by use of the
oxacillin or cefoxitin disk.
Conclusion: Use of the LSMoc medium increases the yield of
MRSA, due to added enrichment for growth and ease of visual
recognition of MRSA isolates. However, the medium still
requires conﬁrmation of presumptive MRSA isolates and
requires prolonged incubation.
P1382
Two evaluation methods for screening specimens
to detect methicillin-resistant Staphylococcus
aureus
Y. Martı´n, A. Rezusta, J. Castillo, M.J. Revillo (Zaragoza, E)
Objectives: Rapid assessment of clinical specimens for the
presence of MRSA is an important part to control measures for
infections taken to reduce the spread of MRSA and thus, to
decrease hospitalization costs. The purpose of this study was to
evaluate the sensitivity, speciﬁcity and the optimal incubation
time from patient specimens by using ORSAB (Oxacillin
Resistance Screening Agar Base) as a primary culture medium
compared with those obtained by using a previous enrichment
broth medium, Tryptone Soy Broth added with 75 lg/ml of
aztreonam (TSB Azt).
Methods: Every MRSA screening swab was inoculated initially
ontoORSAB and incubated aerobically for 48 h at 35C; the plates
were examined after 24 and 48 h. At the same, each specimenwas
introduced in TSB Azt. After 24 h of incubation, they were
subcultured onto ORSAB, following the same process described
previously. All mannitol-fermenting colonies were conﬁrmed as
S. aureus by using a latex agglutination system (Pastorex Staph
Plus Bio Rad). Resistance to methicillin was determined by the
disk diffusion method according to the NCCLS.
Results: Out of 404 studied samples, 90.35% were nose swabs.
MRSA was detected in 15% of these samples. The sensitivity and
speciﬁcity obtained when ORSAB alone was used were 96.6 and
48.3% respectively. When we previously used TSB Azt, the
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results were 94.9 and 49.5%. While 93.0% of MRSA was detected
after 24 h of incubation in the ﬁrst case, it was 98.2% after using
an enrichment broth medium.
Conclusions: ORSAB gave a positive result in 93.0% of the
samples after 24 h of incubation. The three MRSA isolated only
from direct culture onto ORSAB belonged to samples which had
a low amount of microorganisms. Low speciﬁcity was especially
due to Staphylococcus haemolyticus, very common in nose
samples. With such a high number of nose samples, our study
showed that the use of TSB Azt gave a minimum increase of
sensitivity.
P1383
Multiresistant bacteria screening: clinical
evaluation of MRSA ID, a new chromogenic
medium for the screening of methicillin-resistant
Staphylococcus aureus
M.E. Reverdy, S. Orenga, J.M. Roche, S. Delorme,
J. Etienne (Lyon, La Balme les Grottes, Craponne, F)
Objective: Nasal carriage of Methicillin-Resistant S. aureus
(MRSA) is an important cause of nosocomial infection. Screen-
ing of patients during admission is recommended to reduce the
incidence of MRSA. The aim of the study was to evaluate the
new MRSA ID media (bioMe´rieux) for rapid isolation and
identiﬁcation of MRSA.
Methods: MRSA ID was compared to ORSAB medium (Oxoid).
CNA sheep blood agar (COL) was used as the reference method.
A total of 278 nasal swabs were inoculated directly on the media
which were incubated 24 and 48 h at 35C. Green colonies on
MRSA ID, blue on ORSAB and typical S. aureus colonies on COL
were regarded as presumptive MRSA isolates. Conﬁrmation
was performed using a coagulase test and PCR for mecA gene.
Results: A total of 45 swabs were positive for MRSA. After 24 h
incubation, 42, 38 and 42 MRSA strains were isolated on MRSA
ID, ORSAB and COL respectively. MRSA isolates produced
colonies of intense color on chromogenic media. The sensitivity
of detection of MRSA ID (93.3%) was higher than ORSAB
(84.4%). The number of false positives (FP) on ORSAB was
higher (25 coagulase-negative Staphylococc –CNS, and 2 meth-
icillin-sensitive S. aureus) compared to MRSA ID (3 CNS). If only
taking into account colony color, the predictive positive value
(PPV) was 93.3% for MRSA ID, 58.5% for ORSAB. If the
coagulase test result was included, the PPV value of ORSAB
became 95%. After 48 h, MRSA ID enabled the recovery of 1
MRSA strain more (43 strains) whereas 5 strains more were
isolated on ORSAB (43 strains). However the PPV values of both
media decreased because MRSA ID produced many pale green
colonies of CNS, and ORSAB in the same way. Depending on
the interpretative reading of the laboratory, FP on MRSA ID
were easily differentiated from MRSA isolates.
Conclusion: MRSA ID enables rapid and deﬁnitive identiﬁca-
tion of MRSA isolates. Sensitivity of MRSA ID after 24 h was
higher than that of ORSAB. Reading of MRSA ID after 48 hrs is
not recommended due to the possibility of FP results. The use of
MRSA ID does not require any supplementary testing after 24 h,
whereas additional tests are necessary for ORSAB media.
P1384
Is disk diffusion method reliable for detection of
methicillin-resistant Staphylococcus aureus?
M. Rahbar (Tehran, IR)
Objective: The aim of this study was to evaluate using of home
made oxacillin for detection of MRSA
Methods: 96 clinical isolates of S. aureus strains in Milad hospital
were chosen for detection of MRSA Disk diffusion method was
performed as recommended by National Committee for Clinical
Laboratory Standards (NCCLSM2-A8 ) Collectively three kinds of
xoacillin disks from different sources were tested. Two kinds of
diskswere homemade (we calledwith sources of A and B) and the
third was from other country (source c). E-test was selected as
reference method. all test performed at the same condition.
Results: By E-test method of 96 strains of S. aureus 51 strains were
MRSAand45 strainswere susceptible tomethicillin.Oxacillindisks
from company A showed 94MRSA, and two intermediate strains.
Therewasnot any susceptible strainbyusing thisproduct. Byusing
other home made oxacillin disk( B) 60 strains were MRSA , 21
strains intermediate and 22 strains susceptible to methicillin. By
using oxacillin disks from other country(C )of 96 tested S. aureus
isolates 52 strains wereMRSA, 8.strain intermediate and 36 strains
susceptible. Unfortunately, home made disks especially from A
company showed very low sensitivity and speciﬁcity.
Conclusions: This study reveals that in our country using of
disk diffusion method is not reliable for detection of MRSA. This
may be due to limitation in sources of oxacillin disks and very
poor in quality of these products. It is strongly recommended
that using of other methods such as E-test and oxacillin screen
agar methods are highly preferable.
P1385
Evaluation of the new ATB STAPH and rapid
ATB STAPH devices for oxacillin resistance
detection in Staphylococci
V. Vernet-Garnier, J. Madoux, C. De Champs, L. Mullier,
G. Zambardi (Reims, La-Balme-les-Grottes, F)
Objectives: Reliable, simple, rapid and low cost phenotypic
methods are still needed for the oxacillin resistance detection in
Staphylococci. Due to an heterogeneous expression, this detection
is still challenging as demonstrated by the various protocols that
have been proposed: NaCl complementation (2–5%), decreased
temperature (30C) or increased length of incubation (48 h),
increased inoculum size, speciﬁc agar screen test, breakpoints
redeﬁnition according to the species and use of alternative
markers (cefoxitin, moxalactam). The aim of this study is to
evaluate how perform the oxacillin test included in both ATB
STAPH (ref. 14329) and rapid ATB STAPH (ref. 14479) devices
(bioMe´rieux) versus the mecA gene detection (gold standard)
and the oxacillin (5 mcg) and cefoxitin (30 mcg) disk diffusion
tests (OXA DD, FOX DD).
Methods: Two-hundred S. aureus strains were tested with the
various methods (100 mecA+, 100 mecA)). DD tests were
performed according to the French expert guidelines (CA-SFM
2004). For FOX DD, when an Intermediate (non conclusive)
category was obtained, the result was considered S or R
according to, respectively, the absence or presence of the mecA
gene. An additional set of 100 coagulase negative Staphylococci
(CNS) was tested with ATB STAPH only (50 mecA+, 50 mecA)).
Oxacillin MIC and population analysis were also performed for
the mecA+ strains not detected by the ATB devices.
Results: Sensitivity and speciﬁcity results for oxacillin resistance
detection of each method, versus mecA, are shown in the Table.
S.aureus (n=200)
All species
(n = 300)
ATB STAPH
(24 hrs)
rapid ATB STAPH
(4.5 hrs)
OXA DD
(24 hrs)
OXA DD
(48 hrs)
FOX DD*
(24 hrs)
ATB STAPH
(24 hrs)
Sensitivity (%) 95 93 58 85 96 96
Speciﬁcity (%) 93 99 100 100 100 95
* For the FOX DD test, non conclusive results were obtained for 6% of the strains.
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Conclusions: This study highlights that ATB STAPH and rapid
ATB STAPH devices perform as well as the FOX DD test and are
superior to the OXA DD test for the detection of oxacillin
resistance in S. aureus. ATB STAPH performances are still good
when CNS are tested. The resistance is missed only for strains
expressing heterogeneous resistance, as demonstrated by the
low oxacillin MICs (£1 mg/L) and the population analysis
proﬁles. All methods show very good speciﬁcity, except ATB
STAPH for which some S. aureus strains are overcalled resistant.
Based on the 2004 CA-SFM guideline, the FOX DD test is
sometimes non conclusive and this requires additional testing
P1386
Detection of methicillin resistance in
Staphylococci employing the Uro-Quick system
S. Roveta, S. Cagnacci, F. Cavallini, D.L. Rocca, A. Marchese,
E.A. Debbia (Genoa, I)
Objectives: Uro-Quick system has been employed to detect
methicillin-resistance (met-R) in S. aureus and coagulase-negat-
ive Staphylococci (CoNS). In order to achieve full agreement
between the antibiotic susceptibility results obtained by the
reference method (NCCLS) and the Uro-Quick system, the
optimal experimental conditions (inoculum size, time of incu-
bation, antibiotic and NaCl concentration) were determined for
S. aureus and CoNS respectively.
Methods: 72 met-R Staphylococci including different species (42
S. aureus and 30 CoNS, in which 12 S. epidermidis) heterogeneous
in their expression of resistance to b-lactam agents were
screened with the Uro-Quick System. S. aureus ATCC 29213
(mecA negative) and S. aureus ATCC 43300 (mecA positive)
were used for quality control. Oxacillin (in appropriate concen-
tration following the NCCLS breakpoints) was added in a vial
containing 2 ml of suspension of strain to tested (a drug-free vial
was used as control). After an opportune time of incubation the
instrument printed the results: no growth and a growth curve
like the control are representative of a susceptible and resistant
strain respectively.
Results: The best results were obtained using Mueller-Hinton
broth and a concentration of 106 cells/ml for S. aureus and 5x106
for CoNS. All the 42 S. aureus tested grown within 5 hours of
incubation and the met-R phenotype was correctly detected
within 6 hours in 100% of strains (66.7% and 93.3% in 4 and
5 hours respectively). The 97% of CoNS strains grown within
10 hours of incubation, an insufﬁcient growth within this period
of time was observed for 1 strain of S. haemolyticus only. Met-R
was correctly detected within 10 hours in 100% of strain grown
at this time (55%, 64% and 95% in 6, 7 and 8 hours respectively).
Conclusion: On the basis of the present ﬁndings, the Uro-Quick
system appears to be useful for the rapid detection of met-R
Staphylococci. Excellent results were obtained on S. aureus,
concerning CoNS our result suggest that there are differences
in the growth rate among the various members of this group and
in the incubation time necessary for the met-R detection (more
isolates of the respective species must be analysed to reach
generalized conclusion).
P1387
Comparison of different techniques to detect
methicillin resistance in Staphylococci and
evaluation of Vitek2 P523AST cards
O¨. Akan, S. Uysal (Ankara, TR)
Laboratory diagnosis of methicillin resistance has been a
problem and every system should be evaluated before
introduction to routine laboratory practice. In this study the
results of comparison of disk diffusion (oxacillin 1 mcg disks)
(DD), oxacillin agar screen (OAT) tests, miniapi staph 5 AST
system (biomerieux) (MA), and Vitek 2 AST p-523 cards
(biomerieux) (VT) for detection of methicillin resistance in
clinical Staphylococci is presented. MIC values using E-test (AB
biodisk) were used as reference. NCCLS procedures and
manufacturers’ recommendations were used. There was no
difference to detect methicillin resistance in DD, OAT,MA and
E-tests among 151 S. aureus except false susceptibility in OAT in
2 strains (1.3%) and DD in one strain (0.7%). Randomly selected
50 methicillin resistant 43 methicillin sensitive strains were
studied using VT and 13 (14%) strains showed false resistance.
Among them 12 showed discordance in oxacillin screening wells
and MIC detection wells and could not pass advanced expert
system and only 1 (1.1% ) was real false positive. When same
validation is applied to 141 coagulase negative Staphylococi
(CNS) (116 S. epidermidis, 25 CNS) false negativity was more
common in 16 ( 11.3%) OAT (not recommended by NCCLS) and
one strain (0.7%) in DD. 5 strains (3.5%) were falsely resistant by
MA. For VT validation among randomly selected 81CNS strains
(58 S. epidermidis, 23 CNS) only one strain (0.7%) was falsely
resistant. 10 (7.1%) strains showed discordance in oxacillin
screening wells and MIC detection wells. When we ommitted
oxacillin screening well (because of its high antibiotic content to
detect resistant CNS) false positivity in 3 strains still remained.
Antibiotic susceptibility tests were more compatible in S. aureus
isolates. Results obtained from VT shows that this system can be
adopted to our routine laboratory practice, but it should be used
with complementary tests both for S. aureus and CNS in case of
discordant interpretative results between two wells for oxacillin
resistance.
P1388
Comparison of oxacillin resistance screen agar
base with real-time PCR and conventional culture
for rapid detection of methicillin-resistant
Staphylococcus aureus
A. Anders, G. Geis, S. Gatermann (Bochum, D)
Objectives: Rapid and accurate identiﬁcation of methicillin-
resistant S. aureus (MRSA) is crucial for therapy and manage-
ment of infected and colonized patients. The use of conventional
culture techniques requires prolonged incubation and time-
consuming isolation procedures followed by identiﬁcation and
susceptibility testing. An accurate diagnosis may take up to ﬁve
days. The most early point of time for reporting MRSA by
conventional methods is after 48 hours. The aim of this study is
to evaluate the new Oxacillin resistance screen agar base
(ORSAB) and a 24-hour PCR-method for the identiﬁcation of
MRSA in clinical specimen and compare it to the conventional
culture.
Methods: Swabs from various sites were suspended in 1 ml of
0.9 % NaCl and equal aliquots were used for the three methods.
The methods were a) ORSAB (Oxoid) b) real-time PCR detecting
the mecA gene and a S. aureus-speciﬁc marker after an
incubation in a selective broth and c) the conventional culture
consisting of a blood agar plate and tryptic soy broth containing
10% NaCl. The ORSAB, blood agar plates and tryptic soy broth
were inspected after 20–24 and 44–48 hours. PCR was per-
formed after 20–24 hours.
Results: We examined 1024 swabs for the presence of MRSA.
With the PCR, there were 80 positive MRSA results that could be
reported to the clinician after 24 hours . After 48 hours 38 MRSA
could be reported from the ORSAB whereas conventional
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culture with a sheep blood agar plate yielded 67 MRSA. The
ﬁnal evaluation after 5 days resulted in 197 MRSA from blood
agar combined with enrichment broth, 156 MRSA from ORSAB
and 80 MRSA from PCR. No MRSA could be detected in 789
samples.
Conclusions: Real-time PCR for detection of MRSA is a useful
method for providingMRSA results within a very short period of
time. The demand for a very sensitive method can only be met
with a longer incubation time and the use of an enrichment broth
which accounted in our study for additional 25%positive results.
P1389
Co-colonisation of methicillin-resistant
coagulase-negative Staphylococci and
methicillin-susceptible Staphylococcus aureus
strains: risk for misidentiﬁcation in molecular
detection assays
K. Becker, I. Pagnier, B. Schuhen, F. Wenzelburger,
A.W. Friedrich, G. Peters, C. von Eiff (Munster, D)
Objectives: Detection of carriers of methicillin-resistant Staphy-
lococcus aureus (MRSA) is crucial for infection control purposes.
Numerous molecular methods, often simultaneously in multi-
plex format, to identify the mecA gene coding for methicillin
resistance (MR) and genes speciﬁc for the species S. aureus have
been introduced. However, application of molecular methods
for detection of MRSA directly from specimens may be inﬂu-
enced by co-colonization with MR-coagulase-negative Staphylo-
cocci (CoNS) carrying the mecA gene. Studies investigating the
frequency of the co-colonization with methicillin-susceptible
S. aureus (MSSA) and MR-CoNS on the skin and mucous
membranes with the potential risk of false-positive results in
molecular MRSA detection tests are missing.
Methods: A total of 249 nasal swabs were collected directly at
admission to the cardiac surgery department at the University
Hospital of Muenster as well as from known MRSA carriers
(n = 14). Only one swab per patient was included. Staphylococ-
cal isolates were identiﬁed by standard microbiological proce-
dures and conﬁrmed by molecular methods. Methicillin
resistance was determined by mecA ampliﬁcation.
Results: Growth of staphylococcal isolates were found in 232
(93.2%) of the nasal swabs comprising 66 S. aureus isolates
consisting of 45 MSSA and 21 MRSA isolates and 311 isolates of
CoNS (S. epidermidis, n = 216; S. haemolyticus, n = 31, other
CoNS, n = 64). Overall, 130 (41.8%) CoNS isolates were tested
methicillin resistant (MR-S. epidermidis, n = 98; MR-S. haemo-
lyticus, n = 19, other MR-CoNS, n = 13). Co-colonization of the
anterior nares with MSSA and MR-CoNS (MR-S. epidermidis,
n = 6; MR-S. haemolyticus, n = 1; other MR-CoNS, n = 1) were
found in 8 (3.2%) of the nasal swabs tested.
Conclusion: Nasal co-colonization with MSSA and MR-CoNS
was found in a low percentage. However, in a low MRSA
setting, false-positive MRSA test results may lead to a couple of
efforts in eliminating the patient’s putative MRSA colonization
and in additional infection control measures and, consequently,
in a substantial increase in costs and personnel workload.
P1390
Speciﬁc detection of methicillin-resistant
Staphylococcus aureus directly from clinical
specimen by real-time polymerase chain reaction
P. Gofﬁnet, A. Louahabi, N. Hougardy (Arlon, B)
Objectives: Although Staphylococcus aureus (S. aureus) is relat-
ively easy to cultivate, culture methods require 24 h incubation
and conventional identiﬁcation methods may yield false-posit-
ive or false-negative results. Standard susceptibility and peni-
cillin-binding protein latex agglutination tests are time-
consuming because they require colonies to be isolated from
24 h culture or more. The correct identiﬁcation of S. aureus and
the detection of the mecA gene based on molecular methods is
considered as a gold standard in the determination of methicil-
lin-resistant S. aureus (MRSA). Many PCR for simultaneous
detection of S. aureus speciﬁc gene target and mecA gene were
developed, but cannot be applied for the direct detection of
MRSA from nonsterile specimens such as nasal samples without
an isolation step. A more comprehensive real time PCR assay
that targets both an S. aureus-speciﬁc gene and the mecA gene
within a single PCR tube reaction using only one couple of
primer and two adjacent ﬂuorescent probes was established and
evaluated.
Methods: The validation of the assay was performed using 12
MRSA strains and 31 other strains of Staphylococci (not MRSA).
A positive result was obtained for all MRSA strains and not with
the other strains. 437 screening swabs from anterior nares and
throat were obtained from patients hospitalized in the intensive
care unit. S. aureus strains were identiﬁed according to their
characteristic growth morphologies, Gram stain characteristics,
reaction to catalase, coagulase production, colour of colonies on
SAID culture media (Biomerieux) and LightCycler staphylococ-
cus kit (Roche Diagnostics). Resistance to oxacillin was meas-
ured with an AST-P536 card on the VITEK-2 instrument
(Biomerieux) and/or LightCycler MRSA detection kit (Roche
Diagnostics). In order to gain time, we included an automated
DNA extraction protocol on a LC MagNA Pure instrument and
we realised the real-time PCR on a LightCycler instrument.
Results: 24 MRSA could distinctly be detected by this PCR
assay, Vitek-2 and/or LightCycler Staphylococcus–MRSA detec-
tion kits. From these, 14 were detected both by PCR and Vitek-2,
4 only by Vitek-2 and 6 only by the new PCR assay. The per cent
of agreement is 97.7%.
Conclusion: This real-time PCR assay represents a rapid and
powerful method which can be used for the detection of MRSA
directly from specimens containing a mixture of staphylococci.
The turn-around-time for the whole process is only 4 hours.
P1391
Detection of MRSA directly from blood cultures
using real-time PCR
P. Della-Latta, P. Pancholi, F. Wu (New York City, USA)
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA)
septicemia is a life-threatening infection challenging both
clinicians and laboratorians. Early detection of MRSA sepsis is
of utmost importance to decrease patient morbidity and mor-
tality, reduce empiric use of vancomycin and permit effective
decisions for patient management. Real-time PCR using the IDI-
MRSA (Infectio Diagnostic) commercial assay and various
home-brew (HB) PCR assays have been used to detect MRSA
directly from both colonized and infected patients. This study 1)
evaluated a modiﬁcation of the IDI-MRSA in comparison to a
HB PCR assay for direct detection of MRSA from newly positive
blood culture bottles 2) compared the performance of a
modiﬁcation of the IDI assay to conventional culture techniques
3) contrasted time to results of molecular and non-molecular
procedures.
Methods: Aliquots of blood culture bottles (BACTEC 9240,
Becton-Dickinson) obtained from 368 patients at Columbia
University Medical Center that signaled positive and that
Gram stained as gram-positive cocci (GPC) in clusters, were
tested with the IDI-MRSA assay and a HB PCR using the
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SmartCycler (Cepheid). The IDI system detects the staphylococ-
cal cassette mecA – orfX amplicon; whereas the HB assay detects
the nuc and mecA genes. The introduced modiﬁcations of the
IDI system, which included one NaOH wash and two dilution
steps with Tris-buffer, were necessary to decrease false-positive
results due to high bacterial counts. The molecular methods
were compared to culture using the MicroScan Walkaway SI
(Dade Behring, IL) for identiﬁcation and the oxacillin screen
plate.
Results: MRSA was detected from 37 of 368 (10%) of blood
culture sets tested. The sensitivity, speciﬁcity, positive predic-
tive and negative predictive values for IDI-MRSA compared to
culture were 100%, 99.4%, 94.9% and 100%, respectively.
Discordance of IDI and culture was observed in 0.5% of patients
and was resolved using HB PCR. The IDI assay, as opposed to
HB, accurately distinguished MRSA from the 0.4% blood
cultures that were mixed with S. aureus and other bacteria, i.e.
coagulase-negative Staphylococci (CoNS). MRSA detection by IDI
was obtained within 2–24 hr compared to 48–72 hr by culture.
Conclusions: The IDI real-time assay using the SmartCycler can
be successfully adapted for accurate, same-day detection of
MRSA directly from positive blood culture bottles, regardless of
the co-existence of CoNS.
P1392
Molecular diagnosis of Staphylococcus aureus
isolates
N.S. Mariana, V. Neela, S. Zamberi, A.R. Raha, R. Rozita,
S. Radu (Selangor, MYS)
Objective: Frequent outbreaks of Staphylococcus aureus infec-
tions worldwide emphasizes urgent need for rapid and reliable
detection methods for S. aureus, especially in hospital settings
and community. The ultimate aim of the study is to identify
potential diagnostic marker and to develop DNA based assays
that can be used in any microbiological laboratories for the rapid
and reliable detection of S. aureus from pure culture and also
directly from clinical samples.
Methods: To select a genetic target for diagnostic purpose,
S. aureus isolates obtained different hospitals in Malaysia were
ﬁngerprinted using rep (repetitive element sequence) primers.
From rep ﬁngerprint, a marker band present in all isolates was
cloned and sequenced. A primer pair to amplify a 197 bp
fragment and an oligonucleotide probe was designed from the
most conserved region. Primers and probe were tested against
89 local S. aureus isolates and 1 ATCC to validate the ubiquity.
The speciﬁcity of molecular assays were veriﬁed by using
genomic DNA from a battery of gram-positive and gram
negative bacterial species. The ability of assays to detect
S. aureus directly from clinical samples was also tested. PCR
and membrane assays were compared for ubiquity, speciﬁcity,
and rapidity.
Results: The rep fragment sequenced with universal M13
primers determined the size of marker as 489 bp, showed high
similarity (>95%) to GAP (glyceraldehyde-3-phosphate Dehy-
drogenase) Operon in S. aureus genome. The molecular assays
developed with innovated primers and probe was very suc-
cessful, as none of other non-S. aureus species showed positive
signal conﬁrming the ubiquity and speciﬁcity. PCR assay was
more efﬁcient in detection of S. aureus direct from clinical
samples, membrane assay required puriﬁed DNA. In terms of
rapidity, both assays produced results in 2–3 hrs.
Conclusion: The development of simple and rapid molecular
assays with innovated primers and probe, speciﬁc and ubiquit-
ous for S. aureus that can even detect S. aureus directly from clin-
ical samples could be applied in any microbiological laboratory
for fast diagnosis of S. aureus infection. The novel achievements
made in this study will allow the faster and correct identiﬁcation
of S. aureus, establishes the effective antibiotic therapy and
thereby controls and prevent future outbreaks.
P1393
Development of a membrane based assay for the
identiﬁcation of Staphylococcus aureus at species
level and detection of multiple drug resistant
isolates
N.S. Mariana, V. Neela, A.R. Raha (Selangor, MYS)
Objectives: The incidence of Staphylococcus aureus infection has
increased in recent years, due to the spread of multidrug-
resistant isolates. Conventional identiﬁcation based on
biochemical characteristics and determining the antibiotic resist-
ance based on antibiotic susceptibility pattern can identify
S. aureus, but the rapidities and efﬁciencies of these methods
need to be improved. Rapid and direct identiﬁcation of this
bacterium from clinical samples (urine) would be useful for the
early diagnosis of S. aureus infection in the clinical microbiology
laboratory. This study incorporates the development of a single
tube PCR system (multiplex) and membrane based assay for the
identiﬁcation of S. aureus and detection of multiple antibiotic
resistant isolates directly from clinical samples.
Methods: Seventy isolates of S. aureus from different hospitals
in Malaysia were studied. The single tube PCR system for the
identiﬁcation of S. aureus and detection of methicillin, gentamy-
cin, erythromycin and vancomycin resistant genes was carried
out using a set of published primers. The S. aureus was isolated
directly from urine samples by boiling method. The sensitivity
of the system was determined by serially diluting the S. aureus
culture, an aliquot of each dilution was subjected to DNA
isolation and the puriﬁed DNA was used as template for PCR.
The speciﬁcity of the system was veriﬁed using a panel of gram
positive and gram negative isolates. A membrane based assay
was developed based on DNA–probe hybridization technique.
Results: The single tube PCR system yielded products of 108 bp
for S. aureus (identity fragment), 139 bp for erythromycin, 174
for gentamycin and 533 bp for methicillin resistant genes, when
sequenced showed 100% homology. None of the isolates
ampliﬁed vancomycin resistant gene. The assay was very
speciﬁc for S. aureus as none of the other gram negative and
positive isolates ampliﬁed the identity fragment. The sensitivity
level achieved with urine samples was 1 CFU with 25 cycles of
ampliﬁcation. Chemiluminescence detection of hybrid obtained
from membrane based assay with a minimum concentration of
160 ng probe conﬁrmed the identity of S. aureus and detected the
multiple drug resistant isolate.
Conclusions: This study demonstrates the practical value,
sensitivity, rapidity, speciﬁcity and accuracy of the molecular
based method for the diagnosis and thereby treatment of S.
aureus infections with the right choice of drugs.
P1394
Efﬁcient genotyping of methicillin-resistant
Staphylococcus aureus using a combination of
binary markers and single nucleotide
polymorphisms
F. Huygens, A.J. Stephens, G.R. Nimmo, J.M. Schooneveldt,
G.W. Coombs, E.P. Price, P.M. Giffard (Brisbane, AUS)
Objectives: Staphylococcus aureus continues to be a signiﬁcant
human pathogen. Several lineages of methicillin resistant
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S. aureus (MRSA) are common agents of nosocomial infections,
and recent years have seen the appearance and rapid spread of
MRSA clones capable of causing community acquired infections.
The objective of this study was to develop an efﬁcient S. aureus
genotyping method that is carried out using real-time PCR
technology. The method was designed to provide an epidemi-
ological ﬁngerprint and also allow inference of clinically relevant
aspects of the phenotype, through identiﬁcation of the lineage of
the genome backbone using SNPs in combinationwith the testing
for the presence of genes that exhibit binary variability.
Methods: The basis of our approach to designing genotyping
methods is the computerised analysis of comparative sequence
databases in order to identify minimal sets of genetic polymor-
phisms that provide the desired degree of resolving power. Such
analyses are carried out using the computer programme
‘Minimum SNPs’ which assembles sets of single nucleotide
polymorphisms (SNPs) empirically on the basis of maximisation
of the Simpsons Index of Diversity (D). SNPs were interrogated
using allele speciﬁc PCR in the real time format (kinetic PCR).
Results: Analysis of the S. aureus multilocus sequence typing
(MLST) database yielded seven single nucleotide polymor-
phisms (SNPs) that provide a D of 0.95 with respect to the MLST
database i.e. if two sequence types are chosen at random from
the database, there is a probability of 0.95 that they will differ at
one or more of the SNPs. Recalculation of published S. aureus
MLST-based studies has shown that a similar level of discrim-
ination is obtained with actual collections of isolates. The SNP
proﬁles are highly concordant with clonal complexes. A kinetic
PCR method for interrogating the SNPs was shown to be robust,
although a modiﬁed SNP set gave better results with crude
genome preparations. The SNPs gave nine proﬁles with a 107
Australian MRSA isolates. The informative power of a number
of binary genes in combination with the SNPs was tested, and it
was found that testing for presence of the pvl, sdrE and cna
genes, together with three mecA-associated plasmids increased
the number of types to 21.
Conclusion: A rationally designed S. aureus genotyping
approach suitable for routine use on real-time PCR or medium
density chip-based platforms has been demonstrated.
P1395
Development of a green ﬂuorescent protein based
reporter gene system in Staphylococcus
epidermidis
G.C. Franke, S. Dobinsky, M.A. Horstkotte, J.K.-M. Knobloch,
D. Mack, H. Rohde (Hamburg, D; Swansea, UK)
Objectives: Based on its bioﬁlm forming capacity Staphylococcus
epidermidis is the most frequent cause of foreign-body related
infections. Several speciﬁc factors mediating primary attach-
ment and accumulation have been characterized. In order to
analyze the concerted action of these factors methods for in situ
expression analysis are demanded. The aim of the present study
was to establish a Green Fluorescent Protein (GFP) based
reporter gene system in Staphylococcus epidermidis.
Results: Therefore we cloned gfpmut3.1 (Clontech) into pASI
under the control of a xylose-inducible promotor and intro-
duced the resulting construct into S. epidermidis 1457. However,
under xylose induction no signiﬁcant increase of ﬂuorescence
intensity compared to the un-induced control was detected. This
ﬁnding may be attributed to inefﬁcient translation initiation at
the natural Shine-Delgarno (SD) sequence. Indeed, by coupling
different SD-sequences from well-characterized S. epidermidis
genes in front of the gfp start codon the crucial impact of this
element for gfp translation initiation was demonstrated:
whereas a strong ﬂuorescence signal was obtained in presence
of the hld SD sequence, almost no signal was detected with the
sarA SD sequence. The inﬂuence of different SD sequences on
transcription and translation of gfpmut3.1 was also analysed in
real-time transcription and semi-quantitative western blotting
experiments. In all constructs investigated an almost identical
gfp transcription level was found regardless of the SD sequence
present. In contrast, western blot analysis using an anti-GFP
antibody revealed huge differences in GFP amounts that
corresponded to the respective quantitative ﬂuorescence
signal. The calculated half-life in S. epidermidis 1457 is 6.9 h.
Importantly, expression of gfpmut3.1 did not interfere with the
bioﬁlm-positive phenotype of this strain.
Conclusions: In conclusion, using an appropriate SD sequence
for optimal translation initiation gfpmut3.1 offers an attractive
system for monitoring gene expression in S. epidermidis.
Infections and diagnosis in non-HIV immunosuppressed patients
P1396
Isolation of Bordetella pertussis in blood culture
from a patient with multiple myeloma
M. Trøseid, T. Jonassen, M. Steinbakk (Lørenskog, N)
Bordetella pertussis is a fastidious aerobic, Gram-negative cocco-
bacillus that causes the classical disease of whooping cough. The
clinical manifestations of pertussis are due to the toxins that are
produced by the organism locally and not by bacterial invasion.
Isolation from blood cultures is extremely rare and to our
knowledge this is the third reported case of Bordetella pertussis
bacteraemia (1,2). All cases have been reported in immunocom-
promised patients. The patient was a 63 year old man with a
2 year history of multiple myeloma, initially treated with
autologous bone marrow transplantation and currently treated
with chemotherapy due to disease progression. One weak after
treatment with vincristine, adriamycin and dexamethasone
(VAD) he developed a productive cough and fever and was
admitted to medical department. On admission C-reactive
protein was 131 mg/l, WBC count and chest x-ray were
normal and blood cultures were initially negative. He was
treated for 5 days with intravenous cefotaxime for suspected
bronchopneumonia and discharged in good condition.The
patient was readmitted 8 days later with dry cough, hoarseness
and fever. C-reactive protein was 270 mg/l and WBC count was
12.7*10 9/l. Chest X-ray was normal and blood cultures were
negative. Again bronchopneumonia was suspected, and he was
given intravenous penicillin for 7 days. Eventually, blood
culture from the ﬁrst admission revealed growth of an atypical
Gram-negative rod from an aerobic bottle. The bacterium was
identiﬁed as Bordetella pertussis by sequencing of the 16S rRNA
gene. The patient was discarged in good condition and treated
for 10 days with oral clarithromycin. Norway has experienced
an outbreak of whooping cough since 1997 with more than 3000
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
449
reported cases annually. Systemic infections may occur in the
immunocompromised host. Growth in blood culture may be
slow, and prolonged incubation is recommended.
1. Janda WM, Santos E, Stevens J, Celig D, Terrile L, and
Schreckenberger PC. Unexpected Isolation of Bordetella pertussis
from a Blood Culture. Journal Clin Microbiol 1994; 32:2851–3.
2. Centers for Disease Control and Prevention. Fatal case of
Unsuscpected Pertussis Diagnosed from a Blood Culture-
Minnesota. MMWR 2004;53:131–2.
P1397
Current spectrum of bacterial infections in
patients with haematological malignancies
D. Yadegarynia, K.V. Rolston (Tehran, IR; Houston, USA)
Background: Patients with hematologic malignancies (HM)
develop bacterial infections often. Unfortunately most institu-
tions include only bloodstream infections (BSI) when describing
the spectrum of infection in such patients, despite the fact that
BSI account for only 25–35% of infections. Also most data bases
do not include polymicrobial infections either. These omissions
give an incomplete and erroneous impression regarding the
spectrum of bacterial infection.
Objective: To determine the overall spectrum of bacterial
infection (not just – BSI or monomicrobial infections) in patients
with underlying HM, with or without neutropenia.
Methods: A retrospective review of microbiological and clinical
records of patients with HM over a 1 year period (October 2002
to October 2003).
Results: 311 patients with bacterial infections were identiﬁed.
Median age was 65 y (range 20–80 y). Acute leukemias were
most common – 41%, followed by lymphomas – 32%, chronic
leukaemia - 18%, and myelomas – 5%. Only 44% were neutrop-
enic, and 45%were on antibacterial prophylaxis. Sites of infection
included respiratory tract – 38%, BSI (including catheter-related)
– 38%, urinary tract – 10%, skin and skin structure – 8%, and
gastrointestinal tract – 5%. 221 episodes (71%) were monomicro-
bial and 90 (29%) were polymicrobial. Gram-positive bacteria
accounted for 67% of monomicrobial BSI but only 45% of
infections overall (i.e. when polymicrobial infections were also
included in the spectrum). Gram-negative bacteria accounted for
33% of monomicrobial BSI, but only 26% of infections overall.
More than 85% of polymicrobial infections had a gram-negative
component, with P. aeruginosa being the single most common
species isolated. The most common gram-positives were coagu-
lase-negative staphylococci, S. aureus, viridans group streptococci,
and Enterococcus spp. The most common gram-negatives were
E. coli, P. aeruginosa, S. maltophilia, and Klebsiella spp.
Conclusions: Patients with HM develop bacterial infections
even when not neutropenic, and despite prophylaxis. Gram-
positives are not as predominant overall as they are in BSI.
Polymicrobial infections and S. maltophilia infections are more
frequent now than in the past.
P1398
Adequacy of trimethoprim-sulfamethoxazole for
prevention of urinary tract infection in renal
transplant recipients
C.S. Moon, S.H. Kim, H.K. Ki, K.S. Ko, W.S. Oh, K.R. Peck,
N.Y. Lee, J.-H. Song on behalf of the Asian Paciﬁc Research
Foundation for Infectious Disease
Objective: To evaluate the adequacy of trimethoprim-sulfa-
methoxazole (TMP-SMX) for prevention of urinary tract
infection(UTI) in patients underwent renal transplantation in
the setting where TMP-SMX resistance is common.
Methods: All patients underwent renal transplantation at Sam-
sung Medical Center from January 1998 and August 2002 were
included with the completion of 2 year-follow-up. TMP-SMX
was prophylactically administered during 12 months after renal
transplantation. Their medical records and microbiologic data
were reviewed.
Results: A total of 336 patients were enrolled. (male to female
ratio 191:145, mean age 39 ± 10 years). 146 episodes of UTI were
observed in 104 patients (31%) within 2 years after renal
transplantation. 52 episodes (36%) developed during post-
transplantation 30 days, and 87 episodes (60%) during post-
transplantation 6 months. UTI occurred predominantly in
female recipients (124 episodes, p = 0.00001). There was no
difference in the incidence of UTI with regard to the kind of
immunosuppressants (p = 0.69) or graft rejections (p = 0.85).
Among the isolated strains, E. coli (51%) was the most common,
followed by Enterococcus spp. (12%), Pseudomonas spp. (7%),
Enterobacter spp. (6%), Coagulase-negative staphylococci (6%),
Klebsiella spp. (5%), and Streptococcus spp. (1%). Among 75
E. coli isolates, rates of resistance to TMP-SMX, ciproﬂoxacin,
ampicillin/sulbactam, and ceftriaxone were 63%, 35%, 34%, and
1%. There was no difference in mortality rate related with the
occurrence of UTI (p = 0.75).
Conclusion: Despite of high prevalence of TMP-SMX-resistant
E. coli, the incidence of UTI in renal recipients receiving TMP-
SMX are similar to that in the setting where TMP-SMX resistance
is uncommon. Nevertheless, because most episodes of UTI occur
within 1 or 6 months of transplantation, further study is
warranted to evaluate if additional preventive strategies
during early period is needed.
P1399
Prospective evaluation of procalcitonin in adults
with febrile episodes after allogeneic
hematopoietic stem cell transplantation
M. Ortega, M. Rovira, X. Filella, J.A. Martı´nez, M. Almela,
J. Puig, E. Carreras, J. Mensa (Barcelona, E)
Background: We have previously demonstrated that procalci-
tonin (PCT) values higher than 3 ng/mL were associated with
fungal invasive infections (IFI) in patients with persistent fever
after ﬁve days of empirical antibiotherapy during neutropenic
phase after Hematopoietic Stem Cell Transplantation (HSCT).
Objective: To analyse if PCT is an independent and early
diagnostic marker of IFI in high risk adult patients undergoing
allogeneic HSCT.
Patients and methods: PCT levels were determined in 129
febrile episodes developed by 65 consecutive patients receiving
an allogeneic HSCT. There were 72 episodes during neutropenic
period and 57 within the second and third phase of immune
recovery after HSCT. All febrile episodes were classiﬁed
according to the ﬁnal diagnosis in: fever of unknown origin,
microbiological or clinical documented infection and non-
infectious febrile episodes. The microbiological or clinical
documented infection were classiﬁed as possible, probable or
proven IFI according to the EORTC/MSG criteria. The values of
PCT were not included in the classiﬁcation criteria.
Results: The ﬁnal diagnosis of febrile episodes were: fever of
unknown origin in 58 cases, microbiological or clinical docu-
mented infection in 54 and non-infectious fever in 17. Among
the 54 patients with a documented infection, 29 did not fulﬁl any
IFI criteria, and 8, 15 and 2 had a possible, probable and proven
IFI, respectively. Eleven out of 25 IFI cases occurred during the
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neutropenic phase (neutrophil absolute count, NAC,
< 0.5 · 109/L) and 14 cases during the non-neutropenic phase
of HSCT. Mean (ng/mL) (±SD) values of PCT on the ﬁrst day of
fever among neutropenic patients were: 1.0 (±0.3) in patients
with infections other than IFI (n = 19); 0.9 (±1.3) in possible IFI
(n = 5); 1.2 (±2.1) in probable IFI (n = 5) and 0.63 in proven IFI
(n = 1). Mean values of PCT on the ﬁrst day of fever among non-
neutropenic patients were: 1.5 (±0.9) in infections other than IFI
(n = 10); 6.1 (±3.4) in possible IFI (n = 3); 9.7 (±6.1)* in probable
IFI (n = 10) and 6.3 in proven IFI (n = 1), (*p = 0.013, Kruskal-
Wallis; OR: 1.1, IC 95%: 0.92–2.1).
Conclusions: During the non-neutropenic phases of allogeneic
HSCT, a high PCT value on ﬁrst day of fever is associated
signiﬁcatively with IFI. PCT monitoring could be an early and
useful help to the differential diagnosis of febrile episodes in
patients with high risk of IFI.
P1400
Agrobacterium radiobacter peritonitis in
a patient on continuous ambulatory peritoneal
dialysis
H. Konstantakopoulou-Papadaki, S. Botsari, M. Sonician,
D. Vlasopoulos, G. Kouppari (Athens, GR)
Objective: The presentation of Agrobacterium radiobacter perito-
nitis in an adult under continuous ambulatory peritoneal
dialysis (CAPD).
Methods: Peritoneal ﬂuid specimens were examined for cells
count and were cultured in Bactec Plus culture vials (Bactec
plus, Becton Dickinson). After centrifugation the specimen was
also cultured on appropriate media for aerobic and anaerobic
microorganisms and smears were performed by Gram stain. The
identiﬁcation of bacterium was carried out by standard methods
and API-32E, API 32GN (bioMerieux). The susceptibility testing
was performed by disk diffusion method.
Case report: Amale patient aged 87 years, at ﬁnal stage of renal
failure under CAPD for 15 months and deﬁcient renal function,
was admitted to hospital because of the appearance of a cloudy
peritoneal dialysate efﬂuent and nausea. The patient had a
history of three episodes of peritonitis caused by Gram negative
bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa, Flav-
omonas oryzihabitans, Acinetobacter johnsonii). The patient was
successfully treated with IP tobramycin and recovered com-
pletely. On day of admission the peritoneal analysis showed
3100 WBC/ı`l (96% neutrophills). The patient was treated
empirically with IP tobramycin. Forty eight hours after the
incubation of peritoneal ﬂuid gram negative bacterium was
isolated. Tests for oxidase and catalase were positive. The
hydrolysis test of esculine was positive. The bacterium was
identiﬁed as Agrobacterium radiobacter. The bacterium was
susceptible to cefuroxime, ceftriaxone, ciproﬂoxacin, imipenem,
tetracycline and gentamicin and resistant to ampicillin, trimeth-
oprime-sulfamethoxazole, cephalothin and tobramycin. The
patient was treated with cefuroxime 750mgx3 IP for three
weeks and he recovered completely.
Conclusion: Agrobacterium radiobacter is a microorganism found
in the environment and more particularly in several kinds of
soils and is considered a plant pathogen. In rare cases of
immunocompromised patients and especially for patients with
transcutaneous catheters or implanted biomedical protheses,
Agrobacterium radiobacter has been regarded as the cause of
bacteramia and peritonitis.
P1401
Erysipelothrix rhusiopathiae. Septic arthritis
of the knee
M. Lyons, A. Kirk, G. Channon, S. Thomas, B. Reddy (High
Wycombe, UK)
Introduction: E. rhisiopathiae is a rare pathogen found world-
wide. It is a commensal of a wide variety of vertebrate and
invertebrate species but its major reservoir is domestic swine.
The greatest commercial impact of infection is due to swine
erysipelas. Serious infection in humans in extremely rare and
associated with cutaneous infection in those who have had
occupational exposure. Clinical manifestations include brain
abscesses, osteomyelitis and chronic arthritis. Systemic infection
can often be complicated by infective endocarditis, in which the
mortality rate appears to be higher than for other organisms. We
report a rare case of E. rhusiopathiae joint infection.
Case Report: A 74 year old male patient on long term treatment
for rheumatoid arthritis presented to clinic with an isolated knee
sepsis, associated with a raised CRP and WCC. The knee was
aspirated and E. rhusiopathiae isolated from culture broth after
failing to grow on initial culture media. There were no other
systemic manifestations. No direct occupational exposure was
reported. A repeat knee aspirate failed to grow E. rhusiopathiae,
but a third aspirate taken at arthroscopy once more isolated the
organism. It was assumed that a soft tissue infection with E.
rhusiopathiae had led to a bacteraemia which seeded into the
rheumatoid knee joint. He underwent prolonged treatment,
with a six week course of Clindamycin. Unfortunately, a low
grade chronic infection persisted leading to complete disorgan-
isation of the joint. A joint replacement is being considered.
Discussion: This report is of interest because of the exception-
ally unusual nature of the pathogen and because of the lack of
systemic symptoms or history of any social or occupational
exposure to explain the presence of the organism. Diagnosis of
E. rhusiopathiae was problematical but is essential to ensure
effective treatment as most strains are resistant to vancomycin,
which is often used empirically to treat bacteraemia due to gram
positive organisms.
P1402
Invasive nocardiosis: emergence of new species
and usefulness of susceptibility testing
M. Hallin, F. Kidd, O. Denis, S. Rottiers, C. Thiroux,
M.J. Struelens, F. Jacobs (Brussels, B)
Objective: The aim of the study was to review clinical and
microbiological features of the nocardial infections diagnosed in
our 858-bed academic hospital over the past 3 years.
Patients and Methods: All patients with at least one sample
culture positive for Nocardia sp between May 2000 and August
2004 were included. Underlying conditions, immunosuppres-
sive treatments, site of infection, clinical, microbiological and
radiological features, treatment and outcome were compiled.
The identiﬁcation was based on the morphology by Gram and
modiﬁed Kinyoun stains, aspect of the colonies on blood agar,
phenotypical tests and ampliﬁcation-sequencing of a species-
speciﬁc region of the 16S rDNA. Susceptibility tests were
performed by E-test on Mueller-Hinton agar and interpreted
according to NCCLS criteria.
Results: Nocardia sp was recovered from 8 patients (5 males and
3 females, mean age 52 y.). All patients had predisposing
factors: 4 were solid organ transplant recipients and 4 were
treated with glucocorticosteroids. Infection involved the lung in
3 patients, CNS in 2, muscles and soft tissues in 1, and was
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disseminated in 2. The species identiﬁcation of the isolates were
N. farcinica (3), N. nova (3) and newly described N. cyriacigeorgici
(2). Phenotypic and genotypic identiﬁcation methods were
concordant in all cases. All isolates were susceptible to trimeth-
oprim/sulfamethoxazole (TMP/SMX) and amikacin and all but
one N. farcinica strain (MIC imipenem/meropenem >32 lg/ml)
were susceptible to carbapenems. Patients were treated with
high doses of oral or i.v. TMP/SMX (3), i.v. meropenem (3), and
the combination of TMP/SMX and meropenem (1). All patient
rapidly improved except the patient infected with theN. farcinica
strain resistant to carbapenem, until his initial meropenem
treatment was replaced by high doses of i.v. TMP/SMX.
Conclusions: Nocardia can cause various clinical syndromes in
immunocompromised patients. Early microbiological diagnosis
of nocardial infections enabled rapid appropriate management
and favorable outcome of all patients. Furthermore, the initial
clinical failure associated with carbapenem resistance of a N.
farcinica strain underlines the need for rapid and reliable identi-
ﬁcation of Nocardia to species level and susceptibility testing.
P1403
Microbiologic and clinical features of
N. asteroides infections
M. Makarona, H. Moraitou, S. Karabela, G. Dimopoulos,
E. Fragouli, S. Kanavaki (Athens, GR)
Objectives: Lower respiratory system represents the most
frequent site of nocardial infection. However, as the immuno-
compromised population is increasing, the disseminated nocar-
dial disease is not rare. Worldwide, Nocardia asteroides accounts
for the majority of infections. The aim of our study was to
present our experience, regarding the N. asteroides isolations, in
our Hospital.
Methods: During 2000–2004, in the Microbiology Laboratory of
‘Sotiria’ Chest Diseases Hospital of Athens, 8 strains of N.
asteroides were isolated, from 6 male and 2 female patients. Four
of the patients had a localized pulmonary infection, while 4
disseminated. The disseminated infection concerned 3 cases of
pulmonary empyema and 1 of cutaneous abscess of the left arm.
All patients were immunocompromised: 3 of them suffering
from malignancies, 2 from diabetes mellitus, one from collagenic
disease, one from pulmonary tuberculosis and one from ITP.
The microbiologic testing included a combination of methods:
• Colonial and microscopic morphology:using the acid-fast
Kinyoun-modiﬁed stain
• Simple biochemical and hydrolysis testing: casein hydrolysis,
gelatin liquefaction and decomposition of tyrosine, xanthine
and hypoxanthine
• Antibiotic susceptibility proﬁles: susceptibility to cefamandole
and tobramycin.
Results: A high degree of correspondence between biochemical
characteristics and antibiotic susceptibility patterns was noted.
All strainswere identiﬁedasN. asteroides, bybothbiochemical and
susceptibility pattern criteria. Patientswere treated eitherwith co-
trimoxazole, high doses of imipenem or minocyclin. Three
patients died, two suffering from lung cancer and one of ITP.
P1404
Fournier’s gangrene: a life-threatening clinic
disorders in uncontrolled type II diabetes
mellitus patients
O. Oncul, C. Erenoglu, H. Uluutku, M.L. Akin, S. Cavuslu,
T. Celenk (Istanbul, TR)
Objectives: Fournier’s gangrene is a serious skin and soft tissue
infectious-necrotising process in the peri-neogenital area affect-
ing adults, usually in their sixties or seventies. Isolated ﬂora
from cultures of the necrotic lesion is commonly multi-micro-
bial. Although an idiopathic condition is considered in the past,
today a genitourinary, anorectal or dermal triggering factor can
be identiﬁed in most patients. There are a series of systemic host
debilitating disorders such as diabetes mellitus, chronic alcohol
abuse, and malignant neoplasia that are associated with this
condition and may be considered risk factor to suffer this
disease. In this study, 11 patients with FG, eight of whom had
uncontrolled DM were investigated for risk factors, clinical
signs, laboratory ﬁndings and prognosis.
Methods: In this study, 11 FG patients who were hospitalized
in Gulhane Military Medical Academy Haydarpasa Training
Hospital Department of General Surgery Service were presented
between 1998 to 2004. Their age, clinical presentation, predis-
posing factors, microbiology testing, management and progno-
sis were studied. Broad -spectrum parenteral antibiotics, early
and aggressive surgical debridement of the necrotic areas and
hiperbaric oxygene therapy were applied to all cases.
Results: The mean age was 39.2 (21–79) of 11 FG cases. The
average time from begin the symptoms to apply to hospital was
7.2 (3–17) days. The most prominent associated disease was
diabetes, affecting 72.7 per cent of the patients, other potential
contributing factors included trauma and surgical operations in
three cases. The fasting blood glucose levels, HbA1C levels of
the diabetic patients were 182–522 mg/dl and 8.1–10.5, respect-
ively. Bacterial culture results revealed a single organism in
28.6%, and more than one organism in 71.4% of the cases. The
most frequently isolated bacteriae were Escherichia col, Strepto-
coccus pyogenes and Klebsiella pneumoniae from quantitative tissue
cultures. The overall mortality rate was 45 percent. However,
the mortality rate among diabetics was 62.5 per cent (P = 0.001).
Conclusion: Fournier’s gangrene is a very serious life-threaten-
ing disorder in especially diabetic patients despite of early
aggressive debridement with the use of appropriate antimicro-
bial therapy.
P1405
Relationship between uropathogenicity of
Escherichia coli and host compromise status
E. Moreno, A. Andreu, T. Pe´rez, M. Sabate´, G. Prats
(Barcelona, E)
Objectives: To evaluate the role that compromise status play in
the uropathogenicity of E. coli strains, we set virulence factors
and ECOR phylogenetic group against patients with and
without compromise status.
Methods: 50 E. coli strains from patients with pyelonephritis
and negative blood culture and 50 from urinary bacteraemia
were analysed for ECOR phylogenetic groups: A, B1, B2 and D;
virulence factors (VF) genes: papA, papGI, papGII, papGIII,
ﬁmH, afa/draBC, sfa/focDE, hlyA, cnf1, iutA, fyuA, kpsMII,
ibeA, traT, malX by PCR. O antigens associated to UTI (O1, O2,
O4, O6, O7, O18 and O83) were determined using agglutination
microtechnique. Compromise status, obtained from medical
records, included immnunocompromise and/or local predispo-
sing factors to urinary tract infection.
Results: 58% patients with pyelonephritis and 68% with uro-
sepsis were compromised. Pyelonephritic strains from healthy
patients belonged to: group B2 76% and group D 24%, and from
compromised patients: groups A and B1 10%, group B2 59% and
group D 21%. Urosepsis strains from normal patients belonged
to: group A 6% and group B2 94%, and from compromised
patients: group A 21%, group B1 6%, group B2 56% and group D
18%. E. coli strains from noncompromised patients were asso-
ciated to higher virulence score: pyelonephritis 7.52 virulent
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traits and urosepsis 8.50 than strains from compromised host:
pyelonephritis 6.59 virulent traits and urosepsis 7.41. Despite
this, only papGII was signiﬁcantly more prevalent in pyelone-
phritic strains from healthy patients vs compromised (P < 0.05);
whereas malX, papA, kpsMII and fyuA were somewhat more
prevalent in normal people with both pyelonephritis and
urosepsis that in people with compromise, while the remain
traits were similary distributed. Strains from group B2 showed a
high virulence score with a mean of 8.34 traits, followed by
group D (6.06), group B1 (4.80) and A (4.64) (P = 0.004, group B2
vs others).
Conclusions: E. coli strains from normal hosts were predomin-
antly from the ECOR phylogenetic group B2, harbouring a great
number of virulent traits and consequently showed a high
virulence score; whereas strains from phylogenetic group A and
B1, posses few virulent traits and only infect patients with
compromise status. However the substantially prevalence of
group B2 strains, with a lot of virulent traits, among compro-
mised host, could explain the lack of associations between this
condition and reduced virulence.
P1406
Microbiological aspects of peritonitis in patients
undergoing continuous ambulatory peritoneal
dialysis
S. Maraki, A. Georgiladakis, Z. Gitti, E. Nioti,
M. Epanomeritakis, Y. Tselentis (Heraklion, GR)
Objective: Peritonitis is the most important complication of
continuous ambulatory peritoneal dialysis (CAPD). We
reviewed the incidence and the etiology of CAPD-associated
peritonitis.
Methods: A total of 468 peritoneal ﬂuid samples from 76 adult
patients on CAPD were examined from January 2001 to October
2004. Efﬂuent samples were cultured on appropriate solid and
liquid media after 10 min centrifugation. In addition 10 ml of
ﬂuids were inoculated in aerobic and anaerobic VITAL culture
vials (BioMerieux, Marcy-l’ Etoile, France). Enumeration of
WBC was done using a standard counting chamber. The
identiﬁcation of microorganisms was performed using standard
methods and the API systems (BioMerieux).
Results: A total of 102 out of the 468 dialysates were positive
(21.8%). Two of the positive samples were polymicrobial. Gram-
positive organisms accounted for 68.3% of the infections of which
coagulase negative staphylococci (CNS) were the commonest
(35.6%). Gram-negative bacteria were found in 21.1% of the
positive samples, anaerobic bacteria in 1.9%, and fungi in 8.7%.
Conclusion: CAPD-associated peritonitis was most commonly
caused by coagulase negative staphylococci. Prompt identiﬁcation
of the causative agents is essential for the appropriate manage-
ment of microbial peritonitis in patients on CAPD.
P1407
Neisseria sicca peritonitis in patient on
continuous ambulatory peritoneal dialysis: a case
of the ‘nonpathogenic’ Neisseriae infection
C. Papaefstathiou, M. Zoumberi, D. Arvanitis, D. Vlasopoulos,
G. Kouppari (Athens, GR)
Objectives: To report an unusual case of peritonitis caused by
N. sicca in a continuous ambulatory peritoneal dialysis (CAPD)
patient.
Methods: Peritoneal efﬂuent specimens were examined for
WBC count and detection of microorganisms by Gram stained
direct smears. They were cultured on appropriate media after
centrifugation and were also inoculated in Bactec culture vials
(Becton Dickinson). The identiﬁcation of the microorganism was
performed by standard methods, biochemical characteristics,
colonies morphology and API NH system (bioMerieux). Sus-
ceptibility testing was carried out by disc diffusion method
according to the NCCLS performance standard.
Case report: A female 57-year-old CAPD patient end stage renal
failure, was admitted to the hospital because of peritoneal
efﬂuent turbidity. She started CAPD eleven months ago. She
was suffering from systemic lupus erythematosus for 17 years
and was on corticosteroids for 15 years. That was the 1st episode
of peritonitis for her. On admission WBCs count of peritoneal
ﬂuid was 2.600/ ll (95% neutrophils) and was decreased to
1.000/ ll and 200/ ll at second and third day respectively. On
admission was administered cefazolin 1.5 gr I.P. and afterward
300 mg · 6 I.P. for the next 3 days. Gram (-) diplococci (intra-
cellular or not) were seen on direct smears by gram stain. From
two peritoneal efﬂuent cultures Gram(-) diplococcus, oxidase
positive and strict aerobic was isolated. The colonies were white,
opaque, wrinkled, adhesive, peaked. The nitrate reduction was
negative. With API NH (biotype:7101, %id:99,8 :1,00 -very good
identiﬁcation) the strain was identiﬁed as Neisseria spp group,
which included the species N. sicca, N. mucosa I. subﬂava. The
strain was differentiated from I. subﬂava on the base of colony
morphology and from N. mucosa of nitrate reduction. The strain
was beta-lactamase negative and resistant to erythromycin,
trimethoprime/sulphamethoxazole, clindamycin and suscept-
ible to penicillin, cephalosporines, aminoglycosides, ampicillin,
ciproﬂoxacin and tetracycline. The patient was treated with
cefazolin 300 mg · 4 I.P per day for the 18 next days and
recovered completely.
Conclusions: ‘Nonpathogenic’ Neisseria spp can cause severe
disease in immunocompromised patients. This is the ﬁrst case
report of CAPD peritonitis with Neisseria sicca in Greece and
the third world wide.
P1408
Antibiotic resistance of enterococci in faecal
samples from cancer patients
E. Chinou, P. Apostolakopoulos, E. Skouteli, A. Georgouli,
P. Golemati (Athens, GR)
Objectives: The aim of this study was to determine the
prevalence of antibiotic resistance of isolated enterococci in
fecal samples from oncologic patients.
Methods: A total of 38 strains of enterococci were isolated in
fecal cultures from 234 oncologic patients undergoing peripheral
blood stem cell transplantation (PBSCT) or bone marrow
transplantation (BMT) during one year (2003). The fecal samples
were inoculated into bile esculin agar plates with and without
6 mgr/lt vancomycin and into an enrichment bile-esculin broth
supplemented with 4 mgr/lt vancomycin. The identiﬁcation of
the isolated bacteria was performed by standard methods and
the Api-strep system. The susceptibility testing was carried out
by disk diffusion method according to the NCCLS guideline and
by E-test for vancomycin and teicoplanin. All patients were
febrile, with diarrhoea and were treated with antimicrobial
agents before stool cultures.
Results: From 38 strains of isolated enterococci, 28 strains were
identiﬁed as E. faecalis, 8 strains as E.faecium and two strains as
Enterococcus sp. A total of 19 strains were found resistant to
ampicillin (50%) 15 to high level gentamycin (39. 5%), 27 to
ciproﬂoxacin (71%), 21 to tetracycline (55%) and 5 to quinopr-
istin / dalfopristin (13%). All the isolated strains were sensitive
to vancomycin, teicoplanin and linezolid. 7 of the 8 isolated
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strains of E.faecium were observed multidrug resistant and
sensitive only to glycopeptides, linezolid and quinopristin /
dalfopristin.
Conclusions: The present study indicates that the prevalence of
V.R.E. in fecal samples from oncologic patients appears to be
very low. Ciproﬂoxacin, a frequently used antimicrobial agent in
cancer patients, was the less active of the antibiotics tested. In
general, the good activity of the glycopeptides and linezolid
tested shows promise for the combination therapy required in
enterococcal infection in immunocompromised patients.
P1409
Microbiological ﬁndings of early infections in
allogeneic or autologous stem cell transplantation
O. Yildiz, I. Sari, F. Altuntas, E. Alp, B. Aygen, O. Coban Yuksel,
B. Sumerkan (Kayseri, TR)
Objectives: Infections are a major cause of morbidity and
mortality in patients undergoing high-dose therapy and subse-
quent autologous or allogeneic stem cell transplantation (SCT),
despite antimicrobial prophylaxis, use of growth factors and
newer antimicrobial drugs.
Methods: We compared the incidence of early infectious com-
plications between autologous SCT and allogeneic SCT recipi-
ents in a single centre over a 6-year period (between January
1997 and June 2004) in 164 consecutive adult patients. Infections
occurring within the 30 days after transplant were deﬁned as
early infections. Forty-two patients were allografted and 157
autografted. Antimicrobial prophylaxis was mainly quinolones,
ﬂuconazole, acyclovir and trimethoprim/sulfamethoxazole.
Results: Within the ﬁrst 30 days, 120 of 164 patients (73.2%)
developed febrile neutropenia episodes. Infections were docu-
mented in 78 patients (47.6%). Patients undergoing allogeneic
SCT tended to have more documented infections compared to
recipients of autologous SCT (78.6% vs 36.9%, respectively;
p < 0.001). The most frequent infection was bacteremia (41%),
followed by urinary infection (19.2%), pneumonia (16.7%) and
catheter-related infection (15.4%). Pathogens isolated in 66.7% of
the febrile neutropenia episodes were mostly gram-positive
organisms (50.6%), followed by gram-negative rods (46.9%) and
Candida spp. (2.4%). Predominant pathogens were coagulase-
negative staphylococcus (26.5%), E. coli (24.1%) and S. aureus
(16.9%). Infections were responsible for 2.4% of deaths after
transplantation within the 30 days in all patients. Early mortal-
ity associated with infection was 4.8% after allogeneic SCT and
1.6% after autologous SCT (p < 0.005).
Conclusions: Febrile episodes are the most frequent complica-
tion of both autologous and allogeneic SCT and gram-positive
isolates remain the main pathogen in these patients Methicillin
resistance is increasing and glycopeptides remain the only
choice for treating such infections. The high incidence of febrile
episodes and bacteraemia may be due to the lack of efﬁcacy of
antimicrobial prophylaxis. Although the infection rate is high,
measures taken to prevent and treat infections result in very low
rates of mortality from infection in SCT patients. Studies
reporting local microbiological ﬁndings are necessary because
they support an antibiotic choice for prophylaxis or therapy
more accurately than reports from other areas.
P1410
Microbiologically documented infections
following peripheral blood stem cell
transplantation
F. Altuntas, O. Yildiz, B. Eser, E. Alp, I. Sari, M. Cetin,
A. Unal (Kayseri, TR)
Objectives: To assess the isolation rate of bacterial and fungal
causative agents in early and late infections in patients who
underwent peripheral blood stem cell transplantation (PBSCT).
Methods: Conditioning and the pre-engraftment period were
deﬁned as the early period; the post-engraftment period until
one year was deﬁned as the late period. This study was
performed to evaluate early and late infections in 114 patients
who underwent PBSCT (84 autologous, 30 allogeneic) in a single
institution in 1997 until 2003. All the patients received antibiotic
prophylaxis (ciproﬂoxacin, acyclovir, ﬂuconazole and TMP/
SMX orally) and hematopoietic growth factors during neutrope-
nia. Febrile patients received i.v. imipenem or cefepime plus
amikacin or ceftazidime plus amikacin.
Results: A total of 117 episodes with microbiologically docu-
mented infections were seen 90 of 114 patients and 79% of the
patients experienced at least one febrile episode with microbi-
ologically documented infections during their post-transplant
course. Of these episodes, 69 (59%) were in the early period and
48 (41%) were in the late period. In the early period, 38.8% of
causative organisms were gram positive, 51.5% were gram
negative and 7.7% were fungi. The most common pathogens
were Coagulase-negative Staphylococcus (CoNS) and E. coli in the
early period. In the late period, 44.6% of causative organisms
were gram positive, 44.6% were gram negative and 6.8% were
fungi. CoNS and E. coli were also the most commonly isolated
agents in this period. A total of 19 microbiologically documen-
ted catheter infections were seen, of 11 were in the early period
and of 8 were in the late period. The most common pathogen
was CoNS in catheter related infections. Resistance to methicillin
was detected 47.4% of S. aureus and 86.5% of CoNS isolates.
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Conclusions: The isolation rate was in accordance with previ-
ous reports; similar percentages of gram positive and gram
negative isolates were found in patients with underwent PBSCT.
A remarkably low rate of viridans group streptococci and fungi
were observed. The spectrum of pathogens detected in these
cases serves as the basis for recommendations on the choice of
empiric antimicrobial treatment regimens. Therefore, studies
reporting local microbiological ﬁndings as well as their suscep-
tibility proﬁles are necessary. We suggest that local microbio-
logic surveillance should be known before empiric antimicrobial
therapy is started in each institution.
P1411
Detection of human polyomaviruses (BKV and
JCV) infection by PCR assay in patients after
haematopoietic progenitor cell transplantation
K. Rybka, E. Gorczynska, D. Turkiewicz, J. Toporski, K. Kalwak,
A. Dyla, A. Chybicka (Wroclaw, PL)
Objectives: Two human polyomaviruses BK (BKV) and JC
(JCV) are common in population. Following the primary
infection both viruses establish latency in renal tissue and in B
lymphocytes, 60–90% adults are asymptomatic polyomavirus
carriers. Polyomavirus–related disease is largely associated with
immunological impairment. JCV is the causative agent of the
progressive multifocal leukoencephalopathy in AIDS patients as
well as in other immune compromised hosts. In patients
undergoing renal or bone marrow transplantation the reactiva-
tion of both polyomaviruses may result in hemorrhagic cystitis
(HC). Late-onset viral HC mainly related to BKV reactivation is
a signiﬁcant cause of post-transplant morbidity.The aim of the
study was to evaluate the frequency and clinical implication of
human polyomaviruses infections in children who underwent
hematopoietic progenitor cell transplantation (HPCT).
Methods: Polyomavirus DNAwas detected in plasma and urine
with PCR-based assays. Viral DNAwas extracted from plasma or
urine samples by digestion with proteinase K and puriﬁcation on
Qiagen columns according to manufacturer’s protocol. The
primers pair ampliﬁed a 176-bp sequence from BKV genome
and a 173-bp sequence from JCV genome. Digestion of the PCR
products with the BamH1 prior to electrophoresis was used to
discriminate between BKV and JCV sequences.
Results: A regular screening for polyomavirus infections was
performed in 103 children who underwent HPCT. BKV was
detected in urine of 39 children (37.9%) and in serum of 8 patients
(7.8%). JCV was detected in urine of only 4 patients (3.9%) and in
plasma of 1 patient. The most frequent clinical manifestation
probably related to HPV infection was hemorrhagic cystitis,
however almost 50%ofHPVpositive patientswas asymptomatic.
Conclusion: In conclusions we demonstrated that rapid iden-
tiﬁcation of viral agents may allow to initiate effective therapy
and is imperative to polyomavirus infections following hema-
topoietic stem cell transplantation.
P1412
Monitoring of herpesvirus DNA load in children
after allogeneic hematopoietic stem cell
transplantation – EBV and CMV may be
sufﬁcient
P. Hubacek, O. Cinek, S. Voslarova, K. Rakova, M. Zajac,
P. Keslova, P. Sedlacek, J. Stary (Prague, CZ)
Objectives: Herpesvirus reactivation can cause a life threaten-
ing disease in hematopoietic stem cell transplant (HSCT)
recipients. Our work aimed at assessing the prevalence and
clinical correlates to reactivation of seven herpesviruses in a
single paediatric cohort.
Methods: Between January 2001 and September 2004, 88 chil-
dren and adolescents (aged median 8.7 yrs, range 0.2–20.5 yrs)
underwent allogeneic HSCT. We tested 2383 blood samples
drawn weekly for ﬁrst three months after HSCT and less
frequently thereafter. Viral loads were tested using real-time
quantitative PCR, and normalised to 100000 human genomic
equivalents. Results of EBV, CMV and HHV6 were available
within one day, while HSV, VZV and HHV7 were tested
retrospectively in 1405 representative samples. The provisional
positivity threshold was set to 1000 normalised copies.
Results: The positivity threshold was exceeded by EBV load in
51 (2.1%) samples from 17 (19%) children, by CMV load in 71
(3.0%) samples from 17 (19%) children, by HHV6 load in 19
(0.8%) samples from 10 (11%) children. Based on the viral load
results and clinical evaluation, therapy was instituted in 3/17
EBV-positive patients (anti-CD20 antibody), 17/17 CMV posit-
ive and 1/10 HHV6 positive patient (ganciclovir, foscavir,
cidofovir). Of these, only one patient died of CMV pneumonia.
Among retrospectively tested samples, the threshold was
exceeded by HHV7 only (11 samples from 5 children, no clinical
correlate). HSV and VZV were detectable in minute quantities
only.
Conclusions: PCR monitoring of viral load has proven useful
for guiding preemptive therapy for EBV or CMV, as shown by
only one death among 88 transplanted children. On the other
hand, despite relatively high prevalence of HHV6 or HHV7,
their prospective monitoring is unlikely to improve the prog-
nosis of the patients, as the viruses seem to be relatively
harmless. The absence of signiﬁcant load of HSV and VZV may
by associated with preventive administration of acyclovir and
may therefore be speciﬁc for centres using this prophylaxis. The
work is supported by grant of Ministry of Health of Czech
Republic No. 7459
P1413
Quantitative PCR for EBV DNA in paediatric
renal transplant patients
K. Harvey-Wood, A. Balfour, J. Beattie, C. Williams (Glasgow,
UK)
Introduction: Epstein-Barr virus (EBV)-induced post-transplant
lymphoproliferative disorder (PTLD) has been reported in
between 1%–10% of all paediatric renal transplant recipients.
PTLD is a heterogeneous group of conditions characterised by
EBV-driven proliferation of B-lymphocytes in the face of
impaired T-cell immune surveillance. We have performed
longitudinal surveillance EBV DNA levels in renal transplant
patients to attempt to correlate virological ﬁndings with changes
in blood levels of EBV DNA.
Aim: To determine the usefulness of longitudinal measurement
of EBV levels in paediatric patients following renal transplan-
tation.
Methods: EBV in whole blood was quantiﬁed using real time
PCR and clinical data on the patients collected.
Results: We have found no correlation between the absolute
level of EBV DNA and the development of PTLD. All patients
who developed PTLD have positive PCR results but a number of
patients without PTLD also had raised levels of EBV DNA.
Conclusion: Longitudinal Quantitative measurement of EBV
DNA allows the diagnosis of PTLD to be considered but in our
population we have been unable as yet to set either and absolute
cut off or rate of change of count which could be said to be
diagnostic of PTLD.
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P1414
Taxonomic structure and susceptibility of
Candida spp. in surgical ICU of cancer hospital
I. Petukhova, Z.V. Volkova, E. Malysheva, N.
Dmitrieva (Moscow, RUS)
Objective: To study pattern and isolation rate of Candida spp. in
surgical ICU.
Methods: Candida spp. isolated from cancer pts in ICU after
extensive and combined operations for esophageal, gastric, colo-
rectal cancer etc., were analysed. ‘Chromagar’ and semi-automa-
tic analyzer ‘ATB-Expression’ were used for identiﬁcation.
Results: 626 bacterial and fungal strains from 817 pathologic
materials were isolated, including 121 Candida spp. (19.3%).
C.albicans was isolated in 58 of 121 cases (47.9%). 2 strains C.non-
albicans were isolated from blood. Wounds were infected with
mixed microﬂora including Candida spp. in patients who have
previously received 2 or 3 lines of antimicrobial therapy and all
pts had C.non-albicans from wound discharge. 28 C. albicans and
16 C. non-albicans were isolated from sputum and 26 C. albicans
and 27 C. non-albicans were isolated from bronchoscopic mate-
rials in pts with clinical and radiographic evidence of pneu-
monia. Prevalence of C.albicans in sputum may be explained as
this material was taken from less severely ill patients, than
bronchoscopy, which was undertaken in critically ill patients.
Urine was colonized with 4 C. albicans and 13 C. non-albicans. All
pts had urinary cateters and didn’t have clinical evidences of
urinary infection. C. non-albicans consisted of C. glabrata - 30
(24.8%), C. parapsilosis - 13 (10.8%), C. krusei - 6 .0%), C.incon-
spicua/norvegensis - 5 (4.1%), C. tropicalis - 3 (2.5%), N˜. kefyr - 2
(1.7%), N˜. globosa, C. sake, C. lusitaniae, C. dubliniensis - 1 strain
each (0.8% each). Susceptibility testing performed in 3 more
often isolated strains were the follows: All tested strains of
C. albicans were susceptible to amphotericin B, ﬂucitozine,
miconazole. Intermediate susceptibility was seen to ketokonaz-
ole, econazole and nystatin (each - 2%) and resistance was
revealed to nystatin (2%). In C. glabrata 22% of strains had
intermediate susceptibility to ketokonazole, no resistant strains
were found. C. parapsilosis was resistant and had intermediate
susceptibility to miconazole in 50%, to econazole - 63% and was
resistant to nystatin - 10% and amphotericin B - 10%.
Conclusion: ICU patients often suffer from severe infectious
complications and are treated with broad spectrum antibiotics,
resulting in fungal colonization and superinfections. The cause
Candida non-albicans colonization and infections may be exten-
sive and inappropriate prophylactic use of ﬂuconazole.
P1415
Candidemia in Brazilian cancer patients
A.C. Pasqualotto, D.D. Rosa, L.C. Severo (Porto Alegre, BR)
Objectives: To review all cases of candidemia that affected
cancer patients in our medical centre over a 9-year period to
assess demographic features, etiology, therapy, and outcome of
the infection.
Methods: Retrospective cohort study developed in Santa Casa
Complexo Hospitalar, Brazil, during 1995 and 2003. Medical
charts were reviewed to record clinical and demographic
characteristics presented in the period of 30 days before collec-
tion of the ﬁrst blood sample positive for Candida.
Results: During the period of study, 74 patients (38.7%) with
nosocomial candidemia had cancer. Solid tumors occurred in
77.0% and most of them were localized (63.8%). Species other
than C. albicans caused 59.1% of episodes of candidemia in cancer
patients. In comparison with other patients, candidemia in
cancer patients was more frequently associated with neutrope-
nia, mucositis, and port-a-cath. Patients without cancer had
higher exposure to invasive procedures, large spectrum antibi-
otics and surgery. Previous steroids use, chemotherapy, and
cefepime use were more common in patients with haematolog-
ical neoplasia, in comparison with solid tumors. However, major
surgeries were more common in patients with solid cancers
(47.4% and 0.0%), mainly in gastrointestinal tract. Overall
mortality was 50.3%.
Conclusions: Patients with candidemia may have different
predisposing factors to acquire the infection when stratiﬁed
according tobaselinediseases.More studies areneeded to empha-
size speciﬁc risk factors for candidemia in patients with solid
tumors. Following a worldwide trend, species other than Candida
albicans were the main etiology of candidemia in this study.
Therefore, continuous epidemiologic monitoring is necessary to
follow further changes in the patterns of candidal infections.
Mechanisms of resistance to quinolones
P1416
Plasmid mediated quinolone resistance gene
among ESBL-producing E. coli and K. pneumoniae
in Spain
E. Valverde Romero, T. Parras Padilla, A. Herrero Herna´ndez,
J. Ferna´ndez Gorostarzu, J.A. Garcı´a-Rodrı´guez, J.L. Mun˜oz
Bellido (Salamanca, E)
Introduction: Fluoroquinolone resistance has been usually
associated to two main mechanisms, both in Gram positive
and in Gram negative bacteria: mutations in gyrase and/or
topoisomerase IV (mainly in their subunits A) and efﬂux
mechanisms. Recently, a third, plasmid-mediated mechanism
has been described. The gene responsible for this resistance, qnr,
has been found in clinical isolates of Klebsiella pneumoniae and
Escherichia coli. A previous study has shown that qnr was
present in 8% of quinolone-resistant clinical isolates of E. coli
from Shanghai, China. A recent study in the USA has shown the
presence of qnr in 11.1% of ﬂuoroquinolone-resistant K. pneu-
moniae, in two cases associated to a SHV-7 ESBL. We have
determined the presence of this gene in 125 ESBL producing
E. coli and K. pneumoniae isolated in SPAIN during 2004.
Methods: We determined by PCR and sequencing the presence
of the qnr gene in plasmid DNA in 125 ESBL-producing E. coli
and K. pneumoniae clinical isolates. ESBLs had been previously
characterized by isoelectric focusing, PCR and sequencing.
Results: No E. coli isolates harboured qnr gene. qnr was found in
one K. oxytoca isolate producing SHV-12 ESBL. The qnr sequence
was identical to the sequence previosuly described by other
authors. Nevertheless, the isolate was intermediate to nalidixic
acid (16 mg/l), and susceptible to norﬂoxacin and ciproﬂoxa-
cin (<0.1 mg/l). No mutations were found in gyrA and parC
genes.
Comments: qnr gene is still infrequent among ESBL-producing
microorganisms, but can be occasionally found. No qnr har-
bouring, ESBL-producing enterobacteria had been previously
described in Spain. In this case, qnr is not enough, in absence of
topoisomerase mutations, to produce ﬂuoroquinolone resist-
ance, though mutant selection might be more frequent than in
strains which do not harbour qnr.
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P1417
Effect of the plasmid encoded quinolone
resistance determinant in P. stuartii on the
selection of strains with clinical resistance to
ciproﬂoxacin
I. Wiegand, I. Luhmer-Becker, B. Wiedemann (Bonn, D)
Objectives: The inﬂuence of the plasmid encoded quinolone
resistance determinant qnr in E. coli and K. pneumoniae strains
with different single target gene mutations, efﬂux levels and
porin patterns has already been studied. None of the strains was
clinically resistant to ciproﬂoxacin. P. stuartii strains show a
slightly higher ciproﬂoxacin MIC in their natural sensitive
population than the studied E. coli and K. pneumoniae strains. As
we had detected qnr in three different clinical P. stuartii isolates
we wanted to determine the inﬂuence of qnr in this species on
the ability to select ciproﬂoxacin resistant mutants.
Methods: Qnr was transferred to P. stuartii ATCC29914 RifR
using the ﬁlter mating technique with the qnr-positive strain P.
vulgaris Pv123 as donor. A qnr-positive transconjugand
(TCPs123) was selected and used for further studies. MIC
values were determined by E-test according to the manufactur-
ers instructions. Mutants were selected using inocula of more
than 1 · 1010 cells plated on LB agarplates containing ciproﬂ-
oxacin concentrations of 2x–32x the MIC.
Results: Transconjugands were obtained with a conjugation
frequency of 1.2 · 10)5. MIC values are presented in table 1. The
mutant prevention concentration was determined to be 16x the
MIC for both strains. Some mutants that were picked showed
normal colony sizes but also minor subpopulations of small
colony variants (SCVs). These were shown to be stable on
antibiotic free medium for at least three passages. MIC values of
four or more representatives of each colony type per strain were
uniformwithin a small range, themedian value is given in table 1.
Conclusions: For P. stuartii the combination of qnr with a single
mutational event can lead to clinical resistance. Thus it is likely
that with a single quinolone treatment such single step mutants
can be selected. Species other than E. coli and Klebsiella spp. may
be an important reservoir for the qnr resistance determinant.
Their role in the clinical setting remains to be determined.
P1418
Evidence of ﬂuoroquinolone-resistant
mechanism associated with efﬂux pump and
outer membrane protein(OMP) in Neisseria
gonorrhoeae
J. Yoo, B. Kim, C. Yoo, W. Seong (Seoul, KOR)
Objectives: Ciproﬂoxacin resistant N.gonorrhoeae in Korea have
beendramatically increased1% in1999 to 87% in2003.Although it
was known to be mainly caused by mutation within gyrA and
parC, the fact which another mechanisms involved in the resist-
ance to ﬂuoroquinolones was well known in other organisms.
This study was designed to investigate the evidence of another
mechanisms related to resistance to ciproﬂoxacin inN.gonorrhoeae.
Methods: Mutants derived from 2 parent strains which isolated
in Korea were obtained after several in vitro selection on GC
agar supplemented with increasing concentrations of ciproﬂ-
oxacin. Amino acid substitutions within the quinolone resist-
ance-determining region (QRDR) of GyrA, ParC were
determined. SDS-PAGE and 2D gel electrophresis of outer
membrane proteins (OMP) were performed.
Results: A signiﬁcant reduced sensitivity to ciproﬂoxacin was
observed in the selected mutants. MICs of ciproﬂoxacin for
76mu10 and 92mu13 strains were increased seven-, eleven-fold
higher than those of wild type strains respectively. Mutants
derived from 76/WT showed the resistance to PEN, TE and
CRO either. However, It was observed that mutants from 92/
WT had reduced sensitivity to AZI, TE and increased sensitivity
to SPT. On addition of CCCP, a proton motive force uncoupler,
MIC of ciproﬂoxacin for 92mu13 strain was most greatly
reduced by 8- fold. The sequence analysis of the gyrA has
demonstrated a single mutation at 91(S91Y) or 95(D95N) except
1 strain but no mutations in parC for all mutant. 76mu10 strain
only showed both point mutation at 91,95 in gyrA . SDS-PAGE
analysis of the OMPs of 76mu10 strain revealed remarkable
alteration in the expression of proteins which located in the
range from 29 to 50 kDa. And also in 2D analysis, it showed over
thirty spots which is changed in amount ﬁve-fold. Interestingly,
OMPs of 92mu13 strain showed little changes comparing to
wild type.
Conclusion: We induced the two kinds of mutants in which
probably had different ﬂuoroquinolone resistant mechanisms.
Although they had one mutation in gyrA , it was strongly
suggested that the main cause of resistance to ciproﬂoxacin was
reduction of OMPs or increase of efﬂux pump by OMPs analysis
and genetic analysis.
P1419
Streptococcus agalactiae highly resistant to
quinolones
M. Rebollo, E. Miro´, A. Ribera, M. Alvarez, F. Navarro,
B. Mirelis, P. Coll (Barcelona, E)
Objectives: To characterise the mechanism of resistance to
ﬂuoroquinolones in two out of 162 strains of Streptococcus
agalactiae isolated between January 2003 and November 2004.
Methods: Susceptibility studies were performed using a micro-
dilution method (Sensititre R) following NCCLS guidelines, and
Etest following the manufacturer’s procedures. A clonal rela-
tionship between the two strains was ruled out by pulsed-ﬁeld
gel electrophoresis. Mutational alterations in the QRDR of gyrA
and parC were investigated by PCR and sequencing using the
dideoxy method with the Thermo SequenaseTM CyTM5 Dye
Terminator Sequencing kit and the Automatic Laser Fluorescent
DNA Sequencer.
Table 1: MIC value of parent strains and ciproﬂoxacin selected
mutants
Strain
P. stuartii
ATCC
29914 RifR
Mutants of
P. stuartii ATCC
29914 RifR normal
colony size
Mutants of
P. stuartii
ATCC 29914
RifR SCV
TCPs
123
Mutants of
TCPs 123
normal
colony size
Mutants of
TCPs 123
SCV
Ciproﬂoxacin
MIC [mg/L]
0.03 0.25 3 0.5 6 >32
Table 1: Susceptibilities of gonococcal strains to various anti-
microbial agents and amino acid changes in GyrA and MtrR
promotor
Strain
MIC (lg/ml) Mutations in
Pen AZI TE SPT CRO OFL CIP CIP+cccp70 gyrA
mtrR
promoter
76/WT 4 0.25 2 16 0.03 0.5 0.12 0.03 91Tyr A del
76mu6 16 0.25 8 16 0.12 8 4 1 91Tyr A del
76mu10 16 0.25 8 8 0.25 8 16 4 91Tyr, 95Asn A del
92/WT 0.25 0.12 0.12 16 0.008 0.06 0.004 ND – –
92mu6 0.5 1 2 8 0.015 4 2 0.03 95Asn –
92mu13 0.5 1 2 4 0.008 4 8 0.03 95Asn –
Abbreviation; PEN: Penicillin, AZI: Azithromycin, TE: Tetracycline, SPT: Spectinomycin, CRO:
Ceftriaxone, OFL: Oﬂoxacin, CIP: Ciproﬂoxacin, CCCP: Carbonyl cyanide tri-chlorophenyl hydrazone
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Results: The ﬁrst ciproﬂoxacin-resistant S. agalactiae strain
(P0162) was recovered in October 2003; the second (P0425)
was isolated in September 2004. Both strains were isolated from
urological patients previously treated several times with ciproﬂ-
oxacin.The two ciproﬂoxacin-resistant S. agalactiae isolates were
also resistant to tetracycline and susceptible to penicillin,
vancomycin, erythromycin, clindamycin, quinupristin-dalfopr-
istin, chloramphenicol and rifampicin. MICs values of quinolo-
nes for P0162 and P0425 strains were: ciproﬂoxacin >32 mg/L,
norﬂoxacin >256 mg/L, levoﬂoxacin 8 mg/L and >32 mg/L,
sparﬂoxacin 4 mg/L and >32 mg/L, moxiﬂoxacin 0.5 mg/L and
2 mg/L, and clinaﬂoxacin 0.25 mg/L and 0.75 mg/L, respect-
ively. Both quinolone-resistant S. agalactiae isolates showed the
same mutation in parC (Ser79Phe), as well as an additional
mutation in gyrA. The P0162 strain showed Glu85Ala whereas
P0425 strain presented Glu85Lys.
Conclusion: This is the ﬁrst report of S. agalactiae quinolone
resistant strains in Spain, whose mechanism of resistance was
mutations in parC and gyrA. Both strains were isolated from
patients treated with ciproﬂoxacin, and no clonal relationship
was observed among them.
P1420
Novel gyrB and parE mutations detected in the
quinolone-resistance-determining-region of
clinical quinolone-resistant Pseudomonas
aeruginosa
S. Ferreira, T.R. Walsh, S. Mendo (Aveiro, P; Bristol, UK)
Objectives: The aim of the present study was to characterize
mutations occurring in quinolone-resistance-determining-region
(QRDR) region of the gyrA, gyrB, parC and parE genes of the 35
clinical ciproﬂoxacin and peﬂoxacin resistant Pseudomonas aeru-
ginosa isolated from patients in a Hospital from central Portugal.
Methods: Nucleotide sequences of the PCR-ampliﬁed gyrA,
gyrB, parC and parE fragments were determined using an
automated DNA sequencer. The Biological Sequence Alignment
Editor, BioEdit version 7.0.0 was used for DNA and amino acid
sequence alignments. Sequences obtained were compared to
others deposited in the EMBL Genebank.
Results: DNA sequences were analysed for mutations leading
to amino acid changes associated with ﬂuoroquinolone resist-
ance. Nine strains harboured a mutation (Thr ﬁ Ile) in the
codon 83 of gyrA. Some silent mutations were also found. Four
of the P. aeruginosa strains harboured a gyrB mutation that
occurred in codon 464 leading to an amino acid substitution
(Ser ﬁ Tyr). Two strains showed a mutation in codon 465
(Gly ﬁ Arg), also leading to an amino acid substitution.
However compared to the sequence of the gyrB fragment
obtained from P. aeruginosa PAO1, some silent mutations were
found. In parC, four strains exhibited amino acid substitution
(Ser–>Leu) in codon 87. A new mutation occurred in codon 35
leading to an amino acid substitution (Asp ﬁ Glu) in two of the
strains. Silent mutations were also found in the parC QRDR
region. In the nucleotide sequence of the par E gene a few amino
acid replacements were found. Those changes occurred in
codons 431 (Leu ﬁ Val), 483 (Glu ﬁ Gln), 487 (Ala ﬁ Pro), 530
(Ala ﬁ Pro), 538 (Gly ﬁ Val) and 544 (Gln ﬁ His). Two of
these replacements are novel (codon 483, Glu–>Gln and codon
487, Ala ﬁ Pro) and both occurred in the same strain. This
replacement occurred inside the highly conserved motif
EGDSA. Furthermore, silent mutations were also found.
Conclusion: GyrA mutants containing a Thr-83-Ile substitution
showed higher levels of resistance to ﬂuoroquinolones than
mutants containing a different single point mutation. Novel
mutations were detected in gyrB and parE genes. Also, the
results obtained for parC and par E genes revealed that
mutations in type II topoisomerase subunit B are not as rare
as they used to be.
P1421
Single mutations in parC gene among
levoﬂoxacin susceptible clinical isolates of
Streptococcus pneumoniae
E. Mateo, R. Alonso, R. Cisterna (Vitoria, Bilbao, E)
Objectives: Levoﬂoxacin (LVX) is recommended for the treat-
ment of community-acquired pneumonia because increasing
multidrug resistance in Streptococcus pneumoniae. The incidence
of levoﬂoxacin resistance in clinical isolates of S. pneumoniae is
relatively low. LVX resistance requires at least 2 mutations in the
quinolone resistance determining region (QRDR) of topoisom-
erase IV and DNA gyrase. The purpose of this study was to
determine the prevalence of single QRDR mutations in parC
gene of S. pneumoniae.
Methods: Sixty-nine levoﬂoxacin-susceptible pneumococci
(MICs 1–2 mg/L) were isolated at the Microbiology Service of
Hospital de Basuto, Bilbao (Spain) during 2004. Eight isolates
showed a LVX MIC of 2 mg/L and 61 isolates showed a LVX
MIC of 1 mg/L. We used a PCR-RFLP assay to screen 27
randomly chosen pneumococcal isolates with levoﬂoxacin MIC
of 1 mg/L and 8 isolates with a MIC of 2 mg/L for mutations
known to confer resistance (parC: S79, D83; gyrA: S81, E85). The
QRDR region of parC of isolates with suspected mutations was
ampliﬁed by PCR and its DNA sequence determined.
Results: Of the 27 strains with LVX MICs of 1 mg/L, no strains
had a S79 or D83 ParC change. Among 8 strains with LVX MICs
of 2 mg/L, 5 strains (62.5%) had a S79 or D83 ParC change. Four
isolates showed single parC mutation (S79F, D83G, D83V). Only
one isolate showed double parC mutation (S79F + K137N). No
mutations in gyrA gene were detected in any strains.
Conclusions: Fluoroquinolone resistance among S. pneumoniae
remains low, however, an increase in isolates containing a parC
mutation has been observed. The selection of parC mutations
could be related to the use of levoﬂoxacin to treat S. pneumoniae
infections.
P1422
Mutations in parC and gyrA genes among
levoﬂoxacin resistant clinical isolates of
Streptococcus pneumoniae
R. Alonso, E. Mateo, F. Calvo, R. Cisterna (Vitoria, Galda´cano,
Bilbao, E)
Objectives: The incidence of levoﬂoxacin resistance in clinical
isolates of S. pneumoniae is relatively low. LVX resistance
requires at least 2 mutations in the quinolone resistance
determining region (QRDR) of topoisomerase IV and DNA
gyrase. The purpose of this study was to characterize among
recent clinical isolates of S. pneumoniae the mutations that
conferred resistance to levoﬂoxacin.
Methods: Twenty-four levoﬂoxacin-resistant pneumococci
(MICs > 4 mg/L) isolated from respiratory samples during
2004 were analysed. Minimal inhibitory concentrations (CMIs)
to levoﬂoxacin, gatiﬂoxacin, moxiﬂoxacin, and gemiﬂoxacin
were determined by agar dilution method using Mueller–
Hinton agar with 5% horse blood. The QRDR regions of parC
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and gyrA were ampliﬁed by PCR and their DNA sequence
determined.
Results: Levoﬂoxacin resistance was associated with combina-
tions of at least two amino acid substitutions, most commonly
involving ParC Ser79Phe (23/25), and GyrA Ser81Tyr (20/25).
Of the 24 strains, three strains showed single parC mutation
(S79F) and a double gyrA mutation (S81Y + E85G). One strain
showed a K137N substitution in ParC and no mutations were
found in the QRDR of gyrA. This strain may be harbour
mutations in gyrB gene. None of the 24 strains was susceptible
to gatiﬂoxacin; twelve and twenty isolates were susceptible to
moxiﬂoxacin (CMI < 4 mg/L) and gemiﬂoxacin (CMI < 1 mg/
L), respectively.
Conclusions: The results suggest that resistance to levoﬂoxacin
require at least two substitutions of amino acids within the
QRDR region of gyrase and topoisomerase IV, and that there is
considerable cross-resistance among ﬂuoroquinolones associ-
ated with these changes.
P1423
Mechanisms of quinolone resistance in
P. aeruginosa strains with efﬂux pump
overexpression
B. Henrichfreise, I. Wiegand, B. Wiedemann (Bonn, D)
Objectives: The aim of our study was to determine whether
additional mechanisms of quinolone resistance (target modiﬁ-
cation via mutation or protection) can be found in P. aeruginosa
(PA) strains with efﬂuxpump overexpression (EPO).
Methods: 4 levoﬂoxacin-resistant strains of PA were collected
in a German hospital in 2004. EPO was veriﬁed by testing
Levoﬂoxacin (LEV) MICs using broth microdilution both with
and without the efﬂuxpump inhibitor (EPI) MC-270,110. The
QRDR of gyrA and parC, furthermore mexR and the
intergenic region between mexR and mexA (ir) containing
the shared operator-promotor region of mexA-mexB-oprM
and mexR were ampliﬁed and sequenced. Also, a screening
for qnr was conducted. Clonal identity was investigated by
multiple-locus variable number of tandem repeat analysis
(MLVA).
Results: The phenotypic and genotypic characterisation of all
strains is shown in Table 1. In 3 strains (1–3) whose LEV MIC
was reduced by EPI to the wildtype (wt) level of 0.125 mg/L no
aminoacid changes in GyrA and ParC were found. In strain 4
two changes in GyrA and one change in ParC were detected. All
strains showed mutations in mexR but no mutations in ir. The
exchange of V126 to E in strains 2 and 3 was previously
described in LEV-susceptible isolates. Qnr was not detected.
MLVA indicated no clonal relationship among all strains.
Conclusions: For strain 1 and 4 nalB mutations were observed.
The EPO phenotype in strains 2 and 3 could be caused by nalC
or by overexpression of other EPs. Contrary to usual ﬁndings in
our strains no correlation between EPO and target mutation was
found.
P1424
Analysis of sequential isolates of Pseudomonas
aeruginosa from cystic ﬁbrosis patients,
repeatedly treated with ciproﬂoxacin by mutant
prevention concentration, minimal inhibitory
concentration and pulsed ﬁeld gel electrophoresis
J. Blondeau, L. Blondeau, C. Williams (Saskatoon, CAN; Glasgow,
UK)
Objective: MPC measures the propensity of an antimicrobial
(AM) compound to select for AM resistance based on drug
concentrations required to block growth of ﬁrst-step resistant
mutants. Cystic ﬁbrosis patients (CFP) are frequently infected
with Pseudomonas aeruginosa (PA) and require repeat courses of
AM therapy. As AM therapy may precipitate AM resistance, we
tested sequential PA isolates from CFP, repeatedly treated with
Cpx, by MIC and MPC.
Methods: Sequential isolates were collected over a 3-yr period.
PA isolates were tested to Cpx and levoﬂoxacin (Lfx) by
microbroth dilution in accordance with NCCLS guidelines. For
MPC testing, 10 billion organisms were applied to agar plates
containing drug and incubated 24–48 hr. The lowest concentra-
tion preventing growth was the MPC. PA strains were com-
pared by pulsed ﬁeld gel electrophoresis (PFGE) using Spe I.
Results: Patient 1 (P1) (10 isolates) received 6 courses of Cpx
(500–750 mg bid) and patient 2 (P2) 5 courses over the period
collected (3 yrs). MICs for Cpx and Lfx for P1 and P2 ranged
0.031–1 lg/ml and 0.25–2 lg/ml respectively; MPCs ranged 1–
4 lg/ml (79% £ 2 lg/ml) and 2–16 lg/ml (64% ‡ 8 lg/ml)
respectively. PFGE proﬁle for P1 isolates were identical while P2
had 3 different strains. Cpx therapy did result in increased MPC
values. Lfx MPC values were higher than Cpx in every instance.
Conclusion: This represents ﬁrst report of MPC testing on
sequential PA isolates where AM history was available. MPCs
remained constant to Cpx over the duration of organism
isolations. MPCs to Lfx were high and beyond achievable and
sustainable drug concentrations. As P1, P2 have never received
Lfx, yet MPC values were so high, suggests Lfx will more
readily select for quinolone resistant PA. MPC can be used to
monitor changes in susceptibility and as such guide appropriate
selection of AM therapy.
P1425
Detection of a quinolone resistance-mediating
gyrA mutation in a ﬂuoroquinolone susceptible
Salmonella live vaccine strain
A. Preisler, P. Heisig (Hamburg, D)
Objectives: The production of effective vaccines instead of
developing new antibiotics is a promising approach to circum-
vent rapid development of bacterial resistance. Beside an
attenuated Salmonella typhi live vaccine strain used in human,
S. typhimurium strain TAD Salmonella vacT is being used as live
vaccine strain in food-producing chicken. Attenuation of viru-
lence has been achieved by random mutagenesis of the wild-
type S. typhimurium DT009 strain M415 followed by selection for
reduced virulence. Epidemiological markers of vaccine strain
include reduced susceptibilities to rifampicin (rifR) and nalidixic
acid (nalR) and the loss of tensid tolerance, presumably
associated with altered membrane permeability (marker rtt).
Curiously, the vaccine strain retains a high susceptibility to
ﬂuoroquinolones and macrolides. The present study aimed at
understanding the molecular basis for this phenotype.
Table 1
Strain 1 2 3 4
Lev MIC 16 8 8 128
Lev MIC + EPI 0.125 0.125 0.125 2
gyrA/ GyrA wt wt Wt T83to1 D87toG
parC/ ParC wt wt silent mutation
codon 80
S80 to L
maxR/MaxR c insertion
after g75
V126toE V126toE N insertion
after L52
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Methods: TAD Salmonella vacT was characterized by deter-
mination of antibiotic susceptibility pattern, generation time,
DNA-supercoiling degree, and DNA-sequence of the entire
gyrA genes as well as the quinolone resistance-determining
regions (QRDRs) of the remaining ﬂuoroquinolone target genes
gyrB, parC, and parE -encoding the subunits B of gyrase or A
and B of topoisomerase IV, respectively.
Results: Compared to its parent, TAD Salmonella vacT showed
a reduced growth rate, but no signiﬁcant changes in the DNA
supercoiling. DNA sequence analysis of the complete gyrA gene
revealed three novel mutations affecting codons 59 (trp–arg), 75
(gly–ala), and 867 (ser–ile) and one known point mutation at
position 87 (asp–gly). Although the mutation at codon 87 is
known to mediate quinolone resistance, the vaccine strain is
highly susceptible to ﬂuoroquinolones like sparﬂoxacin, and
ciproﬂoxacin and only moderately resistant to nalidixic acid.
Conclusions: Two hypotheses might -alone or in combination-
explain this phenotype (1) At least one of the novel gyrA
mutations compensates for the ﬂuoroquinolone resistance muta-
tion (asp-87–gly) and (2) an increase in drug accumulation,
resulting from the inactivation of a multi-drug efﬂux pump
(presumably associated with the rtt marker) allows for a higher
accumulation of ﬂuoroquinolones -and macrolides- in the cell.
Our results point to a combination of both mechanisms and
therefore provide a molecular basis to understand the reported
stability of the live vaccine in vitro and in the ﬁeld.
P1426
Identiﬁcation of plasmid-mediated quinolone
resistance in enterobacterial isolates in Turkey
P. Nordmann, H. Nazik, B. Ongen, H. Mammeri, L. Poirel
(Le Kremlin Bicetre, F; Istanbul, TR)
Objectives: The plasmid-mediated quinolone-resistance deter-
minant QnrA has been identiﬁed recently from enterobacterial
isolates in USA, China, Thailand, Korea, The Netherlands and
France. These strains were resistant to nalidixic-acid and most of
them produced expanded-spectrum beta-lactamases. Our objec-
tive was to evaluate the prevalence of the qnr gene in nalidixic-
acid resistant enterobacterial isolates recovered at the University
Hospital of Istanbul, Turkey, since it is located just between
mainland Europe and Asia.
Methods: PCR with primers speciﬁc for the qnrA-like gene was
used for screening. Primers speciﬁc for the different ESBL genes
were used to identify the corresponding beta-lactamase genes.
Mating-out assays were attempted to demonstrate the transfer-
ability of the Qnr determinant. Combinations of primers were
used to identify the qnr-surrounding sequences. Eighty-eight
nalidixic-acid resistant enterobacterial strains isolated in 2004
were studied. Among them, 51 were ESBL producers.
Results: The qnrA gene was identiﬁed in two ESBL-positive
isolates (1% of the ESBL (+) strains), an Enterobacter cloacae and a
Citrobacter freundii isolate. TheE. cloacae isolate expressed an SHV-
5-like ESBL thatwas encoded on a plasmid that co-transferred the
nalidixic-acid resistance in addition to resistance to kanamycin,
tobramycin, chloramphenicol, trimethoprim, and sulfonamides.
The C. freundii isolate possessed also a conjugative plasmid that
harboured the qnrA gene associated with the blaVEB-1 gene and
that conferred also resistance to streptomycin, tobramycin,
chloramphenicol, rifampin, and sulfonamides. In both cases, the
qnrA gene was located downstream of the Orf513 recombinase
gene, as previously identiﬁed in other qnrA-positive isolates.
Conclusion: This study emphasizes that the qnrA gene confer-
ring resistance to nalidixic acid is present in distantly-located
European countries. Interestingly, the qnrA gene was found in
association with blaVEB-1 gene, that corresponds to the ﬁrst
identiﬁcation of this latter ESBL in Turkey.
P1427
Norﬂoxacin as an alternative marker of decreased
susceptibility to ﬂuorquinolones in Salmonella
enterica
L. Lo´pez, A. Gisaeus, A. Pascual (Seville, E; Malmo¨, S)
Objective: Treatment failure with ﬂuorquinolones has been a
problem in cases when the salmonella strains show resistance to
Nalidixic acid (NAL). The Ciproﬂoxacin (CIP) MIC value
increase if the salmonella strain is NAL resistant so several
authors have proposed a change of the Ciproﬂoxacin suscepti-
bility breakpoint from £1 to £ 0.125 mg/L for Salmonella enterica.
The VITEK system is extensively used as automated suscepti-
bility system but NAL testing is not included and the lowest CIP
dilution in the VITEK cards is 0.25 mg/L. The aim of this study
is to trace Nalidixic acid resistance in Salmonella enterica isolates
with the VITEK system, using the Norﬂoxacin MIC value as a
marker of nalidixic acid resistance.
Material and methods: Forty-two clinical Salmonella enterica
isolates were collected during July–August 2004. The suscepti-
bility tests were achieved by: 1) using AST-N020 cards and the
VITEK system (bioMe´rieux) according to manufacturer, 2)
testing NAL, CIP, Norﬂoxacin (NOR) and Oﬂoxacin (OFX)
with the microdilution broth method according to NCCLS, and
3) testing discs with NAL 30 microg (Oxoid), CIP 5 microg
(Oxoid) and NOR 10 microg (Oxoid) with the diffusion agar
method according to NCCLS.
Results: Thirty-seven (88%) Salmonella enterica isolates belonged
to serogroup D, 4 (10%) to serogroup B and 1 (2%) to serogroup
C. With the Vitek system ﬁve of the strains tested had a NOR
MIC <0.5 mg/L and 37 showed an increased MIC value for
NOR (2 mg/L), but although within the NCCLS limits for
susceptibility. The ﬁve strains with Norﬂoxacin VITEK
MIC<0.5 mg/L were NAL susceptible (average 25,8 mm and
£0.03 mg/L) and all the isolates with Norﬂoxacin VITEK MIC
2 mg/L were NAL resistant (average 6 mm and ‡256 mg/L).
For Ciproﬂoxacin the lowest VITEK MIC value £0.25 mg/L is
represented for both the Nalidixic acid resistance and suscep-
tible strains. The 37 NAL-R strains showed higher NCCLS MIC
values, ranging from 0.125–0.5 mg/L for Ciproﬂoxacin, 0.5–
4 mg/L for Norﬂoxacin and 0.25–1 mg/L for Oﬂoxacin, than the
NAL-S strains (MIC £0.06 mg/L for Ciproﬂoxacin, Norﬂoxacin
and Oﬂoxacin).
Conclusion: The results of this study show that Norﬂoxacin
MIC >0.5 mg/L should be considered as a marker of Nalidixic
acid resistant Salmonella enterica strains when using VITEK 2
system for susceptibility testing.
P1428
Factors affecting resistance to quinolones
mediated by plasmids containing the qnrA gene
J.M. Rodriguez-Martinez, C. Velasco, A. Pascual, I. Garcia,
L. Martinez-Martinez (Seville, Santander, E)
Objectives: The effect of copy number and transcriptional level
of qnrA on plasmid-mediated quinolone resistance, and the
effect of quinolones in inducing qnrA expression were analysed
in four clinical strains of Klebsiella pneumoniae (UAB1, N5, 1960
and 1132 strains) and in Escherichia coli transconjugants derived
from UAB1, N5 and 1960. No transconjugants containing qnrA
from strain 1132 are available.
Methods: Southern-RFLP analysis was also performed to
investigate basic structural details of plasmids containing
qnrA. Copy number of qnrA was determined by dot blot
hybridization. Transcriptional studies were carried out using
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total RNA isolated from transconjugants grown in the absence
or in the presence of ciproﬂoxacin or moxiﬂoxacin at 0.2, 0.4, 0.8
or 1 x MIC.
Results: qnrA is located in plasmids with similar mobility and
identical Southern- RFLP (in all four plasmids, the qnrA probe
hybridized with one EcoRI fragment of 4.1 Kb). MICs of
quinolones against transconjugants from the same donor were
identical, but MICs against transconjugants from different
parental strains varied within a 4-fold range. qnrA copy
numbers in strains UAB1 and 1132 were 8 times higher than
in strains 1160, and 2.7 times higher than in strain N5. No
differences in qnrA copy number in the E. coli transconjugants
were observed. The amount of qnrA transcripts was at least
5-fold greater in the transconjugant from UAB1 than in the
transconjugants from strain N5 or 1960 without quinolone
induction. Differences in transcription of qnrA in different
transconjugants were also noted at both basal levels and after
induction by quinolones. A dose-response study of the inducing
effect of ciproﬂoxacin on qnrA transcription was performed
with transconjugants from strains UAB1, N5 and 1960, with a
maximum effect at 0.4 XMIC. After induction with ciproﬂoxacin
at 0.4 · MIC, transcription of qnrA increased 4.3, 5.1 and 2.6
times over baseline in transconjugants from strains UAB1, N5,
and 1960, respectively. Induction of qnrA by ciproﬂoxacin was
1.04, 2.2 and 2.03 times higher than that caused by moxiﬂoxacin
against transconjugants from UAB1, N5 and 1960, respectively.
Conclusion: Regulation of qnrA expression may be similar in
all four strains. There are differences in qnrA copy number in
strains containing this gene. Transcriptional analysis revealed
that both ciproﬂoxacin and moxiﬂoxacin are able to induce qnrA
gene, with ciproﬂoxacin being a better inducer than moxiﬂoxa-
cin.
P1429
The use of norﬂoxacin 10 mcg as a screening disc
to predict ﬂuoroquinolone resistance in
Streptococcus pneumoniae
C. Bore´n, R.W. Smyth, W. Hryniewicz, G. Kahlmeter,
E. Sadowy (Va¨xjo¨, S; Warsaw, PL)
Objectives: The use of sensitive screen discs for the detection of
antibiotic class resistance is becoming increasingly important. A
nalidixic acid disc (30 mcg) has been successfully used for the
detection of ﬂuoroquinolone (FQ) resistance in Enterobacteria-
ceae, Haemophilus spp and Neisseria spp. Cefpodoxime has been
used for the detection of ESBL and most recently cefoxitin for
the detection of MRSA. We compared the sensitivity of norﬂ-
oxacin (10 mcg) and ciproﬂoxacin (1 and 5 mcg) discs for the
detection of ﬂuoroquinolone resistance in a collection of FQ
sensitive and resistant Streptococcus pneumoniae.
Methods: A collection of S. pneumoniae strains with (from
Poland) and without (from Sweden) ﬂuoroquinolone resistance
mechanisms were tested with antibiotic discs, norﬂoxacin
10 mcg and ciproﬂoxacin 1 and 5 mcg, from Oxoid UK.
Mueller–Hinton Agar (Oxoid, UK) with 5% deﬁbrinated sheep
blood and IsoSensitest Agar (Oxoid,UK) with 5% deﬁbrinated
horse blood and NAD were used. Mueller–Hinton agar was
investigated with conﬂuent and semi-conﬂuent inoculum while
ISA was tested with a semi-conﬂuent inoculum. Ciproﬂoxacin
MIC-values (E-test, AB Biodisk, Sweden) were determined on
ISA. All plates were incubated at 35–37 C in 5% carbon dioxide
for 18–24 h before measuring the inhibition zones. Strains
exhibiting ciproﬂoxacin MIC-values of 0.125–2.0 mg/L were
considered part of the wild type MIC distribution as deﬁned by
the EUCAST epidemiological cut-off value (www.eucast.org).
Results: Strains with MIC ‡ 32 mg/L were reliably detected
with all methods and discs. Most difﬁcult to reliably separate
from the wild type distribution were strains with MIC 4.0 mg/L.
Irrespective of agar and inoculum the norﬂoxacin 10 mcg disc
more easily distinguished strains with MIC 4 mg/L from strains
of £2 mg/L. Ciproﬂoxacin 1 mcg was slightly inferior to the
norﬂoxacin disc but much more reliable than ciproﬂoxacin
5 mcg.
Conclusion: Using methods based on NCCLS and BSAC/
SRGA methodologies, norﬂoxacin 10 mcg and ciproﬂoxacin
1 mcg were preferable to ciproﬂoxacin 5 mcg in the detection of
ﬂuoroquinolone resistance in S. pneumoniae. We suggest that
ﬂuoroquinolone resistance surveillance is performed with one of
these discs and that ciproﬂoxacin MIC-determination is per-
formed on strains identiﬁed by the screen test.
Antibacterial susceptibility studies – II
P1430
Comparative in vitro activity of several
antimicrobial agents against different Nocardia
species
Y. Glupczynski, C. Berhin, M. Janssens, G. Wauters (Yvoir,
Brussels, B)
Background: Treatment of Nocardia spp. continues to be chal-
lenging and there have been only few surveys on the suscep-
tibility of the different Nocardia species to antibiotics. We
therefore studied the in vitro activity of 11 antimicrobials
against 81 clinical isolates of Nocardia spp.
Methods: Most isolates were isolated from clinical specimens in
different Belgian centres between 1990 and 2004. Identiﬁcation of
all isolates was conﬁrmed to the species level by conventional
phenotypical tests and by 16S rDNA sequencing. Species identi-
ﬁed were: N. farcinica (37), N. nova (16), N. cyriacigeorgica (12),
N. brasiliensis (6), N. abscessus (5), N. paucivorans (2), N. carnea,
N. niigatensis and N. asiatica (1 each). The known origins of the
isolateswere: respiratory samples (34 isolates),wound/soft tissue
infections (13 isolates), blood (7 isolates), brain abscesses (4
isolates), CSF (1 isolate). Antimicrobial susceptibility testing was
performed by E-test on Mueller Hinton agar. MIC values were
read after 48 and 72 h incubation. 18 additional reference strains
(DSM and NCTC collections) belonging to 12 different Nocardia
spp. were also included in the testing.
Results: The MIC values (mg/L) and range of activities of
selected antibiotics tested against Nocardia spp. are summarized
in the Table.N. farcinica and N. brasiliensis showed the highest
MIC values to the different classes of antibiotics tested while
N. nova and N. abscessus appeared as the most susceptible
species on the average. Overall, we found a rather close
correlation between phenotypic susceptibility/resistance pro-
ﬁles and species identiﬁcation.
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Conclusion: On the whole, cotrimoxazole, amikacin, imepe-
nem, minocycline and linezolid displayed the highest intrinsic
activity. The excellent activity of linezolid in particular shows
promises for the treatment of infections due to Nocardia sp.
owing to its good oral availability.
P1431
Antibiotic susceptibility proﬁles of glucopeptide
intermediate Staphylococcus species isolated
from patients with bacteraemia
D. Mylona-Petropoulou, G. Ganderis, E. Yfantis, M. Damala,
H. Malamou-Lada (Athens, GR)
Objectives : To investigate the frequency of glycopeptide
intermediate Staphylococcus species (GISS) and their susceptibility
to other antibiotics.
Methods: Between January 2001 toNovember 2004 the antibiotic
susceptibility pattern of coagulase – negative Staphylococci (CNS)
with reduced susceptibility to glycopeptides, isolated from
patients with bacteraemia, hospitalized in the General Hospital of
Athens ‘G. Gennimatas’, was analysed.The isolates were recog-
nized by theVITEK II automated system (bioMerieux, France), by
the brain heart infusion agar screening plate with 6 mg/L
vancomycin and conﬁrmed by the E test method (AB Biodisk,
Sweden) according to the manufacturer’s recommendations.
Results: A total of 4270 strains of Staphylococciwere isolated from
consecutiveblood culturesduring this period: Threehundred two
(7,07%) S. aureus and 1614 (37,8%) CNS. Seventy three (4,5%)
strains (64 S. epidermidis, 7 S. haemolyticus and 2 S. hominis)
demonstrated reduced susceptibility to glycopeptides. Four
strains were intermediate sensitive (MIC 8–12 mg/L) and
one strain was resistant (MIC: 32 mg/L) to vancomycin. Fourty
seven strains were intermediate sensitive (MIC: 16 mg/L) and 26
strains were resistant (MIC: 32–256 mg/L) to teicoplanin. It is
worthwhile to notice that all the strains with reduced suscepti-
bility to vancomycin were resistant to teicoplanin. Six out of 73
strains (8,2%)were sensitive to oxacillin. The resistance rate (%) of
73 GISS strains to other antibiotics was as follows: gentamicin
(87,7), tobramycin (91,8), rifampin (32,8) trimethoprime / sulfa-
methoxazole (38,3), oﬂoxacin (84,9), while all GISS strains dem-
onstrated sensitivity to quinupristin / dalfopristin and linezolid.
Conclusion: Glycopeptide resistance in Staphylococci is becom-
ing more common in our hospital. Laboratories should use
proper diagnostic techniques to detect such strains, because
these bacteria may play an important role in therapeutic failure
of serious Staphylococcal infections.
P1432
Methicillin-resistant coagulase-negative
staphylococci with increased resistance to
glycopeptides
A. Bisiklis, F. Tsapara, S. Alexiou-Daniel (Thessaloniki, GR)
Objectives: The purpose of our study was to inquire if
there were Vancomycin resistant subpopulations among
coagulase-negative staphylococci, which indicate intermediate
or homogeneous resistance to Teicoplanin.
Methods: We have studied four Staphylococci epidermidis and a
Staphylococcus haemolyticus. These strains were isolated during
second semester in 2003, from two blood cultures, two venous
catheters cultures and a sample culture from operative injury.
These cultures were performed in common nutritive substrates.
The indentiﬁcation and determination of antibiotic sensitivity
was performed by VITEK 2 (BioMe´rieux). The basic features of
strains were the homogeneous resistance to Oxacillin, the
homogeneous or intermediate resistance to Teicoplanin and
their sensitivity to Vancomycin. Oxacillin resistance and Vanco-
mycin sensitivity were conﬁrmed by the classical method of
E-test in Mu¨ller Hinton agar, with inoculation turbidity 0.5 of
MacFarland scale and for 24 hours incubation in 37C. The
determination of subpopulations with increased Glycopeptide-
resistance was performed by macromethod of E-test in Brain
Heart Infusion agar, with inoculation turbidity 2.0 of MacFar-
land scale and for 48 hours incubation in 35C.
Results: Three Staphylococci epidermidis indicated Vancomycin
MIC 2 lg/ml and one 4 lg/ml with the classical method of
E-test. With the macromethod of E-test, the ﬁrst three strains
indicated MIC 8 lg/ml, 8 lg/ml, 12 lg/ml and the fourth
strain 12 lg/ml. Staphylococcus haemolyticus indicated Vanco-
mycin MIC 3 lg/ml and 32 lg/ml with the classical method
and macromethod, respectively. Teicoplanin MIC ranged from
24 lg/ml to over 256 lg/ml for Staphylococcus haemolyticus.
Conclusions: a) We have observed that, all strains, which were
Vancomycin-sensitive consistently with Vitek and classical
method of E-test, revealed subpopulations with increased
Vancomycin-resistance.b)The appearance of high Teicoplanin
MIC for all strains and high Vancomycin MIC for S. haemolyticus
consinstently with macromethod of E-test was remarkable. c)
We suggest that, when Vancomycin is used as a treatment
choice we should seriously consider Oxacillin and Teicoplanin
resistance as determined by routine methods. The presence of
subpopulation with heterogeneity resistance is possible to cause
treatment failure.
P1433
In vitro evaluation of effective antibiotic lock
therapy for treatment of catheter-related
infections caused by Staphylococcus species
J.Y. Lee, K.S. Ko, W.S. Oh, N.Y. Lee, J.-H. Song, K.R. Peck (Seoul,
KOR)
Objective: Antibiotic lock therapy (ALT) is recently recommen-
ded for conserving catheters in treatment of central venous
catheter (CVC)-related infections. We performed this study to
investigate the adequate antibiotics, the concentration of antibi-
otics, and treatment duration in ALT.
Methods : We evaluated the bacterial killing activity of vanco-
mycin, teicoplanin, ciproﬂoxacin, rifampin, cefazolin, gentami-
cin, nafcillin, and erythromycin against bioﬁlms of S. aureus
(SA204 and SA195) and S. epidermidis (ATCC35983 and
ATCC35984). The effectiveness of the antibiotic locks was
assayed after exposure to antibiotics (1, 5, and 10 mg/ml) for
1, 3, 5, 7, 10, or 14 days by using in vitro model of bioﬁlms on
polyurethane (PU) ﬁlm. Bioﬁlm bacteria were quantiﬁed by the
determination of viable counts.
Results: Signiﬁcant bioﬁlm killings were not achieved with
cefazolin, nafcillin, gentamicin, and erythromycin at any of the
time intervals examined.
Antimicrobials MIC range (mg/L) MIC50 MIC90
Amoxicillin 0.016–>256 12 32
Amoxi/Clav. 0.016–>256 2 8
Ceftriaxone 0.032–>256 8 >256
Imipenem 0.002–>32 0.5 2
Ciproﬂoxacin 0.032–>32 4 >32
Clarithromycin <0.016–>256 8 96
Tobramycin <0.016–24 4 12
Amikacin 0.016–2 0.38 1
Minocycline 0.016–4 1.5 3
Linezolid 0.047–3 1 2
Cotrimoxazole 0.002–0.75 0.064 0.38
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Conclusion: These data suggest that ALTs for less than 7 days
with vancomycin, teicoplanin, ciproﬂoxacin, and rifampin (5
mg/ml of each) can be effectively used in treating catheter-related
infections caused by S. epidermidis and S. aureus. It warrants
prospective clinical trials for the evaluation of clinical efﬁcacy.
P1434
Synergism between ultrasound and ceftazidime
in the phagocytosis of Pseudomonas aeruginosa
N.Kashef, Q. BehzadianNejad,M. Sattari,M.Mokhtari (Tehran, IR)
Objectives: Pseudomonas aeruginosa is an opportunistic pathogen
with innate resistance to many antibiotics, predominantly infect-
ing patients with defects in antibacterial defenses. Ultrasound is
currently used in medical practice for diagnostic and therapeutic
purposes. A recent application of ultrasound is in drug delivery.
There are many reports in the literature suggesting that ultra-
soundactivates,potentializes, ormakesmore effective somephar-
macological agents. In this study, we investigated the effect of
ultrasound and sMICs of ceftazidime on phagocytosis of Pseudo-
monas aeruginosa (ATCC 27853) separately and in combination.
Methods: The susceptibility of bacteria to murine macrophage
killing was examined following exposure to ceftazidime and
ultrasound (at a frequency of 1 MHz and power output of
0.25 W). Bacteria were added to macrophage-containing poly-
propylene tubes. After incubation, centrifugation, and washing
of macrophages to remove adherent but unphagocytized organ-
isms, cells were lysed by distilled water. Each sample was plated
and after incubation, the number of viable colonies was counted.
Results: Invitro,pretreatmentof bacteriawith sMICsof antibiotic
and ultrasound separately resulted in an enhancement of macro-
phage phagocytosis and killing of the organisms (p < 0.0001). But
there was a notable enhancement effect manifested by increased
nonopsonic killing following pretreatment of bacteria with those
two independent variables in combination (p < 0.0001).
Conclusion: These results showed that simultaneous application
of ultrasound and ceftazidime has some efﬁcacy in inactivating
Pseudomonas aeruginosa, and improves phagocyte activation. The
physical mechanism of inactivation by ultrasound alone appears
to be transient cavitation, but the mechanism by which ultra-
sound enhanced antibiotic action may be due to perturbation of
the cell membrane or to stress responses by the bacteria. The
mechanism of synergistic effect of ultrasound and ceftazidime
is unknown and many more attempts should be made.
P1435
Occurrence of resistance to wide spectrum of
antimicrobial agents in clinical isolates of the
genus Acinetobacter
E. Sodomova, D. Michalkova-Papajova, M. Vrabelova-Poczova,
D. Rovna, M. Kettner (Bratislava, SVK)
Objectives: The aim of the study was to determine the
occurrence of resistance to 33 antimicrobial agents in Acinetob-
acter clinical isolates.
Methods: Clinical isolates included in the study originated
from Hospital Ruzinov, Bratislava (Slovakia). The majority of 37
isolates tested were obtained from Burn Department (35.1 %)
and from Surgical Department (29.7 %) of this hospital and were
isolated from burn infections (29.7 %) and wounds (27.0 %). The
isolates were identiﬁed by NEFERMtest24 (Pliva-Lachema,
Czech Republic) and selected as resistant to clinically used
beta-lactam antibiotics. Resistance to antimicrobial agents was
determined by standard disk diffusion method according to the
NCCLS recommendations. The following antimicrobials were
tested: mezlocillin, ticarcillin, piperacillin, carbenicillin, ampi-
cillin-sulbactam, piperacillin-tazobactam, ticarcillin-clavulanic
acid, ceftazidime, cefepime, cefoperazone, cefotaxime, ceftriax-
one, ceftizoxime, moxalactam, imipenem, meropenem, aztreo-
nam, gentamicin, amikacin, tobramycin, netilmicin, tetracycline,
doxycycline, minocycline, ciproﬂoxacin, levoﬂoxacin, lomeﬂoxa-
cin, norﬂoxacin, oﬂoxacin, gatiﬂoxacin, chloramphenicol, trim-
ethoprim-sulfamethoxazole, sulfonamides.
Results: In the set of 37 clinical isolates 100.0 % were resistant to
mezlocillin, 86.5 % to ticarcillin, 100.0 % to piperacillin, 100.0 %
to carbenicillin, 10.8 % to ampicillin-sulbactam, 43.2 % to
piperacillin-tazobactam, 32.4 % to ticarcillin-clavulanic acid,
56.8 % to ceftazidime, 21.6 % to cefepime, 100.0 % cefoperazone,
75.7 % to cefotaxime, 75.7 % to ceftriaxone, 86.5 % to ceftizoxime,
75.7 % to moxalactam, 0.0 % to imipenem, 0.0 % to meropenem,
59.5 % to aztreonam, 100.0 % to gentamicin, 62.1 % to amikacin,
10.8 % to tobramycin, 5.4 % to netilmicin, 100.0 % to tetracycline,
54.1 % to doxycycline, 45.9 % to minocycline, 100.0 % to
ciproﬂoxacin, 78.4 % to levoﬂoxacin, 100.0 % to lomeﬂoxacin,
100.0 % to norﬂoxacin, 43.2 % to oﬂoxacin, 83.8 % to gatiﬂoxacin,
100.0 % to chloramphenicol, 59.5 % to trimethoprim-sulfameth-
oxazole and 86.5 % to sulfonamides.
Conclusions: More than 75 % of the clinical isolates were
resistant to 20 or more from 33 antimicrobial agents tested.
Carbapenems (imipenem and meropenem) were the only antimicro-
bial agents effective to all clinical isolates.
P1436
Time-kill studies of linezolid, piperacillin-
tazobactam, imipenem, amikacin, trimethoprim-
sulfametoxazole and moxiﬂoxacin alone or in
combination against Nocardia spp.
M.F. Tripodi, R. Fortunato, G. Ruggiero, S. Cuccurullo,
R. Utili (Naples, I)
Objectives: Nocardia may cause severe infections in immuno-
compromised hosts. Treatment has been largely based on
sulfonamide agents. The aim of the study was to evaluate the
in-vitro bactericidal activity of several antibiotic combinations
against Nocardia spp.
Methods: Seven Nocardia strains (N. asteroides, 3; N. brasiliensis,
2; N. farcinica 1, N. spp. 1) were isolated from pulmonary lesions
in heart-transplant patients. In vitro activity of antibiotic
combinations was evaluated by time-kill method on Mueller
Hinton broth II (MHBII) using the following antibiotics alone or
in combination with each other at the following peak-serum
concentrations (mg/l): LZD, 20; piperacillin-tazobactam (TZP),
200; imipenem (IMP), 43; trimethoprim-sulphametoxazole
(SXT), 3.4/17; amikacin (AN), 38; moxiﬂoxacin (MFX), 4.3.
Time-kill studies were performed in MHBII using an inoculum
of 1 · 106 cfu/ml, incubated at 37C for 72 h. Viability counts
were performed at 0,24, and 72 h, by plating 10 fold dilutions
onto blood agar plates (BioMe`rieux, France). The bactericidal
activity was deﬁned as a decrease major or equal to 3 log10
cfu/ml in the viable count at 24, 72 h compared with the initial
Lock
period
(day)
Musc on of CFU/sheet (mg/ml)
Control VAN TEC CIP HIF
1 5 10 1 5 10 1 5 10 1 5 10
0 6.6 · 104
1 1.5 · 104 2.2 · 104 1.1 · 104 ND 9.1 · 101 1.1 · 106 2.7 · 101 4.1 · 104 4.8 · 101 ND 1.7 · 101 0 0
3 2.9 · 104 1.0 · 104 9.7 · 104 ND 5.6 · 101 4.9 · 104 3.1 · 101 1.4 · 101 0 ND 1.3 · 106 0 0
5 3.6 · 104 1.8 · 104 0 ND 1.2 · 101 1.6 · 101 8.0 · 101 8.2 · 101 0 ND 0 0 0
7 1.4 · 1028 5.7 · 101 0 ND 3.0 · 101 0 0 1.4 · 101 0 ND 0 0 0
10 1.1 · 1028 6.2 · 101 0 ND 0 0 0 0 0 ND 0 0 0
14 2.4 · 1028 3.0 · 101 0 ND 0 0 0 0 0 ND 0 0 0
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inoculum. Synergism or antagonism were deﬁned as a decrease
or increase major or equal to 2 log10 cfu/ml in the viable count
with the combination at 24, 72 h compared with the most active
agent alone.
Results: Only AN, IMP, MFX, as single drug, showed a
bactericidal activity in 7, 4 and 2 strains respectively, all other
agents were bacteriostatic. For antibiotic combinations, high rate
of bactericidal activity was observed with: IMP + AN and
IMP + MFX in all seven strains; TZP + MFX, TZP + AN and
MFX + AN in 6 strains; AN + SXT in 5. Among the bactericidal
combinations, synergism was observed for TZP with MFX or
SXT in 2 and 1 strain respectively. For the other combinations,
synergism was not evaluable due to high bactericidal activity of
AN, IMP and MFX. Linezolid behaved always as bacteriostatic
agent and was bactericidal only in one case with AN and MFX,
respectively, but was antagonistic with AN and IMP in 7 and 2
strains, respectively. All the other antibiotic combinations were
bacteriostatic.
Conclusion: To date there is no standardized treatment for
nocardosis. Based on these data the combinations of IMP and
AN or MFX appears suitable as initial treatment of invasive
nocardiosis. LZD, MFX and SXT may represent a choice for
sequential oral therapy as single drugs.
P1437
Intracellular activity of ampicillin, azithromycin,
telithromycin, ciproﬂoxacin and moxiﬂoxacin
against non-typeable Haemophilus inﬂuenzae
C. Kratzer, W. Graninger, A. Buxbaum,
A. Georgopoulos (Vienna, A)
Objectives: Non-typeable Haemophilus inﬂuenzae (NTHi), a
well-known, major respiratory tract pathogen, has recently
been shown to be able to invade and persist inside human
epithelial cells. In this study we analysed the intracellular in
vitro activity of ampicillin, azithromycin, telithromycin, ciproﬂ-
oxacin and moxiﬂoxacin against NTHi.
Methods: Conﬂuent normal human bronchial epithelial
(NHBE) cells were loaded with 100 bacteria per epithelial cell
for 2 h. Extracellular H. inﬂuenzae were killed by gentamicin,
and the intracellular bacteria were incubated with fresh invasion
medium, supplemented with selected antimicrobial agents at
concentrations of 1 and 10 mg/l for further 4 and 8 h. As ﬁnal
step the invasion medium was removed and the number of
intracellular viable bacteria was determined after lysis of the
epithelial cells.
Results: Moxiﬂoxacin showed the highest bactericidal efﬁcacy
against intracellular NTHi, followed by ciproﬂoxacin, azithro-
mycin and telithromycin. During the ﬁrst 8 h, ampicillin was not
able to inﬂuence the intracellular survival of H. inﬂuenzae in
comparison to a control without antibiotic.
Conclusions: When compared with the other tested antibiotics,
moxiﬂoxacin was most effective in killing intracellular NTHi.
Therefore, moxiﬂoxacin, which combines high extracellular and
intracellular activity, can be seen as an important tool for the
treatment of RTIs.
P1438
Antibiotic susceptibility of Fusobacterium
necrophorum strains causing serious infections
R. Hannula, L. Bevanger (Trondheim, N)
Objectives: F. necrophorum causes abscesses, mainly in the
oropharynx, and Lemierre’s syndrome (postanginal sepsis), a
rare life-threatening disease in young, previously healthy adults.
Long-term antibiotic treatment is often needed.We studied the
susceptibility pattern for F. necrophorum in 13 available clinical
isolates in our hospital from January 1991 until October 2004.
Methods: Four blood-stream isolates and nine other clinical
isolates, mainly from abscesses, were available for testing.The
bacteria were cultured on fastidious anaerobic agar (FAA) and
were identiﬁed by their colony morphology, microscopic mor-
phology, chartreuse ﬂuorescence, lipase positivity and biochem-
ically by the rapid ID 32 A (bioMe´rieux).Bacteria suspended in
Brain Heart broth of 1 McFarland turbidity were swabbed on
PDM agar with 5% deﬁbrinated horse blood. Etest strips
(BIODISK) were applied on the dry agar surface. The plates
were incubated anaerobically for 48 hours before reading the
results. The strains were tested for penicillinase activity with
nitrocephin.
Results: Three strains were resistant for penicillin but did not
produce penicillinase. MIC values for ciproﬂoxacin were gen-
erally higher than for other antibiotics. The colony size on these
agar plates was increased compared to the colonies on the other
plates, suggesting that the growth was stimulated by ciproﬂ-
oxacin. Etest results for imipenem showed a high MIC due to
hazy colonies in the inhibition zone.
Conclusions: Etest results indicate resistance to penicillin and
imipenem in some F. necrophorum strains.Clindamycin and
metronidazole seem to be good therapy alternatives.MIC
values for ciproﬂoxacin were high and ciproﬂoxacin is not a
choice for therapy. Doxycyclin and cefotaxime might be used as
second line therapy. MIC testing should always be performed in
serious anaerobic infections.
P1439
In vitro activities of various antibiotics, alone and
in combination with colistin methanesulfonate
against Pseudomonas aeruginosa strains isolated
from cystic ﬁbrosis patients
C. Bozkurt, A. Gerceker (Istanbul, TR)
The in vitro activities of various antibiotics, either alone or in
combination with colistin methanesulfonate were assessed using
Pseudomonas aeruginosa strains isolated from cystic ﬁbrosis
patients. According to minimum inhibitory concentration
(MIC) values, 100%, 98%, 96% and 84% of the isolates were
found susceptible to amikacin, colistin methanesulfonate, me-
ropenem and ceftazidime, respectively. The minimum bacteri-
cidal concentrations were generally equal to or twice greater
than those of the MICs. The in vitro activities of antibiotics in
combination were determined by microbroth chequerboard
technique and results were interpreted by fractional inhibitory
concentration (FIC) index. With a FIC index of <0.5 as border-
line, synergistic interactions were more frequent in combina-
tions where amikacin was involved than those with colistin
methanesulfonate. No antagonism was observed.
Antibiotics MIC50(mg/l) MIC90(mg/l) MIC range (mg/l)
Penicillin G 0.016 >32 0.004–256
Metronidazole 0.125 0.5 0.016–2
Clindamycin 0.032 0.064 0.016–0.125
Imipenem 1.5 >32 0.004–32
Ciproﬂoxacin 2 6 0.75–32
Cefotaxime 0.016 0.064 0.016–256
Doxycyclin 0.064 0.19 0.016–0.75
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P1440
A comparative in vitro analysis of amoxicillin-
clavulanic acid and seven comparative agents in
15,521 paediatric respiratory isolates
S. Bouchillon, J. Johnson, D. Hoban, D. Butler, S. Min, L. Miller,
D. Payne (Schaumburg, Collegeville, USA)
Background: Several large scale adult surveillance studies have
demonstrated the ongoing effectiveness of amoxicillin-clavul-
anic acid (A/C) even after 20 years of clinical use. This is a
retrospective collection of data comprising over 15,000 paediat-
ric respiratory isolates collected from several surveillance
studies conducted in 54 countries over a period of 5 years. The
in vitro activity of A/C and 7 comparators are reported for S.
pneumoniae (SPN), H. inﬂuenzae (HFLU), M. catarrhalis (MCAT)
and S. pyogenes (SPY). Not all antimicrobials were tested in all
studies, or against all isolates.
Methods: Regional reference laboratories used broth microdi-
lution technique according to NCCLS guidelines.
Results: A/C at the Augmentin ES-600 PK/PD breakpoint of
4 mcg/mL for SPN, was the most active agent tested with 96.5%
susceptible including 83.5% and 88.6% susceptible for PRSP and
ERSP, respectively.
Conclusions: A/C activity was comparable to or better than
comparator agents against all the key respiratory pathogens
including resistant strains involved in paediatric respiratory
infections.
P1441
Activity of telithromycin and oral comparators
against 20,886 Canadian respiratory tract
pathogens isolated from 1997–2003
D.J. Hoban, L.P. Palatnick, B. Weshnoweski, A. Wierzbowski,
K. Nichol, G.G. Zhanel (Winnipeg, CAN)
Objectives: Community-acquired respiratory tract infections
(RTIs) caused by Streptococcus pneumoniae (SPN), Haemophilus
inﬂuenzae (HI), Moraxella catarrhalis (MC), and Streptococcus
pyogenes (SPY) are commonly treated with empiric antibiotic
therapy. Surveillance has documented increasing prevalence of
beta-lactam-, erythromycin-, trimethoprim-sulfamethoxazole-,
and ﬂuoroquinolone-resistant RTI pathogens. In vitro, telithro-
mycin, a ketolide antibacterial, has been shown to be active
against RTI pathogens. This study reviews the activity of
telithromycin against RTI pathogens collected in Canada over
the past 6 years.
Methods: As part of an ongoing national RTI surveillance
study, the MICs for telithromycin and comparative oral agents
to over 20.000 clinically signiﬁcant RTI pathogens collected
across Canada from 1997–2002 were determined according to
NCCLS guidelines (2003).
Results: MIC90 for penicillin, levoﬂoxacin, azithromycin,
clarithromycin, and telithromycin to SPN (8378), HI (7489), MC
(2497) and SPY (2522) were, respectively: SPN: 1, 1, 1, 0.5, and
0.008 lg/ml; HI: 8, 0.12, 2, 16, and 4 lg/ml; MC: 8, 0.12, 0.25, 0.5,
and 0.12 lg/ml; and SPY: 0.03, 1, 0.5, 0.12, and 0.008 lg/ml.
Conclusion: In vitro, telithromycin was active against RTI
pathogens isolated in Canada since 1997, including multi-drug
resistant isolates.
P1442
In vitro susceptibility of methicillin-resistant
Staphylococcus aureus to daptomycin,
vancomycin, and other antibiotics
Z. Samra, O. Oﬁr, H. Shmuely (Petach -Tiqua, IL)
Background: Methicillin-resistant Staphylococcus aureus (MRSA)
is becoming increasingly prevalent as both a nosocomial and a
community-acquired pathogen. Vancomycin is the traditional
drug of choice, but decreasing susceptibility to vancomycin and
other glycopeptides has been recently reported. Daptomycin, a
lipopeptide antibiotic now in phase III clinical trials, is rapidly
bactericidal in vitro against a range of gram-positive organisms,
including MRSA.
Aim: To test the in vitro activity of daptomycin and other
antibiotic agents on clinical isolates of MRSA.
Material and Methods: Susceptibility of 200 MRSA isolates
recovered from 200 hospitalized patients were test:thirty-two
isolates from blood, 168 from wound and other body ﬂuids.
Activity of vancomycin, daptomycin, fusidic acid, trimethoprim
sulfamethoxazole, tetracycline, rifampicin, chloramphenicol,
gentamicin, clindamycin, erythromycin and oﬂoxacin was
tested by disk diffusion method on Mueller-Hinton agar
according to NCCLS criteria. For daptomycin a breakpoint
of > /=18 mm was used to deﬁne susceptibility. S. aureus ATCC
25923 was used for quality control.
Results: All isolates were sensitive to vancomycin and dapto-
mycin. Sensitivity to other antibiotics was: fusidic acid )97.9%,
trimethoprim sulfamethoxazole )96.9%, tetracycline)91.7%, rif-
ampicin )86.6%, chloramphenicol)46.9%, gentamicin )37.6%,
clindamycin )22.2%, erythromycin )20.6% and oﬂoxacin -
73.1%.
Conclusion: These results indicate that the activity of dapto-
mycin against clinical MRSA isolates is equal to vancomycin.
Daptomycin is given once daily and may be considered as an
alternative treatment for patients with vancomycin resistance
strains or those who can not tolerate vancomycin. Among the
other antibiotics fusidic acid and trimethoprim sulfamethoxaz-
ole showed the best activity.
P1443
In vitro activities of gatiﬂoxacin, moxiﬂoxacin and
linezolid versus bloodstream isolates of
methicillin-sensitive and methicillin-resistant
Staphylococcus aureus at a Canadian tertiary-care
centre
T. Karnauchow, M. Binns, W. Wobeser, K. Suh,
G. Evans (Kingston, CAN)
Objectives: Staphylococcus aureus bacteraemia is a signiﬁcant
burden to patients and institutions in terms of morbidity and
ﬁnancial cost. Treatment of S. aureus bacteremias generally
requires 2–4 weeks of IV antibiotics. Newer oral agents with
anti-staphylococcal activity may offer alternative approaches to
treatment and enhance patient quality of life by shortening the
duration of IV therapy. As a ﬁrst step toward investigating this
possibility, we evaluated the in vitro activities of gatiﬂoxacin,
Drug/MIC90/%Sus H.inﬂuenzae S. pneumoniae PRSP ERSP
Amox/Clav 2/99.2 2/92.3a 96.5b 8/67.1a/83.5b 8/81.5a/88.6b
Amp >16/74.6 4/0.0 8/0.0 8/ns
Pen >16/na 2/60.6 4/0.0 4/18.6
Cefuroxime 2/96.7 8/65.2 8/0.7 8/26.0
Azithro 2/99.1 >32/71.4 >32/23.0 >32/0.3
Erythro 8/na >32/71.2 >32/21.5 >32/0.0
TMP/SMX >4/76.5 8/50.2 >8/13.8 8/24.5
a NCCLS breakpoint of 2/1 mcg/mL applied for conventional Augmentin.
b PK breakpoint of 4/2 mcg/mL applied for Augmentin ES-600.
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moxiﬂoxacin and linezolid versus bloodstream isolates of
methicillin-sensitive (MSSA) and methicillin-resistant S. aureus
(MRSA) recovered from patients at Kingston General Hospital
(KGH).
Methods: MICs for gatiﬂoxacin, linezolid, moxiﬂoxacin, ciproﬂ-
oxacin, rifampin, cloxacillin, cefazolin, and vancomycin were
determined against 200 randomly selected non-duplicate MSSA
(05/01–05/03) and 50 consecutive non-duplicate MRSA (05/00–
06/03) blood isolates.Agar dilution and MIC interpretations
were performed in accordance with NCCLS guidelines (M7–A4;
M100–S14).
Results:
Conclusions: Bloodstream isolates of MSSA from KGH dem-
onstrate in vitro susceptibility to gatiﬂoxacin, linezolid, and
moxiﬂoxacin*. MRSA isolates exhibit intermediate susceptibility
to gatiﬂoxacin and moxiﬂoxacin* but are fully susceptible to
linezolid. Linezolid may be an effective oral agent for treatment
of MSSA and MRSA bacteraemia, but use of the newer
ﬂuoroquinolones may be limited to treatment of MSSA bac-
teraemia. Further studies are needed to clarify the role that these
agents may play in the treatment of S. aureus bacteraemia.*(low
MICs for S. aureus ; no moxiﬂoxacin interpretive criteria exist).
P1444
Daptomycin tested against 915 bloodstream
isolates of viridans group streptococci (eight
species) and Streptococcus bovis
J. Streit, J. Steenbergen, G. Thorne, J. Alder, R. Jones (North
Liberty, Lexington, USA)
Background: To evaluate the activity of daptomycin tested
against numerous species of viridans group streptococci (VgS)
and Streptococcus bovis which are pathogens associated with
wound infections, sepsis, cellulitis, endocarditis, abscesses and
dental caries. The incidence of pencillin-resistant (R) or MLSB-R
strains among VgS often varies by species, and large collections
of strains may be required to assess an antimicrobial true clinical
susceptibility (S).
Methods: The activity of daptomycin was compared to seven
other antimicrobial classes using reference broth microdilution
(NCCLS, M7-A6) and disk diffusion (M2-A8) methods tested
against 915 streptococci (815 VgS strains, 66 to 107 per species;
100 S. bovis). Mueller-Hinton broth was supplemented with
2–5% LHB and up to 50 mg/L Ca ++ .
Results: Among VgS and S. bovis, 99.9% of isolates were
daptomycin-S (breakpoint at £ 1 mg/L; MIC90, 0.06 – 1 mg/L).
In contrast, penicillin (65.5 –98.1% S), macrolides (48.6 - 88.7%)
and tetracycline (35.0 - 93.9%) activity varied widely between
species. Erythromycin was least active, in contrast linezolid (99.1
- 100.0% S), vancomycin (100.0%) and quinupristin/dalfopristin
(99.0 - 100.0%) were equally active as daptomycin, but less
potent. Intermethod categorical agreement between daptomycin
and linezolid (comparison agent) disk and microdilution tests
was very high, each showing near complete S (99.9%).
Conclusions: Daptomycin was demonstrated to be an active
agent that has clinically usable potency against these nine
streptococcal species. The highest recorded daptomycin MIC
was only 2 mg/L (1 strain; 0.1%). These results show that
daptomycin would be an excellent candidate for further clinical
trials targeting serious systemic infections caused by VgS/S.
bovis.
P1445
Study of species afﬁliation and susceptibility to
antibiotics of micro-organisms, isolated from
urine of patients with benign prostatic
hyperplasia
M. Sredkova, V. Grigorova, S. Stratev, K. Dragoev,
O. Mihaylov (Pleven, BG)
Objectives: To determine the species afﬁliation and suscepti-
bility to antibiotics of microorganisms, isolated from urine of
patients with benign prostatic hyperplasia (BHP), treated in the
University Hospital, Pleven, Bulgaria.
Methods: Total 186 samples of morning urine, cultured with
calibrated loops according to routine semi-quantitative method
from 109 patients with BHP were tested during a 1-year period
(2003). Ninety-ﬁve strains were isolated totally (30 before and 65
after operative intervention) from 44 patients. The isolated
microorganisms were identiﬁed by conventional routine meth-
ods and the automated miniAPI System (bioMerieux). E. coli
strains were screened for ESBLs producing by the double disc
synergy method. Susceptibility to antimicrobials was tested by a
disk diffusion method according to NCCLS recommendations.
Results: The most frequently isolated microorganisms were:
E. coli (38.9%), P. aeruginosa (21.1%) and E. faecalis (14.7). All
strains E. coli and P. aeruginosawere susceptible to carbapemens,
and enterococci – to vancomycin. The isolated strains of
enteroccoci post-operatively had a high level of resistance to
gentamicin, ciproﬂoxacin and tetracycline (66.7, 66.7 and 77.8%,
respectively). The distribution of ESBLs products among E. coli
strains, isolated after operative intervention was 86.2%. E. coli
strains were highly resistant to ampicillin, amoxicillin/clavul-
anat (93.1 and 93.1%, respectively); to cephalosporins, II and III
generation (86.2 and 86.2% respectively); to gentamicin and
ciproﬂoxacin (82.7 and 82.7%, respectively). P. aeruginosa strains
were highly resistant to azlocillin and piperacillin (73.3 and
73.3%, respectively), gentamicin and ciproﬂoxacin (86.7 and
93.3%, respectively).
Conclusions: E. coli are the most frequent agents of urinary
tract infections (UTI) in patients having BPH (38.9%), followed
by P. aeruginosa (21.1%) and E. faecalis (14.7%). All strains E. coli
and P. aeruginosa were susceptible to carbapemens, andenterococci
– to vancomycin, which determines the pointed antimicrobial
agents as strategic in the acceptable choice of medicines for UTI
in patients having benign prostatic hyperplasia.
P1446
Clinical Pseudomonas spp.: potential factors of
pathogenicity and resistance to antimicrobials
A. Hostacka, I. Ciznar, L. Slobodnikova, D. Kotulova (Bratislava,
SVK)
Objectives: Resistance to 17 antimicrobials, surface hydrophob-
icity, motility, bioﬁlm, production of N-acylhomoserine lactone
signal molecules (C4-HSL, 3-oxo-C12-HSL) and response to
oxidative stress were analysed in 50 clinical Pseudomonas spp.
strains (94% P. aeruginosa). The data represent a part of the
MSSA MIC (n = 200) MRSA MIC (n = 50)
Range (mg/mL) MIC50 MIC90 Range (mg/mL) MIC50 MIC90
Cefazolin 0.25–1.0 £0.5 £1 8.0–>256 £256 >256
Ciproﬂoxacin 0.25–>64 £0.5 £0.5 32–>64 >64 >64
Cloxacilin 0.125–16 £0.25 £0.25 8.0–>128 >128 >128
Gatiﬂoxacin 0.0625–4.0 £0.0625 £0.125 4 £4 £4
Linezolid 2 £2 £2 2 £2 £2
Moxiﬂoxacin 0.025-2.0 £0.025 £0.0625 4 £4 £4
Rifampin 0.0075–0.0175 £0.0075 £0.0375 0.0075–>128 £32 £32
Vancomycin 0.5–1.0 £0.5 £1 1 £1 £1
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project focused to analysis of association between resistance to
antimicrobials and pathogenicity in bacteria.
Methods: MICs were estimated by modiﬁcations of the stand-
ard colorimetric method. Potential factors of pathogenicity were
evaluated in vitro using test for hydrophobicity (adherence to
xylene), motility (0.35% agar), production of bioﬁlm (microtiter
plate assay), HSLs (biosensors: C. violaceum 026 and A. tumefac-
iens NTL4) and response to oxidative stress evoked by hydrogen
peroxide.
Results: The strains demonstrated the greatest level of resist-
ance in addition to natural resistance to cefotaxime (90%).
Isolates in the range of 42–56%were resistant to aminoglycosides
and ciproﬂoxacin, of 26–38% to cephalosporins. On the other
hand, 98% of the strains remained susceptible to meropenem,
92% to piperacillin/tazobactam and 84% to piperacillin. The
majority of the strains (74%) manifested hydrophilic character.
Higher zones of motility showed 12 isolates (in average 54.8 mm)
as compared to the other ones (31.1 mm). One third of the strains
(32%) produced higher amount of bioﬁlm quantiﬁed by meas-
uring of absorbance of solubilized crystal violet (0.2–0.46) than
the rest of isolates (0–0.19). All, but two strains produced 3-oxo-
C12-HSL and in 46% of samples were detected C4-HSL. Only
four isolates with higher bioﬁlm production showed both types
of HSLs. Majority of the strains (68%) manifested higher
resistance to hydrogen peroxide as compared to the rest of
strains. The group of strains resistant to aminoglycosides and
ciproﬂoxacin revealed signiﬁcantly higher number of hydropho-
bic strains as compared to sensitive ones. Such association was
not found among the rest of the tested parameters.
Conclusion: The data obtained in this study indicated that the
resistance to antimicrobials in Pseudomonas spp. isolates was not
always associated with the changes in the production of the
pathogenicity factors.
P1447
Study of synergetic action of dioxidine and
isoniazid on the structure of tubercle bacillus
in vitro
L.F. Stebaeva, L.Y. Krylova, R.G. Glushkov,
A.O. Turaev (Moscow, RUS)
Objectives: While isoniazid (I) actively effects upon mycobac-
teria and dioxidine (D) effects upon gram-negative and gram-
positive bacterium, we have studied its complicated effect on
tubercle bacillus in vitro.
Methods: Effect of the compounds were studied by morpho-
metric and electromicroscopic methods. For our experiment we
used the following component: 100 D + 50 I and 100 D and 250 I.
To be compared, we used I in dose of 7,8,15,6 or 31.2 mcg/ml
and in a dose of 15.6–31.2 mcg/ml.
Results: D and I result in signiﬁcant changes in a structure of
mycobacteria. All changes clearly depend on a dose. However,
as a rule, we can ﬁnd perservered bacteria even if compounds
are highly dose in culture. In our experiment, where D and I are
in conjunction, cells of mycobacteria are dramatically changed.
Upon minimal concentration of compounds, bacteria are heavily
vacuolisated, their basic mass is destroyed, the cells can not be
stained. If the dose is increased up to 31.2 mcg/ml bacteria are
determined by contour shadows. If D and I are used in ratio
1:2.5 we can not ﬁnd living bacteria in the culture.
Conclusion: Our study shows that the conjunction of dioxidine
and izoniazid is effective on mycobacteria. Changes in myco-
bacteria are more crucial compared to the changes in case when
only izoniazid is used. Addition of dioxidine allows us to
decrease a dose of izoniazid, with the same effect to diminish the
possibility to obtain resistant strains of bacteria.
P1448
Tazobactam, more than a beta-lactamase inhibitor
against the Bacteroides fragilis group
K.E. Aldridge (New Orleans, USA)
Objectives: Tazobactam(Tz), a penicillanic acid sulphone deriv-
ative, is a potent beta-lactamase inhibitor of beta-lactamase
enzymes produced by a variety of aerobic and facultatively
anaerobic bacteria when combined with piperacillin(Pip).This
synergistic action is also demonstrated by Pip-Tz against
anaerobes but little data are available detailing the activity of
Tz alone.This study establishes the inherent in vitro activity of
Tz against B. fragilis group pathogens.
Methods: A total of 449 clinical isolates of the B. fragilis group
were tested against Tz,Pip,Pip-Tz,cefoxitin(Fox),and cefotaxi-
me(Tax) using an NCCLS-recommended broth microdilution
method. All isolates were beta-lactamase positive by the
nitrocephin assay. MIC values were determined at 48 hr as
the lowest concentration of each antimicrobial that inhibited the
visible growth of each isolate.
Results: Tz alone showed remarkable inherent activity against
the test isolates overall. Using inhibitory concentrations of = /
< 4.8, and 16 mg/L for comparison Tz inhibited 86%, 97%, and
98% of B. fragilis isolates, compared to 25%, 50%, and 100% of
B. distasonis; 42%,74%, and 100% of B. thetaiotaomicron; 23%,
56%, and 86% of B. ovatus, and 50%, 83%, and 100% of B. vulgatus
at the same concentrations. At 16 mg/L Tz was more active than
Pip(44% to 82%), Fox(36% to 75%) and Tax (36% to 75%) for the
same species using their established NCCLS breakpoints. Pip-Tz
inhibited >99% of the test isolates at = / < 32 mg/L.
Conclusions: Tz alone exhibits potent inherent anti-B. fragilis
group activity and was more active than Pip, Fox and Tax. These
data are particularly signiﬁcant therapeutically in polymicrobial
infections since for the combination Pip-Tz the Pip is excreted
more rapidly than Tz and Tz becomes the predominant
component in serum after 8 to 10 hr which could enhance or
extend the anti-Bacteroides coverage in the presence of low
concentrations of Pip. Pharmacologic studies have shown that,
although dose dependent Tz concentrations reach a % time
above MIC of >50% against the majority of B. fragilis group
isolates with susceptible MIC values.
P1449
Bactercidal activity of daptomycin, tigecycline,
teicoplanin and vancomycin against community-
associated and multidrug-resistant methicillin-
resistant Staphylococcus aureus
B. Tsuji, M. Rybak, C. Cheung, M. Amjad (Detroit, USA)
Background: The epidemiology of S. aureus is rapidly changing.
MRSA has traditionally been conﬁned to institutional settings
and the occurrence of multi-drug resistance is a cause for
concern. However, even more concerning is the increasing
prevalence of MRSA in the community. Therapeutic options for
these infections are limited. DAP is a cyclic lipopeptide recently
released in the USA for clinical use in the treatment of serious
Gram-positive infections. TIG (GAR-936) is a parenteral invest-
igational glycylcyline derivative of minocycline with a wide
spectrum of activity including MRSA. We examined the inhib-
itory and bactericidal activity of DAP, TIG, TEI, and VAN
against CA-MRSA and MDR-MRSA.
Methods: One-hundred clinical stains of CA-MRSA and Fifty-
Five MDR-MRSA (Resistant to at least four antimicrobials
including oxacillin) deﬁned by CDC deﬁnition and SCCmec
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type were evaluated. ATCC 29213 was used as a control.
Molecular methods were used to determine SCCmec type and
the presence of PVL and mecA gene. Minimum inhibitory
concentrations and minimum bactericidal concentrations were
performed per NCCLS. Bactericidal activity was evaluated
using time kill experiments using two randomly selected strains
from each group.
Results: MIC50 (Range) of 100 CA-MRSA (SCCmec IV) for
DAP: 0.25(0.12–1.0), TIG: 0.12(0.06–1.0), TEI: 0.5(0.25–4.0) and
VAN: 2.0(0.25–2). For CA-MRSA the MBC ranged for DAP:0.12–
1.0, TIG:0.12–16.0, TEI:0.25–4.0, VAN:0.25–4.0. MIC50 (Range) of
55 MDR-MRSA (Sccmec II) for DAP: 0.50(0.25–2.0), TIG:
0.25(0.06–1.0), TEI: 1.0(0.25–4.0) and VAN: 2.0(0.5–4.0). For
MDR-MRSA the MBC ranged for DAP:0.25–2.0, TIG:0.25–16,
TEI:0.5–4.0, VAN:1.0–4.0. Overall TIG and DAP exhibited low
MIC against all 155 strains. Time kill experiments demonstrated
that DAP = VAN > TIG = TEI (P < 0.05) against CA-MRSA.
FOR MDR-MRSA DAP > VAN > TEI > TIG. DAP achieved
99.9% kill as early as 4 h against all strains.
Conclusions: Given the limited therapeutic options for serious
CA-MRSA and MDR-MRSA infections, DAP and TIG may offer
additional options as they demonstrated good activity against
clinical strains of CA-MRSA and MDR-MRSA. Against all
isolates, 99.9% kill was achieved as early as 4 h for DAP against
all isolates and TIG achieved > 2 log10 CFU/ml kill. Further
investigations are warranted.
P1450
Bactericidal activity of ciproﬂoxacin in the
presence of chloramphenicol against two
Escherichia coli mutants
S. Roveta, B. Repetto, S. Cagnacci, A. Marchese,
E.A. Debbia (Genoa, I)
Objectives: Quinolones are potent bactericidal agents. While
their mechanism of killing is poorly understood, one interesting
feature is represented by the fact that, under anaerobic condi-
tions, the growth of bacteria is inhibited while their viability is
not affected. A similar effect is observed when these drugs are
associated to protein synthesis inhibitors. In this study was
evaluated the quinolone susceptibility in presence of chloram-
phenicol on two mutant strains previously described (Int. J.
Antimicrob. Agents 2001, 17:S161–2) susceptible to nalidixic acid
under anaerobic environment.
Methods: The mutations were co-transferred with Tn10 inser-
ted at 28.5 min of the E. coli map (P1-mediated transduction
performed by standard method) into wilde-type strain SA224.
Time-kill experiments, under both aerobic and anaerobic con-
dition, were carried out with two different quinolones (ciproﬂ-
oxacin or nalidixic acid 5xMIC) alone or in combination with
chloramphenicol (50 mg/l) following the procedures suggested
by the NCCLS and reported elsewhere (Antimicrob. Agents
Chemother. 2002, 46:4022).
Results: The transductants revealed the same phenotypes as the
original mutants: susceptibility to nalidixic acid under anaerobic
conditions (assessed by time kill) and elongated cells formation
during the aerobic growth, generation time about 65 min in
comparison to 25 min of the control. Time kill experiment under
aerobic environment revealed that the two transductants were
also susceptible to ciproﬂoxacin but not nalidixic acid in the
presence of chloramphenicol.
Conclusion: These results suggest a possible role of bacterial
topoisomerase (topA) in the anaerobic susceptibility to nalidixic
acid of the mutants. Further studies are under way in order
better characterize these strains.
CA-MRSA (n = 100) MDR-MRSA(n = 55)
MIC50 MBC Range D Log10 CFU/ml MIC50 MBC range D Log10 CFU/ml
DAP 0.25 0.12–1 0 )3.88 0.50 0.25–2 )4.12
TIG 0.12 0.12–16.0 )2.37 0.25 0.12–16.0 )2.59
TEI 0.5 0.25–4.0 )1.86 1.0 0.5–4.0 )3.82
VAN 2.0 0.25–4.0 )3.78 2.0 1.0–4.0 )3.97
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Fig. 1. Bactericidal effect of ciproﬂoxacin in presence of chlor-
amphenicol (mean of 10 different experiments)
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Fig. 2. Bacteriostatic effect afnalidixic acid in presence of cho-
loromphenicol (mean of 10 different experiments)
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Antibiotic-resistant community-acquired pathogens - I
P1451
Worldwide antimicrobial susceptibility patterns
of inducible Enterobacteriaceae causing intra-
abdominal infections: results from SMART 2003
F. Baquero, V. Satishchandran, C. Harvey, H. Teppler,
M. DiNubile (Madrid, E; West Point, USA)
Objectives: SMART (Study for Monitoring Antimicrobial
Resistance Trends) is an ongoing global antimicrobial surveil-
lance programme focused on clinical isolates from intraabdom-
inal infections (IAI). The aim of this interim analysis was to assess
antimicrobial susceptibility patterns among inducible Entero-
bacteriaceae from 4 different regions of the world during 2003.
Methods: 71 centres in the North America (NA), Latin Ameri-
can (LA), Europe (EU) & Asia-Paciﬁc (A/P) tested the in vitro
activity of 12 antimicrobial drugs commonly used to treat IAI
against consecutive unique Enterobacteriaceae spp. likely to
harbour inducible beta-lactamases isolated from IAI according
to NCCLS guidelines. All Enterobacter, Serratia, Citrobacter &
Providencia spp., & Morganella morganii were presumed to have
inducible beta-lactamases. Isolates recovered within 48 hours of
hospitalization were considered community-acquired (CA).
Results: 830 isolates of inducible Enterobacteriaceae from 798
patients were tested, of which 282 (34%) were CA. The most
commonspecieswereEnterobacter spp. (52%),Citrobacter spp. (24%)
&M.morganii (14%). The % susceptible are shown by region:
Conclusion: Among inducible Enterobacteriaceae causing IAI,
resistance rates for most antibiotics tested were modestly higher in
A/P& LA than NA& EU. Carbapenems, including Group I agents
like ertapenem,were themost reliably active drugs in vitro. Because
these spp. often harbour a common chromosomal Type 1 cephalo-
sporinase that can be reversibly induced by beta-lactam antibiotics,
they may appear misleadingly susceptible to some cephalosporins.
P1452
Antimicrobial susceptibility among
Enterobacteriaceae causing intraabdominal
infections in Europe: results from SMART 2003
F. Baquero, J. Chow, T. Snyder, V. Satishchandran, C. Harvey,
M. DiNubile (Madrid, E; West Point, USA)
Objectives: SMART (Study for Monitoring Antimicrobial
Resistance Trends) is an ongoing global antimicrobial surveil-
lance programme unique in its focus on isolates from intraab-
dominal infections (IAI). The objective of this subanalysis was to
assess antimicrobial susceptibility patterns among Enterobacteri-
aceae recovered at participating European sites during 2003.
Methods: 32 centres in 7 European countries each tested the
in vitro activity of 12 antimicrobial drugs commonly used to
treat IAI against consecutive non-duplicate Enterobacteriaceae
isolated from intraabdominal specimens using microdilution
techniques according to NCCLS guidelines and breakpoints.
Production of extended-spectrum beta-lactamases (ESBL) was
conﬁrmed in isolates with a MIC of ceftriaxone, ceftazidime, or
cefepime >=2 lg/mL by comparing cefepime MICs with and
without clavulanate. Pathogens recovered within 48 hours of
hospitalization were considered community-acquired (CA).
Results: A total of 1948 Enterobacteriaceae were recovered from
1713 patients. E. coli (1106 isolates; 57%) & Klebsiella spp. (341
isolates; 18%) were the most common isolates. The per cent
susceptible according to labeled MIC breakpoints (without regard
to ESBL production) are reported below.A total of 68 E. coli (6%) &
45 Klebsiella spp. (13%) produced an ESBL. Of the CA isolates, 16/
511 E. coli (3%) & 7/129 Klebsiella spp. (5%)were ESBL-producers.
Conclusions: Among these Enterobacteriaceae causing IAI at
selected sites across Europe in 2003, resistance rates to cefoxitin,
levoﬂoxacin, and ciproﬂoxacin exceeded 10%. ESBL-producing
pathogens were recovered from some CA IAI. Carbapenems and
amikacin were the most reliably active drugs in vitro in this study.
P1453
5-year trends in resistance among community-
acquired lower respiratory tract isolates of
S. pneumoniae from the UK and Ireland
R. Reynolds, D. Felmingham on behalf of the BSAC Working Party
on Respiratory Resistance Surveillance
Objective: To identify trends in antimicrobial resistance in
S. pneumoniae, correcting for possible confounding factors.
Methods: 3584 lower respiratory tract isolates of Streptococcus
pneumoniaewere collected from a total of 27 laboratories in the UK
and Ireland over the ﬁve winters from 1999–2000 to 2003–2004.
Isolates were excluded if they were duplicates within 2 weeks, or
from samples collected > 48 hours after hospitalisation, or from
patientswith cysticﬁbrosis.MICsweredeterminedcentrallyusing
the BSAC agar dilution method and interpreted by BSAC criteria.
Logistic regression models were ﬁtted separately for penicillin-
non-susceptibility and tetracycline-, erythromycin- and ciproﬂ-
oxacin-resistance (PEN-NS, TET-R, ERY-R & CIP-R).
Results: Table 1 shows unadjusted resistance rates. The ﬁnal
models for PEN-NS, TET-R and ERY-R included centre, age group,
and year as a linear function. The ﬁnal model for CIP-R included
centre, age group, and year as a categorical variable. Sex, specimen
type (sputum/other) and care setting (GP/nursinghome/hospital)
were not required in any of the models. Isolates with missing data
(n = 25) were excluded. For PEN-NS, TET-R and ERY-R in Ireland,
there was a signiﬁcant linear trend of falling resistance. The odds
ratios (OR) in Table 2 show the factor by which the odds of
NA (N = 163) LA (N=113) EU (N = 354) A/P (N = 200)
Ertapenem 94 91 98 98
Imipenem 98 98 98 99
Meropenem 99 98 99 100
Cefoxitin 23 30 29 27
Ceftriaxone 75 71 79 60
Ceftazidime 71 69 75 59
Cefepime 92 88 97 89
Piperacillin-Tazobactam 82 78 85 80
Tobramycin 93 79 93 77
Amikacin 99 86 99 91
Levoﬂoxacin 90 80 90 87
Ciproﬂoxacin 87 72 88 81
Table for P1452
Ertapenem Imipenem Meropenem Cefoxitin Cefriaxone Ceﬂazidime Cefepime Tobramycin Amikacin Piperacillin
tazobactam
Levoﬂoxacin Ciproﬂoxacin
Enterobacteriaceae 99 >99 >99 82 91 92 96 93 99 91 86 84
E. coli >99 100 >99 94 95 96 96 92 99 94 81 80
Klebsiella 99 99 99 92 89 94 94 91 98 85 93 89
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resistance change each year. The estimated reduction in odds was
23%per year for PEN-NS, 29%per year for TET-R and24%per year
for ERY-R. There was no signiﬁcant trend in the UK. For CIP-R,
there was no consistent trend over time in Ireland or the UK.
Conclusion: Trends in resistance in S. pneumoniae differed
between Ireland and the UK, and between classes of antimicro-
bials. Resistance to penicillin, tetracycline and erythromycin
decreased in Ireland but not to a similar extent in the UK, and
there was no trend in ciproﬂoxacin resistance. Reasons for these
differences should be sought.
P1454
Inﬂuence of age on resistance in community-
acquired lower respiratory tract isolates of
S. pneumoniae from the UK and Ireland
R. Reynolds, D. Felmingham on behalf of the BSAC Working Party
on Respiratory Resistance Surveillance
Objective: To examine the relationship between patient age and
antimicrobial resistance in S. pneumoniae.
Methods: 3584 lower respiratory tract isolates of Streptococcus
pneumoniae were collected from a total of 27 laboratories in the
UK and Ireland over the ﬁve winters from 1999–2000 to 2003–
2004. Isolates were excluded if they were duplicates within
2 weeks, or from samples collected >48 hours after hospitalisa-
tion, or from patients with cystic ﬁbrosis. MICs were determined
centrally using the BSAC agar dilution method and interpreted
by BSAC criteria. Logistic regression models for penicillin-non-
susceptibility and tetracycline-, erythromycin- and ciproﬂoxa-
cin-resistance (PEN-NS, TET-R, ERY-R & CIP-R) were ﬁtted,
correcting for age, year and collecting laboratory.
Results: Age was unknown for 4 patients. The median age was
62. PEN-NS, TET-R and ERY-R were modelled with age group
as a categorical variable using the 40–49 group as baseline;
resistance was least in this group and greater in both younger
and older patients, as shown by the odds ratios (ORs) in Table 1.
CIP-R was modelled with a linear function of age; ORs
corresponding to the median age within each age group are
shown. Moxiﬂoxacin-resistance (MXF-R, MIC > 1 mg/L) was
too rare for logistic modelling, but was also strongly associated
with age. Of the 29 MXF-R isolates (all with CIP MICs >8 mg/L),
25 (86%) were from patients aged ‡ 60 (Fisher’s exact p < 0.001),
and none was from a patient aged <50. Observed resistance
rates for all isolates and for the baseline age group are shown in
Table 2.
Conclusion: Patient age is a signiﬁcant predictor of resistance in
S. pneumoniae. Isolates from both young and elderly patients had
increased risk of resistance to PEN, TET and ERY, but ﬂuoro-
quinolone resistance increased linearly with age. Resistance to
MXF was rare in the UK and Ireland, and was seen only in
isolates from patients aged over 50.
P1455
Enhanced bacteraemia surveillance of EARSS
pathogens in Ireland 2004
A. Oza, S. Murchan, R. Cunney (Dublin, IRL)
Objectives: Aim of this presentation is to provide an update on
a study investigating the factors that affect bacteraemia caused
by key pathogens isolated in Irish hospitals. The study is
primarily focused on those pathogens exhibiting antibiotic
resistance and the results are used to supply timely feedback
to contributing laboratories.
Method: A sample of hospital laboratories participating in the
European Antimicrobial Resistance Surveillance System
(EARSS) provided additional information on bloodstream infec-
tions arising from EARSS pathogens on a quarterly basis from
the start of 2004. The additional information included patient
demographic and hospital administrative data, risk factors,
primary source and secondary foci. This information was linked
to the resistance data for each isolate and hospital activity
denominator data were used to calculate rates.
Results: Data for quarters 1 and 2 resulted in 433 matched
records from 7 representative hospital laboratories. Analyses of
this dataset AND data received for quarters 3 and 4 of 2004 will
be presented. Preliminary results indicated that most infections
occurred in the younger and older (‡65 years) age groups.
Malignancies were identiﬁed in a third of the patients. Recent
surgery, ICU-stay and haemodialysis were particularly associ-
ated with MRSA bacteraemia. Respiratory tract infection was the
most common source for S. pneumoniae bacteraemia, urinary tract
for E. coli, and intra-abdominal/gastrointestinal tract for both
E. coli and enterococci (including VRE). Different predominant
sources of S. aureus infection were associated with different
levels of methicillin-resistance: skin/soft tissue (low proportion
of MRSA), CVC (medium) and respiratory tract (high).
Conclusions: The ﬁndings so far support the fact that hospital
function can inﬂuence bacteraemia rates as a result of treating
patients with different risk factor proﬁles. The analyses provi-
ded through this surveillance programme could be used to
make informed and targeted infection control decisions.
Table 1
Resistance Year N
PEN-NS %
>0.06 mg/L
TET-R %
>1 mg/L
ERY-R %
>0.5 mg/L
CTP-R %
>2 mg/L
Ireland 1999–2000 66 40.9 24.2 27.3 3.0
2000–2001 59 42.4 25.4 23.7 3.4
2001–2002 68 36.8 16.2 25.0 16.2
2002–2003 89 24.7 10.1 12.4 15.7
2003–2004 76 14.5 7.9 9.2 13.2
UK 1999–2000 595 7.4 7.2 11.8 5.7
2000–2001 608 7.1 6.3 10.0 5.3
2001–2002 631 4.6 4.8 10.8 7.9
2002–2003 683 6.4 5.7 9.7 2.2
2003–2004 709 5.9 6.2 10.6 11.7
Table 2
Trend/year Ireland UK
OR 95% CI P OR 95% CI P
PEN-NS 0.77 0.63, 0.94 0.009 0.95 0.86, 1.06 0.39
TET-R 0.71 0.55, 0.91 0.008 0.94 0 84, 1.05 0.27
EEY-R 0.76 0.60, 0.96 0.024 0.98 0.90,1.07 0.68
Table 1
Odds Ratios
Age Group,
years
Median Age
in Group
N PEN-NS
> 0.06 mg/L
TET-R
> 1 mg/L
ERY-R
> 0.5 mg/L
CIP-R
> 2 mg/L
0–4 0 233 1.66 1.54 1.38 0.61
5–19 11 130 1.57 1.40 1.43 0.69
20–39 33 402 1.20 1.60 1.80 0.88
40–49 45 352 1 1 1 1
50–59 55 527 2.07 2.68 2.31 1.11
60–69 65 759 1.52 1.62 1.84 1.24
70–79 74 746 2.09 2.28 2.04 1.37
‡80 84 431 2.72 1.82 2.30 1.53
Table 2
Observed Resistance
Age Group N PEN-NS % TET-R % ERY-R % CIP-R % MXF-R%
All 3580 8.7 7.0 11.4 7.1 0.8
40–49 352 5.1 3.7 6.3 6.3 0
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P1456
Relationship between co-trimoxazole use and
resistance in Streptococcus pneumoniae,
Haemophilus inﬂuenzae and Moraxella
catarrhalis
P. Ka¨rpa¨noja, S. Huikko, T. Voipio, P. Paakkari, M. Bergman,
P. Huovinen, H. Sarkkinen for the Finnish Study Group for
Antimicrobial Resistance FiRe
Objectives: The combinations of sulfonamides and trimetho-
prim (co-trimoxazoles) are mostly (81 %) prescribed for respir-
atory tract infections in Finnish health care centres (Rautakorpi
et. al, 2001, Scand J Infect Dis 33:920–926). The aim of this study
was to analyse the relationship between co-trimoxazole resist-
ance and co-trimoxazole consumption among the three major
respiratory tract pathogens Streptococcus pneumoniae, Haemophi-
lus inﬂuenzae and Moraxella catarrhalis.
Methods: The consumption rates of co-trimoxazole (sulfameth-
oxazole/trimethoprim and sulfadiatzine/trimethoprim) between
1997 and 2002were obtained from the FinnishNationalAgency for
Medicines. The sale ﬁgures for pharmacies, which correspond to
the use of the antibiotic in community health care,were used in this
analysis. The consumption is expressed as deﬁned daily doses per
1000 inhabitants per year (DDD). The resistance data for the three
pathogens were collected annually between 1998 and 2003 from 27
clinical microbiology laboratories (FiRe –network). The resistance
rates are expressed as percentages. Figures based on at least 30
tested isolates per laboratorywere included. A linear mixedmodel
for repeatedmeasureswasused.A randomeffectsmodelwith time
and consumption as ﬁxed and intercept as randomeffectwasﬁtted.
Results: The total use of co-trimoxazole compounds has
declined in Finland during the study period from 0,98 to 0,57
DDD. The annual resistance rates in the whole country were
between 14.1–21.4 % in S. pneumoniae, 9.7–18.7 % in H. inﬂuenzae
and 3.2–14.5 % in M. catarrhalis. A positive association (p = 0.04)
was found between the level of resistance and the consumption
of co-trimoxazole in S. pneumoniae. The change in resistance was
not signiﬁcant (p = 0796). In H. inﬂuenzae the resistance
decreased signiﬁcantly (p = 0.001). However, this could not be
explained by consumption (p = 0.616). In M. cartarrhalis the
change in resistance was not signiﬁcant (p = 0.358), and the level
of resistance could not be explained by drug use (p = 0.532).
Conclusions: The resistance of co-trimoxazole correlates to
consumption only in S. pneumoniae. However, consumption is
not a strong exogenous variable.
P1457
Analysis of trends in antimicrobial resistance in
Staphylococcus aureus and Escherichia coli in
Ireland, 1999–2004
S. Murchan and the Irish EARSS Steering Group on behalf of the Irish
EARSS participants
Objectives: To analyse antimicrobial resistance (AMR) trends
from surveillance data collected in Ireland, as part of the
European Antimicrobial Resistance Surveillance System
(EARSS), for Staphylococcus aureus and Escherichia coli, two
pathogens commonly associated with bacteraemia.
Methods: Routine susceptibility data on invasive isolates of
S. aureus and E. coli were collected from participating laborat-
ories (EARSS coverage as of mid-2004 was ~95% of the Irish
population). Data were collated, analysed and fed back to
laboratories and public health professionals. The trends over
time, either quarterly or annual as appropriate, in the propor-
tions of isolates resistant to key antibiotics were analysed using
statistical methods {Linear Regression with Analysis of Variance
(ANOVA) and Chi-Squared Test for Trend (Chi2)}.
Results: Between Jan’99 and Jun’04, data were submitted on 4786
S. aureus isolates, of which 1983 (41.4%) were resistant to methi-
cillin. Theannualproportionsover thisperiod ranged from38.9% in
1999 to 42.1% in 2003 and 42.8% up to Jun’04. ANOVA showed that
therewasa linear relationshipwith resistance increasingby~1%per
year (P = 0.01). Chi2 suggested that the increase was of borderline
signiﬁcance (P = 0.06). AmongstMRSA isolates, therewas a highly
signiﬁcant decrease in the proportion of resistance to gentamicin
from58.4% in 1999 to 13.1% in 2003 (P < 0.001). Between Jan’01 and
Jun’04, data were submitted on 2432 E. coli isolates, of which 8.4%
were resistant to ciproﬂoxacin. The quarterly proportions over this
period ranged from2.9% inQuarter 2 (Q2) 2001 to 13.4% inQ22004.
ANOVAshowed that therewasa linear relationshipwith resistance
increasing by ~1% per quarter (P = 0.014). Chi2 suggested that the
increase was highly signiﬁcant (P < 0.001). No signiﬁcant trends
were observed in resistance to 3rd-generation cephalosporins (2.5%
of isolates) or gentamicin (3.7%).
Conclusions: Methicillin resistance in S. aureus remains an
important public health problem in Ireland and has increased
over the past ﬁve years, although the increase is of doubtful
signiﬁcance. Ciproﬂoxacin resistance in E. coli has increased
signiﬁcantly since surveillance began in 2001. Further studies
are warranted to understand the reasons for this. As part of any
surveillance system, continued and appropriate analysis of the
data for trends is essential. The data presented here highlight the
changing proﬁle of AMR in Ireland over time.
P1458
Antimicrobial susceptibility in respiratory
bacterial pathogens among children in
Greenland: little antibiotic resistance in spite of
high antibiotic use
A. Koch, M. Tvede, L. Høgh Andersen, T. Hjuler,
M. Melbye (Copenhagen, DK)
Objectives: In Alaskan natives the prevalence of penicillin-
resistant S. pneumoniae isolates is high. In Greenland respiratory
tract infections in children are frequent, and antibiotic use is high.
As local data on antimicrobial resistance hardly exist in Green-
land, the objective of his study was to obtain such information.
Methods: A population-based cohort of children aged 0–4 years
was followed in Sisimiut, Greenland, for a two-year period (1996 -
1998). Throat swabs were taken when symptoms of respiratory tract
infectionpresentedandeveryhalf-yearwithout symptoms. In caseof
acute purulent ear discharge a swab was taken from the middle ear.
Swabswere placed in Stuart’s transportmedium and sent by airmail
to the University Hospital, Copenhagen, for culturing. Antibiotic
susceptibility was determined by the disk diffusion method with
Danish Blood Agar and Rosco New Sensitabs. Antimicrobial
susceptibility was deﬁned as susceptible, intermediate, or resistant.
Only the ﬁrst isolate from each child was used for analysis.
Results: Overall, 1624 swabs from 376 children (81% of cohort)
were cultured and 2560 isolates identiﬁed. All S. pneumoniae
(n = 153) Isolates were susceptible to Penicillin, Ampicillin,
Erythromycin and other drugs tested. Only 1 of all 270 S. pneu-
moniae isolates was inter-mediately susceptible to Penicillin. Of
237H. inﬂuenzae isolates 92% were susceptible to Ampicillin, and
94% susceptible to Erythromycin. All Ampicillin resistant strains
were beta-lactamase producing. Of 228 beta-haemolytic strepto-
coccal isolates 98% were susceptible to Erythromycin. Of 35
Moraxella spp. isolates 49% were susceptible to Ampicillin and
51% resistant, while 100% were susceptible to Erythromycin.
There was no Meticillin resistant S. aureus (MRSA). The distribu-
tion was unchanged if only throat swabs were analysed.
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Conclusions: Antibiotic resistance is low in Greenland and
similar to that in Scandinavia. With respect to Penicillin,
resistance is less in Greenland than in Alaskan natives. Surveil-
lance of antimicrobial susceptibility in Greenland is warranted.
In 2000 Greenland joined the International Circumpolar Sur-
veillance of infectious diseases.
P1459
Patterns of antibiotic resistance in pathogens
causing respiratory tract infections: results of the
2002–2003 PROTEKT Italy survey
A. Marchese, F. Ardito, S. Stefani, G. Fadda, G. Nicoletti,
G.C. Schito (Genoa, Rome, Catania, I)
Objective: PROTEKT Italy, an extension of PROTEKT Interna-
tional Survey, is an ongoing 3-year surveillance study estab-
lished to assess the susceptibility of community-acquired
respiratory pathogens circulating in this Country.
Methods: 52 (year 1: 2002) and 46 (year 2: 2003) Clinical
Microbiology Laboratories provided 1056 and 1086 S. pyogenes,
848 and 798 S. pneumoniae, 463 and 518 methicillin-susceptible
S.aureus (MSSA), 317 and 349 H.inﬂuenzae, 207 and 196
M. catarrhalis respectively. In vitro susceptibility to 20 (year 1)
and 19 (year 2) antibiotics was determined according to NCCLS-
approved microdilution methods and breakpoints (2004).
Results: High rates of macrolide resistance (30.0%, year 1) and
(34.0%, year 2) were observed in S.pyogenes. Telithromycin
(92.7%–92.8% susceptibility) was active on the great majority of
thesemacrolide-refractory strains. Total pneumococcal penicillin-
resistancewas stable during the study period ranging from 23.7%
to 23.4%,while lack of susceptibility tomacrolides increased from
40.0% to 43.4%. The most active drugs were: telithromycin (99.7–
99.1%), levoﬂoxacin (97.3–97.1%), rifampin (96.7–98.9%), amoxi-
cillin (93.8–96.6%) and ceftriaxone (88.9–93.7%). Percentages of
ampicillin-resistance in H. inﬂuenzae were 26.5% (year 1) and
20.6% (year 2). For the ﬁrst time in 2003 two ampicillin-resistant
beta-lactamase negative (0.6%) isolates were recovered. High
rates of resistancewere found for clarithromycin (36.9–25.7%) and
co-trimoxazole (13.6–14.1%). The remaining drugs tested (ciproﬂ-
oxacin, levoﬂoxacin, moxiﬂoxacin, azithromycin, telithromycin,
amoxicillin-clavulanate, chloramphenicol, tetracycline, 2nd and
3rd generation cephalosporins) were highly active: 100–94.6% of
susceptible strains. InM. catarrhalis the susceptibility rates ranged
from 22.7–18.9% (ampicillin) and 77.3–81.1% (co-trimoxazole) to
100% (amoxicillin-clavulanate, ceftriaxone, ceﬁxime, telithromy-
cin, azithromycin, ciproﬂoxacin, levoﬂoxacin and moxiﬂoxacin).
Against MSSA the most active drugs (100%-92% susceptibility)
were teicoplanin, rifampin, co-trimoxazole, ceftriaxone, cefaclor,
telithromycin and levoﬂoxacin.
Conclusions: Antibiotic resistance among community-acquired
respiratory pathogens circulating in Italy is on the rise in
comparison to the values described in previous National Surveys
(1997–2000). Globally, telithromycin, levoﬂoxacin, amoxicillin-
clavulanate and ceftriaxone are the most active drugs.
P1460
Incidence and antibiotic susceptibility of
pathogens causing severe community-acquired
and nosocomial infections in Italy
G.C. Schito, E.A. Debbia, G. Fadda, F. Ardito, E. Magliano,
G. Nicoletti, V.M. Nicolosi, A. Pantosti, G. Rezza, A. Cassone,
E. Garaci (Genoa, Rome, Milan, Catania, I)
Objectives: To evaluate the incidence and antibiotic suscepti-
bility of pathogens isolated from severe infections in a nation-
wide survey in Italy.
Methods: During 2003, 44 Clinical Microbiology Laboratories
isolated bacterial pathogens from hospitalized patients with
severe infections Strains were sent to three centres in Genoa,
Rome and Catania for conﬁrmation of identity. All pathogens
were then forwarded to a Laboratory in Switzerland for
quality-controlled, centralized susceptibility testing. MICs
were determined employing NCCLS-approved methodologies
and breakpoints. Gram-positive and Gram-negative bacteria
were tested against 12 and 10 antimicrobial molecules respect-
ively.
Results: Septicaemia, all-cause pneumonia and CVC-associated
infections accounted for >50% of all infections, and S. aureus,
P. aeruginosa and E. coli together represented nearly 50% of the
4702 isolates (2516 Gram-negative and 2186 Gram-positive). This
preliminary report describes the major ﬁndings of 759 and 612
tests carried out on the two group of strains. Extended spectrum
beta-lactamase-producers in E.coli increased, in comparison
with previous national studies, from 6.3 to 16.7%, in K. pneumo-
niae from 14 to 23.7%, in Enterobacter from 32.2 to 53%,
remaining stable to 30% in P.mirabilis. Cefotaxime resistance
ranged from 13.2 (S. marcescens) to 14,3% (M.morganii), and
reached 84.5% in P. stuartii. In P.aeruginosa the level of resistance
to 3rd generation cephalosporins (3rdGC) decreased from 14 to
4% and the same was true for imipenem (23.3 to 11.9%). Lack of
susceptibility to ciproﬂoxacin increased from 32.8 to 38.5%. For
A. baumannii and B.cepacia levels of resistance were respectively
13.3 and 73.8% for 3rdGC, 13.3 and 7.2% for piperacillin-
tazobactam, 22.5 and 71.4% for imipenem, and 29 and 92.9% for
ciproﬂoxacin. Among Gram-positive pathogens the major drug-
resistance phenotypes included macrolides (31.8%) in S. pyo-
genes, penicillin (20.0%) and macrolides (35.0) in S.pneumoniae,
methicillin in S. aureus (37.1) and in S. epidermidis (86.7%). In
E. faecalis ampicillin displayed very low (0.4%) and vancomycin
and linezolid no resistance traits.
Conclusions: These preliminary ﬁndings indicate a worrying
negative evolution towards acquisition of drug resistance in
bacterial pathogens causing severe infections in Italy. Know-
ledge of current in vitro potency of the available antibiotic
classes may help clinicians select an effective initial empiric
therapy.
P1461
Patterns of susceptibility of Streptococcus
pneumoniae and Haemophilus inﬂuenzae at a
university hospital
Z. Daoud, N. Hanna, A. Cocosaki, N. Hakime (Beirut, LBN)
Streptococcus pneumoniae and Haemophilus inﬂuenzae are import-
ant pathogens in many community and hospital acquired
respiratory infections. Until early 1990s nearly all Streptococci
were uniformly susceptible to penicillin, and then the ﬁrst
reports of Penicillin Resistant Pneumococcus (PRSP) emerged.
On the other hand, Life-threatening invasive infections caused
by Haemophilus inﬂunezae are more commonly caused by
encapsulated type b strains, however, localized infections are
often treated empirically, a knowledge of antibiotic resistance
determined on the basis of systematic surveillance studies is
essential.
Objective: The objective of this study was to determine the
MICs of the invasive strains of S. pneumoniae and Haemophilus
inﬂuenzae isolated at Saint George Hospital for the period of
three years extending between June 2001 and June 2004.
Results and comments: Streptococcus pneumoniae: In total 116
strains were tested against erythromycin, 18 % of them were
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non susceptible to erythromycin. More than 22 % of the PNSP
showed susceptibility to erythromycin. All tested strains were
highly susceptible to the 3rd generation cephalosporins as well
as to quinolones. Haemophilus inﬂuenzae: 60 % of the total
isolates (n = 129) were resistant to ampicillin. 62.5% of the total
isolates (n = 135) were b-lactamase negative. 6 isolates (2.5%)
were b-lactamase negative, however, resistant to Ampicillin
(BLNAR) and only 1 isolate (0.16%) was b-lactamase positive
but resistant to Amox/clav (BLPACR).The prevalence of inva-
sive S. pneumoniae was seasonal with clear peaks during winter.
The percentage of penicillin non susceptible S. pneumoniae
among these strains displayed no seasonality. The prevalence of
invasive and penicillin non susceptible S. pneumoniae was
highest in children 4 years and younger. This emphasizes the
importance of prudent antimicrobial use of antibiotics and
vaccination in this age group. The proportion of erythromycin
resistance among Penicillin non susceptible S. pneumoniae was
not very high in comparison to other studies done mainly in
Europe (EARSS). PNSP are still in general highly susceptible to
Levoﬂoxacin, Cefotaxime, and Imipenem. The problem of
Ampicillin resistance among our isolates of H. inﬂuenzae is
important (60%) and is complicated by the b-lactamase-negative
strains which were resistant to ampicillin (2.5%) by some other
mechanism perhaps elaboration of altered penicillin-binding
proteins.
P1462
Exotic pets as possible reservoirs of ciproﬂoxacin-
resistant Salmonella typhimurium infecting
children
I. Casin, F. Weill, J. Breuil, R. Lailler, J. Croize´, J. Darchis,
E. Collatz (Paris, Villeneuve-Saint Georges, Maisons-Alfort,
Grenoble, Compie`gne, F)
Objectives: Considering that high-level resistance to ciproﬂ-
oxacin (‡2 mg/L; CipR) in human isolates of salmonellae is still
rare in Europe, we analysed the molecular characteristics of 12
CipR strains isolated from seven children and one adult in order
to explore a possible epidemiological relationship with two
CipR strains isolated from a parrot and a snake. Pet animals of
these species have been reported as reservoirs of salmonellae
sporadically transmitted to humans.
Methods: The strains were characterized by serotyping, phage
typing, antimicrobial susceptibility testing, with or without an
efﬂux pump inhibitor (EPI), and pulsed-ﬁeld gel electrophoresis
(PFGE). Polymerase chain reaction and DNA sequencing were
used to identify integron-borne gene cassettes and mutations in
the GyrA, GyrB, ParC and ParE genes.
Results: All 14 S. enterica strains were of serotype Typhimurium
and of a phage type 12 variant. All were resistant to multiple
antibiotics (AmpStr/SpcTetCmpSul) including Cip (‡16 mg/L)
and, with one exception, Gen and Tmp. CipR was associated in
each case with mutations in GyrA (Ser83Phe, Asp87Asn), GyrB
(Ser464Phe) and ParC (Ser80Arg) and moderately decreased
quinolone efﬂux. The 13 Gen-, Tmp-resistant strains carried oxa-
30 and had a ca. 2 kb integron with aadA2 and dfrXII cassettes,
while the Gen-, Tmp-susceptible strain contained oxa-30 and
aadA2 cassettes, also in a ca. 2 kb integron. Using XbaI, the
PFGE proﬁles of all strains were indistinguishable, while the use
of BlnI revealed 3 discrete subgroups (with 1- or 2-band
differences): a) 3 isolates, from 2 children and the snake which
was identiﬁed as the source of infection; b) 10 isolates, from 4
children, 1 adult and the parrot, without documented contact; c)
the Gen-, Tmp-susceptible isolate from a child who had been in
contact with a pet snake.
Conclusion: While the food chain is the most common route of
animal-to-human transmission of salmonellae which may be
resistant to multiple antibiotics including ﬂuoroquinolones, the
present study raises the possibility that exotic pet animals may
become a reservoir of such strains which may be transmitted
especially to young children.
P1463
Changes in antimicrobial associated resistance,
susceptibility patterns and ‘resistance load’ in
35,956 consecutive UTI Escherichia coli 1993–2003
A. Wimmerstedt, G. Kahlmeter (Va¨xjo¨, S)
Objectives: Antimicrobial resistance is most often expressed as
individual resistance rates for a species against a deﬁned drug.
The objective of this study was to present alternative models to
describe resistance development.
Materials and Methods: During 1993–2003, 35 956 Escherichia
coli from urinary tract infections were systematically categorised
for susceptibility to a ﬂuoroquinolone, trimethoprim, ampicillin,
cefadroxil, mecillinam and nitrofurantoin using the methodo-
logy and interpretive criteria of the Swedish Reference Group of
Antibiotics. Three models were analysed. ‘Associated resistance’
was presented as the resistance rate of each drug in the presence
and absence of resistance to each of the other drugs as
previously described (JAC, 2003; 52, 128). ‘Susceptibility pattern
changes’ were described as a change in rank order of patterns
and in the number of different patterns over time. ‘Resistance
load’ was expressed by transforming the susceptibility pattern
of each strain into a numerical value: the susceptibility pattern
SSSSSR corresponded to 2 (0 + 0 + 0 + 0 + 0 + 2) and the
pattern RSSIRS to 5 (2 0 + 0 + 1 + 2 + 0). The minimum and
maximum ‘resistance load’ were 0 and 12, respectively.
Results: Associated resistance was high all through the obser-
vation period. As an example, trimethoprim resistance in E.coli
resistant and sensitive to ampicillin was 28% versus 3% in
1993 and 43% versus 4% in 2003. The ﬁve most common
S. pneumoniae: Minimum Inhibitory Concentrations
Antibiotic % S Mean MIC-S % R Mean MIC-R
Cefuroxime 95.2 0.33 4.8 3
Cefotaxime 95.2 0.3 4.8 3
Amox-clav 100 0.1 0 –
TMX 47.6 0.22 58.4 14.2
Imipenem 100 0.08 0 –
Erythromycin 82 0.06 18 0.38
Peni G 46 0.02 54 0.51
Levoﬂoxacine 100 0.04 0 5.2
H. inﬂuenzae: Minimum Inhibitory Concentrations
Antibiotic % S Mean MIC-S
Cefuroxime 94.6 0.78
Ceftriaxone 100 0.42
Amox-clav 94.6 0.8
Chloramphenicol 97.2 0.55
TMX 78 0.13
Ampicilline 60 0.29
Levoﬂoxacine 100 0.46
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susceptibility patterns were the same over the 10 years
whereas the number of different patterns increased from 28
in 1993 to 49 in 2003. The proportion of E. coli without any sign
of decreased susceptibility to the 6 drugs decreased from 79.0%
in 1993 to 76.6% in 2003. The mean resistance load in E.coli
with decreased susceptibility to one or more of the drugs
increased from 3.0 in 1993 to 3.4 in 2003. The proportion of
isolates with resistance load of 6 or more increased from 0.8%
in 1993 to 2.2% in 2003.
Conclusion: Antimicrobial resistance is traditionally expressed
as rates over time. More information is obtained by presenting
changes in total ‘resistance load’ and associated resistance over
time. The increasing number of susceptibility patterns is yet
another sign of resistance development and it emphasises the
difﬁculties faced in empirical antimicrobial therapy.
P1464
Increase of resistance to nalidixic acid among four
clinically important Enterobacteriaceae
pathogens in three Central European countries
M. Kresken, D Hafner on behalf of the Working Group for
Antimicrobial Resistance of the Paul-Ehrlich-Society for
Chemotherapy
Objectives: Since 1984 when the ﬁrst ﬂuoroquinolone (FQ) was
introduced in Europe the consumption of the FQ has markedly
increased. To evaluate the inﬂuence of the increasing consump-
tion on the prevalence of resistance to nalidixic acid (NAL) and
FQ in clinical isolates of four clinically important members of the
family Enterobacteriaceae we reviewed the susceptibility data
from two collaborative studies conducted in 1984 (prior to the
introduction of the ﬁrst FQ) and in 2001 by the Working Group
for Antimicrobial Resistance of the Paul-Ehrlich-Society for
Chemotherapy.
Methods: Isolates of Enterobacter cloacae (ECL), Escherichia coli
(ECO), Klebsiella pneumoniae (KPN), and Proteus mirabilis (PMI)
collected in 1984 and 2001 from 23 and 26 laboratories,
respectively, located in Austria, Germany, and Switzerland,
were included. MICs were determined using the broth micro-
dilution method according to the standard of the German DIN.
Results: In 1984 and 2001, a total of 1,640 (198 ECL, 834 ECO,
263 KPN, 345 PMI) and 1,348 (234 ECL, 619 ECO, 268 KPN, 227
PMI) isolates, respectively, were tested. Resistance to NAL
markedly increased in all species between 1984 and 2001, i. e.
from 2.0% to 17.5% in ECL, from 1.6% to 19.2% in ECO, from
12.2% to 21.6% in KPN, and from 2.6% to 15.9% in PMI. Of the
NAL-resistant ECO isolates collected in the 2001 survey
(n = 116), 26.1% were susceptible and 71.4% resistant to ciproﬂ-
oxacin (CPFX). Susceptibility rates of CPFX for ECL, KPN, and
PMI were 53.4%, 43.9%, and 30.6%, respectively. In the 2001
survey, NAL-resistant isolates of all species exhibited lower
susceptibility rates to other therapeutic classes than NAL-
susceptible isolates. Notably in ECO, susceptibilities to cefotax-
ime, ceftazidime, piperacillin-tazobactam, gentamicin, and
tobramycin were signiﬁcantly lower (p < 0.05) among NAL-
resistant isolates (89.9%, 93.3%, 85.7%, 68.9%, 71.4%) than
among NAL-susceptible isolates (99.2%, 99.0%, 94.2%, 91.2%,
95.0%). In contrast, cefepime, carbapenems, and amikacin
retained in vitro activity against NAL-resistant ECO isolates.
Similar trends were observed for the other three species.
Conclusion: Resistance to NAL (and FQ) has markedly
increased among Enterobacteriaceae pathogens recovered from
patients in hospitals located in Germany, Austria, and Switzer-
land. We strongly recommend a judicious use of FQ in order to
combat the spread of FQ resistance in Enterobacteriaceae.
P1465
E. coli and S. aureus – antimicrobial resistance
surveillance and the effect of excluding duplicate
isolates in a consecutive database 1990–2003
M. Sundqvist, G. Kahlmeter (Va¨xjo¨, S)
Objectives: The NCCLS and ESGARS (ESCMID Study Group
on Antimicrobial Resistance Surveillance) have recommended
exclusion of duplicate isolates in studies on antibiotic resistance.
The procedure is not yet standardized. The present study
compared outcome of cut-off levels at 30 and 365 days on
14 years of surveillance data for E.coli and S.aureus.
Materials and methods: All consecutive isolates of E. coli
(n = 62380) and S. aureus (n = 24743) from routine susceptibility
testing at our laboratory (1990–2003) were included. Duplicates
were identiﬁed and excluded based on a unique personal
identiﬁcation number, species and cut-off time (30 and 365 days)
from ﬁrst isolate. Susceptibility testing was performed as recom-
mended by the Swedish Reference Group of Antibiotics and did
not change over the years except for ﬂuoroquinolones (norﬂoxa-
cin 1990–1993, ciproﬂoxacin 1994–2000, nalidixic acid 2001–2003).
Results: The effects on resistance rates of excluding duplicate
isolates (DI) were small despite the fact that almost one third of
the isolates were excluded through the 365 days exclusion
algorithm. Except for ﬂuoroquinolones, resistance rates in E. coli
decreased when DI were excluded on the basis of 30 days but
increased when DI were excluded on the basis of 365 days.
Resistance in S. aureus tended to decrease when duplicates were
excluded independent of cut-off time.
Conclusion: E. coli and S. aureus are two of our most important
pathogens and as such common in resistance surveillance.
Although the effects on resistance rates of exclusion of duplicate
isolates were minor and not statistically signiﬁcant in the
present study we suggest that the exclusion cut-offs should
match the timeline, i.e. if rates are presented as yearly ﬁgures,
the exclusion cut-off should be 365 days, and so on. We
furthermore believe that the effect of excluding duplicates
should be presented in conjunction with presentation of sur-
veillance data. Our data suggests that E. coli re-infection
(infection with the same species more than 30 days after the
ﬁrst incident) is mainly caused by new and less resistant strains
whereas patients who have acquired resistant strains of S. aureus
continue to be colonized with the same strain.
P1466
Haemophilus inﬂuenzae antibiotics resistance in
Greek patients (2001–2004)
S. Kanavaki, M. Makarona, H. Moraitou, K. Kastrisiou,
S. Arbilia, A. Malgarinou, S. Triantafyllou, S. Karabela
(Athens, GR)
Objectives: H. inﬂuenzae represents one of the commonest
pathogens, in community-acquired respiratory infections.
Recently, there is a great concern worldwide regarding the
increased prevalence of beta-lactamase producing strains, the
increasing incidence of resistance to ampicillin and macrolides,
the emergence of ampicillin resistant non-beta-lactamase pro-
ducing isolates (BLNAR), as well as the isolation of beta-
lactamase producing strains resistant to amoxicillin+clavulanic
acid (BLPACR). The aim of our study was to investigate the
susceptibility proﬁles of H. inﬂuenzae isolated in ‘Sotiria’ District
General Hospital, in the period 2001–2004.
Methods: All strains were isolated from sputum samples, in the
Microbiology Laboratory of ‘Sotiria’ Chest Diseases Hospital of
Athens. In total, 421 strains of H. inﬂuenzae were isolated during
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the whole study period: 119 in 2001–2002, 194 in 2002–2003 and
118 in 2003–2004. All isolates were tested for beta-lactamase
production as well as for susceptibility to ampicillin, amoxicillin,
amoxicillin + clavulanic acid (A/C), erythromycin, trimetho-
prime/sulfamethoxazole, ciproﬂoxacin and moxiﬂoxacin, by the
disk diffusion method, according to standard procedures.
Results: An increasing incidence of beta-lactamase producing
strains was noted, rising from 10.9% in 2001–2002 to 19.4% in
2003–2004. In addition, there was an increase in ampicillin
resistance rates, from 10.9% in the period 2001–2002, to 23.1% for
the period 2003–2004, when 5/108 (4.6%) BLNAR strains were
isolated. As a result to the presence of BLNAR isolates, the
resistance rates to A/C was raised from 0% in the beginning, to
4.6% to the end of the period of study. Erythromycin resistance
increased from 49.5% to 58.0%, while trimethoprime/sulfameth-
oxazole resistance decreased from 26.9% to 13.4%. No isolate
was found resistant to quinolones.
Conclusions: From the beginning of 2001 to the end of 2004, a
signiﬁcant increase of H. inﬂuenzae resistance to ampicillin,
amoxicillin, A/C and macrolides was noted, attributable to beta-
lactamase production, as well as the emergence of BLNAR.
P1467
Resistance to antimicrobial agents in human
Salmonella isolated in Bulgaria, 1999–2004
G. Asseva, P. Petrov, I. Ivanov, T. Kantardjiev (Soﬁa, BG)
Objective: To analyse the distribution of resistant Salmonella
and resistance mechanisms among most frequently encountered
serovars in Bulgaria: S. enteritidis, S. typhimurium, S. corvallis.
Methods: Culture, biochemical tests and serotyping for identi-
ﬁcation of strains.Screening for resistance to 14 antimicrobial
agents: Cefotaxime, Cefoxitin, Carbenicillin, Ceftazidime, Cefu-
roxime, Cephalothin, Ampicillin, Amoxicillin/Clavulanic acid,
Gentamicin, Tetracycline, Chloramphenicol, Ciproﬂoxacin, Nal-
idixic acid, Trimethoprim/Sulfamethoxazole with the standard
Bauer-Kirby disk-diffusion method. Double disk synergy
method (Jarlier et al.) was applied to determine ESBLs produc-
tion. Transfer of bla-CTX-M and bla-TEM genes has been
studied with experimental conjugation. For PCR detection of
bla-CTX-M and bla-TEM genes speciﬁc primers have been used.
Results: For a study period 200 Salmonella strains out of 2123
were resistant to one and more antimicrobial agents;23 resistant
strains were isolated from 163 conﬁrmed cases during outbreaks
and 177 of resistant strains were causing sporadic cases of
human illness or carrier state. 104 ESBLs producers have been
detected:5 S. enteritidis,1 S. typhimurium, 1 S. isangi and 97
S. Corvallis with types of extended-spectrum beta-lactamases
CTX-M3,TEM and SHV. All ESBLs producing strains were
multiresistant to 9,10 and 11 antimicrobial agents.Bla-CTX-M3
and bla-TEM genes were successfully transferred into a recipient
E. coli C1A strain simultaneously with genes coding for
resistance to aminoglycosides and sulfonamides (for bla-CTX-
M3)and genes coding for resistance to aminoglycosides and
chloramphenicol (for bla-TEM.PCR ampliﬁcation revealed bla-
CTX-M3 gene in S.Enteritidis and bla-TEM in S.corvallis.Before
1999 all S. Enteritidis were susceptible to all antimicrobial agents
tested. In this study salmonellae have revealed resistance to at
least one antimicrobial agent, most frequently to Nalidixic acid
and Trimethoprim/sulfamethoxazole.Resistance to Nalidixic
acid combined with retained susceptibility to ciproﬂoxacin in
S. enteritidis is suggestive for mutations in the chromosomal
gyrA.Resistance to ampicillin in S.Enteritidis could be explained
with widely distributed plasmids in European countries
including Bulgaria.Selection of multiresistant bla-TEM produ-
cing S.Corvallis is probably unique for our country.
Conclusions: Diversity of resistance genes are widely distri-
buted among the leading causative agents of human salmonel-
loses in Bulgaria.
P1468
Gram-positive bacteria from diabetic foot ulcers
and resistance to currently used antibiotics in a
Greek general hospital
E. Platsouka, E. Perivolioti, M. Dimoutsos, H. Dimoudia,
M. Lekka, Z. Doriza, O. Paniara (Athens, GR)
Objective: Patients with diabetic foot ulcers are usually treated
with various antibiotics for a long period of time. In order to
monitor the development of bacterial resistance because of the
long treatment, Gram-positive isolates from diabetic foot ulcers
were collected and tested to currently used antibiotics, such as
glycopeptides, linezolid and quinopristin-dalfopristin.
Methods: One hundred eighty nine diabetic patients with foot
ulcers were included. Aerobic and anaerobic cultures from the
depth of the wound were obtained after surgical debridement.
The isolates were identiﬁed by commercial ID panels. Suscep-
tibility testing was performed by broth microdilution method
(MIC panels) and E-test according to NCCLS guidelines.
Results: Of the two hundred forty one isolated bacteria, 81 were
Staphylococcus aureus, 59 Enterococcus faecalis, 53 Staphylococcus
epidermidis, 24 Streptococcus viridans, 6 Enterococcus faecium, 2
Streptococcus agalactiae and 16 Peptostreptococcus spp. Twenty-two
(27.2%) of the S. aureus and 19 (35.8%) of the S.epidermidis isolates
were methicillin resistant. Neither vancomycin-resistant entero-
cocci nor glycopeptide-intermediate staphylococci were found.
Three (3.7%) of the S. aureus isolates were found resistant to
quinopristin-dalfopristin. Except for E.faecalis isolates (naturally
resistant), we found two E.faecium strains resistant to quinopris-
tin- dalfopristin. No resistance to linezolid was detected.
Conclusion: The most frequently isolated Gram (+) bacteria
were S. aureus(33.6%) and E. faecalis (24.5%). The proportion of
staphylococci resistant to methicillin is moderate. No resistance
to glycopeptides and linezolid was detected.The resistance of
S. aureus and E. faecium to quinopristin-dalfopristin is low. A
close monitoring of isolates from diabetic foot ulcers is necessary
as local conditions in these lesions might promote selection of
resistant strains
P1469
Microbiological efﬁcacy of antibiotics in patients
with and without antibiotic pre-treatment of
community-acquired pneumonia
T. Chernenkaja, M. Bogdanov (Moscow, RUS)
Objectives: To evaluate microbiological efﬁcacy of antibiotics in
patients with and without antibiotic pre-treatment of commu-
nity acquired pneumonia (CAP).
Methods: In patients hospitalized with CAP in 2000–2003 it was
evaluated the sensitivity of pathogens to erythromycin (ERY),
amoxicillin (AMO), azythromycin (AZY) and 3rd generation
cephalosporins (CEPH, cefotaxime or ceftriaxon) in sputum or
blood or bronchial aspirate. Only the probes received within 3
ﬁrst days of hospitalization were analysed; pathogens from
patients with destructive pneumonia were excluded; atypical
pathogens were not investigated. The identiﬁcation and sensi-
tivity tests were performed according NCCLS for respective
period by disc-diffusion method and at ATB Expression (Bio-
Merieux). The patients’ records were screened to evaluate the
possible antibiotic treatment of current CAP before hospitaliza-
tion. The records which do not contain clear statement for
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antibiotic pre-treatment or absence of such pre-treatment were
excluded from analysis. The pathogens from patients with and
without antibiotic pre-treatment were compared. The null
hypothesis about absence of difference in antibiotics sensitivity
in treated and non-treated patients was tested by Hi2.
Results: The number of etiologically insigniﬁcant pathogens
increasedfrom29%innon-treatedgroup (NTG) to42%inantibiotic
treated group (TG). Among etiologically signiﬁcant pathogens the
frequency ofEnterobacteriaceae spp. grows from12% inNTG to 23%
in TG, changes in other pathogenswere not signiﬁcant on available
sample. Total number of strains sensitive to AMO and AZY were
signiﬁcantly higher in NTG (69.5% and 75.9% respectively) than in
TG (54.2% and 66.7% respectively). The drop in sensitivity to ERY
inNTG from26.3% to 22.9% in TGand toCEPH from 89.5% to 87%
in NTG and TG respectively were not signiﬁcant. The investigated
set of pathogens as well as their sensitivity could be shifted against
other settings because the hospital admission policy facilitates the
entrance of auto plant employees.
Conclusion: The AMO and AZY could be acceptable empirical
choice antibiotics in CAP in NTG of hospitalized patents while
in TG preferential choice is CEPH. ERY and other macrolides
without anti-Haemophilus activity do not poses sufﬁcient
microbiological efﬁcacy even in non-treated patients.
P1470
Microbiological efﬁcacy of antibiotics in patients
with different severity scores of community-
acquired pneumonia
T. Chernenkaja, M. Bogdanov (Moscow, RUS)
Objectives: To evaluate microbiological efﬁcacy of antibiotics in
patients with different severity of community acquired pneu-
monia (CAP).
Methods: In patients hospitalized with CAP in 2000–2003 it was
evaluated the sensitivity of pathogens to erythromycin (ERY),
amoxicillin (AMO), azythromycin (AZY) and 3rd generation
cephalosporins (CEPH, cefotaxime or ceftriaxon) in sputum or
bloodorbronchial aspirate.Only theprobes receivedwithin 3ﬁrst
days of hospitalization were analysed; pathogens from patients
with destructive pneumonia were excluded; atypical pathogens
werenot investigated. The identiﬁcationand sensitivity testswere
performed according NCCLS for respective period by disc-
diffusionmethod and at ATB Expression (BioMerieux). Modiﬁed
Fine scores were used to evaluate the severity of pneumonia. The
pathogens from patients with severity scores less than 70 (1st and
2nd classes) and more than 70 scores (3rd and 4th classes) were
compared. The null hypothesis about absence of difference in
antibiotics sensitivity in patients with different severity of CAP
was tested by Hi2.
Results: In lower severity group (LSG) the predominant patho-
genswereHaemophilus spp. (56%), in higher severity group (HSG)
they drop to 34%. The frequency of Streptococcus spp., non-
fermenting gram-negative bacteria and Staphylococcus spp. was
increased from 10%, 5% and 10% in LSG to 17%, 10% and 18%
respectively in HSG. Nevertheless on the available sample there
were no signiﬁcant differences in total number of sensitive strains
between severity groups; in LSG sensitivity was 64.8% to AMO,
17.6% to ERY , 73.6% to AZY and 87.9% to CEPH, in HSG it was
55,8% to AMO, 26,3% to ERY , 60.0% to AZY , 83.2%to CEPH. The
investigated set of pathogens as well as their sensitivity could be
shifted against other settings because the hospital admission
policy facilitates the entrance of auto plant employees.
Conclusion: Fine severity scores could not predict microbiolo-
gical efﬁcacy of antibiotics in hospitalized patients with CAP.
The total number of pathogens sensitive to AMO and macro-
lides without anti-Haemophilus activity are not sufﬁcient to
legitimize these antibiotics as a ﬁst line treatment of hospitalized
patients with CAP; sensitivity to AZY is marginally acceptable;
CEPH provide the best microbiological efﬁcacy.
P1471
Resistance patterns of selected respiratory tract
pathogens in Poland
A. Skoczynska, M. Kadlubowski, A. Klarowicz,
W. Hryniewicz (Warsaw, PL)
Objective: To obtain the antimicrobial susceptibility data on
major pathogens responsible for community acquired respirat-
ory tract infections (RTI) in Poland.
Methods: In 2002–03 from 35medical centres located in different
parts of Poland 834 isolates were collected: 275 S. pneumoniae, 267
H. inﬂuenzae, 80 M. catarrhalis and 212 S. pyogenes. The ﬁrst three
species were isolated from patients with community acquired
lower RTIs. S. pyogenes was isolated from patients with pharyn-
gitis/tonsilitis. Isolates were identiﬁed to the species level by
standard procedures and MICs were determined by the broth
microdilution method according to the NCCLS guidelines.
Results: Among H. inﬂuenzae isolates 5.2% were resistant to
ampicillin, via production of beta-lactamases, except 1 BLNAR
isolate. All H. inﬂuenzae isolates were susceptible in vitro to
amoxicillin/clavulanic acid, 3rd generation cephalosporins,
Sensitivity of pathogens in community acquired pneumonia in
patients with and without antibiotic pre-treatment
Pathogens
Patients without antbiotic pre-treatment Patients after antibotic pre-treatment
Abs.
% of sensitive strains
Abs.
% of sensitive strains
AMO± ERY AZY± 3rd CEPH AMO ERY AZY 3rd CEPH
S. pneumoniae 13 92.3 100.0 100,0 92.3 3 66.7 100.0 100.0 66.7
S. pyogenes 4 100.0 100.0 100,0 100.0 4 75.0 100.0 100.0 75.0
H. inﬂuenzae 26 88.5 0.0 100.0 100,0 10 80.0 0.0 100.0 100.0
Other Haemophilus sp. 21 90.5 00 1000 100.0 11 90.9 0.0 100.0 100.0
E. coli 5 60.0 0.0 0,0 100.0 1 100.0 0.0 0.0 100.0
Kl. pneumoniae 4 0.0 0.0 0,0 100.0 5 0.0 0.0 0.0 100.0
Other Enterobacteriacae 2 50.0 0.0 0,0 100.0 5 20.0 0.0 0.0 80.0
P. aeruginosa 3 0.0 0.0 0,0 0.0 3 0.0 0.0 0.0 0.0
Other non-fermenting
bacteria
1 0.0 0.0 0,0 0.0 0 0.0 0.0 0.0 0.0
Enterococcus sp 1 100.0 0.0 0,0 0.0 0 0.0 0.0 0.0 0.0
S. aureus 11 9.1 45.5 456 72.7 4 0.0 75.0 75.0 100.0
Staph. coaq (-) 4 50.0 75.0 75.0 75.0 2 50.0 50.0 50.0 100.0
Total 95 69.5 26.3 75.8 89.5 48 54.2 22.9 66.7 87.5
± Total number of sensitive strains for amoxicillin and azythromycin signiﬁcantly higher in patients without
antibiotic pre-treatment, p < 0.05
Sensitivity of pathogens in community acquired pneumonia of
different severity
Pathogens
Less than 70 scores 70 and more scores
Abs. %of sensitive strains Abs % of sensitive strains
AMO ERY AZY 3rd CEPH AMO ERY AZY 3rd CEPH
S.pneumoniae 6 66.7 100.0 100.0 66.7 11 100.0 100.0 100.0 100.0
S. pyogenes 3 66.7 100.0 100.0 66.7 5 100.0 100.0 100.0 100.0
H. inﬂuenzae 25 88.0 0.0 100.0 100.0 18 88.9 0.0 100.0 100.0
Other Haemophilus sp. 26 88.5 0.0 100.0 100.0 14 92.9 0.0 100.0 100.0
E. coli 5 80.0 0.0 0.0 100.0 4 50.0 0.0 0.0 100.0
Kl. pneumoniae 5 0.0 0.0 0.0 100.0 7 0.0 0.0 0.0 100.0
Other Enterobacteriacae 5 20.0 0.0 0.0 80.0 7 28.6 0.0 0.0 85.7
P. aeruginosa 5 0.0 0.0 0.0 0.0 5 0.0 0.0 0.0 0.0
Other non-fermenting
bacteria
0 0.0 0.0 0.0 0.0 5 0.0 0.0 0.0 0.0
Moraxella sp. 0 0.0 0.0 0.0 0.0 1 0.0 100.0 100.0 100.0
Enterococcus sp 2 100.0 0.0 0.0 0.0 1 100.0 0.0 0.0 0.0
S. aureus 6 0.0 83.3 83.3 100.0 13 7.7 38.5 38.5 76.9
Staph. coag(-) 3 33.3 66.7 66.7 100.0 4 50.0 75.0 75.0 75.0
Total 91 64.8 17.6 73.6 87.9 95 55.8 26.3 60.0 83.2
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azithromycin, ﬂuoroquinolones and chloramphenicol, whereas
92.1%, 93.3%, 98.5% and 54.3% were susceptible to cefaclor,
cefprozil, tetracyclines and trimethoprim/sulfamethoxazole,
respectively. Although 83.6% of S. pneumoniae isolates were
susceptible to penicillin G and this percentage remained similar
during the two years tested, in the second year the proportion of
resistant isolates with MIC ‡ 2 mg/l increased from 50 to 81%.
The susceptibility of S. pneumoniae was as follow: amoxicillin
(99.3%), cefaclor (82.5%), 3rd generation cephalosporins (94.2%),
cefprozil (87.3%), macrolides (88.4%), ciproﬂoxacin (94.5%),
levoﬂoxacin (99.6%), clindamycin (91.3%), tetracyclines (82.2%),
trimethoprim/sulfamethoxazole (46.2%) and rifampin (99.3%).
AmongM. catarrhalis isolates 91.3% were found to produce beta-
lactamases. A signiﬁcant number of S. pyogenes isolates was non-
susceptible to tetracycline (25.9%) and erythromycin (10.8%).
Conclusions: The most prevalent bacterial etiologic agents
responsible for community acquired lower RTIs in Poland are
S. pneumoniae and H. inﬂuenzae. Although the percentage of
pneumococci nonsusceptible to penicillin G is stable, a higher
proportion of isolates fully resistant to penicillin G may
eliminate this drug from RTIs therapy caused by this pathogen.
A very high percentage of S. pneumoniae and H. inﬂuenzae
isolates was non-susceptible to trimethoprim/sulfamethoxazole.
P1472
Trends in antimicrobial susceptibility and
serotype distribution of nontyphoidal Salmonella
from chickens in four European countries during
1998–2004
A. de Jong, S. Friederichs (Leverkusen, D)
Objectives: In many countries, nontyphoidal Salmonella is a
leading cause of food-borne illness in humans. Salmonellosis is
usually self-limiting but antimicrobial treatment is recommen-
ded for severe illness, with ﬂuoroquinolones and third-genera-
tion cephalosporins as drugs of choice. As concern was raised
recently regarding poultry as a major source of ﬂuoroquinolone-
resistant Salmonella spp., a surveillance comprising two large EU
regions was conducted.
Methods: In one programme, caecal samples were randomly
takenat aBelgianslaughterhouse fromchickens raised inBelgium,
France or the Netherlands. Caecal contents of 5 birds were pooled
to provide a single sample per ﬂock. In another, carcass meat
samples were collected from chickens processed in several
processing plants across Germany. In total, 2856 Salmonella strains
were isolated. Standardized susceptibility testing to ciproﬂoxacin
(CP) and nalidixic acid (NA) as well as non-quinolones including
ampicillin (AM), cefotaxime (CT), chloramphenicol (CA), gen-
tamicin (GM), streptomycin (S), tetracycline (TE) and trimetho-
prim/sulfadiazine (TS) was performed by agar dilution.
Resistance was assessed, if applicable, using NCCLS criteria.
Results: In all, 52 different serotypes were identiﬁed. The
serotype prevalences differed strikingly between the two geo-
graphical areas as well as in time. In both programmes,
resistance to CP was absent, except for one isolate (MIC 4
lg/ml). Decreased susceptibility was apparent but did not
deteriorate, as indicated by stable CP MIC90 values around
0.25 lg/ml, and 32 and 9 % resistance to NA. Among the
serotypes with decreased susceptibility S. hadar, S. virchow,
S. blockley and S. paratyphi B were relatively the most frequent. In
contrast, resistance to AM, S, TE and TS amounted to 46, 27, 33
and 18 % in the Belgian collection and to 16, 11, 16 and 12 % in
Germany. CA resistance was 8 and 4%, respectively; GM
resistance did not exceed 1 % in both programmes. Of 1832
isolates thus far tested for CT susceptibility, none have been
resistant (MIC 50/90 of 0.12 to 0.25 lg/ml).
Conclusions: Resistance among Salmonella spp. from chickens
varied for non-quinolones from 0 % for CT to considerable
higher rates for some older drugs, while resistance to CP,
particularly important for treating invasive salmonellosis in
humans, approached zero. Decreased CP susceptibility varied
markedly with the different serotypes, which prevalences
differed notably in site and in time.
P1473
Integron class 1-determined antibiotic resistance
in Enterobacteriaceae from blood stream
infections in a Danish county
N. Norskov-Lauritsen, D. Sandvang, H.C. Schonheyder (Aarhus,
Copenhagen, Aalborg, DK)
Objectives: To determine antibiotic resistance gene cassettes
associated with class 1 integrons (Int1) in Enterobacteriaceae
isolated from blood.
Methods: Consecutive blood isolates 1996–1998 of Enterobacteri-
aceae (N = 1362) from the county of Northern Jutland were
investigated. Isolates expressing resistance to sulphonamides
(N = 351)were examined for presence of Int1 byPCRampliﬁcation
of a conserved fragment.Gene cassettes inserted in class 1 integrons
were PCR ampliﬁed with primers located up- and down-stream of
the recombination site in Int1. Amplicons were allocated to types
according to restriction fragment length polymorphism (RFLP)
after digestion with MspI or HinfI. The gene cassettes were
identiﬁed by sequencing of a representative from each type.
Results: Resistance to sulphonamides were expressed in 295 of
940 isolates ofEscherichia coli (30%). One hundred and twenty-ﬁve
were positive for presence of Int1, and they could be divided into
13 RFLP types. Resistance to sulphonamideswere expressed in 56
of 422 isolates of non-E. coli (13%). Twenty-three were positive for
presence of Int1, and they could be divided into 13RFLP types, six
unique and seven which were also found in E. coli.A total of 19
distinct Int1 types with one to three gene cassettes were found in
the 148 isolates. Four types accounted for 72% of the isolates, and
two of these were associated only with E. coli.The predominant
Int1-determined antibiotic resistancewas directed towards strep-
tomycin/spectinomycin (seven distinct genes in 127 isolates) and
trimethoprim (eight distinct genes in 70 isolates). Six isolates
carried a sat1 gene conferring resistance to the veterinary
antibiotic streptotricin. The number of class 1 integrons carrying
genes conferring resistance to ß-lactam antibiotics (four) or
gentamicin (three) was conspicuously low.
Conclusions: Presence of class 1 integrons and acquired resist-
ance to sulphonamides were 2–3 times more prevalent in E. coli
than in other representatives of Enterobacteriaceae. Int1-deter-
mined antibiotic resistance in this collection of isolates was
predominantly directed towards streptomycin/spectinomycin
and trimethoprim, i. e. antibiotics which has been in clinical use
for a long time.
P1474
Molecular basis of the high resistance rates
unrelated to antimicrobial exposure detected in
faecal Escherichia coli from the human
population of a remote rural Bolivian community
L. Pallecchi, C. Lucchetti, A. Bartoloni, F. Bartalesi, H. Gamboa
Barahona, A. Mantella, S. Cresti, M. Strohmeyer, F. Paradisi,
G.M. Rossolini (Siena, Florence, I; Camiri, BOL)
Background: In a recent study, unexpectedly high resistance
rates unrelated to heavy antimicrobials consumption were
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detected in the commensal E. coli of the population of a very
remote rural community in Bolivia. The purpose of this study
was to analyse the molecular basis of the drug-resistance in
isolates collected from that setting.
Methods: 113 drug-resistant E. coli isolates, collected from 72
healthy individuals, were subjected to clonal analysis by means
of RAPD. Isolates presenting the most common multi-drug
resistance (MDR) pattern (ampicillin, tetracycline, chloramphen-
icol, and trimethoprim-sulfamethoxazole: A/T/C/S pattern)
(n = 35) were investigated for the nature and transferability of
resistance determinants, and for plasmid proﬁles.
Results: RAPD results identiﬁed 19 clonal groups, with one
largely prevalent (34 isolates). Intra-familial clonal clustering
was often observed, and in one case the same MDR strain was
detected in the fecal samples of all the members of a family (8
subjects). Heterogeneous resistance phenotypes were observed
within most clonal groups, underlying a relevant role of
transferable resistance determinants.Clonal and plasmid
variability was observed in the 35 MDR isolates showing the
A/T/C/S resistance pattern:i) 20 belonged to the most prevalent
clonal group, showed colicin production and harboured the tetA
gene. Transferability of resistance determinants could not be
detected in these strains;ii) 7 belonged to a different clonal group
and harboured a conjugative plasmid carrying the tetA gene
linked to beta-lactam, chloramphenicol and trimethoprim-sul-
famethoxazole resistance determinants and to genes involved in
colicin production;iii) 8 belonged to further 5 different clonal
groups, did not show colicin production and harboured tetB
genes, often located on conjugative plasmids with different
restriction proﬁles and different carriage of resistance determi-
nants.
Conclusions: The clonal and plasmid diversity suggests that
the presence of MDR isolates in this particular setting is due to a
mechanism more complex than simple dissemination of a single
clone or a single resistance plasmid occasionally introduced into
the community.
Fungal diagnostics
P1475
Sequence-based identiﬁcation of zygomycetes
species of medical interest
P. Schwarz, S. Bretagne, A.S. Delannoy, F. Dromer,
O. Lortholary, E. Dannaoui (Paris, F)
Objectives: Zygomycosis is a life-threatening disease with
increasing incidence in immunocompromised patients. Several
fungi are responsible for these infections but identiﬁcation to the
species level remains difﬁcult by conventional mycological
techniques. The aim of this study was to investigate the
usefulness of rDNA sequencing for species identiﬁcation of
zygomycetes.
Methods: 34 isolates, mostly of clinical origin, belonging to the
order Mucorales were tested. These included the 7 species
(belonging to 5 genera) most commonly responsible for zyg-
omycosis in humans. Mycelium was grown in liquid RPMI 1640
medium and complete genomic DNA was extracted with
CTAB/Chloroform. PCR-ampliﬁcation of the ITS1-5.8S-ITS2
rDNA region was performed with the primer set V9D (5’-3’,
TTAAGTCCCTGCCCTTTGTA) and LS266 (3’-5’, GAG-
TCGAGTTGTTTGGGAATGC). After ampliﬁcation, both
strands sequencing of the fungal DNA was performed and
sequences were aligned and compared with ClustalW.
Results: Sequences of ca. 600–800 bp were obtained and analy-
sis showed that all species studied (except Absidia corymbifera)
were homogeneous with ‡ 99% similarity between strains
within a given species. In contrast, sequence variability between
genera (similarities of £68%) and between species (similarities of
£ 82%) allowed a precise identiﬁcation to the species level. In
particular it was possible to differentiate Rhizopus oryzae from
R. microsporus and to discriminate between the different Mucor
spp. Only the sequences for the 5 A. corymbifera were heteroge-
neous with 60 to 100% similarities between strains. Interestingly,
none of the studied species owned the universal fungal primer
sequence ITS 2 / ITS 3.
Conclusions: The results showed that sequencing of the ITS1-
5.8S-ITS2 region is a reliable molecular tool for identiﬁcation of
agents of zygomycosis to the species level. For strains identiﬁed
as A. corymbifera, a higher number of isolates have to be studied.
The molecular data obtained here are promising for develop-
ment of new diagnosis methods of zygomycosis in patients.
P1476
Molecular identiﬁcation of zygomycetes species
in tissues during experimental zygomycosis
P. Schwarz, S. Bretagne, A.S. Delannoy, F. Dromer,
O. Lortholary, E. Dannaoui (Paris, F)
Objectives: Culture of infected tissues during zygomycosis is
often negative. In these cases the only available diagnostic tool is
histopathology demonstrating large, non-septated hyphae char-
acteristic of zygomycetes. Nevertheless, identiﬁcation at the
genus or species level is not possible by conventional histopa-
thology. The aim of this study was to evaluate the usefulness of
rDNA sequencing for species identiﬁcation in tissues of mice
infected with various zygomycetes.
Methods: Mice were infected intravenously with nine different
species of the order Mucorales (Rhizopus oryzae, R. microsporus
var rhizopodiformis, Absidia corymbifera, Mucor indicus, M. circi-
nelloides, M. racemosus, Rhizomucor pusillus, Cunninghamella
bertholletiae, and Syncephalastrum racemosum). Different inocula
were tested ranging from 104 to 107 sporangiospores/mouse.
Mice challenged with C. bertholletiae and S. racemosum received
100 mg*kg)1*d)1 of hydrocortisone subcutaneously before
infection. Mice were sacriﬁced 3–4 days post infection. Brain
and kidneys were aseptically removed, homogenized and
complete genomic DNA was extracted with CTAB/Chloro-
form. Fungal DNA was PCR-ampliﬁed with the universal
fungal primer set V9D (5’-3’, TTAAGTCCCTGCCCTTTGTA)
and LS266 (3’-5’, GAGTCGAGTTGTTTGGGAATGC). After
ampliﬁcation, both strands sequencing of the fungal DNA
was performed and sequences were aligned and compared
with ClustalW.
Results: Active infection demonstrated by the presence of
hyphae in brain and kidneys was obtained for all tested species
except for M. racemosus and fungal DNA was ampliﬁed directly
from tissues with all the eight former species. Furthermore for
six species, sequencing of the ITS1-5.8S-ITS2 region allowed
identiﬁcation of the infecting strain to the species level while
technical problems impaired analysis of the sequences of
C. bertholletiae and S. racemosum.
Conclusions: We set-up animal models of zygomycosis for the
most common species responsible for infections in humans and
demonstrated that extraction, ampliﬁcation and sequencing of
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fungal DNA is possible directly from infected tissues. These
animal models are valuable to evaluate new diagnostic tools for
zygomycosis. Further studies with parafﬁn-embedded tissue
samples are warranted.
P1477
Molecular identiﬁcation of black grain mycetoma
agents
M. Desnos, S. Bretagne, A.S. Delannoy, F. Dromer,
O. Lortholary, E. Dannaoui (Paris, F)
Objective: Black-grain mycetoma are subcutaneous chronic
infections mostly seen in tropical countries. Several dematia-
ceous fungi can be causative agents of this disease. Identiﬁcation
of these fungi with standard mycological procedures is difﬁcult
because of poor or delayed sporulation. Furthermore it is time-
consuming and required expertise restricted to some reference
laboratories. Thus new diagnostic tools are needed. The aim of
this study was to assess the accuracy of molecular identiﬁcation
of the different fungi responsible for black-grain mycetoma.
Methods: A total of 48 strains, mostly of clinical origin, have
been used including 11 Madurella mycetomatis, 4 Madurella grisea,
13 Leptosphaeria senegalensis, 4 Leptosphaeria tompkinsii, 5 Pyren-
ochaeta romeroi, 4 Curvularia lunata, and 7 Exophiala jeanselmei.
Strains were cultured in liquid RPMI medium and DNA was
extracted from the mycelium by DNEasy plant kit (Qiagen).
ITS1-5.8S-ITS2 region DNA was then PCR ampliﬁed by using
the universal fungal primers LS266 and V9D. Both strands
sequencing was performed, sequences were aligned with Clu-
stalW and both intra- and inter-species sequence similarities
were assessed. Aligned sequences were also used to generate
phylogenetic trees.
Results: M. mycetomatis appeared to be a homogeneous species,
with 91 to 100% homologies between strains (except for one
strain that differed signiﬁcantly and raises the issue of its
identiﬁcation). Similarly, few intra-species variations were
found for C. lunata and E. jeanselmei, with 93 to 100% homologies
between strains. L. senegalensis and L. tompkinsii showed intra-
species similarities of >99% but similarity between the two
species was < 90%. In contrast, P. romeroi andM. grisea appeared
heterogeneous with intra-species similarities of 40 to 100% and
53 to 100%, respectively. Inter-genera and inter-species varia-
tions were important (except between P. romeroi and M. grisea)
with sequence homologies of < 80% between genera.
Conclusions: P. romeroi andM. grisea are heterogeneous species
whereas within the other species a high degree of sequence
homologies are observed. These results show that sequencing of
ITS region is a suitable tool for identiﬁcation of black grains
mycetoma agents usually difﬁcult to identify by standard
phenotypic methods.
P1478
Rapid diagnosis of PCP and resistance to
co-trimoxazole using real-time PCR
K.E. Templeton, J. Gooskens, E.C.J. Claas, E.J. Kuijper (Leiden,
NL)
Objectives: To compare conventional microbiological staining
methods with conventional PCR and real-time PCR methods for
diagnosis Pneumocystis jiroveci in patients suspected for pneumo-
cystis pneumonia (PCP) and to assess positive samples for the
presence of co-trimoxazole(Co-T) resistant mutations.
Methods: Eighty-four sequential bronchoalveolar lavage sam-
ples from patients analysed by methanamine silver and Giemsa
staining methods were stored at )70C and subsequently
analysed by PCRs. The BALs were collected over a 20-month
period. The real-time PCR was designed to the dihydropteroate
synthase (DHPS) to be speciﬁc for P. jiroveci and enable
sequencing of the PCR product to determine resistance muta-
tions at nucleotide positions 165 and 171. A conventional PCR to
the mitochondrial large sub-unit rRNA described by Wakeﬁeld
et al (Lancet. 1990;336:451-3) was also performed on all 84 BALs.
Results: The staining methods showed that 16/84 (19%)
patients had PCP. The real-time PCR and the conventional
PCR both detected P. jiroveci in 19/84 (22.6%). All the samples
positive by the staining method were positive and the 3
additional positives were detected by both PCR methodologies.
Using the staining methods as the ‘Gold Standard’, the sensi-
tivity, speciﬁcity, positive predictive value and negative predic-
tive value for the PCR methods were 100%, 96%, 84% and 100%
respectively. The mean cycle threshold (Ct) value for the 16 stain
positives was 31.5 and for the 3 stain negative/PCR positives
was 41.5. Analysis of the clinical records and microbiological
results of the 3 discrepant samples showed that no other
microbiological agent was found and PCP was the most likely
clinical diagnosis. The 19 positives were all sequenced and no
resistance mutations were found. The time to perform the
different methods was 2.5 hours, 3 hours and 5 hours for the
staining methods, real-time PCR and conventional PCR. The
sequencing could be performed directly after the real-time PCR
and results were available in one working day.
Conclusions: Real-time PCR for P.jiroveci can provide rapid,
sensitive and speciﬁc diagnosis for PCP in BAL samples.
Additionally the Ct value may be useful in determining the
amount of infection. Using this method targeting the DHPS gene
rapid results can also be obtained for resistance to Co-T.
P1479
Identiﬁcation of Trichosporon mucoides isolates
using ID-32C tests (BioMe´rieux) and direct DNA
sequencing of internally transcribed spacer (ITS)
1 and ITS2 of rDNA
U. Nawrot, P-A Fonteyne, F. Fauche, N. Nolard (Wroclaw, PL;
Brussels, B)
Objectives: The identiﬁcation system provided by BioMe´rieux
distinguish three out of the 35 species published so far for to the
genus Trichosporon. The aim of this study was to investigate the
genetical homogeneity of the strains identiﬁed according to
ID-32C as Trichosporon mucoides (Gue´ho, 1992).
Strains: The study was performed on 74 strains from the
BCCM-IHEM collection from clinical (56) environmental (10) or
(8) unknown origin. The strains had been classiﬁed according to
obsolete identiﬁcation schemes as T. beigelii (38 strains),
T. mucoides (22), T. cutaneum (8), T. ovoides (2) and T. sp (4). As
quality control typical strains T. mucoides IHEM13922, T. ovoides
IHEM 19546, T. moniliiforme IHEM 19572, T. jirovecii IHEM
19577, and T. asahii IHEM 19578 were used.
Methods: The ID-32C tests were prepared according to manu-
facturer description. The results were read after 48 h, 72 h and
6 days of incubation at 30 degree C by use ATB automatic reader
(Bio Merieux, France). The complete DNA sequence of the ITS
locus in the rRNA genes was established trough direct sequen-
cing of PCR products. A ‘molecular’ identiﬁcation was proposed
on the basis of comparison with sequences available in public
databases.
Results: After two days incubation, the ID-32C tests identiﬁed
68 strains as T. mucoides (all test positive except laevulinate
assimilation) and 6 strains as C. humicolus (all tests posit-
ive).Interestingly, after 6 days incubation time a shift from
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T. mucoides to C. humicolus was observed for 11 strains.The
analysis of ITS sequence indicated 10 different sequevars for the
74 strains. Four sequevars representing 68 strains were consid-
ered compatible with T. mucoides, with one of them also identical
to the ITS sequence published for T. dermatis (Sugita,2002). The
remaining 6 sequevars were considered as compatible with
T. asahii, T. jirovecii, T. laibachii, T. moniliforme, or T. debeurma-
nianum.
Conclusion: ID32C and ITS were compatible for 62 strains. Six
strains identiﬁed as T. mucoides had incompatible ITS sequences.
Six strains with T. mucoides ITS sequences had incompatible
ID32C results and were identiﬁed as C. humicolus. Considering
ITS sequencing as the golden standard ID32C had a sensitivity
of 91% and speciﬁcity of 91%.
P1480
Molecular characterisation of beta-tubulin gene
in dermatophyte pathogen Trichophyton rubrum
S. Rezaie, K. Zomorodian, M. Rezaian (Tehran, IR)
Trichophyton rubrum (T. rubrum) is an cosmopolitan arthropophi-
lic dermatophyte which causes skin and nail infection. The most
of antifungal drugs available for clinical use are targeted four
molecules including: beta-glucan, sterol-alpha-demethylase,
ergosterol and DNA/RNA synthesis. The limited selection of
effective antifungal agents combined with the emergence of drug
resistance, has resulted in a critical need for development new
drugs directed against novel molecular targets. In the present
study we tried to Characterize the Gene encoded Beta-tubulin
protein in this fungus which can be used as a potential molecular
targets of novel drugs.Clinical isolated of T. rubrumwere cultured
on liquid medium and the Nucleic Acids (DNA & RNA) were
isolated from obtained mycelial mass by standard methods. The
sequences of known Beta-tubulin genes in other fungi were
aligned and pairs of 21 nt primers were designed from highly
conserved regions. Using mentioned primers, we ampliﬁed
predicted molecules by using genomic DNA as well as cDNA
of T.rubrum as PCR templates.By the time, 1200 nucleotides have
been sequenced from this new genewhich encodes a polypeptide
with 400 amino acids. Nucleotide sequence comparison in gene
data banks (NCBI,NIH) for both the partial DNAand its deduced
amino acid sequence revealed signiﬁcant homology with
members of the eukaryotic Beta-tubulin genes. The amino acid
sequence of the encoded protein was about 82% identical to the
sequence of Beta-tubulin proteins from other fungi.Considering
the role of Tubulin protein in formation of mitotic spindle
structure in the cells, the Beta-tubulin gene may be applied in
antifungal research ﬁelds. Moreover it can be used to determin-
ing the molecular action of some drugs including mitotic spindle
structure in fungi, leading to metaphase arrest. The probable
mechanisms of Beta-tubulin expression inhibition as well as
deﬁnition of its possible role in the physiological function of
T. rubrum are still under investigation.
P1481
A rapid PCR-RFLP assay for identiﬁcation of 11
medically important Candida species,
Trichosporon asahii, Cryptococcus neoformans,
Saccharomyces cerevisiae, Hansonula anomala
and Geotrichum candidum
H. Mirhendi, K. Makimura (Tehran, IR; Tokyo, JP)
Opportunistic yeast infections have various clinical features and
are caused by several Candida species and by several other
yeasts belong to other genera. The emergence of these mycoses
is increasing, for example deep-seated candidiasis has increased
dramatically in recent years. Rapid identiﬁcation of yeast
isolates to the species level in the clinical laboratory is necessary
to more rapid and effective antifungal therapy and to facilitate
hospital infection control measures. Conventional phenotype-
based methods for identifying yeasts species are often difﬁcult
and time consuming. Molecular biological techniques provide
useful alternative methods. In this study, ITS1-5.8S-ITS2 region
of the fungal rRNA genes were ampliﬁed in 31 yeast standard
strain and 137 clinical Candida isolates with the universal
primers ITS1 and ITS4. Digestion the PCR product by the
restriction enzymes HpaII and AcsI allowed us to clearly
identify C. albicans, C. glabrata, C. parapsilosis, AC. tropicalis,
AC. krusei, C. dubliniensis, C. guilliermondii, C. lusitania, C. rogosa,
C. famata, C. kefyr, Trichosporon asahii, Cryptococcus neoformans,
Saccharomyces cerevisiae, Hansonula anomala and Geotrichum can-
didum. All clinical isolates were checked by cultivation on
Chrome-agar Candida. This panel of PCR-restriction enzyme
could be rapid, simple and useful in diagnostic and epidemi-
ological studies of Candida and candidiasis and the infections
caused by other yeasts, without any requirement of expensive
equipments.
P1482
A simple PCR-RFLP method for identiﬁcation
and differentiation of eleven Malassezia species
M. Mahzounieh , H. Mirhendi, K. Makimura, K. Zommorodian,
M. Keivanlu (Shahrekord, Tehran, IR; Tokyo, JP)
Malassezia species are part of resident skin ﬂora of human and
other warm-blooded vertebrates. These yeasts are associated
with various superﬁcial diseases including pityriasis versicolor,
seborrheic dermatitis and folliculitis, as well as nosocomial blood-
stream infection in paediatric care units. Although various
DNA-based molecular methods have been described, a simple,
reliable and cost effective method is still needed for differenti-
ation of Malassezia species. In this study, a PCR-RFLP method
using one primer pair to ampliﬁcation of a 580 bp fragment
related to 26S rDNA and using 2 restriction enzymes, CfoI and
BstF51 was developed to clearly identify and differentiate 11
Malassezia species including M. furfur, M. pachydermatis, M.
globosa, M. obtuse, M. restricta, M. sympodialis, M. dermatis, M.
sloofﬁae, M. nana, M. japonica and M. yamatoensis. Malassezia type
and standard strains were examined to verify the method.
Thirteen clinical isolates were also identiﬁed in this study. The
results of PCR-RFLP analysis of clinical isolates were completely
comparable with those from DNA sequencing techniques. This
method enables the cost effective, rapid and reliable identiﬁca-
tion of Malassezia species and therefore it could be suitable for
laboratory applications.
P1483
Mitochondrial DNA variability of human
pathogenic Trichoderma isolates
Z. Antal, J. Varga, L. Kredics, A. Szekeres, L. Manczinger,
C. Va´gvo¨lgyi, E. Nagy (Szeged, HUN)
Objectives: Trichoderma species are ﬁlamentous fungi com-
monly found in soils. Although Trichoderma species have been
known for a long time as nonpathogenic microorganisms, in the
last two decades some Trichoderma strains were identiﬁed as
causative agents of opportunistic fungal infections with increas-
ing frequency. Among them, Trichoderma longibrachiatum isolates
are reported predominantly to cause health problems in humans
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ranging from localized infections to fatal disseminated diseases.
The aim of this study was to investigate and compare the
mitochondrial DNA variability of T. longibrachiatum strains
isolated from clinical and soil samples.
Methods: Mitochondrial DNA (mtDNA) RFLPs of 8 saproph-
ytic and 9 clinical T. longibrachiatum isolates were examined. For
mtDNA characterization total DNA was isolated from mycelia
and digested with BsuRI and Hin6I restriction enzymes. The
mtDNA proﬁles were converted to a similarity matrix, and
genetic distances were calculated to create a dendrogram.
Results: Based on Hin6I RFLP proﬁles, the saprophytic
T. longibrachiatum isolates belonged to 3 different haplotypes,
while clinical isolates exhibited 7 different haplotypes. Using
BsuRI, the saprophytic and clinical isolates belonged into 3 and
5 different haplotypes, respectively. Interestingly, some sa-
prophytic isolates collected in Hungary exhibited the same
mtDNA patterns as isolates from Egypt and UK. The sizes of the
mtDNAs varied between 35.1 and 39.5 kBp. This size variability
is possibly caused by loss of introns or intergenic sequences.
Although on the dendrogram constructed based on mtDNA
RFLP proﬁles 5 clinical isolates form a well-deﬁned group, other
saprophytic and clinical isolates do not form separate clusters.
Conclusion: The high intraspeciﬁc variability of mtDNAs could
be partly due to the higher evolutionary rates of mtDNAs
compared to nuclear DNA. Accordingly, the discriminatory
power of the mtDNA RFLP method was found to be higher than
that of some previously used techniques including sequence
analysis of the ITS region, isoenzyme analysis or carbon source
utilization tests. Besides, the method is more reliable than the
frequently used RAPD technique. Nevertheless the saprophytic
and clinical isolates did not form separate clusters on the
dendrogram, suggesting that every environmental isolate could
have the capacity to cause infection. This work was supported
ﬁnancially by grant F037663 of the Hungarian Scientiﬁc
Research Found.
P1484
A novel rapid vaginal yeast infection test
Z. Greenberg, M. Illouz, R. Margalit, J. Kopelowitz,
M. Shaposhnikov, O. Babai, B. Chertof, M. Lee (Ashdod, IL)
Objectives: Vulvovaginal candidiasis (VVC) is thought to be one of
the most common causes of vaginal infections. Currently, the
diagnosis of VVC relies on microscopy, which has been shown to
have a limited sensitivity and may be subject to signiﬁcant
operator-error. Yeast cultures, the gold standard for diagnosing
VVC, are expensive, underutilized, and may take a week to give
positive results. A rapid test for vaginal yeastwould greatly aid in
thediagnosisofVVC,butnosuchtest currentlyexists.Theneedfor
a rapid test is further emphasized in view of availability of over-
the-counter anti-fungal medications. The use of a home-test will
avoid misuse of medications andmay reduce health-care costs.
Methods: Savyon Diagnostics has recently ﬁnalized the devel-
opment of a diagnostic kit for rapid detection of vaginal Candida
infections. The test is intended to be used as a laboratory, point
of care and over-the-counter test, meaning that vaginal secretion
samples may be obtained through either patient or physician
sampling. The kit is composed of a sampling swab and a unique
detection device, which houses a test strip, functioning as a
lateral ﬂow immuno-chromatographic-based test. The novel
device enables extraction of the Candida antigens from the
sampling swab, in-device dilution, transfer of the sample liquid
into the detection strip via an innovative mechanism, and
providing clear results in short time. All in two steps.
Results: The test provides clear, reliable and unchangeable
results within 5 minutes. It detects Candida albicans, which is the
most abundant species, but also others like C. glabrata, the
secondary in abundance. Sensitivity and speciﬁcity have been
shown to be comparable to the results of yeast culture taken as a
reference method. The results are also in accordance with
clinical symptoms. Precision tests further validate the test
quality. The test kit has been proven to be user friendly, as
shown by the similarity between the results obtained by
physician sampling vs. patient self-sampling. Surveys have
shown high contentment of potential users in regard to the
device operation as well as its innovative shape.
Conclusions: A novel kit including a unique device has been
developed to ﬁll the widely desired need for a rapid and reliable
diagnosis of vaginal yeast infections. The kit may be used either
at home or in the clinic, may avoid misuse of antifungal drugs,
and save health-care costs.
P1485
Rapid detection of yeast infections in patients
with febrile neutropenia by PCR-RFLP
F. Ruzicka, V. Hola, R. Horvath, I. Kocmanova, J. Sterba,
R. Tejkalova, M. Votava, V. Woznicova (Brno, CZ)
Yeasts are frequent pathogens in patients with febrile neutrope-
nia. Very serious complication is Candida sepsis for the patients,
with the mortality rate up to 60%. Early detection and identi-
ﬁcation of fungal pathogens is essential for initiation of effective
antifungal therapy. Conventional methods of detection and
identiﬁcation of the infectious agent, such as cultivation,
microscopy and biochemical identiﬁcation, are time consuming
and may take several days or even weeks. For that reason the
use of fast methods, which are able to detect fungal infection
within hours, is essential for successful treatment of infection.
The detection of fungal DNA or fungal antigens are the
perspective methods. Three hundred and three blood samples
from 57 patients with febrile neutropenia were examined by a
PCR-based assay. The primers for detection of ITS2 sequence
and adjacent regions were prepared. The identiﬁcation of
captured agents was performed by Ampliﬁcation Product
Length Polymorphism and by Restriction Fragment Length
Polymorphism methods. A total number of positive samples
was 15. (C. albicans (8), C. krusei (1), C. glabrata (2), R. rubra (2)
and 2 unidentiﬁable fungi. The same agent was detected
repeatedly in 3 patients. In 2 patiens the agent isolated from
second blood culture was different from that isolated from the
ﬁrst one. In 4 cases out of 10 the results corresponded well with
results of detection of mannan antigen or antimannan antibodies
in serum of the patients. In no cases the blood sample was
positive by cultivation. The possible cause of negative cultiva-
tion was antifungal therapy in most of these patients which
could supress the growth of yeasts in blood cultures. Our results
suggest that the combination of PCR detection of fungal DNA
with the proof of mannan antigen and antimannan antibodies
can help in the diagnostics of fungal blood stream infections,
especially in patients under antimycotic therapy. This work was
supported by the grant agency IGA MZ NR/7980-3.
P1486
Value of antigen detection in the diagnosis
of invasive aspergillosis
A. Grapsa, S. Kartali, M. Kantzanou, D. Margaritis,
S. Karavassiliadou, M. Panopoulou, E. Archondidou,
G. Bourikas (Alexandroupolis, GR)
Introduction: Invasive aspergillosis (IA) has been a signiﬁcant
cause of life-threatening opportunistic infections in
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immunosuppressedhosts. Earlydiagnosis is important to achieve
the best outcome for these patients; however, deﬁnite proof often
is difﬁcult to obtain due to counterindicated invasive procedures.
Serum galactomannan detection is considered to be a useful test
for early diagnosis and follow –up of invasive aspergillosis.
Methods: This study evaluated the speciﬁcity and sensitivity of
the detection of galactomannan(GM) for the diagnostic of IA in
98 adult patients hospitalized in our Hematology unit. Patients
were considered to have conﬁrmed or probable invasive asper-
gillosis, based on clinical and radiological data. Serial screening
of Aspergillus GM circulating antigen was evaluated using a
double sandwich ELISA assay (Platelia Aspergillus, BioRad,
France) on 760 sera. Test positivity was deﬁned in accordance
with the manufacturer’s recommendations.
Results: Among the patients studied, 10 (10.2%) presented with
conﬁrmed IA (n = 8 patients) or probable IA (n = 2 patients).
Seven patients (7.1%) having a positive result (OD index >1.5) in
two consecutive Platelia Aspergillus tests were considered galac-
tomannan – positive cases. No antigens were detected in the sera
from one patient with conﬁrmed IA. Latex agglutination assay
of galactomannan was positive in both patients with probable
IA. In patients without IA, 9 of 88 had positive antigenemia.
Sensitivity (70%), speciﬁcity (89%), were comparable to those of
larger series. Circulating antigens were not detected in the
control group, composed of healthy adults. The gradual rise in
the antigen titer in consecutive samples is a very strong
indication that an infection is present and should be taken into
account when interpreting the results.
Conclusion: The detection of the circulating Aspergillus galacto-
mannan antigen by a sandwich enzyme-linked immunosorbent
assay (ELISA) is one of the most promising method to diagnose
IA in at-risk patients. The presence of antigen has a good
diagnostic value mainly when there is an increase in the titer on
two consecutive sera samples. A repeated negative result is a
strong argument against the diagnosis of IA.
P1487
Inhibition controls are not always necessary for
PCR on human samples
T. Barkham, V. Rajagopal (Singapore, SGP)
Objective: To assess the need for inhibition controls in diag-
nostic PCR on human serum and on blood cultures in BactAlert
FAN media.
Methods: Dengue RT-PCR was performed daily for 6 months
on RNA extracted from serum (Qiagen viral RNA minikit). The
PCR kit (Artus GmbH Germany) included an internal control for
every sample and was performed on a lightcycler (Roche). We
performed an in-house multiplex gel based PCR assay with
primers aimed at C.albicans, C. glabrata, C.tropicalis and C.
parapsilosis. The PCR was applied, without DNA extraction, to
the supernatant from BactAlert FAN bottles that had been left to
stand to allow the charcoal particles to settle. These bottles had
ﬂagged positive and been shown to contain yeasts by Gram’s
stain. Neat and doubling dilutions in saline to 1:8 were tested.
Results: The inhibition control was positive for all sera tested
with the Artus Dengue RT-PCR kit, meaning that the PCR
process was successful without signiﬁcant inhibition in any of
the samples. Inhibition was detected using neat broth from
BactAlert FAN bottles but was not detected at a 1:2 dilution.
Conclusion: Inhibition of PCR performed on sera is not
common and it is unnecessary to control for inhibition. PCR
on the supernatant from BactAlert FAN bottles is subject to
inhibition. However, PCR was successful on all supernatants
diluted 1:2. This assay was used on samples known to contain
yeasts, demonstrated by Gram’s stain, so an absent signal would
suggest inhibition or a species not recognised by the primers.
While a negative result might delay the identiﬁcation to species
level and reﬁnement of antifungal chemotherapy, it would not
delay the diagnosis of candidaemia. This data supports the view
that inhibition controls are unnecessary for PCR applications
validated to perform adequately. Furthermore, inhibition is a
considerable problem with bacterial cultures but it is not
standard practice to detect and report this inhibition, so it
would be inconsistent to make inhibition controls obligatory for
nucleic acid tests.
P1488
Comparison of histoplasma antigen EIA
performed at MiraVista Diagnostics and Statens
Serum Institute shows good correlation
M.C. Arendrup, L.J. Wheat (Copenhagen, DK; Indianapolis, USA)
Objective: Histoplasmosis is a systemic fungal infection
caused by inhaling the spores of the dimorphic fungus
Histoplasma capsulatum. The Histoplasma antigen EIA is
useful for the diagnosis of histoplasmosis but is not widely
available outside the United States. The Histoplasma antigen
EIA was ﬁrst described in 1986 and has been performed for
clinical diagnostic purposes since 1988; it is currently available
at MiraVista Diagnostics (MVD). Recently, a pilot kit was
produced at MVD and sent to Statens Serum Institute (SSI) for
a comparative study that would assess the feasibility of offering
the Histoplasma antigen EIA to the European medical com-
munity at SSI.
Methods: A test panel of 18 samples included two negative
controls, one high positive control, one low positive control, ﬁve
healthy donor urine samples, ﬁve urine samples from known
histoplasmosis cases, and four samples of a dilution series of
galactomannan antigen puriﬁed from Histoplasma capsulatum
cultures was evaluated at SSI and MVD on two separate days.
Brieﬂy, the EIA is a sandwich style system that uses rabbit
polyclonal antibody toHistoplasma antigen as capture; plates are
then blocked and allowed to dry. Test samples are added, allowed
to incubate and washed off. Next, the same polyclonal antibody
used as capture but containing a biotin label is added followed by
streptavidin-horse radish peroxidase. After incubation, the con-
jugates are washed off, and (3,3’,5,5’-tetramethyl benzidine) TMB
is added as substrate. The reaction is stopped using 2N H2SO4,
and the endpoint optical density (OD) is read at 450 nm– 630 nm.
Results: Intralaboratory correlation was good with a single
sample of puriﬁed galactomannan antigen testing positive on
day one and negative on day two in both SSI and MVD labs.
Interlaboratory correlation was excellent, comparing results
from both labs for day two, each of the 18 samples and controls
resulted in an identical result interpretation according to these
guidelines where results are expressed as EIA units (EU):
<1.0 EU is negative (n = 8); >1.0 – <2.0 EU is weak positive
(n = 1); >2.0 – <10.0 EU is moderate positive (n = 4); and
>10.0 EU is high positive (n = 5). All results remained within
these categories at both laboratories.
Conclusion: The excellent correlation of results supports the
feasibility of developing a Histoplasma antigen EIA test kit that
can be used for reference testing at SSI.
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P1490
Blind subculture increases only marginally
detection of fungaemia in high-risk patients
M. Søgaard, U. Hjort, T. Højbjerg, H.C. Schønheyder (Aalborg,
DK)
Objectives: The ability to detect fungaemia with bacteriological
blood culture (BC) media and an automated system may be
questioned. We investigated retrospectively whether blind
subculture on the 3rd day increased detection of fungaemia
with the BacT/Alert system or accelerated the diagnosis in high
risk patients.
Methods: This historical cohort study was conducted at a
university hospital and its afﬁliated hospitals. During a period
of app. 5 years (Nov. 1998 to Dec. 2003) BCs were subcultured
on the 3rd day of incubation if patients based on clinical and
microbiological assessment were believed to be at high risk for
fungaemia. For adult patients each BC set comprised one
standard aerobic, one FAN aerobic and one standard anaerobic
bottle (Bac T/Alert system, bioMe´rieux); aerobic bottles were
vented at reception, and the incubation period was 6.7 days. All
data were recorded in a departmental information system.
Results: 79.165 BCs were drawn during the study period. 359
(0.45%; 95% conﬁdence interval (CI): 0.41-0.50%) yielded growth
of yeast species (C. albicans 62.8%, C. glabrata 14.9% ,
C. parapsilosis 9.0%, C. tropicalis 3.3%, C. krusei 3.3%, other
yeast species 6.8%). A total of 2154 BCs were selected for
subculture originating from 170 patients, 89 of whom were
admitted to ICUs. 102 BCs (4.7%; 95% CI: 3.9–5.7%) from 51
patients turned out yeast positive. However, blind subculture
was instrumental in detecting yeasts in only 26 BCs (25.5%).
Eight BCs (7.8%) were negative on blind subculture, but one or
more bottles were detected positive by the BacT/Alert system
during continued incubation. In 68 BCs (66.7%) growth of yeasts
was detected during the ﬁrst three days of incubation. Contrary
to our expectations, we found time to detection to be shorter in
cases not selected for subculture. In this group 84.9% (95% CI:
79.9–89.1%) of the yeast positive BCs were detected within
3 days as compared to 66.7% (95% CI: 56.6–75.7%) for the
subculture group as stated above.
Conclusion: Patients believed to be at high risk and thus
selected for the subculture group proved to have an approxi-
mately 10 times increased rate of yeast positive BCs. However,
blind subculture on the 3rd day disclosed only a quarter of yeast
positive BCs in this group. Due to the very limited increase in
detection we do not recommend blind subculture as a precau-
tion in patients at high risk for fungaemia.
ELISA-based diagnostics
P1491
Clinical-laboratory correlation study on the
diagnosis of Echinococcus granulosus in Albania
E. Cani (Tirana, AL)
Objective: To evaluate the role of different serological tests in
the diagnosis of Echinococcosis in correlation with the data
obtained from clinical and imaging examination.
Methods: A total of 358 people, 139 males and 219 females,
underwent a serological testing for the diagnosis of Echinococ-
cosis in the Laboratory of Parasitology of IPH, Tirana, from
September 1997 to May 2001. Among them 325 were adults and
33 children of ages 0–14 years old. Everyone had been examined
by a clinician and was checked by ultrasound imaging for the
presence of one or more cysts in one or several organs. Their
symptoms consisted of: light or severe pain in the upper right
abdominal side or other body parts, weakness, weight loss etc.
We ﬁlled out a questionnaire and collected a blood sample from
each person.The sera were analysed depending on the availab-
ility of the diagnostic kit-s in the lab. The ELISA IgG and IHA
tests were performed in our laboratory respectively in 331 and
94 sera. While 194 sera were sent for a second testing by
Western-Blott in the Institute of Parasitology, Bern, CH. 8
patients had been tested again after surgery to follow-up the
titer of antibody. 9 people had been tested for a second and third
time to follow-up the presence of antibody.
Results: Out of 358 people examined, 164 resulted infected with
the parasite Echinococcus granulosus. They were 94 women, 55
men and 8 children.Most of patients infected belonged to the
group ages of 35–44 and 45–54 years old.The three serological
tests used: ELISA IgG, IHA and Western-Blott gave a 100%
correlation. The speciﬁty of these tests reach to 94% and the
sensitivity to 87%. The comparison of surgery data with those of
serology revealed a 100% correlation.However, the ultrasound
results failed in two cases.
Conclusions: Echinococcosis is a parasitosis that presents a big
problem for Public Health in Albania. Based in our data the
incidence of infection is very consistent every year. The parasite
can affect adults and children as well. Women are infected
approximately two times more than men due to longer exposure
to domestic animals and the parasite. There is not a clear
difference between urban and rural areas in terms of where the
prevalence of the disease is higher. The reason is probably a
persistant migration of the population from one area to another.
The laboratory diagnosis of Echinococcosis based on one or more
serological tests has a great importance for the treatment of the
patients.
P1492
Evaluation of ImmunoCard STAT! immunoassay
in the detection of Giardia lamblia and
Cryptosporidium parvum speciﬁc antigens
I. Wybo, D. Pie´rard, M. Reynders, J. Breynaert, L. Covens,
D. Cnudde, S. Lauwers (Brussels, B)
Objectives: The ImmunoCard Stat ! Cryptosporidium/Giardia
assay (Meridian Inc.) is a solid-phase immunochromatographic
assay for the rapid detection and differentiation of Giardia
lamblia and Cryptosporidium parvum antigens in fecal specimens.
The objective of this study was to compare performance of this
assay with routine microscopic examination in the in- and
outpatient population of our 675 bed University hospital.
Methods: 653 consecutive fecal specimens summitted to our
laboratory between January 2002 and October 2004 were
analysed. Stool samples were concentrated according to the
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method of Ritchie and microscopic examination was performed
for the detection of cysts and trophozoites of Giardia (Lugol’s
Iodine stain) and for the oocysts of Cryptosporidium (Modiﬁed
acid-fast stain). The ImmunoCard Stat ! Cryptosporidium/Giardia
assay (Meridian Inc.) was performed on unconcentrated stool
samples according to recommendations of the manufacturer.
Assay results were read after 10 minutes. As prescribed visible
test lines of any intensity were interpreted as positive.
Results: Giardia lamblia. The prevalence of Giardia-positive
stools by microscopy (considered as ‘gold standard’) was 4.7%
(31/653). Giardia antigen was detected in all these samples
except one. Ten additional samples were antigen positive.
Sensitivity, speciﬁcity, positive predictive value (PPV) and
negative predictive value (NPV) of the Giardia immunoassay
were 96.8% (30/31; 95% conﬁdence interval (CI) 81.5–99.8), 98.4
% (612/622; 95% CI 97–99.2), 75% (30/40; 95% CI 58.5–86.8) and
99.8 (612/613; 95% CI 98.9–100) respectively.Cryptosporidium
parvum. Oocysts of Cryptosporidium were detected in 2.1% (14/
653) fecal samples. In all samples except one the Cryptosporidium
antigentest was positive as well. Another 19 samples were
antigen positive. Sensitivity, speciﬁcity, PPV and NPV of the
Cryptosporidium immunoassay were 92.9% (13/14; 95% CI 64.2–
99.6), 97 % (620/639; 95% CI 95.3–98.1), 40.6% (13/32; 95% CI
24.2–59.2) and 99.8%(620/621; 95% CI 99.0–100) respectively.
Conclusions: As compared to microscopy as gold standard for
both Giardia and Cryptosporidium detection, sensitivity, specif-
icity and NPV of the antigentest were very favourable. The rapid
assay was easy to perform and less labour-intensive. Low PPV
could be explained by the low prevalence of both pathogens in
our population or by overrating of the false positives because of
the use of a non-optimal gold standard.
P1493
Yersinia outer membrane protein- and cell
wall-speciﬁc antibodies in sera of healthy adult
Hungarians
A´. Sonnevend, E´. Cziro´k, T. Pa´l (Al Ain, UAE; Budapest, HUN)
Objectives: The aim of the study was to investigate the
presence of anti-Yop IgG and IgA antibodies in healthy blood
donors in Hungary, i.e. in a country with a reportedly low
incidence of yersiniosis (1.0–1.4/100.000/year) and to compare
the data to the prevalence of cell wall-speciﬁc agglutinins.
Methods: Sera of 112 healthy Hungarian blood donors were
collected between December 1999 and January 2000. The
specimens were tested by Yop-speciﬁc IgG and IgA ELISAs
(Mikrogen, Germany). Samples were also subjected to tube
agglutination using Y. enterocolitica O3, O9 and Y. pseudotuberc-
olusis I-II-III-IV-V antigens. Specimens exhibiting agglutination
with yersinia antigens were also tested with brucella and
salmonella OB and OD antigens.
Results: Of the 112 sera tested 46 (41%) exhibited a positive anti-
Yop reaction in the IgG, and 17 (15.1 %) in the IgA class, while the
boundary ﬁgures were 7 (6.2%) and 6 (5.3%), respectively. All the
IgA positive and boundary samples were also positive for IgG.
Samples positive in the IgA class gave a signiﬁcantly stronger
anti-Yop IgG reaction (184.4 ± 70.3 U/ml) compared to those
positive in the IgG class, only (62.13 ± 53.6 U/ml) (p < 0.001).
There was very little correlation between the ELISA and
agglutination data. Only one specimen showing a clear positive
agglutination reaction with the Y. enterocolitica O3 antigen
exhibited also a positive IgG, a boundary IgA, and an equivocal
agglutination titre with Y. pseudotuberculosis IV antigen. Further 3
samples showed equivocal titres with various Y. pseudotuber-
culosis antigens with varying ELISA results in the IgG and IgA
classes. No agglutination with Brucella or Salmonella antigens
were observed in any of the samples tested.
Conclusions: The anti-Yop ELISA data showed very little, if any,
correlation with the results of cell wall antigen-speciﬁc agglutin-
ation. The prevalence of anti-Yop IgG and IgA antibodies in
Hungary was similar to those found in some Western European
countries with a considerably higher incidence of yersiniosis.
Further, more extensive seroepidemiological studies should
clarify whether the reported incidence of yersinia infections in
Hungary reﬂects the real rate of encounter with the pathogens.
P1494
Application of ELISA and conﬁrmative Western
Blot assay for the detection IgG and IgA
antibodies against plasmid-coded secretory
proteins of pathogenic Yersinia strains in
serodiagnosis of paediatric yersiniosis
A. Kostoula, C. Bobogianni, G. Vrioni, I. Sionti, V. Papatolis,
S. Levidiotou (Ioannina, GR)
Objectives: Y. enterocolitica and Y. pseudotuberculosis infections
are manifested as enterocolitis, mesenteric lymphadenitis, react-
ive arthritis and erythema nodosum. Important factors in the
pathogenicity of the yersinias are associated with the presence of
virulence plasmid coded for release proteins (Yersinia outer
membrane proteins, YOPs). The detection of antibodies to these
proteins is a highly speciﬁc and very sensitive method for the
serological diagnosis of all forms of yersiniosis. The aim of this
study was the use of an enzyme immunoassay (ELISA) in
combination with a western blotting assay for the detection of
antibodies against YOPs of pathogenic Yersinia strains in
serodiagnosis of yersiniosis.
Methods: A total number of 171 sera collected from equal
number of children, aged from 5–12 years, referred as probable
cases of yersiniosis were tested. These children were hospital-
ised in the Paediatric Clinic of University Hospital of Ioannina
(NW Greece) during a 4-year period (2001–2004). In a ﬁrst step,
all sera were examined using the Yersinia enterocolitica ELISA
IgG/IgA test (Genzyme Virotech GmbH), which detects speciﬁc
antibodies against antigens of the 70 Kb virulence plasmid of
pathogenic Yersinia. In a second step, positive ELISA-results
were conﬁrmed by a western blotting assay (Yersinia ViraBlot
IgG, IgA test), which detects antibodies against YOPs 51, 44, 41,
37, 35, 33 and 23 kD.
Results: 65 out of 171 children were found positive with ELISA
for detection IgG/IgA antibodies [53 IgG(+) and IgA(+), 8 IgG(+),
4 IgA(+)]. Main clinical manifestations of these children were
fever and abdominal pain. Mesenteric lymphadenitis conﬁrmed
by ultrasonography accounted for one third of cases and
erythema nodosum occurred in 5 cases. Yersinia ViraBlot IgG
and IgA tests conﬁrmed the results for 65 ELISA-positive sera: at
least two clear bands from 51, 44, 41, 37, 35, 33 or 23 kD for IgG
and isolated clear band 35 kD or at least two clear bands 51, 44,
41, 37, 35, 33 or 23 kD for IgA antibodies. All children received
antibiotics and all had an excellent outcome. As a conclusion,
serological examination for yersiniosis should be proceeded as
two-test-approach: in a ﬁrst step the speciﬁc ELISA is recom-
mended and in the second step positive ELISA-results should be
conﬁrmed by the more speciﬁc western blot assay. For the ﬁnal
clinical diagnosis, all results from these tests must be correlated
with clinical history and epidemiological data.
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P1495
The presence of IgM, IgA and IgG antibodies
against chlamydial lipopolysaccharide in
circulating blood immunocomplexes
Z. Medkova, P. Hejnar (Brno, Olomouc, CZ)
Objectives: The aim of the study was to evaluate 1. the presence
of different isotypes of antibodies (IgA, IgG, IgM) against
chlamydial lipopolysaccharide (LPS) in blood circulating
immunocomplexes; 2. the inﬂuence of freezing and defreezing
on the blood levels of the described isotypes of antibodies (Abs).
Methods: 100 human sera showing the presence of speciﬁc anti-
chlamydial LPS IgA and the absence of the IgG in the initial
testing (the same speciﬁcity; 21 sera were anti-LPS IgM positive)
were collected. The sera were stored at -20 degrees of Celsius
temperature, defrosted at room temperature and divided into
two halves.In one aliquot the Abs were unbound from circula-
ting blood immunocomplexes (CIC) by polyethylenglycol pre-
cipitation (PEGP) and the both aliquoths were then tested for the
presence of anti-chlamydial LPS IgA,IgG and IgM respectively.
The diagnostic sets Chlamydia-rELISA IgA, IgG, IgM (medac,
Wedel) were used.
Results: With a mere defreezing IgG developed in 23 and IgM
in 24 sera, whereas IgA developed only in 72 samples. After
completion of PEGP IgG were demonstrated in 21 sera, IgM in
18 and IgA only in eight. On the whole, after a mere defreezing
and PEGP IgG Abs developed in 34 blood samples (29,4%
correspondence between methods), IgM in 30 (40% correspon-
dence) and IgA in 72 (only 11,1% correspondence).
Conclusions: With the use of the presented method the speciﬁc
IgG bound in CIC were demonstrated in about one third of the
samples (and IgM bound in CIC in one tenth of sera). A mere
freezing and defreezing caused destruction of free IgA and IgM
in about 30% sera. PEGP resulted in destruction of free IgA and
IgM in about 90% and 40% tested samples, respectively. Thus, the
interpretation of the chlamydial serology is more complicated
then we could expect, and next research in that area is needed.
P1496
Evaluation of the performance of the new VIDAS
C. difﬁcile Toxin A/B test
A. Carricajo, A.C. Vautrin, N. Fonsale, M.C. Bastide,
A. Foussadier, G. Aubert (Saint Etienne, Marcy l’Etoile, F)
Objective: Evaluate the performance of the VIDAS C. difﬁcile
Toxin A/B (VIDAS CDAB) test (bioMe´rieux, Marcy l’e´toile,
France) for the detection of Clostridium difﬁcile A and B toxins
directly in stool specimens.
Methods: 62 fresh stool specimens sent to the laboratory for
suspected of diarrhoea due to C. difﬁcile were tested in parallel
using the culture test on CCFA media (bioMe´rieux) and the
VIDAS CDAB test (bioMe´rieux). The C. difﬁcile strain isolated
from a positive C. difﬁcile culture was further retested with
VIDAS CDAB (determination of the toxigenic status of the
strain). In case of discrepant results (negative culture/positive
VIDAS CDAB), a cytotoxicity test (ECP) of the stool specimen
was performed using cell culture. The clinical status of the
samples was determined by the concordant results of at least
two of the tests performed: VIDAS CDAB, positive culture of a
toxinogenic strain and ECP.
Results: Among the 62 stool specimens, 29 were found to be
negative and 33 positive. Among the 29 negative stool speci-
mens: 18 were negative with both the culture and the VIDAS
CDAB tests, 9 were positive in culture with a non-toxinogenic
strain of C. difﬁcile (negative result with the VIDAS CDAB test),
and 2 gave false positive results with the VIDAS CDAB test
(positive in culture with a non-toxinogenic strain of C. difﬁcile
(negative result with the VIDAS CDAB test)). Among the 33
positive stool specimens: 25 were positive both with the VIDAS
CDAB tests (among which 6 were negative in culture and
positive in ECP), 5 gave equivocal results with the VIDAS
CDAB test, and 3 gave negative results with the VIDAS CDAB
test.
Conclusion: The VIDAS CDAB test enables rapid and reliable
detection of the toxinogenic C. difﬁcile strains with a speciﬁcity of
93.1% (27/29) and a sensitivity of 89.3% (25/28). Although
conducted on a reduced number of fresh specimens, this survey
is representative of the performance obtained on a signiﬁcant
number of frozen specimens (evaluation performed during the
development of the VIDAS CDAB reagent).
P1497
Evaluation and comparison of indirect
immunoﬂuorescent antibody test and direct
agglutination test for the diagnosis of visceral
leishmaniasis
D. Dorostcar Moghaddam, H. Hejazi, M. Ghasemi (Isfahan, IR)
Objectives: Human visceral leishmaniasis (HVL) is endemic in
several foci in IRAN, such as Ardebil and Fars provinces (in
North western and south part of IRAN) and in some region as
sporadic. Visceral leishmaniasis in Iran is Mediterranean type and
the causative agent is leishmania infantum and its main
reservoir is dog.
Methods: In this study direct agglutination test (DAT) was
compared with indirect ﬂuorescent antibody test (IFAT) for
the diagnosis of visceral leishmaniasis in patients suspected of
kala-azar.A total of 70 serum samples collected from suspec-
ted kala-azar patients mainly in the kala-azar endemic areas.
The leishmania infantum antigens (MHO/TN/80/IPTi) for
these studies were prepared in Department of parasitology,
school of medicine, Isfahan university of medical sciences. The
principal phases of the procedure from making DAT antigen
were mass production of promastigotes of leishmania in the
RPMI1640 + fetal bovine serum, Trypsiniznation of parasites,
staining with coomassie blue and ﬁxing with formaldehyde.
The human serum samples were tested by DAT, as well as,
by IFAT, with the L.infantum antigen prepared in our
laboratory.
Results: The sero positive rate (SPR) with DAT in titers of ‡
1:3200 was 91.4% and with IFAT in titers of ‡ 1:80 was 94.3%.
Geometric means of reciprocal titers (GMRT) were 6309 for
DAT and 692 for IFAT. Therefore, as the titers of ‡ 1:3200 are
usually considered positive in DAT. The titers of ‡ 1:80 were
regarded as positive in IFAT. The coincidence of the two tests
were 92%.
Conclusions: These results showed that a simple local laborat-
ory with one or two trained technicians is quite sufﬁcient for
DAT, sero-diagnosis and serological survey of kala-azar in an
endemic area. According to the results of these studies, it seems
that in Kala azar endemic areas, the clinical symptoms of
Visceral leishmaniasis, particularly among the children with DAT
antibody titers equal or >1:3200 is a good indication for speciﬁc
treatment of Kala-azar.
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P1498
Evaluation of three serodiagnostic methods:
radioimmunoassay, indirect haemagglutination
and immunoelectrodiffusion in human
hydatidosis and the principal subclass speciﬁc
immunoglobulin
D. Dorostcar Moghaddam, A. Andalib, M. Amrollahei (Isfahan,
IR)
Objective: Several techniques have been developed for the
serodiagnosis of hydatid disease. As emphasized by the scien-
tists the percentage of positive results depends partly on
technique utilized and the localization of the cyst. Approxi-
mately 10% of sera from patients with hydatidosis give false
negative reactions. This relatively high ﬁgure necessitates the
use and comparison of several diagnostic techniques for
hydatidosis. In the present study we have attemped to investi-
gate further a solid phase radioimmunoassay for the diagnosis
and compare with indirect heamagglutination (IHA) and im-
munoelectrodiffusion (IED).
Materials and Methods: Sera from 29 patients who had
clinically conﬁrmed hydatid disease were tested by radioim-
munoassay (RIA), IHA and IED. In 21 patients the localization
was hepatic, in 6 pulmonary, and in 2 both hepatic and
pulmonary. In addition, 15 sera from patients with clinically
conﬁrmed hydatidosis, but which were negative by IHA and
IED,were also tested By RIA. The 40 control sera were obtained
from apparently healthy blood donors.
Results: In the present study by RIA,IHA and IED approxi-
mately 80% of the patients with clinically suspected hydatid
disease were conﬁrmed serologicaly. The sensitivity of the three
methods was similar. The Principal subclass of speciﬁc anti-
hydatid immunoglobulin was IgG and high levels of speciﬁc
anti-IgE found in two out of the ﬁve patients studied.
Conclusion: It is concluded that for a satisfactory serodiagnosis
of hydatid disease the RIA and IED should both be used and
that fuether work should be done on the puriﬁcation of hydatid
antigens to improve the sensitivity of the Radioimmunoassay
without loss of speciﬁcity.
P1499
Development of an enzyme-linked
immunosorbent assay speciﬁcally detecting anti-
polysaccharide intercellular-adhesin antibodies
H. Rohde, J. Klettke, N. Siemssen, L. Frommelt, M.A. Horstkotte,
C. Burdelski, J.K.-M. Knobloch, D. Mack (Hamburg, D; Swansea,
UK)
Objectives: Staphylococci, especially Staphylococcus epidermidis
and Staphylococcus aureus, are important pathogens in the
context of implanted medical device infections. The ability to
establish multilayered bioﬁlms on the surface of foreign bodies
signiﬁcantly contributes to the pathogenicity of these species.
The polysaccharide intercellular adhesin (PIA), synthesized by
icaADBC encoded proteins, mediates bioﬁlm accumulation in
S. epidermidis and S. aureus. Therefore, PIA appears to be a
suitable antigen for novel diagnostic tools. In order to measure
the humoral immune response appropriate systems for the
speciﬁc detection of anti-PIA-antibodies are demanded.
Results: We here describe the development of an enzyme-
linked immuno sorbent assay (ELISA) speciﬁcally detecting
anti-PIA antibodies in human sera. 96-well Maxisorp plates
(Nunc) were coated with puriﬁed PIA. Using these PIA-coated
plates, an IgG titer of 1:8000 was detected in the serum of a
rabbit immunized with puriﬁed PIA. In contrast, in the pre
immune serum 16fold lower titers were detected. Absorption of
the anti-PIA antiserum against PIA-positive S. epidermidis 1457
lead to an 84 % reduction of the serum reactivity, whereas
absorption against PIA-negative 1457-M10 had no effect, dem-
onstrating the speciﬁcity of the test. This was conﬁrmed by
competition ELISA experiments where puriﬁed PIA but not
pneumococcal or meningococcal capsule polysaccharides spe-
ciﬁcally inhibited binding of the antibodies to immobilized PIA
up to 68 %. Using this ELISA, in serum samples from 10 patients
with endoprosthesis-associated infections due to clonally inde-
pendent icaADBC- and PIA-positive S. epidermidis strains
anti-PIA-antibody titers ranging from 1:20000 - 1:36000 were
detected. In contrast, in a collection of serum samples from
patients with endoprosthesis-related infections due to icaADBC-
negative S. epidermidis and from healthy blood donors IgG titers
were only 1:2000–1:6000.
Conclusions: Due to the widespread presence of icaADBC in
pathogenic staphylococci PIA appears as a suitable antigen for
novel diagnostic tools in foreign-body infections. Using speciﬁc
ELISA anti-PIA-IgG titers in patients with icaADBC-positive
S. epidermidis infections were signiﬁcantly higher than in a
control collective. Measurement of anti-PIA IgG appears as a
suitable tool for improving the diagnosis of staphylococcal
foreign-body infections.
Clostridium difﬁcile
P1500
Characterisation of Clostridium difﬁcile
associated disease recently observed in a
Canadian tertiary care hospital
A. Labbe´, D.R. MacCannell, L. Poirier, J. Pe´pin, T.J. Louie,
M. Laverdie`re (Montreal, Sherbrooke, Calgary, CAN)
Many hospitals in Montreal have recently experienced an
important increase in the incidence of Clostridium difﬁcile
associated disease (CDAD). At Maisonneuve-Rosemont hospi-
tal, it has increased from 10 per 1000 admissions in 2002 to 30
per 1000 admissions in 2004.
Objectives: To characterize and compare the Clostridium diff-
icile (CD) isolates involved during two distinct periods.
Methods: CD isolates were collected from consecutive cytotox-
in positive stools of patients (one isolate per patient) who
presented diarrhoea during two distinct periods: Nov 2000-Mar
2001 (pre-epidemic period) and Oct 2003-Jan 2004 (epidemic
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period). Minimal inhibitory concentrations (MICs) against met-
ronidazole were determined using an agar dilution method.
Strains from each period were ribotyped and probed for binary
toxin (CDT), and the ermB MLSB resistance determinant.
Clinical charts were reviewed.
Results: Among the 206 isolates, 56 were recovered in 2000–1
and 150 in 2003–4. MICs against metronidazole ranged from 0.25
to 4 mg/L and tended to be higher in 2003–4 (median 2 mg/L)
than in 2000–1 (median 1 mg/L). Two principal epidemic
ribopatterns were identiﬁed, and were annotated as strains ‘A’
(tcdA+/tcdB+/ermB+/CDT-) and ‘B’ (tcdA+/tcdB+/ermB-/
CDT+), respectively. In 2000–1. 46 (82%) of the isolates were
clonally related (ribotype ‘A’), and 10 (18%) of mixed patterns.
In 2003–4, by contrast, a binary toxin-positive straintype (ribo-
type ‘B’) dominated, accounting for 114 (76%) strains, with only
a small subset of ribotype ‘A’ (n = 26; 17%) and mixed types
(n = 10; 7%) remaining. Median MICs against metronidazole
tended to vary according to the ribotype identiﬁed: 2 mg/L for
ribotype ‘B’, 1 mg/L for ribotype ‘A’ and 0.5 mg/L for other
ribotypes. Chart review of 170 patients hospitalized at the time
of their CDAD episode revealed that 167 (98%) had received
antibiotics in-hospital within the preceding 2 months. At least
one relapse of CDAD occurred in 58 (34%) patients. Overall
mortality at 30 days after the ﬁrst CDAD episode was 22%, 13%
and 13% with ribotype ‘B’, ribotype ‘A’ and other ribotypes,
respectively.
Conclusion: The CDAD in our hospital are both predominantly
clonal in nature, and the epidemic strain associated with each
period was genetically distinguishable, with the 2003–4 epi-
demic strain causing an increased incidence of CDAD. Overall
mortality at 30 days was higher for patients infected with ‘B’
strain, but statistically not signiﬁcant.
P1501
Epidemiological examination of Clostridium
difﬁcile isolates from different parts of Hungary
G. Terhes, E. Urban, J.S. Brazier, J. Soki, E. Nagy (Szeged, HUN;
Cardiff, UK)
Objectives: The aims of this study were to continue and extend
our previous investigations, in which the main ribotypes were
determined at a local university hospital. In the present survey,
we determined the prevalence of different ribotypes of C. difﬁcile
strains, and detected the distributions of these types in three
Hungarian regions.
Methods: 105 C. difﬁcile strains were isolated in 5 Hungarian
laboratories from diarrhoeal faeces of both inpatients and
outpatients. The presence of toxin genes such as those of toxin
A (tcdA), toxin B (tcdB) and actin-speciﬁc ADP-ribosyl-transf-
erase (cdtA and cdtB) were detected by PCR in the Szeged
laboratory. The ribotypes of these strains were determined by
PCR ribotyping method at the ARL in Cardiff.
Results: A total of 31 ribotypes were detected among the 105
tested C. difﬁcile strains: 5 ribotypes were distinct from all
previously described types, suggesting that these are new types.
The most common types in Hungary were ribotype 014 (24.8%)
and ribotype 002 (13.3%), while in the UK, the most predom-
inant type was ribotype 001. The distributions of the examined
ribotypes differed in the different Hungarian regions: ribotype
012 was frequent (20.7%) in South Hungary, at the same time in
the Budapest region, this ribotype was rare, while in West
Hungary, we did not detect this type during the examined
period. In West Hungary and the Budapest region, the most
frequent type was ribotype 014 (28.9% and 29% respectively).
Conclusion: Numerous different methods have been used
internationally to study C. difﬁcile strains of different origins.
Comparisons are therefore difﬁcult. The most frequently applied
and most useful typing method is the PCR ampliﬁcation of
rRNA intergenic spacer regions, which is a discriminative,
reproducible and rapid technique for determination of the
different types of C. difﬁcile. Our present survey and previous
studies have revealed that the presence and distribution of
C. difﬁcile ribotypes vary from country to country, and also
depend on the site of isolation and the period in which the
tested strains were isolated. We have now shown that there can
additionally be regional differences within a given country. This
work was supported by a Hungarian Eo¨tvo¨s Scholarship and
grant TO32385 from the Hungarian National Research Founda-
tion (OTKA).
P1502
Tn916-Tn1545-like elements in Clostridium
difﬁcile clinical isolates
P. Spigaglia, V. Carucci, F. Barbanti, P. Mastrantonio (Rome, I)
Objectives: In C. difﬁcile, tetracycline resistance is predomin-
antly due to a tet(M) gene. This gene has been shown to be
carried by Tn5397 in the clinical strain C. difﬁcile 630, whereas by
a Tn916-like element in the environmental strain C. difﬁcile
42373. These two elements are related, but very different in their
integration/excision module and can not be co-present in the
same cell. The aim of the study was to examine Clostridium
difﬁcile clinical isolates for the presence of the Tn916 and Tn1545
like elements.
Methods: Detection of tet(M), erythromycin resistant gene
erm(B) and the integrase gene int (markers for the Tn916) was
performed by PCR, as well as the analysis of the genetic
arrangement of the elements. The ampliﬁed fragments were
used as probes for hybridisation assays on genomic DNA of
C. difﬁcile isolates, after digestion with HindIII. The nucleotide
sequence of tet(M) genes was also analysed. Antibiotic suscep-
tibility of the strains was assessed by the E-test method.
Results: Eighteen C. difﬁcile isolates were positive for tet(M) and
int and the signals obtained using these genes as probes
overlapped. Ten isolates showed one hybridising band of
either 6.3, 9.0 or 14 kb. Seven isolates showed two hybridising
bands of 6.3 and 9.0 kb and one strain two banda of 6.0 and
9.0 kb, indicating the presence of two copies of a Tn916-Tn1545
like elements. Heterogeneity in these elements was observed.
The E-test results indicated that isolates with two copies of
tetracycline resistance elements were resistant (88%) or induc-
ibly resistant to tetracycline (12%), whereas isolates with one
copy were resistant (36%), inducibly resistant (18%) or suscept-
ible (46%) to this antibiotic. Three isolates were also erm(B)-
positive and resistant to erythromycin. The bands obtained
using tet(M) and erm(B) probes overlapped at 9.0 kb, indicating
the presence of a Tn1545-like element. The association of these
genes was also conﬁrmed by PCR. Seven different alleles were
identiﬁed sequencing the tet(M) gene of prototype strains
among those examined.
Conclusion: Heterogenic elements of the Tn1545–Tn916 family
are harboured by C. difﬁcile clinical isolates showing different
phenotypes for tetracycline. These elements carry different
tet(M) alleles and can be found in one or two copies in C. difﬁcile
chromosome. Tn1545-like elements, have been detected for the
ﬁrst time in this pathogenic bacterium.
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P1503
Clostridium difﬁcile among patients in
department of surgery
G. Martirosian, A. Szczesny, J. Silva Jr. (Katowice, PL; Sacramento,
USA)
Nosocomial outbreaks of C. difﬁcile-associated diarrhoea were
described in different hospital units. Patients undergoing surgery
are under special control because of necessity of antibiotic
treatment. The aim of this study was to determine the frequency
of C. difﬁcile infection among patients hospitalized in Department
of Surgery and to compare isolated strains by phenotypic and
genotypic characteristics. During period of 11 months 318 stool
samples taken from patients with gastrointestinal problems,
hospitalized in Department of Surgery of Medical Center UC
Davis and 62 environmental samples were cultured for isolation
of C. difﬁcile strains. Thirty (9.4%) C. difﬁcile strains were isolated
from stool samples cultured on selective CCCA plates (bio-
Merieux, France) with sodium taurocholate and 6 (9.6%) strains
from environmental samples using Rodac plates with TCCA.
Toxigenicity of isolated strains was determined by using of Tox
A/B ELISA test (TechLab, USA) and PCR ( primenrs YT 28/YT29
and YT18/YT19 correspondingly for toxin A and B genes). All
isolated strains were compared by AP-PCR and PCR-ribotyping.
Twenty two toxigenic (A+/B+), 5 nontoxigenic (A-/B-) and 3
toxin A-positive/toxin B-negative C. difﬁcile strains were detec-
ted among patients’isolates and 4 toxigenic and 2 toxin
A-positive/toxin B-negative strains - among environmental
samples. Twenty ﬁve out of 30 C. difﬁcile-positive patients had
performed surgery before C. difﬁcile testing. Majority of C. difﬁ-
cile-positive patients were treated previously by cephalosporins
and penicillins with inhibitors of beta-lactamases. Among
patients, infected by toxigenic strains signiﬁcantly higher leuk-
ocytosis and longer duration of fever were observed. Seven
strains isolated from patients’ fecal samples and one strain
isolated from environment demonstrated high level resistance to
erythromycin and clindamycin (MIC > 256 lg/ml) in E-test. The
results obtained by AP-PCR and PCR-ribotyping revealed
genetic heterogeneity among the strains isolated from patients’
fecal samples. However, similarity was observed among envi-
ronmental strains and strains isolated from patients’ fecal
samples.The resistance of isolated C. difﬁcile strains to clindamy-
cin and erythromycin (E-test, AB Biodisk) indicated possibility of
transmission in the hospital strains with macrolide-lincosamide-
streptogramin B (MLS-B) resistance type.
P1504
Introduction of TcdA-negative, TcdB-positive
Clostridium difﬁcile in a general hospital in
Argentina
R.J. van den Berg, M.C. Legaria, A. de Breij, E.R. van der Vorm,
J.S. Brazier, E.J. Kuijper (Leiden, NL; Buenos Aires, RA;
Amsterdam, NL; Cardiff, UK)
Objectives: Clostridium difﬁcile is the major causative agent of
nosocomial antibiotic associated diarrhoea and pseudomembra-
nous colitis. The main virulence factors are two toxins produced
by this pathogen: TcdA and TcdB. Clinically important TcdA-
negative, TcdB-positive (A-B+) C. difﬁcile strains from different
countries have occasionally been reported, but epidemics are
very rare.
Methods: In a prospective study to determine the incidence of
CDAD in a 200-bed general hospital in Argentina, all faecal
samples of symptomatic patients with a positive immunoassay
(Premier Cytoclone A/B or Triage Micro C. difﬁcile panel) and/
or a positive cytotoxicity assay were cultured for the presence of
C. difﬁcile. The isolated strains were investigated for the presence
of tcdA, tcdB, and erm(B) genes. All isolates were further typed
using PCR-ribotyping and ampliﬁed fragment length poly-
morphism (AFLP). Additionally, a toxinotyping method was
optimised to recognize 24 toxinotypes and was also applied on
the clinical isolates.
Results: The incidence of CDAD per 1,000 admissions varied
from 5.9 (2000), to 10.9 (2001), 6.9 (2002) and 4.7 (2003),
respectively. Most patients were diagnosed at the Departments
of Internal Medicine (57%), Pulmonology (13/%), and Intensive
Care (10%). Of all C. difﬁcile isolates, the percentage A-B+
isolates increased from 12.5% in 2000, 58.1% in 2001, 87.9% in
2002, to 96% in 2003. Comparison of 37 patients with CDAD due
to A+B+ strains with 80 patients with CDAD due to A-B+
strains, revealed no signiﬁcant differences with respect to age
and gender, department, underlying disease, severity of CDAD,
or relapse rate of the patients. All 80 A-B+ C. difﬁcile isolates
belonged to toxinotype VIII and PCR-ribotype 017, and 89%
were resistant to clindamycin due the presence of the erm(B)
gene. The A-B+ isolates could be divided in clusters using AFLP
and belonged to different clusters then the A+B+ strains.
Conclusion: In a period of 4 years, A-B+ strains completely
replaced A+B+ strains. This shift was not accompanied with a
change in incidence, affected patient group, clinical presentation
or relapse rate. All strains belonged to one PCR-ribotype and
toxinotype, but could be distinguished in smaller clusters using
AFLP. Clinicians should be aware of the widespread distribu-
tion of the clindamycin resistant A-B+ strains belonging to
toxinotype VIII and PCR-ribotype 017.
P1505
C. difﬁcile pseudo-outbreak in a general hospital
V. Stempliuk, V. Borrasca, M. Araujo, C. Ciola, A. Cataldi,
S. Costa, M. Souza Dias (Sao Paulo, BR)
C. difﬁcile -associated diarrhoea (CDAD) is the most common
cause of nosocomial diarrhoea. While healthy adults have a 3%
colonization rate, in-hospital colonization can increase to 30%.
Few Brazilian hospitals have the capacity to detect C. difﬁcile
toxins and its epidemiology in Brazil is scarcely known.
Hospital Sirio-Libanes is a private 250-bed community hospital
with predominantly surgical and oncologic patients. In March
2002 the number of cases CDAD cases increased from a mean of
2/ month to 7,6/ month. An outbreak was suspected and
control measures were initiated (contact precautions, chlorine
based environmental desinfection and staff orientation).
Objective: Describe the investigation of an outbreak of C. difﬁcile
associated diarrhoea.
Methods: Detection of toxin A and B (C. difﬁcile Detection test -
toxin A and B - Meridian). Toxin – positive stool samples were
cultivated in anaerobic environment in non-selective blood agar.
Clostridium difﬁcile was diagnosed by 16S rRNA PCR. Genotyp-
ing was done by AP-PCR with arbitrary primer T-7.
Results: From 3/2002 until 12/2003 138 patients were diag-
nosed with CDAD, 96 (70%) became symptomatic during their
hospital stay and 42 (30%) were admitted with diarrhoea – 34
from the community and 8 from other hospitals. At least 10/138
referred they had not used antimicrobial agents in the previous
2 months. The incidence of new ‘hospital acquired’ cases was
0.41% in 2002 and 0.42% in 2003. Clostridium spp. was isolated in
20 samples and C. difﬁcile conﬁrmed in 16 samples. Genotyping
by AP-PCR revealed 13 different band patterns.
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Conclusion: Although epidemiological data indicated an out-
break and possible cross infection, genotyping excluded this
possibility. Control measures may be more efﬁciently directed at
restriction of antimicrobial use then measures to contain cross
infection.
P1506
Laboratory diagnosis of antibiotic associated
diarrhoea in hospitalised patients (Clostridium
difﬁcile or Clostridium perfringens) – preliminary
study in Poland
H. Pituch, P. Obuch-Woszczatynski, D. Wultanska, F. Meisel-
Mikolajczyk, M. Luczak (Warsaw, PL)
Although Clostridium difﬁcile is the most commonly identiﬁed
pathogen in antibiotic associated diarrhoea (AAD), the majority
of the current cases remain undiagnosed. C. perfringens (CPEnt+)
was ﬁrst implicated as a cause of AAD in 1984. The main
virulent factor is a 35 kDa protein-enterotoxin (CPEnt). CPEnt is
encoded by the cpe gene, can be detected in faecal samples by
the Vero cell line and EIA commercial test. In the present study
52 faecal specimens from patients hospitalised in University
Hospital in Warsaw and gastroenterology units of different
Polish hospitals, submitted for C. difﬁcile testing were studied for
C. perfringens infection. C. difﬁcile toxins were detected with
commercial immunoassay test TOX A/B (TechLab, USA). For
detection enterotoxin C. perfringens Enterotoxin Test (TechLab,
USA) was used. All specimens were inoculated onto CCCA
medium for detection of C. difﬁcile and TSN medium for
detection C. perfringens. To detect cpe gene PCR was performed.
We used the Etest to asses for susceptibility to metronidazole.
C. difﬁcile toxins (TcdA and/orTcdB) were detected in 39 faecal
samples. However, enterotoxin (CPEnt) of C. perfringens was
detected in 16 faecal samples. In 16 gave positive tests results for
both C. difﬁcile and C. perfringens toxins. From the same
samples was cultured 16 C. difﬁcile and 15 C. perfringens strains.
In the present study 75% of the specimens were positive for
C. difﬁcile TcdA/TcdB toxins, 31% were positive for CPEnt
C. perfringens and 28% gave positive test results for both
C. difﬁcile and C. perfringens toxins. We were found relatively a
small number of enterotoxigenic C. perfringens (CPEnt) strains.
All strains C. difﬁcile and C. perfringens were susceptible for
metronidazole. The occurrence of C. perfringens (CPEnt) as
etiologic agents of nosocomial diarrhoea is not known in Poland.
In our laboratory, we have found a suprisingly signiﬁcant
number of C. perfringens enterotoxin (CPEnt) positive stools. We
conclude that C. perfringens is a potential cause of AAD in
Poland.
Chlamydia trachomatis
P1507
Detection of Chlamydia trachomatis from self-
collected vaginal swabs in commercial sex-
workers
M.V. Boost, P. Leung, A. Grey, C. Lo (Hong Kong, HK)
Objectives: To determine the level of chlamydial infection in
female commercial sex-workers (CSW) in Hong Kong, and the
acceptability of self-collected vaginal swabs.
Method: CSW were contacted by an outreach worker who
informed them of the risks of untreated chlamydial infection
and offered screening by use of a self-collected vaginal swab.
Those willing to participate were instructed how to collect the
specimen, and provided with a dacron swab, a sterile empty
tube, and an envelope in which to place the tube. Subjects were
asked to complete a short questionnaire on sexual practices and
medical check-ups for sexually transmitted disease (STD).
Specimens were returned to the laboratory within 36 h.
C. trachomatis was detected using a previously validated in-
house PCR method. The tip of the swab was cut off using sterile
scissors and placed into a 2-ml microcentrifuge tube to which
600‡of PBS (pH 7.4) was added. The tube was vortexed for 30 s,
and then the swab pressed against the wall of the tube to
squeeze out the ﬂuid before discarding it using sterile forceps.
The ﬂuid was centrifuged at 13,000 rpm for 20 min, the
supernatant discarded and the pellet resuspended PCR buffer
containing proteinase K and Tween-20. It was incubated at 55C
for 1 h and then heated at 80C to inactivate the proteinase K.
Ten microlitres of the treated sample were used for PCR using
primers for C. trachomatis. Thirty cycles of 30 s at 94C followed
by 1 min at 60C and 1 min at 72C were used for ampliﬁcation,
with ﬁnal annealing of 7 min at 72C and 7 min at 15C. The
ampliﬁed DNA was run on a 1% agarose gel and visualized
with ethidium bromide. Positive and negative controls were
used on each occasion.
Results: Of 180 CSW invited to participate, specimens were
collected from 163, none of whom were aware of a current
infection with C. trachomatis. Nine specimens were positive,
representing a 5% infection rate. Seventy per cent of the CSW
reported usually using condoms with clients.
Conclusion: The level of infection in CSW in Hong Kong was
relatively low compared to other countries. This may reﬂect
regular condom use. Self-collected vaginal swabs and anony-
mous screening were well-accepted by the CSW as many
reported fear of stigmatization and possible legal repercussions
if they attended STD clinics.
P1508
The effect of freezing, washing and high-speed
centrifugation on the outcome of BD ProbeTec
Chlamydia analysis on urine samples
G. Lisby, H. Westh (Hvidovre, DK)
Objectives: When urine samples for Chlamydia trachomatis (CT)
are not analysed immediately, it has been standard procedure to
freeze the samples at –20C until analysis. On known CT-
positive and CT-negative patient samples, we valuated the
impact of freezing, washing or not washing the unfrozen
samples as well as the impact of centrifugating frozen samples
at 10.000 xg prior to analysis.
Methods: All urine samples were analysed (no freezing) with
the BD ProbeTec system. The remaining sample was frozen at –
20 C for inclusion in this study. We carried out three ‘arms’ of
investigation: ‘Arm 1’: Frozen positive samples and frozen
negative samples were thawed and reanalysed after washing.
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‘Arm 2’:Refrigerated positive and negative samples were ana-
lysed without washing. ‘Arm 3’: frozen positive and frozen
negative samples were thawed and analysed after centrifugation
at 10.000 xg and washing. We tested the effect of centrifugation
at 10.000 xg to determine whether 10.000 xg is more efﬁcient
than the traditional 3,000 xg to sediment the CT organisms. Due
to cellular lysis caused by the freeze/thaw cyclus, the intracel-
lular CT will be found in the extracellular phase, and might not
sediment completely at 3,000 xg.
Results: In ‘arm 1’, 181 positive samples were frozen, thawed
and reanalysed after washing. 162 (89.5%) remained positive, 13
(7.2%) became negative and six (3.3%) showed inhibition. Of the
182 negative samples, 166 (91.2%) produced a negative result,
while 15 (8.2%) showed inhibition and one (0.6%) was border-
line positive. In ‘arm 2’, of the 90 positive samples analysed
without a washing step, 85 (94.5%) remained positive and ﬁve
(5.5%) became negative. In 91 negative samples, 70 (76.9%)
produced a negative result, while 21 (23.1%) showed inhibition.
In ‘arm 3’, data are pending.
Conclusion: Compared to standard testing of urine samples by
the BD ProbeTec system, (unfrozen, washed/centrifugated
(3,000 xg) samples), freezing at –20C followed by washing
caused loss of signal in 7.2% of positive samples as well as
inhibition in 3.3% of positive samples and 8.2% of negative
samples. Also compared to standard testing, omitting the
washing step caused 5.5% of the known positive samples to
become negative and of the known negative samples, 23.1%
showed inhibition.
Overall conclusion: 1. Freezing samples reduces sensitivity and
causes low-grade inhibition. 2. Omitting the washing step in
unfrozen samples causes extensive inhibition.
P1509
Comparison of inhibition rates for vaginal and
cervical swabs and urine for the diagnosis of
Chlamydia trachomatis by Aptima Combo 2,
ProbeTec ET and Amplicor
M. Chernesky, D. Jang, M. Smieja, S. Chong, K. Luinstra,
C. MacRitchie, W. Cai, B. Hayhoe (Hamilton, Toronto, CAN)
Background: Inhibitors of nucleic acid ampliﬁcation (NAA)
tests in clinical specimens and analytical test sensitivity may
play a role in the ability of diagnostic assays for Chlamydia
trachomatis to detect infected patients. Some manufacturers
provide ampliﬁcation controls to monitor NAA inhibition. The
objectives were (a) to determine the analytical sensitivity of
APTIMA COMBO 2 (AC2), ProbeTecTM ET (PT) and AMPLI-
COR (AMP) assays and to produce sensitive internal controls
for spiking clinical specimens; (b) to test ﬁrst void urines (FVU),
cervical swabs (CS), and vaginal swabs (VS) for inhibitors and C.
trachomatis nucleic acids from each patient.
Methods: C. trachomatis L2 434 isolate was propagated in
McCoy cells. Aliquots were titrated in each assay for swabs
and FVU, and dilutions where 16/16 replicates were positive
were used for spiking clinical samples. A total of 301 women
signed a consent for collection of three CS, three VS and an FVU
(30 ml). Each sample was tested spiked and unspiked in the
AC2 (Gen-Probe), PT (Becton Dickinson) and AMP (Roche
Diagnostics) assays for C. trachomatis.
Results: The analytical sensitivities determined by one of 16
replicates being positive, were as follows: PT 10–5 to 10–6, AMP
10–5 to 10–6, AC2 10–8. Percent inhibition rates in FVU, VS and
CS were 27.6, 2.5, 2.5 for PT, 12.6, 4.5, 3.8 for AMP and 0.4, 1.2,
0.4 for AC2. Overall, there were 70 infected women. The
percentage of patients positive for C. trachomatis by specimen
type were as follows: by VS, CS and FVU there were 98.6, 91.4,
85.7 by AC2; 67.1, 65.7, 67.1 by PT and 64.3, 60.0, 57.1 by AMP.
The differences between the AC2 results and the other two
assays were statistically signiﬁcant (p < 0.001).
Conclusions: Because of different analytical sensitivities and
inhibition rates, more positive patients were identiﬁed by the
AC2 test. Most patients had more than one specimen type
positive.
P1510
Diagnostics of urinogenital chlamidiosis common
forms in young people
Y. Lobzin, A. Poznyak (Saint-Petersburg, RUS)
Objectives: To study clinical-laboratory manifestations of chla-
midiosis common forms 1002 patients at the age of 18–32 were
observed and treated for acute (urethritis, cervicitis) n = 193,
localized (prostatitis, vesiculoprostatitis, adnexitis, salpingitis),
n = 340 forms of infection, Reiter disease n = 274, acute and
chronic sinusitis, associated with Chlamydia trachomatis, n = 95,
meningitis and encephalitis, n = 100.
Methods: The complex of laboratory methods was used: PCR,
culture method, DIF, indirect immunoﬂuorescence reaction,
EIA, complement ﬁxation reaction, electronic microscopy. Chl-
amydia trachomatis and other agents were revealed in clinical
material from primary (brush cytology of the urethra and the
cervical part of the uterine neck, prostatic secretion, ejaculation,
urinary sediment) and secondary (brush cytology of the throat,
conjunctiva and rectum, sputum, synovial membrane biopsy
material, synovial ﬂuid, maxillary sinuses contents, liquor) foci.
To reveal Chlamydia and other sexually transmitted infections
venous blood test (including white blood cells concentrate) was
made. To specify the localization and manifestation of chlamid-
iosis primary and secondary foci ultrasonic scanning of the
small pelvis organs, radioisotope scintigraphy and single-
photon emission CT were carried out.
Results: Urinogenital chlamidiosis can manifest as common
infections (24.6% of cases) with hematogenic dissemination
and involvement of different organs and systems. Development
of these forms increases with the time interval the urinogenital
system was involved. In such a form of infection Chlamydia
trachomatis is associated with other sexually transmitted infec-
tions in 76.4% of cases. Clinical-laboratory criteria of common
chlamidiosis diagnostics are based on a ﬁnding of chlamydia in
blood, presence of extraurogenital foci of infection in different
organs and tissues (joints, CNS, eyes, ENT-organs, respiratory
organs, distal part of the intestines and others), general infec-
tious intoxication syndrome, immune impairment and intestinal
dysbacteriosis.
Conclusion: Usage of clinical material from the urinogenital
tract cannot solve all the problems of diagnostics of different
urinogenital chlamidiosis forms. Important clinical criterion of
common urinogenital chlamidiosis is the presence of chlamydia in
blood. For detailed localization of secondary foci of chlamidiosis
it is advisable to use radioisotope scintigraphy.
P1511
Vaginal swabs detect more chlamydial infections
than do urine specimens
J. Schachter, M. Chernesky (San Francisco, USA; Hamilton, CAN)
Objectives: Recently the FDA cleared use of vaginal swabs (VS)
in screening for Chlamydia trachomatis (CT) and Neisseria gonor-
rhoeae in Gen-Probe Incorporated’s APTIMA Combo 2 Assay
(AC2) for both organisms. First catch urine (FCU) has been
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considered the noninvasive specimen of choice for screening.
We reanalysed data from a clinical trial assessing the perform-
ance of AC2 to determine the best specimen for screening for
chlamydial infections.
Methods: FCUs and two cervical swabs (CS) were collected
from 1464 women attending STD, family planning and Ob/Gyn
clinics. The FCU and one CS were tested by AC2 and FCU and
the other CS by the BDProbeTecTM ET System CT Assay (BD
Diagnostic Systems). Patient collected VS (PVS) specimens were
also tested by AC2. All positive results were conﬁrmed using an
alternate target ampliﬁcation test speciﬁc for CT, the APTIMA
CT Assay.
Results: The AC2 assay had 174 positive FCU and 171 (98.3%)
were conﬁrmed.The ProbeTec assay had 155 positive FCUs and
144 (92.9%) were conﬁrmed. There were 195 positive CS by AC2
assay and 194 (99.5%) were conﬁrmed. The ProbeTec assay had
159 positive CS specimens and 157 (98.7%) were conﬁrmed.
There were 208 positive PVS by AC2 and 204 (98%) were
conﬁrmed.
Conclusions: AC2 was more sensitive than the ProbeTec assay.
It identiﬁed about 20% more infected women than the ProbeTec
assay with CS (194 vs 157 positive specimens, 24% more) and
FCUs (171 vs 144, 19% more). Testing PVS with AC2 identiﬁed
at least as many infected women as did testing of CS (204 vs 194)
and yielded more positives than did testing of FCUs (204 vs 171,
19% more). VS is a non-invasive specimen which allows for self-
collection. VS can be collected without performing a pelvic
exam, and testing VS will detect more infections. For these
reasons, it is clear that vaginal swabs should be considered the
specimens of choice for screening for C. trachomatis in women.
P1512
International external quality assessment for
C. trachomatis using EIA and molecular methods
A. Rossouw, V. Chalker, P. Patel, H. Vaughan, H. Seyedzadeh,
V.L.A. James (London, UK)
C. trachomatis is a sexually transmitted pathogen that causes
genital tract infections in both men and women. Clinical
symptoms may be absent or silent, delaying treatment and
leading to serious consequences such as infertility. In 1991, UK
NEQAS for Microbiology introduced an international EQA
scheme for the detection of C. trachomatis by EIA and since the
use of molecular methods increased in clinical laboratories more
challenging specimens were included in the distributions.
Objective: To summarise results of an international EQA
scheme for C. trachomatis and compare the performance of EIA
and molecular methods used in the detection of C. trachomatis in
specimens with varying EB/mL consistent with those found in
urine samples.
Methods: A total of 9 positive and 7 negative 0.5 mL specimens
were produced in varying concentration of C. trachomatis (L2
strain in buffer solution with 0.05% Bronidox) and distributed to
participants in 8 panels. Participants were instructed to examine
0.1 mL of each specimen for the presence of C. trachomatis and
report results within 21 days.
Results: Overall detection of C. trachomatis in the positive
specimens by all methods varied from 32.3 to 83.6%. Detection
by molecular methods (66.4–98.6%) was signiﬁcantly higher
than EIA methods (2.3 - 69.2%). Risk difference analysis showed
that all methods were signiﬁcantly more likely to detect
C. trachomatis when present at higher concentrations. Analysis
of speciﬁc molecular assays indicated Abbott LCx detected
72.7–100%, BDProbeTeET detected 31.4–100% and the Roche*
methods detected 84.5–100%. Participants using the BDProb-
eTecET were less likely to give positive results at dilutions of
1:1200 and greater, whereas Abbott LCx was less likely to give
positive results at dilution of 1:2500 and higher and the Roche
methods were more likely to report a positive result on less
concentrated specimens.False positive reporting was rare with
the negative specimens (19/1985; 0.3–1.5%) and more common
with EIA users.
Conclusion: Detection was excellent at higher concentrations of
C. trachomatis irrespective of the method used. However, at
lower concentrations molecular methods are superior to EIA
based assays for the detection of C. trachomatis (L2 strain) in
simulated EQA specimens. * Includes all participants stating
Roche, Roche AMPLICOR CT/NG or Roche COBAS AMPLI-
COR CT/NG.
P1513
Detection of Chlamydia trachomatis using an
automated PCR-based system
A. Babic-Erceg, G. Vojnovic, S. Ljubin Sternak (Zagreb, HR)
Objectives: Chlamydia trachomatis urogenital infection is the
most common bacterial sexually transmitted disease in both,
men and women. It causes cervicitis, salpingitis, urethritis,
pelvic inﬂamatory disease, infertility, ectopic pregnancy and
chronic pelvic pain. Laboratory testing for C. trachomatis con-
tinues to be a challenge to clinical laboratories. Usual methods,
enzyme immunoassay, direct ﬂuorescent assay, even isolation in
cell culture, lack sensitivity when compared with nucleic acid
ampliﬁcation methods.
Methods: A PCR Cobas Amplicor CT/NG method; Roche Diag-
nostics, semi automated test was used. The Cobas Amplicor is a
two-segment thermal cycler which automates ampliﬁcation,
denaturation, hybridisation, incubation, washing, colorimetric
endpoint and results reporting. Specimen preparation was the
only step conducted manually. Cervical and urethral swabs
were transported in 2-SP transport medium, and ﬁrst-voided
urine specimens in the sterile containers.
Results: In a three month period, total of 1270 specimens from
outpatients were examined. There were 1166 cervical swabs, 87
urethral swabs (25 female, 62 male), and 17 urine samples
(8 female, 9 male). The prevalence of C. trachomatis infection was
2.1% (25 cervical specimens, 1 male urethral swab and 1 female
urine sample). In a hundred cervical swabs and 17 urin samples,
no inhibition was observed.
Conclusion: Our results in a short period of time show low
prevalence of C. trachomatis infection. Lack of inhibition is due to
an adequate transport medium used and pooling of specimens.
P1514
Results of early performance studies of the
COBAS TaqManTM CT (TaqMan) test for
detecting Chlamydia trachomatis in male and
female urine specimens on the Roche COBAS
TaqManTM 48 analyzer
D.V. Ferrero, D.E. Schultz, J. Cuerpo, S. Stewart, R. Dalal,
S.A. Willis (Stockton, USA)
Objective: We evaluated Roche’s next generation polymerase
chain reaction (PCR) test, the COBAS TaqManTM CT test (Roche
Molecular Diagnostics) for use in clinical and public health
laboratories. This test is not yet commercially available. The
COBAS TaqManTM 48 analyzer incorporates automated real-
time ampliﬁcation and detection of DNA or RNA for up to four
simultaneous detections. Our study compares TaqMan perform-
ance in detecting Chlamydia trachomatis (CT) from ﬁrst catch
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urine (FCU) specimens to the COBAS AMPLICORTM CT/NG
(AMPLICOR) (Roche Molecular Diagnostics) and the BD Probe-
TecTM ET (ProbeTec) (Becton Dickinson Company) nucleic acid
ampliﬁcation systems.
Methods: FCU specimens were collected from patients attend-
ing STD and family planning clinics. Specimens were collected,
transported and tested according to the manufacturer’s recom-
mendations. Specimens were tested by the ProbeTec, AMPLI-
COR, and TaqMan tests for CT. TaqMan was compared to
‘infected patient status’, which deﬁned a patient as infected
whenever any two comparator results were positive.
Results: FCU specimens were obtained from 406 patients. The
overall TaqMan sensitivity for FCU when compared to infected
patient status was 97.2% (70/72). The overall TaqMan speciﬁcity
for FCU when compared to infected patient status was 99.0%
(298/301). There were 31 inhibitory results in the ProbeTec test,
4 in the AMPLICOR test and 3 in the TaqMan test.
Conclusion: The TaqMan test produced excellent overall results
when compared to the AMPLICOR and the ProbeTec tests in
sensitivity and speciﬁcity in detecting CT from FCU. The
TaqMan test had fewer inhibited test results than either the
ProbeTec or the AMPLICOR tests. The TaqMan test demonstra-
ted a faster turnaround time than COBAS AMPLICOR CT/NG
Test. These excellent results indicate the TaqMan test to be
robust nucleic acid ampliﬁcation next generation technology.
P1515
The role of Chlamydia trachomatis urinary tract
infection in children
I. Choroszy-Krol, R. Bednorz, M. Frej-Madrzak,
D. Teryks-Wolyniec, B. Kowalska-Krochmal (Wroclaw, PL)
Objectives: Chlamydia trachomatis (C. trachomatis) is an import-
ant patogen (agent?) responsible for variety of genitourinary
diseases in children and in adults. Since C. trachomatis infection
requires speciﬁc treatment and prevention it should be taken
into account in practice. The aim of our study was to determine
the prevalence of chlamydial urethritis in children with different
urinary tract diseases.
Methods: In 195 children and adolescents aged 14 to 18 years
(115 girls and 79 boys) with urinary tract infection (UTI) urethral
swabs were taken. It those with positive result for C. trachomatis
blood and urine were collected. Bacteriological evaluation was
done using MicroTrak Chlamydia trachomatis Direct Specimen
Test (Trinity Biotech plc, Ireland). Urine samples were tested for
chlamydia DNA using the polymerase chain reaction (DNA-
Gdansk II s.c. Polska).
Results: C. trachomatis infection was detected in 99 of 195
(50.7%) patients (64 of 116 (55.1%) girls and 35 of 79 (44.3%)
boys. C. trachomatis DNA in urine was detected in 16 of 23
(69.5%) patients (8 of 14 (57.1%) girls and 7 of 9 (77.7%) boys.
Conclusions: High prevalence (50.7%) of C. trachomatis in
urethral swabs indicates that chlamydia has a signiﬁcant role
in UTI in children.
P1516
Comparison of Chlamydia and Mycoplasma
incidence between different female populations
in Greece
M. Simou, K. Avdeliodi, S. Tzortzatou, T. Lazaraki,
H. Kada (Athens, GR)
Objectives: To determine the incidence of Chlamydia trachomatis
and Mycoplasma infection in female population of reproductive
age after the signiﬁcant increase of foreign women (immigrants)
in Greece during the last years..
Methods: 3152 cervical and vaginal smears of women in
reproductive age who attended the Outpatient Dpt. of our
Hospital from January 2003 till November 2004, were tested for
the presence of Chlamydia trachomatis and Mycoplasmas. From
the total of 3152 women, 2773 were Greek and 379 were
immigrants. The detection of C. trachomatis was performed by
ligase chain reaction method (Lcx Abbott) and Probe Tec assay
(Becton Dickinson). Mycoplasma identiﬁcation and sensitivity
test was performed using the Mycofast Screening Evolution 2 kit
(International Microbio, France).
Results: From the total of 3152 women a percentage of 4,15%
were positive for C. trachomatis. The prevalence of C. trachomatis
among Greek (3.4%) and immigrants (9.2%) was statistically
signiﬁcant (P < 0.001).From the total of 3152 women a percen-
tage of 27.2% were positive for mycoplasmas. Greek women
were positive in a percentage of 25.3% and immigrants were
positive in a percentage of 42.2% (P < 0.001).
Conclusions: The incidence of chlamydia and mycoplasma
infection has increased during the last years compared to our
previous studies where the prevalence of Chlamydia trachomatis
was 3.8% and the prevalence of Mycoplasma was 24.2%.The
increase of chlamydia and mycoplasma infection in general
female population is due to the increase of immigrants who
attended the Outpatient Dpt. during the last years. Care should
be taken to discover and treat all chlamydia positive and
mycoplasma positive women with appropriate antimicrobials in
order to diminish the danger of infection and related problems
in conception and fertility.
P1517
Antibiotic susceptibility of Mycoplasma hominis
and Ureaplasma urealyticum strains isolated from
symptomatic and asymptomatic women
M. Svabic-Vlahovic, I. Dakic, I. Cirkovic (Belgrade, CS)
The examinations was carried out on the 400 symptomatic and
asymptomatic women, aged 15–59, middle value 29.3. 274 of
them had in the history pregnancy, four of them were pregnant
in the moment of examination, and 112 passed examination
because of infertility treatment. Among the examined patients
102 (50.25%) had signs of cervicitis or inﬂamations of vaginal
mucose or disorders in secretion. 84 of examined women had in
anamnesis treatment with antibiotics, and in 36 cases we
established that board spectrum antibiotics was used. Isolation
and identiﬁcation of U. Urealyticum (UU) and M. hominis (MH)
were carried out on home made media,and for 40 samples we
used two media - home made media and BioMerieux (ist 2)
media. Presence of C. trachomatis in cervical swobs was exam-
ined by direct IF (BioMerieux). Other bacteria and microorgan-
isms (Candida) are isolated by standard methodology.
Results: UU was isolated from 146 patients (36.5%) and MH
from 38 patients (9.5%). From the groupe of women with signs
of inﬂamation, UU was isolated in 37%, MH in 23%. In this
group 2% patients had in same time both microorganisms (MH
+ UU). C trachomatis was present in 16 patients, but eight of
them were with local inﬂamation. 64 patients had more than 8
PMN in direct smear and 11 vaginosis were conﬁrmed (Nugent
score), 10 from 11 vaginoses were present among group with
local disorders. 66 patients had Gram negative bacteria, 22
Enterococcus spp. and 12 S. agalactiae.MICs was carried out for all
isolated strains in microtitration plates. Among 146 strains of
UU 11 were resistant to Doxicyclin, 3 to Oﬂoxacin, 9 to
Ciproﬂoxacin (but 28 strains were with MIC value of 2). There
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were no strains resistant to Tetracycline. 38 MH strains were
tested: 3 were resistant to Doxyciclin, 1 to Tetrracycline, 8 to
Ciproﬂoxacin, 3 to Oﬂoxacin.
P1518
Aetiology of urethritis among Yemeni patients
A.Y. AL-Haiﬁ, I. Alshami, A. Aljaufy, T. Salam,
S.A.H. Awad (Sanaa, YE; Manchester, UK)
Objectives: There are no previous or recent trends in study the
aetiology and epidemiological characteristics of speciﬁc micro-
organisms causing urethritis in Yemen; therefore we designed
this study to determine the prevalence and susceptibility rate of
different causes of urethritis infection among Yemeni patients.
Methods: During 11 months we investigated a total of 420
patients with urethritis (55 males and 365 females) attending the
Yemeni hospitals with a clinical presentation of urethritis. The
study subjects include 93.8% married, 93% monogamy, 87.9%
with genital discharge, 37.9% with lower abdominal pain, 46.9
with urinary retention and dysurea or urinary tract infection,
18.8% with joint pain, 8.8% travelling abroad and 6.4% with
partner complain urethral discharge. Etiology was deﬁned with
special methods of diagnosis including direct examination,
cytological test, culture, Immunoserological and immunochro-
matographic tests.
Results: N. gonorrhoea, C. trachomatis, and T. vaginalis represent
only 15.2% of the etiological agents of urethritis in yemen. The
other 84.2% of urethritis could be attributed to other infectious
agents or other causes of inﬂammation. There were 22 cases of
N. gonorrhoea (5.2%), 30 cases of C. trachomatis (7.1%) and 12
cases of T. vaginalis urethritis (2.9%). There was mixed infection
(0.95%) for N. gonorrhoea and C. trachomatis, (0.7%) for
N. gonorrhoea and T. vaginalis and (0.95%) for C. trachomatis
and T. vaginalis.
Conclusion: Urethritis and other STDs are difﬁcult to assess in
Yemen due to lack of recording system in hospitals and clinics
and lack of facilities for conducting and conﬁrming the diagno-
sis. Knowledge about STDs and their methods of transmission
and protection system is limited. Education about the methods
of transmission and protection are necessary for elimination of
STDs and urethritis.
P1519
Optimisation and evaluation of the detection of
Chlamydia trachomatis from sperm and urine
specimens by combining an automated extraction
protocol and a commercial real-time PCR assay
F. Grattard, S. Thamm, H. Tuzet, A. Ros, E. Gaillard,
B. Pozzetto (Saint Etienne, F; Wiesbaden, D; Rungis, F)
Objectives: To optimise and evaluate the use of an automated
extraction on m1000 apparatus (Abbott) before performing real-
time PCR using the RealArt C. trachomatis TM PCR kit (Abbott)
for a rapid and sensitive detection of Chlamydia trachomatis (CT)
in sperm and urine specimens. In France, the detection of CT in
sperm is mandatory before assisted reproductive techniques are
performed, justifying the need to have validated methods to test
such specimens known to contain PCR inhibitors.
Methods: An automated protocol was deﬁned on the m1000
apparatus and applied to the extraction of urine and sperms
previously tested positive by the Cobas Amplicor test (Roche
Diagnostics) and kept frozen at –20C. The quality of the
extraction on sperm samples was evaluated by the quantiﬁca-
tion of the beta-globin gene by an in-house real-time PCR. The
sensitivity of CT detection was evaluated on sperm samples
spiked with dilutions of a positive cloned PCR product included
in the PCR kit. In the ﬁnal protocol, the internal control of the
PCR kit was incorporated in the sample tube on the m1000
apparatus in order to control the whole extraction protocol.
These extraction and PCR conditions were then evaluated in a
prospective study involving 300 clinical specimens of sperm
(n = 285) or urine (n = 15).
Results: In the preliminary experiments, the specimens detec-
ted positive by Cobas Amplicor and kept frozen were all found
positive by combining the automated extraction protocol and
real-time PCR. The extraction protocol was found suitable either
on crude sperms or on sperm pellets, with a reproducible
quality of extraction on the m1000 apparatus, as evaluated after
quantiﬁcation of the human beta-globin gene. The sensitivity of
detection in sperms was at least of 1 copy/microlitre elution
volume of positive control. In the prospective study, 5 positive
specimens were detected, one in urine (6.6%) and 4 in sperm
(1.4%). The inhibition rate in sperm was 1.4% (4/285); a pre-
treatment of samples with proteinase K and SDS removed these
inhibitors. The whole duration of the process, including auto-
mated extraction and real-time PCR testing, was 4 hours for at
least 30 samples.
Conclusion: The m1000 apparatus was found suitable and
convenient for the rapid and automated extraction of DNA from
sperm and urine specimens before detection of CT by real-time
PCR.
P1520
Simultaneous isolation of Chlamydia
trachomatis, Neisseria I, Mycoplasma genitalium
and Ureaplasma urealyticum from urine, using
chlamCAP, an automated sample preparation
system based on magnetic particle separation
J. Lyse´n, H.K. Høidal Berthelsen, M. Angle`s d’Auriac,
M. Espelund, U.H. Refseth (Oslo, N)
Objectives: Chlamydia trachomatis and Neisseria gonorrhoeae
infections are a worldwide public health problem with a
combined estimated incidence of over 75 million cases. For
C. trachomatis alone approximately 4 mill new cases is registered
every year. Sexually transmitted diseases are often caused by
more than one microorganism. For instance, co-infections of
C. trachomatiswithN. gonohorroeaemaybe ashighas 20% in certain
countries. Of nonchlamydial, nongonococcal urethrisis,Mycoplasma
genitalium and Ureaplasma urealyticum are considered to be the
microorganismsmost commonly involved.M. genitaliumhasbeen
directly implicated in numerous genitourinary tract pathologies,
andU. urealyticum has been associated with acute prostatatis and
preterm delivery in connection with pregnancy.
Methods: Here, we present a new system, chlamCAP, for
simultaneous sample preparation of DNA for all four bacteria
mentioned above from urine samples followed by four separate
PCR ampliﬁcations using speciﬁc primers. With the new
method, the bacteria is initially adsorbed to uniquely coated
paramagnetic particles and magnetically separated from the
sample. A rapid lysis at room temperature releases DNA, which
is adsorbed onto the same magnetic particles. After washing, the
robot transfers puriﬁed DNA to microwells for PCR analysis.
Results: A C. trachomatis positive urine sample was spiked with
N. gonorrhoeae, M. genitalium, U. urealyticum in all combinations
of four different concentrations , with the highest concentration
at approximately 10.000 CFU/ml. All samples were positive for
C. trachomatis indicating that the presence of the other bacteria
does not negatively interfere with the capture of this bacterium.
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In most samples, all four species could be detected. Moreover,
increased concentration of N. gonorrhoeae had a positive effect on
the detection of the other species, which can be described as
interspecies hitchhiking.
Conclusion: In summary, the results obtained demonstrate that
the chlamCAP system can be used to simultaneously detect all
these STD species. This new system represents a solution for
analysis of the bacteria most frequent involved in STD using
urine samples, and could be an important contribution to reduce
their prevalence.
P1521
A new ﬂexible automated sample preparation
method based on paramagnetic particles for the
isolation of Chlamydia trachomatis from urine
samples, for downstream analysis using three
different naat systems
M. Angle`s d’Auriac, M. Espelund, T. Engen, S. Jeansson,
G. Størvold, S. Hjelmevoll, S.A. Nordbø, I.J. Haugen,
U.H. Refseth (Oslo, Tromsø, Trondheim, N)
Objectives: Chlamydia trachomatis is the leading cause of sexu-
ally transmitted disease worldwide. It is important to improve
diagnostic methods using non-invasive sample collection to
favor increased testing. With the current available methods,
swab still prevails over urine sampling mainly due to higher
NAAT inhibition and the necessity of centrifugation of urine
samples.
Method: A method avoiding centrifugation, chlamCAP (Gen-
point, Norway), initially developed for C. trachomatis has been
automated using a customized Tecan Miniprep 75 robotic
system for DNA preparation from urine samples. A multi-
centre study is presented where urine samples were analysed
for C. trachomatis using the automated chlamCAP system
combined with three different NAAT 1) BDProbeTecTM ET
(Becton Dickinson), 2) validated in-house Taqman PCR and 3)
Cobas Amplicor (Roche). Evaluation was performed using the
results produced in parallel by the on-site reference DNA
preparation methods and a third independent method was used
to resolve discrepant results. With this new method, bacterial
cells are initially adsorbed to uniquely coated paramagnetic
particles and magnetically separated from the urine, removing
NAAT inhibiting substances. After lysis at RT and washing, the
robot transfers puriﬁed DNA, resuspended in the appropriate
buffer, to the ﬁnal NAAT recipient.
Results: With the BDProbeTecTM ET SDA as downstream
analysis system, speciﬁcity obtained for both sample prepara-
tions was 99.9 %, whereas a sensitivity of 98.8% and 97.6% was
obtained for BDProbeTecTM ET and chlamCAP, respectively. No
inhibition was observed using the magnetic particles. For the in-
house developed Taqman analysis sensitivity was 95% and
98.3% for on-site reference sample preparation and chlamCAP,
respectively. For the Cobas Amplicor analysis, sensitivity was 93.1
and 98.3% and speciﬁcity at 99.7% and 100%, using Cobas
Amplicor and chlamCAP procedure for DNA isolation, respect-
ively.
Conclusion: The clear improvements brought by this new
automated DNA preparation method will help promote the
choice of urine as sample material, alleviating the need of a
physician for sample collection. Finally, its compatibility
towards diverse NAAT and potential for DNA preparation of
other STD organisms such as Neisseria gonorrhoeae, Mycoplasma
genitalium and Ureaplasma urealyticum, enables the development
of a universal automated DNA preparation platform suitable for
most STD laboratories.
Hepatitis A, B and E viruses
P1522
Efﬁcacy of hepatitis B immunoprophylaxis in
children with malignant diseases at the time of
chemotherapy
O. Geludcova, N. Predeina, M. Rusanova, I. Borodina (Moscow,
Chelyabinsk, RUS)
Objectives: To estimate efﬁcacy of the hepatitis B immuno-
prophylaxis in children with malignant diseases.
Materials and methods: 250 children with different malignancy
at the age from 0 to 16 years (median 6 years) which received
the chemotherapy were included in the study. 124 patients
received an active immunization by the recombinant vaccines
«Engerix B» or «HB-Vax II» by scheme: 0–1–2–6 months, 10 mkg
– 21 patients, 20 mkg – 92 patients. 13 patients received a
combined immunoprophylaxis – speciﬁc antibody «Hepatekt»
20 MU/kg by scheme: 0–1–2–3–4–5 months along with «HB-Vax
II», 0–1–2–6 months, 10 mkg. Vaccination was conducted in the
children without serologic marker of the hepatitis B at the ﬁrst
3–7 day after the diagnosis of malignancy. 113 children with
malignancy not received the speciﬁc immunoprophylaxis, and
formed a control group.
Results: After the 6 months, the level of the protective antibod-
ies (anti-HBs) was exceeded 10 mMU/ml (the titre median
15.3 mMU/ml) in 66% of children, which received 20 mkg
vaccines, and in 25% of children, which received 10 mkg
vaccines (g < 0.05). The titre of protective antibodies in 13
patients, which received a combined immunoprophylaxis, was
revealed earlier (g < 0.05). The titre median of anti-HBs after 3, 6
and 12 months were accordingly 193.5 mMU/ml, 126.2 mMU/
ml and 47.4 mMU/ml. The contamination of the hepatitis B in
group with speciﬁc immunoprophylaxis was 13.7%, in control
group – 41%, (g < 0.05).
Conclusion: Vaccination in children with malignancy at the
time of chemotherapy in the redoubled dose or combined
immunoprophylaxis were effective.
P1523
Quantiﬁcation of serum HBV-DNA with Cobas
Taqman for the diagnosis, monitoring and
prognosis of chronic hepatitis B virus infection
A.S. Hadziyannis, H. Panopoulou, A. Laras, E.S. Hadziyannis,
G. Colucci, S.J. Hadziyannis (Athens, GR; Rotkreuz, CH)
Objectives: Currently commercially available techniques for
the detection and quantiﬁcation of serum HBV-DNA present a
number of problems in their application for the diagnosis,
monitoring and treatment of chronic HBV infection. The
objective of our study was to evaluate in this context the
efﬁcacy of the new High Pure System Viral Nucleic Acid /
COBAS TaqMan HBV Test (Roche Molecular Systems).
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Methods: 400 sera from individuals with current or past HBV
infection, chronic HDV infection and subjects unexposed to the
hepatitis B virus were tested with the COBAS TaqMan HBV
Test. The results were compared to the ﬁndings of the COBAS
Amplicore HBV Monitor Test (Roche) and our in house Real
Time PCR.
Results: The TaqMan test correlated best with our PCR
(r = 0.98, p < 0.001). Its speciﬁcity was very high, with the
TaqMan Test being negative in the samples of persons unex-
posed to the virus. In samples from patients with low level
viraemia, its sensitivity was much higher, picking up 69% of
PCR negative and 94% of monitor negative samples. Among
patients diagnosed as long-term inactive HBsAg carriers, 95% of
the samples were positive with levels ranging from 32 to
106 copies/ml, whereas 16% and 20% of the samples were
negative with PCR and monitor respectively. Low HBV virae-
mia levels were also picked up in patients with markers of past
infection, who were negative by the compared PCR methods.
All patients with HDV infection had detectable HBV-DNA with
a maximum of 15,000 copies/ml. Data from serial samples of
patients undergoing antiviral treatment showed that many
individuals were wrongly classiﬁed as virologic responders on
the basis of non detectability with the compared methods, when
in fact HBV-DNA was positive or exhibited a breakthrough
increase under therapy.
Conclusions: The COBAS TaqMan HBV Test is a sensitive
method for detection and quantiﬁcation of HBV-DNA in serum
and can be used for a better monitoring of treatment results.
When sequential samples are tested, this method can predict
earlier a subsequent breakthrough of the response to antiviral
therapy.
P1524
Hepatitis B virus genotype distribution in Greek
population and economic immigrants and
association with HBeAg status
M. Theodorou, I. Petinelli, A. Mavrommati, A. Tsellou,
M. Menexidou, A. Toliopoulos, A. Papanastasiou, A. Chounda,
L. Boniatsi, E. Sagana (Athens, GR)
Introduction: HBV strains have been classiﬁed into seven
genotypes designated A–G based on an intergenotypic nucleo-
tide divergence exceeding 8% of the complete genome. HBV
genotypes seem to have a characteristic geographic distribution.
More over the majority of Greek patients with CHB are HBeAg
(()/HBeAb(+). During the last decade Greece has hosted a great
number of economic immigrants.
Aim: Our intention is to assess the prevalence of HBVgenotypes
and associate them with HBeAg status.
Patients/Methods: 83 patients (63.8% Greeks, 15.6% Albanians
and 20.5% Eastern Europeans–Asians) with clinical proﬁle of
chronic HBV infection, HBV DNA(+). HBV Genotype was
identiﬁed by nested PCR of HBV pol B-C and reversed hybrid-
isation (INNO-LIPA INNOGENETICS).HBeAb andHBeAgwere
determined by MEIA (AXSYM ABBOTT). HBV DNA was quan-
tiﬁed by nucleic acid ampliﬁcation, hybridization to type speciﬁc
probes and detected by Elisa (Amplicor Monitor ROCHE).
Results: 1) Genotype distribution is as follows; in Greek patients:
D 94.3%, A 3.8%, A/D 1.9%. In Albanian patients: D 92.3%, A/D
7,7% and in Eastern European–Asian patients: D 88.2%,A 5.9%, C
5.9%. 2) Genotype D associates with 92.2% HBeAg (() and
Genotype A associates with 33,3% HBeAg ((). 3) Genotype D
detection among different ethnic groups is: in Greek 94.3%, in
Albanian 92.3%, in Eastern European–Asian patients 88.2%.
Conclusions: Our results suggest that: 1) the distribution of the
HBV genotype does not differ among Greeks and economic
immigrants. 2) Genotype D predominates in Greeks and host
population (92.7%) while genotypes A, A/D, C appear to
insigniﬁcant percentages. 3) Genotype D is strongly associated
(92.2%) with HBeAg negative/HBeAb positive CHB infection
while genotype A does not seem to be related with HBeAg
negative/HBeAb positive CHB infection.
P1525
Evaluation of two commercial HBsAg assays for
low-end sensitivity to hepatitis B surface antigen
J. van Helden, O. Lentzen (Mo¨nchengladbach, D)
Objectives: The development of immunoassays with the highest
possible sensitivity for detecting those HBV infections most
commonly encountered in the routine clinical setting is a major
challenge for manufacturers. Currently, the diagnostic sensitivity
of most commercial HBsAg tests is below 0.5 ng/ml. However,
false negative results are still obtained. This may be due to the
presence of HBsAg below the detection limit of the assay, which
could occur in early acute disease or in chronic and convalescent
phases of the disease. Mutant HBV strains with altered antigens
have been shown to affect the reactivity of the antigenswith some
commercial HBsAg assays. The incidence of these viral variants
appears tobe limited to chronically infected individuals especially
those under medically or naturally induced immune pressure.
Methods: The present study was designed to evaluate the low-
end sensitivity of two commercial HBsAg immunoassays, the
Bayer ADVIA Centaur HBsAg assay and Abbott AxSYM
HBsAg assay. The following materials were utilized to evaluate
HBsAg assay sensitivity: PEI standards for HBsAg ad/ay sub-
types, one BBI HBsAg (ad/ay) sensitivity panel, 3 low-titer and
mixed-titer panels, BBI, BCP and NABI HBsAg seroconversion
panels, and the Teragenix Hepatitis B Precore Mutant panel.
Results: The Bayer ADVIA Centaur HBsAg assay has a better
low-end sensitivity and detects the presence of HBsAg at an
earlier stage than the Abbott AxSYM HBsAg assay, thus
Table 1. HBsAg Sensitivity
HBsAg Material +
dilution used
Bayer ADVIA
Centaur HBsAg s/co
[Cut-off = 1]
Abbott AxSYM
HBsAg s/co
[Cut-off = 2]
PEI Standard HBsAg ay
1.10,000 0.01 U/mL
1.12 POS 1.86 NEG
BBI PHA 106-09 1:2 2.11 POS 1.78 NEG
HBsAg -0. 06 IU/mL 2.34 1.87
BBI PHA 106-11 1:4 1.54 POS 1.84 NEG
HBsAg -0. 05 lU/mL 1.66 1.91
BBI PHA 807-06 1:5 2.19 POS 1.84 NEG
HBsAg ad- 0.03 IU/mL 2.25 1.97
BBI PHA 807- 19 undiluted 8.63 POS 1.97 NEG
HbsAg ay- 0.05 IU/mL 7.85 1.85
BBI PHA 807- 20 undiluted 1.32 POS 1.75 NEG
HBsAg ay- 0.02 IU/mL 1.45 1.68
Table 2. Comparison of HBV sero conversion panels
Panel ID HBsAg Positive Result From Initial
Draw Date
ADVIA centaur Assay vs. AxSYM
Assay
ADVIA Centaur
HBsAg Assay (Days)
AxSYM HBsAg
Assay (Days)
Difference in
Bleeds*
Difference in
Days
BCP 62433 19 22 +1 +3
BCP 62675 19 19 0 0
BCP 63568 14 10 )1 )4
BCP 62825 26 29 +1 +3
BCP 64121 27 27 0 0
BCP 63133 36 36 0 0
BCP 61291 112 98 )3 )14
PHM 933 7 7 0 0
PHM 931 19 19 0 0
PHM 932 50 61 +1 +11
PHM 930 0 3 +1 +3
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reducing the window period. The study results also indicate that
both assays detect all HBV precore mutants. Results are
summarised in Tables 1 and 2.
Conclusions: The improved low-end sensitivity of the ADVIA
Centaur HBsAg provides a clinically important advantage for
routine HBsAg testing.
P1526
Hepatitis B vaccination in chronic renal failure
patients with a 4-week schedule
M. Tato, J.L. Teruel, M. Fernandez-Lucas, J. Chacon,
M.L. Mateos (Madrid, E)
Objectives: Standard vaccination schedule against hepatitis B
consists of three doses of hepatitis B vaccine (20 mcg each), at
days 0, 30, 180 (sometimes a fourth booster dose is necessary at
day 360). In chronic renal failure patients, the schedule is the
same but doses are doubled (40 mcg). Recently, a shorter
schedule has been reported to confer the same seroprotection
rate as the standard schedule in the general population. This
schedule consists of three doses of vaccine, at days 0, 14, 28. The
aim of this study was to evaluate the efﬁcacy of a shorter
schedule for hepatitis B vaccination and to compare it with the
standard schedule in chronic renal failure patients.
Patients and methods: 56 patients on haemodialysis were
vaccinated against HBV with the classic schedule: 40 mcg of
Engerix (GlaxoSmithKline, S.A.) i.m. in the deltoid region.
Eighteen chronic renal failure patients (creatinine clearance 12–
27 ml/min/1.73 m2) and 33 patients on haemodialysis received
three doses of 40 mcg of Engerix with the short schedule. In
non-responders, a fourth dose was administered six months
after the third. Antibodies to HBsAg (anti-HBs) were measured
with an immunoenzyme assay (Assxym, Abbott Diagnostics).
More than 10 UI/l of anti-HBs two months after the ﬁrst dose of
vaccine was considered as protective.
Results: Forty-three of the 56 patients (77%) vaccinated with the
classic schedule seroconverted (>10 UI/l of anti-HBs). Eleven of
the 18 patients (61%) with chronic renal failure and 10 (30%) of
the 30 hemodialysis patients vaccinated with the short schedule
seroconverted. Among hemodialysis patients, the response rate
was lower in patients vaccinated with the short schedule (30%
and 77%, p < 0.001). In 16 non-responders, 9 seroconverted after
the fourth dose of vaccine.
Conclusion: In chronic renal failure patients, the short schedule
of vaccination against hepatitis B is less efﬁcient than the
standard 6-months schedule. A 4-week schedule may be
indicated only in patients who have no time to receive a
vaccination with a classic schedule. Our data indicate that a
booster dose of HBV vaccine will be needed in most of chronic
renal failure patients.
P1527
A study of HBV vaccination among anti-HBs
negative hospital health care workers
B.-M. Shin, H.M. Yoo, S.M. Yoo, S.K. Park (Sanggye, KOR)
Objective: Needle stick injury is not a rare accident among
hospital health care workers. Hepatitis B virus (HBV) infection is
one of the main infectious agent through needle stick injury.
Therefore, HBV vaccination is strongly recommended for HBV
exposure risk group. Through the surveillance we studied how
many HCWs could get anti-HBs after vaccination and analysed
the effects of HBV vaccination in Korean HCWs.
Methods: We surveyed 571 hospital HCWs (doctors, nurses,
aid-nurses and technicians) about previous HBV vaccination
history and tested HBsAg, anti-HBs with titer and HBcAb,IgG
using enzyme immunoassay. After that, we recommended HBV
vaccinations according to 3 cycle schedules (0.1 and 2 months)
in 118 cases of anti-HBs negative HCWs.
Results: Of 571 persons, 118 showed anti-HBs negative results.
Among them, 58 persons had completely ﬁnished 3 cycle HBV
vaccination programme. The ratio of male to female was
11:47(19%:81%). The positive rate of anti-HBs were 65.5%(38),
81.0%(47) and 93.1%(54) after 1st, 2nd and 3rd cycle respect-
ively. However, the anti-HBs titers were not associated with
vaccination cycles. The 4 cases of anti-HBs negative persons had
no previous vaccination histories and HBcAb were also negat-
ive. The HBcAb negative group showed remarkably higher anti-
HBs titers compared with HBcAb positive group (622 IU/mL
vs. 52 IU/mL) though their anti-HBs formation rates were lower
than HBcAb positive group (92% vs. 100%)
Conclusions: The lower rate of programme performance
(49.2%) needed further regular education about risk of HBV
infection among HCWs. The result of HBV vaccination was
excellent after 3 cycles and could reduce the risk of HBV
infection among HCWs. According to anti-HBs titers, no further
vaccination was needed if anti-HBs was acquired during the any
vaccination cycles. The different results about anti-HBs forma-
tion and the titers of anti-HBs between HBcAb positive and
negative group suggested pre-existing under-detectable anti-
HBsAb and different memory B cell functions.
P1528
A study of HBV viral marker with HBV
vaccination histories in healthcare workers in
case of needle stick injury
B.-M. Shin, H.M. Yoo, S.K. Park, A.S. Lee (Sanggye, KOR)
Objective: Needle stick injury associated with HBV is not a rare
accident among hospital healthcare workers (HCWs). The
prevalence of HBV infection was reported as 5–8% in Korea.
Therefore basic data about prevalence of HBV viral markers
(HBsAg, HbsAb and HBcAb) with vaccination histories in
health care workers are very useful for the guideline of hospital
infection control and HCW beneﬁt.
Methods: We tried to survey 725 HCWs including doctors,
nurses, aid-nurses and technicians and 571 HCWs (123 male and
448 female) participated in the surveillance and answered about
previous HBV vaccination histories. HBsAg, HBsAb (Elecsys
2010, Roche) and HBcAb, IgG (Centaur, Bayer) were analysed
with enzyme immunoassay.
Results: The positive rate of HBsAg and HBsAb was 2.4% and
76.8% respectively. HBsAg())/HBsAb()) cases were 20.7%. The
range of HBsAb positive rates were 64.3%–79.6% according to
the occupational divisions. The division of nurse was the most
(80%) and group of doctors (64%) were the least prevalent
HBsAb positive groups respectively. Of all cases, 24.2% did not
have HBV vaccination histories and 68.8% had experienced
more than 1 time of HBV vaccination. The HBsAb titers between
100 and <1000 IU/mL were most popular in HBsAb positive
cases. Among 571 cases, 74.1% showed negative HBcAb, IgG
and 76.1% of them had HBsAb. The cases showing positive
HBcAb also represented 78.1% positive in HBsAb tests.
Conclusion: The prevalence of HBsAg and HBsAb in HCWa in
a Korean hospital was similar to general population on Korea.
We need more education or announcement for the group of
doctors about HBV vaccination. About 75% of hospital HCWs
had not been exposed to HBV mainly because of HBV vaccina-
tions. However, no difference was found between vaccination
group and non-vaccination group in HBsAb positivity, suggest-
Abstracts
496
ing Korea is still high prevalent area about HBV infection.
Therefore, we need to practice HBV vaccination programme for
about 20% of HCWs in case of HBV exposures, such as a needle
stick injury.
P1529
Short-term use of lamivudine for patients with
severe acute hepatitis B, a series of cases
A. Radulescu, D. Tatulescu, M. Turdean, V. Zanc (Cluj-Napoca,
RO)
Objectives: There are limited data on the use of lamivudine for
patients with acute hepatitis B. We present our experience with
the use of lamivudine in seven patients with severe acute
hepatitis B. Short-term use of lamivudine was considered based
on almost complete viral suppression within 2–3 weeks and on
practical issues (prompt recovery and drug availability).
Methods: Noncomparative prospective study on the use of
lamivudine in severe hepatitis B. Diagnosis of fulminant
hepatitis B was established based on accepted criteria: clinical
signs, portal encephalopathy, high aminotransferases levels,
prothrombin levels of less than 50%. Severe hepatitis B was
diagnosed upon prolonged and worsening evolution. Serologic
tests were performed for hepatitis B surface antigen, Ig M
antibodies to hepatitis B core antigen also for hepatitis A and C.
Lamivudine at a dose of 100 mg per day was introduced since
hepatitis was severe and progressive under supportive treat-
ment. Patients were monitored till hospital discharge and the
routine follow-up was ensured.
Results: Fulminant hepatitis B developed in three healthy
individuals (27–50 years) and in two cases (50, 62 years),
having liver injury due to isoniazid-rifampin and alcohol
abuse, respectively. One severe cholestatic hepatitis B occurred
in a 62-year-old patient at three months after surgery for
cholelitiasis. After initiation of lamivudine astonishing clinical
recovery occurred in six cases, the aminotransferases and
billirubin levels decreased quickly and patients were discharged
well in three weeks without lamivudine treatment excepting the
two cases, with previous liver injury who continued the
treatment for 3–6 months. After drug cessation, no clinical
signs and biochemical tests suggested a rebound. AgHBs
seroconversion was documented in three patients at 3 and
6 months, all six patients being well with normal biochemical
ﬁndings. In a healthy 33-year-old woman, who developed
aggressive fulminant hepatitis due to strenuous physical effort
and use of anti-inﬂammatory drugs before onset lamivudine
was postponed. No beneﬁt was observed and she died before
liver transplantation after seven days of treatment with lami-
vudine.
Conclusion: Short-term use of lamivudine in severe hepatitis B
induced a prompt recovery and sustained serological response.
Our data encourage the use of this safe drug that seems to be
effective in short regimens covering the period of hepatic failure.
P1530
Detection and characterisation of a hepatitis B
surface antigen mutant in a heart transplant
patient
A. Boel, A. Vankeerberghen, H. De Beenhouwer (Aalst, B)
Objective: Analysis of mutations in the surface gene (S-gene) of
a Hepatitis B Virus (HBV)-mutant in a Heart Transplant (HTx)
patient and comparison of the performance of different com-
mercial serological assays for HBV surface antigen (HBsAg)
detection for this case.
Methods: HBsAg testing was done with Vidas HbsAg and
HbsAg-Ultra (bioMe´rieux), Advia Centaur HBsAg (Roche),
Axsym HbsAg (V2) (Abbott), Abbott Prism HBsAg (Abbott)
and Access AgHBs (Analis). HBV surface antibodies (HBsAb),
HBV e antigen and antibody (HBeAg and HBeAb) were tested
with Vidas (bioMe´rieux), HBV core antibodies (HBcAb) with
Access (Analis). DNA was extracted from serum and ampliﬁ-
cation was done by real time PCR with primers directed to the
precore/core gene of HBV.For analysis of the S-gene sequence,
cycle sequencing was done with primers targeting the small
S-gene.
Results: Before HTx, the patient was HBsAg and HBV DNA
negative but HBcAb and HbsAb positive. Three years after HTx,
elevated liver tests were found repeatedly but serological
investigation for HAV, HCV, CMV, HSV and EBV was negative.
Real time PCR detected high load of HBV-DNA. None of the
above mentioned serological assays was able to detect HBsAg in
the serum of the HTx patient. However, HBcAb, HBsAb, HBeAg
as well as HBeAb were positive.The HBV small surface antigen
sequences were analysed by cycle sequencing and compared
with NCBI Genbank sequences. This revealed the presence of
multiple missense mutations: 15 mutations (compared to
AY236162) were found in the major hydrophilic loop (aa 98–
169), the most antigenic part of the small surface antigen.
Conclusion: The virus escaped detection by all commercial
serological HBsAg assays tested. The majority of the antibodies
used in these assays are directed against the small surface
antigen, and binding is strongly inﬂuenced by the presence of
missense mutations at crucial loci present in the viral DNA.
Future serological assays for detection of HBsAg should take
mutations in the major hydrophilic loop into account in an
attempt to detect as much HBV mutants as possible.
P1531
Complete genome sequence and phylogenetic
relatedness of hepatitis B virus isolates from Iran
S. Amini-Bavil-Olyaee, R. Sarrami-Forooshani, M. Azizi,
A. Adeli, F. Sabahi, M. Abachi, F. Mahboudi (Tehran, IR)
Objectives: To date, no study has been carried out by the
hepatitis B virus (HBV) complete genome sequence from Iranian
HBV infected patients. The objective of this study was to
investigate phylogenetic analysis, genome organization and
genotype characterization of HBV strains which obtained from
Iranian chronic infected subjects and compared with HBV
genotypes reported from the Middle East countries.
Methods: HBsAg-positive sera were collected from the ﬁve
Iranian chronic HBV carriers. The complete HBV genome was
ampliﬁed using two novel primers that have introducedHind III
and EcoR I restriction enzyme cleavage sites. The HBV full-
length amplicon was cloned into pCR2.1 plasmid and then
sequenced. The Iranian HBV genome sequences were compared
with 23 human HBV genome sequences. Alignment was
achieved using CLUSTALX software, genetic distance was
estimated using the Kimura two-parameter algorithm and
then phylogenetic trees were constructed by the neighbor-
joining method. Recombination was investigated using SimPlot,
BootScanning programme and a web-based genotyping tool for
viral sequences.
Results: Results showed that the ﬁve strains were closely
related to each other, with 97–100% nucleotide similarity.
Phylogenetic analysis based on the complete genome sequence
revealed that all stains were classiﬁed into genotype D. The S
gene encoded Arg122, Pro127 and Lys160 corresponding to
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subtype ayw2. All strains had nucleotide lengths of 3182 bp
except the IR-P4 strain with a unique 3185 bp and with a Phe89
insertion in the X gene. The intragenotypic divergence of the
complete genome sequence of Iranian strains was 1.8% and the
intergenotypic to the genotype D was 3.8% and to other
genotypes was 7.9–15.4%. The Middle East countries HBV
gene sequences analyses ﬁndings showed that HBV genotype D
subtype ayw2 is the most dominant. Results showed that Saudi
Arabia isolates has the most similarity to Iranian isolates and
then Turkish, Egyptian and Yemeni isolates ranked next,
respectively.
Conclusion: This is the ﬁrst report of the full-length nucleotide
sequences and genome organization investigation of the HBV
isolates from Iran. This study revealed that the HBV genotype D,
subtype ayw2 is present in the Iranian infected patients. A
unique amino acid insertion in the X gene of the one Iranian
strain was detected with an unprecedented length of 3185 bp.
The update Middle East HBV geographical genotypic distribu-
tion map was depicted.
P1532
Autochthonous sporadic acute hepatitis E cases in
Madrid, Spain
A. Molina, J.L. Patier, V. Moreira, J. Chacon, F. Baquero,
M.L. Mateos (Madrid, E)
Introduction: Hepatitis E virus (HEV) infection is an important
cause of epidemic and acute sporadic hepatitis in developing
countries where HEV is considered endemic. In Western Europe
hepatitis E virus (HEV) infection is rare and only imported cases
have been reported. Recently, autochthonous cases in some
industrialized countries have emerged in patients who had
never travelled to endemic areas .The aim of this study was to
describe nine autochthonous sporadic cases of HEV infection in
Madrid (Spain).
Methods: From June 1999 to September 2004, nine patients with
acute hepatitis and IgG anti-HEV antibodies in serum specimens
were detected at our hospital. Viral markers for HAV, HBV and
HCV were negative with an EIA assay (Assxym, Abbott
Diagnostics). IgG and IgM anti-HEV antibodies were studied
by EIA (Bioelisa HEV IgG and Bioelisa HEV IgM, Biokit;
Barcelona, Spain). Detection of RNA-HVC and DNA-HVB was
performed with TaqManR (Roche Diagnostics). All patients had
increased aminotransferase levels and symptoms of acute
hepatitis. Patients were questioned about epidemiological risk
factors related to HEV infection such as travelling to endemic
areas or contact with animals.
Results: Anti-HEV IgG and IgM antibodies were found in all
patients. Seven patients were males and two females, mean age
61.4 years (46–80) with mean ALT values of 1418 (84–5727). No
risk factors for HEV infection were found except in two patients:
one who worked in a slaughter-house and another who was an
occasional horse rider. Patients denied to have travelled to
endemic areas.
Conclusions: In endemic areas, HEV infections are most fre-
quently found in young adults. Our patients were older than
those reported by other authors. Given that some animals may
be reservoirs of HEV and animal-to-human transmission occurs,
we think that two of our patients had a risk factor for HEV
infection. Although HEV infection is very rare in non-endemic
areas, it must be considered in the diagnosis of acute hepatitis
with negative viral markers for HAV, HBV and HCV, even if
patients have never been in endemic areas. HEV infection must
be considered as emergent in our country because of the
increasing immigration and geographical situation.
P1533
Seroepidemiology of hepatitis A and hepatitis B
virus in Luxembourg
J. Mossong, L. Putz, S. Patiny, F. Schneider (Luxembourg, LUX)
Objectives: A prospective seroepidemiological survey was
carried out in Luxembourg in 2000–2001 to determine the
antibody status of the Luxembourg population against hepatitis
A virus (HAV) and hepatitis B virus (HBV). One of the
objectives of this survey was to assess the impact of the hepatitis
B vaccination programme, which started in May 1996 and
included a catch-up campaign for all adolescents aged 12–15.
Methods: Venous blood from 2679 individuals were screened
for the presence of antibodies to hepatitis A virus antigen and
antibodies to hepatitis B surface antigen (HBsAg) using an
enzyme immunoassay. Samples positive for HBsAg antibody
were tested for antibody to hepatitis B core antigen (anti-HBc)
using a chemiluminiscent microparticle immunoassay to distin-
guish between individuals with past exposure to vaccine or
natural infection.
Results: The estimated age-standardized anti-HAV seropreva-
lence was 42% in the population above four years of age.
Seroprevalence was age-dependent and highest in adult immi-
grants from Portugal and former Yugoslavia. The age-standard-
ized prevalence of anti-HBsAg and anti-HBc was estimated at
19.7% and 3.16%, respectively. Anti-HBsAg seroprevalence
exceeding 50% was found in the cohorts targeted by the routine
hepatitis B vaccination programme, which started in 1996.
Conclusions: Our study illustrates that most young people in
Luxembourg are susceptible to HAV infection. The hepatitis B
vaccination programme is having a substantial impact on
population immunity in children and teenagers.
P1534
Hepatitis A outbreak in a school observed after
an explosion in the sewer system
G. Sengoz, M. Bakar, T. Colakoglu, E. Celiikkol, S. Kilic¸arslan,
S. Uz, E. Tuncer (Istanbul, TR)
Objectives: Hepatitis A is a classical example of infections
transmitted by fecal-oral route and its prevalence is closely
related with the socioeconomical status. In societies showing
moderate endemicity, primary transmission route is personal
contact, on the other hand water originated outbreaks may be
seen.
Methods and Results: In this study, a hepatitis A outbreak
observed in a local school following an explosion in the sewer
system in a street in Istanbul Sariyer on September 27th 2004, is
investigated. 32 children attending this school and living at
homes around had hepatitis A, clinically, the ﬁrst case seen
25 days after the explosion. Age distribution of the children is 1–
18 and the mean age is 8.4. The ﬁrst case was detected on
October 22nd and 21 cases were reported in the ﬁrst 6 days and
32 cases were seen in 17 days. Water samples were taken and
fecal contamination was searched at the school in order to ﬁnd
out the origin. The canteen and the toilets were also searched.
All the students were checked up to ﬁnd out new cases.
Teachers and students were educated about the disease and
hygiene by doctors of Health Group Presidency, continuity of
education was provided by a doctor in charge throughout the
outbreak and other schools around were checked and educated
by cooperation with Directory of National Education. Origin
research was also performed at homes of all cases and the
families were informed about the disease and quarantine
precautions. ISKI was quickly informed about the subject and
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controls by taking water examples and documentations were
also done by ISKI.
Conclusion: The dimensions of an outbreak of an infectious
disease transmitted by water fecal-orally in a metropolis of
11 million population may be great. In our country report of
hepatitis A is obligatory. Because of this, the origin of the disease
is searched soon after reported cases and the isolation of the
cases is provided. Hepatitis A vaccine is not included in the
National Vaccination Programme of our country. If there is not a
serious risk to have the disease in childhood, there is no need for
passive immunization. All the contacts were evaluated in this
respect, also. The outbreak was under control at the end of the
ﬁrst week by the precautions and education at the school with a
population of 1400.
P1535
Prevalence of anti-HAV antibodies in different
age groups in Spain
S. Mun˜oz Criado, E. Rodrı´guez Tarazona, A. Rodrı´guez
Achaerandio, J.L. Mun˜oz Bellido, J.A. Garcı´a-Rodrı´guez,
M.C. Sa´enz Gonza´lez (Salamanca, E)
Introduction: The hepatitis A virus (HAV) usually spreads by
the fecal-oral route, and is frequently associated with poor
hygiene habits and conditions. The prevalence of HAV decrea-
ses when hygiene conditions improve. IgG antibodies against
HAV last for years (frequently lifetime) in patients who have
suffered hepatitis A, and seroprevalence can so be used to know
the frequency of contact with the HAV in a group.We have
studied the seroprevalence of IgG antibodies against HAV in
sera from non-selected, healthy individuals, obtained in 1997
and 2004, in order to know the seroprevalence in different age
groups and the evolution of seroprevalence.
Methods: 250 sera samples obtained in 1997 and 250 sera
obatined in 2004 from healthy patients were studied. Both sera
groups were organized in 5 age group including 50 sera each, as
follows: group 1: patients 18–25 years old, group 2: 26–35 years
old, group 3: 36–45, group 4: 46–55 and group 5: 56–65. Sera
were studied by EIA (HAV Liaison, Saluggia, Italy.
Results: Appear in Table 1. In 1997, more than 50% of patients
between 26 and 35 years old, and almost all patients older than
36 years had anti-HAV antibodies, while only 28% of patients
between 18 and 25 years were positive. In sera obtained in 2004,
the seroprevalence has changed signiﬁcantly. The seropreva-
lences in groups 1, 2 and 3 are much lower (8% vs. 28%, 22% vs.
56%, and 58% vs. 98%), while a seroprevalence of 100% remain
in groups 4 and 5.
Comments: Seroprevalence of anti-HAV antibodies has been
very high in adult individuals in Spain, but is decreasing very
fast. At this moment, seroprevalence remains around 100% only
in patients older than 45 years, and is around 50% in patients
between 36 and 45 years, but is becoming very infrequent in
young adults. This situation shall be had in account in order to
stablish vaccination protocols against HAV.
Herpes virus
P1536
Antibodies to varicella zoster virus: no role in
prognosis of Herpes zoster
W. Opstelten, G.A. van Essen, A.J.M. van Wijck, K.G.M. Moons,
C.J. Kalkman, A.M. van Loon, T.J.M. Verheij on behalf of ESPRIT
Objectives: To measure antibodies (IgA, IgM, and IgG) to
varicella-zoster (VZ) virus in patients with clinical herpes zoster
(HZ) and to relate these ﬁndings to clinical symptoms of acute
HZ and to the occurrence of postherpetic neuralgia (PHN).
Methods: Prospective study of elderly (>50 years) patients
presenting to their general practitioner with acute HZ (rash
<1 week). Personal and demographic data were registered from
patients and pain was assessed using visual analogue scale and
quality of life questionnaires. Blood samples were collected at
baseline and one week later and analysed for IgA, IgG, and IgM.
Pain was assessed at the initial visit and subsequently after 1, 2,
3, 4, 8, 12, and 26 weeks.
Results: 270 patients were included. In 26 (10%) of them HZ
could not be serologically conﬁrmed. A signiﬁcant association
was found between titers of IgA and IgG at the initial visit and
age and severity and duration of rash. There was no signiﬁcant
association between reported pain and titers of antibodies.
Serological data did not contribute to the prediction of occur-
rence of PHN.
Conclusions: The clinical diagnosis of HZ made by the general
practitioner can be serologically conﬁrmed in most cases. The
titers of antibodies are correlated with the severity and duration
of the rash. They are, however, not associated with the intensity
of pain, neither are they predictive for the duration of pain.
P1537
Herpes zoster in hospitalised Turkish children
N. Dalgic, E. Ciftci, Z. O¨rgerin, S. O¨ncel, N. Belet, E. Ince,
U¨. Dogru (Ankara, TR)
Objectives: To investigate clinical features and outcome of
herpes zoster in hospitalized children.
Methods: All records of the children hospitalized for herpes
zoster between 1998 and 2004 in the Department of Paediatric
Infectious Diseases at Ankara University Medical School, were
retrospectively evaluated. Data about age, dermatome involve-
ment, underlying disease, history of previous varicella, the
interval between varicella and herpes zoster, herpes zoster-
associated pain, treatment and outcomes of the patient were
recorded.
Results: During the period of 6 years, 19 children with herpes
zoster were identiﬁed. Ten out of 19 (52%) were male. The mean
Seroprevalence rate (%)
Age groups 1997 2004
1 28 8
2 56 22
3 98 58
4 96 100
5 100 100
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age at presentation was 119.3 ± 55.5 months (ranges from
9 months to 15 years). Established underlying diseases for
childhood herpes zoster were found in 17 (89%) of 19 cases.
The most common underlying diseases were lymphoma (6
patients) and acute lymphoblastic leukaemia (5 patients). No
history of varicella was recalled in 9 (47%) of 19 cases. The
interval between varicella and herpes zoster ranged from 4 to
144 months. Involved dermatomes were thoracic (10 patients),
servical (7 patients) and sacral (2 patients). Two dermatomal
involvement was detected in only two children. Two children
experienced mild pain during the eruption, without requiring
speciﬁc therapy. In 3 (15%) of 19 cases, herpes zoster-associated
complications including pneumonia, hepatitis and keratocon-
junctivitis were noted. None of the patients was immunized
against varicella. The mean period between the onset of rash and
the initiation of acyclovir treatment was 2.4 ± 1.1 days (range 1–
5 days). Eighteen of 19 cases received intravenous acyclovir
treatment. Five of these patients had received sequential
parenteral/oral acyclovir treatment, whereas only one patient
received only oral treatment. Acyclovir treatment was discon-
tinued because of renal toxicity in one child. The mean treatment
period was 7.7 ± 1.0 days (range 7–10 days) in 18 patients. No
cases with post herpetic neuralgia were recorded.
Conclusion: Acyclovir treatment started on time, is very
important for the prevention of progress of the disease.
Acyclovir treatment is so effective that acyclovir prophylaxis
seems unnecessary to prevent or modify clinical varicella in
immunocompromised children. Varicella immunization is
important for prevention of varicella and herpes zoster.
P1538
Effects of acyclovir on nitric oxide and cell death
in herpesvirus type 1 and 2 infected HEp-2 cells
H. Baskin, Z. Yazici, Y. Baskin, N. Olgun, A. Ozkul,
I.H. Bahar (Izmir, Samsun, Ankara, TR)
Objectives: Herpesviruses are among the most ‘successful’
human pathogens. Inhibition of apoptosis is a common strategy
of viral pathogenesis that favors virus replication and may
contribute to oncogenesis. The herpes simplex viruses 1 and 2
(HSV1, HSV2) code for a variety of proteins that cooperate in
blocking apoptosis triggered by virus infection. Nitric oxide
(NO), a potentially toxic signal molecule, has been implicated in
a wide range of diverse pathophysiological process. The
crosstalk between cell destructive and protective signaling
pathways, their activation or inhibition under the modulatory
inﬂuence of NO will determine the possible role of NO in
apoptotic cell death and/or survival. Acylovir’s effect mechan-
ism targets at the viral DNA polymerase, acts as a chain
terminator. Its ﬁrst phosphorylation step is catalyzed by the
virus encoded thymidine kinase. Acyclovir’s interactions with
cell death and NO seem to be very important because of ‘post
treatmental cognitive functions’that may be encountered due to
treatment processes for encephalitis, meningitis cases.
Methods: HEp-2 cells were infected by HSV1 (KOS strain) (and
UV-inactivated Mock of the same strain) and HSV2 (G strain)
(and UV-inactivated Mock of the same strain). Infected cells
were treated by non apoptotic doses of acyclovir (48.8; 24.4; 12.2;
6.1; 3; 1.5 lg/mL), respectively. Following 24 hours of infection
cells were detected by Hoechst 33342 and propidium iodide for
apoptosis/necrosis, and culture supernatants by Griess reagent
for NO.
Results: NO responses were signiﬁcantly higher in HSV 1
infected cells in 48.4; 24.4; 12.2, but after 6.1, in 3 and in 1.5 NO
responses were higher in HSV2 infected cells. Also in HSV1
infected cells with 48.4; 24.4; 12.2 doses of acyclovir, apoptotic
responses were higher than HSV2. But necrosis responses were
signiﬁcantly higher in HSV2 infected cells (48.8; 24.4; 12.2; 6.1;
3 lg /mL).
Conclusion: In this study, it is shown that there are signiﬁcant
differences between HSV 1 and 2 in apoptosis/necrosis, and NO
responses. It is assumed that involvement of acyclovir in doses
higher than 6 lg/mL may trigger the necrotic pathway in HSV2
infected cells, the same compound seems to cause statistically
signiﬁcant higher NO response in HSV1 infected cells in contrast
to those infected with HSV2. These results deserve further
studies in order to explain the effects of acyclovir in treatment
processes especially in ‘cognitive functions’.
P1539
Clinical evaluation and signiﬁcance of herpes
viruses DNA ampliﬁcation in the central nervous
system of neurological patients (2000–2004)
J. Reina, M.D. Macia, O. Gutierrez, E. Ruiz de Gopegui (Palma de
Mallorca, E)
Objectives: To retrospective study the clinical manifestations
and evaluate the Herpes viruses DNA ampliﬁcation signiﬁcance
in the CNS of patients with neurological symptoms.
Methods: From January 2000 to September 2004, we studied the
CSF of all patients with different clinical symptoms of neuro-
logical disease. A commercial nested PCR (Real, Durvitz,
Valencia), which ampliﬁes simultaneously the HSV, VZV,
CMV, EBV and HHV-6, was used for the detection of Herpes
viruses genome. All clinical samples were also inoculated in the
MRC-5 cell line for the isolation of entero viruses. The clinical
characteristics of patients with a PCR positive were reviewed.
Results: During the study period, 745 CSFs were analysed. Of
these, 38 (5.1%) were considered positive, corresponding to
different patients. Positive percentages varied over the study
period from 1.2% in 2003 to 7.8% in 2004. The 38 CSFs were
positive for: 25 HSV (65.7%), 10 CMV (26.3%), 2 VZV (11.1%)
and 1 HHV-6 (5.5%). Of the 38 patients, 22 (57.8%) were adults
and 16 (42.2%) were children (<15 years); 26 (68.4%) were male
and 12 (31.6%) female (p < 0.05). The deﬁnitive clinical diag-
nosis of the HSV-positive patients were: 10 (40%) encephalitis, 6
(24%) lymphocytic meningitis, 3 (12%) intracraneal hemorrhage,
2 (8%) tuberculosis meningitis, and 4 (16%) other neurological
syndromes; in this group 4 (16%) patients were HIV-positive. Of
the 10 CMV-positive patients, 3 (30%) presented with a
congenital CMV infection, 3 (30%) were HIV-positive, 2 (20%)
had a lymphocytic meningitis, and 2 (20%) other neurological
syndromes. The 2 (100%) VZV-positive patients were children
with a clinical post-varicella encephalitis. The only HHV-6
positive patient was a child of 4 years with exanthem subitum
with neurological manifestations (convulsions).
Conclusions: The correlation between Herpes viruses genome
ampliﬁcation in the CSF and the clinical study of the patients
analysed (clinical signiﬁcance) was 64% in the HSV, 80% in
CMV and 100% in VZV and HHV-6, with an overall correlation
of 71%. Of the CMV and HSV-positive patients, 30% and 16%
respectively were HIV-positive (p < 0.05). The PCR is a highly
sensitive technique although in some cases the results obtained
are difﬁcult to relate with clinical symptoms, especially in
tuberculosis meningitis and cerebral hemorrhage (false posi-
tive).
Abstracts
500
P1540
The crystal structure of HCMV UL44 and analysis
of its interaction with UL54: new targets for drug
discovery
A. Loregian, B. Appleton, J.M. Hogle, D.M. Coen,
G. Palu` (Padua, I; Boston, USA)
The human cytomegalovirus DNA polymerase is composed of a
catalytic subunit, UL54, and an accessory protein, UL44, which
has been proposed to act as a processing factor. We have solved
the crystal structure of UL44 to 1.85 A resolution. Remarkably,
the structure revealed a dimer of UL44 shaped like a C-clamp
that could partially surround double-stranded DNA. Each
monomer resembles herpes simplex virus UL42, with the
dimer interface near the base of a region of UL44 identiﬁed in
the crystal structure as the ‘connector loop’. Analytical ultra-
centrifugation and gel ﬁltration measurements demonstrated
that UL44 also forms a dimer in solution, and substitution of
large hydrophobic residues along the homodimer interface with
alanine disrupted dimerization and decreased DNA binding. In
addition, to deﬁne individual residues in UL44 and UL54 that
are crucial for interacting with each other, we have engineered
several mutations both in the C-terminal region of UL54 and in
the connector loop of UL44. Substitution of alanine for Ile135 in
UL44 and for Leu1227 or Phe1231 in UL54 greatly impaired both
the UL54/UL44 interaction in pull-down assays and long-chain
DNA synthesis, identifying these residues as crucial for subunit
interaction. Using isothermal titration calorimetry, we quantita-
tively measured the binding of peptides corresponding to the
extreme C-terminus of UL54 to UL44. We found that a peptide
corresponding to last 22 residues of UL54 bound speciﬁcally
UL44 in a 1:1 complex with a dissociation constant of approxi-
mately 0.7 lM, and that substitution at UL44 residue 135
completely abolished binding to the peptide. Thus, the results
identify speciﬁc side chains that appear to be crucial for UL54/
UL44 interaction. This information and the structure of UL44
may aid in the rational design of new anti-HCMV compounds
which act by disrupting the UL44/UL44 or the UL54/UL44
interaction.
P1541
Development of a real-time NASBA for herpes
simples virus 1+2
B. Deiman, F. Jacobs, S. Vermeer, C. Schrover, D. van
Strijp (Boxtel, NL)
Objectives: The aim was to develop and evaluate a Herpes
simplex virus assay based on NASBA ampliﬁcation and inclu-
ding real-time detection with molecular beacons. In this study,
the performance of this new test is evaluated.
Methods: HSV DNA is isolated using a semi automated
magnetic extraction method and the NucliSens miniMag. An
internal control is added to the sample prior to nucleic acid
extraction. Primers are directed against the POL-gene region of
the HSV genome and both HSV 1 and 2 and the internal control
are ampliﬁed with the same primer set. The assay includes three
molecular beacon probes: two genotype-speciﬁc molecular
beacon probes for the detection of HSV 1 and HSV 2 speciﬁcally,
and one additional beacon for the detection of the internal
control. Ampliﬁcation reactions were performed in a NucliSens
EasyQ Analyser allowing real-time detection.
Results: HSV 1, HSV 2 and IC are detected in one and the same
reaction using a three-label approach. In co-infections, both HSV
1 and HSV 2 are detectable. Using serial dilutions of in
vitro DNA, HSV detection is shown down to £10 copies in
ampliﬁcation for both HSV 1 and HSV 2. Good results are
obtained with the QCMD panel: HSV was detectable down to
1–6 · 102 Geq/ml (lowest concentration) and the genotypes of
the HSV samples were identiﬁed correctly. In addition, HSV is
detectable in clinical samples (CSF, swabs). VZV and EBV are
not detectable with this assay. With the real-time assay, HSV in
CSF samples is detectable within approximately 3.0 hours.
Conclusions: The data showed that the real-time and internally
controlled HSV assay is a rapid, sensitive and speciﬁc qualitative
assay for the detection of HSV 1 and HSV 2 in one and the same
reaction. The use of standardized reagents offers considerable
beneﬁts in a routine setting for the clinicalmanagementofpatients
with HSV infections. This assay will bring same-day results,
enabling early and accurate clinical intervention leading to better
patient care and considerable overall health care cost savings.
P1542
Development of type speciﬁc based glycoprotein
G assay to identify of HSV-2 infection
M. Jamalidoust, F. Fotouhi Chahooki, H. Soleimanjahi,
M. Roostaee (Tehran, IR)
Objective: Herpes Simplex Virus type-2 (HSV-2) is the main
cause of genital herpes infection. Its prevalence is increasing
worldwide and varies widely with generally higher rate in
developing than developed countries and urban than rural
areas. For studying prevalence and seroepidemology survey,
HSV gG-2 was prepared in prokaryotic system to recognize
asymptomic and unknown symptomic individuals.
Methods: HSV-2 Iranian isolate was propagated in HeLa cell
line. The viral genome was extracted by phenol-chloroform, and
used as template in nested polymerase chain reactions (n-PCR) to
amplify gG-2 gene. The ampliﬁed gene was cloned into a cloning
vector (pTZ57R/T) after sequencing. In the next step competent
E-coli DH5a was transformed with constructed plasmid. The
resulted white colonies were selected in the presence of ampici-
lin; X-gal and IPTG. The recombinant plasmid (pTZ57R-gG2)
was extracted and puriﬁed in the large scale after restriction
enzyme analysis. The 1.1 Kb fragment was extracted and
puriﬁed from LMP gel after treated with BamHI and HindIII
enzymes. The isolated gene was subcloned into appropriate sites
of pET32 (a) plasmid as an expression vector .The protein
production was conﬁrmed by SDS-PAGE and western blotting
after induction by IPTG using a polyclonal antibody.
Result: The HSV-2 gG gene was conﬁrmed by sequencing. The
results of western blotting analysis revealed that glycoprotein G
of Herpes Simplex Virus type 2 was expressed efﬁciently in the
prokaryotic system.
Conclusion: The pure gG-2 can be used as a candidate antigen
instead of crude whole HSV-2 in the serological tests such as
ELISA.
P1543
Markers of inﬂammatory process in genital virus
infection
A.V. Shurshalina, L.A. Marchenko, G.T. Sukhikh (Moscow, RUS)
Objectives: Severe genital herpes may be the reason of infer-
tility, recurrent pregnancy loss and IVF failures.
Methods: 103 women (mean age 30.8 ± 0.82) with severe
genital herpes (mean recurrence per year 7.5 ± 0.6) were
included in study. We tested cervical samples for cytokines
(IL-6, IL-10, TNF-alfa, IFN-gamma) and serum samples for
CD69+, CD25+ and HLA-DR+ during recurrence, remission and
after 8-month Valaciclovir treatment in the dose of 500 mg per
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day. Control group was ten healthy women without genital
herpes and HSV antibodies G and M in serum.
Results: During herpes recurrence, the local levels of TNF-alfa
increased twice and 8 times as much as compared to remission
and the controls, IFN-gamma – 1.5 and 2.3 times, CD69+ – 1.4
and 3.3 times, CD25+ – 1.4 and 2.5 times, HLA-DR+ – 1.6 .and
2.5 times (p < 0.05). IL-10 decreased 4 and 3.3 times as less. After
Valaciclovir treatment, the cervical levels of TNF-alfa decreased
by 60%, CD69+ – 26%, HLA-DR+ – 23.6% (p < 0.05).
Conclusion: very high levels of inﬂammatory markers in cervix
and serum during severe genital herpes conﬁrm an important
role of HSV in genital inﬂammation, cervical and endometrial
pathology, and allow to consider genital herpes as an inﬂam-
matory process.
P1544
Herpes simplex virus – causative agent, or
innocent bystander?
K. Soltysova, E. Bronska, D. Picha, V. Maresova (Prague, CZ)
Objectives: Herpes simplex virus (HSV) is a well-known
causative agent of sporadic necrotising encephalitis. Encephal-
itis occurs during HSV virus primoinfections and reactivations.
HSV neuroinfections may also have milder forms that often
remain unnoticed if the patient’s cerebrospinal ﬂuid (CSF) is not
directly tested for the HSV DNA presence.
Methods: Medical records of 1800 patients hospitalized with
neuroinfections from 1998 to 2003 were retrospectively searched
for examination results indicating the presence of HSV DNA in
CSF. 89 patients were examined. The presence of HSV was
tested using the nested PCR method at the National Reference
Laboratory in Prague. Out of these patients, 6 cases of immu-
nocompetent adults were identiﬁed, which themselves con-
tained another etiological agent. The following data was
collected: severity of the symptoms, the hospitalization length,
permanent neurological sequels, and the results of neuroimag-
ing methods including EEG. The clinical course of dual
infections was then compared to all the imunocompetent
adults hospitalized with neuroinfection in 2001, 185 in total.
Results: 14 cases of HSV DNA were identiﬁed, including the 6
dual infections mentioned above. Among the 6 cases, 4 corres-
ponded to the tick-born encephalitis agent (serologically con-
ﬁrmed), 1 case to neuroborreliosis, and 1 case to purulent
meningitis. The 6 patients were 27–80 years old, with an average
age of 58. All showed a substantial neurological involvement
during the entrance examinations. The average hospitalization
period for the dual infections was 14 days longer than in the 185
reference patients. Focal neurological sequels, typical for HSV
encephalitis, were conﬁrmed only in 1 case, the other 5 showed
normal CT results. All 6 patients were treated with Acyclovir at
least for 10 days. Despite the dual infection and severe entrance
neurological involvement, the treatment showed positive results.
Conclusion: The number of patients suffering from dual infec-
tions is underestimated. Reactivation of herpes viruses is one
cause of the dual infections. Since dual infections have additive
effects, it is desirable to identify these cases and to cure them
causatively.
P1545
Increasing evidence of primary cytomegalovirus
infection in otherwise healthy adults
R. Manfredi, L. Calza, F. Chiodo Bologna, I
Introduction: The increased availability of serology-biomolec-
ular assays for acute Cytomegalovirosis (C),allows us to include
these assays in the workout of fever of unknown origin (FUO) of
immunocompetent adults. A retrospective survey of patients (p)
diagnosed with primary C after referring to our centre because
of a FUO associated with a broad spectrum of constitutional
signs-symptoms was performed.
Patients and Methods: Since the year 2001,103 p aged
14–42 years (64 females), were assessed for FUO.C serology
was carried out in the 1st-step workout, together with haema-
tological–biochemistry studies, and assays for collagen vascular
and autoimmune disorders, thyroid function, and microbiology
studies for mononucleosis, toxoplasmosis, HIV, community-
acquired respiratory, urinary, and stool pathogens, and tuber-
culosis. All p underwent C serology for IgM-IgG search, a
minority of p had viral DNA-antigen search.
Results: Of 103 p,14 (13.6%) had a positive IgM search for C,
conﬁrmed in 4 cases by biomolecular-antigen assays.A cross-
reaction with EBV serology was found in 8 p, but IgM antibody
titres against EBV were lower and rapidly declined during a
6–12 month follow-up. An altered leukocyte count and differ-
ential was always present,and lymphocyte subsets showed a
transient imbalance of CD4/CD8 cell ratio, a decrease of rate
and absolute number of CD4 cells (250–580/lL), and an
expansion of CD8 subset. Underlying signs-symptoms included
fever in all p associated with a mononucleosis-like syndrome in
11 p, usually characterized by a moderate lymphadenopathy
and pharyngodinia. In 10 cases a moderate (2–4-fold) elevation
of transaminases was present and hepatosplenomegaly was
conﬁrmed by ultrasonography. In 3 p only fever, fatigue and
anorexia were the predominant signs and symptoms. A nor-
malization of hepatic enzymes and leukocyte differential pre-
ceded the disappearance of lymphadenopathy and
hepatosplenomegaly, while positive C IgM search lasted until
36 months in 1 p (mean time to disappearance:10–26 months).
Discussion: Primary C is a self-limiting disease, whose appar-
ent increase in frequency is probably attributable to the easier
access to speciﬁc laboratory testing. Although no treatment is
indicated in otherwise immunocompetent p, clinicians should
maintain an elevated suspicion for primary C when a FUO is of
concern, since C may last signiﬁcantly and p with missed
diagnosis are at risk of a vicious circle between an apparently
unexplained disease, and the need of further examinations.
P1546
Risk factors and seroprevalence of serum
antibody to human herpesvirus 8 among HIV
seropositive and seronegative adults from Croatia
O. Dakovic Rode, J. Begovac, S. Zidovec Lepej (Zagreb, HR)
Objectives: Human herpesvirus 8 (HHV-8) IgG antibodies
precede and strongly predict the development of Kaposi’s
sarcoma (KS), but HHV-8 requires additional factors to exert its
effect in KS development. The aim of this study was to estimate
possible predictors of HHV-8 infection.
Methods: A cross-sectional study was conducted at the Uni-
versity Hospital for Infectious Diseases in Zagreb from May
1999 till August 2001. A total of 166 serum samples from adult
HIV-infected patients and 219 from blood donors were analysed
for IgG antibodies to HHV-8 by enzyme-linked immunosorbent
assay (ELISA) using whole virus lysate as antigen (ABI,
Columbia, USA). We analysed HHV-8 infection according to
gender, age, geographic origin (Mediterranean part of Croatia
compared to other parts of the country), HIV-infection and
herpes simplex 2 (HSV-2) infection determined by a gG2-speciﬁc
ELISA (DiaSorin, Saluggia Italy). Bivariate and multivariate
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logistic regression was used to evaluate association between
HHV-8 and investigated parameters.
Results: The prevalence of HHV-8 was 13.3% among HIV-
infected patients and 4.1% in blood donors. There were no
differences among HHV-8 prevalence according to gender and
geographic origin. HHV-8 prevalence among HIV-infected
patients was signiﬁcantly higher in older age (OR 4.0; 95%CI
1.39–14.29). Independent predictors of HHV-8 infection inclu-
ded HIV-infection (OR 2.72; 95%CI 1.11–6.65), HSV-2 infection
(OR 2.53; 95%CI 1.09–5,89) and male gender (OR 5.0; 95%CI
1.12–20.00)
Conclusion: HHV-8 infection was independently associated
with HIV, HSV-2 and male gender. Our results suggest that
sexual transmission of HHV-8 is the most important mode of
infection with HHV-8 in adults from Croatia.
P1547
Enzyme immunoassay for the detection of anti-
Kaposi’s sarcoma-associated herpes virus IgG
antibodies based on new mosaic protein
N. Kornienko, M. Gladysheva, T. Ulanova, V. Puzyrev,
A. Burkov, L. Loginova, A. Obriadina (Nizhniy Novgorod, RUS)
Background: Kaposi’s sarcoma-associated herpes virus (or
human herpes virus type 8 HHV-8) is a recently discovered
gamma-herpesvirus associated with 4 clinical and epidemiolog-
ical variants of Kaposi sarcoma (classic, endemic, iatrogenic, and
acquired immunodeﬁciency virus-associated), primary effusion
lymphoma and multicentric Castleman’s disease.
Objective: The aim of this study was to learn the antigenic
properties of new recombinant mosaic protein and to develop
and evaluate a screening enzyme immunoassay (EIA) for the
detection of anti HHV-8 IgG activity in serum specimens.
Materials and methods: Mosaic of 2 antigenic domains from
the proteins encoded by open reading frames 65 (140–170 aa)
and K8.1 (32–62 aa) of HHV-8 was produced as GST fusion
protein to develop an assay for the detection of anti HHV-8
antibodies.Assay conditions were optimized to reduce the
possibility of false positive and false negative results. To
validate the speciﬁcity and sensitivity of new EIA sera from
HIV-infected individuals (n = 163), children (0–15 years)
(n = 170), patients with sexual transmitted diseases (STD)
(n = 136), and from European normal blood donors (n = 1349)
were tested. Serum samples from KS patients (n = 30) were
initially tested as positive by immunoﬂuorescence assay with
LANA protein. All specimens were additionally tested for IgG
anti-HHV-8 activity by commercially available EIA (Vecto
HHV-8-IgG-strip,Russia).
Results: 27 out of 30 HHV-8-positive samples were positive on
the novel EIA. Assay sensitivity was calculated at 90%. Coin-
cidence with commercially available EIA was 98.21%. The
percentages of positive reactivity in all investigated groups were
as follows: 119 for health blood donors, 1.76 for children, 2.21 for
STD-patients and 3.38 for HIV-infected. Speciﬁcity of the assay
was around 98.2%–98.8% and there were no signiﬁcant differ-
ences between health donors/children and groups at highest
risk of acquiring HHV8 infection.
Conclusion: The artiﬁcial mosaic protein used in this study
demonstrated signiﬁcant potential as diagnostic reagent. The
new EIA is highly speciﬁc diagnostic assay for the detection of
anti-HHV-8 activity in serum specimens and may be useful tool
for studies of HHV-8 epidemiology.KSHV seroprevalence in the
Russian European population is low both among health donors
and HIV-infected people.
P1548
Human herpes virus 8 infection and pulmonary
hypertension in lung transplantation candidates
E. Nicastri, C. Vizza, S. Cicalini, F. Carletti, R. Badagliacca,
R. Poscia, F. Fedele, N. Petrosillo (Rome, I)
Objectives: Human herpes virus-8 (HHV-8) has been detected
in biological samples of patients affected by Kaposi Sarkoma,
Castleman disease and primary-effusion B-cell lymphomas.
HHV-8 has been recently described in the pathogenesis of
idiopathic pulmonary arterial hypertension (IPAH). We con-
ducted a seroprevalence study aimed at detecting antibodies to
HHV-8 among a population of lung transplantation candidates;
we assessed the HHV-8 antibodies seroprevalence among
pulmonary hypertension (PH) patients with and without
IPAH, and we compared them with non-PH patients.
Methods: From January 2001 to February 2004, 75 patients
referred to the Department of Cardiovascular and Respiratory
Sciences of the University of Rome La Sapienza for clinical and
serological evaluation for lung transplantation were consecu-
tively enrolled in the study. The diagnosis of PH was based on
international criteria. We performed assays for antibodies
directed to lytic antigens of HHV-8 in plasma samples using
an indirect immune ﬂuorescent assay based on BCBL-1 cell line.
Samples reactive at 1:40 dilution in the anti-lytic test were
considered as positive.
Results: Thirty-three patients out of 75 transplant candidates
had signiﬁcant PH (mean pulmonary arterial pressure
>25 mmHg. Sixteen of them had IPAH, the ramining had
secondary-PH. HHV-8 antibodies were detected in 9 out of 75
patients (11.5%). Three patients with HIV infection were HHV-8
Ab negative. A difference in the HHV-8 seroprevalence was
found between the PH patients (3.0%) and the patients without
PH (19.0%). Particularly, among the 33 patients with PH , one
patient out of 16 with IPAH (6.3%) had serological HHV-8
antibodies, whereas no patient with secondary-PH had HHV-8
antibodies. Among the 42 patients with no clinical or diagnostic
evidence of PH, ﬁve patients out of 29 with cystic ﬁbrosis
(17.2%), and three patients out of 13 with interstitial lung disease
(23.1%) had HHV-8 antibodies, all of them affected by idiopathic
pulmonary ﬁbrosis. No difference in the HHV-8 seroprevalence
rate was reported neither in patients with cystic ﬁbrosis nor in
patients with interstitial lung disease
Conclusions: A 11.5% HHV-8 prevalence rate similar to that
found in the Italian general population was reported among can-
didates to lung transplantation. No relationship between HHV-8
infection and PH, both idiopathic and secondary, was shown.
P1549
Molecular epidemiology of Kaposi sarcoma
herpesvirus in Cuban and German patients with
Kaposi’s sarcoma (KS) and asymptomatic sexual
contacts of Cuban KS patients
V. Kouri, A. Marini, R. Doroudi, M. Rodriguez, V. Capo,
S. Resik, O. Blanco, B. Mantecon, U. Hengge (Havana City, CUB;
Dusseldorf, D)
Objectives: Since the discovery of Kaposi sarcoma herpesvirus
(KSHV) in 1994, many questions arose about the origin, transmis-
sionandpathogenesis ofKSHV.TheORFK1gene isused todeﬁne
ﬁve major subtypes A-E, with 15–30% of amino acid variability.
There is not previous reports of ORF K1 Real Time assay.
Methods: We analysed the K1 gene phylogenetically in 17
Cuban and 19 German KS tissues (most HIV+) by nested PCR
and sequencing. In addition, we studied for the ﬁrst time–24
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PBMC specimens from Cuban asymptomatic sexual contacts of
KS patients for the presence of circulating KSHV DNA by Real-
Time PCR and also we sequenced those whose results. More-
over, we compared KSHV viral load between PBMC and KS
tissues.
Results: Ten of 24 (41.7%) PBMC samples showed KSHV
infection by the K1 nested PCR, reinforcing that KSHV is
sexually transmitted. Phylogenetic characterization revealed the
majority of German samples belonging to subtypes C (n = 13)
and A (n = 6), as has been previously described for European
KSHV strains. Cuban samples showed a wide range of subtypes,
including A (n = 17.4 were A5), C (n = 7) and B (n = 2), and one
newly described subtype E. Subtypes A5 and B have previously
been reported as African genotypes and E subtype has been
recently found in Amerindians from Brazil and Ecuador.
Furthermore, Real-time PCR detected 5 additional patients
with very low KSHV viral load in PBMC that were not
detectable with nested PCR. The KSHV viral load in KS tissues
was much more higher than in PBMC of asymptomatic infected
patients, there was also correlation among KSHV antibodies and
the two DNA ampliﬁcation methods.
Conclusions: The subtype variability reﬂects the mixed ethnic
background of Cubans. This new DNA ampliﬁcation assay (Real
Time PCR) represents a reliable technique to identify individ-
uals at risk for developing KS lesions as well as following KSHV
viral load during therapy.
New drugs: in vitro studies
P1550
In vitro activity of plectasin, an antimicrobial
peptide from the fungus Pseudoplectania nigrella
P. Mygind, K. Schnorr, M. Hansen, C. Sonksen, D. Raventos,
B. Christensen, J. Vind, D. Yaver, H.-H. Kristensen (Bagsvaerd,
DK; Davis, USA)
Objectives: Plectasin (NZ2000) is a newly discovered defensin-
type antimicrobial peptide of 40 amino acids isolated from the
saprophytic ascomycete fungus Pseudoplectania nigrella. Plectasin
is active against several Gram-positive bacteria including drug
resistant strains but shows very poor activity against Gram-
negative bacteria. In addition, Plectasin has shown activity in
murine pneumonia and peritonitis models against clinical
isolates of Streptococcus pneumoniae when the peptide is dosed
intraveneously.
Methods: Antimicrobial activity and spectrum were assessed
by determining the minimum inhibitory and bactericidal con-
centrations in cationic-adjusted Mueller-Hinton broth using the
NCCLS guidelines. Bactericidal activity was characterized by
time kill experiments at several concentrations.
Results: Puriﬁed Plectasin showed potent activity against a
range of Gram-positive bacteria with MICs as low as 0.25 lg/ml
against clinical isolates of S. pneumonia including penicillin,
tetracycline, chloramphenicol and trimethoprim resistant isolates.
Plectasin is cidal as demonstrated by MBCs that are equivalent to
the MICs and has rapid kill kinetics in time kill experiments.
After 24 hours incubation in 90% human serum, Plectasin is
stable as measured by both ELISA and antimicrobial activity.
Conclusions: Plectasin is a novel antimicrobial peptide that
displays potent antimicrobial activity against Gram-positive
bacteria including drug resistant organisms. The peptide is
rapidly cidal against all Gram-positive bacteria but inactive
towards Gram-negative bacteria. Results reported here on
serum stability as well as in vivo animal models suggest that
Plectasin may have potential as a systemic therapeutic agent
against Gram-positive bacteria.
P1551
In vitro evaluation of the peptide deformylase
inhibitor LBM415 in combination with aztreonam
to determine the synergistic potential against
Gram-positive and Gram-negative pathogens
D. Biedenbach, R. Jones, T. Fritsche (North Liberty, USA)
Objective: To evaluate the interactions between LBM415 (LBM)
and aztreonam (AZT) in vitro. LBM is a peptide deformylase
inhibitor (PDI), a class of compounds with a novel mechanism of
action against Gram-positive (GP) organisms and some respir-
atory tract Gram-negative (GN) fastidious pathogens that is
currently in clinical development.
Methods: A checkerboard broth microdilution test method was
used to test 108 clinical isolates: Enterobacteriaceae (ENT; 81), non-
fermentative GN (NFGN; 15),N. meningitis (NM; 2), Staphylococci
(included MRSA and MR-CoNS; 6) and Enterococcus spp. (4).
Tests were performed using Mueller-Hinton broth (supplemen-
ted with lysed horse blood for NM). The following deﬁnitions
were used in characterizing combination MIC results: antagon-
ism (ANT), ‡4-fold increase of both agents; synergy (SYN), ‡4-
fold decrease of both agents; partial SYN (PSYN), ‡4-fold
decrease of 1 agent/2-fold decrease of the other; additive
(ADD), 2-fold decrease of both agents; indifference (IND), no
decrease or only a 2-fold decrease or increase for 1 agent.
Results: No ANT was observed for any isolate or tested
combination. All 10 GP pathogens showed IND to the combina-
tion of LBM and AZT. The ENT showed a signiﬁcant enhanced
activity with 69–100% of each species giving additive or greater
interaction results (exception, S. marcescens). Among Klebsiella
spp. (KSP) isolates, 53% displayed SYN, E. coli (EC) and
Enterobacter spp. (EBS) showed 56% PSYN or SYN and 80% of
P. mirabilis (PM) showed PSYN. Among the NFGN, Acinetobacter
(ASP) isolates showed 60% SYN and 40% PSYN, whereas only
27% of P. aeruginosawere PSYN or ADD. S. maltophilia (40%) and
B. cepacia (20%) isolates displayedADD effects; the rest were IND
to the combination. One of the NM showed an ADD effect.
Conclusions: The combination of LBM and AZT provided
predominant SYN or PSYN interactions against many GN
organisms (ASP, KSP, EC, EBS and PM). Several strains of
other GN species showed at least an ADD interaction effect.
These preliminary studies demonstrate that PDIs may display
enhanced activity when tested in combination with a GN active
agent and a complete lack of ANT in either GP or GN pathogens,
potentially expanding the spectrum of activity of both agents.
The unique mechanism of action of PDIs warrants further
investigation into their potential role in combination therapy.
P1552
Antimicrobial activity of LBM415 (NVP PDF-713)
against a recent (2003) international collection of
Gram-positive and respiratory tract pathogens
A. Watters, R. Jones, M. Stilwell, T. Fritsche (North Liberty, USA)
Objective: To evaluate the spectrum and potency of LBM415
(LBM; formerly NVP PDF-713) when tested against an
international collection of common bacterial pathogens compri-
sing the 2003 LBM surveillance programme. LBM is the ﬁrst
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member of the peptide deformylase inhibitor (PDI) class being
considered for clinical trials for treatment of community-
acquired respiratory tract infections and serious infections
caused by antimicrobial-resistant Gram-positive cocci.
Methods: Non-duplicate, clinically-signiﬁcant bacterial isolates
(10,903 strains) were collected from more than 70 medical centres
participating in the global surveillance programme, and originated
fromNorth America, Europe, South America and Asia geographic
areas. All isolates were susceptibility (S) tested usingNCCLS broth
microdilution methods and interpretive criteria, where applicable.
LBMwas comparedwith representative agents used in the empiric
or directed therapy of the targeted indications or species.
Results: The antimicrobial activity of LBM is shown in the table:
Antibiogram characteristics of the collection include: 28%
oxacillin-resistant (OR) SA, 76% OR CoNS, 34% penicillin-non-
susceptible SPN, 22% vancomycin-R ENT, and 21% ampicillin-R
HI. LBM was highly active against Staphylococci, Streptococci,
Enterococci and MCAT, resulting in ‡99% inhibition at £4 mg/L,
as well as 93% inhibition of HI strains at the same concentration.
No differences were noted in the activity of LBM between S and
R subsets of SA, CoNS, SPN, ENT and HI for antimicrobials
such as oxacillin, penicillin, ampicillin, macrolides, vancomycin
and ﬂuoroquinolones. While regional differences were apparent
with some comparator agents, activity of LBM did not vary
between geographic samples.
Conclusions: LBM displays a broad-spectrum of activity
against the common Gram-positive pathogens, including R
subsets, with no regional differences in potency. Some fastidious
Gram-negative species (HI, MCAT) were also inhibited by LBM.
As a class of antimicrobials, the PDI compounds exhibit a
spectrum of activity and unique mode of action that promises to
be a signiﬁcant advance in chemotherapy.
P1553
A baseline assessment of telavancin’s activity
against a collection of Gram-positive isolates,
including resistant phenotypes
D.C. Draghi, R. Blosser, M. Jones, D.F. Sahm (Herndon, USA;
Hilversum, NL)
Objectives: As new antimicrobial agents are developed, it is
important to examine their in vitro activity against a collection
of organisms for which they are targeted. Telavancin (TLV) is a
rapidly bactericidal lipoglycopeptide with multiple mechanisms
of action that is in Phase 3 development for the treatment of
serious infections caused by gram-positive pathogens. The
current study examines the in vitro activity of TLV against 101
staphylococci, Enterococci, and Streptococci, including clinically-
relevant resistant phenotypes.
Methods: 50 Staphylococcus aureus (SA), 11 coagulase-negative
Staphylococci (CNS), 10 Enterococcus faecalis (EF), 10 Enterococcus
faecium (EM), 10 Streptococcus pneumoniae (SP), and 10 other
Streptococcus spp. (STR) were tested against TLV and compara-
tor agents by broth microdilution (BMD; NCCLS, M7-A6, 2003)
and E-test. BMD and Etest MICs were analysed on an isolate-
per-isolate basis, and MICs within plus or minus one doubling
dilution were considered correlative.
Results: Against the SA tested, TLV had an MIC range of 0.12–
4 mg/L. MICs were similar against both MSSA (0.12–1 mg/L)
and MRSA (0.12–1 mg/L). TLV MICs to vancomycin (VAN)-
nonsusceptible (NS; intermediate and resistant) SA (n = 4) were
2–4 mg/L and against daptomycin-NS SA (n = 3) were 0.5–
2 mg/L. TLV showed MICs against CNS of 0.03–0.5 mg/L with
consistent activity against oxacillin-susceptible (S) (0.03–0.5
mg/L) and -resistant (R) (0.12–0.25 mg/L) strains. Against
VAN-S EF and EM, TLV showed MICs of 0.25–0.5 mg/L and
0.06–0.5 mg/L, respectively and elevated MICs of 0.25–8 mg/L
and 4–8 mg/L against VAN-R strains. TLV showed low MICs
against all Streptococci (£0.06 mg/L), including penicillin-R and
multidrug-R SP (MICs = 0.015 mg/L). TLV MICs generated
using E-test were similar to those generated using BMD.
Correlations between E-test and BMD were 84% for SA, 100%
for CNS, 100% for EF, 90% for EM, 100% for SP, and 100% for STR.
Conclusions: TLV showed potent in vitro activity against the
gram-positive organisms tested, including isolates with clinic-
ally-relevant resistant phenotypes.
P1554
Antimicrobial activity of daptomycin tested
against Gram-positive strains collected from
European medical centres in 2004
H. Sader, T. Fritsche, R. Jones (North Liberty, USA)
Background: Daptomycin (DAP) is a recently FDA approved
lipopeptide with activity against relevant Gram-positive path-
ogens. We evaluated the in vitro activity of DAP tested against
recent clinical isolates collected in Europe in 2004.
Methods: A total of 2103 consecutive strains were collected in
23 medical centres located in 12 European countries. The main
pathogens evaluated were: S. aureus [SA; 1172 isolates, 27%
oxacillin (OXA)-resistant (R)]; coagulase-negative Staphylococci
(CoNS; 404, 79% OXA-R), E. faecalis (EF; 195; 2% vancomycin
[VAN]-R), E. faecium (EFM; 90, 14% VAN-R), beta-haemolytic
Streptococcus spp. (BHS; 150), and viridans group Streptococcus
spp. (VGS; 73). The strains were tested by NCCLS broth
microdilution methods in Mueller-Hinton broth supplemented
to 50 mg/L calcium. Numerous comparators were also tested.
Results: DAP activity is summarized in the table: All isolates,
except 2 VAN-S EFM, were inhibited at DAP MIC of £4 mg/L.
DAP and linezolid were the most active agents against VAN-R
Enterococci. All CoNS and 99.7% of SA isolates evaluated were
inhibited at DAP MIC £1 mg/L. DAP was highly active against
BHS (MIC50, £0.06 mg/L) and 97% of VGS strains were
inhibited at DAP MIC £1 mg/L (susceptible).
Organisms (no. tested) MIC (mg/L) Cum. % of strains inhibited at
MIC (mg/L):
50% 90% £1 2 4 8
S. aureus (SA; 3,955) 0.5 1 99 99 100 -
Coag-neg staphylococci (CoNS; 1,485) 0.5 1 95 99 100 -
S. pneumoniae (SPN, 736) 1 2 76 93 100 -
Viridans group streptococci (134) 0.25 1 99 100 - -
Beta-haemolytic streptococci (356) 0.5 1 96 100 - -
Enterococci (ENT, 2,062) 2 4 48 87 99 100
E. faecalis (1,432) 2 4 37 83 99 100
E. faecium (553) 1 2 70 96 100 -
H. inﬂuenzae (HI 1,855) 2 4 49 78 93 99
M. catarrhalis (MCAT, 108) 0.25 0.5 99 100 - -
Organism (no. tested)
DAP MIC (mg/L) %S
50% 90% Range
SA OXA-3 (860) 0.25 0.5 £0.06–2 99.9
OXA-R (312) 0.5 0.5 0.12–2 99.0
CoNS OXA-S (85) 0.5 0.5 0.12–1 100.0
OXA-R (319) 0.5 0.5 £0.06–1 100.0
EF(195) 1 1 £0.06–4 100.0
EFM VAN-G (77) 4 4 1–8 97.4
VAN-R (13) 1 4 1–4 100.0
Enterococcus spp. (19) 1 4 0.5–4 100.0
BHS (150) £0.06 0.25 £0.06–0.5 100.0
VGS (73) 0.25 1 £0.06–2 -
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Conclusions: R to other compounds did not inﬂuence the high
DAPactivity against Staphylococci,Enterococci or Streptococci. DAP
showed high potency and broad spectrum against recent clinical
isolates of facultative Gram-positive cocci isolated in European
medical centres, including multi-drug resistant subsets.
P1555
Comparative in vitro activity of XRP 2868, a new,
oral streptogramin
D. Felmingham, M.J. Robbins, J. Shackcloth, C. Dencer,
L.Williams,C.Couturier,A. Bryskier (London,UK;Romainville, F)
Objective: XRP 2868 is an investigational, oral streptogramin
comprised of a 70:30 mixture of RPR 132552A (a pristinamycin
IIB derivative) and RPR 202868 (a pristinamycin 1A derivative).
In this study, the in vitro activity of XRP 2868 was determined in
comparison with Synercid, pristinamycin and erythromycin A,
against bacterial pathogens causing respiratory tract and skin/
soft tissue infections.
Methods: Minimum inhibitory concentrations (MIC) of XRP
2868 and comparators were determined using appropriate
NCCLS methods.
Results: Results from the study are summarised in Table 1. XRP
2868 was highly active against isolates of Staphylococcus aureus,
Streptococcus pneumoniae, and Streptococcus pyogenes, including
isolates resistant to erythromycin A by a variety of genetic
mechanisms. XRP 2868 was also very active against isolates of
Haemophilus inﬂuenzae with improved activity when compared
with Synercid and pristinamycin.
Conclusions: XRP 2868 is a suitable candidate for further
investigation as a potential oral, anti-infective therapeutic agent.
P1556
Antimicrobial proﬁle of the new biocide akacid
A. Buxbaum, C. Kratzer, W. Graninger,
A. Georgopoulos (Vienna, A)
Objectives: Akacid is a new member of the polymeric bigua-
nide family of disinfectants. It was especially developed to
enhance the antimicrobial activity of this class with signiﬁcantly
less toxicity. This paper describes the wide range of biocidal
activity and low potential for induction of resistance of akacid.
Methods: A total of 370 recent clinical isolates from patients
with documented infections in hospitals located in Austria was
studied. The organisms tested by reference methods included:
Staphylococcus aureus (98), S. epidermidis (9), Enterococcus faecalis
(37), Klebsiella spp. (45), Escherichia coli (65), Salmonella spp. (6),
Shigella spp. (2), Yersinia enterocolitica (1), Acinetobacter spp. (4),
Helicobacter pylori (7), Proteus spp. (7), Pseudomonas aeruginosa
(59), Stenotrophomonas maltophilia (4), Mycobacterium spp. (6),
Legionella pneumophila (3), Candida spp. (10), Aspergillus spp. (7).
Additionally, spores of Bacillus subtilis ATCC 6633 and B.
anthracis CH10 (anthrax spores reg.no. G112/WET/ACT 36/47)
were tested. Also, in-vitro selection of resistance to akacid was
carried out on 30 strains.
Results: Akacid showed good activity against both gram-
positive and gram-negative bacteria, regardless of their antibi-
otic resistance-proﬁle. Generally, MICs of tested isolates were
the same for antibiotic-sensitive and multiresistant strains.
Potent activity was also observed against L. pneumophila,
Mycobacterium spp. and against spores of B. subtilis and B.
anthracis. Good antifungal efﬁcacy could be recorded against
Candida spp. and Aspergillus spp. Bactericidal action was
observed at 1 · MIC,that is that MIC values equaled MBC
values. The in-vitro selection of resistance test showed no
increase in MIC values in any isolate after 30 passages.
Conclusions: This study clearly demonstrates the excellent
antimicrobial properties of akacid. Akacid was highly active
against bacteria (including Mycobacterium spp. and L. pneumo-
phila), spores and fungi, without being affected by the resistance
proﬁle of the strains. These properties, together with a very low
potential to select for resistance, make akacid a promising tool
for the battle against rising resistance and therapeutic failures.
P1557
Selective and effective antimicrobial properties of
newly synthesised transition metal ions chelates
with N, N-Dimethylbiguanide (DMGB)
R. Olar, M. Badea, M. Balotescu, R. Cernat, M. Bucur,
V. Lazar (Bucharest, RO)
Biguanidine derivatives and their transition metal compounds
are known to exhibit interesting biological properties, such as
glucose lowering agents, analgesic, antimalarial and antimetab-
olite by competition for folic acid.In this study a series of newly
synthesised complexes of type M(DMBG)2X2ÆnH2O ((1) M:Ni,
X:CH3COO, n = 0; (2) M:Cu, X:CH3COO, n = 2; (3) M:Ni,
X:ClO4, n = 0; (4) M:Cu, X:ClO4, n = 0) and previously charac-
terised for their thermal stability and the coordination geometry
by a range of techniques, including elemental and thermal
analysis, IR, EPR and electronic reﬂectance spectra were
screened in vitro for their ability to inhibit the microbial
growth. The modiﬁcations evidenced in IR spectra were corre-
lated with the presence of DMBG as chelate through N1 and N4.
The EPR and electronic spectra are typical for a square-planar
surrounding of Ni (II) and respectively an distorted octahedral
one for Cu (II). The in vitro antimicrobial testings were
performed by broth microdilution method, in order to establish
the minimal inhibitory concentration (MIC), against Gram-
positive (Bacillus subtilis, Listeria monocytogenes, Staphylococcus
aureus), Gram-negative (Psedomonas aeruginosa, Escherichia coli,
Klebsiella pneumoniae, Salmonella enteritidis), as well as Candida
sp., using both reference and clinical, multidrug resistant
strains. The antimicrobial effects were comparatively evaluated
for the ﬁnal compounds and for the transition metals salts. Our
results showed that the transition metals salts exhibited
MIC > 256 mcg/ml, for all tested strains. The tested compounds
exhibited a speciﬁc antimicrobial activity, both concerning the
microbial spectrum and the MIC value. The MICs values ranged
between 1024 and 16 mcg/ml. The compounds no. (1) and (4)
were highly active against Listeria monocytogenes (MIC < 2
mcg/ml). The compound no. (4) showed intermediate activity
against Psudomonas and Bacillus strains (MIC 128 mcg/ml) and
compound no. (2) against Salmonella (MIC 128 mcg/ml). The
other tested strains (S. aureus, Escherichia coli and Candida) were
Table 1
Species N MIC50/MIC90 (mg/L)
XRP 2868 Synercid Pristinamycin Erythromycin A
S. aureus (MS) 41 0.12/0.25 0.5/0.5 0.25/0.25 0.25/>64
S. aureus (MR) 53 0.25/0.5 0.5/1 0.5/1 >64/>64
S. pneumoniae 106 0.25/0.5 1/4 0.5/1 >32/>32
S. progenes 60 0.06/0.06 0.25/0.25 0.12/0.12 >64/>64
Streptococcus spp 63 0.12/0.5 1/4 0.25/0.5 0.06/0.12
E. faecalis 36 1/4 8/16 2/8 >64/>64
E. faecium 38 0.25/0.5 0.5/2 0.25/0.5 >64/>64
L. monocytogenes 23 0.5/0.5 1/1 0.5/0.5 0.12/0.12
A. haemolyticum 9 £0.015-0.03* 0.12-0.25* £0.03-0.06* £0.015-0.03*
H. inﬂuenzae 52 0.5/1 4/8 2/4 4/8
H. parainﬂuenzae 20 2/8 32/32 8/16 2/8
M. catarrhalis 30 0.06/0.12 1/1 0.25/0.5 0.12/0.12
B. pertussis 10 0.03-0.06 0.12-0.25 all 0.06 0.06-0.12
N meningitidis 20 0.03/0.06 0.25/0.5 0.06/0.12 0.12/0.25
* £10 isolates, MIC range only.
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resistant to all of the metal complexes exhibiting MICs >
256 mcg/ml. Our studies demonstrated that among the multiple
biological activities of biguanidine complex combinations, they
could also exhibit some effective antimicrobial properties
against selected bacterial strains.
P1558
In vitro activity of human intestinal anaerobic
bacteria against Nisin
E. Wahlund, E. Sillerstro¨m, C.E. Nord (Stockholm, S)
Objectives: Nisin is a new bacteriocin used as a food preser-
vative. Resistance to Nisin is not associated with increased
resistance to antibiotics. Nisin will be used in animal foods and
it is therefore important to investigate if Nisin has an impact on
the normal human intestinal microﬂora. The aim of the present
investigation was to study the antimicrobial activity of Nisin
against anaerobic bacteria isolated from the normal human
intestinal microﬂora.
Methods: Anaerobic strains were isolated from the human
intestinal normal microﬂora in healthy subjects at the Karolinska
University Hospital, Stockholm, Sweden. All strains were
identiﬁed according to techniques such as morphological tests,
biochemical tests and gas-liquid chromatography. The antibac-
terial susceptibility tests were performed by the agar dilution
method according to NCCLS. The minimum inhibitory concen-
tration (MIC) was deﬁned as the lowest concentration of the
drug that inhibited growth. The appearance of a single colony or
of a barely visible haze was disregarded. Six control strains were
used for monitoring the antibacterial susceptibility test: Bacter-
oides fragilis ATCC 25285, Bacteroides thetaiotaomicron ATCC
29741, Clostridium perfringens ATCC 13124, Eubacterium lentum
ATCC 43055, Escherichia coli ATCC 25922, and Enterococcus
faecalis ATCC 29212. The Nisin agent was obtained from
ImmuCell Corporation, Portland, Maine, USA.
Results: All Clostridium perfringens strains (11) were susceptible
to Nisin. The minimum inhibitory concentrations were 0.25–
0.5 mg/l. Eleven Eggerthella lentum strains showed high suscep-
tibility to Nisin with minimum inhibitory concentrations of
0.125 mg/l. The Nisin agent was active against Lactobacilli (10)
with minimum inhibitory concentrations between 0.125–16 mg/
l. All Peptostreptococci (10) except one strain were highly
susceptible to Nisin (0.064–1.0 mg/l). The Bacteroides fragilis
strains (12) had high minimum inhibitory concentration values
for Nisin (>256 mg/l). Most Fusobacteria (9) showed high
minimum inhibitory concentration values for Nisin (>256
mg/l). Three strains had lower minimum inhibitory concentra-
tion values (0.5–16 mg/l).
Conclusions: The present study showed that Nisin had good
activities against anaerobic Gram-positive bacteria but was less
active against anaerobic Gram-negative bacteria isolated from
the human normal intestinal microﬂora.
P1559
In vitro activity of tigecycline and comparative
agents against Enterococci in Sweden
L.E. Nilsson, G. Kronvall, M. Walder, M. So¨rberg (Linko¨ping,
Stockholm, Malmo¨, Solna, S)
Background: Tigecycline is a new glycylcycline, which has been
shown to have potent activity against Enterococci. The activity of
tigecycline and comparative against clinical isolates from inten-
sive care units (ICUs) and other hospital wards in three
university hospitals in Sweden were determined.
Methods: A total of 609 initial clinical isolates of Enterococci
were collected during November 2003–October 2004 at ICUs
and other hospital wards at university hospitals in Linko¨ping,
Stockholm and Malmo¨. The isolates were identiﬁed to Entero-
coccus faecalis (N = 395) and Enterococcus faecium (N = 214),
respectively. MICs were determined with E-test on Mueller
Hinton broth and the breakpoints of the Swedish Reference
Group for Antibiotics (www.srga.org) were use for all antibiot-
ics except for tigecycline (tentative breakpoints £2 lg/ml)
Results: A total of 4% of the E. faecium isolates were vancomy-
cin resistant (VRE). The van B gene was detected in these
isolates. High level gentamicin resistance (HLGR) was seen
among a total of 18% and 13% of the E. faecalis and the E.faecium
isolates, respectively.
Conclusion: E. faecalis showed a high susceptibility against all
the tested antibiotics both in the ICUs and the other hospital
wards. Tigecycline, linezolid and vancomycin were the only
antibiotics that showedhigh susceptibility againstmostE. faecium.
P1560
In vitro activity of tigecycline and comparative
agents against Staphylococci in Sweden
L.E. Nilsson, G. Kronvall, M. Walder, M. So¨rberg (Linko¨ping,
Stockholm, Malmo¨, Solna, S)
Background: Tigecycline is a new glycylcycline, which has been
shown to have potent activity against Staphylococci. The activity
of tigecycline and comparative against clinical isolates from
intensive care units (ICUs) and other hospital wards in three
university hospitals in Sweden were determined.
Methods: A total of 877 initial clinical isolates of Staphylococci
were collected during November 2003–October 2004 at ICUs and
other hospital wards at university hospitals in Linko¨ping, Stock-
holm and Malmo¨. The isolates were identiﬁed to Staphylococcus
aureus (N = 443) and Coagulase Negative Staphylococci (CoNS)
(N = 433), respectively. MICs were determined with E-test on
Mueller-Hinton agar and the breakpoints of the Swedish Refer-
ence Group for Antibiotics (www.srga.org) were use for all anti-
biotics except for tigecycline (tentative breakpoints S £2 lg/ml).
Results: Only a total of 2% of the S. aureus isolates were
oxacillin resistant. The mec A gene was detected in these
isolates.
Conclusion: The incidence of MRSA was low. Tigecycline,
linezolid and vancomycin showed a high susceptibility both
against oxacillin resistant and susceptible S. aureus and CoNS.
The other antibiotics show lower susceptibility against CoNS
especially at the ICUs.
Susceptibility ICU/non-ICU (%)
Antibiotic E. faecalis E. faecium
Tigecycline 100/100 100/100
Ampicillin 99/99 17/8
Linezolid 98/99 98/99
Piperacillin/Tazobactam 99/100 7/7
Vancomycin 100/100 93/98
Susceptibility ICU/non-ICU (%)
Antibiotic S. aureus Coagulase Negative Staphylococci
Tigecycline 100/100 100/100
Oxacillin 97/98 34/48
Clindamycin 99/96 54/70
Fusidic acid 91/93 55/71
Linezolid 100/100 100/100
Rifampicin 99/99 86/97
Vancomycin 100/100 100/100
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P1561
In vitro activity of tigecycline and comparative
agents against selected species of
Enterobacteriacae in Sweden
L.E. Nilsson, M. Walder, G. Kronvall, M. So¨rberg (Linko¨ping,
Malmo¨, Stockholm, Solna, S)
Background: Tigecycline is a new glycylcycline, which has been
shown to have potent activity against most species of Entero-
bacteriacae.
Objective: The activity of tigecycline and comparative agents
against clinical isolates from intensive care units (ICUs) and
other hospital wards in three university hospitals in Sweden
were determined.
Methods: A total of 1662 initial clinical isolates of Enterobacte-
riaecae were collected during November 2003–October 2004 at
ICUs and other hospital wards at university hospitals in
Linko¨ping, Stockholm and Malmo¨. MICs were determined
with E-test on Mueller-Hinton agar at each site. The breakpoints
of the Swedish Reference Group for Antibiotics (www.srga.org)
were use for all antibiotics except for tigecycline (tentative
breakpoint S £2 lg/ml). Detection of ESBLs was made by E-test
using cefepime, cefotaxime and ceftazidime ± clavulanic acid.
Results: The ESBL phenotype among Escherichia coli, Klebsiella
pneumoniae, Klebsiella oxytoca and Enterobacter spp was detected
in 1.8, 1.2, 3.9 and 0.2 % of the isolates, respectively.
Conclusion: Tigecycline showed a high susceptibility against
all the selected species both in the ICUs and the other hospital
wards. The susceptibility of Enterobacter spp against ciproﬂoxa-
cin, the cephalosporins , piperacillin/tazobactam and merope-
nem was lower especially at the ICUs.
P1562
Comparative in vitro activity of AVE6971A and
AVE2221A, novel inhibitors of DNA
topisomerase IV, against Staphylococcus aureus
M.J. Robbins, A. Bryskier, D. Felmingham (London, UK;
Romainville, F)
Objective: AVE6971A and AVE2221A are both novel inhibitors
of DNA-topoisomerase IV, an important antibacterial target in
Gram-positive bacteria. In this study, the in vitro activity of
AVE6971A and AVE2221A was determined against populations
of methicillin-susceptible and -resistant, recent clinical isolates
of Staphylococcus aureus.
Methods: Minimum inhibitory concentrations (MIC) of
AVE6971A, AVE2221A, Synercid, pristinamycin, teicoplanin,
linezolid and moxiﬂoxacin were determined using the NCCLS
agar dilution method.
Results: Results are summarised in Table 1. AVE6971A and
AVE2221A exhibited potent antibacterial activity against both
methicillin-susceptible and -resistant isolates of Staphylococcus
aureus. This level of activity was generally similar to Synercid
and pristinamycin and 2–4 fold greater than that of teicoplanin
and linezolid. AVE6971A and AVE2221A were 4–8 times less
active than moxiﬂoxacin against ﬂuoroquinolone-susceptible
isolates of Staphylococcus aureus but, importantly, retained
activity against ﬂuoroquinolone-resistant strains of this species.
Conclusion: AVE6971A and AVE2221A are interesting mole-
cules worthy of further investigation as candidates for devel-
opment as anti-staphylococcal compounds particularly in view
of the current problem of diminishing therapeutic options for
the treatment of infection caused by methicillin and multi-drug
resistant strains of Staphylococcus aureus.
P1563
In vitro activity of garenoxacin in comparison
with other ﬂuoroquinolones against isolates of
E. coli, P. aeruginosa, and S. aureus, including
genetically deﬁned ﬂuoroquinolone-resistant
mutants
A. Heisig, T. Claußen, P. Heisig (Hamburg, D)
Objectives: Enhanced research activites aimed at overcoming
the increasing incidence of ﬂuoroquinolone (FQ) resistant bacter-
ial pathogens and at extending the spectrum of activity to Gram-
positive pathogens have resulted in the development of the new
6–desﬂuoro-quinolone garenoxacin (GRN, former BMS-284756).
Methods: To evaluate its in-vitro activity in comparison to 6-
ﬂuoroquinolones levoﬂoxacin (LVX), gatiﬂoxacin (GAT), and
ciproﬂoxacin (CIP), MICs of garenoxacin (GRN) were deter-
mined for susceptible isolates of E. coli, P. aeruginosa, and S.
aureus and a series of isogenic mutants carrying different
combinations of known resistance mutations that affect either
target, DNA gyrase and topoisomerase IV, as well as multiple
drug resistance (mdr) efﬂux pumps.
Results: For susceptible isolates and most low-level resistant
mutants of E. coli, theMICs of GRN and CIPwere between 0.008/
0.015 and 1/2 lg/ml, respectively, and thus, slightly lower than
those of GAT and LVX (0.03–4). The activity of GRN against high-
level resistantmutants of E. coliwas comparable to CIP but higher
to LVX, and GAT, while GRN (MIC 0.015–4 lg/ml) was superior
to all tested FQs (MICs 0.03–>256 lg/ml) against susceptible and
resistant S. aureus. The susceptibility ofwild-typeP. aeruginosa for
GRNandGATwas comparable (MIC0.5–1 lg/ml), but higher for
CIP and LVX (MICs 0.25 and 0.5 lg/ml). Overexpression of mdr
efﬂux pumpsMexAB,MexCD, andMexEFhada similar impact on
all FQs and GRN increasing the MIC by 2–3 serial dilution steps.
Conclusions: Garenoxacin is a promising new quinolone deriv-
ative that combines a high activity against both, Gram-positive
and Gram-negative, pathogens including clinically relevant
mutants of S. aureus with multiple resistance mutations.
Susceptible isolates ICU/non ICU (%)
Antibiotic E. coli K. pneumoniae K. oxytoca Enterobacter spp
Tigecycline 100/100 93/98 100/100 91/96
Cefepime 98/99 98/100 100/96 84/92
Cefotaxime 98/99 98/100 100/96 67/81
Ceftazidime 98/99 98/100 100/100 75/89
Cefuroxime 92/94 87/94 100/92 50/53
Ciproﬂoxacin 93/90 83/88 100/96 88/92
Gentamicin 98/98 98/100 100/100 99/100
Imipenem 99/100 100/99 100/100 96/98
Meropenem 100/99 100/100 100/100 89/96
Pip/Tazo 98/99 97/100 100/94 78/93
Table 1
Antimicrobial methicillin susceptible
Staphylococcus aureus
(n = 41), MIC (mg/L)
methicillin resistant
Staphylococcus aureus
(n = 53), MIC (mg/L)
50% 90% range 50% 90% range
AVE 6971A 0.5 0.5 0.06–1 0.5 1 0.12–2
AVE 2221A 0.25 0.25 0.06–0.25 0.25 0.25 0.06–0.5
Erythromycin A 0.25 >64 0.25–>64 >64 >64 0.25–>64
Synercid 0.5 0.5 0.25–1 0.5 1 0.12–1
Pristinamycin 0.25 0.25 0.12–0.5 0.5 1 0.12–1
Teicoplanin 1 1 0.25–2 1 2 0.5–8
Linezolid 2 2 0.5–2 2 2 1–32
Moxiﬂoxacin 0.06 0.12 0.03–8 2 8 0.06–16
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P1564
In vitro activity of garenoxacin, a novel Des-F(6)-
quinolone, and other orally administered
antimicrobials tested against 50,217
Enterobacteriaceae collected wordwide by the
SENTRY Antimicrobial Surveillance Programme
(1999–2003)
H. Sader, T. Fritsche, M. Stilwell, R. Jones (North Liberty, USA)
Objective: To compare the activity of garenoxacin (GRN;
formerly BMS284756) with selected antimicrobials against a
worldwide collection of Enterobacteriaceae (ENT). GRN, unlike
recently marketed ﬂuoroquinolones (FQ), lacks ﬂuorine at the
C-6 position.
Methods: The isolates were consecutively collected from >70
medical centres from bloodstream, respiratory, urinary and skin
and soft tissue infections and tested by reference broth micro-
dilution methods according to NCCLS guidelines. A GRN
susceptible (S) breakpoint of £2 mg/L was applied for compar-
ison purposes only.
Results: The results of themajor organismgroups tested follows:
GRN showed excellent activity against this large collection of
ENT (MIC50, 0.06 mg/L) and 87% of isolates were inhibited at
£2 mg/L. The in vitro activity of GRN was similar to that of
ciproﬂoxacin (CIP) against most ENT species, the exceptions
were Serratia and indole-positive Proteus where CIP was slightly
more active. In general GRN andCIP showed higher potency and
a broader spectrum than orally administered beta-lactams or
TMP/SMX. GRN was also highly active against E. coli O157:H7
and Yersinia enterocolitica (MIC90, 0.25 mg/L for both).
Conclusions: GRN in vitro activity was similar to that of the
most commonly used FQs and superior to other listed orally
administered antimicrobials when tested against over 50,000
global ENT isolates.
P1565
Potency of garenoxacin, a new des-
F(6)-quinolone, tested against community-
acquired respiratory tract infection pathogens
worldwide (29,837 Strains): report from the
SENTRY Antimicrobial Surveillance Programme
(1999–2003)
R. Jones, T. Fritsche, M. Stilwell, H. Sader (North Liberty, USA)
Objective: To evaluate the spectrum and potency of garenoxa-
cin (GRN; formerly BMS284756) tested against typical commu-
nity-acquired respiratory tract infection (CARTI) pathogens
isolated from clinic patients emphasizing S. pneumoniae (SPN),
H. inﬂuenzae (HI) and M. catarrhalis (MCAT). A comprehensive
collection of 29,837 isolates was assessed from Europe, Asia and
the Americas, each susceptibility (S) tested by reference methods
in centralized laboratories.
Methods: All testing were performed by NCCLS M7-A6 (2003)
methods and results were interpreted by M100-S15 (2005). The
breakpoint for GRNwas deﬁned as S at £1 mg/L for comparison
with ﬂuoroquinolones (FQs): gatiﬂoxacin (GATI) S at £1 mg/L;
levoﬂoxacin (LEVO) S at £2 mg/L (£1 mg/L used for compari-
sons here); and moxiﬂoxacin (MOXI) S at £1 mg/L. The QRDR
regions of gyrA, parC and parE were sequenced in those strains
that had a GRNMIC ‡0.25 mg/L and/or were R to FQs.
Results: The SPN strains (11,878) were characterized as follows:
penicillin non-S at 35.1% (R at 19.4%; this rate was higher than
community-acquired, hospitalized pneumonia cases); erythro-
mycin-R at 29.7%; and ciproﬂoxacin (CIPRO)-R (‡4 mg/L; Chen
et al., 1999) at 3.9% = possible QRDR mutations. HI strains
(12,569) overall had ampicillin (AMP)-R at 22.8% and beta-
lactamase-negativeAMP-R (BLNAR) at 1.0%with 98/132 of these
strains fromAsia (Japan). MCAT (5,390) strains were dominantly
beta-lactamase-positive (PEN-R; 95.3%). The following table lists
key GRN and FQ MIC results: FQ-R SPN strains (GRN MIC, 1–
>4 mg/L) hadmultipleQRDRmutations (gyrA at S83F or T, parC
at S79F or T or D83N and parE at I460V). One FQRHI had QRDR
mutations (gyrA at S84L and parC at E88K). The overall rank
order of activity versus SPN using MIC90 (mg/L) results was:
GRN (0.06) > MOXI (0.25) > GATI (0.5) > LEVO(1) > CIPRO(2).
Conclusions: GRN was the most active quinolone tested
against a global collection of 29,837 typical CARTI pathogens
and was at lease 4-fold more active than MOXI against SPN
isolates. GRN should be a welcome addition to our antimicrobial
formularies for ambulatory care treatment of FQR and multi-
drug-R species associated with CARTI.
P1566
Garenoxacin activity against isolates from
patients hospitalised with community-acquired
pneumonia (Streptococcus pneumoniae,
Haemophilus inﬂuenzae and Moraxella
catarrhalis; 3,087 strains): report from
the SENTRY Antimicrobial Surveillance
Programme (1999)
R. Jones, T. Fritsche, H. Sader, M. Stilwell (North Liberty, USA)
Objective: To evaluate the potency of garenoxacin (GRN), a
new des-F(6)-quinolone, susceptibility (S) when tested against
organisms isolated from patients hospitalized with community-
acquired respiratory tract infections (CARTI) i.e. S. pneumoniae
(SPN), H. inﬂuenzae (HI) and M. catarrhalis (MCAT). Organisms
from 1999–2003 were available for study, each isolated in
Europe, the Americas or Asia; and their origin was lower
respiratory tract cultures. Although, MCAT was monitored, it
was not isolated in sufﬁcient numbers for analysis.
Methods: Consecutive, non-duplicate cultures of SPN (1,444)
and HI (1,643) were tested by reference NCCLS broth microdi-
lution methods with concurrent QC, and interpretation guided
Organism
(no. tested)
GRN
(MIC 50/% S) Ciproﬂoxacin Levoﬂoxacin
%S Amox/
Clav Cefuroxime
TMP/
SMXa
E. coli (22,698) £0.03/87 87 88 81 76 76
Klebsiella (10,513) 0.12/90 91 92 80 71 86
Enterobacter spp. (5,759) 0.12/86 88 90 4 21 89
Salmonella spp. (2,985) 0 06/99 99 99 89 62 92
P. mirabilis (2391) 0.5/78 83 89 91 91 80
Serratia spp. (2385) 1/75 89 93 3 1 91
Citrobacter spp. (1,206) 0.12/87 90 92 40 57 90
Indole-pos. Proteae (1,109) 0.5/74 80 82 23 16 80
Shigella spp (787) £0.03/>99.9 100 100 65 96 32
Total (50,217) 0.06/87 89 90 67 63 81
a TMP/SMX ¼ Trimethoprim/sulfamethoxazole
MIC (mg/L) % inhibited at £ 1 mg/L
Organism (no. tested) 50% 90% GRN GATI LEVO MOXI
SPN
PEN-S (7,703) 0.06 0.06 99.9 99.4 97.4 99.4
PEN-I (1,865) 0.06 0.06 99.8 98.9 96.9 99.3
PEN-R (2,310) 0.06 0.06 99.9 93.2 96.4 96.4
CIPRO-R (460) 0.06 1 97.8 76.1 37.4 80.7
HI
Amp-S (9,707) £0.03 £0.03 >99.9 >99.9 >99.9 >99.9
Amp-R (2,862) £0.03 £0.03 100.0 100.0 100.0 100.0
BLNAR (132) £0.03 £0.03 100.0 100.0 100.0 100.0
MCAT
PEN-S (254) £0.03 £0.03 100.0 100.0 100 0 100.0
PEN-R (5,136) £0.03 £0.03 100.0 100.0 100.0 100.0
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by NCCLS M100-S15 (2005). Comparison agents numbered >20
and included four ﬂuoroquinolones (FQs): ciproﬂoxacin
(CIPRO), gatiﬂoxacin (GATI), levoﬂoxacin (LEVO) and moxiﬂ-
oxacin (MOXI). The QRDR regions of gyrA, parC and parE were
sequenced in those strains with elevated GRN MICs (‡0.25
mg/L) or resistant (R) to other FQs.
Results: The SPN collection was characterized as follows:
penicillin-S at 70.1% (R rate, 16.6%); macrolide-R at 26.1%;
clindamycin-R at 11.9%; and amoxicillin/clavulanate- and cef-
triaxone (CTRI)-R at 1.4 and 1.1%, respectively. Rank order of
FQ activity was (MIC90, mg/L): GRN (0.06) > MOXI
(0.12) > GATI (0.5) > LEVO (1, 0.8% R) > CIPRO (2). The HI
collection was deﬁned as follows: ampicillin (AMP)-R at 20.3%;
beta-lactamase-negative AMP-R at 1.5% (nearly 80% of strains
from Japan; rate was <0.5% for all other regions); GRN MIC50/
90 at £0.008/0.016 mg/L; and one FQ-R strain had multiple
QRDR mutations. See table for co-R analysis among SPN: Co-R
trends were observed among beta-lactams, macrolides, tetra-
cyclines, TMP/SMX, but not for FQs. An increase in LEVO-R
among penicillin-R SPN was observed. Sixty-one % of all SPN
GRN MIC values were 0.06 mg/L, a dominant MIC mode.
Conclusions: GRN exhibited superior activity (lower MIC
results) against SPN and HI isolates associated with pneumonias
in CARTI patients; 2- to 32-fold more potent than other FQs.
SPN and HI isolates with GRN MIC values of more than
0.25 mg/L were very rare (11/3,087; 0.4%) and secondary to
numerous QRDR mutations in gyrA, parC and E. GRN appears
to be an excellent candidate to treat multi-drug R CARTI
pathogens in hospitalized patient populations.
P1567
Potency and spectrum of garenoxacin tested
against an international collection of skin and
soft tissue infection pathogens: report from the
SENTRY Antimicrobial Surveillance Programme
(1999–2003)
T. Fritsche, H. Sader, R. Jones (North Liberty, USA)
Objective: To evaluate the spectrum and potency of garenoxa-
cin (GRN), a novel des-F(6)-quinolone, against a large interna-
tional collection (9,227) of Gram-positive and -negative bacterial
pathogens that cause skin and soft tissue infections (SSTI).
Methods: Consecutive, non-duplicate bacterial isolates were
collected from 1999 to 2003 from patients with documented
community-acquired or nosocomial SSTI in >70 medical centres
participating in the SENTRY Programme in North America
(36.1%), Europe (24.1%), Latin America (16.1%) and the Asia-
Paciﬁc region (23.7%). All isolates were tested using NCCLS
broth microdilution methods against GRN, the currently mar-
keted ﬂuoroquinolones (FQ) ciproﬂoxacin (CIPRO), levoﬂoxacin
(LEVO), gatiﬂoxacin (GATI) and representative comparator
agents used for the empiric therapy of SSTI.
Results: The Table lists the potency and cumulative inhibition
rates for GRN against the top 10 (by frequency) SSTI pathogens:
Published data demonstrate that the agents causing SSTI are
comprised of a distinct set of Gram-positive cocci and Gram-
negative aerobic and facultative bacilli. GRNwas themost potent
agent tested against SA, and was at least 2-fold more potent than
GATI (MIC50, 0.06 mg/L) and 8-fold more potent than either
CIPRO or LEVO (MIC50, 0.25 mg/L). Furthermore, GRN was 4-
to 8-foldmore potent than the FQ against BHS and viridans group
Streptococci (VGS), and 2- to 4-foldmore potent against ESP. GRN
was comparable with CIPRO, LEVO and GATI against EC KSP
and ASP, but less active than these agents against PSA.
Conclusions: GRN was the most potent FQ when tested against
SA, BHS, VGS and ESP, and was similar in activity to these
agents against other species including EC, KSP and ASP. The in
vitro data suggest that GRN maybe superior to the FQ for the
treatment of SSTI infections caused by Staphylococci and Strep-
tococci, warranting further clinical studies.
P1568
Antimicrobial susceptibility of 5,859 non-
Enterobacteriaceae Gram-negative organisms
other than Pseudomonas aeruginosa tested against
the novel Des-F(6)-quinolone, garenoxacin
(SENTRY Antimicrobial Surveillance
Programme, 1999–2003)
H. Sader, T. Fritsche, M. Stilwell, R. Jones (North Liberty, USA)
Objective: To compare the antimicrobial activity of garenoxacin
(GRN) and selected antimicrobial agents against 5,859 non-
enteric Gram-negative organisms other than P. aeruginosa
collected as part of the SENTRY Antimicrobial Surveillance
Programme (1999–2003).
Methods: The isolates were consecutively collected at >70
medical centres on six continents from bloodstream, respiratory,
urinary and skin and soft tissue infections and tested by NCCLS
broth microdilution methods. A GRN susceptible (S) breakpoint
of £2 mg/L was applied for comparison purposes only.
Results: The results of major organism groups tested: Overall,
GRN (MIC50, 1 mg/L; 59% S) was more active than ciproﬂoxa-
cin (MIC50, 2 mg/L; 49% S), ceftazidime (MIC50, 8 mg/L; 56%
S), piperacillin/tazobactam (MIC50, 32 mg/L; 45% S) and
amikacin. GRN was the most active compound tested against
Penicillin category
Parameter (1,444 strains) S Intermediate R
GRN
MIC50 (mg/L) 0.06 0.06 0.06
MIC90 (mg/L) 0.06 0.06 0.06
% £1 mg/L 100.0 100.0 99.6
CIPRO MIC ‡ 4 mg/L(%) 3.9 4.7 3.3
LEVO-R (%) 0.6 0.7 1.6
CTRI-R (%) 0.1 2.1 6.2
MIC (mg/L) % inhibited at MIC (mg/L)
Organism (# tested) 50 £1 2 4
S. aureus (SA; 3,790) £0.03 87 93 97
P. aeruginosa (PSA; 1 ,080) 2 41 61 70
E. coli (EC; 864) 0.03 83 84 84
Enterococcus spp, (ESP;650) 0.25 63 71 86
Klebsiella spp. (KSP; 465) 0.12 85 88 90
Enterobacter spp. (ENT; 463) 0.12 86 88 90
b-haemolytic streptococci (BHS; 420) 0.06 100 - -
Coagulase neg.
staphylccocci (CoNS; 365)
0.12 73 86 95
P. mirabilis (PM: 238) 0.5 81 82 84
Acinetobacter spp. (ASP; 210) 2 48 50 60
Cum % inhibited at GRN MIC (mg/L)
Organism (no. tested) MIC 50 <0.5 1 2 4
Alcaligenes/Achromobacter spp. (170) >4 5 7 9 19
Acinetobacter spp. (3,260) 2 46 49 51 60
Aeromonas spp. (387) 0.12 79 88 95 97
Burkholderia spp. (180) 4 6 18 38 56
Chryseobacterium spp. (59) 0.25 81 90 93 95
N. meningitidis (130) £0.03 100 100 100 100
P. multocida (59) £0.03 97 97 98 100
S. maltophilia (1,449) 2 22 44 66 83
Total (5,859) 1 43 51 59 70
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Chryseobacterium spp. GRN was also highly active against
Aeromonas spp. (MIC90, 2 mg/L; 95% S), N. meningitidis
(MIC90, £0.03 mg/L; 100% S) and P. multocida (MIC90,
£0.03 mg/L; 98% S). Additionally, 83% of S. maltophilia strains
were inhibited at 4 mg/L of GRN.
Conclusions: GRN exhibited reasonable in vitro activity against
many of the rarely isolated Gram-negative species and maybe an
alternative therapy for infections caused by these ‘difﬁcult to
treat’ organisms.
P1569
Activity of ceftobiprole against recent clinical
isolates of Enterobacteriaceae from respiratory
infections from hospitalised patients in Europe
and USA
M. Heep, D.F. Sahm, D.C. Draghi, M.E. Jones (Basel, CH;
Herndon, USA)
Objectives: Ceftobiprole (BPR), formerly BAL9141, is the ﬁrst of
a new class of anti-MRSA cephalosporins and has broad-
spectrum activity towards most clinically relevant bacterial
pathogens. This study aimed at evaluating the in vitro activity of
BPR and other beta-lactams against Enterobacteriaceae isolates
from respiratory infections, including extended spectrum beta-
lactamase (ESBL) producing strains.
Methods: A total of 372 organisms were studied, comprising
non-repeat isolates derived from quality respiratory specimens
from ICU and inpatients from Europe and USA during 2001–4.
The species distribution was: 20 Citrobacter freundii, 7 Citrobacter
koseri (diversus), 17 Enterobacter aerogenes, 60 Enterobacter
cloacae, 60 Escherichia coli, 25 Klebsiella oxytoca, 60 Klebsiella
pneumoniae, 61 Proteus mirabilis, and 62 Serratia marcescens.
MICs of BPR, cefepime, cefepime/clavulanate cefotaxime
cefotaxime/clavulanate, cefoxatin, ceftazidime ceftazidime/cla-
vulanate, and ciproﬂoxacin were determined by broth micro-
dilution according to NCCLS guidelines. BPR breakpoints used
were 4 mg/L susceptible, 8 mg/L intermediate and 16 mg/L
resistant.
Results: Overall BPR displayed excellent activity against
Enterobacteriaceae. MIC distributions show 92.2% of isolates
were inhibited at a concentration 4 mg/L (cefepime 96.2%,
cefotaxime, 84.7%). Overall BPR demonstrated limited activity
against putative ESBL producers (38.1% inhibited at 4 mg/L)
but good activity, superior to cefotaxime or ceftazidime, against
putative high–level AmpC producers (66.7% inhibited at 4 mg/
L). MIC90 values to drugs tested are shown.
Conclusion: In addition to its anti-MRSA activity, the spec-
trum of activity of BPR resembles that of 3rd generation
cephalosporins and cefepime, demonstrating activity against
Enterobacteriaceae associated with hospital acquired respiratory
infections.
P1570
Ceftobiprole activity against epidemic strains of
methicillin-resistant Staphylococcus aureus from
hospitalised patients in Belgium
O. Denis, A. Deplano, C. Nonhoff, R. De Ryck, S. Rottiers,
M.J. Struelens (Brussels, B)
Background: Ceftobiprole (formerly BAL9141, Basilea Pharma-
ceutica Ltd., Switzerland) is a new broad-spectrum cephalosp-
orin in clinical development with potent bactericidal activity on
Gram-positive cocci including beta-lactam resistant Staphylo-
cocci. We compared its antimicrobial activity with that of 18
antimicrobial agents against methicillin-resistant Staphylococcus
aureus (MRSA) strains collected during a national survey
conducted in 2003 in Belgian hospitals.
Methods: In 2003, 521 MRSA strains were collected from 112
hospitals and conﬁrmed by PCR for 16S rRNA, nuc and mecA
genes. Strains were genotyped by pulsed ﬁeld gel electrophor-
esis (PFGE) after SmaI macrorestriction, SCCmec type, and
MLST. MICs of 19 antimicrobials were determined by agar
dilution methods according to NCCLS. Vancomycin suscepti-
bility was further evaluated on vancomycin screen agar.
Results: The proportion of MRSA strains resistant to amino-
glycosides ranged from 0.1% for amikacin to 44% for tobramy-
cin; 63% were resistant to erythromycin and 40% to clindamycin.
More than 90% of strains were susceptible to tetracycline,
minocycline, fusidic acid, rifampin and cotrimoxazole. Ciproﬂ-
oxacin resistance rate was 98 %, high-level mupirocin resistance
(MIC > 524 lg/ml) 3.4%, respectively. No strains resistant to
glycopeptides, linezolid, or ceftobiprole were detected. The
MIC50, MIC90 and range of MIC for ceftobiprole were: 0.5, 2,
0.06–4 lg/ml. By molecular typing, 90% of MRSA strains
belonged to 9 epidemic genotypes: PFGE type B2 ST45-
SCCmec IV (n = 251), A20 ST8-SCCmec IV (n = 97), G10
ST5-SCCmec II (n = 27), A21 ST8-SCCmec IV (n = 26), C1 ST5-
SCCmec II (n = 13), C3 ST5-SCCmec IV (n = 12) A1 ST247-
SCCmec I (n = 12), D8 ST228-SCCmec I (n = 11) and L1 ST22-
SCCmec IV (n = 10).
Conclusion: The new parenteral cephalospirin, ceftobiprole,
showed an excellent activity against all MRSA strains from
hospitalized patients in Belgium. These strains belonged to 9
genotypes of ﬁve pandemic MRSA lineages associated with
nosocomial infections.
P1571
In vitro activity of AVE1330A, a novel b-lactamase
inhibitor, in combination with aztreonam or
ceftazidime against ceftazidime-resistant isolates
of species of the Enterobacteriaceae
J. Shackcloth, L. Williams, J. Northwood, A. Bryskier,
D. Felmingham (London, UK; Romainville, F)
Objective: To determine the ability of AVE1330A, an investi-
gational, non b-lactam, b-lactamase inhibitor, to protect ceftaz-
idime and aztreonam against hydrolysis by various b-
lactamases.
Methods: Minimum inhibitory concentrations (MIC) of ceftaz-
idime and aztreonam, alone and in combination with AVE1330A
at a ﬁxed concentration of 4 mg/L, and, for ceftazidime only, in
ﬁxed ratio combinations of 4:1 and 4:2 (antimicrobial : inhibitor),
were determined using the NCCLS agar dilution method for
isolates of ceftazidime-resistant species of the Enterobacteriaceae
(n = 45), Klebsiella spp expressing SHV-ESBL (n = 24) and
Escherichia coli transformants expressing TEM and OXA B-
lactamases (n = 4).
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Results: Results are summarised in Table 1. At a ﬁxed concen-
tration of 4 mg/L, AVE1330A was a potent inhibitor of unclas-
siﬁed b-lactamases responsible for ceftazidime and aztreonam
resistance in species of the Enterobacteriaceae including; Escheri-
chia coli (n = 12), Citrobacter freundii (n = 6), Klebsiella pneumoniae
(n = 12), Enterobacter cloacae (n = 13) and Morganella morganii
(n = 2) with the great majority of isolates inhibited by £1 mg/L
of either antimicrobial in combination with the inhibitor.
AVE1330A inhibited the activity of TEM 6, 9, 10, and OXA 5
in ceftazidime-resistant Escherichia coli transformants expressing
these enzymes, reducing MIC to £1 mg/L. AVE1330A restored
the activity of ceftazidime and aztreonam (MIC £2 mg/L and
£1 mg/L respectively) against isolates of Klebsiella spp expres-
sing SHV-ESBL. Fixed ratio combinations of ceftazidime and
AVE1330A at 4 : 1 and 4 : 2, respectively demonstrated similar
inhibitory activity against the b-lactamase producing isolates.
However, MIC were generally 2–8 fold higher when compared
to those achieved with ceftazidime plus a 4 mg/L ﬁxed
concentration of AVE1330A.
Conclusion: AVE1330A is a potent inhibitor of a wide range of
b-lactamases, including SHV-ESBL and restores potent activity
to ceftazidime and aztreonam against ceftazidime-resistant
isolates of species of the Enterobacteriaceae.
P1572
High afﬁnity for PBP 2’ enables RO490–8463
(CS-023), a unique guanidine-pyrrolidine
carbapenem, to achieve good in vitro activity
against MRSA, which is conﬁrmed in murine
infection models
E. Namba, H. Inoue, T. Koga, T. Fukuoka, I. Simpson (Tokyo, JP;
Ely, UK)
Objectives: RO49O-8463 (RO) is a carbapenem with a unique
guanidine-pyrrolidine side chain which confers exceptional
broad-spectrum activity against diverse hospital pathogens,
including MRSA. This study was undertaken to determine (1)
the afﬁnity (IC50, mg/L) of RO for the PBPs of MRSA and (2)
efﬁcacy (% survival) of RO in immunocompetent and neutrop-
enic mice infected with MRSA.
Methods: MICs were determined to NCCLS guidelines. Afﬁnit-
ies of RO, imipenem (IMI) and meropenem (MPM) for the PBPs
of MSSA (ATCC 6538P) and MRSA 123 were determined using a
competitive assay with 14C-labelled penicillin G. In vivo efﬁcacy
of RO was assessed in two systemic infection models, using
immunocompetent (Model 1) or neutropenic (Model 2) mice,
with dosing regimens designed to simulate human plasma
pharmacokinetics. In Model 1, 4-week-old male immunocom-
petent SPF ddY mice were challenged intraperitoneally with
1.5 · 109 cfu/mouse of MRSA 12394. In Model 2, 5-week-old
male neutropenic SPF ddY mice were challenged intraperiton-
eally with 2.3 · 103 cfu/mouse of MRSA 12394 (MIC of RO,
8 mg/L). In both models, RO was subcutaneously administered
at 30 minute intervals in fractionized, decreasing doses to
simulate human plasma concentrations after a single intraven-
ous infusion at doses of 1500, 1000, 750, 500 and 250 mg (10
mice/dose). Mortality was monitored for 5 days after infection.
Results: For MRSA 123, RO exhibited substantially lower MIC
(8 mg/L) and PBP afﬁnities (5.3 mg/L) than IMI (32 mg/L and
170 mg/L) and MPM (32 mg/L and 130 mg/L). In Model 1, all
untreated immunocompetent mice died within 3 days. RO
achieved survival rates of 50% at 250 mg, 80% at 500 and
750 mg and 100% at >1000 mg. In Model 2, 90% of untreated
neutropenic mice died within 3 days. RO achieved survival rates
of 70% at 250 mg, 90% at 500 and 750 mg and 100% at >1000 mg.
Conclusions: RO represents a new class of guanidine-pyrroli-
dine carbapenems with good activity against MRSA, which may
be attributable to high afﬁnity for PBP 2’. In immunocompetent
and neutropenic murine models infected with MRSA, RO
achieved >80% survival at doses simulating the pharmacoki-
netics of a single 500 mg infusion in humans.
P1573
Activity and pharmacodynamics of RO490–8463
(CS-023), a carbapenem with activity against
MRSA
M.E. Jones, D.P. Nicolau, J.L. Kuti, C. Nightingale, D.C. Draghi,
R.K. Flamm, D.F. Sahm (Hilversum, NL; Hartford, Herndon, USA)
Objectives: R0490–8463 is a unique carbapenem, containing
guanidine and pyrrolidine rings, and demonstrates broad-
spectrum activity against diverse hospital pathogens including
MRSA. This study was designed to establish activity against a
representative selection of nosocomial pathogens from EU and
US hospitals, comprising S. aureus (SA), coagulase-negative
Staphylococci (CNS), P. aeruginosa (PA), S. pneumoniae (SP), E. coli
(EC) and K. pneumoniae (KP). For SA, Monte Carlo (MC)
simulations were used to determine target attainments (TA) of
different dosage regimens for RO at speciﬁc MICs.
Methods: RO and comparators were tested against 363 SA (58
MSSA/305 MRSA), 43 CNS, 275 PA, 159 SP, 121 EC and 132 KP,
using NCCLS guidelines (2004). Isolates were non-repeat clinical
isolates collected through 2004. Using a 5000 subject MC
simulation, TA for achieving free drug concentrations above
the MIC (>40% dosing interval) was assessed for SA using
pharmacokinetic data from Phase I studies.
Results: For MSSA/MRSA respectively, RO MIC90s (lg/ml)
were 0.25/8 (US) and0.12/16 (EU) and forCNS, 2 (US) and 4 (EU).
For IMP-S/IMP-RPA respectively, ROMIC90s (lg/ml)were 0.5/
8 (US) and 2/16 (EU). For PEN-S/PEN-R SP MIC90s (mg/ml)
were £0.008/0.5 for both regions. RO showed good activity
against ESBL and AmpC producing EC and KP (0.12–0.25, US;
0.03, EU). For SA, TA for RO regimens of 750 mg q12 h/750 mg
q8 h were 81.4%/96.3% respectively for US and 59.3%/80.9%
respectively for EU isolates. For SA, TA for RO regimens of
1500 mg q12 h/1500 mg q8 h were 96.0%/99.8% respectively for
US and 80.9%/98.7% respectively for EU isolates.
Conclusions: RO demonstrated broad spectrum in vitro activity
against resistant phenotypes commonly encountered within the
hospital setting, including MRSA. To achieve bactericidal
exposures for MRSA, MC simulations support the use of
750 mg q8 h or 1500 mg q12 h in the US and 1500 mg q8 h in
EU, as a 1 hour infusion.
Table 1
Aztreonam MIC
range (mg/L) Ceftazidime MIC range (mg/L)
Species n Alone
+4mg/L
AVE
1330A Alone
+ 4mg/L
AVE1330A
4:1 ratio
with
AVE1330A
4:2 ratio
with
AVE1330A
E. coli (ceftazidimeR) 12 4->64 £0.06-0.12 16->128 £0.03-1 0.25-16 0.25-8
Citrobacter freundii (ceftazidimeR) 6 4-64 0.12-0.25 32->128 0.25-1 0.5-4 0.5-2
Klebsiella pneumoniae (ceftazidimeR) 12 2->64 £0.06-0.05 12B- > 128 £0.03-1 1-4 1-4
Enterobacter cloacae (ceftazidime R) 13 0.5->64 £0.06-1 16- > 128 0.25-8 2-8 0.5-8
Morganella morganii (ceftazidimeR) 2 2/8 £0.06/0.25 16/64 0.12/0.25 0.5/2 0.25/0.5
E. coli (TEM 9 transformant) 1 16 0.12 >128 0.5 NT NT
E. coli (TEM 9 transformant) 1 64 £0.06 >128 0.5 NT NT
E. coli (TEM 9 transformant) 1 64 <0.06 >128 0.5 NT NT
E. coli (TEM 10 transformant) 1 32 0.12 >128 0.5 NT NT
E. coli (OXA 5 transformant) 1 16 0.12 64 0.5 NT NT
Klebsiella spp (SHV-ESBL
producers)
24 4->64 £0.06-1 8->64 0.015-2 0.5-8 0.25-8
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P1574
Delayed resistance selection for doripenem
when passaging P. aeruginosa isolates with an
aminoglycoside
D. Biedenbach, H. Huynh, R. Jones (North Liberty, USA)
Background: doripenem (DOR) (MIC50, 0.5 mg/L), a parenter-
al carbapenem, has activity equal or superior to meropenem
(MIC50, 0.5) and imipenem (MIC50, 1) against PSA. This study
determined the resistance selection of DOR ± gentamicin
(GENT) during subinhibitory passaging using 6 P. aeruginosa
(PSA) strains.
Methods: PSA bloodstream strains (2003) with DOR MICs at or
near the proposed susceptible breakpoint (£4 mg/L). Broth
microdilution methods were used to establish baseline MICs for
DOR (2–8) and GENT (4–>256). After overnight incubation, the
organism suspension, one well below the MIC was transferred
into fresh media and allowed to grow (0.5 McFarland) then
inoculated into panels containing DOR ± GENT (MIC/4; not to
exceed 4 mg/L). Isolates were passaged over 7 days.
Results: The table shows baseline and 7 day passaging results:
After 7 days, strain MIC increases were: DOR alone at ‡4X (3),
2X (1), NC (2); + GENT at 4X (1), 2X (2), NC (3). No strain was
resistant to DOR + GENT (MIC, ‡16 mg/L) and enhanced
combination activity was noted for nearly all strains during
the ﬁrst 3 passages.
Conclusions: The combination of a co-drug (GENT) with DOR
against PSA provided enhanced activity during early passaging
and minimized the number of DOR-R strains. DOR and amino-
glycoside combinationsmaybe an effective treatment regimen for
infections caused by PSAwith elevated carbapenemMIC values.
P1575
Heterologous expression of lysK encoding a lysin
with anti-MRSA activity from the genome of the
anti-staphylococcal phage K
A. Coffey, W. Meaney, G. Fitzgerald, P. Ross,
S. O’Flaherty (Cork, Fermoy, IRL)
Objectives: The emergence of antibiotic resistant Staphylococci
has prompted the need for alternative antibacterial controls
other than antibiotics. Thus the objective of this study was to
develop and evaluate a non-antibiotic antimicrobial with activ-
ity against Staphylococcus aureus.
Method, background and approach: The bacteriophage K was
previously shown to exhibit a very broad host range against
Staphylococcus and lysed a range of methicillin-resistant S. aureus
(MRSA) strains from Irish hospitals, hetro-vancomycin and
vancomycin resistant S. aureus (hVRSA and VRSA) and also
teicoplanin resistant strains (Coffey et al., 2004 Use of polyvalent
anti-staphylococcal bacteriophages for the biocontrol of methi-
cillin-resistant Staphylococcus aureus and other Staphylococci.
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ECCMID). The phage was subjected to genome sequencing
(O’Flaherty et al. 2004, Genome of staphylococcal phage K: a
new lineage of Myoviridae infecting Gram-positive bacteria
with a low G-C content. Journal of Bacteriology, 186). Genome
analysis revealed a linear DNA genome of 127,395 base pairs,
which encodes 118 putative ORFs. The gene encoding the lysin
protein was identiﬁed and standard molecular biology tech-
niques were utilized to clone the lysin protein.
Results: Bioinformatic analysis of the bacteriophage lysin (lysK)
gene indicated that it was interrupted by an intron. This
observation was conﬁrmed by RT-PCR, and the resulting
cDNA was found to encode 495 amino acid protein. The lysK
gene was heterologously over-expressed in both Escherichia coli
(using the T7 promoter) and Lactococcus lactis (using a nisin-
inducible promoter) with a view to generating cell factories for
lysin production. Results from zymograms with dead staphylo-
coccal cells indicated that active recombinant LysK product was
generated in both cases exhibiting cell wall degrading activity
against coagulase negative Staphylococci, MRSA strains, a VRSA
and S. aureus associated with bovine infections.
Conclusions: The bacteriophage lysin cloned in this study
exhibits activity against drug resistant S. aureus. Thus it is a
promising candidate as an antimicrobial for eliminating prob-
lematic S. aureus strains.
P1576
Circumventing resistance to beta-lactam
antibiotics in Staphylococcus aureus
C. Fuda, S. Mobashery (Notre Dame, USA)
Objective: Emergence of methicillin-resistant Staphylococcus
aureus (MRSA) has created challenges in treatment of nosocomi-
nal infections. S. aureus normally produces four PBPs, which are
susceptible to modiﬁcation by b-lactam antibiotics, an event that
leads to bacterial death. The gene product of mecA fromMRSA is
a penicillin-binding protein (PBP) designated PBP2a. PBP2a is
refractory to the action of all available b-lactam antibiotics.
Furthermore, PBP2a is capable of taking over the functions of the
other PBPs of S. aureus in the face of the challenge by b-lactam
antibiotics. The basis for resistance of PBP2a to inhibition by b-
lactam antibiotics has been studied by us. These methodologies
have been applied to investigations of three cephalosporins from
ABRI (Antibiotic Research Institute, Vienna), Sandoz, which
were speciﬁcally developed for inhibition of PBP2a in MRSA.
Methods: The mecA gene was cloned and expressed in E. coli,
and PBP2a was puriﬁed to homogeneity. Also, synthetic cell
wall fragments have been produced for these studies.
Results: The kinetic parameters for interactions of typical b-
lactam antibiotics and PBP2a were evaluated. PBP2a manifests
resistance to inhibition by available b-lactam antibiotics by
attenuation of the microscopic rate constant for acylation (k2)
and by elevation of the dissociation constants (Kd). The two
factors working in concert result in drug resistance. The ABRI
cephalosporins, developed for treatment of MRSA, exhibit lower
Kd values and k2/Ks ratios were approximately one to two
orders of magnitude higher than those of other b-lactams. We
have documented that binding of portions of the cell wall
outside of the active site of PBP2a facilitates the opening of the
active site (from a closed conformation), such that PBP2a
becomes more predisposed to modiﬁcation by the ABRI antibi-
otics, manifesting in increases in k2/Ks of over 1000-fold
compared to typical b-lactam antibiotics.
Conclusions: The recent emergence of variants of MRSA
resistant to oxazolidinone and glycopeptide antibiotics has
created challenges in treatment of certain strains of S. aureus, a
disconcerting situation clinically. The studies from our laborat-
ory provide mechanistic details for the inhibition of PBP2a. The
results with the ABRI cephalosporins demonstrate how the
problem presented by this unique PBP can be circumvented,
presenting opportunities in antibiotic design.
DOR/+GENT MIC (mg/L) by passage
Strain* Baseline Day 1 2 3 4 5 6 7
30-3232A 2 2/2 2/1 2/2 4/4 2/4 4/4 2/8
107-3347A 4 4/2 4/2 16/4 >16/4 16/4 >16/4 >16/8
45-11372A 4 4/2 16/4 16/4 >16/8 >16/4 >16/8 >16/8
75-3075A 4 8/2 8/2 8/2 8/4 8/4 8/4 16/4
24-3338A 8 8/2 8/2 8/4 16/8 16/8 16/8 16/8
38-12060A 8 8/8 8/8 16/8 16/8 8/8 8/8 8/8
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P1577
Telavancin possesses low potential for resistant
mutant selection in serial passage studies of
Staphylococcus aureus and Enterococci
K.M. Krause, B.M. Benton, D.L. Higgins, K. Kaniga, M. Renelli,
P.K. Humphrey (South San Francisco, USA)
Objectives: Serial passage selection studies are useful for
predicting the development of endogenous antibiotic resistance
in the clinical setting. Telavancin (TLV) is a rapidly bactericidal
lipoglycopeptide with multiple mechanisms of action against
Gram-positive bacteria. Previous serial passage mutant selection
experiments performed using solid media failed to generate
stable TLV-resistant isolates from Staphylococcus aureus or
Enterococci. In the present study we report results of multi-step
selection studies performed in liquid media.
Methods: Selection for spontaneous resistance was performed
by serial passage inoculation of liquid media containing a range
of TLV concentrations with 106 CFU/mL of each of 7 strains of
MRSA (ATCC 33591, MCJ-25, MCJ-10, KPB-08, S-1, SFVA-09,
MED-121); MSSA ATCC 29213, VSE E. faecalis ATCC 29212,
VanA-type VRE E. faecalis MGH-01 and E. faecium CDC-01, and
E. faecium KPB-01 for 20 consecutive passages. Isolates with
increased TLVMIC were characterized for stability of resistance,
susceptibility to other agents, and growth rate.
Results: Mutants with TLV MICs elevated 2–4X that of parental
levels were selected from each strain. However, TLV failed to
select mutants with MICs >4X that of parental strains following
20 passages. No major changes were observed in the growth
properties of isolates with reduced susceptibility to telavancin.
Two mutants with TLV MIC 4X that of their parental strains
(32 lg/mL) were selected from the VRE strains. These mutants
exhibited reduced susceptibility to daptomycin at or near the
same fold MIC increase observed for telavancin, however, no
signiﬁcant cross-resistance to other antimicrobial agents was
observed. Mutant phenotypes were stable upon extended
subculture (approximately 300 generations) in drug-free
medium.
Conclusions: High-level resistance to TLV was not selected
from glycopeptide-sensitive organisms, including MRSA,
MSSA, or VSE, following continuous exposure for 20 consecu-
tive passages. Mutants with 4X-reduced susceptibility to TLV
were selected from 2 out of the 3 VRE strains. These data suggest
that TLV possesses a low potential for resistant mutant selection.
New drugs: in vivo studies
P1578
Population pharmacokinetic analysis of
dalbavancin
M. Buckwalter, M. Stogniew, J.A. Dowell (King of Prussia, USA)
Objectives: Dalbavancin is a novel, second generation lipogly-
copeptide antibiotic in late stage clinical development for
complicated skin and skin structure infections (cSSSI). Its
distinct pharmacokinetic characteristics support once weekly
dosing. A population pharmacokinetic analysis was preformed
to estimate patient pharmacokinetic parameters and to deter-
mine the signiﬁcance of possible covariates.
Methods: A population pharmacokinetic analysis was per-
formed that included 1668 dalbavancin concentrations from
532 patients across 3 completed phase 2 and 3 clinical trials. The
majority of patients (n = 502) had SSSI with suspected or
conﬁrmed Gram-positive bacterial pathogens. The remaining
patients (n = 30) had catheter-related bloodstream infections.
Most patients received a weekly dalbavancin administration:
1000 mg on Day 1 and a second dose of 500 mg on Day 8.
Mixed-effects models were evaluated using the First Order (FO)
and FO Conditional Estimation with Interaction (FOCEI) maxi-
mum likelihood estimation method in NONMEM. Possible
covariates examined on the model included patient demography
and concomitant medication use.
Results: The pharmacokinetic model determined for dalbavan-
cin was a two-compartment model with interpatient variability
(IPV) described on all the parameters. The typical value and IPV
(CV%) of clearance (CL) was 0.0571 L/h (18.0%) and was
inﬂuenced by body surface area (BSA) and creatinine clearance
(CLCR). Patients in the studies had CLCR of greater than
50 mL/min. Volume of distribution of the central compartment
(V1) was 4.15 L (24.5%) and was inﬂuenced by BSA. The inter-
compartmental clearance and the peripheral volume of distri-
bution were 0.476 L/h and 11.4 L, respectively. The estimated
values for the predominant half-life and volume of distribution
at steady state derived from this model were 8.5 days and 15.7
L, respectively. Although BSA and CLCR were identiﬁed as
sources of variability on CL, and BSA as a source of variability
on V1, the addition of these covariates described less than 25%
of the IPV.
Conclusion: Dalbavancin pharmacokinetic parameters in
patients were predictable, demonstrating low IPV. BSA and
CLCR were determined to be statistically important covariates
on the model, but had no clinically signiﬁcant effect on drug
concentrations. No dosage adjustment is required for dalbavan-
cin based on the covariates examined in the model, including
BSA, patient weight, or CLCR (>50 mL/min).
P1579
A randomised, double-blind, placebo-controlled,
parallel-design trial of multiple doses of
tolevamer in healthy male volunteers
D. Davidson, A. Porzio, P. Nealon, J. Peppe (Waltham, USA)
Background: Tolevamer potassium-sodium (tolevamer) is a
novel, high molecular weight, non-antibiotic polymer developed
to treat Clostridium difﬁcile associated diarrhoea (CDAD). The
current form has been modiﬁed from an earlier compound,
tolevamer sodium, by the addition of potassium to prevent the
anionic polymer from exacerbating hypokalemia by binding and
excreting intestinal potassium in the stool. Tolevamer sodium
was shown to resolve the symptoms of CDAD with similar
efﬁcacy as vancomycin in a large Phase 2 study. Tolevamer is
currently in Phase 3 development.
Objective: To determine the safety and tolerability of liquid
tolevamer given at four different dose levels (6.0 g, 9.0 g, 12.0 g,
and 15.0 g) to healthy male volunteers.
Methods: A randomized, double-blind, placebo-controlled, par-
allel-design, multiple dose study consisting of a screening
period, a 9 day treatment period and a 1 week follow-up
period was conducted. For each dose group, 10 subjects were
randomized: 8 to active drug, and 2 to matching placebo. Half
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the subjects in each dose group received a loading dose (single
dose equivalent to a total daily dose) on Day 1, while the other
half received their loading dose on Day 9. All subjects received
tolevamer t.i.d. on Days 2 through 8. Subjects received a
controlled diet averaging 6600 mg/day potassium.
Results: Tolevamer was well tolerated with all forty subjects
completing the study. All adverse events were of mild intensity,
transient and resolved without sequelae. No dose relationship
was apparent. Those considered related to study treatment were
gastrointestinal disorders. Flatulence was the most common
event. No clinically relevant changes were found in safety
laboratory values, vital signs, or physical examination. Analysis
of 24-hour urine collections demonstrated that potassium
balance was achieved with tolevamer with the exception of a
small reduction in mean potassium excretion from baseline to
endpoint in the 15.0 g/day dose group of approximately
10 mmol potassium/day. No dose response was evident in
urinary potassium excretion, and serum potassium was not
adversely affected in any dose group.
Conclusion: Oral treatment with a daily dose of up to 15.0 g
tolevamer divided t.i.d. and as a loading dose was safe and well
tolerated by healthy male volunteers.
P1580
Tolerability and efﬁcacy of N-chlorotaurine in
infections of different body sites: results of phase
II clinical trials
M. Nagl, A. Neher, B. Teuchner, R. Ho¨pﬂ,
W. Gottardi (Innsbruck, A)
Objectives: N-chlorotaurine (NCT) is a long-lived oxidant pro-
duced by human leukocytes during inﬂammation. Its crystalline
sodium salt can be synthetized chemically, and it has broad
spectrum antimicrobial activity against bacteria, fungi, and
viruses. Because of mild activity and therefore low toxicity NCT
is thought to be useful as an antiseptic applicable to different body
sites. We performed three clinical phase II studies to evaluate
efﬁcacy and tolerability in otitis externa, epidemic keratoconjunc-
tivitis, and chronic leg ulcers with a purulent coating.
Methods: Aqueous 1% NCT (55 mM) solution was applied
topically for 5–7 days in all three indications. All studies were
designed with a randomized test (NCT) and control group
(standard medication). The otitis externa and epidemic kerato-
conjunctivitis study were double-blind. Evaluation was done
clinically using a scoring system for subjective and objective
symptoms and microbiologically.
Results: NCT was well tolerated in all indications, little burning
in the eye for a few minutes in few patients like sweat and
signiﬁcantly less burning (P < 0.05) than by chloramine T in
purulent crural ulcers were the only side effects. Granulation
and re-epithelialization in ulcers appeared earlier in the NCT
group (P < 0.05). NCT was equally effective in removal of the
purulent coating than the stronger antiseptic chloramine T. The
clinical symptoms of external otitis decreased 2 days earlier in
the test group than in the control group treated with a
combination of polymyxin B, neomycin, and hydrocortisone
(P < 0.01). Regarding epidemic conjunctivitis, severe courses
caused mainly by adenovirus type 8 showed a reduction of
symptoms after 3–5 days, which was earlier than in the control
group mock treated with gentamicin (P < 0.05).
Conclusion: The mild antiseptic NCT is excellently tolerated
and effective in infections of different body sites. As an
endogenous amino acid derivative toxic and allergic side effects
have never been observed, and it can be applied without
additives. Because of these advantages NCT can be estimated as
a very promising antimicrobial agent in human medicine.
P1581
Ertapenem as initial antimicrobial monotherapy
for patients with typical community-acquired
pneumonia
C. Petrogiannopoulos, G. Svoukas, K. Papamichael,
A. Deliousis, K. Kanakis, P. Papasava, N. Kostakos,
A. Zaharof (Athens, GR)
Objectives: Ertapenem, a Group 1 carbapenem, is a once-a-day
parenteral a-lactam antibiotic which is used as initial antimicro-
bial monotherapy for treatment of community-acquired pneu-
monia (CAP). The aim of our study was to evaluate the clinical
response and the safety proﬁle of ertapenem.
Methods: We studied 64 patients (34 female, 30 male) of 61.
mean age (range 18–9) with CAP that was proved clinically,
radiographically and after blood test examinations. All blood
cultures were negative, while sputum cultures were positive for
Streptococcus pneumoniae in 6 patients and Klebsiella pneumoniae in
2 patients. The patients recieved 1 gr ertapenem intravenous (iv)
daily, as initial antimicrobial therapy, for 5 days at least.
Everyday, haematological and biochemical tests were made in
order to evaluate the clinical response and the safety proﬁle of
ertapenem. Clinically improving patients were switched to oral
antibiotic therapy after 5 days.
Results: After 5 days therapy with ertapenem 61 patients
(95,3%) had clinical and haematological improvment, concern-
ing the reduction of fever, WBC from 14000 ± 1700–7800 ± 1200
and CRP value from 9.1 ± 1.1–2.2 ± 0.8. The most common
drug-related adverse experiences reported during parenteral
therapy in patients treated with ertapenem were diarrhoea
(6.1%), infused vein complication (4.7%), nausea (3.1%) and
headache (1.6%), while liver function tests were normal before
and after treatment.
Conclusion: These data provided evidence for the efﬁcacy of
ertapenem as initial antimicrobial monotherapy for patients
with CAP. Ertapenem, given 1 gr once a day by iv infusion was
generally well tolerated and had overall a very good safety and
tolerability proﬁle.
P1582
Treatment of chronic MRSA infections using a
novel aqueous extract of allicin (AB1000)
R.R. Cutler, P.D. Josling, N.J. Bennett (London, Rye, UK)
Allicin is recognised as the main bioactive agent from Allium
sativum or garlic. This compound is highly active but generally
unstable. Using a cold aqueous extraction method, we have
obtained a novel extract of allicin (AB1000) that we have
reported is stable and highly active in vitro against methicillin
resistant Staphylococcus aureus (MRSA).Due to national publicity
of AB1000, patients with long standing unresolved MRSA
infections requested this agent for treatment. MRSA is com-
monly related to delayed closure for many chronic and acute
wounds. This is associated with high levels of bacteria in tissues
but they can also through toxin secretion. These toxins can cause
local necrosis and disrupt the delicate balance of critical
mediators such as cytokines and proteases necessary for healing
progression. We present initial ﬁndings from three patients who
have completed a course of treatment. These courses consisted
of capsules (450 mg, 3 per day); spraying liquid AB1000
(1000 lg ml-1) onto the affected areas once per day and applying
AB1000 Cream (500 lg ml)1) to the infected area once daily.
Patients were screened, nasal and wound for MRSA prior and
during treatment. All patients were nose and wound swab
MRSA positive prior to treatment. All were over 60 years of age
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and had either major surgery or long term skin infections
leading to the formation of ulcers infected by MRSA. Two of the
MRSA infections were community acquired and one hospital
acquired. The strains isolated from each patient were tested in
vitro against AB1000 and all were susceptible.Patients reported
an improvement in their condition after 2 and 6 weeks treatment
and the infections resolved in 3–4 months. Although the
timescales required for treatment may be longer than those
normally required using antibiotics, the initial relief from
weeping ulcers and pain was much quicker. It should be
noted these the patients had been receiving unsuccessful
treatment with antibiotics for months or years prior to treatment
with AB1000. A possible reason for the initial relief from
symptoms could relate to the reported activity of garlic extracts
to neutralise bacterial exoenzymes in vitro. This could account
for the ﬁndings that patients got relief from their symptoms
before the MRSA were fully removed from the lesion site.
P1583
In vitro and in vivo antibacterial activity of DA-
7218, a new oxazolidinone, against Staphylococci
and Enterococci
S. Choi, T. Lee, E. Kang, T. Son, W. Im, J. Rhee, W. Kim, D. Yong,
J.H. Yum, K. Lee (Yongin-Si, Seoul, KOR)
Objectives: With the approval of linezolid as the ﬁrst thera-
peutically acceptable oxazolidinone, efforts have been made to
identify new oxazolidinones with improved antibacterial prop-
erties. This study was performed to establish the in vitro and in
vivo antibacterial activity of DA-7218 against Staphylococci and
Enterococci compared to linezolid.
Methods: MICs were determined against S. aureus, CNS,
E. faecalis and E. faecium using NCCLS agar dilution method.
In vivo protection tests of DA-70218 were carried out in a
murine systemic infection against S. aureus, CNS, E. faecalis and
E. faecium. Drugs were administrated intravenous (i.v.) or orally
(p.o.).
Results: MIC90 values of DA-7157, an active metabolite of DA-
7218, were 0.5 lg/ml for both methicillin-susceptible and -
resistant Staphylococci and 0.25–0.5 lg/ml for both vancomycin-
susceptible and -resistant Enterococci, and they were 4- to 8-fold
lower than those of linezolid. ED50s of DA-7218 were 2–4 fold
and 4–8 fold lower than those of linezolid upon p.o. and i.v.
administration in staphylococcal and enterococcal systemic
infections, respectively.
Conclusions: DA-7157 showed 4–8 fold better in vitro antibac-
terial activity than linezolid against Staphylococci and Enterococci,
and DA-7218 had excellent in vivo efﬁcacies against staphylo-
coccal and enterococcal infections.
P1584
Inhibition of ampicillin-induced resistance by
targeted recombinant beta-lactamase monitored
by PFGE and antibiograms of Escherichia coli
S. Mentula, T.A. Virtanen, J. Harmoinen, M. Carson,
E. Ko¨no¨nen (Helsinki, Espoo, FIN)
Objectives: Targeted recombinant beta-lactamase (TRBL) has
been designed to degrade beta-lactam antibiotic residues in the
gastrointestinal tract and thereby inhibit the emergence of
resistance. In the present study the changes in resistance rates
and persistence of different intestinal Escherichia coli strains were
followed in beagles during ampicillin treatment with or without
TRBL.
Methods: Eighteen laboratory beagles were randomised to
receive ampicillin (AMP), ampicillin + TRBL (AMP/TRBL) or
placebo (PLA). Susceptibility of 961 intestinal E. coli isolates,
collected before during and after the treatment, was tested
against 9 antimicrobial agents by the NCCLS disk diffusion
method. Selected 402 isolates were typed using pulsed-ﬁeld gel
electrophoresis (PFGE) after XbaI restriction of total DNA.
Results: Vast genetic heterogeneity, including 25 different
PFGE types displaying 19 different resistance patterns, was
detected. The beagles harboured on average 5 PFGE types
during the study and shared several common clones. Although
the number of resistant isolates increased and similar resistance
patterns were detected in all treatment groups, no single
ampicillin-resistant PFGE type was widely spread between
groups. Ampicillin resistance was found in 6 PFGE types and in
9 different combinations of co-resistance. The proportion of
resistant isolates (98%, 36% and 28%) and number of dogs (6, 5
and 3) carrying ampicillin-resistant strains during the treatment
was higher in AMP group than in AMP/TRBL and PLA groups,
respectively. New resistant PFGE types appeared and exten-
sively replaced the previous types in the AMP group but there
were 2 cases where a previously susceptible strain acquired
resistance during the treatment. In the AMP/TRBL group the
slight increase in resistance was due to enrichment of resistant
strains in dogs that already carried resistance. In the PLA group
new resistant PFGE types appeared but their proportions
remained moderate.
Conclusions: TRBL seems to inhibit the selection pressure by
preserving the genetic diversity of intestinal E. coli populations.
Increase in resistance is due to selection of heterogeneous
resistant strains rather than emergence of resistance among
previously susceptible strains.
Pharmacokinetics/pharmacodynamics of anti-staphyloccal drugs
P1585
Kinetics of linezolid release from
polymethylmethacrylate beads
P. Anguita Alonso, M. Rouse, K.E. Piper, D.J. Jacofsky,
D.R. Osmon, A.D. Hanssen, J.M. Steckelberg, R. Patel
(Rochester, USA)
Objective: To study the release of linezolid from polymethyl-
methacrylate (PMMA) beads loaded with three different con-
centrations of antimicrobial.
Methods: PMMA beads were prepared loading Surgical Sim-
plex P radiopaque bone cement with 2.5%, 7.5% and 15%
(w/w) linezolid. Each bead was placed in a continuous ﬂow
chamber with 1 ml Krebs Ringer buffer, ﬂowing at 1 ml/h at
37C for 48 h. The antimicrobial concentrations were deter-
mined in triplicate by disk diffusion antimicrobial bioassays
(lower detection limit was 5 mcg/ml). The detection time,
Cmax, Tmax, AUC0-inﬁnity and per cent antimicrobial recov-
ered from the beads were calculated.
Results: Results are listed in the table as mean ± standard
deviation of three values. No antimicrobial greater than the limit
of detection of the assay was present for 2.5% linezolid loaded
beads. Elution parameters of linezolid were similar for beads
containing 7.5 and 15 % of antimicrobial.
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Conclusions: Linezolid peak concentration and AUC were
greater than calculated for vancomycin with similar detectable
number of hours. In vivo studies with linezolid loaded PMMA
are warranted.
P1586
Predicted AUC/MIC using a simple vancomycin
nomogram exceeds proposed pharmacodynamic
targets for Staphylococcus aureus infections
S. Davis, M. Rybak, B. Domagala, P. McKinnon
(Detroit, Grand Rapids, St. Louis, USA)
We previously reported on a validated vancomycin (V) dosing
nomogram (NM) with minimal trough level monitoring that
achieves clinical outcomes equivalent to traditional pharmaco-
kinetic dosing. A proposed target for V in the treatment of
S. aureus (SA) is an AUC/MIC of ‡400. [Moise-Broder et al. Clin
Pharmacokinet 2004]
Objective: To determine if a simple nomogram for dosing V
achieves an AUC above proposed pharmacodynamic (PD)
targets for SA infections.
Methods: 516 patients who received V per NM from 1996–2003
were evaluated. Demographics, antibiotic therapy, microbiology,
and clinical outcomes were collected. Predicted area under the
curve (AUC24), Cmax, and Cmin were extrapolated from
patient-speciﬁc data, and clinical outcomes were assessed.
Recent SENTRY data representing 35,488 SA isolates from the
US demonstrates anMIC90 of 1. [Fritsche T et al. Int J Antimicrob
Agents 2004] Therefore, for MIC values reported as <2 mcg/mL,
a value of 1 was assumed in AUC/MIC calculations.
Results: The study population (n = 516) was 63% male, average
age 49 ± 17 years. Average Clcr was 82 ± 28 mL/min, and
average duration of therapy was 9.2 ± 7.5 days. 57% of patients
received 1 g every 12 h, 19% 1 g every 8 h, 12% 1 g every 24 h,
6% 0.5 g every 12 h, and 6% other doses. Average predicted
AUC24 was 532 ± 213, and Cmin was 15.1 ± 8.1. Actual Cmin in
patients with troughs was similar, 15.7 ± 10.4. AUC was noted
to be slightly higher in patients with lower Clcr. For those with
Clcr of 31–60 ml/min, AUC was (mean, 95%CI) 642 (592–692);
61–90 ml/min was 565 (540–588), and >90 ml/min was 421
(403–438). In the subset of patients with documented SA
infections (n = 201), 76% were methicillin-resistant, and all
isolates had a vancomycin MIC <2. Bacteremia accounted for
46% of infections, while 30% were skin/soft tissue, 15% lung,
and 9% other infections. Figure 1 presents clinical and micro-
biologic outcomes of SA infection by groupings of AUC/MIC.
Conclusions: This previously developed V nomogram exceeds
adequate Cmin and AUC/MIC targets for the treatment of SA
infections and produces reliable clinical success rates. Use of
the NM can obviate the need for routine serum concentra-
tion monitoring of V in all patients. In patients with higher
Clcr, AUC was slightly lower but still exceeded proposed PD
targets.
P1587
In vitro and in vivo release of daptomycin or
vancomycin from polymethacrylate beads
M. Rouse, E. Hall, K.E. Piper, M. Jacobson, A.D. Hanssen,
D.J. Jacofsky, R. Patel (Rochester, USA)
Objective: Polymethylmethacrylate (PMMA) is used as a local
antimicrobial delivery in the treatment and prevention of bone/
joint infection. We developed an in vitro assay to determine
release proﬁles of antimicrobial agents from PMMA. In this
study we compared the in vitro release kinetics of daptomycin
or vancomycin in a continuous ﬂow chamber with in vivo
release in a rat model.
Methods: Daptomycin or vancomycin (7.5% w/w) was loaded
into the powder component of PMMA; the liquid monomer
added and mixed. Antimicrobial loaded PMMA was formed
into 3 mm beads and allowed to polymerize for 24 h. The effect
of PMMA components and polymerization on the activity of
daptomycin or vancomycin was determined by homogenizing
loaded beads in 2 ml of Kreb’s Ringer buffer and assaying the
buffer for antimicrobial activity. In vitro antimicrobial release
kinetics were determined by placing a bead in a chamber
containing 1 ml of Kreb’s Ringer buffer, with 1 ml/h Kreb’s
Ringer buffer ﬂowing through the chamber. Buffer eluted from
the system was collected hourly and assayed for antimicrobic
using a bioassay. Each bead/antimicrobial was tested in
triplicate. In vivo antimicrobial release kinetics were performed
by surgically implanting single beads into bone defects in the
proximal left tibia of rats. Three rats with a daptomycin loaded
bead and three with a vancomycin loaded bead were sacriﬁced
at 2, 4, 6, 8, 10, 14, 18 and 21 d after placement. Bone tissue
within 5 mm of the bead was recovered, homogenized in 2 ml
Kreb’s Ringer buffer, incubated 24 h, and assayed for antimicro-
bic. The per cent released listed is total antimicrobial detected in
buffer or tissue/total amount of antimicrobial loaded into each
bead.
Results: 100% of daptomycin and 89% of vancomycin loaded
into PMMA beads was detected immediately after polymeriza-
tion. Pharmacokinetic results are shown the mean concentra-
tions in the table.
Conclusion: The peak daptomycin or vancomycin concentra-
tion observed in vivo was approximately three-fold the peak
observed in vitro. Daptomycin loaded PMMA produced higher
antimicrobial concentrations than did vancomycin loaded
PMMA in vitro and in vivo.
Antimicrobial
concentration
Time initially
detectable (h)
Time no
longer
detectable (h)
Peak
concentration
mcg/ml
Peak
time (h)
AUC
(mcgh/ml)
Percent
initial amount
detected
Linezolid 2.5% - - <5 - - -
Linezolid 7.5% 1 ± 0 18 ± 9 64 ± 39 1 ± 1 315 ± 144 17 ± 6
Linezolid 15% 1 ± 0 19 ± 4 65 ± 31 1 ± 0 330 ± 64 18 ± 5
Vancomycin 7.5% 3 ± 0 23 ± 1 19 ± 4 4 ± 0 180 ± 8 11 ± 0
* From Clin Orthop Rel Res 2002;403:49
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Clinical success Bacterial Eradication
AUC/MIC groups:
<200 (n=6)
200-400 (n=34)
>400 (n=156)
Elultion
mode Cmax Tmax
Percent
released AUCn-2
Daptomycin invitro 62 mcg/ml 6 h 18% 272 h · mcg/ml
invivo 178 mcg/g 4 d 19% 621 d · mcg/g
Vancomycin invitro 19 mcg/ml 4 h 11% 180 h · mcg/ml
invivo 49 mcg/g 4 d 7% 206 d · mcg/g
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P1588
Comparative pharmacodynamics of daptomycin
and vancomycin with Staphylococcus aureus:
multiple-dose simulations using an in vitro
dynamic model
S. Zinner, M. Smirnova, I. Alferova, I. Lubenko, S. Vostrov,
Y. Portnoy, A. Firsov (Cambridge, USA; Moscow, RUS)
Objective: To compare the pharmacodynamics of daptomycin
and vancomycin, killing kinetics of S. aureus were studied in
ﬁve-day treatment courses over a wide range of ratios of the
24-h area under the curve (AUC) to MIC.
Methods: A clinical isolate S. aureus 866 with MIC of dapto-
mycin of 0.35 mg/L and MIC of vancomycin of 0.7 mg/L was
exposed to once-daily daptomycin and twice-daily vancomycin
for ﬁve consecutive days. Mono-exponential concentration-time
proﬁles were simulated with half-lives of 9 h (daptomycin) and
6 h (vancomycin) over a 16-fold range of the AUC/MIC ratio:
from 16–256 h. The antimicrobial effect was expressed by its
intensity (IE–the area between the control growth curve in the
absence of antibiotics and the time-kill/regrowth curve
observed in the presence of antibiotic). The cumulative effect
of each treatment was determined from time zero to the time the
effect no longer could be detected, i.e. the time after the last
antibiotic dose at which the number of antibiotic-exposed
bacteria reached at least 9 LogCFU/ml. This value was the
cutoff level used to determine IE.
Results: With both daptomycin and vancomycin, bacterial
regrowth followed initial killing over the entire range of the
simulated AUC/MIC ratio. Anti-staphylococcal effects of the
antibiotics depended on the AUC/MICs: the higher the AUC/
MIC, the lower numbers of surviving organisms and the later
the regrowth. The IE-log AUC/MIC plots were linear and
virtually superimposed for daptomycin and vancomycin. Based
on the IE-AUC/MIC relationship of the IE, the anti-staphylo-
coccal effect of the proposed therapeutic dose of daptomycin
(4 mg/kg; AUC/MIC 1100 h for S. aureus 866) is 20% greater
than that of two 1-g doses of vancomycin given at a 12-h interval
(AUC/MIC 570 h).
Conclusion: These ﬁndings predict greater anti-staphylococcal
efﬁcacy of clinically achievable AUC/MICs of daptomycin
relative to vancomycin.
P1589
Relative abilities of daptomycin and vancomycin
to prevent the enrichment of resistant
Staphylococcus aureus mutants in an in vitro
dynamic model
A. Firsov, I. Alferova, M. Smirnova, I. Lubenko, S. Vostrov,
E. Mirchink, Y. Portnoy, S. Zinner (Moscow, RUS; Cambridge,
USA)
Objectives: The mutant selection window (MSW) hypothesis
has been successfully tested in our recent study with S. aureus
866 (MIC of DAP 0.35 mg/L and MIC of VAN 0.70 mg/L)
exposed to daptomycin (DAP) and vancomycin (VAN) over a
wide range of the 24-h area under the curve (AUC) to MIC. To
explore if the AUC/MIC relationships of resistance are bacterial
strain-independent, a less susceptible S. aureus 10 (MIC of DAP
1.1 mg/L and MIC of VAN 2.2 mg/L) was tested using the
same model.
Methods: Five-day treatments were mimicked with once-daily
DAP (half-life 9 h) and twice-daily VAN (half-life 6 h). S. aureus
10 was exposed to a series of pharmacokinetic proﬁles of DAP
and VAN that provide peak concentrations equal to the MIC,
between the MIC and the mutant prevention concentration
(MPC), i.e., within the MSW, and above the MPC (AUC/MIC
16–256 h). MPCs of DAP and VAN were 5.5 and 10.9 mg/L,
respectively. Changes in the susceptibility of S. aureus 10 to DAP
or VANwere examined by repeated MIC determinations at each
24 h and in the end of treatment. To determine the resistance
frequency (f), the surviving organisms were counted by plating
the specimens on agar containing 2 · and 4 · MIC of DAP or
VAN.
Results: Both in terms of susceptibility testing and the popu-
lation analysis, selection of the resistant mutants occurred at
DAP and VAN concentrations that fell into the MSW (AUC/
MIC from 32 to 128 h) but not at concentrations out of MSW
(AUC/MIC 16 and 256 h). Bell-shape AUC/MIC relationships
of resistance of S. aureus 10 were similar to those observed with
DAP- and VAN-exposed S. aureus 866 as well as with S. aureus
exposed to ﬂuoroquinolones. Based on these ﬁndings, an AUC/
MIC ratio that may protect from the selection of resistant
mutants was predicted at 256 h for both DAP and VAN. For
S. aureus 10, this protective value is less than AUC/MIC
provided by usual 4 mg/kg dose of DAP (350 h) but not by
two 1-g doses of VAN (180 h).
Conclusions: Clinically achievable concentrations DAP may be
more effective than those of VAN in prevention of the selection
of resistant S. aureus. Also, these ﬁndings support the MSW
hypothesis.
P1590
The inﬂuence of Staphylococcus aureus accessory
gene regulator function on the development of
glycopeptide heteroresistance in an in vitro
pharmacodynamic model
B. Tsuji, M. Rybak (Detroit, USA)
Objective: The development of glycopeptide heteroresistance
in patients with S. aureus infections has been associated with
prolonged exposure to sub-therapeutic levels of vancomycin.
S. aureus which display accessory gene regulator (agr) dysfunc-
tion have been associated with persistent bacteraemia and may
be predisposed to develop glycopetide resistance: sub-inhibitory
concentrations of vancomycin have selected for heteroresistance
in vitro in agr-null group II S. aureus. We studied the effect of
administering varying exposures of vancomycin and the devel-
opment intermediate-level glycopeptide resistance in agr posit-
ive and negative group II S. aureus in an in vitro
pharmacodynamic model (IVPM).
Methods: One agr+ group II (RN6607) and the respective agr)
group II, null derivate (RN9120) strain of S. aureuswere obtained
from the Network on Antimicrobial Resistance in Staphylococcus
aureus (NARSA). MICs were determined by Etest & microdilu-
tion according to NCCLS. An IVPM was used to simulate
regimens of vancomycin of 1 g, 750 mg, 500 mg, 250 mg and
125 mg q12 h (Targeted Peak/Trough concentrations 40/10.0,
30/7.5, 20/5.0, 10/2.5 and 5/1.2 lg/ml). Simulations were
performed in triplicate and bacterial quantiﬁcation occurred
over 72 h. The development of vancomycin heteroresistance was
evaluated at 24, 48 and 72 h.
Results: Pre-exposure vancomycin MIC were 1.0 against both
agr+ group II and agr) group II strains. Against agr+ II S. aureus,
exposure to all simulated of vancomycin regimens did not result
in the development of resistance over 72 h. Post-exposure MICs
for all regimens were £2.0 lg/ml. Against agr) II, over 72 h,
exposure to vancomycin 1 g q12 h (24 h Area Under Concen-
tration Curve (AUCfree24/MIC:510 lg/ml/hr) and 750 mg
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q12 h (AUCfree24/MIC: 382) resulted in post-exposure MICs of
1–3 lg/ml. Increased post-exposure MICs up to 3 lg/ml were
noted secondary to exposure to 500 mg (AUCfree24/MIC: 264)
and 250 mg (AUCfree24/MIC: 123). Exposure to 125 mg (AUC-
free24/MIC:67) resulted in the development of vancomycin
heteroresistance, as post-exposure MICs increased to 6 lg/ml.
Conclusions: Sub-optimal exposures of vancomycin resulted in
the development of glycopeptide heteroresistance in agr-null
group II S. aureus. These ﬁndings suggest that prolonged, low-
level vancomycin concentrations or decreased vancomycin
penetration in sequestered infections may provide conditions
that select for glycopeptide heteroresistance.
P1591
Killing kinetics of Staphylococcus aureus exposed
to linezolid, alone and in combination with
doxycycline, in an in vitro dynamic model
M. Smirnova, I. Alferova, I. Lubenko, S. Vostrov, Y. Portnoy,
E. Isakova, S. Zinner, A. Firsov (Moscow, RUS; Cambridge, USA)
Objective: To predict the possible advantages of linezolid/
doxycycline combinations, their pharmacodynamics were stud-
ied with S. aureus in an in vitro dynamic model that mimics
human pharmacokinetics of the antibiotics.
Methods: A clinical isolate of S. aureus at a starting inoculum of
8 Log CFU/ml was exposed to twice-daily linezolid (half-life
6 h), alone and in combination with once-daily doxycycline
(half-life 15 h) for ﬁve consecutive days. The MIC of linezolid
was 1.56 mg/L and MIC of doxycycline was 6.25 mg/L. With
linezolid, a clinically attainable ratio of the 24-h area under the
curve (AUC) to MIC (200 h) was simulated. To achieve the same
AUC/MIC ratio with linezolid/doxycycline, a 60-h AUC/MIC
of linezolid was combined with a 140-h AUC/MIC of doxycy-
cline. In addition, similar ﬁve-day treatments were performed
with linezolid at AUC/MIC of 60 h alone. To provide simulta-
neous mono-exponential elimination of linezolid and doxycy-
cline with different half-lives, a previously described dynamic
model was modiﬁed according to Blaser and Zinner.
Results: Regardless of the simulated AUC/MIC, linezolid alone
produced a relatively slow initial reduction of the starting
inoculum (8 Log CFU/ml), with minimal numbers of surviving
organisms on the second day and regrowth on the ﬁfth day of
treatment. AUC/MIC-dependent killing was observed begin-
ning from the third day when numbers of surviving organisms
were signiﬁcantly lower after linezolid exposure at AUC/MIC
of 200 than 60 h. The respective intensities of the anti-staphylo-
coccal effect (IEs) were 180 and 110 (Log CFU/ml) · h. The
linezolid/doxycycline combination exhibited a more rapid
initial killing followed by much lower numbers of surviving
organisms with later regrowth. The respective IE was 1.7 times
greater than mono-therapy with linezolid at the same AUC/
MIC (200 h) and 2.7 times greater than at linezolid’s AUC/MIC
of 60 h.
Conclusions: These data predict the ability of doxycycline to
enhance anti-staphylococcal effects of linezolid.
Infections in neutropenic patients
P1592
Empirical antibiotics against Gram-positive
infections for febrile neutropenia. Systematic
review and meta-analysis of randomised
controlled trials
M. Paul, S. Borok, A. Fraser, L. Vidal, L. Leibovici
(Petah Tikva, IL)
Background: The use of glycopeptides for febrile neutropenia
has increased, following the prevalence of gram-positive (GP)
infections among these patients. Withholding empirical glyco-
peptide treatment is ecologically wise stipulating that this does
not result in increased mortality. We performed a systematic
review and meta-analysis of trials assessing the addition of anti-
GP treatment in febrile neutropenia.
Methods: Included were randomised trials comparing one
antibiotic regimen with or without placebo against the same
regimen with additional antibiotics against GP infections. We
searched Medline, Embase, the Cochrane Library, references
and conference proceedings. No date, language, age or publi-
cation limits were imposed. Two reviewers extracted data
independently. Relative risks and 95% conﬁdence intervals
were estimated using the ﬁxed effect model. Values <1 favor the
addition of anti-GP antibiotics.
Results: Thirteen trials and 2392 participants were included.
Antibiotics against gram-positive infections included glycopep-
tides in 9 studies. , cephalotin in 2, ﬂucloxacillin and trimeth-
oprim-sulphamethoxazole one each. Eleven studies randomised
patients at onset of febrile neutropenia, and 2 studies random-
ised patients with persistent fever at 72–96 hours. No signiﬁcant
reduction in all-cause mortality was seen with the addition of
antibiotics against gram-positive infections (ﬁgure), RR 0.86
[0.58–1.26]. Overall failure was equivalent in both study arms,
RR 1.00 [0.79–1.27] while failure including modiﬁcations
occurred more frequently in the control arm due to empirical
addition of glycopeptides, RR 0.76 [0.68–0.85]. Amphotericin
was added more frequently to the intervention arm in non-
blinded trials, RR 1.51 [0.80–2.83] but not in double-blind
studies, RR 0.99 [0.75–1.33]. The subgroup of patients with
documented GP infections was assessed and no difference in
mortality or failure was detected. Meta-regression demonstrated
no association between the rate of GP bacteraemia and the
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relative risk for mortality or failure. Empirical glycopeptides
were associated with a signiﬁcant reduction in bacterial super-
infections, RR 0.38 [0.24–0.59], more speciﬁcally gram-positive
superinfections, RR 0.21 [0.11–0.37], and increased nephrotoxic-
ity, 1.43 [1.06–1.94].
Conclusions: Addition of glycopeptides to the antibiotic treat-
ment of febrile neutropenic patients, in general, can be safely
deferred for the documentation of resistant GP infections.
P1593
Linezolid in febrile neutropenic oncology
patients
G. Martinelli, C. Hartman, L. Leonard, K.J. Tack (Milan, I;
Ann Arbor, USA)
Objectives: Gram-positive bacteria are common pathogens in
neutropenic oncology patients. Linezolid (LZD) is effective for
the treatment of infections caused by Gram-positive pathogens
including methicillin resistant Staph spp., glycopeptide resistant
Enterococcus spp., and multi-drug resistant Strep pneumoniae.
LZD was compared to vancomycin (VAN) in a randomized,
double-blind, multi-centre trial in febrile neutropenic oncology
patients.
Methods: Eligible oncology patients with febrile neutropenia
(absolute neutrophil count <500/mm3) and a proven or suspec-
ted Gram-positive infection received LZD (600 mg) or VAN
(1 g) IV q12 h for 10–28 days. Test of cure (TOC) assessment was
conducted 7 days posttherapy. Clinical efﬁcacy was analysed
using sponsor deﬁned clinical outcome.
Results: 605 patients were treated (304 LZD, 301 VAN); groups
were similar with respect to demographics, comorbidities,
severity/type of illness, and degree of neutropenia. Hemato-
logic/lymphatic cancers were the most frequently observed
(95.4% LZD, 93.7% VAN). Average duration of treatment was
similar between groups (LZD 11.4 days; VAN 11.5 days). Mean
time until defervescence (oral temperature £ 37.5C) in LZD
patients was 6.4 days vs 6.7 days in VAN patients (p = 0.54).
Overall mortality rate at 16 days posttherapy was 5.6% for LZD
patients vs 7.6% for VAN (p = 0.31). Overall clinical success
rates at FU were comparable between LZD and VAN in the
intent-to-treat (ITT) population (57.0% vs 52.9%, p = 0.32).
Clinical success rates within the subgroups of primary infections
were also similar between LZD and VAN (Table 1). Microbio-
logic outcomes were similar in the two groups. Clinical
laboratory results for hematology and biochemistry tests, such
as change from baseline and clinically abnormal values, were
similar between groups. Drug-related adverse events (DRAEs)
occurred signiﬁcantly less frequently for LZD patients than for
VAN patients (52/303 [17.2%] vs 72/300 [24.0%], p = 0.04).
Nausea, vomiting, rash, erythema, and diarrhoea were the most
frequently reported DRAEs for both treatment groups. No
DRAE was reported signiﬁcantly more often in the LZD group,
however VAN patients reported a signiﬁcantly higher percent-
age of drug-related kidney failure (LZD 0/303 vs VAN 4/300,
p = 0.04).
Conclusion: LZD is as effective as VAN and is a safe thera-
peutic option for treating febrile neutropenic oncology patients
with proven or suspected Gram-positive infections of varying
underlying etiologies.
P1594
UK Survey of antibiotic treatment of febrile
neutropenia
H. Ziglam, K. Gelly, W. Olver (Dundee, UK)
Objectives: Is to perform a nationwide survey to deﬁne the
different practice in managing febrile neutropenia in haematol-
ogy units.
Methods: The design was a single round audit questionnaire
was sent out to the selected haematologist of 220 haematology
units in the UK. Questions were asked regarding both antimi-
crobial chemotherapy of choice and antimicrobial prophylaxis in
managing febrile neutropenia.
Results: Responses were received from 167 (76%) of the 220
haematology units providing care to patients with febrile neu-
tropenia. Febrile neutropenia is empirically treated with pipera-
cillin-tazobactam or carbapenem monotherapy by 10% of
haematologists. Overall, dual therapy (i.e., an aminoglycoside
plus a piperacillim-tazobactam) is prescribed by 72% of haema-
tologists. When response to initial empirical therapy does not
occur after 3–4 days, 32% of haematologists may add glycopetide
(vancomycin or teicoplanin) or 29.1%may change to carbapenem
and glycopeptide. Forty-eight per cent of haematologists will
routinely add conventional amphotericin to the ongoing antibi-
otics in persistent neutropenia, compared to 39% using liposomal
amphotericin. Granulocyte colony-stimulating factor is fre-
quently used as an adjuvant in managing febrile neutropenia
(47% of haematologists). For antifungal prophylaxis, ﬂuconazole
is prescribed by 57%of haematologist followedby itraconazole by
33%. Forty-seven of haematologists use antifungal prophylaxis in
all neutropenic patients compared to 17%whomused antifungals
only in patients with neutrophil less than 0.1 · 109/L.
Conclusions: Rationalization of using antimicrobial chemother-
apy in the management of febrile neutropenia, by adopting
Clinical Outcome by primary infection (ITT)*
Linezolid
[% (n/N)]
Vancomycin
[% (n/N)]
P-Value
BAC 48.3 (42/87) 41.0 (34/83) 0.34
CRI 63.3 (19/30) 59.3 (16/27) 0.75
FUO 59.3 (51/86) 56.8 (50/88) 0.74
PNE 60.0 (15/25) 50.0 (10/20) 0.50
SSI 72.7 (16/22) 61.1 (11/18) 0.44
UTI 50.0 (1/2) 66.7 (2/3) 0.71
Other 56.3 (18/32) 62.2 (23/37) 0.62
* Does not include patients designated as missing or indeterminate at TOC BAC (bacteremia of unknown source),
CRI (vascular catheter related infections), FUO (fever of uncertain origin), PNE (pneumonia), SSI (skin/skin
structure infection), UTI (urinary tract infection)
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nationally agreed practice guidelines, could signiﬁcantly reduce
costs and improve patient’s care.
P1595
Ciproﬂoxacin versus an aminoglycoside as
combination therapy to a beta lactam for the
treatment of febrile neutropenia: a meta-analysis
of randomised controlled trials
I. Bliziotis, A. Michalopoulos, S. Kasiakou, G. Samonis,
C. Christodoulou, S. Chrysanthopoulou, M. Falagas (Athens,
Iraklion, GR)
Background: Ciproﬂoxacin has been used extensively for pre-
vention and treatment of infections in neutropenic patients in
both the outpatient and inpatient setting.
Objectives: To compare the effectiveness and toxicity of
ciproﬂoxacin versus an aminoglycoside (both in combination
with a beta lactam) for the treatment of febrile neutropenia in the
inpatient setting.
Design: Meta-analysis of randomized controlled trials (RCTs).
Data sources: Data for this meta-analysis were identiﬁed from
PubMed (1/1950 to 10/2004), Current Contents, Cochrane
central register of controlled trials, references from relevant
articles, and abstracts presented in international conferences.
Study selection: RCTs comparing ciproﬂoxacin with an ami-
noglycoside as combination therapy to a beta lactam for the
treatment of febrile neutropenia and reporting effectiveness,
mortality, and/or toxicity data were included in the analysis.
Studies that examined quinolones as monotherapy, the combi-
nation of a quinolone with an aminoglycoside, use of quinolones
in the outpatient setting from the start of treatment, or
quinolones other than ciproﬂoxacin were excluded.
Data extraction: Data for 3 primary and 2 secondary outcomes
were extracted by two investigators.
Data synthesis: A total of 8 RCTs were included in the analysis.
Better outcomes (some with statistical signiﬁcance) were
observed with ciproﬂoxacin/beta-lactam compared to amino-
glycoside/beta-lactam combination; clinical cure without modi-
ﬁcation of the initial regimen (OR 1.32, 95% CI 1.00–1.74), clinical
cure in the subset of patients with documented infections (OR
1.56, 95 % CI 1.05–2.31), all cause mortality (OR 0.85, 95% CI
0.54–1.35), withdrawal of the study drugs due to toxicity (OR
0.87, 95% CI 0.57–1.32), and nephrotoxicity (OR 0.30, 95% CI
0,16–0.59). The ciproﬂoxacin-containing combination was also
associated with better clinical cure in the subset of RCTs with
non-low-risk patients (OR 1.38, 95% CI 1.01–1.88).
Limitations: The study results may not be extrapolated to
patients who received prior a quinolone for prevention of
infection nor to patients who receive per os or intravenous
treatment for febrile neutropenia in the outpatient setting.
Conclusions: The combination of ciproﬂoxacin with a beta-
lactam antibiotic should be considered as an important thera-
peutic option in hospitalized febrile neutropenic patients who
have not been receiving a quinolone for prevention of infections.
P1596
Blood cultures statistic study in febrile
neutropenic cancer patients
E. Chinou, A. Apostolakopoulos, A. Georgouli, E. Skouteli,
P. Golemati (Athens, GR)
Objectives: The aim of this study is to evaluate the frequency
and susceptibility patterns of bacterial pathogens isolated from
blood cultures in febrile neutropenic cancer patients hospital-
ized in an anticancer hospital over a two years period.
Methods: A total number of 586 blood cultures were examined,
using the automated Bact/Alert Microbial Detection System
(aerobic FAN and anaerobic FN). After classic subculture
methods, all isolates were characterized at species level by the
Api 20 system. Minimal inhibitory concentrations were per-
formed using the semi automated method Microscan according
to NCCLS recommendations. All the investigated patients were
neutropenic (WBC <1 · 10 to the power of 9 per liter) with fever
(>38C) and were under antimicrobial and antifungal therapy at
the time of blood culture.
Results: Over the two years period (2002–2003) 586 blood
cultures were performed on the basis of the physicians request
from 81 patients hospitalized in the two oncology and one
hematologist ward of our hospital. The mean length of neutrope-
nia was 13 days. The pathogens were isolated from 64 blood
cultures in 21 patients (25%). Among the 22 bacterial strains
isolated from bloodstream infections, 72.7% were Gram negative
strains (n = 16), 18,1% Gram positive cocci (n = 4), one strain
L. monocytogenes and one strain C. kruzei. In the group of Gram-
negative strains E. coli was dominant with an increase antibiotic
resistance (7/9 resistant to Amoxicillin / Clavulanic acid and 5/9
resistant to Ciproﬂoxacin). All the Gram-negative rods were
highly susceptible to Imipenem (15/16), Meropenem (16/16) and
Piperacillin/tazobactam (16/16). In the group of Gram-positive
bacteria glycopeptide resistant strains were no found. All the
Staphylococci strains were susceptible to Methicillin.
Conclusions: We observed rising trends in the number of
Gram-negative isolates and in antibiotic resistance of all gram-
negative rods. The empiric therapy with wide range antibiotics
in febrile neutropenic cancer patients seems to be the optimal
option, but the monitoring of antibiotic susceptibility of bacterial
strains is still required.
P1597
Epidemiological, clinical and prognostic features
of febrile neutropenia in cancer patients
M. Aguilar-Guisado, E. Cordero, J. Cisneros, I. Espigado,
R. Parody, J. Pacho´n (Seville, E)
Objective: To describe epidemiology, aetiology, clinical and
prognostic features of febrile neutropenia (FN) in patients with
solid or haematological neoplasms.
Method: Prospective observational study of all FN episodes,
among patients admitted in Oncology and Haematology
Departments during 21 months (November 2002–August 2004)
with either haematological or solid neoplasm of any localization.
Results: We studied 292 episodes of FN in 227 patients. 50.3%
were males. Median age was 51 years (16–84). 79% had a
haematological neoplasm, 21% a solid neoplasm, and 21% were
blood stem-cell transplantation recipients. Most frequent malig-
nat disease was acute leukaemia (36%) followed by lymphoma
(24%). 22% had a chronic disease different from the neoplasm. A
diagnosis of infection was established in 59% of episodes
(N = 173), and in 48.5% of them an aetiological diagnosis was
established. More frequent infections were pneumonia (30%),
catheter infection (22%), primary bacteraemia (20%) and urinary
tract infections (9%). 73 patients (42%) had bacteraemia. Bacteria
(82%) were the most common infectious aetiology, followed by
mixed infectionsby fungi andbacteria (14%)and fungal infections
alone (4%). Between bacteria, the most frequent were: Staphylo-
coccus coagulase-negative (30%), Escherichia coli (20%), Pseudo-
monas aeruginosa (13%), Staphylococcus aureus (9%), Enterococcus
faecium (3%) and Proteus mirabilis (3%). Between fungi the most
frequentwereAspergillus spp (13%) andPneumocystis jiroveci (3%).
21%ofFNpresentedwtih severe clinical features, among themthe
most frequent were arterial hypotension (16%) and acute renal
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failure (8%). FN episodes with a diagnosis of infection had a
higher frequence of severe clinical features in comparison with
these with unknown aetiology (p = 0.003; RR 2.18; IC 95%: 1.3–
5.3). Mortality at 30th day of episode was 17%. Pneumonia
(p = 0.04;RR 2.2; IC 95%: 1.1–4.8), aetiological diagnosis of
infection (p < 0.01;RR 2.3; IC 95%: 1.2–4.5), and septic shock
(p < 0.001; RR 10; IC 95%: 3.5–28.9) were adverse outcome factors
identiﬁed by multivariate analysis.
Conclusions: Infection is the cause of at least 59% of FN episodes
in patientswith cancer. The aetiology of infection is established in
one half of episodes,with a predominance of bacteria. Pneumonia
and catheter infection are the most frequent infection foci.
Pneumonia, aetiological diagnosis of infection and septic shock
are adverse outcome factors in patients with FN and cancer.
P1598
Bloodstream infections in adult patients with
malignant blood disorders and neutropenia:
microbial spectrum and antimicrobial
susceptibility pattern
S. Levidiotou, P. Bouranta, H. Gesouli, G. Vrioni, C. Pappa,
V. Alymara, K.L. Bourantas (Ioannina, GR)
Objectives: Bloodstream infections are a major cause of mor-
bility and mortality among patients with haematological disor-
der. The aim of the present study was the bacterial spectrum and
antimicrobial susceptibility pattern of organisms causing blood-
stream infections among patients hospitalized in a hematology
centre.
Methods: A total of 90 episodes of bacteraemia and fungaemia in
63 patients were identiﬁed. All patients were treated in the
haematology ward during a 5-year period (2000–2004) and had
an underlying haematological disorder (lymphoma, leukaemia
and myeloma). There were 42 male and 21 female patients, aged
17–80 years old.
Results: A total of 101 microbial strains were isolated in 90
episodes. Fifty-one (50.5%) isolates were Gram-negative bac-
teria, forty-seven (46.5%) Gram-positive bacteria (46.5%) and 3%
yeasts. Polymicrobial bacteraemia was observed in 11 from 90
(12.2%) episodes. The dominated pathogens were coagulase-
negative Staphylococci (CNS) 24%, Pseudomonas aeruginosa 21%,
E. coli 16%, Enterococcus spp. 8% and S. aureus 7%. The mortality
rate was 30.15% (19 patients) being higher in patients with
bacteraemia caused by P. aeruginosa, CNS and Klebsiella spp.
Oxacillin resistance was detected in 43% of S. aureus isolates and
in 63% of CNS. Vancomycin resistance was detected only in one
strain E. faecium (12.5%). E. coli strains produced ESBL in 2/16
(12.5%). Among P. aeruginosa isolates, one strain was resistant to
all tested agents, 14.3% were susceptible only to colistin and
9.5% only to carbapenems and colistin.
Conclusion: The identiﬁcation of the microbiology proﬁle of
bloodstream infections and antimicrobial susceptibility pattern
of isolated strains may help in managing these infections in
haematology patients, and reviewing infection control and
antibiotic policies.
P1599
Incidence of bacteraemia in patients with
haematological and other malignancies after
placement of central venous catheter
G. Pedersen, M. Nørgaard, H.C. Schønheyder, H. Larsson,
M. Kiiveri, E. Stolberg, P.W. Andersen, H.T. Sørensen (Aalborg,
Aarhus, DK)
Objective: Patients with cancer, and in particular patients
with haematological malignancies are susceptible to infections
including bacteraemia. Central venous access devices are used
for intravenous chemotherapy in these patients, but data on the
risk of bacteraemia are few. We therefore estimated the
incidence of ﬁrst time bacteraemia and type of microorganisms
after placement of the ﬁrst central venous catheter in patients
with haematological (haem) and other types of cancer (‘other’).
Methods: We conducted the study in North Jutland County
from 2000 to 2002 based on data from three databases: the
Danish Cancer Registry (cancer patients of age >14 years), the
Hospital Discharge Registry (central venous catheter and co-
morbidity) and the Bacteraemia Research Database (bacterae-
mia). Three different types of central venous access devices were
used: short-term catheters (S) and two long-term catheters:
Hickmann (H) and Port-a-cath (P).
Results: A total of 362 patients were identiﬁed, 107 in the haem
group and 252 in the ‘other’ group. The predominant malig-
nancies were breast cancer (n = 121), non Hodgkin lymphoma
(n = 32), ovarian cancer (n = 29), and acute myeloid leukaemia
(n = 29). Compared with patients in the haem group, we found
a predominance of elderly females in the ‘other’ group. The
distribution of ﬁrst central venous catheters was: S = 70 (haem:
46), H = 53 (all were haem patients) and P = 239 (haem: 8). A
total of 83 patients presented with bacteraemia (haem: 55); the
distribution in relation to catheters was: S = 33 patients, H = 26
patients and P = 24 patients. The incidence rate of bacteraemia
according to catheter type was S = 8.3/person-year, H = 2.0/
person-year, and P = 0.2/person-year. Incidence rate ratio (IRR)
for bacteraemia in patients in the haem group compared with
the ‘other’ group was 13.4 (95% CI: 7.9–22.7) adjusted for age,
sex and comorbidity. The most frequent microorganisms were
Staphylococcus aureus (n = 20), polymicrobial (n = 17), Escherichia
coli (n = 13) and coagulase-negative staphylococci (n = 9). Since
all H. catheters were in the haem group and nearly all P. catheters
in the ‘other’ group, we could not rule out the signiﬁcance of
catheter type.
Conclusion: Patients with haematological malignancies have a
13-fold increased incidence of bacteraemia compared with other
cancer patients. The signiﬁcance of catheter type warrants
further study.
P1600
Aetiology and clinical outcome of blood-stream
infections in patients with haematological
malignancies in two Danish university hospitals
2000–2003
J.K. Møller, B. Gahrn-Hansen, B.G. Bruun (Skejby, Odense,
Hillerød, DK)
Objectives: To compare etiologies of blood-stream infections
according to haematological diagnosis and clinical outcomes of
dominating microbiological species/groups at two Danish
haematological departments.
Methods: A total of 995 blood-stream infections detected in 622
patients between 2000 and 2003 in the two departments were
included. Blood-stream infections caused by coagulase-negative
staphylococci, coryneforms and propionibacteria were excluded.
Bactec (OUH) or BacT/ALERT (AUH) blood culture systems
were used for blood culturing. Subcultivation and identiﬁcation
was done using standard microbiological laboratory methods.
Haematological diagnoses and clinical outcomes were recorded
retrospectively by electronic data analysis.
Results: Distributions of haematological diagnoses at the two
departments were approximately the same, except for myelo-
matosis that comprised 19% in AUH and 11% in OUH. We
detected a total of 652 and 412 isolates in 609 and 386 blood-
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stream infections in 360 and 262 patients at AUH and OUH,
respectively. A similar proportion of episodes in both hospitals
(6%) were polymicrobial. The following differences between
microbiological etiology were found: S. pneumoniae, non-hae-
molytic streptococci, and Gram-negative enterics occurred more
frequently at AUH, while enterococci and Gram-negative non-
enterics occurred more frequently at OUH. Bacteremia with
S. pneumoniae was found in < 1% of AML patients and in about
25% of myelomatosis patients, while E. coli + K. pneumoniae
bacteraemia occurred in about 60% of AML patients and 20% of
myelomatosis patients. The mortality rate was highest in
P. aeruginosa and fungal infections.
Conclusion: It is important to perform local surveillance of
blood culture etiology and clinical outcomes of blood stream
infections, as these vary between haematological departments.
Differences in mortality for speciﬁc microorganisms necessitate
continuing considerations regarding optimal antimicrobial and
adjuvant therapy.
P1601
Fatal acute liver failure due to varicella zoster
virus infection in a child with acute
lymphoblastic leukaemia
A.M. Spanaki, E. Markaki, N. Anagnostatou, P. Smirnaki,
E. Vasilaki, N. Katzilakis, E. Barbounakis, G. Briassoulis,
M. Kalamnti (Heraklion, GR)
Varicella Zoster Virus (VZV) is frequently associated with mild
hepatitis and rarely with acute liver failure. Immunologic
impairment is a signiﬁcant predisposing factor.
Objectives: We report a 4 years-old girl with Acute Lymphob-
latic Leukemia (ALL) and acute fatal liver necrosis after VZV
infection.
Methods/Results: She was the second child of the family, with
a negative history of VZV disease or vaccination. ALL had
diagnosed six months ago, the child was treated according to the
ALL - BFM 2000 protocol and was then in complete remission.
On the time of admission, she was three weeks on dexameth-
asone (10 mgr/m2/day) (re-induction). The child was ﬁrst
admitted in the Hematology/Ongology Department with
severe abdominal pain, fever (38C) and elevated transaminases.
Next day, cutaneous lesions appeared on the chest and face,
suggesting VZV infection, and antiviral therapy with acyclovir
was immediately initiated. Two days later the patient was
transferred to the PICU with severe clinical and laboratory
deterioration, high fever, tachypnea with positive chest x-ray
(right low lobe consolidation with pleural effusion), abdominal
distention, liver enlargement, gross haematuria and GI bleeding,
vesicular rash on the chest, face and scalp and generalized
petechiae and echymoses. The patient had pancytopenia,
marked elevated hepatic enzymes and bilirubin, hypoalbumine-
mia and severe disseminated intravascular coagulopathy. She
was continuously transfused with FFP, RBC, PLT and cryopre-
cipitate. The child was intubated in hours, because of progres-
sive respiratory and neurological deterioration. Renal failure
was developed. Assistance was asked from a liver transplant
team and the little girl was urgently transferred to a special
department for emergency liver transplantation. Unfortunately,
two days after transportation, the child developed deep coma
and severe hypotension and died. VZV antibody levels were
negative, but VZV DNA was detected from liver biopsy and
blood specimen, with PCR.
Conclusions: Immunocompromised children are potentially
threatened of infections, such as highly contagious chickenpox.
The mortality of VZV- induced hepatic failure is very high. Only
few patients survived with liver transplantation.
P1602
Usefulness of procalcitonin measurement in the
diagnosis of febrile neutropenia
S. Blanco, J. Sancho, C. Prat, B. Xicoy, J.A. Domı´nguez, C. Ferra`,
M. Gime´nez, J. Grau, E. Martro´, M. Batlle, M.D. Sa´nchez,
L. Matas, J. Ribera, V. Ausina (Barcelona, E)
The diagnosis of infection in patients with neutropenia secon-
dary to chemotherapy is difﬁcult because clinical signs are
unspeciﬁc, being fever the only manifestation of sepsis in most
of the cases.
Objective: 1. To study the usefulness of procalcitonin (PCT)
measurement for the diagnosis of systemic bacterial infection in
neutropenic patients with fever. 2. To establish baseline values
of PCT in patients with haematological malignancies at the time
of admission as well as at the onset of neutropenia.
Patients and Methods: 43 patients with diagnosis of haemato-
logical malignancies who underwent induction chemotherapy
or were on conditioning regimens for stem cell transplantation
were included. Sera samples on the day of admission, at the
beginning of neutropenia, the ﬁrst day of fever and daily for
6 days were collected. Immunoluminometric assay was used for
PCT measurement. Episodes of fever were classiﬁed according
to the clinical and microbiological diagnosis in three groups: (1)
documented bacteraemia; (2) bacterial infection without bacter-
aemia; and (3) fever of unknown origin, with negative cultures.
Results: PCT mean levels at the time of admission and at the
onset of neutropenia were 0.337 and 0.33 ng/ml, respectively.
Group 1: ﬁfteen patients presented documented bacteraemia.
The isolated microorganisms were Escherichia coli (4 patients),
Klebsiella pneumoniae (1), coagulase-negative Staphylococcus (5),
Streptococcus mitis (1), Staphylococcus aureus (1), Streptococcus
salivarius (1) and Lactobacillus sp (1). PCT mean levels at 24–
48 hours from the beginning of fever were 3.681 ng/ml in gram-
negative and 1.73 ng/ml in gram-positive infections. Group 2:
nine patients were included (urinary tract infection in 4,
respiratory tract infection in 4 and catheter-related in one)
with mean PCT level of 1.51 ng/ml. Group 3: twenty patients
presented fever of unknown origin, related with mucositis in
eleven of them. PCT mean level was 0.51 ng/ml. Signiﬁcative
differences were only observed between patients with gram-
negative bacteraemia and patients with fever of unknown origin
(p < 0.05)
Conclusions: PCT levels remain at normal values in patients
with haematological malignancies at the time of admission and
at the beginning of neutropenia. Determination of PCT is useful
in the diagnosis of neutropenic fever from infectious origin
especially when gram-negative bacteraemia. Supported in part
by Grants FIS P1/020098 and predoctoral grant from SEIMC.
P1603
Association between the serum chemokine
RANTES, platelets and infection in patients with
haematological malignancy
M. Ellis, B. al-Ramadi, U. Hedstrom, C. Frampton, H. Alizadeh,
J. Kristensen (Al Ain, UAE)
Objectives: To describe changes in the leucocyte trafﬁcking
chemokine RANTES in haematological pts undergoing chemo-
therapy, it’s relation to platelets and outcome from infection.
Methods: A prospective observational study of 40 pts with
haematological cancer receiving chemotherapy. Venous blood
samples were collected at 6am daily throughout treatment.
Serum RANTES was determined by ELIZA (R&D systems).
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Results: At start of chemotherapy RANTES mean (SD) concen-
trations were 6561 ± 3290 and fell progressively to a nadir of
1436 ± 2038 pg/ml. Corresponding platelet concentrations fell
from 104 (IQR 43–205) to 5.5 (IQR 4–8) x 109/L. The correlation
between platelets and RANTES was highly signiﬁcant (r = 0.82
(IQR 0.72–0.89)), conﬁrming platelets as the major source of
RANTES. During episodes of SIRS/sepsis or severe sepsis/
shock mean RANTES levels were lower at 3394 and 2939
respectively (p < 0.01). Bacteremic pts also had lower RANTES
levels (3022 vs 5111 pg/ml, p < 0.01) and platelet concentrations
(18.1 vs 36.3, p = 0.07). In pts who survived the level at recovery
was 6433 pg/ml, not signiﬁcantly different from pre-chemother-
apy values. 63 of 67 infection episodes resolved despite
persistent low RANTES levels. However 4 of the 40 pts died
(aspergillosis, candidosis, pneumonia or infectious colitis) – their
RANTES concentrations were extremely low (1629) and irre-
coverable. RANTES levels began to recover 4.5 days before
platelet levels (p < 0.001) and ‘bursts’ of RANTES were
observed during thrombocytopenia, suggesting an additional
extra-platelet reservoir for RANTES. Platelet transfusions
temporarily elevated the RANTES concentrations. When exam-
ined simultaneously within a nested mixed model regression
analysis, platelets were the only independent variable among
steroids, hematopoietic colony stimulating factor, recombinant
human interleukin-11, sepsis status and neutropenia associated
with RANTES concentration. The following ﬁgure illustrates the
relation between RANTES and platelets in 1 pt.
Conclusions: A signiﬁcant hypo-RANTES immunologic envi-
ronment is created by chemotherapy, driven by accompanying
thrombocytopenia, but does not affect the ability of most
patients with infection to recover and questions the role of
RANTES in such situations. However patients who die from
sepsis uniformly have profoundly low RANTES concentrations
– whether RANTES is a surrogate marker or important for
adequate host response remains a moot point.
Procalcitonin, other markers of infection
P1604
Evaluation of procalcitonin as a diagnostic
marker of bacteraemia
S. Levidiotou, E. Papantoniou, A. Charitou, V. Charitou,
H. Sakkas, D. Papamichael (Ioannina, GR)
Objectives: Procalcitonin (PCT) was reported to be a reliable
marker for severe bacterial infections. The aim of the present
study was to clarify the diagnostic value of PCT in patients with
bacteraemia.
Methods: We prospectively determined the PCT level in 41
adult patients with bacteraemia hospitalized for a period of
4 months (September to December 2004). In 25 of those patients
the bacteraemia was caused by Gram (+) bacteria: coagulase-
negative Staphylococci (CNS) 12, Staphylococcous aureus 2,
Enterococcus spp. 4, Pneumoniococcus 3, Clostridium perﬁngens
1, Corynebacterium acnes 3. In the remaining 16 patients the
bacteraemina was caused by Gram (-) bacteria: Klebsiella spp. 6,
E. coli 5, Pseudomonas aeruginosa 2, Acinetobacter baumannii 3.
Serum PCT was estimated with an assay based on immuno-
chemiluminescence (BRAHMS Diagnostica, Berlin, Germany).
Results: Among patients with bacteraemia caused by Gram (-)
bacteria the PCT levels (ng/ml) were 2–10 ng/ml (n = 6) and
>10 ng/ml (n = 10). In patients with bacteraemia caused by
CNS the PCT levels were <0.5 ng/ml (n = 6) and 0.5–2 ng/ml
(n = 6). By S. aureus the PCT levels were >10 ng/ml. By
Enterococcus spp., Pneumoniococcus, Clostridium perﬁngens
and Corynebacterium acnes the PCT levels were >2 ng/ml.
Conclusion: Bacteraemia associated with CNS may fail to
elevate serum procalcitonin levels while bacteraemia associated
with Gram (-) bacteria elevate signiﬁcantly. More studies are
needed to conﬁrm our ﬁndings.
P1605
Procalcitonin measurement in post-surgical
neonates: a guide to antibiotic management
E. Broadis, J. Tong, C. Davis, C. Lucas, C. Williams (Glasgow,
UK)
Measurement of plasma C-reactive protein (CRP) has become an
established means of monitoring response to antimicrobial
therapy. However raised levels are indicative of inﬂammatory
processes in general and do not speciﬁcally signal infection, this
could result in a tendency to over-prescribe antibioticsIn adult
patients Procalcitonin (PCT) measurement has speciﬁcally dif-
ferentiated infection from other inﬂammatory processes but to
date paediatric data, especially in neonates, is limited.
Aim: to assess the potential for PCT as a guide to infection in
post-surgical neonates.
Methods: A prospective study was undertaken in post-surgical,
intensive care babies between September 2003 and March 2004.
Plasma CRP and PCT measurements were performed in parallel
on a daily basis. Blood cultures were performed as clinically
indicated.
Results: 60 patients (24–42 weeks gestation) underwent 138
operations/procedures. 726 PCT/CRP assays were performed
and 198 blood cultures were taken.
• Normal PCT levels consistently accompanied normal CRP
levels
• PCT was not elevated in the absence of other inﬂammatory
markers.
• Of 65 positive blood cultures, PCT was normal in only 3
instances in each of which the CRP remained <30 mg/l,
platelet and white cell counts were normal and potential
contaminants were cultured.
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• 70% of PCT levels measured on day 6 post surgery had
normalised, in comparison to 30% of CRP levels
Conclusions: • Culture conﬁrmed bacterial sepsis is reliably
accompanied by a raised PCT level in neonatal patients.
• Earlier cessation of antimicrobial therapy based on sequential
PCT measurements may be possible.
P1606
Plasma procalcitonin levels and urinary tract
infections among elderly patients
M. Belechri, D. Dimou, N. Ioakimides, N. Marougas,
C. Kotsovassilis, P. Tsiodra (Athens, GR)
Objectives: To evaluate whether measurements of PCT levels,
can help distinguish acute fever due to UTI from fever of other
non-microbial inﬂammatory processes, among elderly patients
treated in an internal medicine department.
Methods: We prospectively examined 77 patients with acute
fever admitted in our department. Variables recorded included
patient demographics and principal diagnosis. PCT, C-reactive
protein (CRP), Erythrocyte Sedimentation Rate (ESR) and white
blood cell count (WBC) were measured. Blood samples were
collected 24–48 hours after the presence of fever. Patients were
distinguished according to aetiological diagnosis, based on
clinical assessment and laboratory results, to those with fever
due to urinary track infection (UTI) (Group A) and those with
fever of other inﬂammatory processes (Group B). Statistical tests
applied were Student’s t-test and Chi-Square.
Results: Of 77 study patients, 37 (48%) had fever due UTI and
40 (52%) due to other inﬂammatory processes. 32 (42%) were
males, 45 (58%) females and mean age of patients studied was
73 years (±SD 7.6), The mean plasma concentrations of PCT in
patients with UTI were 1.16 ng/ml (±SD 1.76) vs 0.41 ng/ml
(±SD 0.5) in patients of Group B (p = 0.01). Patients in Group A,
had as expected, higher values of ESR, 58 mm/h (±SD 33.4) vs
90 mm/h (±SD 28.9) (p < 0.0001) and CRP compared with
patients in Group B, although the last did not reach statistical
signiﬁcance (p = 0.07). The mean values of WBC did not differ
between the two groups, while percentage of neutrophil differ at
a signiﬁcant level (p = 0.002).
Conclusions: Among hospitalized elderly patients with fever,
levels of PCT seem to be higher among those with UTI
compared to patients with fever of other inﬂammatory proces-
ses. PCT can probably be used as an indicator of bacterial
infection among older patients with acute fever treated in a
department of internal medicine.
P1607
Procalcitonin trend identiﬁes critically ill patients
at high risk of mortality
J. Jensen, M. Tvede, L. Heslet, T. Hartvig Jensen, K. Espersen,
P. Steffensen (Copenhagen, DK)
Objectives: Serum procalcitonin (PCT) has been shown to be an
accurate predictor of sepsis, and elevation of PCT blood levels
occurs early in the course of a bacterial infection. We investi-
gated the PCT trend to evaluate this as a predictor of mortality
in the intensive care unit (ICU).
Methods: We enrolled all patients admitted to a multidiscipli-
nary Intensive Care Unit in 2002. Daily PCT measurements,
were carried out during the study period. Antimicrobial therapy
was, among other factors, guided by the PCT course. The clinical
end point was all cause mortality during the stay in the intensive
care unit and in a 90-day follow up period of time.
Results: PCT measurements evaluated in 472 critically ill
patients. Overall mortality of critically ill patients in the one-
year study was 19.1%. Odds Ratio for mortality in the ICU for
patients with increasing compared to decreasing PCT trend after
reaching a level of 1.0 ng/ml was after one day: 2.1 (95% CI 1.2–
3.7), after two days: 3.4 (95% CI 1.7–7.0) and after three days: 6.0
(95% CI 2.6–14.1).
Conclusion: PCT trend increase for one to three days is
associated with high and increasing risk of mortality in the
ICU. PCT trend may be a useful tool in fast stratiﬁcation of
critically ill patients in high and low risk patients.
P1608
Procalcitonin PCT and other routine measured
factors of bacterial infections
I. Moran˜ska, J. Niscigorska, A. Boron-Kaczmarska (Szczecin, PL)
Objective: Procalcitonin PCT is one of the recently accepted
markers of the systemic inﬂammatory response to severe
bacterial infections, especially to sepsis. The aims of this study
were: 1. to analyse level of PCT in patients with conﬁrmed sepsis
and other infections with systemic clinical manifestations, 2. to
assess possible correlations between PCT and other parameters
used in routine diagnosis of infections.
Methodology: We have analysed 28 patients with sepsis and
systemic inﬂammatory response syndrome (SIRS), 20 men and 8
women, aged 17–80 years, mean 47,8. In all patients we have
measured concentration of PCT (ng/ml), C-reactive protein CRP
(mg/l), ﬁbrinogen (mg/dl) and counts of leukocytes (K/ll) and
platelets (K/ll). All measurements were made immediately
after admission to hospital, before antibiotic treatment. In the
statistical analysis W Shapiro-Wilk test, Pearson’s and rang
Spearman’s correlation coefﬁcients were used. P values below
0,05 determined statistical signiﬁcance.
Results: 1) The studied population contained 13 patients with
conﬁrmed sepsis (3-Staph. aureus, 5-Str. pneumoniae,1- Neisse-
ria meningitidis, 2-Salmonella typi C, 1- Staph. hominis,
1-Leptospira icterohaemorrhagiae), 2 patients with bacterial
meningitis, 2 patients with malaria, 11 patients with signs of
SIRS caused by bacterial infections without positive blood
cultures. 2) We observed high concentrations of PCT (>10 ng/
ml) in 11 patients with sepsis, 2 patients with malaria, 1 patient
with bacterial meningitis and 5 patients with SIRS in course of
localized bacterial infection. 3) CRP concentration ranges from
13,8 to 654,32 mg/l, ﬁbrinogen from 115,9 to 1094 mg/dl, WBC
from 2,39 to 39,2 K/ll, PLT from 11,8 to 304 K/ll. 4) We did not
ﬁnd any correlations between concentration of PCT and other
inﬂammatory parameters like CRP, WBC, PLT and ﬁbrinogen.
Conclusions: 1) Our study conﬁrmed previous observations
that PCT is a very characteristic, early and sensitive parameter of
severe systemic bacterial or parasitic infections. 2) PCT is an
independent factor of severe systemic infections and did not
correlate with other routine measured parameters like CRP,
WBC, PLT and ﬁbrinogen. 3) In our opinion measurement of
PCT is very important in an early differential diagnosis of sepsis
and should be made in clinical daily practice.
P1609
Comparison of cerebrospinal ﬂuid procalcitonin
levels with serum C-reactive protein in the
diagnosis of meningitis
Z. Ozkurt, S. Erol, M. Ertek, K. Ozden, M.A. Tasyaran (Erzurum,
TR)
Objective: Procalcitonin (PCT) is a new marker connected to
bacterial infection. The aim of the study was to evaluate clinical
usefulness of serum procalcitonin measurements in the
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differential diagnosis of purulent versus tuberculosis and viral
meningitis in adults.
Methods: A prospective study including adult patients who
were suspected of having meningitis and who were admitted to
an Department of Infectious Diseases. The diagnosis of menin-
gitis was based on clinical ﬁndings, Gram staining, culture, and
chemical analysis of CSF. The value of cerebrospinal ﬂuid (CSF)
PCT for differentiating between acute purulent, tuberculous and
viral meningitis was assessed and compared to serum C-reactive
protein (CRP) values. Thirty patients with acute purulent
meningitis, 30 with tuberculous menengitis, 29 with viral
meningitis, and 10 patients with a noninﬂammatory central
nervous system diseases as the controls were included in this
study. All CSF samples were taken at patient admission and
PCT was detected by immunoluminometric assay (PCT LUMI-
TEST, Brahms Diagnostica, Germany).
Results: Mean CSF PCT concentrations were 0.18 ng/mL in
purulent menengitis, 0.10 ng/mL in tuberculous menengitis and
0.10 ng/mL in viral meningitis, and 0.03 ng/mL in control.
There was no any statistical difference in CSF PCT values
between acute purulent, tuberculous and viral meningitis
groups (p > 0.05). Mean serum CRP values were 19.1 mg/dL
in purulent meningitis, 5.9 mg/dL in tuberculous meningitis,
2.1 mg/dL in viral meningitis and 0.3 mg/dL in the control
group (p = 0.000).
Conclusion: Serum CRP values were found useful, but not CSF
PCT values, for differential diagnosis of meningitis. Addition-
ally, CRP is a practical and an inexpensive diagnostic test.
P1610
Value of body temperature, white blood cell
count and C-reactive protein for the diagnosis of
intensive care unit-acquired infections: a
prospective study
E. Akinci, A. Erbay, A. C¸olpan, H. Bodur, M.A. C¸evik,
S.S. Eren (Ankara, TR)
Objectives: Markers of infection like fever, high C-reactive
protein (CRP) and leukocytosis may be associated with nonin-
fectious causes like trauma, surgical operations and inﬂamma-
tions. Due to the patients in intensive care units are subjected to
multiple inﬂammatory stimuli, the diagnosis of intensive care
unit-acquired infections is difﬁcult. The aim of this prospective
study was detection of the value of CRP, white blood cell count
(WBC) and body temperature for the diagnosis of intensive care
unit-acquired infections.
Patients and Methods: The patients staying for more than
72 hours in intensive care unit and had no infection during
admission were included in the study. They were visited daily
and data were recorded in to the individual forms. CRP was
measured within 72 hours of admission and thereafter every
three days. The patients were classiﬁed as ‘infected’ if infections
were identiﬁed and as ‘noninfected’ if no infection was identi-
ﬁed during their stay in the intensive care unit. The highest body
temperature in the day (Tmax), daily WBC count and CRP values
were compared between the two groups statistically. STATA 7.0
(College station TX) programme was used for statistical analysis.
Results: Sixty-seven patients were included in the study. Of
these patients, 31 were within the infected group and 36 were
within the noninfected group. In univariate analysis, CRP, Tmax
and WBC were signiﬁcantly high for the infected patients
(p < 0.05). In multivariate analysis, only CRP was associated
with infection signiﬁcantly and independently (OR:1.037,
%95CI:1.019–1.054, p < 0.001). The presence of CRP > 50 mg/L
yielded sensitivity as % 75, speciﬁcity % 96.3, positive predictive
value % 96.7 and negative predictive value % 72.2. After
development of infection, the increase in CRP and Tmax was
statistically signiﬁcant (p < 0.05). For 27 (87%) infected patients,
increase in CRP level was greater than 25%.
Conclusion: This study concludes that CRP is the most useful
parameter for the diagnosis of intensive care unit-acquired
infections. According to this result, routine measurement of CRP
level in intensive care units and follow up the changes in the
serum concentration of CRP are recommended.
P1611
Erythrocyte sedimentation rate and C-reactive
protein are useful preoperative predictors of the
absence of prosthetic hip and knee infection
A. Trampuz, K.E. Piper, D.R. Hanssen, D.R. Osmon,
J.M. Steckelberg, R. Patel (Rochester, USA)
Objective: Leukocyte count, erythrocyte sedimentation rate
(ESR) and C-reactive protein (CRP) are often obtained on
patients with prosthetic joints prior to arthroplasty surgery. We
evaluated the value of these parameters for the diagnosis of
prosthetic joint infection (PJI).
Methods: We prospectively analysed preoperative leukocyte
count, ESR and CRP level in patients prior to revision or
resection knee or hip arthroplasty at Mayo Clinic, Rochester,
MN between January 1998 and November 2004. PJI was deﬁned
as growth of the same microorganism from at least two
specimens, synovial ﬂuid or periprosthetic purulence, acute
inﬂammation on histopathologic evaluation, or the presence of a
sinus tract. Sensitivity, speciﬁcity, positive predictive values
(PPV) and negative predictive values (NPV) were calculated
using 2 · 2 contingency tables.
Results: 231 preoperative blood specimens from 227 patients
prior to total knee (n = 192) or hip (n = 37) replacement were
analysed. The median age was 70 years (range, 41–101 years);
55% were male. The primary diagnosis was osteoarthritis
(n = 209), inﬂammatory joint disease (n = 13), trauma (n = 8)
and osteonecrosis (n = 1). Causative organisms were coagulase-
negative staphylococci (n = 26), Staphylococcus aureus (n = 8),
enterococci (n = 3), Propionibacterium acnes (n = 3), corynebac-
teria (n = 3), viridans group streptococci (n = 2), mycobacteria
(n = 2) and gram-negative bacilli (n = 2). Three infections were
polymicrobial and 12 were culture-negative. 39 patients (61%)
had received antimicrobial treatment in the month prior to
surgery. Table 1 shows the median (range) leukocyte count, ESR
and CRP in those with aseptic failure versus PJI. Sensitivity,
speciﬁcity, PPV and NPV for PJI (with 95% conﬁdence interval)
are summarized in Table 2.
Conclusion: Leukocytes did not reliably predict PJI. The combi-
nation of normal ESR (30 mm/h or less) and CRP (1.0 mg/dl or
less) predicted the absence of PJI in 92% of patients in our study.
Parameter Aseptic failure (n = 167) PJI(n = 64)
Leukocytes, · 109/1 6.7 (3.1–14.7) 7.8 (4–14.7)
ESR, mm/h 10 (1–75) 43 (3–123)
CRP level, mg/dl 0.3 (0–2.7) 3.1 (0.3–20.2)
Cutoff Values Sensitivity Speciﬁcity PPV NPV
Leukocytes >10 · 109/1 17 (8–27) 93 (89–97) 48 (27–68) 75 (69–81)
ESR > 30 mm/h 66 (53–78) 90 (85–95) 72 (60–84) 87 (81–92)
CRP > 1.0 mg/dl 77 (65–88) 84 (77–90) 66 (54–77) 90 (85–95)
ESR > 30 mm/h or
CRP > 1.0 mg/dl
84 (74–94) 80 (73–87) 64 (53–75) 92 (87–97)
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P1612
Serum neopterin levels in patients with active
pulmonary tuberculosis, in patients with
brucellosis and healthy individuals
S. Cesur, S. Aksaray, H. Irmak, G. Tarhan, T. Aslan, I. Ceyhan,
E. Gu¨vener (Ankara, TR)
Objectives: Neopterin is a sensitive indicator for activation of
cell-mediated immune reactions and thus, determination of
neopterin concentrations in various body ﬂuids is of diagnostic
marker in a variety of infectious diseases in which T lympho-
cytes and macrophages are involved. Cell mediated immune
reactions play important roles in intracellular bacteria such as
Mycobacterium tuberculosis and Brucella species. The aim of
this study was to compare the serum neopterin levels in patients
with active pulmonary tuberculosis, in patients with brucellosis
and healthy subjects.
Methods: Thirty-nine patients with active pulmonary tubercu-
losis ( 10 females, 29 males, mean age: 40.6) 16 patients with
brucellosis (7 females, 9 males, mean age: 35.8) and 39 healthy
subjects (16 females, 23 males, mean age: 41.2) were included in
this study. The patients who had another infection, malignity,
autoimmune disease , surgical intervention and recently blood
transfusion were not included the study. Serum samples were
collected from the patients and control groups and stored at
)20C until analysed. Neopterin concentrations were measured
by ELISA according to the protocol of manufacturer by IBL
(Hamburg, Germany).
Results: Mean neopterin levels were 18.56 ± 14.23 nmol/L in
patients with active pulmonary tuberculosis, 33.82 ±
22.27 nmol/L in patients with brucellosis and 9.87 ±
2.90 nmol/L in healthy subjects, respectively. Serum neopterin
levels were found to be signiﬁcantly higher in patients with
active tuberculosis and in patients with brucellosis compared
with healthy controls (p < 0.001). Besides, there were differences
between patients with active pulmonary tuberculosis and
patients with brucellosis (p < 0.001).
Conclusion: This study showed that neopterin levels increased
both in patients with active pulmonary tuberculosis and in
patients with brucellosis. Neopterin can be used in follow up the
patients who had chronic infectious diseases such as brucellosis
and tuberculosis.
Diagnosis of viral infections: new methods
P1613
Automated extraction of RNA and DNA from
different specimen types feeding the detection of
several markers in the ﬁeld of molecular
diagnostics
S. Thamm, K. Beuselinck, T. Bourlet, S. Kares, R. Karhu, H.
Mairhofer, H. Nitschko, B. Pozzetto, J. van Eldere, G.
Michel (Wiesbaden, D; Leuven, B; St. Etienne, F; Tampere, FIN;
Munich, D)
Objective: A recently introduced automated generic RNA and
DNA extraction system, m1000, enables a throughput of 48
samples in less than 2 hours. Several studies have shown that
m1000 is a suitable automated extraction system for many
different sample types feeding molecular diagnostics assays.
Methods: Unlinked surplus specimens from the clinical routine
were used. Cross contamination studies were designed with
high titer samples interspersed between negative samples giving
a checkerboard pattern on the m1000 subsystem. Diagnostic
assays used during these studies were either commercially
available or homebrew assays validated for the laboratory
routine.
Results: No cross-contamination was observed in using HIV
RNA of 5–7 log copies/ml, HCV RNA of 5–7 log IU/ml, and
polyomavirus DNA of 8 log copies/ml. A total of 437 serum or
plasma samples were processed for RNA extraction using LCx
HIV or HCV RNA Quantitative assays with 97.6–99.0% agree-
ment to Cobas Amplicor Monitor HIV/HCV assays. Coextrac-
tion of HIV/HCV RNA from 28 serum or plasma samples
revealed no impairment of LCx assay results when compared to
monoextraction. Reaching a 100% agreement between manual
and automated extraction on 53 initially positive urine samples
on Cobas Amplicor Ct showed the feasibility of extracting
bacterial DNA of C. trachomatis with m1000. Genomic DNA
extraction from 31 whole blood samples for homebrew HLA-B27
typing revealed a 100% agreement to the manual extraction.
Automated extraction of viral DNA of HBV from 25 serum or
plasma samples revealed a correlation coefﬁcient of r = 0.96
compared to the manual extraction. 2–7 replicates of HBV
quantitation standards were tested with homebrew real-time
PCR after automated extraction with excellent linearity and a
100% detection rate of all concentration levels down to
100 IU(ml. Viral DNA has been successfully extracted from
spinal ﬂuid, urine, cell culture supernatant, BAL, nasopharyn-
geal washing, breast milk, biopsy, leukocytes, and bone marrow
samples for CMV, HSV, or polyomaviruses JC and BK testing
with homebrew real-time PCR (n = 48).
Conclusion: Taken together, these studies have shown that
m1000 provides a versatile solution for automated extraction of
viral RNA or DNA, and bacterial or genomic DNA from 12
different specimen types feeding 8 different molecular diagnos-
tics assays in the ﬁeld of hepatitis B/C, HIV, sexually transmit-
ted diseases, transplantation, and HLA typing.
P1614
Evaluation of automated extraction of RNA and
DNA for high throughput ‘in-house’ quantitative
real-time PCR assays
K. Beuselinck, J. Van Eldere (Leuven, B)
Objective: Nucleic acid (NA) extraction has become the most
critical and labour intensive step in NA based diagnostics. The
performance of NA based diagnostics is primarily dependent on
the NA extraction yield, purity and the amount of sample that
can be extracted. Recently, Abbott introduced the m1000, a fully
automated generic RNA and DNA extraction system that uses
magnetic micro-particle processing allowing extraction of up to
48 samples in 2 hours.
Methods: In this study, the performance of the m1000 as a
front-end extraction system for high throughput ‘in-house’
quantitative real-time PCR assays (HCV, HBV, CMV, EBV)
was analysed and compared to manual extraction for plasma
and serum samples (HCV and HBV) and EDTA-blood samples
(CMV and EBV).
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Results: Linearity of extraction was tested on dilution series of
HCV and HBV reference material. The correlation coefﬁcient for
standard curves based on repeated extraction runs of these
dilutions was 0.970 + 0.060 for HCV and 0.971 + 0.025 for HBV,
indicating a linear extraction between 100 – 1.0 · 105 HCV IU/
ml and 100 – 1.0 · 106 HBV IU/ml. Intra- and inter-run vari-
ability was not signiﬁcantly different and below 0.2 log10 IU/ml
for 2.98 – 5.28 log10 HCV IU/ml and 2.70 – 5.20 log10 HBV IU/
ml. Correlation between automated and manual extraction was
very good . For HCV, the correlation coefﬁcient was 0.91 and the
mean difference in viral load was 0.128 log10 IU/ml (SD: 0.44
log10 IU/ml). For HBV the correlation coefﬁcient was 0.98 and
the mean difference in viral load 0.612 log10 HBV IU/ml (SD:
0.52 log10 IU/ml). Cross-contamination was tested with strongly
positive polyomavirus samples (8.10 log10 copies/ml) and
polyomavirus-negative samples. No cross-contamination was
observed. The turn-around time for 48 samples was 2.5 h and
hands-on time was 0.5 h compared to 4.4 h for manual
extraction. The list-price reagent cost was around 11.6 euro per
sample compared to 8.0 euro for manual extraction (HCV and
HBV).
Conclusion: Automated extraction as offered by this system
offers high reliability of extraction at a total cost that is inferior
to manual extraction.
P1616
Performance of a new ampliﬁcation based assay
for quantiﬁcation of human immunodeﬁciency
virus-1 (HIV-1) RNA
C. Wagner, C. Lin, S. Bhade, R. Torres, S. Nicol, J. Surtihadi,
G. Gorrin (Berkeley, USA)
Objectives: A new quantitative HIV-1 RNA kinetic ampliﬁca-
tion assay is under development. Analytical performance
characteristics of this assay were evaluated, including: sensitiv-
ity, speciﬁcity, linearity, and the ability to detect group M and O
subtypes. Data from these evaluations are presented.
Methods: Viral RNA was extracted from panels and donor
samples using an automated silica-bead based method, after
which reverse transcription, ampliﬁcation, and detection steps
were performed. The assay includes an internal control (IC) and
chemical contamination control using recombinant cod UNG
(rcUNG). Linear range, precision, and sensitivity were evaluated
by testing serial dilution panels prepared from HIV-18E5/LAV
Clade B virus (quantiﬁed by VERSANT HIV-1 RNA 3.0 (bDNA))
spiked into pooled normal human plasma. Panels ranged in
concentration from 10 to 107 copies/mL. Assay speciﬁcity was
evaluated by testing plasma from 360 HIV-1 antibody-negative
donors. The ability of the assay to detect all HIV-1 group M (A-
H) and O subtypes was evaluated with both transcripts
quantiﬁed by phosphate analysis and OD260, and panels
prepared from electron microscopy quantiﬁed HIV-1 group M
(A to H) and O cultured isolates (Boston Biomedica, Inc.).
Multiple subtype A, B, C, and O isolates were tested in the
evaluation.
Results: The linear range of the assay was determined to be
from 24 to 13,000,000 copies/mL, with 100% speciﬁcity. HIV-1
transcripts and virus panels representing all Groups M and O
subtypes were detected at "d 50 copies/mL. Total %CV of
quantitation was "T 25% above 1000 copies/mL, and "T 50%
between 50 and 1000 copies/mL. The IC worked across the
entire range of the assay.
Conclusion: The assay was demonstrated to detect RNA of all
group M (A-H) and O subtypes down to 50 copies/mL.
Sensitivity (24 copies/mL) and speciﬁcity (100%) of the new
automated HIV-1 viral load assay under development were both
excellent. The assay internal control and chemical contamination
control methods were effective.
P1617
Evaluation of a new Dot Blot assay for
conﬁrmation of human immunodeﬁciency virus
type 1 (HIV-1) and 2 (HIV-2) infections using
recombinant p24, gp41, gp120 and gp36 antigens
M. Ravanshad, F. Sabahi, F. Mahboudi , M. Roostaee,
A. Kazemnejad (Tehran, IR)
A Dot Blot assay using four recombinant proteins corresponding
to human immunodeﬁciency virus type 1 (HIV-1) and type 2
(HIV-2) gene products was developed to conﬁrm the presence of
antibodies to HIV-1 and 2 in sera reactive in screening ELISAs.
Serum samples for testing were obtained from healthy seroneg-
ative blood donors and from different categories of HIV-infected
individuals (asymptomatic HIV-infected, and AIDS). A positive
reaction was deﬁned as reactivity against gag (p24) and at least
one other env (either gp41 or gp120) HIV gene products;
negative result was deﬁned as no reaction with any antigen; and
indeterminate result was deﬁned as reactivity with gag (p24) or
with env (gp41 or gp120) alone. None of the 180 serum samples
from healthy seronegative blood donors gave a positive result,
and only 4 of these samples (2.2%) gave indeterminate results.
The recombinant HIV Dot blotting assay identiﬁed seropositive
individuals with a high degree of accuracy; none of the 125 HIV-
seropositive subjects had a negative test result. Reactivity with
these antigens, demonstrated 100% sensitivity and speciﬁcity in
distinguishing seronegative from seropositive sera. All seroneg-
ative and seropositive samples were tested with the commer-
cially available Western blot. The developed in-house HIV Dot
blot assay accurately identiﬁed more seropositive and seroneg-
ative samples and had fewer indeterminate results than did
commercial Western blot (as interpreted by CDC criteria).
P1618
Hepatitis B virus DNA testing by nested-PCR,
PCR-ELISA and hybrid capture II from a blood
and blood products
J.-H. Lim, H.-S. Jung, S.-E. Choi, S.-N. Kim, C.-M. Hong,
S.-N. Park, H.-K. Min, S.-H. Hong (Seoul, KOR)
The purpose of this study is to establish Nested-PCR for the
detection of hepatitis B virus (HBV) in blood and blood
products. The primer pair set was designed to amplify 513 bp
in S-region of HBV genome in the ﬁrst PCR and 233 bp of ﬁrst
PCR amplicon with Rubisco (internal control) in the second
PCR. To assess the speciﬁcity of PCR results, all the samples
were tested cross-reactivity or interference in the assay. In case
of HBV spiked blood products such as immunogloubulin and
coagulation factors, this method could detect HBV DNA up to
62.5 IU/ml. Nested-PCR was compared with PCR-ELISA and
hybrid capture II (HC-II), the PCR-ELISA showed a sensitivity
of 96% (HC-II; 77%) and a speciﬁcity of 98% (HC-II; 100%)
(p < 0.005). The results of the study show that Nested-PCR and
PCR-ELISA could be used equally in the management for HBV
detection in blood and blood products.
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P1619
An in vitro assay for ﬂavivirus NS2B/NS3 serine
protease
M. Bessaud, C.N. Peyreﬁtte, B. Pastorino, M. Grandadam,
H.J. Tolou (Marseille, F)
Objectives: The genus Flavivirus comprises more than 70
viruses. Many of them cause severe human diseases. The
genome of ﬂavivirus, a single strand RNA molecule with
positive polarity, is translated into a large polyprotein that is
processed into structural and non-structural proteins by both
viral and cellular proteases. The virus-encoded protease is a
binary complex constituted by the NS3 protein and its co-factor,
NS2B. As the viral protease plays a critical role in the virus
replication cycle, it represents one of the main targets for
antiviral therapy against members of the Flavivirus genus.The
aim of this study was to develop an in vitro assay using the
protease of several ﬂaviviruses belonging to different groups in
order to characterize their enzymatic properties, such as tem-
perature, pH and salt-sensitivity and substrate speciﬁcity.
Methods: Sequences encoding the viral proteinase were located
on the genome of 8 ﬂaviviruses. NS2B/NS3 proteinase were
expressed as hexahistidine-tagged recombinant proteins and
then puriﬁed by immobilized-metal afﬁnity chromatography.
Their enzymatic properties were characterized in vitro using
BAPNA, a chromogenic substrate for trypsin-like proteases.
Results: The protease moiety of the 8 ﬂaviviruses were suc-
cessfully produced and puriﬁed. 5 of them exhibited activity
towards BAPNA. Effect of temperature, ionic strength and pH
on enzymatic activity were determined. Our results suggest that
the hydrophilic domain of NS2B is necessary for proteolytic
activity.
Conclusion: The system we developed will allow us to estab-
lish a screening test so as to identify or to design inhibitors
active as antiviral drugs against one or more pathogenic
ﬂaviviruses. The lack of activity of 3 of the 8 proteases we
assayed could indicate slight differences in ﬂaviviral proteases’
selectivity and activity.
P1620
Diagnosis of dengue infection by enzyme-linked
immunosorbent assay and reverse transcription-
nested polymerase chain reaction from dried
urine spots on ﬁlter paper
J. Pupaibool, N. Jaimchariyatam, S. Krajiw,
K. Arunyingmongkol, P. Suandork, O. Prommalikit, R. Sittichai,
A. Nisalak, C. Pancharoen, U. Thisyakorn,
W. Kulwichit (Bangkok, TH)
Objectives: Polymerase chain reaction (PCR) and enzyme-
linked immunosorbent assay (ELISA) from serum are used for
diagnosis of dengue infection. However, in certain areas of the
world, these are not readily available. Storage of specimens on
ﬁlter paper to be tested later at a centre is an attractive way to
conﬁrm a clinical diagnosis or for an epidemiologic study. We
performed a pilot study to see if urine spots on ﬁlter paper can
be used for dengue diagnosis.
Methods: Adults and children admitted to King Chulalongkorn
Memorial Hospital suspected of dengue infection were enrolled.
Final diagnosis of dengue infection was based on the standard
serum ELISA assay. Patients with negative serology served as
controls. Urine specimens were collected twice, 5 days to
3 weeks apart, spotted on ﬁlter paper and stored at 4 degrees
for a minimum of 10 days before testing. RT-nested PCR and
ELISA were performed on extracts from the spots. Our ELISA
criteria for urine were single IgM > 10 units for primary dengue
infection or single IgG > 10 units or 2-fold increase in IgG titer
with the second titer >10 units for secondary dengue infection.
Results: 139 patients were enrolled. 64 and 71 specimens were
analysed by RT-PCR and ELISA, respectively. The results are
summarised in the Table:
If 3 primary dengue cases were excluded, the sensitivity of
ELISA for secondary cases were 84.21%.
Conclusions: This is the ﬁrst study using dried urine samples
on ﬁlter paper for dengue diagnosis. In this study, fresh urine
was spotted onto ﬁlter paper in the laboratory, and cross
contamination was possible. Realistically, this process would be
done on a near-patient basis with vastly lower likelihood of such
contamination and thus better results of RT-PCR. Collection of
urine is less invasive than that of blood and is especially suitable
for children. This method would be highly applicable in
epidemiologic studies, such as during dengue outbreaks. Due
to a low number of primary cases in an endemic area such as
Thailand, a study elsewhere is needed to assess the utility of
urine spots in such cases.
P1621
A rapid sequencing based prototype assay for
detection of high risk HPV strains in cervical
samples
N. Marlowe, R. Bruce, M. Owens, T. White,
M. Zoccoli (Alameda, USA)
Background: Human papillomavirus (HPV) is one of the most
common causes of sexually transmitted diseases resulting in an
estimated 288,000 deaths yearly from cervical cancer worldwide.
Of more than 30 types found in the anogenital tract, at least 13
are considered high risk (HR), as they are signiﬁcantly associ-
ated with progression to invasive cervical cancer. In an effort to
accommodate high throughput screening for HR HPV types, we
recently developed a prototype HPV assay using a Single Base
Dye Primer Proﬁling (SBDPP) approach. In the present study,
we evaluate prototype assay performance on 74 patient samples.
Objective: To evaluate SBDPP assay for the detection of HR
HPV strains in cervical samples.
Methods: Genomic DNA puriﬁed from 74 retrospective cervical
samples was used for this feasibility study. Fifty-four out of 74
were previously typed successfully with the Digene Hybrid
Capture 2 (HC2) assay. The remaining 20 samples yielded
inconclusive results with the HC2 assay. Using consensus PCR
primer sequences conserved among HPV types, a fragment of
the L1 region was ampliﬁed in the presence of an intercalating
dye. HPV-positive samples were identiﬁed by ampliﬁcation Ct
values and dissociation curve melting proﬁles, sequenced with a
rapid SBDPP protocol and analysed on the ABI PRISM 3100
Genetic Analyzer. HR HPV types were identiﬁed by their
unique single base distribution proﬁles.
Results: The presence of HR HPV types was determined in 28/
74 clinical samples using the SBDPP assay. HPV types were
Method
Patients
Sensitivity Speciﬁcity PPV NPVAdult Children
RT-PCR 36 28 21/51 cases 41.18% 11/13 cases 84.62% 21/23 cases 91.30% 11/41 cases 26.83%
ELISA 25 46 49/60 cases 81.67% 10/11 cases 90.91% 49/50 cases 98.00% 10/21 cases 47.62%
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conﬁrmed by NCBI BLAST (v2.2.9) analysis using four-color
sequencing data. Twenty-four of the 54 HC2-typed samples
were typed as HR HPV, while 30 were HPV-negative/low risk
HPV. Four of the twenty previously untyped samples were
genotyped as HR HPV. Type determinations for 24 HR HPV
samples were concordant between the SBDPP and HC2. Of the
28 cervical samples identiﬁed as HR types, 5 samples were
determined to be HPV mixed infections.
Conclusion: This feasibility study demonstrates the potential of
the SBDPP assay to type patients harbouring HR HPV strains.
Genotyping results obtained with the prototype assay are highly
comparable to the four-color DNA sequencing data. These
ﬁndings conﬁrm that a rapid SBDPP method can be used for
high-throughput screening of cervical samples for the presence
of HR HPV types.
P1622
DNA microarray format for detection of human
papillomavirus: discrepancies between
techniques applied to detect HPV DNA
M. Dominguez-Gil, R. Ortiz de Lajarazu Leonardo, J. Eiros,
A. Curiel, M. Moreno, S. Jimenez, L. Sobrino, I. Gracia,
A. Tenorio, C. Labayru, M. Ortega, B. Hernandez, A. Rodriguez
Torres (Valladolid, E)
Introduction: The large variety of techniques available for
detection and subtyping of the multitude of HPV types
illustrates the fact that no single technique provides the ultimate
and complete solution to this effect.
Objective: Explain the diagnostic correlation between the tech-
niques applied to detect HPV DNA and typing in cervical
samples from women suspected to have ginecological lession
selected to HPV.
Methods: A total of 40 genital smears with HPV evidences were
selected by a solution hybridisation assay (Hybrid Capture,
Digene, Gaithersburg, USA). The applied hybridisation tech-
nique classiﬁes the virus on those associated to a low or
moderated-high risk of cell transformation. We analysed the
agreement between these results and those obtained by PCR and
subsequent typing by means of digestion with restriction
enzymes (HPVfast, Genomica S.A.U., Madrid, Spain). We used
a Papillomavirus Clinical Arrays (Genomica S.A.U., Madrid,
Spain).
Results: The results obtained by means of hybridisation were
distributed as follows: 47.5% of the smears revealed HPV of
moderated-high risk of cell transformation, 12.5% was associ-
ated to a HPV of low risk of transformation and the remaining
40% were positive on both groups of HPV. PCR revealed the
presence of HPV DNA in 40% of analysed smears (N = 40). The
40% of moderated-high risk HPV was not detected by means of
PCR. The 15% was not detected by means of DNA Microarray
Format (N = 20). The 100% (N = 4) among low-risk HPV and
the 75% (N = 16) of those positive for both HPV groups were not
detected by means of PCR. The 100% of low-risk HPV and those
positive for both HPV groups was detected by means of DNA
Microarray Format.
Conclusions: The detection of HPV DNA by hybridisation was
associated in a greater percentage to positive results than it
actually applied to the PCR Technique used. However hybrid-
isation and DNA Microarray Format were in more agreement.
The PCR identiﬁcation technique was not able to detect a
signiﬁcation number of HPV positive samples, mainly on the
HPV H-m risk and less for the others. Then there is a better
correlation between DNA Microarray Format and DNA hybrid-
isation for detection and subtyping of human papillomavirus
and more discrepancies among PCR and hybridation
P1623
Evaluation of human papillomavirus PCR
detection in urine and cervical swabs of patients
attending a colposcopy unit: a viable screening
alternative?
A. Daponte, S. Pournaras, I. Mademtzis, I. Kristo, A.N. Maniatis,
I. Messinis (Larissa, GR)
Objectives: To evaluate the performance of Human Papilloma-
virus (HPV) PCR detection in urine compared with cervical
swabs, among patients attending a colposcopy unit. The
appropriate detection of HPV in urine would serve as a viable
alternative for screening and prevention of cervical cancer.
Methods: Paired urine and cervical specimens were collected
from 60 consecutive patients referred to a colposcopy clinic.
Urinalysis and urine microscopy was performed for evaluation
of potential PCR inhibitors and specimen epithelial cell content.
In-house PCR and a commercial PCR for the detection of HPV
16 and 18, as well as a commercial multiplex PCR for HPV 6, 16,
18, 31 and 33 were performed in all samples. To test the
sensitivity of HPV detection in urine, urine samples were spiked
with cell lines infected with HPV.
Results: The in-house PCR exhibited the highest detection rate.
Cervical samples were tested positive for the oncogenic HPV
types 16 or 18 in 21 of the 47 (44.7%) cases of women that proved
to have pre-malignant or malignant lesion by histology. 14 of the
47 (29.8%) urine samples, with histologically proven pre-
malignant or malignant lesions were positive for HPV16 or 18.
In all cases the respective cervical samples were positive for the
same HPV type. The HPV detection concordance was 14/21
(66.7%). The HPV detection concordance was better in histolog-
ical diagnoses of cancer and high-grade lesions compared to
low-grade lesions. The sensitivity of HPV detection in urine was
similar to that in distilled water.
Conclusions: This study is one of the few that examined the
presence of HPV in urine samples from patients referred to a
colposcopy unit. High HPV type-speciﬁc concordance between
cervical and urine samples and good sensitivity of urine
detection are reported. Only specimens with two or more
epithelial cells in 400 · magniﬁcation are worth processing with
the more expensive HPV detection method. This report supports
the possibility that self-testing for HPV, using urine, will one
day give to low-income groups and speciﬁc populations like
young adolescents a good screening alternative.
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Diagnosis of viral infections: respiratory and herpes viruses
P1624
Signiﬁcance of rapid detection methods versus
serological tests in human respiratory viruses
isolation
R. Ortiz de Lejarazu Leonardo, L. Sobrino, A. Tenorio, I. Gracia,
M. Domı´nguez-Gil (Valladolid, E)
Objectives: Descriptive, retrospective and observational study
to research the incidence of respiratory viruses in our environ-
ment and to evaluate the most useful samples and detection
methods.
Methods: The period of the study was 2000 January to 2004
May. We received 2763 diverse samples registering patient data
(sex, age, source); 1694 serum for complement ﬁxation test (CFT)
and 1069 diverse samples for rapid detection methods (RDM):
shell vial culture, direct immunoﬂuorescence (DIF), enzyme-
linked ﬂuorescent assay (ELFA) and immunochromatographic
test (ICT).
Results: We obtained 386 positive results, 227 in men and 159 in
women. Classiﬁcation by ages: 0–1 year old, 197 positive cases;
1–2 years old, 48; 2–14 years old, 48; 14–30 years old, 5; 30–
65 years old, 16; more than 65 years old, 56. Isolated viruses:
inﬂuenza A virus (Flu A), 96; inﬂuenza B virus (Flu B), 24;
respiratory syncytial virus (RSV), 226; parainﬂuenza virus (PIV),
25; adenovirus (ADV), 14. Monthly evolution of samples
received and positive cases shows that patterns of serum and
the other samples are different. The 1st graphic represents the
monthly sending of serum that does not follow a seasonal curve
on the contrary than the other samples represented in the 2nd
graphic; it occurs the same when we look at the positive results
distribution. Samples: Serum was positive in 73 cases; nasopha-
ryngeal wash in 276; pharyngeal smear in 33; Bronchoalveolar
wash and tracheal aspirate, 4. Detection methods: CFT was
positive in 73 cases; Shell vial culture was positive in 276, but in
132 was the unique method that achieve an isolation; ELFA in
134; DIF in 86; ICT was positive in 11 cases, but was only used
since 2004 January. Rapid methods combined accurate 313
positive cases.
Conclusions: Children are the most affected by human respir-
atory viruses, according with the bibliography. RSV and Flu A
were the predominant viruses detected. The maximal monthly
positively results for respiratory viruses reached in cold season
but PIV do not followed a seasonal curve. Rapid detection
methods are more sensitive than CFT. Based on these results, we
recommend to take nasopharyngeal washes to combine rapid
detection methods and accurate the best rate of virus isolation.
P1625
Evaluation of a real-time NASBA assay for the
detection of inﬂuenza A and B viruses in clinical
respiratory samples
J.N. Telles, G. Billaud, A. Lefeuvre, M. Perret, D. Thevenot,
F. Komurian-Pradel, G. Vernet, A. Troesch, D. Floret, B. Lina,
G. Paranhos-Baccala` (Marcy l’Etoile, Lyon, F)
Objectives: bioMe´rieux is developing a real-time NASBA assay
to detect Inﬂuenza A and B RNA in different kind of respiratory
clinical samples. The Nuclisens EasyQ Inﬂuenza A+B assay, in
combination with Nuclisens MiniMag sample preparation
system, was evaluated on 89 nasal/throat swabs from hospit-
alized children during 2003/2004 inﬂuenza season at the
Paediatric Emergency Department of Edouard Herriot hospital
(HEH-Lyon, France). The assay is designed to detect in a single
tube, a wide range of both Inﬂuenza A and B viruses by
targeting conserved regions of the genome. The aim of this
study was to evaluate the real-time NASBA sensitivity against
classical cell culture method.
Methods: 89 Nasal/throat swabs in transport medium from
children 0 to 16 years age were used for the evaluation of
Inﬂuenza viruses presence. RNA extraction was performed
using the bioMe´rieux Nuclisens MiniMag instrument and
reagents. Extracted RNA were submitted to NASBA ampliﬁca-
tion and detection using the Nuclisens EasyQ Inﬂuenza A+B
assay. The obtained data were analysed by Nuclisens Director
2.0 software. The results were then compared to the cell culture
results already performed on the samples.
Results: To be conﬁdent in the sensitivity of real-time NASBA
assay, we showed that no interference was observed with
Inﬂuenza A and B strains spiked in different negative swabs.
Among 89 swabs tested in this study, real-time NASBA detected
10 (11.2%) samples for Inﬂuenza A and 2 (2.2%) samples for
Inﬂuenza B. Comparatively, by cell culture method only 5 (5.6%)
samples were identiﬁed as Inﬂuenza A and none as Inﬂuenza B.
Interestingly, 1 Inﬂuenza A positive sample identiﬁed by cell
culture was found negative in real-time NASBA.
Conclusion: In this study, we showed that Nuclisens EasyQ
Inﬂuenza A+B assay detected 50% more Inﬂuenza A virus than
cell culture method. Moreover, real-time NASBA detected 2
Inﬂuenza B positive samples which were not detected by cell
culture. In conclusion, our Nuclisens EasyQ Inﬂuenza A+B
assay demonstrated clinical relevance in samples from hospit-
alized children suffering from respiratory diseases.
P1626
Evaluation of a protein microarray assay for
detecting antibodies to SARS-coronavirus
B.M. Willey, N. Kreiswirth, H. Zhu, G. Jona, X. Zhu, M. Snyder,
A. McGeer, Y. Li, M. Cameron, W. Gold, A. Tyler,
T. Mazzulli (Toronto, CAN; New Haven, USA; Winnipeg, CAN)
Objectives: Several diagnostic tests for the detection of SARS
antibodies from serum have been previously evaluated, inclu-
ding ELISA and IIFT assays. This study evaluated a novel
protein chip assay, the Coronavirus Protein Microarray (CoV-
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PM), that has been developed for the detection of antibodies to
multiple coronaviruses, including SARS-CoV, comparing it to
the currently accepted commercially available gold standard
assay, the EUROIMMUN SARS-CoV IgG Indirect Immunoﬂu-
orescence test (IIFT).
Methods: The CoV-PM comprised of all the SARS-CoV proteins
and protein fragments, along with proteins from 5 additional
coronaviruses that infect human, cats, mice and cows. The
arrays were used to probe a selection of 399 previously
validated, challenge samples of human sera for antibodies to
SARS-CoV that included samples from the same patients from
different dates. These sera included 40 SARS-CoV IgG-negatives
(neg) from acute SARS cases (ACUT), 164 SARS-CoV IgG
positive (pos) from convalescent cases (CONV), 112 SARS-CoV-
neg from patients with other respiratory illness (RESP), and 84
from healthcare workers (HCW; 17 SARS-CoV IgG pos; 66 neg).
Each grid on the CoV-PM was probed with 1 lL serum/patient,
reacted with ﬂuorescently labeled antibodies and signals were
detected using a standard microarray scanner. Scans were
analysed by two readers using a programme developed to
predict the nature of each serum.
Results: Of the 181 SARS-CoV-pos sera, 168 were read as
positive by CoV-PM by both readers (93.3% sensitivity), while 8
CONV sera were read as CoV-PM pos by one reader but not by
the other, whereas 16 and 7 were called neg and inconclusive by
both readers. Interestingly, in the majority of cases, SARS-CoV
pos sera that tested discrepant by CoV-PM were CoV-PM pos in
other samples from the same patients from later dates. 64 HCW,
40 ACU and 100 RESP from 218 SARS-CoV-neg sera were CoV-
PM-neg (speciﬁcity 99.1%), with SARS-CoV antibodies found in
1 HCW and 1 RESP while 2 others were inconclusive. Some of
the SARS-CoV pos sera also reacted with 229E proteins,
suggesting concurrent or prior infection with this coronavirus;
some sera within this selection tested positive for 229E/OC43 by
Western blot assay.
Conclusions: The CoV-PM appears to be a sensitive and
speciﬁc method for the detection of SARS-CoV antibodies
from serum. The added value of its ability to detect antibodies
to other coronaviruses requires further evaluation.
P1627
Comparison of Roche MagNA Pure Total Nucleic
Acid Isolation Kit and LC SARS-CoV
Quantiﬁcation assay against Qiagen RNeasy Kit
and artus RealArt HPA-Coronavirus LC RT PCR
assay for detecting SARS-CoV RNA in autopsy
tissue
B.M. Willey, P. Akhavan, N. Kreiswirth, G. Farcas, K. Kain,
S. Poutanen, T. Mazzulli (Toronto, CAN)
Objectives: The occurrence of new cases of SARS-associated
Coronavirus (SARS-CoV) infection in China after the outbreak
was declared over emphasized the continued need for rapid and
reliable molecular tests for the detection of SARS-CoV. This
study compared the ability of the Roche MagNA Pure Total
Nucleic Acid Isolation Kit and LC SARS-CoV Quantiﬁcation
Assay (MP-RSA) to the Qiagen RNeasy Kit and artus RealArt
HPA-Coronavirus LC RT PCR Assay (QIA-ACA) for the
detection of SARS-CoV in autopsy tissues.
Methods: SARS-CoV RT-PCR ampliﬁcation using the Roche
LightCycler 1.2 (LC) instrument was performed on 296 homo-
genized tissue samples (79 SARS-CoV positives - all from known
SARS cases that met the CDC/WHO case deﬁnition, and 217
SARS-CoV-negatives; 162 lung, 22 spleen, 20 liver, 21 kidney, 19
large bowel,19 small bowel, 15 lymph node, 18 skeletal muscle).
Using aliquots from the same tissue homogenates, RNA extrac-
tions and SARS-CoV detections were performed using
QIA-ACA and MP-RSA methods. MP extracts that gave MP-
RSA-negative results from QIA-ACA-positive samples were
retested by ACA to determine if the MP or the RSA had failed:
ACA-positives would indicate a false-negative RSA result,
whereas ACA-negative would indicate a MP extraction failure
or degraded sample. If the ACA was negative, a new QIA
extract was made from which both PCR assays were redone. If
the ACA and the RSA were negative, the RNA was presumed
degraded and the sample excluded from the study.
Results: TheQIA-ACAdetected SARS-CoV in 79 of 296 samples,
whereas the MP-RSA detected SARS-CoV in only 32 of these
samples. The MP-RSA did not detect any SARS-CoV in the 190
QIA-ACA SARS-negative samples. ACA detected SARS-CoV in
27 of 47 discrepant MP-RSA-negative/QIA-ACA-positive sam-
ples. The 20 remaining samples thatwereMP-ACA-negativewere
re-extracted by QIA from the initial homogenate and retested. 15
of these 20 new extracts were ACApositive and 5 that were ACA-
negative were excluded from the study as the samples were
presumed to be degraded.On retesting thesewith the RSA, only 4
of the 15 were found to be SARS-CoV-positive.
Conclusion: In comparison to the QIA-ACA, the MP-RSA was
substantially less sensitive, detecting SARS-CoV in only 46% of
the tissue samples from conﬁrmed SARS cases. The speciﬁcity of
the combined assays was 100%. The lack of RSA sensitivity may
be due to evolutionary mutations. Future sequencing of the
target region (pol gene) may be necessary.
P1628
Analysis of respiratory viruses and new viruses
with combined cell culture/PCR testing
C. Larcher, H.P. Huemer (Innsbruck, A)
The prevalence of respiratory viruses in hospitalised patients is
rather unclear. Due to the rather large effort of reverse
transcriptase (RT)-PCR methods, the poor sample quality of
many specimens and the sensitivity of most rapid antigen
detection tests, many viruses are not diagnosed. With nucleic
acid tetection methods there is also question, whether there are
acute replicating viruses or residual genetic material detected. In
this presentation we describe our results from a study using a
combined cell culture/PCR method suitable for detection of
productive infection of different respiratory viruses. By cultiva-
tion of a total of 266 nasopharyngeal secretions and bronchio-
alveolar lavages (BAL) from children hospitalized in the local
paediatrics department and from adult transplant patients on
HEp-2 human larynx epithelial and MA-104 monkey kidney
cells we were able to detect also slow growing viruses like
human metapneumovirus (HMPV). The method was also able to
detect Parainﬂuenza Virus or Rhinoviruses and to a certain
extent Adenoviruses. Additionally Inﬂuenzaviruses, Respirat-
ory-Syncytial Virus (RSV) and Adenoviruses were detected by
commercial antigen detection assays. The epidemiology of
respiratory viruses in Western Austria for the winter season
2003/04 reveals a Parainﬂuenza 1 outbreak as conﬁrmed by
sequencing right before the main Flu season, a relatively weak
RSV season and many of HMPV isolations with some double
infections as indicated below. Additionally the samples were
also tested for ‘exotic’agents like Mimiviridae. Mimiviruses are a
new species which has been described most recently in water
amoeba and their nearest relatives appear to be aquatic
Phycodnaviruses. As replication of Mimivirus similar to the
Leginella spp., which also replicate in amoeba, has been
suggested to occur also in alveolar cells of humans we decided
to test our patient samples using a ‘suicide-PCR‘ protocol.
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Disappointingly enough we did neither detect this type of virus
in our respiratory samples, nor in samples from water tanks
containing amoeba species.
P1629
Rapid detection of parainﬂuenza virus in
respiratory samples: a 3-year experience
P. Bruynseels, W.A. Verstrepen, M. Boers, A. Mertens
(Antwerp, B)
Introduction: Parainﬂuenzavirus (PI) is a paramyxovirus caus-
ing acute respiratory illness, mostly in children. Four human PI
have been described, PIV-I and PIV-II tend to produce epidem-
ics in autumn and early winter, PIV-III has peak activity in
spring and summer. PIV-IV usually causes mild upper respir-
atory disease.
Objectives: To evaluate the indirect immunoﬂuorescence assay
(IIF) with pooled PI- I, II & III monoclonal antibodies (MAB)
(Chemicon International) performed directly on respiratory
specimens as compared to conventional shell vial culture
(SVC) on VERO cells.
Methods: 2272 nasopharyngeal aspirates of children presenting
with respiratory symptoms between January 2002 and June 2004
were processed. PI detection was done with both the IIF
performed directly on the specimen and IFF after SVC on
VERO cells. Simultaneous detection of other common respira-
tory viruses was done using the appropriate techniques.
Results: PI was detected in 116/2272 (5.1%)samples. 86 PI were
detected by IFF performed directly on the sample (sensitivity
74.1%). In 5 IFF positive samples, no virus could be detected by
the conventional SVC (speciﬁcity 99.8%). Positive (94.5%) and
negative (98.6%) predictive values were excellent.
Conclusion: IIF performed directly on respiratory specimens
may prove to be a valuable technique for rapid PI detection in
children presenting with respiratory illness, given the high
speciﬁcity and predictive values of the test. Negative IFF results
should be conﬁrmed by conventional detection methods.
P1630
Development of a real-time NASBA respiratory
syncytial virus assay
B. Deiman, F. Jacobs, C. Schrover, S. Vermeer (Boxtel, NL)
Objective: The aim was to develop and evaluate a Respiratory
Syncytial virus assay based on NASBA ampliﬁcation and
including real-time detection with molecular beacons. In this
study the performance of this new test is evaluated.
Methods: RSV RNA is isolated using a semi automated mag-
netic extraction method and the NucliSens miniMag. An
internal control is added to the sample prior to nucleic acid
extraction. Primers are directed against the F-gene region of the
RSV genome and both RSV A and B and the internal control are
ampliﬁed with the same primer set. One generic molecular
beacon probe is designed to detect both RSV A and B. An
additional beacon is designed for the detection of the internal
control. Ampliﬁcation reactions were performed in a Nucli-
Sens EasyQ Analyser allowing real-time detection.
Results: Using serial dilutions of in vitro RNA, the 95% hit rate
of the real-time RSV assay was found to be 62 copies in isolation
for both RSV A and RSV B. Using tissue culture samples, the
assay sensitivity was approximately 0.01 TCID50 in isolation for
RSV A and 0.1 TCID50 in isolation for RSV B. No cross reactivity
was observed with PIV2, PIV3, hMPV A1, hMPV A2, hMPV B1,
hMPV B2, or measles. With the real-time assay, RSV in nose
swab samples is detectable within approximately 3,0 hours.
Conclusions: The data showed that the real-time RSV assay is a
rapid and sensitive qualitative assay for the detection of RSV.
The use of standardized reagents offers considerable beneﬁts in
a routine setting for the clinical management of patients with
RSV infections.
P1631
Intrathecal synthesis of speciﬁc antibodies in
facial nerve palsy
J. Bednarova, P. Stourac, H. Stroblova, A. Sevcikova (Brno, CZ)
Objectives: According to literature at least part of idiopathic
facial nerve palsies is caused by herpetic viruses, for example
varicella zoster virus in Ramsay-Hunt syndrome. The aim of our
study was to detect intrathecal synthesis of speciﬁc IgG
antibodies against varicella zoster virus in patients with idio-
pathic facial nerve palsy and to evaluate the importance of this
examination for establishing the etiology of this disease and
subsequent treatment.
Methods: We investigated a cohort of 30 patients: 15 patients
were diagnosed as idiopathic facial nerve palsy and 15 patients
were diagnosed as neuroborreliosis (NB) with facial nerve palsy
as a part of their clinical symptoms. Serum and CSF samples
were analysed at each patient. We used the diagnostic kit of
Human Company, Germany (Varicella-Zoster Virus Human
ELISA IgG Antibody Test) and the diagnostic kit of Test-Line
Company, Clinical Diagnostics, Czech Republic (EIA Borrelia
garinii IgG) for the detection of speciﬁc IgG antibodies. The
intrathecal synthesis was evaluated as speciﬁc antibody index –
AI according to Reiber´s method.
Results: Intrathecal synthesis of IgG antibodies against varicella
zoster virus was detected in 20% patients with idiopathic facial
nerve palsy. All these patients had negative intrathecal anti-
borrelia antibody synthesis. In the NB subgroup all patients had
negative intrathecal antibody synthesis against varicella zoster
virus. The statistical signiﬁcance of speciﬁc antibody intrathecal
synthesis was conﬁrmed by Spearman rank coefﬁcient and
Wilcoxon test.
Conclusion: Our statistically supported data emphasize the
importance of intrathecal synthesis of speciﬁc antibodies as a
diagnostic method in patients with idiopathic facial nerve palsy.
It reveals a subgroup of patients with viral ethiology who can
thus proﬁt from speciﬁc antiviral treatment.
P1632
Second quality control for the detection of herpes
simplex virus in cerebrospinal ﬂuid in Belgium
D. Ursi, K. Loens, H. Goossens, M. Ieven (Edegem, B)
Objectives: A second quality control was organized in Belgium
in 2004 to test the ability of laboratories to detect Herpes simplex
virus (HSV) in cerebrospinal ﬂuid (CSF). This panel also
included a positive sample artiﬁcially inhibited by the addition
of fraxiparine to address the issue of possible false negative PCR
results.
Methods: The panels were prepared in a pool of CSF speci-
mens. Each panel consisted of 10 coded specimens: 4 negative
specimens, 1 specimen containing cytomegalovirus (CMV), 3
specimens containing HSV type 1 at a concentration of 4.102 ,
7.5, 102 and 3.75. 103 TCID50/ml on Vero cells and 2 specimens
containing HSV type 2 at a concentration of 4.102 and 4.103
TCID50/ml. One specimen (containing HSV type1 at a concen-
tration of 7.5. 102 TCID50/ml) was artiﬁcially inhibited by the
addition of fraxiparine at a concentration of 356 U/ml. Panels
were sent to 13 laboratories together with a questionnaire
concerning the methods employed.
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Results: All laboratories sent their results and all but one
laboratory answered the questionnaire. All used an ‘in house’
PCR. All but one laboratory used real-time PCR and all but two
laboratories did monitor inhibition. Overall, 97% of the speci-
mens were correctly reported All positive specimens were
correctly identiﬁed. False positive results were reported in 6.6%
of the negative specimens by 3/13 participants. Six laboratories
had an assay that distinguishes between HSV type 1 and 2. The
different types were correctly distinguished by all. The specimen
containing CMV was never reported positive. Remarkably, the
different assays seem to be inﬂuenced at varying degrees by
inhibitory factors. Only 7/13 (54%) participants reported the
specimen containing fraxiparine as positive despite the inhibi-
tion. Six of these labs used the same QiaAmp DNA kit (Qiagen)
for extraction and one lab did not specify the extraction method.
Five laboratories reported the fraxiparine containing specimen as
inconclusive because inhibited and one participant who did not
monitor inhibition reported this specimen as false negative. Only
1/6 labs used the QiaAmp DNA kit (Qiagen) for extraction.
Conclusions: The results of this second quality control for the
detection of HSV in CSF specimens were excellent. The most
striking conclusion of this quality control was the difference in
PCR results obtained with a positive specimen artiﬁcially
inhibited, being probably a reﬂection of the different DNA
extraction methods used.
P1633
Rapid diagnosis herpes simplex genital infection
using real-time PCR after automated extraction
nucleic acid
M.C. Nogales, M. Ramirez, C. Serrano, I. Pueyo,
E. Martin-Mazuelos (Cadiz, E)
Objectives: Herpes simplex virus genital infections have been
increased in the last years. A sensitive and speciﬁc method for
detecting herpes simplex virus type 1 (HSV-1) and herpes
simplex virus type 2 (HSV-2) is important for diagnosing genital
infections and to avoid HSV-1 and HSV-2 transmission. The aim
of these study is to show our short experience on the diagnosis
of HSV-1 and HSV-2 genital infection using real-time PCR after
automated extraction nucleic acid.
Methods: A total of 86 specimens (44 genital ulceration/vesicle,
21 endocervical, 14 urethral and 7 rectal) were collected from 61
patients (33 women and 28 men). All of them ask for the
begining of symptoms and none have risk factor. All the patients
were followed at STD clinic, Seville, Spain. The sample were
collected following the manufacters rules. Magnapure was used
to extraction nucleid acid. These products were used for
determinating genital infection by using Light-cycler real-time
PCR. (Roche Diagnostic System LC HSV1/2 detection). Positive
and negative controls were used in all cases.
Results: Of the total of the samples, 37.2% (32/86) were positive
to HSV. Genital lesions and vesicles were positive in 61% (27/
44), 19% (4/21) endocervival swabs, 7.1% (1/14) urethral swabs.
Of the all positive results in 23 cases were detected HSV-1
(71.8%), in 6 cases (18.8%) HSV-2, and in 3 cases (9.4%). All the
patients with urethral and endocervical swabs positive have
genital lesion positive too. All the HSV positive were in patients
with primary infection.
Conclusion: 1. Magnapure is an easy, effective, and non-time
consuming method for automated extraction nucleid acid of the
direct sample. 2. Real-time PCR using LC allows the detection of
HSV1 y 2 on genital lesion and it is possible to distinguish
between two types clearly.3. In our study the most proﬁtable
sample for the diagnosis of herpes simplex genital infection was
genital ulcerations and vesicles.
P1634
Human herpesvirus-6, Epstein-Barr virus and
cytomegalovirus viral load in cases of sudden
death in children. An approach with real-time
PCR assay
A. Ferna´ndez-Rodrı´guez, R. A´lvarez-Lafuente, M.P. Sua´rez-
Mier, B. Aguilera, S. Ballesteros, G. Vallejo, J. Go´mez (Madrid, E)
Objectives: The aim of this work was to determine the viral
load of three ubiquitous viruses, Human Herpesvirus-6 (HHV-
6), Epstein-Barr virus (EBV), and Cytomegalovirus (CMV), with
a quantitative real-time polymerase chain reaction (PCR) assay,
in 22 parafﬁn-embedded tissues from 9 cases of sudden children
death (SCD) in which viruses had been previously detected by
other techniques (serology, viral culture or nested PCR).
Methods: The QIAamp DNA Mini Kit (Qiagen) was used for
the extraction of DNA from 22 parafﬁn-embedded tissues from 9
cases of SCD, according to the manufacturer’s protocol. DNA
concentration was determined by reading the optical density at
260 nm. Two blank reactions were extracted together with each
set of ten samples in order to evaluate a possible cross-reaction.
For the detection of HHV-6, EBV and CMV genomes, quanti-
tative real-time PCR was carried out with speciﬁc sets of primers
and TaqMan probes; a beta-actin PCR was carried out as an
internal control to assure the quality of the DNA of each sample
and its suitability for PCR. Each sample was analysed in
duplicate for each one of the viruses and the internal control.
Results: The viral loads (in copies/lg of DNA) were as follows:
Patient 1 (1.7 years) had HHV-6 in liver (19.3) and in spleen (25)
and CMV in spleen (24.8), and was negative for the three
herpesviruses in lung. Patient 2 (2.6 years) had CMV in liver
(30.6), and was negative for the three herpesviruses in larynx
and lung. Patient 3 (2 years) had EBV in amygdale (28.5), and
CMV in amygdale (49.3) and kidney (34.3). Patients 4 (3 months)
and 5 (a newborn) were negative for the three herpesviruses in
lung. Patient 6 (3 months) had HHV-6 in spleen (2.1), and was
negative for the three viruses in lung. Patient 7 (2.2 years) had
HHV-6 in amygdale (34.8) and EBV in lung (36.8). Patient 8
(1.2 years) had CMV in spleen (78.1), and was negative for the
three viruses in lung. Patient 9 (3 months) had HHV-6 in
lymphoid tissue (45.4) and EBV in heart (24.9).
Conclusion: We have shown that quantitative real-time PCR
could be an important tool in the diagnosis of viral infections in
SCD cases, since its sensitivity allowed us to ﬁnd the presence of
pathogens that other assays did not detect because of their low
yields. We emphasise the need to establish a viral load threshold
in order to make an accurate interpretation of the presence of
herpesviruses in tissues.
P1635
The contribution of IgG avidity in the diagnosis
of CMV infection
P. Koudounis, M. Pagkalou, G. Triantaﬁllou, P. Rozi (Serres, GR)
Objectives: The evaluation of measurement of Cytomegalo-
virus immunoglobulin G avidity for distinguishing recent CMV
infection from the past.
Methods: Blood samples were taken from 262 patients attend-
ing the Outpatient’s Department or who were hospitalized in
the General Hospital of Serres with symptoms and signs of
recent CMV infection in 18 months (7/2002 to 12/2003).The
presence of speciﬁc CMV antibodies was determined using the
microparticle enzyme immunoassay (ABBOTT-AXSYM system)
and conﬁrmed with the enzyme linked ﬂuorescent assay
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(Vidas). IgG CMV avidity test also made in Vidas system
(bioMerieux, France).
Results: A total of 262 patients (126 men–70 women–66 chil-
dren) suggesting recent CMV infection, were examined. Thirty
four (ﬁrst group) had both IgM and IgG positive tests, while 6
(second group) had only IgM positive antibodies. The use of the
IgG avidity test on the patients of the ﬁrst group excluded recent
primary infection (less than 3 months) in 27 out of 34 patients
(79%). In the remaining 7, recent infection was conﬁrmed by the
second method of detection IgM antibodies. In all the above
patients that were examined, a second blood sample was taken
after 3 weeks. The last results of the 6 patients (second group)
for IgM antibodies were negative.
Conclusion: The CMV IgG avidity is a useful diagnostic tool in
laboratory conﬁrmation of acute infection.
P1636
Screening for cytomegalovirus infection in lung-
transplant patients: viral load or virus isolation?
K. Van Vaerenbergh, W. Laffut, M. Develter, G. Verleden,
J. Van Eldere (Leuven, B)
Objective: Cytomegalovirus is a major cause of morbidity and
mortality in transplant patients. Efforts have focused on iden-
tifying patients at risk for disease (especially D+R-) before the
onset of symptoms, in order to start pre-emptive antiviral
treatment. In this study, we evaluated the use of quantitative
real-time Taqman PCR on whole blood versus isolation of CMV
from urine and respiratory tract specimens.
Methods: 71 lung-transplant recipients were prospectively
studied. At 400 time points PCR and rapid detection of CMV
by shell vial assay (SVA, urine and throat) were performed on
linked samples.
Results: Concordance of the three test results was obtained in
76% (negative in 69%, positive in 7%). In 12.5% of the samples
studied, PCR was positive with negative isolations. In 5.5% a
negative PCR was obtained, with at least one positive isolation.
Positivity of only one isolation site combined with a positive
PCR was observed in a minority of cases (5% urine, 1% throat).
Patients with consecutive low copy numbers in PCR ((500 c/ml)
had intermittently positive isolations, with the best concordance
between urine isolation and viral load. Rarely, isolations
remained completely negative. For patients with continuously
positive viral loads, there was a good correlation of PCR and
isolations, although occasionally an isolation remained negative.
In only 2 patients (both R+) three consecutive positive urine
cultures were observed, with a negative viral load. For both
patients there was no evidence of CMV disease. Other discord-
ances between PCR (negative) and isolation (positive) were
preceded or followed by positive PCR.
Conclusions: In this patient population of lung-transplant
recipients, viral load and virus isolation in urine were highly
concordant.
P1637
Two-year analysis of prospective CMV-PCR
surveillance data in lung transplant recipients
J. Harwood, A. Krause, K. Gould, J. Dark, P. Corris (Newcastle
upon Tyne, UK)
Description: CMV is a major cause of mortality and morbidity
in transplant (tx) recipients. We commence weekly Quantitative
CMV PCR (QPCR) surveillance on our CMV positive (+)
recipients four weeks post-tx for three months. The CMV
mismatch (MM) recipients commence weekly QPCR for three
months, two weeks after the cessation of prophylactic ganciclo-
vir (GCV), which is given for the ﬁrst three months post-tx in
this group. CMV ( recipients receive no prophylaxis. During the
surveillance period, pre-emptive therapy (Rx) with oral GCV is
given if QPCR is (1 · 104 copies/ml and the patient is asymp-
tomatic. IV GCV is given in symptomatic patients above this cut-
off.
Objectives: 1. To estblish whether there is a correlation between
clinical symptoms associated with CMV disease and the viral
load of CMV. 2. To review the present viral load cut-off above
which pre-emptive Rx is considered in asymptomatic patients to
prevent development of disease.
Methods: We conducted a prospective analysis of patients’ notes
who underwent lung tx between Novemeber 2001 and Novem-
ber 2003. Thirty eight patients (>18 years) and one patient
(<18 years) who survived six months were included in the study.
Results: Of all the patients, six remained QPCR negative
throughout the study (3 CMV MM, 3 CMV+). Twelve patients
had low level QPCR levels, 103–104 copies/ml, of which one
MM patient developed symptoms and required pre-emtpive Rx.
Eleven patients had QPCR levels of 104–105 copies/ml, of which
4 (1 MM, 3 CMV+) received IV GCV for symptomatic disease.
Nine patients had QPCR levels (105 copies/ml (4MM, 5 CMV+)
of which 3 received treatment for symptomatic disease.
Conclusions: We did not ﬁnd any association between viral
load level and development of CMV disease. Only 9 patients
developed CMV disease requiring treatment, whereas 23
patients had raised QPCR levels with no disease. This data
suggests that our current cut off of (104 copies/ml is appropriate
for the initiation of pre-emptive therapy in asymptomatic
patients and is effective in preventing disease.
P1638
Evaluation of a new IgM test for detection of
cytomegalovirus IgM antibody
P. Chen, S. Binder, C. Hixson, R. Kaul, K. Johnson, S. Garcia,
F. Torres (Hercules, USA)
Objectives: Cytomegalovirus (CMV) is a ubiquitous pathogen
in humans. CMV infection can be asymptomatic in immuno-
competent adults, or life threatening in newborns and immu-
nocompromised individuals. CMV IgM is a sensitive and
speciﬁc indicator of on-going and recent infection, but may
not be speciﬁc for primary infection due to the persistence of
CMV IgM in some adults. IgG avidity testing has been useful in
identifying and excluding non-acute infection when the IgM
tests were discrepant (R. Kaul. et al. J. Clin. Microbiol. in press).
We developed a CMV IgM assay speciﬁcally to detect IgM
antibody to CMV using Bio-Rad’s fully automated, random
access BioPlex 2200 immunoassay analyzer (BioPlex) which
measures multianalytes in a single test. This study examines the
performance of the BioPlex CMV IgM assay in conjunction with
a CMV IgM assay and an avidity test.
Methods: A total of 186 patient samples were tested on the
BioPlex and characterized by bioMerieux VIDAS CMV IgM and
IgG assays (Marcy-l’Etoile, France) as follows: 2 were CMV IgM
positive and IgG negative, 38 were both CMV IgM and IgG
positive, 86 were CMV IgG positive and IgM negative, and 60
were both CMV IgM and IgG negative. The CMV IgG positive
samples were also tested by the Dade Behring Enzygnost Anti
CMV IgG avidity kit (Marburg, Germany).
Results: Compared to the VIDAS CMV IgM assay, the BioPlex
CMV IgM assay results yielded a sensitivity of 90.0% (36/40)
and speciﬁcity of 95.9% (140/146). Six false positive samples on
the BioPlex exhibited a low IgG avidity indicating primary
infection, and 4 false negative samples had a high IgG avidity
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suggesting non-acute infection. The sensitivity and speciﬁcity of
the BioPlex CMV IgM assay increased to 97.7% and 100%,
respectively, when the ten discrepant samples were resolved by
the avidity test results. In the samples with low IgG avidities, the
sensitivity of CMV IgM assay was 96.2% (25/26) for the BioPlex
versus 73.1% (19/26) for the VIDAS. One of the low IgG avidity
samples was IgM negative in both the VIDAS and BioPlex CMV
IgM assay. In the samples with high IgG avidities, the sensitiv-
ities of the VIDAS and BioPlex IgM assays were 19.4% (19/98)
and 15.3% (15/98), respectively.
Conclusion: The BioPlex 2200 CMV IgM assay described here is
sensitive and speciﬁc for detecting CMV IgM antibody, and
exhibited an ability to detect CMV IgM in specimens containing
low avidity IgG antibodies.
Bioﬁlms: pathogenesis and antibiotic susceptibility
P1639
The effect of atmosphere and inoculum size on
Staphylococcus epidermidis bioﬁlm density
J.S. Cargill, M. Upton (Manchester, UK)
Objectives: Staphylococcus epidermidis is a potential cause of
nosocomial infection, and its pathogenicity is related to its
ability to form a bioﬁlm. The aim of this study was to assess the
variation in bioﬁlm density of Staphylococcus epidermidis strains
(including the reference strain RP62A) at different concentra-
tions and in different atmospheres.
Methods: Staphylococcus epidermidis strains were cultured over-
night in typtone soya brothwith an additional 0.25%w/v glucose
(TSB). Sterile ﬂat-bottomed polystyrene 96-well cell culture plates
were prepared with 100 ll of fresh TSB in 10 columns. 100 ll of
overnight culture was added to an empty column, and serial
dilutions performed in the TSB containing wells, with 100 ll
discarded from the ﬁnal dilution. One column was left blank as a
reference. The plates were then incubated at 36C for 20 hours
before the wells were emptied by pipette, washed three times in
200 ll phosphate-buffered saline and air dried. They were then
stained with 0.4% crystal violet solution for ten minutes before
rinsing under gently running water. Bioﬁlm density was meas-
ured as the optical density at 450 nm (OD > 0.12, weak positive;
OD > 0.24, strong positive). 200 ll of 1:100 dilutions of overnight
culturewere added to the columnsof 2 96-well plates.One setwas
incubated in normal atmosphere and the other in a 5% carbon
dioxide enhanced atmosphere. Bioﬁlm density was assessed as
above. Each experiment was repeated three times.
Results: For most strains the bioﬁlm density of the serial
dilutions remained approximately constant at dilutions above
1:4, although some showed a gradual reduction in density above
this level. One strain showed a pronounced drop in bioﬁlm
density between 1:8 and 1:32 dilution. Eight of ﬁfteen strains
showed bioﬁlm positive results above 1:4 dilution in all three
repeats.Nine of ﬁfteen strains showed increased bioﬁlm densi-
ties in a normal atmosphere while four strains showed increased
density in when grown in the presence of elevated carbon
dioxide. Two strains did not show statistically signiﬁcant
(Mann–Whitney test) overall differences.
Conclusion: This study shows that the bioﬁlm density of some
Staphylococcus epidermidis strains are affected by the dilution, and
hence inoculum size, and the atmosphere. The results vary in a
strain dependant manner.
P1640
Desferrioxamine increases Staphylococcus
epidermidis bioﬁlm density
J.S. Cargill, M. Upton (Manchester, UK)
Objectives: Staphylococcus epidermidis is a potential cause of
nosocomial infection, and its ability to form a bioﬁlm is
important in pathogenicity. This study was designed to evaluate
the change in bioﬁlm density of clinical isolates and the
reference strain RP62A in the presence of an iron source and
the iron chelator desferrioxamine.
Methods: Staphylococcus epidermidis strains were cultured over-
night in typtone soya broth with an additional 0.25% w/v
glucose (TSB). Overnight cultures were diluted 1:50 in fresh TSB,
and 100 ll used to seed the columns of sterile ﬂat-bottomed
polystyrene 96-well cell culture plates. Serial dilutions of Sigma
iron supplement were prepared from a maximum of 4 ml/l and
100 ll added to the wells. This gave 1:100 dilutions of staphy-
lococci with reducing concentrations of iron supplement from
2 ml/l. A reference control was provided by a 1:100 dilution
without iron supplement. After 20 hours incubation the plates
were washed in triplicate in phosphate buffered saline and
stained with crystal violet. Bioﬁlm density was assessed by
recording the optical density at 450 nm (OD > 0.12, weak
positive; OD > 0.24, strong positive). Some of the strong positive
strains were tested in the presence of desferrioxamine with
2 ml/l iron supplement in the same manner as above, together
with set of replicates without iron supplement.
Results: 3/15 strains were bioﬁlm negative at all iron concen-
trations. 2/15 strains gave weak positive to negative results at all
iron concentrations. 4/15 strains were weak to strong positive
without iron, and showed maximum bioﬁlm density at 1.0 ml/l
of iron supplement. The remaining 6/15 were strong positive
and showed maximum density at 2 ml/l. Three of these strains
were tested with desferrioxamine and showed increased density
in the presence of the iron chelator.
Conclusions: Iron supplementation increases the bioﬁlm den-
sity of bioﬁlm positive Staphylococcus epidermidis strains. Some
strains show increased bioﬁlm density in the presence of
desferrioxamine. Even though desferrioxamine has previously
been shown to inhibit the growth of S. epidermidis, it may be
acting as a staphylococcal siderophore.
P1641
Low levels of vancomycin increase the density of
Staphylococcus epidermidis bioﬁlms
J.S. Cargill, M. Upton (Manchester, UK)
Objectives: Staphylococcus epidermidis is a potential cause of
nosocomial infection, and its pathogenicity is related to its
ability to form a bioﬁlm. The antibiotic vancomycin is often used
to treat Gram-positive infections, although resistance can be
found in some staphylococcal strains. The aim of this study was
to assess the change in bioﬁlm density of a variety of clinical
isolates and the reference strain RP62A in the presence of
vancomycin.
Methods: Bioﬁlm forming Staphylococcus epidermidis strains
were cultured overnight in typtone soya broth with an addi-
tional 0.25% w/v glucose (TSB). Overnight cultures were
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diluted 1:50 in fresh TSB, and 100 ll used to seed ﬁve columns
of sterile ﬂat-bottomed polystyrene 96-well cell culture plates
(two strains per plate). Various concentrations of sterile ﬁltered
vancomycin in TSB were added to four columns per strain, with
TSB alone added to the remaining column. Four different
repeats of the experiment were performed, giving results for
1:100 dilutions of eight strains with 0 (control), 40, 20, 10, 5 lg/
ml vancomycin (1 set), 0, 8, 4, 2, 1 lg/ml (2 sets) and 0, 5, 4, 3,
2 lg/ml (1 set). Each set comprised of eight replicates of each
condition. The plates were then incubated at 36C for 20 hours
before the wells were emptied by pipette, washed three times in
200 ll phosphate-buffered saline and air dried. They were then
stained with 0.4% crystal violet solution for ten minutes before
rinsing under gently running water. Bioﬁlm density was
measured as the optical density at 450 nm (OD > 0.12 taken as
positive). Repeats of the same condition were combined by
expressing the results as a multiple of the control condition.
Statistical signiﬁcance was assessed using the Mann–Whitney
test (p < 0.5 taken as signiﬁcant).
Results: Five of the eight strains showed statistically signiﬁcant
increases in bioﬁlm density in the presence of low vancomycin
concentrations, resulting in bioﬁlm-positive results in 95% of
wells (see table).
Conclusion: This study has shown that the bioﬁlm density of
some strains of S. epidermidis increased in the presence of low
concentrations of vancomycin. It is unknown whether this
reﬂects increased bioﬁlm-forming ability of less sensitive clones
within a population, an effect on the cell wall of the organisms,
or modulated gene expression.
P1642
Regulation of bioﬁlm formation by SigmaB is a
common mechanism in Staphylococcus
epidermidis and is not mediated by the SigmaB
dependent sarA transcript
S. Ja¨ger, D. Mack, M.A. Horstkotte, H. Rohde,
J.K. Knobloch (Hamburg, D)
Objectives: The alternative sigma factor SigmaB was identiﬁed
as a major regulator of bioﬁlm formation in Staphylococcus
epidermidis 1457, whereas for S. aureus only a minor impact of
SigmaB on bioﬁlm formation could be observed. To exclude an
individual behavior of S. epidermidis 1457 we further investi-
gated in this study the inﬂuence of SigmaB on bioﬁlm formation
and sarA transcription in the methicillin susceptible clinical
isolate S. epidermidis 8400 as well as in the methicillin resistant
clinical strain 1057.
Methods: Mutants with various deletions within the sigB
operon were characterized phenotypically by a quantitative
bioﬁlm assay and by a PIA speciﬁc immunoﬂuorescence assay.
Transcription analysis of the genes icaA, icaR, sarA, and asp23
was performed using quantitative real-time PCR.
Results: All mutants with dysfunctional SigmaB activity dis-
played a decreased bioﬁlm formation, whereas for mutants with
inactivation of the antisigmafactor RsbW an increased bioﬁlm
formation was observed. Transcriptional analysis revealed that
icaA transcription was down-regulated in SigmaB negative
mutants while icaR transcription was up-regulated. However,
the observed differences of icaR transcription in these mutants
did not always reach a signiﬁcant level, indicating that addi-
tional SigmaB dependent regulators are involved in regulation
of bioﬁlm expression. Except for the mutant with inactivation of
RsbW in S. epidermidis 8400, which displayed a signiﬁcant
increase of icaA transcription congruent with a strong increase
of bioﬁlm formation mutants with inactivation of the antisigma-
factor displayed only minor transcriptional differences. Analysis
of sarA transcription revealed no or only minor differences
compared to the respective wild types.
Conclusions: The similar inﬂuence on phenotypes as well as a
comparable transcriptional regulation of icaR and icaA by the
alternative sigma factor SigmaB in three independent genetic
backgrounds of clinical S. epidermidis isolates suggests that
regulation of bioﬁlm formation by SigmaB is a general feature in
S. epidermidis. Therefore, the SigmaB dependent regulatory
pathway could be a promising target for new strategies to
prevent foreign body-associated infections. The lack of signiﬁ-
cant differences of sarA transcription indicates that the SigmaB
dependent sarA transcript is not involved in the observed
phenotypic changes.
P1643
Foreign body infection and ‘wild type’
Staphylococcus epidermidis – Potential of bioﬁlm
formation and antimicrobial resistance
B. Parschalk, A. Grisold, F. Yassin, H. Adametz, W. Graninger,
E. Presterl (Vienna, Graz, A)
Objectives: Foreign body infections (FBI) due to Staphylococcus
epidermidis have become major clinical problems associated with
considerable morbidity and costs. Bioﬁlm formation and resist-
ance to multiple antibiotics are the major obstacles for a
successful treatment. The aim of the study was to test Staphy-
lococcus epidermidis isolates from patients with veriﬁed foreign
body infections i) for their ability to form bioﬁms and ii) for their
susceptibility to 12 standard antibiotics, and compare these to
‘wild type’ Staphylococcus epidermidis isolated from the skin of
healthy volunteers.
Methods: Sixty patients with veriﬁed FBI were evaluated.
Hundred and twenty-nine blood culture isolates from 60
patients with FBI, and 52-skin isolates from healthy, not
hospital-associated, volunteers were analysed. Identiﬁcation of
Staphylococcus epidermidis was done using routine methods. To
exclude doubles FBI isolates were genotyped by PFGE. The
susceptibility testing was done using disk diffusion method
according to the NCCLS. Antimicrobial agents tested were
penicillin, oxacillin, erythromycin, clindamycin, gentamicin,
amikacin, vancomycin, fosfomycin, fusidic acid, rifampicin,
ciproﬂoxacin, trimethoprim and linezolid. Bioﬁlm formation
was tested using a microtiter plate bioﬁlm model.
Results: Among the 129 FBI isolates 86 strains with distinct
PFGE proﬁles were identiﬁed. Bioﬁlm formation was detected in
86.4% of FBI strains and in 76.9% of the ‘wild type’ isolates (not
Strain
Vancomycin*
(lg/ml)
Relative bioﬁlm
density**
Mann-Whitney
p-value
RP62A 3.0 0.99 (0.34) 0.370
s2 4.0 1.46 (0.11) <0.001
s4 0.5 0.82 (0.17) <0.001
s5 2.0 1.96 (1.69) 0.020
s41 3.0 1.12 (003) <0.001
s79 1.0 0.83 (0.12) <0.001
s159 3.0 1.14 (0.16) 0.020
s163 3.0 1.26 (0. 06) <0.001
* Vancomycin concentration at which 95% of test wells gave bioﬁlm-
positive results.
** Mean (SD) of the bioﬁlm density expressed as a multiple of the
result at a vancomycin concentration of 0.
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signiﬁcant). More than 30% of all FBI strains were resistant to
penicillin, oxacillin, erythromycin, clindamycin, ciproﬂoxacin
and trimethoprim. The 52 ‘wild type’ Staphylococcus epidermidis
were generally more susceptible than the clinical isolates
(p < 0.05): However, 46.2 % of these controls were resistant to
penicillin and to erythromycin, 17.3% were resistant to
clindamycin.
Conclusions: Bioﬁlm formation is present to the same extent in
both, FBI-associated and ‘wild type’ Staphylococcus epidermidis
strains demonstrating the potential of skin ﬂora to cause FBIs.
Although it is well known that nosocomial Staphylococcus
epidermidis are resistant to multiple antibiotics, the ‘wild type’
isolates show alarming resistance to erythromycin and clinda-
mycin possibly reﬂecting the abundant use of macrolides for
minor infections in the population.
P1644
barAB a new regulatory gene locus mediating
NaCl induction of Staphylococcus epidermidis
bioﬁlm formation
J.K. Knobloch, K. Bartscht, S. Ja¨ger, H. Rohde, M.A. Horstkotte,
D. Mack (Hamburg, D)
Objectives: Bioﬁlm expression in Staphylococcus epidermidis is a
major virulence factor and attachment to polymeric surfaces
leads to reduced susceptibility against antimicrobial substances.
The alternative sigma factor SigmaB is an important regulator of
bioﬁlm formation in S. epidermidis. However, bioﬁlm formation
is under inﬂuence of additional yet uncharacterized regulators,
which were examined in this study.
Methods: The Tn917 insertion of the bioﬁlm-negative mutant
M12 generated in the bioﬁlm-positive genetic background of
S. epidermidis 1457 was identiﬁed by arbitrary PCR. The
transcription of the icaADBC locus, essential for bioﬁlm forma-
tion as well as of the inactivated genes was investigated. The
function of the inactivated genes was characterized by comple-
mentation studies under different environmental conditions.
Results: In M12 Tn917 was inserted at the distal end of an orf
homologous to the regulatory gene purR in Bacillus subtilis. The
gene upstream of purR is conserved between S. epidermidis,
B. subtilis, and S. aureus furthermore two additional orfs (orf3
and orf4) homologous to B. subtilis, and S. aureus are located
downstream of the Tn917 insertion site. Within the purR genes
of S. epidermidis, B. subtilis, and S. aureus a highly conserved
motif homologous to the consensus sequence for SigmaB
dependent promoters was identiﬁed upstream of Tn917. The
SigmaB dependent transcription of the orf3 and orf4 could be
demonstrated in mutants with inactivation of sigB. In M12
transcription of the bioﬁlm associated genes icaADBC was
abolished, whereas the transcription of their negative regulatory
gene icaR was unaffected. Complementation with the single
genes showed no effect in M12, whereas complementation of
M12 with orf3 and orf4 together was able to restore bioﬁlm
formation under high osmotic conditions. Interestingly, under
standard conditions used for bioﬁlm formation as well as under
bioﬁlm induction with subinhibitory concentrations of ethanol
no bioﬁlm formation was observed in the complemented
mutant.
Conclusions: We identiﬁed two new regulators of S. epidermidis
bioﬁlm formation, which we designate now as bioﬁlm accumu-
lation regulators A and B (barAB). BarA and B act as positive
regulators of icaADBC transcription independent of the regula-
tory gene icaR. BarAB is a SigmaB dependent gene locus, which
is at least partially responsible for the NaCl induction of bioﬁlm
formation in S. epidermidis.
P1645
Role of Fur and transferrin binding protein in
Staphylococcus epidermidis during in vitro and in
vivo bioﬁlm formation
C. Massonet, J. Van Eldere (Leuven, B)
Objectives: To determine whether GADPH (transferrin binding
protein-TBP) and its regulator (Fur) play a role in the bioﬁlm
formation by Staphylococcus epidermidis.
Methods: A bioﬁlm forming strain of S. epidermidis, isolated
from a patient with proven catheter-related infection was used.
RNA and DNA isolations were performed as described by S.
Vandecasteele et al. (Biochem. Biophys. Res. Commun. 2002.
291:528–534). For In vitro studies bacteria were grown overnight
in BHI or RPMI, without iron (fRPMI) and re-incubated in
fRPMI or fRPMI with 1 lm FeCl3 or fRPMI with apotransferrin
(iron free; 20 lg/ml) or fRPMI with holotransferrin (iron-
saturated; 20 lg/ml). For in vivo studies a subcutaneous rat
model was used. Samples were quantiﬁed through real-time
PCR described by S. Vandecasteele et al. (Biochem. Biophys.
Res. Commun. 2002. 291:528–534).
Results: During the growth of the bacteria, the expression of fur
and tbp for planktonic bacteria was higher in an iron depleted
medium and lower in an iron rich medium. In vitro studies in an
iron depleted medium show a statistically signiﬁcant (2-way
ANOVA, Bonferonni, N = 12) up regulation of fur expression in
sessile bacteria in comparison with planktonic bacteria. In an
iron rich environment there is no variation in the expression of
fur between sessile and planktonic bacteria. In fRPMI with
holotransferrin or apotransferrin the expression of fur for sessile
bacteria in comparison with that of planktonic bacteria is
signiﬁcantly up regulated in fRPMI with holotransferrin and
down regulated in medium with apotransferrin. The results
obtained for tbp are similar. In vivo, the expression of fur is
down regulated in the beginning, followed by an increase of
expression after one week. The expression of tbp is very low and
stays constant over a period of two weeks. (Statistically
signiﬁcant: 1-way ANOVA, Bonferroni, N = 16).
Conclusion: According to in vitro results, the lack of iron has a
greater impact on sessile bacteria than on planktonic bacteria.
Holotransferrin and apotransferrin also affect the expression of
fur and tbp in sessile bacteria, but further investigation is
required. In vivo results show that fur plays a role in the late
stages of the bioﬁlm.
P1646
Effect of iron on iron-regulated genes in bioﬁlm-
associated Staphylococcus epidermidis
C. Massonet, R. Merckx, J. Van Eldere (Leuven, B)
Objectives: To determine whether iron and iron-related genes
(sirR, coding for the regulator; sitA, coding for ATP binding
protein; sitB, coding for membrane protein; sitC, coding for
lipoprotein) play a role in bioﬁlm formation of Staphylococcus
epidermidis.
Methods: A bioﬁlm-forming strain of S. epidermidis, isolated
from a patient with proven catheter-related infection was used.
RNA and DNA isolations were performed as described by S.
Vandecasteele et al. (Biochem. Biophys. Res. Commun. 2002.
291:528–534). For In vitro studies iron was removed from RPMI
medium and experiments were performed with 1 lm FeCl3
added or without iron. For in vivo studies a subcutaneous rat
model was used. Samples were quantiﬁed through real-time
PCR described by S. Vandecasteele et al. (Biochem. Biophys.
Res. Commun. 2002. 291:528–534).
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Results: In vitro results show that in an iron-limited environ-
ment, the planktonic form of S. epidermidis produces sidero-
phores and grows slower than in an iron-rich environment. In
vitro, during an 18 hours observation period, the expression of
sirR stays constant and is independent of iron concentration.
The expression of sitA, sitB and sitC on the other hand is higher
in medium with low iron content than in the medium with
added iron. In vitro studies also indicate that sirR has a
statistically (2-way ANOVA, Bonferroni, N = 12) signiﬁcant
higher expression in sessile bacteria compared to planktonic
bacteria. The expression of sitC is signiﬁcantly (2-way ANOVA,
Bonferroni, N = 9) higher for sessile bacteria than for planktonic
bacteria in an iron-limited medium. The expression of sitC in an
iron-rich medium is identical for both forms. In vivo (1-way
ANOVA, Bonferroni, N = 16), the expression of sirR is high and
remains stable over a time period of two weeks. SitC, sitA and
sitB are also highly expressed during this two weeks time
period.
Conclusion: The constant high in vivo expression of sitABC
and the regulator sirR could indicate a role of these genes in the
bioﬁlm growth mode. In vitro results show an iron-regulated
expression of sitABC. The expression of sirR (in vitro) is not
iron-regulated but a speciﬁc regulation mechanism is not yet
known.
P1647
Role of virulence regulator genes in
Staphylococcus epidermidis bioﬁlm formation
V. Pintens, S. Vandecasteele, R. Merckx, J. Van Eldere
(Leuven, B)
Objective: To monitor gene expression of Staphylococcus epider-
midis regulator loci during early in vitro and in vivo bioﬁlm
formation.
Methods: AgrA, RNAIII, sarA, rsbU, rsbV and sigB expression
in vitro was examined at 0, 10, 30, 60, 120 and 180 min after
inoculation in 0.9% NaCl in planktonic (n = 68) and sessile
(n = 70) bacterial cultures. Gene expression during in vivo
bioﬁlm formation was evaluated over two weeks. Catheter
fragments inoculated with S. epidermidis were implanted subcu-
taneous in rats as described by S. Vandecasteele et al. (Biochem
Biophys Res Commun. 2002; 291: 528–534). Catheters (n = 295)
were explanted 0, 15, 30, 60, 90, 120, 240, 360, 720, 1440, 2880,
5760, 10080 and 20160 min after implantation. Expression was
determined by TaqmanTM real-time PCR as described by S.
Vandecasteele (Biochem Biophys Res Commun. 2002; 291: 528–
534).
Results: In vitro expression of rsbU, the ﬁrst gene of the sigB
operon, is signiﬁcant higher in sessile than in planktonic
bacteria. Relative expression levels of RNAIII and sarA are
higher in planktonic than in sessile bacteria. There is no
signiﬁcant difference between in vitro expression of agrA, sigB
and rsbV in sessile versus planktonic bacteria. In vivo, expres-
sion of all genes reaches a peak level between 1 and 2 h after
implantation (0.5–1.5 log10 times the expression level at implan-
tation) and subsequently decreases towards its lowest level at
6 h. For agrA, expression remains stable during the whole
observation period; expression of RNAIII and sarA decreases
and remains thereafter at a very low level. SigB expression
remains at a high level for the whole observation period,
whereas expression of rsbV and rsbU increases. RsbU is
expressed to a signiﬁcantly higher degree than the other sigB
operon genes.
Conclusion: In contrast to S. aureus, the sigB operon and
particularly rsbU seem to be important factors in S. epidermidis
bioﬁlm formation.
P1648
Staphylococcal bioﬁlm as a target for linezolid,
vancomycin, oxacillin and/or lysostaphin
E. Walencka, B. Sadowska, S. Rozalska, W. Hryniewicz,
B. Rozalska (Lodz, Warsaw, PL)
Objectives: Medical device-associated infections, frequently
caused by staphylococci, are related to bioﬁlm formation. Che-
motherapy of such infections is seldom fully effective, due to
high bioﬁlm resistance. A number of alternative approaches to
antimicrobial treatment have been proposed. The aim was
to study the activity of antibiotics in monotherapy or in
combination with lysostaphin, towards S. aureus bioﬁlm.
Methods: S. aureus: ATCC29213 (MSSA), A3 (clinical MRSA),
1474/01 (clinical hVISA), were used as planktonic cultures or 24-
hour-old bioﬁlm built in the wells of microplate, in the chambers
of a LabTekII chamber slide or on the polyethylene catheter.
MICs of linezolid, vancomycin, oxacillin and lysostaphin for
planktonic bacteria were determined according to the standards
of NCCLS. BIC/BEC (Bioﬁlm Inhibitory/Eradicating Concen-
tration) were estimated by the MTT assay measuring active
metabolism of bacteria that survived a single or cyclical dose of
antimicrobials (antibiotic alone or in combination with subMIC
lysostaphin given earlier or together with antibiotic). The
integrity of bioﬁlm treated with antimicrobials was also exam-
ined: in catheter study: visually by TTC reduction assay, in
chambers of a LabTekII chamber slide: by staining with FITC
and confocal ﬂuorescence microscopy.
Results: We have demonstrated the effectiveness of lysostaphin
in the treatment (3–24 hours) of bioﬁlm built not only on the ﬂat
surface (wells of microplate, chambers of a LabTekII chamber
slide) but also on catheter extra- and intraluminal surfaces.
MIC/BIC of lysostaphin were 0.25, 8/16 mg/L for MSSA and
MRSA, 0.06, 4/8 mg/L for hVISA, respectively. The synergistic
effect of subMIC lysostaphin + oxacillin was observed for MSSA
and MRSA bioﬁlms (BICoxa/Lin dropped after 24 h from >128
to <4 mg/L) but such effect was not demonstrated for hVISA
strain (BICOxa was still >128 mg/L). SubMIC lysostaphin + -
linezolid or + vancomycin, given as 3 cycles therapy, were
effective in disruption of MSSA, MRSA, hVISA or MSSA and
MRSA bioﬁlms, respectively. Thus, lysostaphin in combination
with antibiotics, was effective in preventing the bioﬁlm re-
building (BEC) in experiments lasting 5 days.
Conclusions: Our study indicates that staphylococcal bioﬁlm
eradication could be achieved by treatment with lysostaphin
alone or in combination with selected antibiotics. However,
complete bioﬁlm removal needs the cyclical therapy.Supported
by Grant 3PO4C08124 (KBN)
P1649
Zinc concentration and porin proﬁle of
P. aeruginosa forming bioﬁlms on siliconized
latex urinary catheters
M.C. Conejo, I. Garcı´a, L. Picabea, A´. Pascual (Seville, E)
Objective: Zinc compounds are used in the siliconized latex
urinary catheters (SLUCs) manufacture. Studies in vitro have
shown that Zn elutes from SLUCs and determines decreased
susceptibility to carbapenems in planktonic Pseudomonas aerugi-
nosa. This effect is associated with OprD loss. P. aeruginosa is
able to adhere efﬁcaciously to the surface of SLUC forming
bioﬁlms. The objective of this study was to evaluate the
relevance of this phenomenon in P. aeruginosa forming bioﬁlms
on SLUCs.
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Methods: Bioﬁlms of P. aeruginosa PAO1 were grown on 1 cm
SLUCs segments in Mueller–Hinton broth for 24 hours. Bacterial
bioﬁlms were detached by sonication and Zn accumulation in
bioﬁlms was determined by inductively coupled plasma atomic
emission spectrometry (ICP-AES). SLUC segments without
bioﬁlms were used as control. To study the outer membrane
proteins (OMPs) of bacterial bioﬁlms, cells were disrupted by
sonication (40 kHz, two minutes in a sonication water bath) and
OMPs were isolated as sodium-lauryl sarcosynate insoluble
material and the proteins were resolved by SDS-PAGE. OMP
pattern was compared to that expressed by planktonic bacteria
grown in Mueller–Hinton broth supplemented or not with Zinc
Chloride (40 mg of Zn/L).
Results: P. aeruginosa PAO1 SLUC bioﬁlms did not accumulate
Zn. Zn values reached by bacterial bioﬁlms (1.67 ± 0.32 lg/g of
catheter) were similar to that those obtained with the control
(1.88 ± 0.27 lg/g of catheter). P. aeruginosa PAO1 forming
bioﬁlms lost OprD2 and expressed OprD3, showing the same
OMP proﬁle as planktonic bacteria in the presence of Zn.
Conclusion: P. aeruginosa PAO1 SLUC bioﬁlms did not
expressed OprD, the porin responsible for carbapenem entry
into P. aeruginosa. Zn eluted from SLUCs did not accumulate by
PAO1 bioﬁlms.
P1650
Diversity in adhesion, initial bioﬁlm formation
and motility abilities among clonal lineages of
nosocomial strains of Pseudomonas aeruginosa
A.P. Fonseca, P. Correia, A.F. Fonseca, R. Tenreiro,
J.C. Sousa (Porto, Lisbon, P)
Objectives: The objective of this study was to test for potential
constraints of genotypes on several virulence parameters and to
examine the extent of phenotypic diversity in the context of
clonal lineages (CLs) among nosocomial strains of P. aeruginosa.
Methods: A combination of two genomic typing systems, the
minisatellite-primed PCR (MSP-PCR) and the enterobacterial
repetitive consensus sequence PCR (ERIC-PCR), was used to
discriminate the 96 strains collected at a Portuguese Central
Hospital and isolated from 5 different sources. The data was
analysed using BioNumerics software. Bacterial adhesion to
polystyrene (PS2h) and initial bioﬁlm formation (PS6h) were
studied by growing bacteria in LB in a modiﬁed microtiter-plate
assay. Strains were screened for their capacity to adhere to
hydrophobic biomaterials such as silicone and hexadecane
(CSH) using a biphasic separation method. The opportunistic
P.aeruginosa were also screened for their capacity to swim
(ﬂagella) and twitch (pili). All tests were run in triplicate.
Results: Our combined genotypic and phenotypic analysis
revealed extensive diversity in all the parameters within CLs
of P. aeruginosa strains and no signiﬁcant differences among CLs.
However, small clusters of strains with relatively high PS2h and
PS6h abilities can be found; one speciﬁc group containing 2
strains of CL1 (similarity 70%) are worth mentioning; a group of
2 strains from CL7 (similarity 60%) had low PS2h and PS6h
abilities. Positive correlations (Spearman’s) were observed
between PS2h and PS6h (0.748, P < 0.01), between PS2h and
CSH (0.233, P < 0.05), between PS6h and CSH (0.228, P < 0.05)
and between PS6h and twitching (0.220, P < 0.01). The strain
with highest adhesion value was one of the most efﬁcient initial
bioﬁlm producer and other strain had the same behavior but
had the lowest value. The strain with highest CSH was also one
of the most efﬁcient in adhesion to silicone and the strain with
lowest adhesion was the same for the two parameters.
Conclusion: Our results suggest extensive diversity, namely by
wide variations in virulence parameters among strains within a
CL and no signiﬁcant differences between CLs in all the
virulence parameters. These results also suggest the importance
of hydrophobicity in adhesion ability to abiotic surfaces, the
importance of twitching in bioﬁlm formation and the correlation
between PS2h and PS6h ability.
Acknowledgments: This study was supported by Fundac¸a˜o
Calouste Gulbenkian.
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Comparative study of antibiotic susceptibility
levels of some clinical strains of P. aeruginosa as
planktonic and adherent growing in bioﬁlms
cells
V. Lazar, M. Balotescu, M. Bucur, O. Banu, R. Cernat,
D. Bulai (Bucharest, RO)
Background: Besides the well known genetic antibiotic resist-
ance of Pseudomonas aeruginosa strains, the growing bioﬁlms on
medical implants are responsible for persistent infections, being
much less susceptible to antimicrobial agents than are their
planktonic counterparts. This recalcitrance could be due to self-
aggregation and bacterial adherence to different substrata,
generation of a protecting exopolysaccharidic mathrix limiting
the antibiotic diffusion in the bioﬁlm, underexpression of porins,
overexpression of multidrug resistance pumps, the presence of
persisters that survive in the presence of an antibiotic that
inhibits their growth. For highlighting some of the above-
mentioned factors, we have investigated the antibiotic resistance
levels of P. aeruginosa planktonic cells comparatively with cells
growing in bioﬁlms developed on central venous catheter pieces
imersed in nutrient broth (original experimental model) or
included in agar mimicking the bioﬁlm mathrix.
Methods: The study was performed on some P. aeruginosa
strains isolated from central venous catheter related infections in
patients admitted for cardiovascular surgery. The strains were
ﬁrstly submitted to antimicrobial testings performed by stand-
ard disk diffusion method and 25 strains susceptible to amino-
glycosides, beta-lactams and quinolones were further tested by
two experiemental models for antibiotic susceptibility of bac-
terial cells included in bioﬁlms formed in liquid and solid
media. The strains were also studied for slime production and
for cell hydrophobicity.
Results: Our results showed that the P. aeruginosa cells growing
in bioﬁlms are signiﬁcantly less susceptible to antibiotics, in a
dose-response (increased MICs and MBCs) and time-dependent
manner. This aspect was particularly evidenced and statistically
conﬁrmed for aminoglycosides, which poorly penetrate the
bioﬁlm, due to their policationic structure. The majority of the
tested strains produced high amounts of slime, evidenced after
safranin staining of the bioﬁlm developed on glass tube walls,
expressed both at 37C and 4C and well correlated with the
presence of bacterial capsule. All the tested strains exhibited
high hydrophobicity levels evidenced by decreased absorbance
values of the aqueous phase of bacterial cultures in the presence
of paraxilen and also by the ability to self-aggregate, raising the
risk of colonizing the inert materials and of catheter related
persistent infections.
P1652
Bioﬁlm formation of nosocomial Acinetobacter
baumannii strains
F. Can, O. Kurt Azap, M. Demirbilek, F. Timurkaynak,
G. Karabay, H. Arslan (Ankara, TR)
Acinetobacter baumannii an important nonocomial pathogen,
usually found on various surfaces of the hospital environment.
Abstracts
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Bioﬁlm formation is a virulence factor for A. baumannii. In this
study, 17 blood isolates of A. baumannii were studied for the
ability to form bioﬁlms on the surface of polystyrene and
ultrastructural cell wall properties of bioﬁlm-formatted strains
were evaluated.
Methods: A total of 17 A. baumannii strains isolated from blood
cultures of different patients in intensive care units between
2003 and 2004 were selected. The ability of Acinetobacter strains
to form bioﬁlm was determined on polystyrene microtiter plates
using Brain Heart Infusion supplemented with 0.25% Glucose as
a growth medium. Additionally, transmission electron micros-
copy of strains was performed for the presence of ﬁmbria, cell
wall thickness and, an amorphous material cover the cell
described for some other bacteria.
Results: Bioﬁlm formation was detected in 9 (52.9%) of
A. baumannii strains. Ultra structural analysis showed that
ﬁmbriae were found all of the isolates while the thickest layers
of amorphous material was observed around the bioﬁlm-
positive strains.
Conclusion: Bioﬁlm formation of A. baumannii strains from
patients with bacteriemia was found high. The results obtained
in electron microscopy studies suggested that amorphous
material covers the bacteria probably plays an important role
of the maintenance of the bacterium in the hospital environment
and protect it against the defense mechanisms of the host.
P1653
Strains of Enterobacter cloacae isolated in
hospital environment: ability to adherence to
Hep-2 cell line and to bioﬁlm forming
K.W. Pancer, S. Fila, A. Trzcinska, A.E. Laudy, T. Wernik,
E. Mikulak, A. Gliniewicz, H. Stypulkowska-
Misiurewicz (Warsaw, PL)
Bacteria Enterobacter cloacae were observed as etiological agents
of nosocomial infections in Poland, especially hospital-acquired
pneumonia (9–11%) and urinary tract infections (3–7%). More-
over the majority of E. cloacae strains isolated from patients with
HAP, hospitalized at ICUs showed resistance to ceftazidime. The
aim of our study was the examination of virulence properties
like: adherence to human cell line and forming bioﬁlm of 15
strains of E. cloacae isolated from patients (infection or colonisa-
tion) and of 11 strains isolated from the body surface of German
cockroaches collected in hospitals. The examination of ability to
adherence to human cell line (Hep-2) was done according
Knutton et al. method. Three patterns of adhesion were
observed: A. aggregative; B. localized and C. diffuse adhesion.
Moreover determination of activity of 3 selected chemical
disinfectant to bacteria growing as a planctonic form (by
evaluation MICs) and growing as a bioﬁlm on catheter (effect-
iveness of working solution) was done. Patterns of adhesion to
Hep-2 cell line varied among tested strains. The aggregative
adhesion was observed among 2 strains of E. cloacae colonising
patients and one isolated from infections. No one of 11 E. cloacae
strains isolated from the surface of cockroaches showed this
pattern of adhesion. According to statistical analysis the signi-
ﬁcant number of E.cloacae strains isolated from cockroaches
presented lack of adhesion to Hep-2 cell line or diffuse adhesion
in comparison to strains collected from patients. Totally 65% E.
cloacae strains showed mannose-sensitive mechanism of adher-
ence to Hep-2 cell line (71% of strains from the colonised patients,
62.5% of strains that caused infection and 63.6% of strains from
the surface of cockroaches). 27% of the strains showed stronger
adhesion in presence of mannose. Only one E. cloacae strain did
not form the bioﬁlm on catheter. The majority of tested strains
growing 5 days on catheter were resistant to working solution of
potassium persulfate, glucoprotamin and sodium dichloroisocy-
janurate. However, E. cloacae strains that caused infection were
the only resistant to all 3 disinfectants working solution, even if
the MIC values were similar to the MICs of these strains from
patient colonisation or from cockroaches. The study on virulence
markers presented by E. cloacae hospital strains should be
continued.
P1654
The development of crystalline Proteus mirabilis
bioﬁlms on Foley catheters
S.D. Morgan, D.J. Stickler (Cardiff, UK)
Objective: The management of many patients undergoing long-
term bladder catheterisation is complicated by the encrustation
and blockage of their catheters. The problems result from
infection by urease producing bacteria. The organisms colonize
the catheters, the urease induces alkaline conditions under
which calcium and magnesium phosphates precipitate and the
resulting crystalline bioﬁlm blocks the ﬂow of urine. The aim of
this study was to investigate the early stages of bioﬁlm
formation on a range of catheter types.
Methods: A laboratory model of the catheterised bladder was
supplied with urine and infected with Proteus mirabilis NSM6, a
clinical isolate from an encrusted catheter. Models were ﬁtted
with ﬁve different types of catheters. After incubation for
various periods up until the times they blocked, catheters were
removed from the models for examination. Scanning electron
microscopy and X-ray microanalysis were used to follow the
colonization of catheters by bacteria and crystalline material.
Results: All-silicone, hydrogel-coated latex and silicone-coated
latex catheters all acquired a layer of crystalline material within
4 h. These deposits consisted predominantly of calcium phos-
phate. Subsequently, they become colonized by large numbers
of bacilli and the rapidly developing crystalline bioﬁlm blocked
the catheters within 12.5 h–42.5 h. In the case of a nitrofurazone-
impregnated all-silicone catheter, although the initial process
was slower, with the crystalline layers being ﬁrst observed at
12 h, catheter blockage occurred at 29 h. Triclosan-impregnated
silicone catheters however, showed little sign of encrustation or
bioﬁlm formation and were still draining urine freely at 7 days
when the experiment was terminated.
Conclusion: The catheters currently available for long-term
bladder management were rapidly colonized by crystalline P.
mirabilis bioﬁlm. Triclosan-impregnated catheters however were
able to resist encrustation and bioﬁlm formation in vitro for up
to 7 days.
P1655
The role of capsules in Klebsiella pneumoniae
bioﬁlm formation
C. Struve, S. Molin, K.A. Krogfelt (Copenhagen, DK)
Objectives: K. pneumoniae is an important opportunistic patho-
gen and frequent cause of hospital infections. K. pneumoniae cells
are characteristically surrounded by a pronounced polysaccha-
ride capsule, which has been proven to be an important
virulence factor for the bacteria. The ability of bacteria to form
bioﬁlms is recognized to play a role in the pathogenicity of many
bacterial species. In bioﬁlms bacteria are organised in micro-
colonies embedded in a matrix of exo-cellular polymeric
substances (EPS). The EPS is considered to stabilize the bioﬁlm
structure and protect the bacteria against host defence mecha-
nisms and the actions of antibiotics. In this study we investigate
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the role of the polysaccharide capsule on K. pneumoniae bioﬁlm
formation.
Methods: The gene-cluster encoding the synthesis of the K16
capsule was cloned and sequenced from the clinical K. pneumo-
niae isolate 3091, and an isogenic non-capsulated mutant was
constructed. The wildtype and mutant were tagged chromoso-
mally with ﬂuorescent markers and grown in continuous ﬂow-
cell systems to characterize their bioﬁlm formation using
confocal laser scanning microscopy.
Results: The wildtype stain was found to form thick irregularly
shaped bioﬁlms. The bioﬁlms mainly consisted of loose clusters
of bacteria, up to 40 lm thick. Although the bioﬁlm covered
most of the substratum, open areas were also present within and
between the bacterial clusters. The non-capsulated mutant was
also able to form bioﬁlms; however the architecture differed
from that of the wildtype. The non-capsulated mutant spread as
a conﬂuent thin layer of cells covering the substratum. The vast
majority of the bioﬁlm was less than 5 lm thick, and only
occasionally thicker bacterial clusters resembling the wildtype
bioﬁlm phenotype were observed.
Conclusions: K. pneumoniae cells are able to form thick bioﬁlms
when grown in continuous ﬂow systems. The polysaccharide
capsule was not found to be essential for bioﬁlm formation per
se but its absence signiﬁcantly affected bioﬁlm development and
architecture. Future studies may reveal the inﬂuence of capsules
on bioﬁlm resistance against host defence systems and actions of
antibiotics.
P1656
The bioﬁlm formation by Klebsiella strains
isolated from various infections on chemically
different catheters
B.M. Maczyn˜ska, D.S. Smutnicka, A.P.M. Przondo-Mordarska,
M.B. Bartoszewicz, U.K. Kasprzykowska (Wroclaw, PL)
Objectives: Klebsiella bacilli are frequently cases of nosocomial
infections associates with usage urinary (CAUTI) and intraven-
ous catheters (CR-BSI) due to its ability to bioﬁlm formation on
biomaterials. The aim of our study was the correlation between
pathogenic properties in clinical Klebsiella strains (the capsule,
the types of adhesins), the type of using biomaterials and degree
of in vitro formation the bioﬁlm structure on the catheters.
Material and Methods: The 69 clinical Klebsiella strains produ-
cing several distinct types of ﬁmbria were tested (30 isolated
from UTI, 23 from blood and 16 from other clinical samples).
Inﬂuence of capsule on ability of the bioﬁlm formation was
estimated using uncapsulated mutants and their capsulated
variants. In the investigations the urinary catheters-polyvinyl
chloride Nelaton, latex Foley, all-silicone Foley and venous
catheter-polyurethan Cavaﬁx were tested. In vitro bioﬁlm
formation was evaluated by Richard method. In this assay,
soluble colourless TTC is reduced to insoluble red formazan by
electron transfer associated with active oxidative bacterial
metabolism and is precipitated intracellulary. This assay were
validated by electron microscopy.
Results: All investigated strains showed the ability of formation
of the bioﬁlm on the catheters after 24 hours incubation. For
most of strains the value of fomazan reduction were evaluated
like as intermediate or strong. The highest level of bioﬁlm
formation showed the strains to venous catheters from poly-
urethan and urinary catheters from polyvinyl chloride. The
lowest adhesion rate was observed in case of all-silicone Foley
catheters. The capsulated strains made the bioﬁlm weaker then
the uncapsulated strains. The presence of the characteristic
bioﬁlm structure on catheters was conﬁrmed in electron
microscopy.
Conclusions: The level of adhesion in clinical Klebsiella bacilli to
biomaterials was associated with the chemical type of catheters.
The capsule absence leads in case of investigated strains to the
stronger bioﬁlm formation on the surface of biomaterials. The
various Kebsiella strains showed in electron microskopy various
structures of bioﬁlms The correlation between the type of
expressed ﬁmbria and degree of bioﬁlm formation was not
observed in this investigation.
Acknowledgments: This study was supported by the
Polish Committee of Scientiﬁc Studies (KBN Grant No 4 P05A
064 24).
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Bioﬁlm formation in uropathogenic Escherichia
coli clinical isolates
S.M. Soto, J.A. Martı´nez, A. Smithson, J.P. Horcajada, J. Mensa,
M.T. Jime´nez de Anta, J. Vila (Barcelona, E)
Objectives: Bioﬁlm is composed of surface-attached cells and
excreted exopolymeric substances. Bacterial bioﬁlm infections
are particularly problematic because sessile bacteria are more
resistant to antibiotics and host immune responses, leading to
therapeutic difﬁculties. The objective of this study was to
analyse the capacity of bioﬁlm formation of E. coli clinical
isolates causing different urinary tract infections (cystitis-CT,
pyelonephritis-PNA, and prostatitis-PT).
Methods: A total of 151 uropathogenic E. coli strains (44 from
cystitis, 75 from pyelonephritis, and 32 from prostatitis) were
analysed. Capacity of ’in vitro’ bioﬁlm formation was deter-
mined by bacterial growth in minimal glucose medium, stained
with 1% violet crystal, and washed with PBS. The cells were
dissolved with DMSO and the plate was automatically read in a
spectrophotometer. The HC-91255 strain was used as a control
strain and the experiments were made in duplicate.
Results: Bioﬁlm formation was noted in 19 (43%), 30 (40%), and
20 (63%) strains from patients with CT, PNA, and PT, respect-
ively. The ability to form bioﬁlm was signiﬁcantly more frequent
in PT than in PNA strains (p = 0.03), and showed a trend to be
signiﬁcantly more frequent than in CT strains (p = 0.09). No
differences between CT and PNA strains regarding bioﬁlm
production were noted (p = 0.7). After pooling CT and PNA
strains together, bioﬁlm formation was the only characteristic
which was signiﬁcantly associated with strains causing PT in
both univariate and multivariate analysis (OR = 2.38, 95%
CI = 1.06–5.35, p = 0.03).
Conclusions: Bioﬁlm formation is signiﬁcantly more prevalent
among strains of E. coli involved in acute prostatitis than in
those causing other urinary tract infections. Bioﬁlm formation
can be relevant in promoting persistent prostate infection; and
given the high frequency of bioﬁlm production among strains
causing acute prostatitis, the treatment of these patients should
be conducive to the eradication of microbial bioﬁlms.
P1658
Environmental maltose and glucose
concentrations regulate bioﬁlm formation in
Enterococcus faecalis
J. Huebner, A. Kropec, S. Koch, R. Creti (Freiburg, D; Boston,
USA; Rome, I)
Objectives: Bioﬁlm formation in E. faecalis seems to play an
important role in a number of enterococcal infections, but little is
know regarding the underlying mechanisms. We wanted to
identify environmental signals that regulate bioﬁlm formation in
enterococcus.
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Methods: We have recently identiﬁed a genetic locus involved
in bioﬁlm formation of E. faecalis. Bioﬁlm formation was
measured using a polystyrene plate assay and media supple-
mented with oligosaccharides. The expression of genes was
measured by real-time PCR and the locus was sequenced.
Homology was assessed using BLAST and related programmes.
Results: The genetic locus identiﬁed by us is also involved in
maltose uptake and metabolism. The expression of genes in this
locus is regulated by maltose and glucose in the growth medium
indicating that nutritional oligosaccharides may promote or
inhibit bioﬁlm formation. While the wild-type strain was able to
produce bioﬁlm in medium containing either glucose or malt-
ose, two mutants (one transposon mutant and one deletion
mutant) showed opposite effects. A transposon mutant showed
a reduced bioﬁlm formation when grown in medium containing
1% glucose while a deletion mutant produced more bioﬁlm
when grown in glucose, but was unable to form bioﬁlm when
maltose was added to the growth medium. The sugar-binding
transcriptional regulator bopD seems to bind to an operator
upstream of the bop locus and a consensus binding sequence
shown to bind to the maltose repressor MalR is present in the
non-coding region upstream of bopA.
Conclusions: The bioﬁlm-positive phenotype of the wild-type
strain seems to facilitate colonization of enterococci in the gut and
the presence of oligosaccharides in food may regulate bioﬁlm
formation and therefore colonization of enterococci in the gastro-
intestinal system.
P1659
Bioﬁlm formation and morphology of group A
streptococci isolates of patients with sepsis or
necrotising fasciitis
E. Presterl, M. Eder, S. Reichmann, R. Gattringer,
A.M. Hirschl (Vienna, A; Golm, D)
Objectives: Group A streptococci may cause severe sepsis
associated with multiorgan failure and high mortality. Addi-
tionally, they are the primary cause of necrotizing fasciitis. The
objective of this study was to evaluate the ability to form
bioﬁlms and the morphology of these bioﬁlms produced by GAS
isolated from blood of patients with sepsis and from the tissue of
patients with necrotizing fasciitis.
Methods: Twenty-six GAS isolates from blood cultures of
patients with sepsis and bacteraemia, and 26 isolates from
tissue of patients with necrotizing cellulitis and fasciitis were
collected. They were isolated and identiﬁed using routine
methods, and frozen at –73C in BHI broth with 3% glycerol.
To test their ability to form bioﬁlms, the isolates were grown in
microtiter plates in tryptone soya broth for 24 or 48 hours. To
examine the morphology of the bioﬁlm formation the isolates
were either examined unﬁxed or ﬁxed with 2% glutaraldehyd
using electrone microscope scanning (Philips XL30 ESEM). For
quantiﬁcation they were ﬁxed with 2% glutaraldehyd and dyed
with 1% crystal violet to measure the mean optical density (OD
using a routine microtiter-plate-reader at 550 nm wavelength.
To calculate differences in the frequency in the groups the
Fisher’s exact test and to calculated differences in the OD the
Mann–WhitneyU-Test were used.
Results: Seventeen out of 26 isolates from patients with sepsis
and 14 out of 26 isolates fom patients with necrotizing fasciitis
formed bioﬁlms (difference not signiﬁcant). Scanning electron
studies conﬁrmed bioﬁlm formation however it looked some-
what scarce in isolates from necrotizing fasciitis. For the bioﬁlm
forming isolates, the OD of isolates from sepsis were signiﬁ-
cantly higher than the OD of isolates from necrotizing fasciitis
(0.996 versus 0.578, p < 0.001).
Conclusions: GAS isolates from both, bloodstream and tissue,
had ability to form bioﬁlms. Bioﬁlms of blood stream isolates
were signiﬁcantly denser than bioﬁlms of the tissue isolates.
This surplus opacity of blood stream isolates was conﬁrmed by
the scanning electron microscopy studies which revealed a more
scanty looking morphology of the tissue GAS isolates. The lesser
density of the bioﬁlms of GAS isolated from the tissue might be
important for the pathogenesis of necrotizing fascitiis probably
facilitating to the rapid spread of the bacteria within the tissue.
P1660
Inhibition of Candida growth and bioﬁlm
formation on polyurethanes by ﬂuconazole
adsorption
G. Donelli, I. Francolini, V. Ruggeri, E. Guaglianone,
A. Piozzi (Rome, I)
Objectives: Recent attempts to prevent device-related infec-
tions included several strategies among which catheter coating
with antibiotics resulted to be one of the most promising.
However, so far only sporadic studies were designed to prevent
fungal colonization of devices presumably because of the only
recently described ability of Candida species to form bioﬁlms. In
this study we report in vitro experiments on the efﬁcacy of
coating of newly synthesized polyurethanes with the antifungal
drug ﬂuconazole in preventing polymer colonization and
bioﬁlm formation by Candida albicans.
Methods: Polymers used in this study are three synthesized
urethane polymers having different functional groups in the
side-chain: hydroxyl groups, primary amino groups and tertiary
amino groups. Fluconazole was adsorbed on round shaped
disks made of the above described polyurethanes. The kinetics
of ﬂuconazole release from polymers, either containing or not
albumin as pore forming agent, was studied by keeping
ﬂuconazole-loaded polymeric disks in water for increasing
times up to 8 days. The antifungal activity of polymers was
studied by the Kirby–Bauer test and scanning electron micros-
copy.
Results: Among the tested polymers, the most hydrophilic ones
were able to adsorb higher drug amounts by establishing
‘hydrogen bond’ and ‘van der Waals’ interactions. The kinetics
of ﬂuconazole release from polymers was inﬂuenced by the
degree of polymer swelling in water and resulted signiﬁcantly
improved by the albumin incorporation in polyurethanes which
increased polymer porosity. In our best experimental in vitro
model consisting of an hydrophilic polymeric disk (average
weight 250 mg) impregnated with 62.5 mg albumin and 62.5 mg
ﬂuconazole, the Candida albicans growth was inhibited, as
evidenced by the Kirby–Bauer test, and bioﬁlm formation on
polymeric surface was not observed up to 8 days, as evidenced
by scanning electron microscopy.
Conclusion: Overall, data obtained from our newly synthesized
functionalized polyurethanes, treated with albumin and loaded
with ﬂuconazole, seem to be very promising in the perspective
to develop medical devices refractory to Candida colonization.
P1661
In vitro activity of caspofungin against Candida
bioﬁlms
C. Cocuaud, M.-H. Rodier, G. Daniault, C. Imbert (Poitiers, F)
Candidiasis can be associated with the formation of bioﬁlms on
bioprosthetic surfaces and the intrinsic resistance of Candida
albicans bioﬁlms to the most commonly used antifungal agents
has been demonstrated.
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Objectives: In this study, we report on the antifungal activity
of two concentrations of caspofungin on C. albicans and
C. parapsilosis bioﬁlms with different ages of maturation.
Methods: Fifteen strains of C. albicans (ten strains were sus-
ceptible to ﬂuconazole in vitro and ﬁve strains were resistant to
this antifungal agent) and six strains of C. parapsilosis (all were
susceptible to ﬂuconazole in vitro) were studied. The antifungal
activity of caspofungin was assessed by looking for a signiﬁcant
inhibition of the metabolic activity of yeasts included in bioﬁlms,
after the antifungal treatment. Bioﬁlms were obtained in vitro,
on silicone catheters.
Results: Caspofungin used at MIC did not modify the meta-
bolic activity of yeasts, whatever the Candida species and the
maturation age of bioﬁlms. The use of a therapeutic concentra-
tion of caspofungin (2 mg/L) induced a signiﬁcant decrease in
the metabolism of the all tested strains of C. albicans and C.
parapsilosis, independently of the maturation age of bioﬁlms.
This high antifungal potency of caspofungin on C. albicans
bioﬁlms was observed independently of the susceptibility of
yeasts to ﬂuconazole.
Conclusion: This study demonstrated that caspofungin used at
MIC was not efﬁcient to reduce Candida bioﬁlms but it suggested
that caspofungin used at 2 mg/L could represent a good
Candidate in the prevention of candidiasis associated with
silicone medical devices. Our results also suggested that
ﬂuconazole resistance of yeasts did not modify caspofungin
activity.
P1662
Effect of short-time desiccation on bioﬁlm-
associated bacteria
I. Turetgen, E.I. Sungur, A. Cotuk (Istanbul, TR)
Objectives: Microorganisms tend to form bioﬁlms consisting of
cells embedded in a highly hydrated, extracellular polymeric
matrix. Bioﬁlms may be responsible for a wide variety of
nosocomial infections. Sources of bioﬁlm-related infections can
include the surfaces of catheters, medical implants, dental unit
water lines or other types of devices, as well as cooling towers,
shower heads. The bioﬁlm protects its inhabitants from antimi-
crobial agents, pH alterations, and confers protection against
desiccation. It is possible to encounter desiccation in natural or
man-made environments through evaporation, ﬂowing-off or
system shutdown. However bioﬁlm-associated bacteria can
survive for a while in the absence of water within systems. In
this study the survival of heterotrophic bacteria, sulphate
reducing bacteria (SRB) and amoeba were evaluated against
short time desiccation.
Methods: Bioﬁlms were allowed to grow for 30 and 60 days on
stainless steel coupons. For the desiccation experiment, coupons
were taken out from the reactor and left air-dried. Desiccated
cells were rehydrated in 10 ml of sterile phosphate buffer after 6,
24, 48, 72, 96, 168 hours and bioﬁlm were removed from
coupons. For enumeration of heterotrophic bacterial count,
samples are plated on R2A agar for 10 days at 27C. Postgate
medium B was used for SRB cultures. For amoeba isolation
bioﬁlm homogenates were spread on non-nutrient agar plate
overlaid with Eschericha coli.
Results: After 72 h of desiccation of 30 d old bioﬁlm, SRB
growth was seen while no heterotrophic bacterial growth was
observed. Whereas on 60 d old bioﬁlm, heterotrophic bacterial
growth was observed after 96 h, however SRB growth was seen
after 168 h. No signiﬁcant differences were found between zero
time and 24 h counts regarding heterotrophic bacteria.
Discussion: Heterotrophic bacteria are located at the bioﬁlm-
water interface; whereas anaerobic bacteria niched in the deeper
layers of the bioﬁlm. The ability of some pathogenic bacteria to
survive within the cysts of amoebas is suggested as a possible
mechanism by which the organism evades disinfection and
spreads to colonize new environments. Bacterial resistance to
desiccation has been reported frequently, but the maximal
tolerance of microorganisms in the air-dried state is still
unknown. The study showed that diurnal absence of water
could not affect bioﬁlm-associated microorganisms signiﬁcantly.
P1663
Effects of food preservatives on oral streptococci
bioﬁlm generated in a bioﬁlm reactor
A. Al-Ahmad, T.M. Auschill, K. Kobberstad, G. Braun,
M. Sendic, E. Hellwig, N.B. Arweiler (Freiburg, D)
Objectives: The aim of this laboratory study was to evaluate the
inﬂuence of the preservatives sodium benzoate, potassium
sorbate and sodium nitrite on mixed species bioﬁlms generated
by oral streptococci.
Methods: A modiﬁed bioﬁlm reactor (Bio Surfaces Technol-
ogies, Corp., Bozeman, USA) was used to build up a bioﬁlm on
bovine enamel slabs (BES). A mixture of six oral streptococci
(S. mutans, S. mitis, S. oralis, S. sanguis, S. salivarius and
S. sobrinus) was investigated to generate bioﬁlms over a period
of four days.Eight slabs each (with the adhering bioﬁlms) were
treated with one of the following solutions for one minute: a)
Saline (0.9%, negative control), b) 0.2% chlorhexidine digluco-
nate (CHX, positive control), c) 0.1% sodium benzoate (SB), d)
0.1% potassium sorbate (PS) and e) 0.06 sodium nitrite (SN).
After treatment four slabs each were washed in saline and a
vital-dead staining was conducted on the adhering bioﬁlms. The
slabs were then analysed in situ for bioﬁlm thickness and
vitality using confocal laser scanning microscopy (CLSM).From
the other four slabs bioﬁlms were dispersed in saline and the
colony forming units (CFUs) on Columbia blood agar as well as
total bacterial counts using DAPI-staining were determined.
Results: The bioﬁlm thickness of the different tested BES was
between 12.3 and 35.8 lm in average. The vitality of the negative
control was determined to be 86.14 ± 4.6% and 37.27 ± 8.11% for
positive control. For sodium benzoate and potassium sorbate a
vitality of 74.39 ± 8.08% and 71.11 ± 6.93% was measured,
respectively. The treatment with sodium nitrite led to a vitality
of 66.73 ± 6.36%.The mean log10 CFUs of untreated bioﬁlm was
determined to be 7.83 ± 0.14 and 7.28 ± 0.33 for the bioﬁlm
treated with CHX. After treatment with SB and PS the mean
log10 CFUs was 7.20 ± 0.20 and 6.98 ± 0.24, respectively. For
bioﬁlm treated with SN a mean log10 CFUs was determined to
be 7.12 ± 0.40. The plating efﬁciency was determined as fol-
lowed: 56.16 ± 8.78 for the negative control, 24.97 ± 13.30 for the
positive control, 22.89 ± 11.71 for SB treated bioﬁlm,
22.82 ± 13.19 for PS treated bioﬁlm and 19.06 ± 10.81 for SN
treated bioﬁlm.
Conclusions: Our results indicate that legal concentrations of
the tested preservatives may have antibacterial effects on oral
streptococci. An anti-cariogenic inﬂuence of food preservatives
can be suggested and should be conﬁrmed in in situ studies
using intraoral bioﬁlms.
P1664
Dynamics of bioﬁlm formation as a function of
temperature and nutrition
V. Hola, F. Ruzicka, M. Votava (Brno, CZ)
Chronic infections caused by bioﬁlm-forming staphylococci rep-
resent serious medical problem. Their higher prevalence now-
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adays is associated with more frequent use of artiﬁcial implants
and medical devices. Surface of these implants facilitates
adhesion of bacteria, which than form bioﬁlm. The knowledge
of bioﬁlm formation dynamics is fundamental for the under-
standing of processes running in the bioﬁlm layer. The aim of
this study was to determine with mathematical models the
differences in bioﬁlm formation in different conditions and to
determine the minimum time and conditions necessary for the
development of the homogenous and matured bioﬁlm layer
suitable for the antibiotic testing. The Staphylococcus epidermidis
bioﬁlm-positive strains were used in this study. As the positive
control, strain CCM 7221 was used. The bioﬁlm was grown on
tissue culture microtiter plates. The strains were cultivated in
different concentrations of glucose and at different tempera-
tures. Each strain was cultivated simultaneously in 4 wells. In
the ﬁrst 48 hrs the data were collected every hour, than up to
96 hrs every 6 hrs. After cultivation the wells of microtiter plates
were stained with crystal violet and the bioﬁlm formation was
assessed spectrophotometrically. Data were processed with the
Multiple Analysis of Covariance (MANCOVA) and mathemat-
ical models were evaluated with Regression Analysis. For the
image analysis and visualisation of the bioﬁlm in different
stages of formation, speciﬁc dyes (alcian blue, acridin orange,
Rylux etc.) were also used. All tested strains showed better
growth of the bioﬁlm at the temperature of 37C in the nutrient-
richer environment. The model can be simply described as
follows: the ﬁrst signs of bacterial adhesion were visible after
2–4 hrs of cultivation, the ﬁrst homogenous but a very thin layer
was visible after 5 hrs, after 7 hrs the bioﬁlm layer was cca
3-times thicker. After 10 hrs the bioﬁlm layer seemed to be
mature–the changes in the thickness were not so evident after
this time. After the cultivation longer than 34–42 hrs the parts of
the bioﬁlm layer started to detach, so the bioﬁlm became
unhomogenous. In the regression modelling, other nutrient and
temperature conditions showed also different inﬂuence on the
formation of bioﬁlm. For the antibiotic testing, the bioﬁlm
cultivation for 12 hrs should be sufﬁcient.The study was
supported by the grants IGA MZ 7980-3 and FRVS 0448-2004.
P1665
Electron microscopic, bacteriological and clinical
studies of biliary stent blockage
A. Yosry, H. Yehia, M. Diab, H. El-Khayat, A. Negm (Cairo,
Giza, EGY)
Objective: Biliary stenting is a common treatment for the
palliation of malignant obstructive jaundice. However, stent
occlusion due to sludge adhesion remains an important clinical
problem. For more understanding of the mechanism of such
occlusion, the present work dealt with studying the bacterio-
logical characteristics of bile samples.
Methods: Taken from 40 patients with extra hepatic cholestasis
before biliary decompression(group1). Also,bile samples and
sludge material from13 patients presenting with recurrent
jaundice due to late stent blockage (group2), were processed
for microbiological and transmission electron microscopic study
(TEM). Bacteriological analysis included isolation and identiﬁ-
cation of various bacterial species as well as detection of B-
glucouronidase and several esterase activities (19enzymes)of the
isolated species.
Results: Bacteriological analysis disclosed a wider prevalence
of monomicrobial Gram negative isolated (80.7%) than Gram
positive isolates (19.3%) among patients of group1. The TEM
examination of sludge material (group2) revealed the presence
of clusters of Gram negative bacteria embedded in an amor-
phous matrix. The visualized microcolonies of bacterial growth
were conﬁned to the same morophotype for each case. Bacterio-
logical analysis conﬁrmed the TEM results and showed that the
most frequent isolated species were Escherichia coli(E.coli)
(41.6%), Samonella arizona (S. arizona) (25%) Klebsiella species
(16.6%) and Enterobocter(8.3%) Although S. arizona isolated from
blockage stents were the most abundant producers (14 out of 19)
and they elaborated 4 out of 5 such enzymes, yet they recorded
the longest patency duration among the blocked tudied stents.
By TEM it was noticed that the bioﬁlm matrix changed
according to the type of bacteria detected. The bioﬁlm matrix
in S. arizona cases was shown to be fenestrated. It looked thick
and more etectron dense when compared to the matrix of E. coli
cases. The latter showed a clealr thin matrix, more electron
lucent and detected ﬁbres were mostly thin.
Conclusion: The present work conﬁrms the pivotal role of
Gram negative bacteria in stent blockage therefore antibiotics
against Gram negative bacteria are mandatory 24 hours before
endoscopic retrogade cholangiopancreatography (ERCP). Also,
the current study highlights the relation between the type of
microorganism and the morphology of the formed bioﬁlm
matrix which may be an important underlying factor in stent
blockage and its duration of patency.
P1666
Lethal bioﬁlm formation in a biliary stent
H. Krogh Johansen, N. Høiby (Copenhagen, DK)
Objective: Medical implants are widely used in a variety of
clinical treatments, but they frequently become colonised by
opportunistic bacteria, which form bioﬁlm on the device surface.
We describe this medical problem in a 57-yr old alcoholic man
who had a biliary stent inserted because of intra- and extrahe-
patic bile stasis, probably caused by a cystic process in the
pancreatic head that blocked the ﬂow.
Methods: A 7 cm long teﬂon coated polyurethane biliary stent
was inserted endoscopically in the common bile duct. Antibiotic
prophylaxis or treatment was not used and the patient was
discharged in healthy condition after 5 days.
Results: Two weeks after insertion of the biliary stent the
patient was readmitted with sepsis, severe abdominal pain and
increasing liver enzymes. Ultrasound scan revealed intrahepatic
bile stasis, a large inﬂamed abscess in the pancreatic head, a
ﬁstula between the abscess and the common bile duct and
blockage of the lumen of the stent. The stent was replaced by
two 10 cm long stents. The patient was treated with ampicillin,
metronidazole and gentamicin for only 3 days. Ampicillin
susceptible E. coli were cultured from the blood. After 5 days
the patient was discharged in healthy condition. Three weeks
after the second stents were inserted the patient was admitted
emergently with septic shock and treated with ceftriaxone,
netilmicin and metronidazole. After 12 hours of intensive
treatment the patient died. E. coli and K. oxytoca were cultured
from the blood, pancreas, and the stents. Pulsed-ﬁeld-gel-
electrophoresis was performed and the E. coli cultured during
the two septic episodes had the same pattern. This indicates that
the bacteria escaped the brief antibiotic treatment probably
because of bioﬁlm formation.
Conclusions: This case underlines the need for antibiotic
prophylaxis when bile stents are inserted into infected areas
and continuous antibiotic therapy when patients with a medical
implant experience a septic episode.
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